Name	Gene.s.	Protein.change	Condition.ref	Condition.s.	Clinical.significance..Last.reviewed.	Review.status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID.s.	dbSNP.ID	Canonical.SPDI	ref	alt	label
NM_007375.3(TARDBP):c.883G>A (p.Gly295Ser)	TARDBP		Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Jun 30, 2021)	no assertion criteria provided	VCV000021485	1	11082349	1	11022292	21485	34337	rs80356723	NC_000001.11:11022291:G:A	G	A	CLINICAL
NM_007375.3(TARDBP):c.892G>A (p.Gly298Ser)	TARDBP		Normal	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000005232	1	11082358	1	11022301	5232	20271	rs4884357	NC_000001.11:11022300:G:A	G	A	CLINICAL
NM_007375.3(TARDBP):c.943G>A (p.Ala315Thr)	TARDBP		Normal	Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia	Pathogenic(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005236	1	11082409	1	11022352	5236	20275	rs80356726	NC_000001.11:11022351:G:A	G	A	CLINICAL
NM_007375.3(TARDBP):c.991C>A (p.Gln331Lys)	TARDBP	Q331K	Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 21, 2008)	no assertion criteria provided	VCV000005229	1	11082457	1	11022400	5229	20268	rs80356727	NC_000001.11:11022399:C:A	C	A	CLINICAL
NM_007375.3(TARDBP):c.1035C>A (p.Asn345Lys)	TARDBP	N345K	Normal	Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000021467	1	11082501	1	11022444	21467	34319	rs80356732	NC_000001.11:11022443:C:A	C	A	CLINICAL
NM_007375.3(TARDBP):c.1144G>A (p.Ala382Thr)	TARDBP		Normal	FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|not provided|Amyotrophic lateral sclerosis type 10	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021474	1	11082610	1	11022553	21474	34326	rs367543041	NC_000001.11:11022552:G:A	G	A	CLINICAL
NM_206933.4(USH2A):c.4645C>T (p.Arg1549Ter)	USH2A	R1549*	Normal	Usher syndrome, type 2A|Rare genetic deafness|not provided|Usher syndrome, type 2A|Retinitis pigmentosa 39	Pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504513	1	216270538	1	216097196	504513	496156	rs199679165	NC_000001.11:216097195:G:A	G	A	CLINICAL
NM_000447.3(PSEN2):c.717G>A (p.Met239Ile)	PSEN2	M239I	Normal	Alzheimer disease, type 4|not provided	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000008850	1	227076680	1	226888979	8850	23889	rs63749884	NC_000001.11:226888978:G:A	G	A	CLINICAL
NM_001042681.2(RERE):c.4304A>T (p.His1435Leu)	RERE	H1435L, H881L	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart|not provided	Likely pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000452391	1	8418291	1	8358231	452391	442892	rs1553154130	NC_000001.11:8358230:T:A	T	A	CLINICAL
NM_001042681.2(RERE):c.4303C>T (p.His1435Tyr)	RERE	H1435Y, H881Y	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562005	1	8418292	1	8358232	562005	553145	rs1557582259	NC_000001.11:8358231:G:A	G	A	CLINICAL
NM_001042681.2(RERE):c.3146C>T (p.Pro1049Leu)	RERE	P1049L, P495L	Normal	not provided|Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000235329	1	8420421	1	8360361	235329	237016	rs878853011	NC_000001.11:8360360:G:A	G	A	CLINICAL
NM_022787.4(NMNAT1):c.25G>A (p.Val9Met)	NMNAT1	V9M	Normal	Leber congenital amaurosis 9	Pathogenic(Last reviewed: Sep 1, 2012)	no assertion criteria provided	VCV000037140	1	10032156	1	9972098	37140	45801	rs387907294	NC_000001.11:9972097:G:A	G	A	CLINICAL
NM_001371928.1(AHDC1):c.2365C>T (p.Arg789Ter)	AHDC1	R789*	Normal	Xia-Gibbs syndrome|not provided	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000827795	1	27876262	1	27549751	827795	815977	rs1571235473	NC_000001.11:27549750:G:A	G	A	CLINICAL
NM_015100.4(POGZ):c.3022C>T (p.Arg1008Ter)	POGZ	R1008*, R999*, R946*, R913*, R955*	Normal	not provided	Pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000426598	1	151378489	1	151406013	426598	414728	rs1085307702	NC_000001.11:151406012:G:A	G	A	CLINICAL
NM_002016.1(FLG):c.1501C>T (p.Arg501Ter)	FLG	R501*	Normal	Eczema|Dermatitis, atopic, 2|Ichthyosis vulgaris|Dermatitis, atopic|Ichthyosis vulgaris|Dermatitis, atopic, 2|Dermatitis, atopic, 2, susceptibility to|not provided|FLG-related disorders|Ichthyosis vulgaris	Pathogenic/Likely pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016319	1	152285861	1	152313385	16319	31358	rs61816761	NC_000001.11:152313384:G:A	G	A	CLINICAL
NM_018489.3(ASH1L):c.6427G>T (p.Glu2143Ter)	ASH1L	E2143*, E2148*	Normal	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446516	1	155340680	1	155370889	446516	440034	rs1553247374	NC_000001.11:155370888:C:A	C	A	CLINICAL
NM_019026.6(TMCO1):c.463C>T (p.Arg155Ter)	TMCO1	R206*, R172*, R143*	Normal	Global developmental delay|Autistic disorder of childhood onset|Scoliosis|Rib fusion|Strabismus|Cleft palate|Pulmonic stenosis (disease)|Sensorineural hearing loss|Bilateral cleft palate|Severe visual impairment|Relative macrocephaly|Hemivertebrae|Bilateral cleft lip|Unilateral renal agenesis|Bilateral cleft lip and palate|Cryptorchidism|Abnormality of the sternum|Renal agenesis|Delayed speech and language development|Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000598963	1	165712409	1	165743172	598963	590035	rs765379963	NC_000001.11:165743171:G:A	G	A	CLINICAL
NM_019026.4(TMCO1):c.412C>T (p.Arg138Ter)	TMCO1	R138*, R75*, R104*	Normal	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000088739	1	165721403	1	165752166	88739	94316	rs201213306	NC_000001.11:165752165:G:A	G	A	CLINICAL
NM_014408.5(TRAPPC3):c.184C>T (p.Arg62Trp)	TRAPPC3	R70W, R16W, R62W	Normal	Bardet-Biedl syndrome	Likely pathogenic	no assertion criteria provided	VCV000266073	1	36605377	1	36139776	266073	260897	rs751375244	NC_000001.11:36139775:G:A	G	A	CLINICAL
NM_004550.4(NDUFS2):c.268G>A (p.Ala90Thr)	NDUFS2	A90T	Normal	Leber hereditary optic neuropathy	Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000522715	1	161176262	1	161206472	522715	513236	rs1553249704	NC_000001.11:161206471:G:A	G	A	CLINICAL
NM_006996.3(SLC19A2):c.484C>T (p.Arg162Ter)	SLC19A2	R162*	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005955	1	169446716	1	169477478	5955	20994	rs74315373	NC_000001.11:169477477:G:A	G	A	CLINICAL
NM_145277.5(HJV):c.-180A>T	HJV	R54*	Normal	Hemochromatosis type 2A	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000002373	1	145415341	1	146019672	2373	17412	rs121434375	NC_000001.11:146019671:T:A	T	A	CLINICAL
NM_213653.3(HJV):c.1006G>T (p.Gly336Ter)	HJV	G336*, G223*, G110*	Normal	Hemochromatosis type 2A	Pathogenic(Last reviewed: Jun 6, 2018)	no assertion criteria provided	VCV000560162	1	145416661	1	146018352	560162	550878	rs1553769428	NC_000001.11:146018351:C:A	C	A	CLINICAL
NM_006996.3(SLC19A2):c.152C>T (p.Pro51Leu)	SLC19A2	P51L	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Mar 15, 2004)	no assertion criteria provided	VCV000005964	1	169454853	1	169485615	5964	21003	rs121908540	NC_000001.11:169485614:G:A	G	A	CLINICAL
NM_213653.3(HJV):c.959G>T (p.Gly320Val)	HJV	G320V, G207V, G94V	Normal	Hemochromatosis type 2A|Hemochromatosis type 1|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002365	1	145416614	1	146018399	2365	17404	rs74315323	NC_000001.11:146018398:C:A	C	A	CLINICAL
NM_004958.4(MTOR):c.5930C>T (p.Thr1977Ile)	MTOR	T1977I	Normal	not provided|CEBALID syndrome|Focal cortical dysplasia type II|MTOR-related megalencephaly and pigmentary mosaicism in skin	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584432	1	11188164	1	11128107	584432	575484	rs587777893	NC_000001.11:11128106:G:A	G	A	CLINICAL
NM_006996.3(SLC19A2):c.428C>T (p.Ser143Phe)	SLC19A2	S143F	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Sep 3, 2013)	no assertion criteria provided	VCV000492806	1	169446772	1	169477534	492806	485691	rs761957186	NC_000001.11:169477533:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1622G>A (p.Arg541His)	LMNA	R541H, R429H, R460H	Normal	Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Dilated cardiomyopathy 1A	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066860	1	156107458	1	156137667	66860	77757	rs61444459	NC_000001.11:156137666:G:A	G	A	CLINICAL
NM_001029882.3(AHDC1):c.2773C>T (p.Arg925Ter)	AHDC1	R925*	Normal	not provided|Xia-Gibbs syndrome|Abdominal obesity-metabolic syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000496678	1	27875854	1	27549343	496678	488150	rs777736953	NC_000001.11:27549342:G:A	G	A	CLINICAL
NM_001368809.2(AMPD2):c.1457G>A (p.Arg486Gln)	AMPD2	R486Q, R459Q, R465Q, R422Q	Normal	Brain malformation|Seizures|Global developmental delay	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183289	1	110171314	1	109628692	183289	181397	rs192669225	NC_000001.11:109628691:G:A	G	A	CLINICAL
NM_001010898.4(SLC6A17):c.484G>A (p.Gly162Arg)	SLC6A17	G162R	Normal	Mental retardation, autosomal recessive 48	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000187769	1	110716634	1	110174012	187769	185667	rs775085213	NC_000001.11:110174011:G:A	G	A	CLINICAL
NM_004958.4(MTOR):c.4448G>T (p.Cys1483Phe)	MTOR	C1483F	Normal	Glioblastoma|Smith-Kingsmore syndrome|Breast neoplasm|not provided|Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000190121	1	11217230	1	11157173	190121	187953	rs786205165	NC_000001.11:11157172:C:A	C	A	CLINICAL
NM_004980.4(KCND3):c.1123C>T (p.Pro375Ser)	KCND3	P375S	Normal	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000626318	1	112329712	1	111787090	626318	614649	rs1571636508	NC_000001.11:111787089:G:A	G	A	CLINICAL
NM_004980.4(KCND3):c.1076G>T (p.Trp359Leu)	KCND3	W359L	Normal	Intellectual disability|Seizures	Likely pathogenic	criteria provided, single submitter	VCV000816626	1	112524273	1	111981651	816626	804831	rs1571939623	NC_000001.11:111981650:C:A	C	A	CLINICAL
NM_020699.4(GATAD2B):c.1537C>T (p.Gln513Ter)	GATAD2B	Q513*	Normal	Mental retardation, autosomal dominant 18	Likely pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000545450	1	153784318	1	153811842	545450	535694	rs1553187362	NC_000001.11:153811841:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.1432C>T (p.Arg478Ter)	GATAD2B	R478*	Normal	not provided|Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265610	1	153784596	1	153812120	265610	259631	rs761820222	NC_000001.11:153812119:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.1429C>T (p.Gln477Ter)	GATAD2B	Q477*	Normal	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, single submitter	VCV000435288	1	153784599	1	153812123	435288	427639	rs1553187443	NC_000001.11:153812122:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.1426G>T (p.Glu476Ter)	GATAD2B	E476*	Normal	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 29, 2017)	criteria provided, single submitter	VCV000448968	1	153784602	1	153812126	448968	442546	rs1553187446	NC_000001.11:153812125:C:A	C	A	CLINICAL
NM_020699.4(GATAD2B):c.1408C>T (p.Gln470Ter)	GATAD2B	Q470*	Normal	Mental retardation, autosomal dominant 18|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000039665	1	153785737	1	153813261	39665	48264	rs587776931	NC_000001.11:153813260:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.1075C>T (p.Gln359Ter)	GATAD2B	Q359*	Normal	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000584436	1	153788890	1	153816414	584436	575485	rs1557781252	NC_000001.11:153816413:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.709C>T (p.Gln237Ter)	GATAD2B	Q237*	Normal	not provided|Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000432992	1	153790536	1	153818060	432992	425312	rs1553188314	NC_000001.11:153818059:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.694C>T (p.Gln232Ter)	GATAD2B	Q232*	Normal	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: Apr 30, 2014)	no assertion criteria provided	VCV000374387	1	153790551	1	153818075	374387	361157	rs1057518674	NC_000001.11:153818074:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.574C>T (p.Gln192Ter)	GATAD2B	Q192*	Normal	Mental retardation, autosomal dominant 18	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801547	1	153791290	1	153818814	801547	789845	rs1570929904	NC_000001.11:153818813:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.535C>T (p.Arg179Ter)	GATAD2B	R179*	Normal	Intellectual disability|Mental retardation, autosomal dominant 18|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000435290	1	153791329	1	153818853	435290	427641	rs1553188463	NC_000001.11:153818852:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.346C>T (p.Arg116Ter)	GATAD2B	R116*	Normal	GATAD2B-Related Disorder|Mental retardation, autosomal dominant 18|not provided|GATAD2B-related intellectual disability syndrome	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280408	1	153792201	1	153819725	280408	263969	rs886041621	NC_000001.11:153819724:G:A	G	A	CLINICAL
NM_020699.4(GATAD2B):c.91C>T (p.Arg31Ter)	GATAD2B	R31*	Normal	Mental retardation, autosomal dominant 18	Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000816673	1	153800733	1	153828257	816673	804861	rs1570938113	NC_000001.11:153828256:G:A	G	A	CLINICAL
NM_018489.3(ASH1L):c.6427G>T (p.Glu2143Ter)	ASH1L	E2143*, E2148*	Normal	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446516	1	155340680	1	155370889	446516	440034	rs1553247374	NC_000001.11:155370888:C:A	C	A	CLINICAL
NM_018489.3(ASH1L):c.2170G>T (p.Ala724Ser)	ASH1L	A724S	Normal	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000446511	1	155450491	1	155480700	446511	440029	rs1293246328	NC_000001.11:155480699:C:A	C	A	CLINICAL
NM_170707.4(LMNA):c.433G>A (p.Glu145Lys)	LMNA	E145K, E33K, E64K	Normal	not provided|Hutchinson-Gilford progeria syndrome, atypical|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000014502	1	156100484	1	156130693	14502	29541	rs60310264	NC_000001.11:156130692:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.667G>A (p.Glu223Lys)	LMNA	E223K, E142K, E111K	Normal	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162409	1	156104623	1	156134832	162409	172110	rs797044485	NC_000001.11:156134831:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1380+1G>A	LMNA		Normal	Charcot-Marie-Tooth disease type 2B1|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Mandibuloacral dysplasia with type A lipodystrophy|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066817	1	156106228	1	156136437	66817	77714	rs267607552	NC_000001.11:156136436:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys)	LMNA	T528K, T416K, T447K	Normal	Hutchinson-Gilford syndrome|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066849	1	156106998	1	156137207	66849	77746	rs57629361	NC_000001.11:156137206:C:A	C	A	CLINICAL
NM_170707.4(LMNA):c.1771T>A (p.Cys591Ser)	LMNA	C561S, C591S, C479S	Normal	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162411	1	156108351	1	156138560	162411	172112	rs797044486	NC_000001.11:156138559:T:A	T	A	CLINICAL
NM_170707.4(LMNA):c.1821G>A (p.Val607=)	LMNA		Normal	not provided|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000014516	1	156108401	1	156138610	14516	29555	rs59886214	NC_000001.11:156138609:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1822G>A (p.Gly608Ser)	LMNA	G608S, G578S, G496S	Normal	not provided|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000014501	1	156108402	1	156138611	14501	29540	rs61064130	NC_000001.11:156138610:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1968G>A (p.Gln656=)	LMNA		Normal	Hutchinson-Gilford syndrome|Hutchinson-Gilford progeria syndrome, atypical	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000162412	1	156108548	1	156138757	162412	172113	rs797044487	NC_000001.11:156138756:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1968+1G>A	LMNA		Normal	not provided|Hutchinson-Gilford syndrome|Lethal tight skin contracture syndrome	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000066879	1	156108549	1	156138758	66879	77776	rs113436208	NC_000001.11:156138757:G:A	G	A	CLINICAL
NM_170707.4(LMNA):c.1968+2T>A	LMNA		Normal	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162414	1	156108550	1	156138759	162414	172115	rs113860699	NC_000001.11:156138758:T:A	T	A	CLINICAL
NM_170707.4(LMNA):c.1968+5G>A	LMNA		Normal	Hutchinson-Gilford progeria syndrome, atypical|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Aug 1, 2015)	no assertion criteria provided	VCV000162417	1	156108553	1	156138762	162417	172117	rs797044488	NC_000001.11:156138761:G:A	G	A	CLINICAL
NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys)	KCNJ10	R297C	Normal	not provided|EAST syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007467	1	160011434	1	160041644	7467	22506	rs137853071	NC_000001.11:160041643:G:A	G	A	CLINICAL
NM_002241.5(KCNJ10):c.595C>T (p.Arg199Ter)	KCNJ10	R199*	Normal	EAST syndrome	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV000007463	1	160011728	1	160041938	7463	22502	rs137853067	NC_000001.11:160041937:G:A	G	A	CLINICAL
NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val)	KCNJ10	A167V	Normal	EAST syndrome|Pendred syndrome|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|EAST syndrome	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, single submitter	VCV000007466	1	160011823	1	160042033	7466	22505	rs137853070	NC_000001.11:160042032:G:A	G	A	CLINICAL
NM_002241.5(KCNJ10):c.491C>T (p.Thr164Ile)	KCNJ10	T164I	Normal	EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007465	1	160011832	1	160042042	7465	22504	rs137853069	NC_000001.11:160042041:G:A	G	A	CLINICAL
NM_002241.5(KCNJ10):c.193C>T (p.Arg65Cys)	KCNJ10	R65C	Normal	EAST syndrome	Likely pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000030251	1	160012130	1	160042340	30251	39207	rs387906834	NC_000001.11:160042339:G:A	G	A	CLINICAL
NM_001122764.3(PPOX):c.503G>A (p.Arg168His)	PPOX	R168H, R135H, R32H, R6H	Normal	not provided|Variegate porphyria	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008697	1	161138253	1	161168463	8697	23736	rs41270025	NC_000001.11:161168462:G:A	G	A	CLINICAL
NM_019026.6(TMCO1):c.463C>T (p.Arg155Ter)	TMCO1	R206*, R172*, R143*	Normal	Global developmental delay|Autistic disorder of childhood onset|Scoliosis|Rib fusion|Strabismus|Cleft palate|Pulmonic stenosis (disease)|Sensorineural hearing loss|Bilateral cleft palate|Severe visual impairment|Relative macrocephaly|Hemivertebrae|Bilateral cleft lip|Unilateral renal agenesis|Bilateral cleft lip and palate|Cryptorchidism|Abnormality of the sternum|Renal agenesis|Delayed speech and language development|Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000598963	1	165712409	1	165743172	598963	590035	rs765379963	NC_000001.11:165743171:G:A	G	A	CLINICAL
NM_019026.4(TMCO1):c.412C>T (p.Arg138Ter)	TMCO1	R138*, R75*, R104*	Normal	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000088739	1	165721403	1	165752166	88739	94316	rs201213306	NC_000001.11:165752165:G:A	G	A	CLINICAL
NM_018122.5(DARS2):c.228-22T>A	DARS2		Normal	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000030862	1	173797449	1	173828311	30862	39819	rs1557853625	NC_000001.11:173828310:T:A	T	A	CLINICAL
NM_002074.5(GNB1):c.352G>T (p.Asp118Tyr)	GNB1	D118Y, D18Y	Normal	not provided|Behavioral abnormality|Dystonia|Mental retardation, autosomal dominant 42	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2020)	no assertion criteria provided	VCV000812755	1	1735936	1	1804497	812755	800980	rs1570640673	NC_000001.11:1804496:C:A	C	A	CLINICAL
NM_018136.5(ASPM):c.2938C>T (p.Arg980Ter)	ASPM	R980*	Normal	Primary autosomal recessive microcephaly 1|Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000021569	1	197094320	1	197125190	21569	34421	rs199422151	NC_000001.11:197125189:G:A	G	A	CLINICAL
NM_018136.5(ASPM):c.2389C>T (p.Arg797Ter)	ASPM	R797*	Normal	Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000004965	1	197102510	1	197133380	4965	20004	rs145489194	NC_000001.11:197133379:G:A	G	A	CLINICAL
NM_006618.5(KDM5B):c.895C>T (p.Arg299Ter)	KDM5B	R299*, R335*, R254*	Normal	Intellectual disability, autosomal recessive 65	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000626239	1	202731850	1	202762722	626239	614525	rs1558498928	NC_000001.11:202762721:G:A	G	A	CLINICAL
NM_006618.5(KDM5B):c.787C>T (p.Pro263Ser)	KDM5B	P299S, P218S, P263S	Normal	Intellectual disability, autosomal recessive 65	Pathogenic(Last reviewed: Sep 10, 2018)	no assertion criteria provided	VCV000560602	1	202733198	1	202764070	560602	551677	rs375695605	NC_000001.11:202764069:G:A	G	A	CLINICAL
NM_172362.3(KCNH1):c.1546C>T (p.Leu516Phe)	KCNH1	L489F, L516F	Normal	Temple-Baraitser syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162521	1	210977425	1	210804083	162521	172194	rs727502820	NC_000001.11:210804082:G:A	G	A	CLINICAL
NM_012424.6(RPS6KC1):c.2710G>A (p.Gly904Ser)	RPS6KC1	G692S, G552S, G783S, G873S, G439S, G904S, G607S, G723S, G892S	Normal	Muscular hypotonia|Periventricular leukomalacia|Hypoplasia of the corpus callosum|Delayed myelination|Abnormality of the cerebral white matter|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242892	1	213415529	1	213242186	242892	243977	rs61751035	NC_000001.11:213242185:G:A	G	A	CLINICAL
NM_012414.4(RAB3GAP2):c.3154G>T (p.Gly1052Cys)	RAB3GAP2	G1052C	Normal	Cataract-intellectual disability-hypogonadism syndrome	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000001820	1	220338075	1	220164733	1820	16859	rs121434310	NC_000001.11:220164732:C:A	C	A	CLINICAL
NM_012414.4(RAB3GAP2):c.1276C>T (p.Arg426Cys)	RAB3GAP2	R426C	Normal	Warburg micro syndrome 2|Cataract-intellectual disability-hypogonadism syndrome|Cataract-intellectual disability-hypogonadism syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000100787	1	220364621	1	220191279	100787	106652	rs587777167	NC_000001.11:220191278:G:A	G	A	CLINICAL
NM_001791.4(CDC42):c.203G>A (p.Arg68Gln)	CDC42	R68Q	Normal	Takenouchi-Kosaki syndrome|not provided|Abnormality of the immune system|Abnormality of blood and blood-forming tissues|Postnatal growth retardation|Abnormal facial shape|Neurodevelopmental abnormality	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000450370	1	22412956	1	22086463	450370	442723	rs1553196096	NC_000001.11:22086462:G:A	G	A	CLINICAL
NM_001791.4(CDC42):c.511G>A (p.Glu171Lys)	CDC42	E171K	Normal	Takenouchi-Kosaki syndrome|Noonan-like syndrome|Abnormality of blood and blood-forming tissues|Abnormality of the immune system|Abnormal facial shape|Neurodevelopmental abnormality|Postnatal growth retardation	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000487654	1	22417945	1	22091452	487654	480738	rs1553196539	NC_000001.11:22091451:G:A	G	A	CLINICAL
NM_020435.4(GJC2):c.787G>A (p.Glu263Lys)	GJC2	E263K	Normal	Leukodystrophy, hypomyelinating, 2	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000060683	1	228346246	1	228158545	60683	75257	rs397514734	NC_000001.11:228158544:G:A	G	A	CLINICAL
NM_000029.4(AGT):c.604C>T (p.Gln202Ter)	AGT		Normal	Renal dysplasia	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000018071	1	230845993	1	230710247	18071	33110	rs121912702	NC_000001.11:230710246:G:A	G	A	CLINICAL
NM_003193.5(TBCE):c.1113T>A (p.Cys371Ter)	TBCE	C371*, C422*, C258*	Normal	Hypoparathyroidism-retardation-dysmorphism syndrome	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005292	1	235600786	1	235437471	5292	20331	rs121908384	NC_000001.11:235437470:T:A	T	A	CLINICAL
NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp)	AKT3	R465W	Normal	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2|not provided|Capillary hemangiomas|Global developmental delay|Macrocephalus|Polymicrogyria|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039814	1	243668598	1	243505296	39814	48413	rs587776935	NC_000001.11:243505295:G:A	G	A	CLINICAL
NM_205768.2(ZBTB18):c.1355G>A (p.Cys452Tyr)	ZBTB18	C452Y, C443Y	Normal	Mental retardation, autosomal dominant 22	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000666591	1	244218431	1	244055129	666591	654114	rs1572531830	NC_000001.11:244055128:G:A	G	A	CLINICAL
NM_205768.3(ZBTB18):c.1391G>A	ZBTB18	R464H, R455H	Normal	Intellectual disability|Mental retardation, autosomal dominant 22|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000617452	1	244218467	1	244055165	617452	608800	rs1558149913	NC_000001.11:244055164:G:A	G	A	CLINICAL
NM_031844.3(HNRNPU):c.1714C>T (p.Arg572Ter)	HNRNPU	R572*, R553*	Normal	Epileptic encephalopathy|Intellectual disability|Seizures	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000267737	1	245020059	1	244856757	267737	263009	rs1135401733	NC_000001.11:244856756:G:A	G	A	CLINICAL
NM_006015.6(ARID1A):c.2879-1G>A	ARID1A		Normal	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000812670	1	27092947	1	26766456	812670	800921	rs1570607996	NC_000001.11:26766455:G:A	G	A	CLINICAL
NM_006015.6(ARID1A):c.6410C>A (p.Ala2137Asp)	ARID1A	A2137D, A1920D	Normal	Coffin-Siris syndrome|not provided	Likely pathogenic(Last reviewed: Nov 28, 2015)	criteria provided, single submitter	VCV000432033	1	27106799	1	26780308	432033	425361	rs1553153771	NC_000001.11:26780307:C:A	C	A	CLINICAL
NM_017837.3(PIGV):c.467G>A (p.Cys156Tyr)	PIGV	C156Y	Normal	Hyperphosphatasia with mental retardation syndrome 1|not provided	Likely pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000030821	1	27120992	1	26794501	30821	39778	rs387907023	NC_000001.11:26794500:G:A	G	A	CLINICAL
NM_017837.3(PIGV):c.494C>A (p.Ala165Glu)	PIGV	A165E	Normal	not provided|Hyperphosphatasia with mental retardation syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000135662	1	27121019	1	26794528	135662	139380	rs376328153	NC_000001.11:26794527:C:A	C	A	CLINICAL
NM_017837.3(PIGV):c.766C>A (p.Gln256Lys)	PIGV	Q256K	Normal	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001286	1	27121291	1	26794800	1286	16325	rs267606952	NC_000001.11:26794799:C:A	C	A	CLINICAL
NM_017837.3(PIGV):c.1022C>A (p.Ala341Glu)	PIGV	A341E	Normal	Inborn genetic diseases|Hyperphosphatasia-intellectual disability syndrome|not provided|Hyperphosphatasia with mental retardation syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001284	1	27121547	1	26795056	1284	16323	rs139073416	NC_000001.11:26795055:C:A	C	A	CLINICAL
NM_199342.4(SVBP):c.82C>T (p.Gln28Ter)	SVBP	Q28*	Normal	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly|Microcephaly|Lower limb spasticity|Intellectual disability	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000635968	1	43282134	1	42816463	635968	623782	rs1570520175	NC_000001.11:42816462:G:A	G	A	CLINICAL
NM_006516.4(SLC2A1):c.724C>T (p.Gln242Ter)	SLC2A1	Q242*	Normal	Intellectual disability|GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000202196	1	43395407	1	42929736	202196	198605	rs794729221	NC_000001.11:42929735:G:A	G	A	CLINICAL
NM_006516.3(SLC2A1):c.458G>T (p.Arg153Leu)	SLC2A1	R153L	Normal	GLUT1 deficiency syndrome 1|Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207227	1	43396355	1	42930684	207227	201160	rs794727642	NC_000001.11:42930683:C:A	C	A	CLINICAL
NM_006516.3(SLC2A1):c.376C>T (p.Arg126Cys)	SLC2A1	R126C	Normal	Stomatin-deficient cryohydrocytosis with neurologic defects|GLUT1 deficiency syndrome 1|not provided|Dystonia 9|GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016118	1	43396437	1	42930766	16118	31157	rs80359818	NC_000001.11:42930765:G:A	G	A	CLINICAL
NM_006516.3(SLC2A1):c.274C>T (p.Arg92Trp)	SLC2A1	R92W	Normal	Intellectual disability|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016119	1	43396718	1	42931047	16119	31158	rs202060209	NC_000001.11:42931046:G:A	G	A	CLINICAL
NM_006516.3(SLC2A1):c.107C>T (p.Pro36Leu)	SLC2A1	P36L	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625202	1	43408904	1	42943233	625202	613535	rs1570600997	NC_000001.11:42943232:G:A	G	A	CLINICAL
NM_006516.3(SLC2A1):c.101A>T (p.Asn34Ile)	SLC2A1	N34I	Normal	GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000016115	1	43408910	1	42943239	16115	31154	rs80359812	NC_000001.11:42943238:T:A	T	A	CLINICAL
NM_006279.5(ST3GAL3):c.38C>A (p.Ala13Asp)	ST3GAL3	A13D	Normal	Mental retardation, autosomal recessive 12	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000030587	1	44201971	1	43736300	30587	39544	rs387906943	NC_000001.11:43736299:C:A	C	A	CLINICAL
NM_017739.3(POMGNT1):c.1738C>T (p.Arg580Ter)	TSPAN1|POMGNT1	R580*, R437*, R558*	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Muscle eye brain disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056586	1	46655573	1	46189901	56586	71225	rs386834018	NC_000001.11:46189900:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.1462C>T (p.Arg488Ter)	TSPAN1|POMGNT1	R488*, R466*, R345*	Normal	Inborn genetic diseases|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000665448	1	46657847	1	46192175	665448	628122	rs727504103	NC_000001.11:46192174:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.1413+1G>T	TSPAN1|POMGNT1		Normal	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3	Likely pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000003986	1	46657979	1	46192307	3986	19025	rs587777821	NC_000001.11:46192306:C:A	C	A	CLINICAL
NM_017739.3(POMGNT1):c.1324C>T (p.Arg442Cys)	TSPAN1|POMGNT1	R442C, R420C, R299C	Normal	Muscle eye brain disease|not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3|Retinitis pigmentosa 76|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003992	1	46658069	1	46192397	3992	19031	rs28940869	NC_000001.11:46192396:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.931C>T (p.Arg311Ter)	TSPAN1|POMGNT1	R311*, R289*, R168*	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Muscle eye brain disease|Retinitis pigmentosa 76|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|not provided	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056610	1	46659546	1	46193874	56610	71249	rs386834039	NC_000001.11:46193873:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.652+1G>T	TSPAN1|POMGNT1		Normal	Muscle eye brain disease|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000642934	1	46660515	1	46194843	642934	650690	rs386834035	NC_000001.11:46194842:C:A	C	A	CLINICAL
NM_017739.3(POMGNT1):c.643C>T (p.Arg215Ter)	TSPAN1|POMGNT1	R215*, R193*, R72*	Normal	not provided|Retinitis pigmentosa 76|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Muscle eye brain disease|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3	Pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056604	1	46660525	1	46194853	56604	71243	rs386834034	NC_000001.11:46194852:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.636C>T (p.Phe212=)	TSPAN1|POMGNT1		Normal	Muscle eye brain disease|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Retinitis pigmentosa 76	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265399	1	46660532	1	46194860	265399	259673	rs190057175	NC_000001.11:46194859:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.511C>T (p.Arg171Ter)	TSPAN1|POMGNT1	R149*, R171*, R28*	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000648374	1	46661506	1	46195834	648374	628128	rs1424631447	NC_000001.11:46195833:G:A	G	A	CLINICAL
NM_017739.3(POMGNT1):c.236-1G>T	POMGNT1		Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Muscle eye brain disease	Likely pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370425	1	46662522	1	46196850	370425	357109	rs1057516477	NC_000001.11:46196849:C:A	C	A	CLINICAL
NM_001290130.1(POMGNT1):c.-243C>T	POMGNT1	R63*, R41*	Normal	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3|not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Retinitis pigmentosa 76	Pathogenic(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000003994	1	46662690	1	46197018	3994	19033	rs193919337	NC_000001.11:46197017:G:A	G	A	CLINICAL
NM_000329.3(RPE65):c.1084C>T (p.Gln362Ter)	RPE65	Q362*	Normal	Retinal dystrophy|Rod-cone dystrophy|Global developmental delay|Nystagmus|Autistic disorder of childhood onset	Pathogenic	no assertion criteria provided	VCV000812758	1	68903914	1	68438231	812758	800988	rs1571164333	NC_000001.11:68438230:G:A	G	A	CLINICAL
NM_015215.4(CAMTA1):c.2639G>A (p.Trp880Ter)	CAMTA1	W880*, W850*	Normal	Cerebellar ataxia, nonprogressive, with mental retardation	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801430	1	7725246	1	7665186	801430	789998	rs1576691273	NC_000001.11:7665185:G:A	G	A	CLINICAL
NM_000350.3(ABCA4):c.4139C>T (p.Pro1380Leu)	ABCA4	P1380L	Normal	not provided|Retinal dystrophy|Stargardt disease 1|Retinitis pigmentosa 19|Stargardt disease 1|Age-related macular degeneration 2|Cone-rod dystrophy 3|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|Mandibulofacial dysostosis with mental deficiency|ABCA4-Related Disorders|Stargardt disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007904	1	94496666	1	94031110	7904	22943	rs61750130	NC_000001.11:94031109:G:A	G	A	CLINICAL
NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys)	NMNAT1	E257K	Normal	Retinal dystrophy|Leber congenital amaurosis|Leber congenital amaurosis 9|not provided|Retinal dystrophy|Global developmental delay|Severe visual impairment|Diarrhea|Nystagmus|Developmental regression|Gastrointestinal dysmotility	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000037134	1	10042688	1	9982630	37134	45795	rs150726175	NC_000001.11:9982629:G:A	G	A	CLINICAL
NM_012243.3(SLC35A3):c.342+1G>A	SLC35A3		Normal	Arthrogryposis, mental retardation, and seizures	Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000541613	1	100464972	1	99999416	541613	516200	rs1553201582	NC_000001.11:99999415:G:A	G	A	CLINICAL
NM_007375.3(TARDBP):c.1144G>A (p.Ala382Thr)	TARDBP		Normal	FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|not provided|Amyotrophic lateral sclerosis type 10	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021474	1	11082610	1	11022553	21474	34326	rs367543041	NC_000001.11:11022552:G:A	G	A	CLINICAL
NM_000157.4(GBA):c.1504C>T (p.Arg502Cys)	GBA|LOC106627981	R502C, R415C, R453C	Normal	Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease type III|Parkinson disease, late-onset|Hereditary late onset Parkinson disease|Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Lewy body dementia|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004295	1	155204987	1	155235196	4295	19334	rs80356771	NC_000001.11:155235195:G:A	G	A	CLINICAL
NM_000157.4(GBA):c.1297G>T (p.Val433Leu)	GBA|LOC106627981	V433L, V384L, V346L	Normal	Gaucher disease|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|Gaucher disease type I|Lewy body dementia|Gaucher disease type 3C|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type II|Gaucher disease type III|Hereditary late onset Parkinson disease|Gaucher disease type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004292	1	155205563	1	155235772	4292	19331	rs80356769	NC_000001.11:155235771:C:A	C	A	CLINICAL
NM_000157.4(GBA):c.946C>T (p.Arg316Cys)	GBA|LOC106627981	R229C, R267C, R316C	Normal	Hereditary late onset Parkinson disease|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000813338	1	155207185	1	155237394	813338	801584	rs1264734195	NC_000001.11:155237393:G:A	G	A	CLINICAL
NM_022089.4(ATP13A2):c.1903C>T (p.Gln635Ter)	ATP13A2	Q635*, Q630*	Normal	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465252	1	17318840	1	16992345	465252	447471	rs773246271	NC_000001.11:16992344:G:A	G	A	CLINICAL
NM_022089.4(ATP13A2):c.490C>T (p.Arg164Trp)	ATP13A2	R164W, R159W	Normal	Kufor-Rakeb syndrome	Pathogenic	no assertion criteria provided	VCV000143196	1	17330894	1	17004399	143196	152914	rs199624796	NC_000001.11:17004398:G:A	G	A	CLINICAL
NM_032409.3(PINK1):c.650C>A (p.Ala217Asp)	PINK1	A217D	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000002414	1	20964597	1	20638104	2414	17453	rs74315360	NC_000001.11:20638103:C:A	C	A	CLINICAL
NM_032409.3(PINK1):c.774C>A (p.Tyr258Ter)	PINK1	Y258*	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000631591	1	20966483	1	20639990	631591	619987	rs756783990	NC_000001.11:20639989:C:A	C	A	CLINICAL
NM_032409.3(PINK1):c.813C>A (p.His271Gln)	PINK1|PINK1-AS	H271Q	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002405	1	20971019	1	20644526	2405	17444	rs28940284	NC_000001.11:20644525:C:A	C	A	CLINICAL
NM_032409.3(PINK1):c.836G>A (p.Arg279His)	PINK1|PINK1-AS	R279H	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002411	1	20971042	1	20644549	2411	17450	rs74315358	NC_000001.11:20644548:G:A	G	A	CLINICAL
NM_032409.3(PINK1):c.926G>A (p.Gly309Asp)	PINK1|PINK1-AS	G309D	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000002404	1	20971132	1	20644639	2404	17443	rs74315355	NC_000001.11:20644638:G:A	G	A	CLINICAL
NM_032409.3(PINK1):c.1311G>A (p.Trp437Ter)	PINK1|PINK1-AS	W437*	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000002406	1	20975547	1	20649054	2406	17445	rs74315356	NC_000001.11:20649053:G:A	G	A	CLINICAL
NM_007262.5(PARK7):c.78G>A (p.Met26Ile)	PARK7	M26I	Normal	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007065	1	8022923	1	7962863	7065	22104	rs74315351	NC_000001.11:7962862:G:A	G	A	CLINICAL
NM_207370.4(GPR153):c.217C>T (p.Arg73Cys)	GPR153	R73C	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208391	1	6314749	1	6254689	208391	204612	rs776061422	NC_000001.11:6254688:G:A	G	A	CLINICAL
NM_007375.3(TARDBP):c.881G>C (p.Gly294Ala)	TARDBP	G294A	Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000005230	1	11082347	1	11022290	5230	20269	rs80356721	NC_000001.11:11022289:G:C	G	C	CLINICAL
NM_007375.3(TARDBP):c.*83T>C	TARDBP		Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000021465	1	11082794	1	11022737	21465	34317	rs80356744	NC_000001.11:11022736:T:C	T	C	CLINICAL
NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys)	MUTYH	Y165C, Y179C, Y59C, Y176C, Y151C, Y162C, Y36C, Y152C, Y166C	Normal	Stomach cancer|Pilomatrixoma|MYH-associated polyposis|Neoplasm of stomach|Hereditary cancer-predisposing syndrome|none provided|MYH-associated polyposis|not specified|not provided|Carcinoma of colon|Endometrial carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005293	1	45798475	1	45332803	5293	20332	rs34612342	NC_000001.11:45332802:T:C	T	C	CLINICAL
NM_000016.6(ACADM):c.199T>C (p.Tyr67His)	ACADM	Y67H, Y71H, Y31H	Normal	not provided|Medium-chain acyl-coenzyme A dehydrogenase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003597	1	76198409	1	75732724	3597	18636	rs121434280	NC_000001.11:75732723:T:C	T	C	CLINICAL
NM_000447.3(PSEN2):c.364A>C (p.Thr122Pro)	PSEN2	T122P	Normal	Alzheimer disease, type 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008849	1	227073246	1	226885545	8849	23888	rs63749851	NC_000001.11:226885544:A:C	A	C	CLINICAL
NM_001042681.2(RERE):c.4319A>G (p.Gln1440Arg)	RERE	Q1440R, Q886R	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562007	1	8418276	1	8358216	562007	553144	rs1321809020	NC_000001.11:8358215:T:C	T	C	CLINICAL
NM_001042681.2(RERE):c.4304A>G (p.His1435Arg)	RERE	H1435R, H881R	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522858	1	8418291	1	8358231	522858	513409	rs1553154130	NC_000001.11:8358230:T:C	T	C	CLINICAL
NM_001042681.2(RERE):c.3785C>G (p.Pro1262Arg)	RERE	P1262R, P708R	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart|not provided	Likely pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000236217	1	8418810	1	8358750	236217	237785	rs878853270	NC_000001.11:8358749:G:C	G	C	CLINICAL
NM_004958.4(MTOR):c.5663T>G (p.Phe1888Cys)	MTOR	F1888C	Normal	not provided|Smith-Kingsmore syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224083	1	11189846	1	11129789	224083	225813	rs869312666	NC_000001.11:11129788:A:C	A	C	CLINICAL
NM_213653.3(HJV):c.238T>G (p.Cys80Gly)	HJV	C80G	Normal	Hemochromatosis type 2A|not provided	Likely pathogenic(Last reviewed: Jan 22, 2015)	criteria provided, single submitter	VCV000216012	1	145415419	1	146019594	216012	212074	rs28940586	NC_000001.11:146019593:A:C	A	C	CLINICAL
NM_006996.3(SLC19A2):c.807+2T>G	SLC19A2		Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432105	1	169446391	1	169477153	432105	425321	rs1234256852	NC_000001.11:169477152:A:C	A	C	CLINICAL
NM_018122.5(DARS2):c.492+2T>C	DARS2		Normal	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome|not provided|EMG: axonal abnormality|CNS demyelination|Sensorimotor neuropathy|Clubfoot|Cerebral cortical atrophy|Difficulty walking|Gout|Hypertensive disorder|Impaired vibration sensation in the lower limbs|Abnormality of the foot|Gait imbalance|Gait ataxia|Dysmetria|Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	Pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001062	1	173800770	1	173831632	1062	16101	rs142433332	NC_000001.11:173831631:T:C	T	C	CLINICAL
NM_033440.3(CELA2A):c.639+1G>C	CELA2A		Normal	Familial partial lipodystrophy 6|Diabetes|Hypertensive disorder|Coronary artery disease|Hypertriglyceridemia	Pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000633594	1	15792640	1	15466145	633594	622027	rs752331004	NC_000001.11:15466144:G:C	G	C	CLINICAL
NM_170707.4(LMNA):c.1488+5G>C	LMNA		Normal	not provided|Familial partial lipodystrophy 2	Pathogenic(Last reviewed: Oct 3, 2016)	criteria provided, single submitter	VCV000066833	1	156106824	1	156137033	66833	77730	rs267607543	NC_000001.11:156137032:G:C	G	C	CLINICAL
NM_015967.6(PTPN22):c.-1123C>G	PTPN22|AP4B1-AS1		Normal	Diabetes mellitus, insulin-dependent, susceptibility to	risk factor(Last reviewed: Mar 15, 2006)	no assertion criteria provided	VCV000008910	1	114415368	1	113872746	8910	23949	rs2488457	NC_000001.11:113872745:G:C	G	C	CLINICAL
NM_004958.4(MTOR):c.7500T>G (p.Ile2500Met)	MTOR	I2500M	Normal	Renal cell carcinoma, papillary, 1|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Smith-Kingsmore syndrome|Breast neoplasm	Likely pathogenic(Last reviewed: Apr 11, 2019)	no assertion criteria provided	VCV000376455	1	11169375	1	11109318	376455	363334	rs1057519915	NC_000001.11:11109317:A:C	A	C	CLINICAL
NM_004958.4(MTOR):c.5663T>G (p.Phe1888Cys)	MTOR	F1888C	Normal	not provided|Smith-Kingsmore syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224083	1	11189846	1	11129789	224083	225813	rs869312666	NC_000001.11:11129788:A:C	A	C	CLINICAL
NM_000701.8(ATP1A1):c.905T>C (p.Leu302Pro)	ATP1A1	L302P, L271P	Normal	Hypomagnesemia, seizures, and mental retardation 2	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000617641	1	116932211	1	116389589	617641	609044	rs1557785499	NC_000001.11:116389588:T:C	T	C	CLINICAL
NM_000701.8(ATP1A1):c.907G>C (p.Gly303Arg)	ATP1A1	G303R, G272R	Normal	Hypomagnesemia, seizures, and mental retardation 2	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000617642	1	116932213	1	116389591	617642	609045	rs1557785503	NC_000001.11:116389590:G:C	G	C	CLINICAL
NM_000701.8(ATP1A1):c.2791T>C (p.Trp931Arg)	ATP1A1|ATP1A1-AS1	W931R, W900R	Normal	Hypomagnesemia, seizures, and mental retardation 2	Pathogenic	no assertion criteria provided	VCV000619298	1	116943824	1	116401202	619298	610696	rs1570980551	NC_000001.11:116401201:T:C	T	C	CLINICAL
NM_005957.5(MTHFR):c.1517A>G (p.Tyr506Cys)	MTHFR	Y506C, Y547C	Normal	Mental deterioration|Generalized tonic-clonic seizures|Global developmental delay|Delayed speech and language development|Lower limb spasticity	Pathogenic(Last reviewed: Nov 30, 2019)	no assertion criteria provided	VCV000873154	1	11853977	1	11793920	873154	861284	rs764650203	NC_000001.11:11793919:T:C	T	C	CLINICAL
NM_170707.4(LMNA):c.694G>C (p.Gly232Arg)	LMNA	G232R, G120R, G151R	Normal	Charcot-Marie-Tooth disease type 2B1|Familial partial lipodystrophy 2|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Primary dilated cardiomyopathy|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2|not provided	Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV000066924	1	156104650	1	156134859	66924	77821	rs267607609	NC_000001.11:156134858:G:C	G	C	CLINICAL
NM_170707.4(LMNA):c.936+2T>C	LMNA		Normal	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000208496	1	156105105	1	156135314	208496	205007	rs797045011	NC_000001.11:156135313:T:C	T	C	CLINICAL
NM_170707.4(LMNA):c.1619T>C (p.Met540Thr)	LMNA	M540T, M459T, M428T	Normal	not provided|Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000066858	1	156107455	1	156137664	66858	77755	rs267607547	NC_000001.11:156137663:T:C	T	C	CLINICAL
NM_170707.4(LMNA):c.1968+1G>C	LMNA		Normal	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162413	1	156108549	1	156138758	162413	172114	rs113436208	NC_000001.11:156138757:G:C	G	C	CLINICAL
NM_170707.4(LMNA):c.1968+2T>C	LMNA		Normal	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162415	1	156108550	1	156138759	162415	172116	rs113860699	NC_000001.11:156138758:T:C	T	C	CLINICAL
NM_170707.4(LMNA):c.1968+5G>C	LMNA		Normal	Hutchinson-Gilford syndrome	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000162416	1	156108553	1	156138762	162416	172118	rs797044488	NC_000001.11:156138761:G:C	G	C	CLINICAL
NM_002241.5(KCNJ10):c.225T>G (p.Phe75Leu)	KCNJ10	F75L	Normal	EAST syndrome	Pathogenic(Last reviewed: Jan 1, 2011)	no assertion criteria provided	VCV000030252	1	160012098	1	160042308	30252	39208	rs757159382	NC_000001.11:160042307:A:C	A	C	CLINICAL
NM_001122764.3(PPOX):c.1046A>C (p.Asp349Ala)	PPOX	D349A, D187A, D213A, D316A	Normal	Variegate porphyria, homozygous	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000008698	1	161140257	1	161170467	8698	23737	rs28936676	NC_000001.11:161170466:A:C	A	C	CLINICAL
NM_153747.2(PIGC):c.566T>G (p.Leu189Trp)	PIGC|C1orf105	L189W	Normal	Glycosylphosphatidylinositol biosynthesis defect 16	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000471151	1	172411197	1	172442057	471151	472237	rs1553259614	NC_000001.11:172442056:A:C	A	C	CLINICAL
NM_002074.5(GNB1):c.353A>G (p.Asp118Gly)	GNB1	D118G, D18G	Normal	Mental retardation, autosomal dominant 42|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000521213	1	1735935	1	1804496	521213	511195	rs1553194162	NC_000001.11:1804495:T:C	T	C	CLINICAL
NM_002074.5(GNB1):c.301A>G (p.Met101Val)	GNB1	M101V, M1V	Normal	Mental retardation, autosomal dominant 42|hypotonia|Neurodevelopmental Disability|Seizures|EEG with generalized epileptiform discharges|Multifocal epileptiform discharges|Focal seizures with impairment of consciousness or awareness|Developmental regression|Seizures|Intellectual disability|Global developmental delay|Muscular hypotonia|Expressive language delay|Generalized tonic-clonic seizures|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224717	1	1735987	1	1804548	224717	226496	rs869312825	NC_000001.11:1804547:T:C	T	C	CLINICAL
NM_002074.5(GNB1):c.233A>G (p.Lys78Arg)	GNB1	K78R	Normal	Mental retardation, autosomal dominant 42|hypotonia|Neurodevelopmental Disability|Seizures|GNB1-Related Disorder|Inborn genetic diseases|EEG with generalized epileptiform discharges|Seizures|Global developmental delay|Feeding difficulties|Growth delay|Muscular hypotonia|Infantile muscular hypotonia|Strabismus|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224714	1	1737948	1	1806509	224714	226499	rs869312823	NC_000001.11:1806508:T:C	T	C	CLINICAL
NM_002074.5(GNB1):c.228T>G (p.Asp76Glu)	GNB1	D76E	Normal	Neurodevelopmental Disability|hypotonia|Seizures|Global developmental delay|Limb hypertonia|Focal seizures with impairment of consciousness or awareness|Failure to thrive|Seizures|Strabismus	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000224712	1	1737953	1	1806514	224712	226501	rs869312822	NC_000001.11:1806513:A:C	A	C	CLINICAL
NM_002074.5(GNB1):c.227A>G (p.Asp76Gly)	GNB1	D76G	Normal	Neurodevelopmental Disability|Seizures|hypotonia|Infantile muscular hypotonia|Muscular hypotonia|Intellectual disability|Global developmental delay|Mental retardation, autosomal dominant 42|Acute lymphoid leukemia|not provided	Pathogenic(Last reviewed: Jun 29, 2021)	criteria provided, single submitter	VCV000224711	1	1737954	1	1806515	224711	226502	rs869312821	NC_000001.11:1806514:T:C	T	C	CLINICAL
NM_006618.5(KDM5B):c.4109T>G (p.Leu1370Ter)	KDM5B	L1370*, L1406*, L1325*	Normal	Intellectual disability, autosomal recessive 65	Likely pathogenic(Last reviewed: May 17, 2019)	criteria provided, single submitter	VCV000560600	1	202700104	1	202730976	560600	551675	rs1558478047	NC_000001.11:202730975:A:C	A	C	CLINICAL
NM_172362.3(KCNH1):c.1508A>G (p.Gln503Arg)	KCNH1	Q503R, Q476R	Normal	Temple-Baraitser syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162522	1	210977463	1	210804121	162522	172195	rs727502821	NC_000001.11:210804120:T:C	T	C	CLINICAL
NM_172362.3(KCNH1):c.1480A>G (p.Ile494Val)	KCNH1	I494V, I467V	Normal	Zimmermann-Laband syndrome 1|Temple-Baraitser syndrome|Zimmermann-Laband syndrome 1|Temple-Baraitser syndrome	Pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000162520	1	210977491	1	210804149	162520	172193	rs727502819	NC_000001.11:210804148:T:C	T	C	CLINICAL
NM_014053.4(FLVCR1):c.1477G>C (p.Gly493Arg)	FLVCR1	G493R	Normal	Posterior column ataxia-retinitis pigmentosa syndrome	Pathogenic(Last reviewed: May 1, 2011)	no assertion criteria provided	VCV000030775	1	213062551	1	212889209	30775	39732	rs1558121050	NC_000001.11:212889208:G:C	G	C	CLINICAL
NM_001791.4(CDC42):c.62T>C (p.Ile21Thr)	CDC42	I21T	Normal	Takenouchi-Kosaki syndrome|not provided|Neurodevelopmental abnormality|Postnatal growth retardation|Abnormality of blood and blood-forming tissues|Abnormal facial shape|Abnormality of the immune system	Likely pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000422537	1	22405033	1	22078540	422537	405057	rs1064795845	NC_000001.11:22078539:T:C	T	C	CLINICAL
NM_001791.4(CDC42):c.137T>C (p.Ile46Thr)	CDC42	I46T	Normal	Takenouchi-Kosaki syndrome	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000666573	1	22408246	1	22081753	666573	654113	rs1570024112	NC_000001.11:22081752:T:C	T	C	CLINICAL
NM_001791.4(CDC42):c.247T>C (p.Ser83Pro)	CDC42	S83P	Normal	not provided|Takenouchi-Kosaki syndrome|Abnormality of blood and blood-forming tissues|Abnormality of the immune system|Abnormal facial shape|Neurodevelopmental abnormality|Postnatal growth retardation	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000487652	1	22413000	1	22086507	487652	480736	rs1553196101	NC_000001.11:22086506:T:C	T	C	CLINICAL
NM_001206641.3(COA6):c.267G>C (p.Trp89Cys)	COA6	W59C, W89C, W13C	Normal	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	Pathogenic(Last reviewed: Jul 9, 2015)	no assertion criteria provided	VCV000144036	1	234510030	1	234374284	144036	153775	rs1558123786	NC_000001.11:234374283:G:C	G	C	CLINICAL
NM_006352.4(ZBTB18):c.133T>C (p.Cys45Arg)	ZBTB18	C54R, C45R	Normal	Mental retardation, autosomal dominant 22	Likely pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000224125	1	244217236	1	244053934	224125	225855	rs869312689	NC_000001.11:244053933:T:C	T	C	CLINICAL
NM_006352.4(ZBTB18):c.1274T>C (p.Leu425Pro)	ZBTB18	L425P, L434P	Normal	Marfanoid habitus and intellectual disability|Mental retardation, autosomal dominant 22	Likely pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000559857	1	244218377	1	244055075	559857	550579	rs1553270599	NC_000001.11:244055074:T:C	T	C	CLINICAL
NM_006352.4(ZBTB18):c.1466A>C (p.His489Pro)	ZBTB18	H498P, H489P	Normal	Mental retardation, autosomal dominant 22	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000545593	1	244218569	1	244055267	545593	536094	rs1553270640	NC_000001.11:244055266:A:C	A	C	CLINICAL
NM_006015.6(ARID1A):c.3067T>C (p.Trp1023Arg)	ARID1A	W1023R	Normal	not provided|Mental retardation, autosomal dominant 14	Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000635055	1	27094359	1	26767868	635055	622861	rs1557612048	NC_000001.11:26767867:T:C	T	C	CLINICAL
NM_006015.6(ARID1A):c.5138T>C (p.Leu1713Pro)	ARID1A	L1713P, L1496P	Normal	Mental retardation, autosomal dominant 14	Likely pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000210260	1	27105527	1	26779036	210260	206793	rs797045264	NC_000001.11:26779035:T:C	T	C	CLINICAL
NM_017837.3(PIGV):c.1154A>C (p.His385Pro)	PIGV	H385P	Normal	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001285	1	27121679	1	26795188	1285	16324	rs267606951	NC_000001.11:26795187:A:C	A	C	CLINICAL
NM_000157.4(GBA):c.1503C>G (p.Asn501Lys)	GBA|LOC106627981	N414K, N452K, N501K	Normal	Gaucher disease type II	Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000691989	1	155204988	1	155235197	691989	679732	rs755265316	NC_000001.11:155235196:G:C	G	C	CLINICAL
NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)	GBA|LOC106627981	L483R, L434R, L396R	Normal	not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093449	1	155205043	1	155235252	93449	99356	rs421016	NC_000001.11:155235251:A:C	A	C	CLINICAL
NM_000157.4(GBA):c.1226A>G (p.Asn409Ser)	GBA|LOC106627981	N409S, N322S, N360S	Normal	Gaucher disease, perinatal lethal|Dementia, Lewy body, susceptibility to|not provided|Gaucher disease type I|Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Lewy body dementia|Gaucher disease, perinatal lethal|none provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Parkinson disease, late-onset|Hereditary late onset Parkinson disease|Akinesia|Rigidity|Gaucher disease|Thrombocytopenia|Abnormal bleeding|Susceptibility to Parkinson disease|Parkinson disease	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004290	1	155205634	1	155235843	4290	19329	rs76763715	NC_000001.11:155235842:T:C	T	C	CLINICAL
NM_022089.4(ATP13A2):c.2561T>G (p.Met854Arg)	ATP13A2	M810R, M854R, M849R	Normal	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	VCV000066098	1	17316234	1	16989739	66098	77000	rs587777053	NC_000001.11:16989738:A:C	A	C	CLINICAL
NM_022089.4(ATP13A2):c.477+2T>G	ATP13A2		Normal	not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Neurodegeneration with brain iron accumulation	Likely pathogenic(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000546591	1	17331185	1	17004690	546591	537080	rs758014228	NC_000001.11:17004689:A:C	A	C	CLINICAL
NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu)	TNNT2	F110L, F120L, F105L	Normal	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Wolff-Parkinson-White syndrome|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177807	1	201334370	1	201365242	177807	172501	rs727504331	NC_000001.11:201365241:A:C	A	C	CLINICAL
NM_032409.3(PINK1):c.1040T>C (p.Leu347Pro)	PINK1|PINK1-AS	L347P	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000002408	1	20972133	1	20645640	2408	17447	rs28940285	NC_000001.11:20645639:T:C	T	C	CLINICAL
NM_032409.3(PINK1):c.1291T>C (p.Tyr431His)	PINK1|PINK1-AS	Y431H	Normal	Parkinson disease 6	risk factor(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000002416	1	20975527	1	20649034	2416	17455	rs74315361	NC_000001.11:20649033:T:C	T	C	CLINICAL
NM_007262.5(PARK7):c.192G>C (p.Glu64Asp)	PARK7	E64D	Normal	Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000007067	1	8025485	1	7965425	7067	22106	rs74315353	NC_000001.11:7965424:G:C	G	C	CLINICAL
NM_007262.5(PARK7):c.446A>C (p.Asp149Ala)	PARK7	D149A	Normal	Parkinson disease 7	Pathogenic(Last reviewed: Aug 2, 2013)	no assertion criteria provided	VCV000007066	1	8044990	1	7984930	7066	22105	rs74315352	NC_000001.11:7984929:A:C	A	C	CLINICAL
NM_007262.5(PARK7):c.497T>C (p.Leu166Pro)	PARK7	L166P	Normal	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007064	1	8045041	1	7984981	7064	22103	rs28938172	NC_000001.11:7984980:T:C	T	C	CLINICAL
NM_001035.3(RYR2):c.2238A>C (p.Gln746His)	RYR2	Q746H	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208397	1	237664045	1	237500745	208397	204611	rs863223355	NC_000001.11:237500744:A:C	A	C	CLINICAL
NM_007375.3(TARDBP):c.800A>G (p.Asn267Ser)	TARDBP		Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000021482	1	11082266	1	11022209	21482	34334	rs80356718	NC_000001.11:11022208:A:G	A	G	CLINICAL
NM_007375.3(TARDBP):c.1009A>G (p.Met337Val)	TARDBP		Normal	Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005228	1	11082475	1	11022418	5228	20267	rs80356730	NC_000001.11:11022417:A:G	A	G	CLINICAL
NM_007375.3(TARDBP):c.1028A>G (p.Gln343Arg)	TARDBP	Q343R	Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000005235	1	11082494	1	11022437	5235	20274	rs80356731	NC_000001.11:11022436:A:G	A	G	CLINICAL
NM_007375.3(TARDBP):c.1055A>G (p.Asn352Ser)	TARDBP		Normal	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000021468	1	11082521	1	11022464	21468	34320	rs80356734	NC_000001.11:11022463:A:G	A	G	CLINICAL
NM_007375.3(TARDBP):c.1147A>G (p.Ile383Val)	TARDBP	I383V	Normal	not provided|Amyotrophic lateral sclerosis type 10	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000021476	1	11082613	1	11022556	21476	34328	rs80356740	NC_000001.11:11022555:A:G	A	G	CLINICAL
NM_007375.3(TARDBP):c.1153T>G (p.Trp385Gly)	TARDBP		Normal	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190400	1	11082619	1	11022562	190400	188226	rs797044595	NC_000001.11:11022561:T:G	T	G	CLINICAL
NM_000447.3(PSEN2):c.715A>G (p.Met239Val)	PSEN2	M239V	Normal	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Aug 31, 1995)	no assertion criteria provided	VCV000008846	1	227076678	1	226888977	8846	23885	rs28936379	NC_000001.11:226888976:A:G	A	G	CLINICAL
NM_000447.3(PSEN2):c.365C>G (p.Thr122Arg)	PSEN2	T122R	Normal	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000008851	1	227073247	1	226885546	8851	23890	rs28936380	NC_000001.11:226885545:C:G	C	G	CLINICAL
NM_001042681.2(RERE):c.4300T>C (p.Ser1434Pro)	RERE	S1434P, S880P	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000562004	1	8418295	1	8358235	562004	553146	rs1557582271	NC_000001.11:8358234:A:G	A	G	CLINICAL
NM_198173.3(GRHL3):c.1795C>G (p.Leu599Val)	GRHL3	L599V, L604V, L553V	Normal	Inborn genetic diseases	Likely pathogenic(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000208652	1	24680964	1	24354474	208652	205219	rs797044857	NC_000001.11:24354473:C:G	C	G	CLINICAL
NM_012243.3(SLC35A3):c.886A>G (p.Ser296Gly)	SLC35A3	S296G, S338G	Normal	Arthrogryposis, mental retardation, and seizures	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000089030	1	100483370	1	100017814	89030	94576	rs141952252	NC_000001.11:100017813:A:G	A	G	CLINICAL
NM_019026.4(TMCO1):c.476+3G>C	TMCO1		Normal	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	VCV000218899	1	165721336	1	165752099	218899	215660	rs372701032	NC_000001.11:165752098:C:G	C	G	CLINICAL
NM_170707.4(LMNA):c.1073A>G (p.Glu358Gly)	LMNA	E358G, E246G, E277G	Normal	Arrhythmogenic right ventricular dysplasia 9	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000265834	1	156105828	1	156136037	265834	260506	rs1114167345	NC_000001.11:156136036:A:G	A	G	CLINICAL
NM_145277.5(HJV):c.-102T>C	HJV	C80R	Normal	Hemochromatosis type 2A	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002369	1	145415419	1	146019594	2369	17408	rs28940586	NC_000001.11:146019593:A:G	A	G	CLINICAL
NM_145277.5(HJV):c.503T>C (p.Ile168Thr)	HJV	I281T, I168T, I55T	Normal	Hemochromatosis type 2A|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002368	1	145416497	1	146018516	2368	17407	rs74315326	NC_000001.11:146018515:A:G	A	G	CLINICAL
NM_012243.3(SLC35A3):c.886A>G (p.Ser296Gly)	SLC35A3	S296G, S338G	Normal	Arthrogryposis, mental retardation, and seizures	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000089030	1	100483370	1	100017814	89030	94576	rs141952252	NC_000001.11:100017813:A:G	A	G	CLINICAL
NM_001010898.4(SLC6A17):c.1898C>G (p.Pro633Arg)	SLC6A17	P633R	Normal	Mental retardation, autosomal recessive 48	Pathogenic(Last reviewed: Mar 5, 2015)	no assertion criteria provided	VCV000187770	1	110740780	1	110198158	187770	185668	rs375380880	NC_000001.11:110198157:C:G	C	G	CLINICAL
NM_004958.4(MTOR):c.7292T>C (p.Leu2431Pro)	MTOR	L2431P	Normal	Smith-Kingsmore syndrome|not provided	Likely pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, single submitter	VCV000391346	1	11174383	1	11114326	391346	364356	rs1057524044	NC_000001.11:11114325:A:G	A	G	CLINICAL
NM_000701.8(ATP1A1):c.2576T>G (p.Met859Arg)	ATP1A1|ATP1A1-AS1	M859R, M828R	Normal	Hypomagnesemia, seizures, and mental retardation 2	Pathogenic(Last reviewed: Feb 4, 2019)	no assertion criteria provided	VCV000617643	1	116943486	1	116400864	617643	609046	rs781629728	NC_000001.11:116400863:T:G	T	G	CLINICAL
NM_005105.5(RBM8A):c.67+32G>C	RBM8A|LIX1L-AS1		Normal	not provided|Global developmental delay|Clinodactyly of the 5th finger|Abnormality of brain morphology|Radial aplasia-thrombocytopenia syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030465	1	145507765	1	145927328	30465	39422	rs201779890	NC_000001.11:145927327:C:G	C	G	CLINICAL
NM_018489.3(ASH1L):c.8356G>C (p.Ala2786Pro)	ASH1L	A2786P, A2791P	Normal	Intellectual disability, autosomal dominant 52	Pathogenic(Last reviewed: Dec 5, 2017)	no assertion criteria provided	VCV000446517	1	155311831	1	155342040	446517	440035	rs1553241570	NC_000001.11:155342039:C:G	C	G	CLINICAL
NM_170707.4(LMNA):c.1868C>G (p.Thr623Ser)	LMNA	T593S, T623S, T511S	Normal	Hutchinson-Gilford syndrome|not provided	Pathogenic(Last reviewed: Jan 8, 2015)	no assertion criteria provided	VCV000066869	1	156108448	1	156138657	66869	77766	rs59267781	NC_000001.11:156138656:C:G	C	G	CLINICAL
NM_002241.5(KCNJ10):c.418T>C (p.Cys140Arg)	KCNJ10	C140R	Normal	EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007464	1	160011905	1	160042115	7464	22503	rs137853068	NC_000001.11:160042114:A:G	A	G	CLINICAL
NM_002241.5(KCNJ10):c.229G>C (p.Gly77Arg)	KCNJ10	G77R	Normal	EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007468	1	160012094	1	160042304	7468	22507	rs137853072	NC_000001.11:160042303:C:G	C	G	CLINICAL
NM_002241.5(KCNJ10):c.194G>C (p.Arg65Pro)	KCNJ10	R65P	Normal	Renal tubular dysfunction|Spastic diplegia|Cerebellar ataxia|Microcephaly|Bilateral sensorineural hearing impairment|EAST syndrome	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000007462	1	160012129	1	160042339	7462	22501	rs137853066	NC_000001.11:160042338:C:G	C	G	CLINICAL
NM_019026.4(TMCO1):c.476+3G>C	TMCO1		Normal	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	VCV000218899	1	165721336	1	165752099	218899	215660	rs372701032	NC_000001.11:165752098:C:G	C	G	CLINICAL
NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)	ATP13A2	G504R, G499R	Normal	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: May 8, 2007)	no assertion criteria provided	VCV000001221	1	17322503	1	16996008	1221	16260	rs121918227	NC_000001.11:16996007:C:G	C	G	CLINICAL
NM_153747.2(PIGC):c.635T>C (p.Leu212Pro)	PIGC|C1orf105	L212P	Normal	Glycosylphosphatidylinositol biosynthesis defect 16	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000471154	1	172411128	1	172441988	471154	472239	rs1553259602	NC_000001.11:172441987:A:G	A	G	CLINICAL
NM_002074.5(GNB1):c.284T>C (p.Leu95Pro)	GNB1	L95P	Normal	Neurodevelopmental Disability|Seizures|hypotonia|Strabismus|Expressive language delay|Seizures|Inability to walk|Multifocal epileptiform discharges|Limb hypertonia|Nystagmus|Cortical visual impairment|Feeding difficulties|Failure to thrive|Muscular hypotonia|Growth delay|Intellectual disability|Global developmental delay|Microcephaly|Mental retardation, autosomal dominant 42	Likely pathogenic	criteria provided, single submitter	VCV000224716	1	1736004	1	1804565	224716	226497	rs869312824	NC_000001.11:1804564:A:G	A	G	CLINICAL
NM_002074.5(GNB1):c.239T>C (p.Ile80Thr)	GNB1	I80T	Normal	Global developmental delay|Dystonia|Growth delay|Intellectual disability|Infantile axial hypotonia|Cleft palate|Hypothyroidism|Upper limb hypertonia|Limb hypertonia|Global developmental delay|Growth delay|Nystagmus|EEG with generalized epileptiform discharges|Developmental regression|Multifocal epileptiform discharges|Muscular hypotonia|Failure to thrive|Strabismus|Expressive language delay|Inability to walk|Seizures|Intellectual disability|Myelodysplastic syndrome|LEUKEMIA, CHRONIC LYMPHOCYTIC, SOMATIC|Neurodevelopmental disorder|Neurodevelopmental abnormality|Mental retardation, autosomal dominant 42|not provided|Inborn genetic diseases|hypotonia|Neurodevelopmental Disability|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208722	1	1737942	1	1806503	208722	205216	rs752746786	NC_000001.11:1806502:A:G	A	G	CLINICAL
NM_002074.5(GNB1):c.230G>C (p.Gly77Ala)	GNB1	G77A	Normal	not provided|Mental retardation, autosomal dominant 42	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431082	1	1737951	1	1806512	431082	424605	rs1135401746	NC_000001.11:1806511:C:G	C	G	CLINICAL
NM_052965.4(TSEN15):c.226T>G (p.Trp76Gly)	TSEN15	W76G	Normal	Pontocerebellar hypoplasia, type 2f|Seizures|Primary microcephaly|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183315	1	184023870	1	184054736	183315	181398	rs730882223	NC_000001.11:184054735:T:G	T	G	CLINICAL
NM_172362.3(KCNH1):c.651G>C (p.Lys217Asn)	KCNH1	K217N	Normal	Temple-Baraitser syndrome	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000162523	1	211192506	1	211019164	162523	172196	rs727502822	NC_000001.11:211019163:C:G	C	G	CLINICAL
NM_001791.4(CDC42):c.191A>G (p.Tyr64Cys)	CDC42	Y64C	Normal	Abnormality of blood and blood-forming tissues|Neurodevelopmental abnormality|Postnatal growth retardation|Abnormal facial shape|Abnormality of the immune system|Inborn genetic diseases|Takenouchi-Kosaki syndrome|not provided	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218950	1	22412944	1	22086451	218950	215784	rs864309721	NC_000001.11:22086450:A:G	A	G	CLINICAL
NM_001791.4(CDC42):c.196A>G (p.Arg66Gly)	CDC42	R66G	Normal	Abnormality of blood and blood-forming tissues|Abnormality of the immune system|Abnormal facial shape|Postnatal growth retardation|Neurodevelopmental abnormality|Takenouchi-Kosaki syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000208668	1	22412949	1	22086456	208668	205218	rs797044870	NC_000001.11:22086455:A:G	A	G	CLINICAL
NM_001009999.3(KDM1A):c.1196A>G (p.Asp399Gly)	KDM1A	D399G, D375G	Normal	Intellectual disability|not provided	Likely pathogenic(Last reviewed: Jun 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000451410	1	23395048	1	23068555	451410	442742	rs1553130904	NC_000001.11:23068554:A:G	A	G	CLINICAL
NM_001008216.2(GALE):c.548T>C (p.Leu183Pro)	GALE	L183P	Normal	UDPglucose-4-epimerase deficiency	Pathogenic(Last reviewed: Jan 25, 2011)	no assertion criteria provided	VCV000003675	1	24123618	1	23797128	3675	18714	rs121908045	NC_000001.11:23797127:A:G	A	G	CLINICAL
NM_006352.4(ZBTB18):c.1256T>G (p.Phe419Cys)	ZBTB18	F419C, F428C	Normal	Mental retardation, autosomal dominant 22	Likely pathogenic(Last reviewed: Jul 2, 2019)	no assertion criteria provided	VCV000807724	1	244218359	1	244055057	807724	798468	rs1572531730	NC_000001.11:244055056:T:G	T	G	CLINICAL
NM_205768.2(ZBTB18):c.1382A>G (p.Asn461Ser)	ZBTB18	N461S, N452S	Normal	Mental retardation, autosomal dominant 22|Inborn genetic diseases|Intellectual disability	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208690	1	244218458	1	244055156	208690	205220	rs797044885	NC_000001.11:244055155:A:G	A	G	CLINICAL
NM_006516.3(SLC2A1):c.859A>C (p.Ile287Leu)	SLC2A1	I287L	Normal	Microcephaly|Abnormality of metabolism/homeostasis|Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625201	1	43395272	1	42929601	625201	613534	rs1431778557	NC_000001.11:42929600:T:G	T	G	CLINICAL
NM_001365999.1(SZT2):c.5025-2A>G	SZT2		Normal	Central hypotonia|Abnormality of the anterior fontanelle|Cryptorchidism|Macrocephalus|Seizures|Global developmental delay|Abnormality of the cerebral white matter|Deep plantar creases|Early infantile epileptic encephalopathy 18	Likely pathogenic	criteria provided, single submitter	VCV000598948	1	43897129	1	43431458	598948	590037	rs1557569831	NC_000001.11:43431457:A:G	A	G	CLINICAL
NM_017739.3(POMGNT1):c.1814G>C (p.Arg605Pro)	TSPAN1|POMGNT1	R605P, R462P, R583P	Normal	Muscle eye brain disease|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|not provided|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003998	1	46655211	1	46189539	3998	19037	rs267606962	NC_000001.11:46189538:C:G	C	G	CLINICAL
NM_015215.4(CAMTA1):c.3230A>G (p.Tyr1077Cys)	CAMTA1	Y1077C, Y1047C, Y120C, Y101C	Normal	Cerebellar ataxia, nonprogressive, with mental retardation	Likely pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	VCV000216897	1	7796567	1	7736507	216897	213522	rs863224853	NC_000001.11:7736506:A:G	A	G	CLINICAL
NM_001232.3(CASQ2):c.2T>C (p.Met1Thr)	CASQ2	M1T	Normal	Wolff-Parkinson-White syndrome|not provided	Likely pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452250	1	116311161	1	115768540	452250	442590	rs1553197939	NC_000001.11:115768539:A:G	A	G	CLINICAL
NM_000157.3(GBA):c.1448T>C	GBA|LOC106627981	L483P, L396P, L434P	Normal	Dementia, Lewy body, susceptibility to|Gaucher disease, perinatal lethal|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Hypomimic face|Movement disorder|Resting tremor|Thoracolumbar scoliosis|Parkinsonism|Gaucher disease type I|not provided|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease	Pathogenic, risk factor(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004288	1	155205043	1	155235252	4288	19327	rs421016	NC_000001.11:155235251:A:G	A	G	CLINICAL
NM_000157.4(GBA):c.1342G>C (p.Asp448His)	GBA|LOC106627981	D448H, D361H, D399H	Normal	Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Lewy body dementia|Gaucher disease, perinatal lethal|not provided|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004293	1	155205518	1	155235727	4293	19332	rs1064651	NC_000001.11:155235726:C:G	C	G	CLINICAL
NM_000157.4(GBA):c.762-1G>C	GBA|LOC106627981		Normal	Parkinson disease, late-onset|Gaucher disease	Pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000633240	1	155207370	1	155237579	633240	621703	rs1237637353	NC_000001.11:155237578:C:G	C	G	CLINICAL
NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)	ATP13A2	G504R, G499R	Normal	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: May 8, 2007)	no assertion criteria provided	VCV000001221	1	17322503	1	16996008	1221	16260	rs121918227	NC_000001.11:16996007:C:G	C	G	CLINICAL
NM_001256864.2(DNAJC6):c.801-2A>G	DNAJC6		Normal	Parkinson disease 19a, juvenile-onset|Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088854	1	65851393	1	65385710	88854	94423	rs398122404	NC_000001.11:65385709:A:G	A	G	CLINICAL
NM_001256864.2(DNAJC6):c.2779A>G (p.Arg927Gly)	DNAJC6	R927G, R857G, R870G	Normal	Parkinson disease 19b, early-onset|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000253094	1	65877077	1	65411394	253094	247505	rs879255630	NC_000001.11:65411393:A:G	A	G	CLINICAL
NM_007375.3(TARDBP):c.881G>T (p.Gly294Val)	TARDBP	G294V	Normal	Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV000021484	1	11082347	1	11022290	21484	34336	rs80356721	NC_000001.11:11022289:G:T	G	T	CLINICAL
NM_007375.3(TARDBP):c.1042G>T (p.Gly348Cys)	TARDBP		Normal	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005234	1	11082508	1	11022451	5234	20273	rs80356733	NC_000001.11:11022450:G:T	G	T	CLINICAL
NM_003944.4(SELENBP1):c.481+1G>A	SELENBP1		Normal	Extraoral halitosis due to methanethiol oxidase deficiency	Pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	VCV000585260	1	151340674	1	151368198	585260	576310	rs1357490520	NC_000001.11:151368197:C:T	C	T	CLINICAL
NM_000447.3(PSEN2):c.254C>T (p.Ala85Val)	PSEN2	A85V	Normal	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Apr 22, 2008)	no assertion criteria provided	VCV000008853	1	227071518	1	226883817	8853	23892	rs63750048	NC_000001.11:226883816:C:T	C	T	CLINICAL
NM_000447.3(PSEN2):c.1289C>T (p.Thr430Met)	PSEN2	T430M, T429M	Normal	not provided|Alzheimer disease, type 4	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000008848	1	227083222	1	226895521	8848	23887	rs63750666	NC_000001.11:226895520:C:T	C	T	CLINICAL
NM_000447.3(PSEN2):c.422A>T (p.Asn141Ile)	PSEN2	N141I	Normal	Alzheimer disease, type 4|not provided	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008845	1	227073304	1	226885603	8845	23884	rs63750215	NC_000001.11:226885602:A:T	A	T	CLINICAL
NM_002074.5(GNB1):c.229G>A (p.Gly77Ser)	GNB1	G77S	Normal	Neurodevelopmental Disability|Seizures|hypotonia|Inborn genetic diseases|Autism spectrum disorder|Muscular hypotonia|Global developmental delay|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000224713	1	1737952	1	1806513	224713	226500	rs758432471	NC_000001.11:1806512:C:T	C	T	CLINICAL
NM_001042681.2(RERE):c.4293C>A (p.His1431Gln)	RERE	H1431Q, H877Q	Normal	Inborn genetic diseases|Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart|Cerebral visual impairment and intellectual disability|not provided	Likely pathogenic(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224822	1	8418302	1	8358242	224822	226644	rs869312871	NC_000001.11:8358241:G:T	G	T	CLINICAL
NM_001042681.2(RERE):c.3466G>A (p.Gly1156Arg)	RERE	G1156R, G602R	Normal	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic(Last reviewed: Jan 8, 2018)	no assertion criteria provided	VCV000236216	1	8419976	1	8359916	236216	237784	rs766951273	NC_000001.11:8359915:C:T	C	T	CLINICAL
NM_004958.4(MTOR):c.5395G>A (p.Glu1799Lys)	MTOR	E1799K	Normal	Intellectual disability, severe|Intellectual disability|Rare genetic intellectual disability|Inborn genetic diseases|CEBALID syndrome|Focal cortical dysplasia type II|Smith-Kingsmore syndrome|not provided	Pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217823	1	11190804	1	11130747	217823	214480	rs863225264	NC_000001.11:11130746:C:T	C	T	CLINICAL
NM_004958.4(MTOR):c.4785G>A (p.Met1595Ile)	MTOR|MTOR-AS1	M1595I	Normal	Smith-Kingsmore syndrome	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000224088	1	11204792	1	11144735	224088	225818	rs869312671	NC_000001.11:11144734:C:T	C	T	CLINICAL
NM_006516.3(SLC2A1):c.1199G>A (p.Arg400His)	SLC2A1	R400H	Normal	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|not provided	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280046	1	43393355	1	42927684	280046	264004	rs776095655	NC_000001.11:42927683:C:T	C	T	CLINICAL
NM_020066.5(FMN2):c.547A>T (p.Ile183Phe)	FMN2	I183F	Normal	not provided|Mental retardation, autosomal recessive 47	Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429780	1	240255956	1	240092656	429780	421230	rs757511770	NC_000001.11:240092655:A:T	A	T	CLINICAL
NM_006996.3(SLC19A2):c.1082G>A (p.Trp361Ter)	SLC19A2	W361*, W160*	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Aug 8, 2016)	no assertion criteria provided	VCV000492807	1	169438023	1	169468785	492807	485690	rs1553211899	NC_000001.11:169468784:C:T	C	T	CLINICAL
NM_006996.3(SLC19A2):c.750G>A (p.Trp250Ter)	SLC19A2	W250*	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Jul 1, 1999)	no assertion criteria provided	VCV000005958	1	169446450	1	169477212	5958	20997	rs74315374	NC_000001.11:169477211:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.398G>T (p.Arg133Leu)	LMNA	R133L, R21L, R52L	Normal	not provided|Hutchinson-Gilford progeria syndrome, childhood-onset|Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Jul 5, 2020)	criteria provided, single submitter	VCV000014488	1	156100449	1	156130658	14488	29527	rs60864230	NC_000001.11:156130657:G:T	G	T	CLINICAL
NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp)	LMNA	R482W, R401W, R370W	Normal	Familial partial lipodystrophy 2|not provided|Familial partial lipodystrophy|Inborn genetic diseases|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014489	1	156106775	1	156136984	14489	29528	rs57920071	NC_000001.11:156136983:C:T	C	T	CLINICAL
NM_145277.5(HJV):c.624C>A (p.Cys208Ter)	HJV	C321*, C208*, C95*	Normal	Hemochromatosis type 1|Hemochromatosis type 2A	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000002371	1	145416618	1	146018395	2371	17410	rs121434374	NC_000001.11:146018394:G:T	G	T	CLINICAL
NM_006996.3(SLC19A2):c.515G>A (p.Gly172Asp)	SLC19A2	G172D	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000005957	1	169446685	1	169477447	5957	20996	rs28937595	NC_000001.11:169477446:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.568C>T (p.Arg190Trp)	LMNA	R190W, R109W, R78W	Normal	Cardiovascular phenotype|Charcot-Marie-Tooth disease, type 2|Dilated cardiomyopathy 1S|not provided	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066908	1	156104248	1	156134457	66908	77805	rs59026483	NC_000001.11:156134456:C:T	C	T	CLINICAL
NM_006996.3(SLC19A2):c.1074G>A (p.Trp358Ter)	SLC19A2	W358*, W157*	Normal	Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000005963	1	169438031	1	169468793	5963	21002	rs74315375	NC_000001.11:169468792:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.29C>T (p.Thr10Ile)	LMNA	T10I	Normal	Inborn genetic diseases|Lipodystrophy (disease)|Familial partial lipodystrophy 2|not provided|Dilated cardiomyopathy 1A	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000066888	1	156084738	1	156114947	66888	77785	rs57077886	NC_000001.11:156114946:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp)	LMNA	R349W, R237W, R268W	Normal	Monogenic diabetes|Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 2B1|Dilated cardiomyopathy 1A|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066762	1	156105800	1	156136009	66762	77659	rs267607555	NC_000001.11:156136008:C:T	C	T	CLINICAL
NM_012243.3(SLC35A3):c.514C>T (p.Gln172Ter)	SLC35A3	Q172*, Q214*	Normal	Arthrogryposis, mental retardation, and seizures	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089029	1	100476969	1	100011413	89029	94575	rs398122524	NC_000001.11:100011412:C:T	C	T	CLINICAL
NM_005645.4(TAF13):c.119T>A (p.Met40Lys)	TAF13	M40K	Normal	Mental retardation, autosomal recessive 60|not provided	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000375726	1	109608842	1	109066220	375726	362616	rs1060505029	NC_000001.11:109066219:A:T	A	T	CLINICAL
NM_005645.4(TAF13):c.92T>A (p.Leu31His)	TAF13	L31H	Normal	Mental retardation, autosomal recessive 60|not provided	Pathogenic(Last reviewed: Apr 7, 2017)	no assertion criteria provided	VCV000375727	1	109617623	1	109075001	375727	362617	rs1060505030	NC_000001.11:109075000:A:T	A	T	CLINICAL
NM_001408.3(CELSR2):c.3830C>T (p.Pro1277Leu)	CELSR2	P1277L	Normal	Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	VCV000402154	1	109801573	1	109258951	402154	389103	rs561330579	NC_000001.11:109258950:C:T	C	T	CLINICAL
NM_004958.4(MTOR):c.6981G>A (p.Met2327Ile)	MTOR	M2327I	Normal	Smith-Kingsmore syndrome|not provided	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242349	1	11177096	1	11117039	242349	243900	rs878855328	NC_000001.11:11117038:C:T	C	T	CLINICAL
NM_004958.4(MTOR):c.5395G>A (p.Glu1799Lys)	MTOR	E1799K	Normal	Intellectual disability, severe|Intellectual disability|Rare genetic intellectual disability|Inborn genetic diseases|CEBALID syndrome|Focal cortical dysplasia type II|Smith-Kingsmore syndrome|not provided	Pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217823	1	11190804	1	11130747	217823	214480	rs863225264	NC_000001.11:11130746:C:T	C	T	CLINICAL
NM_004958.4(MTOR):c.4785G>A (p.Met1595Ile)	MTOR|MTOR-AS1	M1595I	Normal	Smith-Kingsmore syndrome	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000224088	1	11204792	1	11144735	224088	225818	rs869312671	NC_000001.11:11144734:C:T	C	T	CLINICAL
NM_004980.4(KCND3):c.950G>A (p.Cys317Tyr)	KCND3	C317Y	Normal	Spinocerebellar ataxia type 19/22	Pathogenic(Last reviewed: Apr 20, 2019)	criteria provided, single submitter	VCV000626316	1	112524399	1	111981777	626316	614651	rs1571939905	NC_000001.11:111981776:C:T	C	T	CLINICAL
NM_020699.4(GATAD2B):c.1241G>A (p.Arg414Gln)	GATAD2B	R414Q	Normal	not provided|Mental retardation, autosomal dominant 18	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381463	1	153785904	1	153813428	381463	364424	rs1057521041	NC_000001.11:153813427:C:T	C	T	CLINICAL
NM_020699.4(GATAD2B):c.597+1G>A	GATAD2B		Normal	Mental retardation, autosomal dominant 18|Inborn genetic diseases	Likely pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666293	1	153791266	1	153818790	666293	653912	rs1570929867	NC_000001.11:153818789:C:T	C	T	CLINICAL
NM_006118.3(HAX1):c.568C>T (p.Gln190Ter)	HAX1	Q190*, Q142*	Normal	Kostmann syndrome	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000004650	1	154247641	1	154275165	4650	19689	rs74315322	NC_000001.11:154275164:C:T	C	T	CLINICAL
NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg)	ADAR	G1007R, G712R, G981R, G1016R, G962R, G686R	Normal	Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6|not provided|Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039458	1	154560601	1	154588125	39458	48057	rs398122822	NC_000001.11:154588124:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	LMNA	R335W, R223W, R254W	Normal	Laminopathy|Primary dilated cardiomyopathy|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Lethal tight skin contracture syndrome|Dilated cardiomyopathy 1A|Congenital muscular dystrophy, LMNA-related|Heart-hand syndrome, Slovenian type|Mandibuloacral dysplasia with type A lipodystrophy|Charcot-Marie-Tooth disease type 2B1|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome|Familial partial lipodystrophy 2|Arrhythmogenic right ventricular cardiomyopathy|Heart-hand syndrome, Slovenian type|Left ventricular noncompaction|Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036473	1	156105758	1	156135967	36473	45135	rs386134243	NC_000001.11:156135966:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp)	LMNA	R349W, R237W, R268W	Normal	Monogenic diabetes|Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease type 2B1|Dilated cardiomyopathy 1A|Congenital muscular dystrophy, LMNA-related|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066762	1	156105800	1	156136009	66762	77659	rs267607555	NC_000001.11:156136008:C:T	C	T	CLINICAL
NM_170707.4(LMNA):c.1824C>T (p.Gly608=)	LMNA		Normal	not provided|Lethal tight skin contracture syndrome|Charcot-Marie-Tooth disease, type 2|Hutchinson-Gilford syndrome|Hutchinson-Gilford syndrome|Primary dilated cardiomyopathy	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014500	1	156108404	1	156138613	14500	29539	rs58596362	NC_000001.11:156138612:C:T	C	T	CLINICAL
NM_002241.5(KCNJ10):c.512G>A (p.Arg171Gln)	KCNJ10	R171Q	Normal	EAST syndrome	Likely pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000656970	1	160011811	1	160042021	656970	626986	rs200320916	NC_000001.11:160042020:C:T	C	T	CLINICAL
NM_000702.4(ATP1A2):c.2936C>T (p.Pro979Leu)	ATP1A2	P979L	Normal	Familial hemiplegic migraine type 2|Familial hemiplegic migraine|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012925	1	160109525	1	160139735	12925	27964	rs121918615	NC_000001.11:160139734:C:T	C	T	CLINICAL
NM_002074.5(GNB1):c.976G>A (p.Ala326Thr)	GNB1	A326T, A226T	Normal	Neurodevelopmental Disability|Seizures|hypotonia|Generalized tonic-clonic seizures|Seizures|Muscular hypotonia|Intellectual disability|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2016)	no assertion criteria provided	VCV000224718	1	1718817	1	1787378	224718	226495	rs869312826	NC_000001.11:1787377:C:T	C	T	CLINICAL
NM_002074.5(GNB1):c.274G>A (p.Ala92Thr)	GNB1	A92T	Normal	not provided|Mental retardation, autosomal dominant 42|Intellectual disability	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000633546	1	1736014	1	1804575	633546	621936	rs1557889974	NC_000001.11:1804574:C:T	C	T	CLINICAL
NM_002074.5(GNB1):c.239T>A (p.Ile80Asn)	GNB1	I80N	Normal	Neurodevelopmental Disability|Seizures|hypotonia|Focal seizures with impairment of consciousness or awareness|Seizures|Multifocal epileptiform discharges|Limb hypertonia|Cortical visual impairment|Feeding difficulties|Failure to thrive|Infantile muscular hypotonia|Muscular hypotonia|Growth delay|Global developmental delay|Mental retardation, autosomal dominant 42|not provided|Acute lymphoid leukemia	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000224715	1	1737942	1	1806503	224715	226498	rs752746786	NC_000001.11:1806502:A:T	A	T	CLINICAL
NM_002074.5(GNB1):c.229G>A (p.Gly77Ser)	GNB1	G77S	Normal	Neurodevelopmental Disability|Seizures|hypotonia|Inborn genetic diseases|Autism spectrum disorder|Muscular hypotonia|Global developmental delay|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000224713	1	1737952	1	1806513	224713	226500	rs758432471	NC_000001.11:1806512:C:T	C	T	CLINICAL
NM_002074.5(GNB1):c.158G>A (p.Gly53Glu)	GNB1	G53E	Normal	Mental retardation, autosomal dominant 42	Likely pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617622	1	1747240	1	1815801	617622	609017	rs1557898800	NC_000001.11:1815800:C:T	C	T	CLINICAL
NM_018136.5(ASPM):c.2967G>A (p.Trp989Ter)	ASPM	W989*	Normal	Primary autosomal recessive microcephaly 1|Primary autosomal recessive microcephaly 5	Pathogenic	criteria provided, single submitter	VCV000021570	1	197094291	1	197125161	21570	34422	rs199422152	NC_000001.11:197125160:C:T	C	T	CLINICAL
NM_172362.3(KCNH1):c.1070G>A (p.Arg357Gln)	KCNH1	R357Q, R330Q	Normal	Abnormal facial shape|Intellectual disability, severe|Seizures|not provided|KCNH1-related disorders|Inborn genetic diseases|Zimmermann-Laband syndrome 1|Temple-Baraitser syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279981	1	211093374	1	210920032	279981	263996	rs886041300	NC_000001.11:210920031:C:T	C	T	CLINICAL
NM_001791.4(CDC42):c.242G>T (p.Cys81Phe)	CDC42	C81F	Normal	not provided|Postnatal growth retardation|Neurodevelopmental abnormality|Abnormal facial shape|Abnormality of blood and blood-forming tissues|Abnormality of the immune system|Takenouchi-Kosaki syndrome	Likely pathogenic(Last reviewed: Feb 19, 2016)	criteria provided, single submitter	VCV000432071	1	22412995	1	22086502	432071	425337	rs1553196100	NC_000001.11:22086501:G:T	G	T	CLINICAL
NM_020247.5(COQ8A):c.1228C>T (p.Arg410Ter)	COQ8A	R410*	Normal	not provided|Global developmental delay	Pathogenic(Last reviewed: Jun 15, 2015)	criteria provided, single submitter	VCV000379797	1	227171527	1	226983826	379797	364923	rs753254213	NC_000001.11:226983825:C:T	C	T	CLINICAL
NM_001206641.3(COA6):c.349G>T (p.Glu117Ter)	COA6	E87*, E117*, E41*	Normal	Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4	Pathogenic(Last reviewed: Jul 1, 2014)	no assertion criteria provided	VCV000144037	1	234510112	1	234374366	144037	153776	rs146440690	NC_000001.11:234374365:G:T	G	T	CLINICAL
NM_000254.3(MTR):c.3518C>T	MTR	P1173L, P1122L, P766L	Normal	Inborn genetic diseases|Methylcobalamin deficiency type cblG|Intellectual disability, profound|Seizure disorder|not provided|Disorders of Intracellular Cobalamin Metabolism|Homocystinuria|Decreased methionine synthase activity	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014278	1	237058770	1	236895470	14278	29317	rs121913578	NC_000001.11:236895469:C:T	C	T	CLINICAL
NM_020066.5(FMN2):c.547A>T (p.Ile183Phe)	FMN2	I183F	Normal	not provided|Mental retardation, autosomal recessive 47	Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429780	1	240255956	1	240092656	429780	421230	rs757511770	NC_000001.11:240092655:A:T	A	T	CLINICAL
NM_006642.5(SDCCAG8):c.679A>T (p.Lys227Ter)	SDCCAG8	K227*, K129*, K259*	Normal	Bardet-Biedl syndrome 16	Pathogenic(Last reviewed: Sep 1, 2011)	no assertion criteria provided	VCV000000061	1	243468018	1	243304716	61	15100	rs267607031	NC_000001.11:243304715:A:T	A	T	CLINICAL
NM_006642.5(SDCCAG8):c.740+356C>T	SDCCAG8		Normal	Bardet-Biedl syndrome 16|Senior-Loken syndrome 7	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000060	1	243468435	1	243305133	60	15099	rs397515337	NC_000001.11:243305132:C:T	C	T	CLINICAL
NM_205768.2(ZBTB18):c.142C>T (p.Arg48Ter)	ZBTB18	R48*, R39*	Normal	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431091	1	244217218	1	244053916	431091	424614	rs1135401770	NC_000001.11:244053915:C:T	C	T	CLINICAL
NM_006352.4(ZBTB18):c.370G>T (p.Glu124Ter)	ZBTB18	E133*, E124*	Normal	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Nov 6, 2013)	no assertion criteria provided	VCV000088856	1	244217473	1	244054171	88856	94425	rs398122406	NC_000001.11:244054170:G:T	G	T	CLINICAL
NM_006352.4(ZBTB18):c.556C>T (p.Arg186Ter)	ZBTB18	R186*, R195*	Normal	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Apr 14, 2017)	no assertion criteria provided	VCV000417741	1	244217659	1	244054357	417741	404642	rs1064792999	NC_000001.11:244054356:C:T	C	T	CLINICAL
NM_205768.2(ZBTB18):c.1183C>T (p.Gln395Ter)	ZBTB18	Q395*, Q386*	Normal	Mental retardation, autosomal dominant 22|Inborn genetic diseases	Pathogenic(Last reviewed: May 24, 2016)	criteria provided, single submitter	VCV000225892	1	244218259	1	244054957	225892	227705	rs875989786	NC_000001.11:244054956:C:T	C	T	CLINICAL
NM_205768.2(ZBTB18):c.1390C>T (p.Arg464Cys)	ZBTB18	R464C, R455C	Normal	Mental retardation, autosomal dominant 22|not provided	Pathogenic(Last reviewed: Dec 4, 2020)	no assertion criteria provided	VCV000440857	1	244218466	1	244055164	440857	434502	rs750922282	NC_000001.11:244055163:C:T	C	T	CLINICAL
NM_205768.2(ZBTB18):c.1444C>T (p.Arg482Cys)	ZBTB18	R482C, R473C	Normal	Mental retardation, autosomal dominant 22	Pathogenic(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000548012	1	244218520	1	244055218	548012	538333	rs1553270634	NC_000001.11:244055217:C:T	C	T	CLINICAL
NM_006352.4(ZBTB18):c.1438G>T (p.Asp480Tyr)	ZBTB18	D480Y, D489Y	Normal	Mental retardation, autosomal dominant 22	Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689797	1	244218541	1	244055239	689797	677403	rs1572532005	NC_000001.11:244055238:G:T	G	T	CLINICAL
NM_006015.6(ARID1A):c.1348C>T (p.Gln450Ter)	ARID1A	Q450*	Normal	Mental retardation, autosomal dominant 14|ARID1A-related BAFopathy	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560946	1	27056352	1	26729861	560946	552043	rs1557591264	NC_000001.11:26729860:C:T	C	T	CLINICAL
NM_006015.6(ARID1A):c.2758C>T (p.Gln920Ter)	ARID1A	Q920*	Normal	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000030293	1	27092737	1	26766246	30293	39249	rs387906845	NC_000001.11:26766245:C:T	C	T	CLINICAL
NM_006015.6(ARID1A):c.3148G>T (p.Asp1050Tyr)	ARID1A	D1050Y	Normal	Mental retardation, autosomal dominant 14|ARID1A-related BAFopathy	Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000689740	1	27094440	1	26767949	689740	677404	rs1570609440	NC_000001.11:26767948:G:T	G	T	CLINICAL
NM_006015.6(ARID1A):c.3679G>T (p.Glu1227Ter)	ARID1A	E1227*	Normal	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Mar 9, 2017)	no assertion criteria provided	VCV000225844	1	27099442	1	26772951	225844	227658	rs875989849	NC_000001.11:26772950:G:T	G	T	CLINICAL
NM_006015.6(ARID1A):c.4003C>T (p.Arg1335Ter)	ARID1A	R1335*	Normal	Coffin-Siris syndrome 1|Mental retardation, autosomal dominant 14	Pathogenic	criteria provided, single submitter	VCV000030294	1	27100207	1	26773716	30294	39250	rs387906846	NC_000001.11:26773715:C:T	C	T	CLINICAL
NM_006015.6(ARID1A):c.5164C>T (p.Arg1722Ter)	ARID1A	R1722*, R1505*	Normal	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Dec 30, 2015)	criteria provided, single submitter	VCV000434343	1	27105553	1	26779062	434343	427794	rs1485978447	NC_000001.11:26779061:C:T	C	T	CLINICAL
NM_006015.6(ARID1A):c.5965C>T (p.Arg1989Ter)	ARID1A	R1989*, R1772*	Normal	Mental retardation, autosomal dominant 14	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000225842	1	27106354	1	26779863	225842	227656	rs879255270	NC_000001.11:26779862:C:T	C	T	CLINICAL
NM_006015.6(ARID1A):c.6196A>T (p.Asn2066Tyr)	ARID1A	N2066Y, N1849Y	Normal	Mental retardation, autosomal dominant 14	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801462	1	27106585	1	26780094	801462	789960	rs1570622663	NC_000001.11:26780093:A:T	A	T	CLINICAL
NM_017837.3(PIGV):c.55C>T (p.Arg19Cys)	PIGV	R19C	Normal	Hyperphosphatasia with mental retardation syndrome 1	Likely pathogenic(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000547943	1	27117361	1	26790870	547943	538334	rs759988046	NC_000001.11:26790869:C:T	C	T	CLINICAL
NM_017837.3(PIGV):c.1022C>T (p.Ala341Val)	PIGV	A341V	Normal	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000001287	1	27121547	1	26795056	1287	16326	rs139073416	NC_000001.11:26795055:C:T	C	T	CLINICAL
NM_006516.3(SLC2A1):c.940G>A (p.Gly314Ser)	SLC2A1	G314S	Normal	not provided|GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|GLUT1 deficiency syndrome 2	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016113	1	43394913	1	42929242	16113	31152	rs121909739	NC_000001.11:42929241:C:T	C	T	CLINICAL
NM_006516.3(SLC2A1):c.272G>A (p.Gly91Asp)	SLC2A1	G91D	Normal	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000016110	1	43396720	1	42931049	16110	31149	rs80359814	NC_000001.11:42931048:C:T	C	T	CLINICAL
NM_006279.5(ST3GAL3):c.1108G>T (p.Asp370Tyr)	ST3GAL3	D370Y, D439Y, D385Y, D256Y, D339Y, D354Y, D408Y, D424Y, D225Y, D272Y, D326Y, D340Y	Normal	Mental retardation, autosomal recessive 12	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000030588	1	44395873	1	43930201	30588	39545	rs1557612719	NC_000001.11:43930200:G:T	G	T	CLINICAL
NM_017739.3(POMGNT1):c.1895+1G>A	TSPAN1|POMGNT1		Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Retinitis pigmentosa 76|Muscle eye brain disease	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV000056592	1	46655129	1	46189457	56592	71231	rs386834024	NC_000001.11:46189456:C:T	C	T	CLINICAL
NM_017739.3(POMGNT1):c.1769G>A (p.Trp590Ter)	TSPAN1|POMGNT1	W590*, W568*, W447*	Normal	Muscle eye brain disease|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Retinitis pigmentosa 76	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056587	1	46655542	1	46189870	56587	71226	rs386834019	NC_000001.11:46189869:C:T	C	T	CLINICAL
NM_017739.3(POMGNT1):c.1469G>A (p.Cys490Tyr)	TSPAN1|POMGNT1	C490Y, C347Y, C468Y	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Muscle eye brain disease|not provided|Muscle eye brain disease|Limb-girdle muscular dystrophy-dystroglycanopathy, type C3|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Retinitis pigmentosa 76	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004000	1	46657840	1	46192168	4000	19039	rs267606960	NC_000001.11:46192167:C:T	C	T	CLINICAL
NM_017739.3(POMGNT1):c.652+1G>A	TSPAN1|POMGNT1		Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3|Muscle eye brain disease	Likely pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000003999	1	46660515	1	46194843	3999	19038	rs386834035	NC_000001.11:46194842:C:T	C	T	CLINICAL
NM_172225.2(DMBX1):c.352C>T (p.Arg118Trp)	DMBX1	R123W, R118W	Normal	Hearing impairment|Muscular hypotonia|Seizures|Strabismus|Hypermetropia|Global developmental delay	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183286	1	46976625	1	46510953	183286	181403	rs730882203	NC_000001.11:46510952:C:T	C	T	CLINICAL
NM_001256864.2(DNAJC6):c.2410C>T (p.Gln804Ter)	DNAJC6	Q734*, Q747*, Q804*	Normal	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088855	1	65871735	1	65406052	88855	94424	rs398122405	NC_000001.11:65406051:C:T	C	T	CLINICAL
NM_015215.4(CAMTA1):c.2863C>T (p.Arg955Trp)	CAMTA1	R955W, R925W	Normal	Cerebellar ataxia, nonprogressive, with mental retardation	Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431151	1	7737742	1	7677682	431151	424639	rs1135401818	NC_000001.11:7677681:C:T	C	T	CLINICAL
NM_000157.4(GBA):c.1604G>A (p.Arg535His)	GBA|LOC106627981	R535H, R486H, R448H	Normal	Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Lewy body dementia|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided|Gaucher disease type I|Hereditary late onset Parkinson disease|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004311	1	155204793	1	155235002	4311	19350	rs75822236	NC_000001.11:155235001:C:T	C	T	CLINICAL
NM_000157.4(GBA):c.1294T>A (p.Trp432Arg)	GBA|LOC106627981	W432R, W383R, W345R	Normal	Parkinson disease, late-onset	Pathogenic	no assertion criteria provided	VCV000599275	1	155205566	1	155235775	599275	590519	rs1557901552	NC_000001.11:155235774:A:T	A	T	CLINICAL
NM_000157.4(GBA):c.887G>A (p.Arg296Gln)	GBA|LOC106627981	R296Q, R209Q, R247Q	Normal	Gaucher disease, perinatal lethal|not provided|Parkinson disease, late-onset|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Lewy body dementia|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Hereditary late onset Parkinson disease|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004328	1	155207244	1	155237453	4328	19367	rs78973108	NC_000001.11:155237452:C:T	C	T	CLINICAL
NM_000157.4(GBA):c.764T>A (p.Phe255Tyr)	GBA|LOC106627981	F255Y, F168Y, F206Y	Normal	not provided|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004298	1	155207367	1	155237576	4298	19337	rs74500255	NC_000001.11:155237575:A:T	A	T	CLINICAL
NM_000157.4(GBA):c.653G>A (p.Trp218Ter)	GBA|LOC106627981	W218*, W169*, W131*	Normal	Thrombocytopenia|Abnormal bleeding|Hereditary late onset Parkinson disease|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632834	1	155208033	1	155238242	632834	621059	rs867929413	NC_000001.11:155238241:C:T	C	T	CLINICAL
NM_000157.4(GBA):c.115+1G>A	GBA		Normal	not provided|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease|Hereditary late onset Parkinson disease|Parkinson disease, late-onset|Lewy body dementia|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093445	1	155210420	1	155240629	93445	99352	rs104886460	NC_000001.11:155240628:C:T	C	T	CLINICAL
NM_022089.4(ATP13A2):c.2629G>A (p.Gly877Arg)	ATP13A2	G877R, G833R, G872R	Normal	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000066099	1	17314950	1	16988455	66099	77001	rs144701072	NC_000001.11:16988454:C:T	C	T	CLINICAL
NM_022089.4(ATP13A2):c.1306+5G>A	ATP13A2		Normal	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001219	1	17322876	1	16996381	1219	16258	rs786205056	NC_000001.11:16996380:C:T	C	T	CLINICAL
NM_022089.4(ATP13A2):c.943G>A (p.Gly315Arg)	ATP13A2	G315R, G310R	Normal	Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000209136	1	17326602	1	17000107	209136	205722	rs150519745	NC_000001.11:17000106:C:T	C	T	CLINICAL
NM_032409.3(PINK1):c.13C>T (p.Gln5Ter)	PINK1	Q5*	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000661098	1	20960054	1	20633561	661098	627313	rs1005937012	NC_000001.11:20633560:C:T	C	T	CLINICAL
NM_032409.3(PINK1):c.736C>T (p.Arg246Ter)	PINK1	R246*	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000002407	1	20966445	1	20639952	2407	17446	rs74315357	NC_000001.11:20639951:C:T	C	T	CLINICAL
NM_032409.3(PINK1):c.938C>T (p.Thr313Met)	PINK1|PINK1-AS	T313M	Normal	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000002413	1	20971144	1	20644651	2413	17452	rs74315359	NC_000001.11:20644650:C:T	C	T	CLINICAL
NM_032409.3(PINK1):c.1366C>T (p.Gln456Ter)	PINK1|PINK1-AS	Q456*	Normal	Parkinson disease 6, autosomal recessive early-onset|not provided	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000002415	1	20975602	1	20649109	2415	17454	rs45539432	NC_000001.11:20649108:C:T	C	T	CLINICAL
NM_032409.3(PINK1):c.1474C>T (p.Arg492Ter)	PINK1|PINK1-AS	R492*	Normal	Parkinson disease 6, autosomal recessive early-onset|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431963	1	20975710	1	20649217	431963	425331	rs34208370	NC_000001.11:20649216:C:T	C	T	CLINICAL
NM_001256864.2(DNAJC6):c.454C>T (p.Arg152Ter)	DNAJC6	R82*, R152*, R95*	Normal	Parkinson disease 19a, juvenile-onset|Malignant tumor of prostate	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000219301	1	65831790	1	65366107	219301	220990	rs864622011	NC_000001.11:65366106:C:T	C	T	CLINICAL
NM_001256864.2(DNAJC6):c.2223A>T (p.Thr741=)	DNAJC6		Normal	Parkinson disease 19b, early-onset|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000253095	1	65867559	1	65401876	253095	247506	rs879255554	NC_000001.11:65401875:A:T	A	T	CLINICAL
NM_001256864.2(DNAJC6):c.2410C>T (p.Gln804Ter)	DNAJC6	Q734*, Q747*, Q804*	Normal	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088855	1	65871735	1	65406052	88855	94424	rs398122405	NC_000001.11:65406051:C:T	C	T	CLINICAL
NM_001256864.2(DNAJC6):c.2536C>T (p.Gln846Ter)	DNAJC6	Q789*, Q776*, Q846*	Normal	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000265964	1	65874368	1	65408685	265964	260693	rs886039854	NC_000001.11:65408684:C:T	C	T	CLINICAL
NM_007262.5(PARK7):c.115G>T (p.Ala39Ser)	PARK7	A39S	Normal	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000007069	1	8025408	1	7965348	7069	22108	rs137853051	NC_000001.11:7965347:G:T	G	T	CLINICAL
NM_001035.3(RYR2):c.2236C>T (p.Gln746Ter)	RYR2	Q746*	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208396	1	237664043	1	237500743	208396	204610	rs863223354	NC_000001.11:237500742:C:T	C	T	CLINICAL
NM_000110.3(DPYD):c.1863G>A (p.Trp621Ter)	DPYD	W621*	Normal	Dihydropyrimidine dehydrogenase deficiency	Likely pathogenic(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370307	1	97915657	1	97450101	370307	357161	rs1057516388	NC_000001.11:97450100:C:T	C	T	CLINICAL
NM_004082.5(DCTN1):c.1864A>T (p.Ile622Phe)	DCTN1	I488F, I585F, I599F, I602F, I605F, I615F, I622F	Normal	Amyotrophic lateral sclerosis	Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV000976655	2	74595249	2	74368122	976655	964790	rs1328116832	NC_000002.12:74368121:T:A	T	A	CLINICAL
NM_020919.4(ALS2):c.3520A>T (p.Lys1174Ter)	ALS2	K1174*	Normal	Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000645923	2	202588157	2	201723434	645923	629297	rs757972700	NC_000002.12:201723433:T:A	T	A	CLINICAL
NM_020919.4(ALS2):c.3415C>T (p.Arg1139Ter)	ALS2	R1139*	Normal	Inborn genetic diseases|Amyotrophic lateral sclerosis type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393199	2	202589115	2	201724392	393199	366307	rs767350733	NC_000002.12:201724391:G:A	G	A	CLINICAL
NM_020919.4(ALS2):c.2761C>T (p.Arg921Ter)	ALS2	R921*	Normal	not provided|Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000100653	2	202593315	2	201728592	100653	106525	rs587777132	NC_000002.12:201728591:G:A	G	A	CLINICAL
NM_020919.4(ALS2):c.2104G>T (p.Glu702Ter)	ALS2	E702*	Normal	Infantile-onset ascending hereditary spastic paralysis|Amyotrophic lateral sclerosis type 2|Juvenile primary lateral sclerosis	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804391	2	202609047	2	201744324	804391	792725	rs1574748038	NC_000002.12:201744323:C:A	C	A	CLINICAL
NM_020919.4(ALS2):c.2002G>T (p.Gly668Ter)	ALS2	G668*	Normal	Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Mar 25, 2014)	no assertion criteria provided	VCV000183239	2	202609149	2	201744426	183239	181372	rs730882255	NC_000002.12:201744425:C:A	C	A	CLINICAL
NM_020919.4(ALS2):c.601C>T (p.Arg201Ter)	ALS2	R201*	Normal	Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis|Amyotrophic lateral sclerosis type 2|Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804392	2	202626116	2	201761393	804392	792726	rs1574787779	NC_000002.12:201761392:G:A	G	A	CLINICAL
NM_005235.3(ERBB4):c.3823C>T (p.Arg1275Trp)	ERBB4	R1275W, R1259W	Normal	Amyotrophic lateral sclerosis 19|not provided	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000064626	2	212248444	2	211383719	64626	75590	rs397514263	NC_000002.12:211383718:G:A	G	A	CLINICAL
NM_006000.3(TUBA4A):c.643C>T (p.Arg215Cys)	TUBA4A	R215C, R200C	Normal	Amyotrophic lateral sclerosis 22 with frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180185	2	220115778	2	219251056	180185	178368	rs730880028	NC_000002.12:219251055:G:A	G	A	CLINICAL
NM_001927.4(DES):c.735+1G>A	DES		Normal	Myofibrillar myopathy 1|not provided|Muscular dystrophy, limb-girdle, type 2R|Myofibrillar myopathy 1	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044268	2	220285069	2	219420347	44268	53435	rs397516698	NC_000002.12:219420346:G:A	G	A	CLINICAL
NM_003108.4(SOX11):c.1286G>A (p.Trp429Ter)	SOX11	W429*	Normal	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374396	2	5834139	2	5694007	374396	361177	rs1057518672	NC_000002.12:5694006:G:A	G	A	CLINICAL
NM_022893.4(BCL11A):c.529C>T (p.Gln177Ter)	BCL11A	Q177*, Q143*	Normal	Intellectual developmental disorder with persistence of fetal hemoglobin|not provided	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000503758	2	60689518	2	60462383	503758	495129	rs1553403736	NC_000002.12:60462382:G:A	G	A	CLINICAL
NM_022893.4(BCL11A):c.193G>T (p.Glu65Ter)	BCL11A	E65*	Normal	Marfanoid habitus and intellectual disability|Intellectual developmental disorder with persistence of fetal hemoglobin	Likely pathogenic(Last reviewed: Jan 13, 2016)	criteria provided, single submitter	VCV000559890	2	60773298	2	60546163	559890	550587	rs1553353022	NC_000002.12:60546162:C:A	C	A	CLINICAL
NM_022893.4(BCL11A):c.154C>T (p.Gln52Ter)	BCL11A	Q52*	Normal	Intellectual developmental disorder with persistence of fetal hemoglobin	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000253305	2	60773337	2	60546202	253305	247748	rs886037868	NC_000002.12:60546201:G:A	G	A	CLINICAL
NM_022893.4(BCL11A):c.143G>T (p.Cys48Phe)	BCL11A	C48F	Normal	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253301	2	60773348	2	60546213	253301	247744	rs886037865	NC_000002.12:60546212:C:A	C	A	CLINICAL
NM_004522.3(KIF5C):c.709G>A (p.Glu237Lys)	KIF5C	E237K	Normal	not provided|Cortical dysplasia, complex, with other brain malformations 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000140740	2	149803532	2	148947018	140740	150453	rs587777570	NC_000002.12:148947017:G:A	G	A	CLINICAL
NM_013450.4(BAZ2B):c.5036A>T (p.Glu1679Val)	BAZ2B	E1625V, E1679V, E1643V, E1654V	Normal	Neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 12, 2017)	no assertion criteria provided	VCV000800363	2	160205619	2	159349108	800363	788958	rs1575883384	NC_000002.12:159349107:T:A	T	A	CLINICAL
NM_013450.4(BAZ2B):c.628C>T (p.Arg210Ter)	BAZ2B	R147*, R208*, R210*	Normal	Neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 12, 2017)	no assertion criteria provided	VCV000800361	2	160303361	2	159446850	800361	788960	rs780189423	NC_000002.12:159446849:G:A	G	A	CLINICAL
NM_001040142.2(SCN2A):c.2810G>A (p.Arg937His)	SCN2A	R937H	Normal	not provided|Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000432034	2	166201312	2	165344802	432034	425417	rs1553579488	NC_000002.12:165344801:G:A	G	A	CLINICAL
NM_001040142.2(SCN2A):c.3964G>A (p.Gly1322Arg)	SCN2A	G1322R	Normal	not provided	Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000381961	2	166229849	2	165373339	381961	365592	rs1057521223	NC_000002.12:165373338:G:A	G	A	CLINICAL
NM_152384.3(BBS5):c.532G>A (p.Gly178Arg)	BBS5	G178R	Normal	not provided|Bardet-Biedl syndrome	Likely pathogenic	no assertion criteria provided	VCV000191306	2	170350260	2	169493750	191306	189109	rs786205636	NC_000002.12:169493749:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.325-1G>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000558064	2	73635749	2	73408621	558064	542245	rs764337753	NC_000002.12:73408620:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.299C>A (p.Ser100Ter)	ALMS1	S100*	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000556678	2	73613292	2	73386164	556678	542347	rs1553396296	NC_000002.12:73386163:C:A	C	A	CLINICAL
NM_015120.4(ALMS1):c.11547+1G>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000556594	2	73800552	2	73573425	556594	542801	rs1553418638	NC_000002.12:73573424:G:A	G	A	CLINICAL
NM_152384.3(BBS5):c.817-1G>A	BBS5		Normal	Bardet-Biedl syndrome	Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000583267	2	170359604	2	169503094	583267	557727	rs1466289570	NC_000002.12:169503093:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.11669-1G>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000552775	2	73827804	2	73600677	552775	542682	rs750737346	NC_000002.12:73600676:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.10384+1G>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000557218	2	73786270	2	73559143	557218	542701	rs766366221	NC_000002.12:73559142:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.12299-1G>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000551947	2	73830367	2	73603240	551947	542876	rs1313101326	NC_000002.12:73603239:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.11872+2T>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000554708	2	73828010	2	73600883	554708	542705	rs1553421657	NC_000002.12:73600882:T:A	T	A	CLINICAL
NM_015120.4(ALMS1):c.10216+1G>A	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558643	2	73784482	2	73557355	558643	542723	rs374681570	NC_000002.12:73557354:G:A	G	A	CLINICAL
NM_152384.3(BBS5):c.413G>A (p.Arg138His)	BBS5	R138H	Normal	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000068066	2	170349410	2	169492900	68066	78957	rs179363897	NC_000002.12:169492899:G:A	G	A	CLINICAL
NM_152384.3(BBS5):c.214G>A (p.Gly72Ser)	BBS5	G72S	Normal	Bardet-Biedl syndrome 5|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	no assertion criteria provided	VCV000006161	2	170344321	2	169487811	6161	21200	rs121908581	NC_000002.12:169487810:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.7674+1G>A	ALMS1		Normal	Alstrom syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000545447	2	73682423	2	73455296	545447	535697	rs1417025395	NC_000002.12:73455295:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.11787G>A (p.Trp3929Ter)	ALMS1	W3929*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000545448	2	73827920	2	73600793	545448	535698	rs1318520999	NC_000002.12:73600792:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.7316C>A (p.Ser2439Ter)	ALMS1	S2439*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	no assertion criteria provided	VCV000560536	2	73680967	2	73453840	560536	551615	rs1558651680	NC_000002.12:73453839:C:A	C	A	CLINICAL
NM_025000.4(DCAF17):c.341C>A (p.Ser114Ter)	DCAF17	S114*	Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031582	2	172305210	2	171448700	31582	40266	rs760978794	NC_000002.12:171448699:C:A	C	A	CLINICAL
NM_015120.4(ALMS1):c.11207C>A (p.Ser3736Ter)	ALMS1	S3736*	Normal	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280474	2	73800208	2	73573081	280474	264140	rs367877017	NC_000002.12:73573080:C:A	C	A	CLINICAL
NM_015120.4(ALMS1):c.2822T>A (p.Leu941Ter)	ALMS1	L941*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224801	2	73676473	2	73449346	224801	226620	rs539612316	NC_000002.12:73449345:T:A	T	A	CLINICAL
NM_015120.4(ALMS1):c.7247C>A (p.Ser2416Ter)	ALMS1	S2416*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000403943	2	73680898	2	73453771	403943	393090	rs1060500039	NC_000002.12:73453770:C:A	C	A	CLINICAL
NM_015120.4(ALMS1):c.8766C>A (p.Cys2922Ter)	ALMS1	C2922*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000659575	2	73717849	2	73490722	659575	630505	rs765908556	NC_000002.12:73490721:C:A	C	A	CLINICAL
NM_015120.4(ALMS1):c.10992G>A (p.Trp3664Ter)	ALMS1	W3664*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000003974	2	73799993	2	73572866	3974	19013	rs193919339	NC_000002.12:73572865:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.164T>A (p.Leu55Ter)	ALMS1	L55*	Normal	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000555236	2	73613157	2	73386029	555236	542228	rs755760721	NC_000002.12:73386028:T:A	T	A	CLINICAL
NM_015120.4(ALMS1):c.11994G>A (p.Trp3998Ter)	ALMS1	W3998*	Normal	Alstrom syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489198	2	73828440	2	73601313	489198	481664	rs1553421725	NC_000002.12:73601312:G:A	G	A	CLINICAL
NM_015120.4(ALMS1):c.6800T>A (p.Leu2267Ter)	ALMS1	L2267*	Normal	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554903	2	73680451	2	73453324	554903	542399	rs761071372	NC_000002.12:73453323:T:A	T	A	CLINICAL
NM_023083.4(CAPN10):c.471-176G>A	CAPN10		Normal	Type 2 diabetes mellitus	risk factor(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000005093	2	241531174	2	240591757	5093	20132	rs3792267	NC_000002.12:240591756:G:A	G	A	CLINICAL
NM_001040142.2(SCN2A):c.4308+1G>A	SCN2A		Normal	Complex neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: Jun 2, 2016)	criteria provided, single submitter	VCV000265589	2	166234161	2	165377651	265589	259702	rs886039648	NC_000002.12:165377650:G:A	G	A	CLINICAL
NM_001040142.2(SCN2A):c.2645G>A (p.Gly882Glu)	SCN2A	G882E	Normal	Complex neurodevelopmental disorder|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 8, 2014)	criteria provided, single submitter	VCV000520571	2	166201147	2	165344637	520571	511343	rs1553579305	NC_000002.12:165344636:G:A	G	A	CLINICAL
	LCT		Normal	lactose persistence	associated			2	136608646	2	135851076	NA	NA	rs4988235	NC_000002.12:135851075:G:A	G	A	CLINICAL
NR_023343.1(RNU4ATAC):n.16G>A	RNU4ATAC|CLASP1		Normal	Short stature|Intellectual disability|Roifman syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000218082	2	122288471	2	121530895	218082	214736	rs750325275	NC_000002.12:121530894:G:A	G	A	CLINICAL
NR_023343.1(RNU4ATAC):n.55G>A	RNU4ATAC|CLASP1		Normal	Short stature|Intellectual disability|Osteodysplastic primordial dwarfism, type 1	Pathogenic(Last reviewed: May 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030179	2	122288510	2	121530934	30179	39135	rs575472572	NC_000002.12:121530933:G:A	G	A	CLINICAL
NM_207312.3(TUBA3E):c.643C>T (p.Arg215Cys)	TUBA3E	R215C	Normal	Seizures|Primary microcephaly|Lissencephaly|Global developmental delay	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183299	2	130951772	2	130194199	183299	181404	rs730882212	NC_000002.12:130194198:G:A	G	A	CLINICAL
NM_012233.3(RAB3GAP1):c.748+1G>A	RAB3GAP1		Normal	Warburg micro syndrome 1|not provided	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007058	2	135878489	2	135120919	7058	22097	rs587776651	NC_000002.12:135120918:G:A	G	A	CLINICAL
NM_012233.3(RAB3GAP1):c.899+1G>A	RAB3GAP1		Normal	not provided|Warburg micro syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000100769	2	135883820	2	135126250	100769	106635	rs587777152	NC_000002.12:135126249:G:A	G	A	CLINICAL
NM_012233.3(RAB3GAP1):c.1410C>A (p.Tyr470Ter)	RAB3GAP1	Y470*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000007061	2	135891514	2	135133944	7061	22100	rs267606996	NC_000002.12:135133943:C:A	C	A	CLINICAL
NM_012233.3(RAB3GAP1):c.1555-1G>A	RAB3GAP1		Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800519	2	135893133	2	135135563	800519	789110	rs1573584395	NC_000002.12:135135562:G:A	G	A	CLINICAL
NM_012233.3(RAB3GAP1):c.1734G>A (p.Trp578Ter)	RAB3GAP1	W578*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000007060	2	135893313	2	135135743	7060	22099	rs137853053	NC_000002.12:135135742:G:A	G	A	CLINICAL
NM_006895.3(HNMT):c.179G>A (p.Gly60Asp)	HNMT	G60D	Normal	Mental retardation, autosomal recessive 51	Pathogenic(Last reviewed: Oct 15, 2015)	no assertion criteria provided	VCV000219125	2	138727776	2	137970206	219125	216927	rs758252808	NC_000002.12:137970205:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.3118C>T (p.His1040Tyr)	ZEB2	H1016Y, H1040Y	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000496685	2	145147545	2	144389978	496685	488152	rs1553960788	NC_000002.12:144389977:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.3109A>T (p.Lys1037Ter)	ZEB2	K1037*, K1013*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000437324	2	145147554	2	144389987	437324	427883	rs1553960793	NC_000002.12:144389986:T:A	T	A	CLINICAL
NM_014795.4(ZEB2):c.3046C>T (p.Arg1016Ter)	ZEB2	R1016*, R992*	Normal	Mowat-Wilson syndrome|not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280856	2	145154000	2	144396433	280856	264012	rs886041989	NC_000002.12:144396432:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.3025C>T (p.Gln1009Ter)	ZEB2	Q1009*, Q985*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000572098	2	145154021	2	144396454	572098	559208	rs1560604977	NC_000002.12:144396453:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.2932G>T (p.Asp978Tyr)	ZEB2	D978Y, D954Y	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jul 17, 2012)	criteria provided, single submitter	VCV000217029	2	145154114	2	144396547	217029	213524	rs863224942	NC_000002.12:144396546:C:A	C	A	CLINICAL
NM_014795.4(ZEB2):c.2761C>T (p.Arg921Ter)	ZEB2	R921*, R897*	Normal	Mowat-Wilson syndrome|not provided|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000160323	2	145155993	2	144398426	160323	168023	rs587784566	NC_000002.12:144398425:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.2095C>T (p.Gln699Ter)	ZEB2	Q675*, Q699*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801755	2	145156659	2	144399092	801755	790048	rs1573716158	NC_000002.12:144399091:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.2083C>T (p.Arg695Ter)	ZEB2	R695*, R671*	Normal	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jan 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004755	2	145156671	2	144399104	4755	19794	rs137852981	NC_000002.12:144399103:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.1876G>T (p.Gly626Ter)	ZEB2	G626*, G602*	Normal	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000167854	2	145156878	2	144399311	167854	177329	rs727504224	NC_000002.12:144399310:C:A	C	A	CLINICAL
NM_014795.4(ZEB2):c.1645A>T (p.Arg549Ter)	ZEB2	R549*, R525*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004754	2	145157109	2	144399542	4754	19793	rs137852980	NC_000002.12:144399541:T:A	T	A	CLINICAL
NM_014795.4(ZEB2):c.1489C>T (p.Gln497Ter)	ZEB2	Q497*, Q473*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000437333	2	145157265	2	144399698	437333	427889	rs1553961702	NC_000002.12:144399697:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.1381C>T (p.Gln461Ter)	ZEB2	Q461*, Q437*	Normal	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095620	2	145157373	2	144399806	95620	101518	rs398124274	NC_000002.12:144399805:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.1027C>T (p.Arg343Ter)	ZEB2	R343*, R319*	Normal	Mowat-Wilson syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189281	2	145157727	2	144400160	189281	187166	rs786204815	NC_000002.12:144400159:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.904C>T (p.Arg302Ter)	ZEB2	R302*, R278*	Normal	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160329	2	145158778	2	144401211	160329	168031	rs587784571	NC_000002.12:144401210:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.823C>T (p.Gln275Ter)	ZEB2	Q275*, Q251*	Normal	Mowat-Wilson syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160328	2	145158859	2	144401292	160328	168032	rs587784570	NC_000002.12:144401291:G:A	G	A	CLINICAL
NM_014795.4(ZEB2):c.703G>T (p.Glu235Ter)	ZEB2	E235*, E211*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000619079	2	145161587	2	144404020	619079	610477	rs1553962069	NC_000002.12:144404019:C:A	C	A	CLINICAL
NM_014795.4(ZEB2):c.502C>T (p.Gln168Ter)	ZEB2|LOC111721705	Q168*, Q144*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561146	2	145162493	2	144404926	561146	552051	rs1560609721	NC_000002.12:144404925:G:A	G	A	CLINICAL
NM_018328.4(MBD5):c.397+1G>A	MBD5		Normal	Mental retardation, autosomal dominant 1|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000536667	2	149221489	2	148463920	536667	516447	rs1553517991	NC_000002.12:148463919:G:A	G	A	CLINICAL
NM_018328.4(MBD5):c.4235C>A (p.Ser1412Ter)	MBD5	S1412*	Normal	Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561057	2	149248135	2	148490566	561057	552052	rs1559099927	NC_000002.12:148490565:C:A	C	A	CLINICAL
NM_015702.3(MMADHC):c.748C>T (p.Arg250Ter)	MMADHC	R250*	Normal	Methylmalonic acidemia with homocystinuria cblD	Pathogenic(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000000767	2	150426631	2	149570117	767	15806	rs118204048	NC_000002.12:149570116:G:A	G	A	CLINICAL
NM_005378.6(MYCN):c.231G>A (p.Trp77Ter)	MYCNOS|MYCN	W77*	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000013895	2	16082417	2	15942295	13895	28934	rs121913667	NC_000002.12:15942294:G:A	G	A	CLINICAL
NM_005378.6(MYCN):c.1014C>A (p.Tyr338Ter)	MYCN	Y338*, Y127*	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000433149	2	16085838	2	15945716	433149	426710	rs367962377	NC_000002.12:15945715:C:A	C	A	CLINICAL
NM_005378.6(MYCN):c.1145G>A (p.Arg382His)	MYCN	R382H, R171H	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000013898	2	16085969	2	15945847	13898	28937	rs121913666	NC_000002.12:15945846:G:A	G	A	CLINICAL
NM_005378.6(MYCN):c.1177C>A (p.Arg393Ser)	MYCN	R393S, R182S	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000013893	2	16086001	2	15945879	13893	28932	rs104893647	NC_000002.12:15945878:C:A	C	A	CLINICAL
NM_005378.6(MYCN):c.1178G>A (p.Arg393His)	MYCN	R393H, R182H	Normal	not provided|Feingold syndrome 1	Pathogenic(Last reviewed: Mar 23, 2021)	no assertion criteria provided	VCV000013892	2	16086002	2	15945880	13892	28931	rs104893646	NC_000002.12:15945879:G:A	G	A	CLINICAL
NM_005378.6(MYCN):c.1181G>A (p.Arg394His)	MYCN	R394H, R183H	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: Apr 4, 2019)	no assertion criteria provided	VCV000013894	2	16086005	2	15945883	13894	28933	rs104893648	NC_000002.12:15945882:G:A	G	A	CLINICAL
NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys)	SCN1A	R393C	Normal	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy with suppression bursts|Intellectual disability, mild|Seizures	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068505	2	166903480	2	166046970	68505	79397	rs121917929	NC_000002.12:166046969:G:A	G	A	CLINICAL
NM_001165963.4(SCN1A):c.985G>T (p.Gly329Cys)	SCN1A	G329C	Normal	Intellectual disability|Severe myoclonic epilepsy in infancy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206933	2	166905439	2	166048929	206933	201600	rs781746113	NC_000002.12:166048928:C:A	C	A	CLINICAL
NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met)	SCN1A	T226M	Normal	Severe myoclonic epilepsy in infancy|Familial hemiplegic migraine type 3|Generalized epilepsy with febrile seizures plus, type 2|Early infantile epileptic encephalopathy with suppression bursts|DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B|not provided|Seizures|Global developmental delay|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068578	2	166909379	2	166052869	68578	79470	rs121917984	NC_000002.12:166052868:G:A	G	A	CLINICAL
NM_001165963.4(SCN1A):c.664C>T (p.Arg222Ter)	SCN1A	R222*	Normal	Early infantile epileptic encephalopathy with suppression bursts|not provided|Severe myoclonic epilepsy in infancy|History of neurodevelopmental disorder|Intellectual disability|Generalized epilepsy with febrile seizures plus, type 2|Familial hemiplegic migraine type 3|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012889	2	166909392	2	166052882	12889	27928	rs121918624	NC_000002.12:166052881:G:A	G	A	CLINICAL
NM_025000.4(DCAF17):c.341C>A (p.Ser114Ter)	DCAF17	S114*	Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031582	2	172305210	2	171448700	31582	40266	rs760978794	NC_000002.12:171448699:C:A	C	A	CLINICAL
NM_025000.4(DCAF17):c.387G>A (p.Trp129Ter)	DCAF17	W129*	Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031580	2	172305256	2	171448746	31580	40264	rs1559264135	NC_000002.12:171448745:G:A	G	A	CLINICAL
NM_025000.4(DCAF17):c.906G>A (p.Trp302Ter)	DCAF17	W302*	Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000031581	2	172325465	2	171468955	31581	40265	rs761229686	NC_000002.12:171468954:G:A	G	A	CLINICAL
NM_007315.3(STAT1):c.1154C>T (p.Thr385Met)	STAT1	T385M	Normal	Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C|Immunodeficiency 31a|Liver abscess|Severe T-cell immunodeficiency|Short stature|Hypothyroidism|Delayed speech and language development|Primary hypothyroidism|Chronic oral candidiasis|Chronic diarrhea|Hypothyroidism|Failure to thrive|Bronchiectasis|Combined T and B cell immunodeficiency|Cognitive impairment|Immunodeficiency 31C|Inherited Immunodeficiency Diseases|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000144006	2	191851647	2	190986921	144006	153737	rs587777630	NC_000002.12:190986920:G:A	G	A	CLINICAL
NM_001303052.2(MYT1L):c.1733C>T (p.Ala578Val)	MYT1L	A578V, A576V	Normal	Mental retardation, autosomal dominant 39	Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000666586	2	1914096	2	1910324	666586	654116	rs1573483715	NC_000002.12:1910323:G:A	G	A	CLINICAL
NM_001303052.2(MYT1L):c.1695G>T (p.Arg565Ser)	MYT1L	R565S, R563S	Normal	Mental retardation, autosomal dominant 39	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801647	2	1915806	2	1912034	801647	790142	rs1573501865	NC_000002.12:1912033:C:A	C	A	CLINICAL
NM_001303052.2(MYT1L):c.1678C>T (p.His560Tyr)	MYT1L	H560Y, H558Y	Normal	Mental retardation, autosomal dominant 39|Intellectual disability	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000617493	2	1915823	2	1912051	617493	608860	rs1558371790	NC_000002.12:1912050:G:A	G	A	CLINICAL
NM_024989.4(PGAP1):c.1952+1G>T	PGAP1		Normal	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Jan 31, 2014)	no assertion criteria provided	VCV000101081	2	197712670	2	196847946	101081	106842	rs587777202	NC_000002.12:196847945:C:A	C	A	CLINICAL
NM_024989.4(PGAP1):c.1396C>T (p.Gln466Ter)	PGAP1	Q466*, Q292*, Q77*	Normal	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: May 24, 2021)	no assertion criteria provided	VCV000222978	2	197740500	2	196875776	222978	224699	rs143038880	NC_000002.12:196875775:G:A	G	A	CLINICAL
NM_024989.4(PGAP1):c.1066A>T (p.Lys356Ter)	PGAP1	K356*, K182*	Normal	Mental retardation, autosomal recessive 42	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801848	2	197757093	2	196892369	801848	790146	rs1576164991	NC_000002.12:196892368:T:A	T	A	CLINICAL
NM_024989.4(PGAP1):c.427C>T (p.Gln143Ter)	PGAP1	Q143*	Normal	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000474992	2	197781192	2	196916468	474992	450375	rs1410587479	NC_000002.12:196916467:G:A	G	A	CLINICAL
NM_001172509.2(SATB2):c.1990C>T (p.Gln664Ter)	SATB2	Q664*	Normal	Micrognathia|Global developmental delay|Hyperplasia of midface|Microcephaly|Speech articulation difficulties|Downturned corners of mouth|Abnormal facial shape	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523422	2	200137146	2	199272423	523422	513919	rs1553538917	NC_000002.12:199272422:G:A	G	A	CLINICAL
NM_001172509.2(SATB2):c.1375C>T (p.Arg459Ter)	SATB2	R459*	Normal	Dystonia|Intellectual disability|History of neurodevelopmental disorder|Cleft palate, isolated|Chromosome 2q32-q33 deletion syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522269	2	200193432	2	199328709	522269	512805	rs1553547838	NC_000002.12:199328708:G:A	G	A	CLINICAL
NM_001172509.2(SATB2):c.715C>T (p.Arg239Ter)	SATB2	R239*	Normal	not provided|Chromosome 2q32-q33 deletion syndrome|Cleft palate|Intellectual disability	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002519	2	200213882	2	199349159	2519	17558	rs137853127	NC_000002.12:199349158:G:A	G	A	CLINICAL
NM_001959.4(EEF1B2):c.383C>A (p.Ser128Ter)	EEF1B2	S128*	Normal	Seizures|Moderate global developmental delay|Intellectual disability	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000689450	2	207026814	2	206162090	689450	677043	rs1576016842	NC_000002.12:206162089:C:A	C	A	CLINICAL
NM_001079866.2(BCS1L):c.518G>A (p.Gly173Asp)	BCS1L	G173D, G53D, G6D	Normal	Intellectual disability|Microcephaly|Intellectual disability, severe|Sparse hair|Movement disorder|Microcephaly|Sparse hair|Movement disorder	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625208	2	219526539	2	218661816	625208	613537	rs375876694	NC_000002.12:218661815:G:A	G	A	CLINICAL
NM_000784.4(CYP27A1):c.1214G>A (p.Arg405Gln)	CYP27A1	R405Q	Normal	Cholestanol storage disease|not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004260	2	219679132	2	218814409	4260	19299	rs121908099	NC_000002.12:218814408:G:A	G	A	CLINICAL
NM_013335.4(GMPPA):c.545G>A (p.Gly182Asp)	GMPPA|ASIC4-AS1	G182D	Normal	Alacrima, achalasia, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088693	2	220368860	2	219504138	88693	94273	rs397518462	NC_000002.12:219504137:G:A	G	A	CLINICAL
NM_013335.4(GMPPA):c.853+1G>A	GMPPA|ASIC4-AS1		Normal	Alacrima, achalasia, and mental retardation syndrome	Pathogenic	criteria provided, single submitter	VCV000446258	2	220370278	2	219505556	446258	439637	rs1553624347	NC_000002.12:219505555:G:A	G	A	CLINICAL
NM_001348323.3(TRIP12):c.4903C>T (p.Arg1635Ter)	TRIP12	R1561*, R1608*, R1609*, R1630*, R1290*, R1560*, R1588*, R1631*, R1593*, R1635*, R1601*, R1636*	Normal	Intellectual disability|not provided	Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000812759	2	230652313	2	229787597	812759	801062	rs1574994308	NC_000002.12:229787596:G:A	G	A	CLINICAL
NM_001348323.3(TRIP12):c.3208C>T (p.Arg1070Ter)	TRIP12	R1028*, R1001*, R1044*, R1070*, R1071*, R725*, R995*, R1041*, R1043*	Normal	not provided|Intellectual disability, autosomal dominant 49	Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000817548	2	230664098	2	229799382	817548	805296	rs1575161164	NC_000002.12:229799381:G:A	G	A	CLINICAL
NM_001284214.2(TRIP12):c.3085C>T (p.Gln1029Ter)	TRIP12	Q1057*, Q987*, Q1014*, Q1027*, Q981*, Q1056*, Q1029*, Q1030*, Q711*	Normal	Intellectual disability, autosomal dominant 49	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801907	2	230667008	2	229802292	801907	790207	rs1575203936	NC_000002.12:229802291:G:A	G	A	CLINICAL
NM_001348323.3(TRIP12):c.1684C>T (p.Arg562Ter)	TRIP12	R217*, R520*, R562*, R514*, R533*	Normal	Intellectual disability, autosomal dominant 49	Pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, single submitter	VCV000812668	2	230679862	2	229815146	812668	800918	rs1575419803	NC_000002.12:229815145:G:A	G	A	CLINICAL
NM_001284214.2(TRIP12):c.1651C>T (p.Arg551Ter)	TRIP12	R503*, R551*, R206*, R509*, R522*	Normal	not provided|Intellectual disability, autosomal dominant 49	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489242	2	230679895	2	229815179	489242	481645	rs1553636520	NC_000002.12:229815178:G:A	G	A	CLINICAL
NM_006037.3(HDAC4):c.743C>T (p.Pro248Leu)	HDAC4	P248L	Normal	not provided|Inborn genetic diseases|Intellectual disability, profound	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000424498	2	240066401	2	239144705	424498	405676	rs1064797002	NC_000002.12:239144704:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.4678C>T (p.Gln1560Ter)	KIF1A	Q1560*, Q1594*, Q1578*, Q1569*, Q1661*	Normal	Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000664959	2	241659231	2	240719814	664959	629704	rs1575514086	NC_000002.12:240719813:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.3523C>T (p.Arg1175Ter)	KIF1A	R1175*, R1276*, R1184*, R1209*	Normal	Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000576241	2	241679550	2	240740133	576241	558320	rs368078424	NC_000002.12:240740132:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.2323C>T (p.Arg775Ter)	KIF1A	R809*, R784*, R775*	Normal	not provided|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000665003	2	241700176	2	240760759	665003	629727	rs1327297188	NC_000002.12:240760758:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.1927C>T (p.Gln643Ter)	KIF1A	Q643*, Q652*, Q677*	Normal	Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000568993	2	241702504	2	240763087	568993	561233	rs748477031	NC_000002.12:240763086:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.946C>T (p.Arg316Trp)	KIF1A	R316W	Normal	Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIA|Inborn genetic diseases|Intellectual disability, autosomal dominant 9|not provided|Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162060	2	241715280	2	240775863	162060	171771	rs672601370	NC_000002.12:240775862:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.914C>T (p.Pro305Leu)	KIF1A	P305L	Normal	Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|not provided|Spastic paraplegia 30, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000428604	2	241715312	2	240775895	428604	420290	rs1131690804	NC_000002.12:240775894:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.821C>T (p.Ser274Leu)	KIF1A	S274L	Normal	Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Intellectual disability, autosomal dominant 9|not provided|Spastic paraplegia 30, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000211298	2	241722504	2	240783087	211298	206978	rs797045655	NC_000002.12:240783086:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.773C>T (p.Thr258Met)	KIF1A	T258M	Normal	not provided|Inborn genetic diseases|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000464261	2	241723181	2	240783764	464261	450732	rs1553638086	NC_000002.12:240783763:G:A	G	A	CLINICAL
NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp)	KIF1A	R254W	Normal	Intellectual disability, autosomal dominant 9|Inborn genetic diseases|Hereditary sensory and autonomic neuropathy type IIA|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245636	2	241723194	2	240783777	245636	244362	rs879253888	NC_000002.12:240783776:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.646C>T (p.Arg216Cys)	KIF1A	R216C	Normal	not provided|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|PEHO syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208160	2	241724480	2	240785063	208160	204421	rs797045164	NC_000002.12:240785062:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.430G>T (p.Val144Phe)	KIF1A	V144F	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV000162054	2	241725930	2	240786513	162054	171778	rs672601364	NC_000002.12:240786512:C:A	C	A	CLINICAL
NM_004321.7(KIF1A):c.296C>T (p.Thr99Met)	KIF1A	T99M	Normal	PEHO syndrome|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|not provided|Intellectual disability, autosomal dominant 9	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030169	2	241727535	2	240788118	30169	39125	rs387906799	NC_000002.12:240788117:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.206C>T (p.Ser69Leu)	KIF1A	S69L	Normal	Spastic paraplegia 30, autosomal recessive|not provided|Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Hereditary spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188057	2	241727625	2	240788208	188057	185949	rs786200949	NC_000002.12:240788207:G:A	G	A	CLINICAL
NM_004321.7(KIF1A):c.173C>T (p.Ser58Leu)	KIF1A	S58L	Normal	Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162052	2	241728663	2	240789246	162052	171780	rs672601362	NC_000002.12:240789245:G:A	G	A	CLINICAL
NM_015662.3(IFT172):c.4630C>T (p.Arg1544Cys)	IFT172	R1544C	Normal	Joubert syndrome|Short-rib thoracic dysplasia 10 with or without polydactyly	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, single submitter	VCV000097024	2	27670411	2	27447544	97024	102929	rs587777079	NC_000002.12:27447543:G:A	G	A	CLINICAL
NM_001330078.2(NRXN1):c.773-1G>T	NRXN1		Normal	Intellectual disability	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000637966	2	51153094	2	50925956	637966	625830	rs1574949440	NC_000002.12:50925955:C:A	C	A	CLINICAL
NM_003108.4(SOX11):c.1286G>A (p.Trp429Ter)	SOX11	W429*	Normal	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374396	2	5834139	2	5694007	374396	361177	rs1057518672	NC_000002.12:5694006:G:A	G	A	CLINICAL
NM_003849.4(SUCLG1):c.448C>T (p.Gln150Ter)	SUCLG1	Q150*	Normal	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic with methylmalonic aciduria)	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000018412	2	84668454	2	84441330	18412	33451	rs267607098	NC_000002.12:84441329:G:A	G	A	CLINICAL
NM_003896.4(ST3GAL5):c.862C>T (p.Arg288Ter)	ST3GAL5	R288*, R260*, R47*, R160*, R265*	Normal	not provided|GM3 synthase deficiency	Pathogenic(Last reviewed: Sep 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005556	2	86071665	2	85844542	5556	20595	rs104893668	NC_000002.12:85844541:G:A	G	A	CLINICAL
NM_004836.7(EIF2AK3):c.2758C>T (p.Gln920Ter)	EIF2AK3|LOC101928371	Q920*, Q769*	Normal	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000435051	2	88874243	2	88574725	435051	428103	rs1553407942	NC_000002.12:88574724:G:A	G	A	CLINICAL
NM_004836.7(EIF2AK3):c.2707C>T (p.Arg903Ter)	EIF2AK3|LOC101928371	R752*, R903*	Normal	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000807600	2	88874294	2	88574776	807600	798515	rs1178109063	NC_000002.12:88574775:G:A	G	A	CLINICAL
NM_004836.7(EIF2AK3):c.1192C>T (p.Gln398Ter)	EIF2AK3	Q398*, Q247*	Normal	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	VCV000208168	2	88888393	2	88588875	208168	204423	rs864621972	NC_000002.12:88588874:G:A	G	A	CLINICAL
NM_004836.7(EIF2AK3):c.994G>T (p.Glu332Ter)	EIF2AK3	E332*, E181*	Normal	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Jul 1, 2006)	no assertion criteria provided	VCV000005878	2	88890344	2	88590826	5878	20917	rs121908570	NC_000002.12:88590825:C:A	C	A	CLINICAL
NM_001267550.2(TTN):c.92683C>T (p.Arg30895Ter)	TTN-AS1|TTN	R30895*, R21955*, R22022*, R21830*, R28327*, R29254*	Normal	Wolff-Parkinson-White pattern|Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	VCV000223300	2	179413670	2	178548943	223300	225032	rs869312065	NC_000002.12:178548942:G:A	G	A	CLINICAL
NM_001267550.2(TTN):c.66904C>T (p.Leu22302=)	TTN|TTN-AS1		Normal	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487595	2	179445202	2	178580475	487595	480681	rs1553624186	NC_000002.12:178580474:G:A	G	A	CLINICAL
NM_003937.3(KYNU):c.468T>A (p.Tyr156Ter)	KYNU	Y156*	Normal	not provided|Vertebral, cardiac, renal, and limb defects syndrome 2|Congenital NAD deficiency disorder	Pathogenic/Likely pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000403730	2	143713804	2	142956235	403730	390705	rs758865880	NC_000002.12:142956234:T:A	T	A	CLINICAL
NM_005633.3(SOS1):c.1654A>G (p.Arg552Gly)	SOS1	R552G	Normal	not provided|Noonan syndrome 4|Gingival fibromatosis 1|Noonan syndrome 4|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012871	2	39249915	2	39022774	12871	27910	rs137852814	NC_000002.12:39022773:T:C	T	C	CLINICAL
NM_020919.4(ALS2):c.1233T>G (p.Tyr411Ter)	ALS2	Y411*	Normal	Infantile-onset ascending hereditary spastic paralysis|Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533743	2	202622363	2	201757640	533743	517535	rs369577952	NC_000002.12:201757639:A:C	A	C	CLINICAL
NM_015189.3(EXOC6B):c.1299T>G (p.Tyr433Ter)	EXOC6B	Y433*, Y320*	Normal	not provided	Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421388	2	72725621	2	72498492	421388	406011	rs1064795104	NC_000002.12:72498491:A:C	A	C	CLINICAL
NM_003590.5(CUL3):c.173A>G (p.Tyr58Cys)	CUL3	Y58C, Y64C	Normal	NEURODEVELOPMENTAL DISORDER WITHOUT AUTISM OR SEIZURES|Autosomal dominant pseudohypoaldosteronism type 1|not provided	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000559557	2	225422467	2	224557750	559557	550280	rs1553535841	NC_000002.12:224557749:T:C	T	C	CLINICAL
NM_015120.4(ALMS1):c.10079-1G>C	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000557183	2	73784346	2	73557219	557183	542676	rs1361885101	NC_000002.12:73557218:G:C	G	C	CLINICAL
NM_015120.4(ALMS1):c.1240+2T>C	ALMS1		Normal	not provided|Alstrom syndrome	Likely pathogenic(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000390220	2	73652032	2	73424904	390220	366694	rs916056435	NC_000002.12:73424903:T:C	T	C	CLINICAL
NM_015120.4(ALMS1):c.646+2T>C	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000660041	2	73646448	2	73419320	660041	651006	rs1572911143	NC_000002.12:73419319:T:C	T	C	CLINICAL
NM_002500.4(NEUROD1):c.309C>G (p.Arg103=)	NEUROD1		Normal	Maturity-onset diabetes of the young type 6	Pathogenic	no assertion criteria provided	VCV000218145	2	182543279	2	181678552	218145	214793	rs149703259	NC_000002.12:181678551:G:C	G	C	CLINICAL
NM_005544.2(IRS1):c.1823C>G (p.Thr608Arg)	IRS1	T608R	Normal	Type 2 diabetes mellitus	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000029762	2	227661632	2	226796916	29762	38717	rs104893642	NC_000002.12:226796915:G:C	G	C	CLINICAL
NM_000408.5(GPD2):c.1904T>C (p.Phe635Ser)	GPD2	F635S	Normal	Type 2 diabetes mellitus	Pathogenic(Last reviewed: Feb 24, 1997)	no assertion criteria provided	VCV000016081	2	157435621	2	156579109	16081	31120	rs121918407	NC_000002.12:156579108:T:C	T	C	CLINICAL
NM_014585.6(SLC40A1):c.430A>G (p.Asn144Asp)	SLC40A1	N144D	Normal	Hemochromatosis type 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801843	2	190436525	2	189571799	801843	790140	rs104893662	NC_000002.12:189571798:T:C	T	C	CLINICAL
NM_152384.3(BBS5):c.619-1G>C	BBS5		Normal	Bardet-Biedl syndrome 5|Bardet-Biedl syndrome|Retinal dystrophy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000812227	2	170354136	2	169497626	812227	800686	rs753234582	NC_000002.12:169497625:G:C	G	C	CLINICAL
NM_152384.3(BBS5):c.143-1G>C	BBS5		Normal	Bardet-Biedl syndrome 5|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000569727	2	170343578	2	169487068	569727	557725	rs1054138918	NC_000002.12:169487067:G:C	G	C	CLINICAL
NM_023083.4(CAPN10):c.471-187T>C	CAPN10		Normal	Polycystic ovary syndrome, susceptibility to|Type 2 diabetes mellitus	risk factor(Last reviewed: Nov 1, 2003)	no assertion criteria provided	VCV000005096	2	241531163	2	240591746	5096	20135	rs2975760	NC_000002.12:240591745:T:C	T	C	CLINICAL
NM_012233.3(RAB3GAP1):c.52A>C (p.Thr18Pro)	RAB3GAP1	T18P	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000100771	2	135810033	2	135052463	100771	106637	rs587777154	NC_000002.12:135052462:A:C	A	C	CLINICAL
NM_012233.3(RAB3GAP1):c.560G>C (p.Arg187Pro)	RAB3GAP1	R187P	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000545409	2	135872863	2	135115293	545409	535674	rs1553444935	NC_000002.12:135115292:G:C	G	C	CLINICAL
NM_006895.3(HNMT):c.623T>C (p.Leu208Pro)	HNMT	L208P	Normal	Mental retardation, autosomal recessive 51	Pathogenic(Last reviewed: Oct 15, 2015)	no assertion criteria provided	VCV000219126	2	138771444	2	138013874	219126	216928	rs745756308	NC_000002.12:138013873:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.3356A>G (p.Gln1119Arg)	ZEB2	Q1119R, Q1095R	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000004768	2	145147307	2	144389740	4768	19807	rs137852983	NC_000002.12:144389739:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.3164A>G (p.Tyr1055Cys)	ZEB2	Y1055C, Y1031C	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000431481	2	145147499	2	144389932	431481	424988	rs1135402759	NC_000002.12:144389931:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.3134A>G (p.His1045Arg)	ZEB2	H1045R, H1021R	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056827	2	145147529	2	144389962	56827	71450	rs397515449	NC_000002.12:144389961:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.3122A>G (p.His1041Arg)	ZEB2	H1017R, H1041R	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801753	2	145147541	2	144389974	801753	790046	rs1573708153	NC_000002.12:144389973:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.3023T>G (p.Phe1008Cys)	ZEB2	F1008C, F984C	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547836	2	145154023	2	144396456	547836	537691	rs1553961332	NC_000002.12:144396455:A:C	A	C	CLINICAL
NM_014795.4(ZEB2):c.2555C>G (p.Ser852Ter)	ZEB2	S852*, S828*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004762	2	145156199	2	144398632	4762	19801	rs137852982	NC_000002.12:144398631:G:C	G	C	CLINICAL
NM_014795.4(ZEB2):c.1277T>G (p.Leu426Ter)	ZEB2	L426*, L402*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189273	2	145157477	2	144399910	189273	187163	rs786204807	NC_000002.12:144399909:A:C	A	C	CLINICAL
NM_014795.4(ZEB2):c.899A>G (p.His300Arg)	ZEB2	H300R, H276R	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 18, 2019)	no assertion criteria provided	VCV000807725	2	145158783	2	144401216	807725	798481	rs1573718595	NC_000002.12:144401215:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.808-2A>G	ZEB2		Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000569478	2	145158876	2	144401309	569478	557565	rs1560607925	NC_000002.12:144401308:T:C	T	C	CLINICAL
NM_014795.4(ZEB2):c.660C>G (p.Tyr220Ter)	ZEB2	Y220*, Y196*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189269	2	145161630	2	144404063	189269	187168	rs111724246	NC_000002.12:144404062:G:C	G	C	CLINICAL
NM_025000.4(DCAF17):c.982-2A>C	DCAF17		Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Likely pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000582382	2	172330374	2	171473864	582382	558913	rs780493577	NC_000002.12:171473863:A:C	A	C	CLINICAL
NM_001303052.2(MYT1L):c.1923T>G (p.Tyr641Ter)	MYT1L	Y639*, Y641*	Normal	Mental retardation, autosomal dominant 39	Pathogenic(Last reviewed: Aug 30, 2016)	no assertion criteria provided	VCV000208429	2	1906961	2	1903189	208429	204647	rs869320676	NC_000002.12:1903188:A:C	A	C	CLINICAL
NM_024989.4(PGAP1):c.2274C>G (p.Tyr758Ter)	PGAP1	Y369*, Y758*, Y584*	Normal	Mental retardation, autosomal recessive 42	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801847	2	197710618	2	196845894	801847	790145	rs1576086299	NC_000002.12:196845893:G:C	G	C	CLINICAL
NM_024989.4(PGAP1):c.1090-2A>G	PGAP1		Normal	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: May 24, 2021)	no assertion criteria provided	VCV000222981	2	197755637	2	196890913	222981	224702	rs869025581	NC_000002.12:196890912:T:C	T	C	CLINICAL
NM_002156.5(HSPD1):c.86A>G (p.Asp29Gly)	HSPD1	D29G	Normal	Leukodystrophy, hypomyelinating, 4	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000017558	2	198363487	2	197498763	17558	32597	rs72466451	NC_000002.12:197498762:T:C	T	C	CLINICAL
NM_001172509.2(SATB2):c.598-2A>G	SATB2		Normal	Intellectual disability	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625206	2	200233432	2	199368709	625206	613549	rs1574554519	NC_000002.12:199368708:T:C	T	C	CLINICAL
NM_002491.3(NDUFB3):c.64T>C (p.Trp22Arg)	NDUFB3	W22R	Normal	Mitochondrial complex 1 deficiency, nuclear type 25|Mitochondrial complex I deficiency, nuclear type 1|Mitochondrial complex I deficiency|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000252575	2	201943669	2	201078946	252575	246907	rs142609245	NC_000002.12:201078945:T:C	T	C	CLINICAL
NM_013335.4(GMPPA):c.1000A>C (p.Thr334Pro)	GMPPA|ASIC4-AS1	T334P	Normal	Alacrima, achalasia, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088692	2	220370982	2	219506260	88692	94272	rs397518461	NC_000002.12:219506259:A:C	A	C	CLINICAL
NM_004321.7(KIF1A):c.4016-2A>G	KIF1A		Normal	Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000574244	2	241662977	2	240723560	574244	557970	rs1559477798	NC_000002.12:240723559:T:C	T	C	CLINICAL
NM_004321.7(KIF1A):c.919C>G (p.Arg307Gly)	KIF1A	R307G	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000435636	2	241715307	2	240775890	435636	428023	rs369692236	NC_000002.12:240775889:G:C	G	C	CLINICAL
NM_004321.7(KIF1A):c.737T>G (p.Leu246Arg)	KIF1A	L246R	Normal	Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000647033	2	241723217	2	240783800	647033	629739	rs1575626071	NC_000002.12:240783799:A:C	A	C	CLINICAL
NM_004321.7(KIF1A):c.265T>G (p.Tyr89Asp)	KIF1A	Y89D	Normal	Intellectual disability, autosomal dominant 9	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224157	2	241727566	2	240788149	224157	225885	rs869312711	NC_000002.12:240788148:A:C	A	C	CLINICAL
NM_003108.4(SOX11):c.178T>C (p.Ser60Pro)	SOX11	S60P	Normal	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: Jun 2, 2014)	no assertion criteria provided	VCV000139530	2	5833031	2	5692899	139530	143174	rs587777480	NC_000002.12:5692898:T:C	T	C	CLINICAL
NM_003108.4(SOX11):c.353A>C (p.Tyr118Ser)	SOX11	Y118S	Normal	Mental retardation, autosomal dominant 27	Pathogenic(Last reviewed: Jul 30, 2018)	no assertion criteria provided	VCV000807694	2	5833206	2	5693074	807694	798510	rs1572216329	NC_000002.12:5693073:A:C	A	C	CLINICAL
NM_015575.4(GIGYF2):c.1370A>C (p.Asn457Thr)	GIGYF2	N457T, N451T, N478T	Normal	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000754	2	233659545	2	232794835	754	15793	rs116074753	NC_000002.12:232794834:A:C	A	C	CLINICAL
NM_004082.4(DCTN1):c.1712T>C (p.Met571Thr)	DCTN1	M571T, M437T, M534T, M564T, M551T	Normal	Amyotrophic lateral sclerosis, susceptibility to	risk factor(Last reviewed: Aug 24, 2004)	no assertion criteria provided	VCV000008403	2	74595997	2	74368870	8403	23442	rs121909343	NC_000002.12:74368869:A:G	A	G	CLINICAL
NM_022893.4(BCL11A):c.385+2T>C	BCL11A		Normal	Intellectual developmental disorder with persistence of fetal hemoglobin|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521857	2	60773104	2	60545969	521857	511432	rs1553352926	NC_000002.12:60545968:A:G	A	G	CLINICAL
NM_022893.4(BCL11A):c.139A>C (p.Thr47Pro)	BCL11A	T47P	Normal	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253300	2	60773352	2	60546217	253300	247743	rs886037864	NC_000002.12:60546216:T:G	T	G	CLINICAL
NM_006593.4(TBR1):c.1165A>G (p.Lys389Glu)	TBR1	K389E	Normal	Autism 5	Pathogenic(Last reviewed: Dec 19, 2018)	no assertion criteria provided	VCV000599053	2	162276743	2	161420232	599053	590230	rs1553510677	NC_000002.12:161420231:A:G	A	G	CLINICAL
NM_015120.4(ALMS1):c.2T>G (p.Met1Arg)	ALMS1	M1R	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000551649	2	73612998	2	73385870	551649	542401	rs1553396091	NC_000002.12:73385869:T:G	T	G	CLINICAL
NM_001378454.1(ALMS1):c.4743C>G (p.Tyr1581Ter)	ALMS1	Y1582*, Y1581*	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV000638587	2	73678397	2	73451270	638587	626367	rs1572935708	NC_000002.12:73451269:C:G	C	G	CLINICAL
NM_015120.4(ALMS1):c.7675-2A>G	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000557127	2	73716759	2	73489632	557127	542689	rs748477695	NC_000002.12:73489631:A:G	A	G	CLINICAL
NM_015120.4(ALMS1):c.3870T>G (p.Tyr1290Ter)	ALMS1	Y1290*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000648250	2	73677521	2	73450394	648250	630487	rs369314182	NC_000002.12:73450393:T:G	T	G	CLINICAL
NM_015120.4(ALMS1):c.5145T>G (p.Tyr1715Ter)	ALMS1	Y1715*	Normal	Retinal dystrophy, early-onset severe|Alstrom syndrome|not provided	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212728	2	73678796	2	73451669	212728	209346	rs772136379	NC_000002.12:73451668:T:G	T	G	CLINICAL
NM_015120.4(ALMS1):c.1730C>G (p.Ser577Ter)	ALMS1	S577*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801720	2	73675381	2	73448254	801720	790290	rs756389027	NC_000002.12:73448253:C:G	C	G	CLINICAL
NM_015120.4(ALMS1):c.9194T>G (p.Leu3065Ter)	ALMS1	L3065*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801722	2	73718277	2	73491150	801722	790292	rs1434010689	NC_000002.12:73491149:T:G	T	G	CLINICAL
NM_152384.3(BBS5):c.166A>G (p.Arg56Gly)	BBS5	R56G	Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585188	2	170343602	2	169487092	585188	576216	rs1559121920	NC_000002.12:169487091:A:G	A	G	CLINICAL
NM_015120.4(ALMS1):c.5906C>G (p.Ser1969Ter)	ALMS1	S1969*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000662562	2	73679557	2	73452430	662562	630494	rs1490127694	NC_000002.12:73452429:C:G	C	G	CLINICAL
NM_000122.1(ERCC3):c.355A>C (p.Thr119Pro)	ERCC3	T119P, T55P	Normal	Trichothiodystrophy 2, photosensitive	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000016584	2	128050302	2	127292726	16584	31623	rs121913046	NC_000002.12:127292725:T:G	T	G	CLINICAL
NM_012233.3(RAB3GAP1):c.649-2A>G	RAB3GAP1		Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000007057	2	135878387	2	135120817	7057	22096	rs730882183	NC_000002.12:135120816:A:G	A	G	CLINICAL
NM_012233.3(RAB3GAP1):c.1237-2A>G	RAB3GAP1		Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623318	2	135890463	2	135132893	623318	612346	rs1558792168	NC_000002.12:135132892:A:G	A	G	CLINICAL
NM_012233.3(RAB3GAP1):c.1310C>G (p.Ser437Ter)	RAB3GAP1	S437*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560923	2	135890538	2	135132968	560923	552049	rs1558792256	NC_000002.12:135132967:C:G	C	G	CLINICAL
NM_012233.3(RAB3GAP1):c.1908C>G (p.Tyr636Ter)	RAB3GAP1	Y636*	Normal	Warburg micro syndrome 1|not provided	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635325	2	135893487	2	135135917	635325	623129	rs1573585099	NC_000002.12:135135916:C:G	C	G	CLINICAL
NM_012233.3(RAB3GAP1):c.2642T>G (p.Leu881Ter)	RAB3GAP1	L881*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 13, 2015)	criteria provided, multiple submitters, no conflicts	VCV000211979	2	135922199	2	135164629	211979	206843	rs797045905	NC_000002.12:135164628:T:G	T	G	CLINICAL
NM_014795.4(ZEB2):c.3211T>C (p.Ser1071Pro)	ZEB2	S1071P, S1047P	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056826	2	145147452	2	144389885	56826	71449	rs397515448	NC_000002.12:144389884:A:G	A	G	CLINICAL
NM_014795.4(ZEB2):c.73+2T>C	ZEB2		Normal	not provided|Mowat-Wilson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095639	2	145274843	2	144517276	95639	101537	rs398124282	NC_000002.12:144517275:A:G	A	G	CLINICAL
NM_018328.4(MBD5):c.440C>G (p.Ser147Ter)	MBD5	S147*	Normal	not provided|Mental retardation, autosomal dominant 1	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000267726	2	149225952	2	148468383	267726	262998	rs886041003	NC_000002.12:148468382:C:G	C	G	CLINICAL
NM_001165963.4(SCN1A):c.5422T>C (p.Phe1808Leu)	SCN1A|LOC102724058	F1797L, F1808L, F1779L, F1780L, F994L, F1796L	Normal	not provided|Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000068661	2	166848363	2	165991853	68661	79553	rs121918757	NC_000002.12:165991852:A:G	A	G	CLINICAL
NM_001165963.4(SCN1A):c.3706G>C (p.Ala1236Pro)	SCN1A|LOC102724058	A1225P, A1236P, A1208P, A1224P, A1207P, A422P	Normal	Intellectual disability|Severe myoclonic epilepsy in infancy	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189933	2	166868792	2	166012282	189933	187768	rs794726770	NC_000002.12:166012281:C:G	C	G	CLINICAL
NM_025000.4(DCAF17):c.1091+6T>G	DCAF17		Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000533	2	172330491	2	171473981	533	15572	rs1559289651	NC_000002.12:171473980:T:G	T	G	CLINICAL
NM_001303052.2(MYT1L):c.1559T>C (p.Leu520Pro)	MYT1L	L520P, L518P	Normal	Mental retardation, autosomal dominant 39	Likely pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000375549	2	1921036	2	1917264	375549	362360	rs1057519560	NC_000002.12:1917263:A:G	A	G	CLINICAL
NM_024989.4(PGAP1):c.2338-2A>C	PGAP1		Normal	Mental retardation, autosomal recessive 42	Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000571870	2	197708801	2	196844077	571870	559514	rs1559328283	NC_000002.12:196844076:T:G	T	G	CLINICAL
NM_033066.3(MPP4):c.946T>C (p.Trp316Arg)	MPP4	W316R	Normal	Generalized hypotonia|Wide nasal bridge|Seizures|High palate|Intellectual disability|Strabismus|Global developmental delay	Pathogenic	no assertion criteria provided	VCV000375383	2	202539978	2	201675255	375383	362135	rs1057519443	NC_000002.12:201675254:A:G	A	G	CLINICAL
NM_181458.4(PAX3):c.124G>C (p.Gly42Arg)	PAX3	G42R	Normal	Intellectual disability|Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488034	2	223161894	2	222297175	488034	481054	rs773327091	NC_000002.12:222297174:C:G	C	G	CLINICAL
NM_004321.7(KIF1A):c.4565+1G>C	KIF1A		Normal	Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive	Likely pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000532856	2	241660330	2	240720913	532856	518077	rs1553624714	NC_000002.12:240720912:C:G	C	G	CLINICAL
NM_004321.7(KIF1A):c.2089+1G>C	KIF1A		Normal	Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive	Likely pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000532854	2	241702135	2	240762718	532854	518099	rs1553633687	NC_000002.12:240762717:C:G	C	G	CLINICAL
NM_001244008.1(KIF1A):c.833T>C (p.Leu278Pro)	KIF1A	L278P	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic	no assertion criteria provided	VCV000430721	2	241722492	2	240783075	430721	424260	rs1131692159	NC_000002.12:240783074:A:G	A	G	CLINICAL
NM_004321.7(KIF1A):c.799G>C (p.Glu267Gln)	KIF1A	E267Q	Normal	Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC	Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000645308	2	241722526	2	240783109	645308	629738	rs1553637932	NC_000002.12:240783108:C:G	C	G	CLINICAL
NM_004321.7(KIF1A):c.643A>C (p.Ser215Arg)	KIF1A	S215R	Normal	Intellectual disability, autosomal dominant 9|not provided	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162057	2	241724483	2	240785066	162057	171775	rs672601367	NC_000002.12:240785065:T:G	T	G	CLINICAL
NM_004321.7(KIF1A):c.604G>C (p.Ala202Pro)	KIF1A	A202P	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV000162056	2	241725756	2	240786339	162056	171776	rs672601366	NC_000002.12:240786338:C:G	C	G	CLINICAL
NM_004321.7(KIF1A):c.506G>C (p.Arg169Thr)	KIF1A	R169T	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666256	2	241725854	2	240786437	666256	653809	rs876661168	NC_000002.12:240786436:C:G	C	G	CLINICAL
NM_015662.3(IFT172):c.4607T>C (p.Leu1536Pro)	IFT172	L1536P	Normal	Short-rib thoracic dysplasia 10 without polydactyly	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000097025	2	27670434	2	27447567	97025	102930	rs587777080	NC_000002.12:27447566:A:G	A	G	CLINICAL
NM_022893.4(BCL11A):c.152G>C (p.Cys51Ser)	BCL11A	C51S	Normal	Microcephaly|Profound global developmental delay|Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	VCV000598955	2	60773339	2	60546204	598955	590046	rs1558519731	NC_000002.12:60546203:C:G	C	G	CLINICAL
NM_003124.5(SPR):c.305-2A>G	SPR		Normal	Dystonia|Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625209	2	73115441	2	72888312	625209	613550	rs1573882268	NC_000002.12:72888311:A:G	A	G	CLINICAL
NM_004082.4(DCTN1):c.221A>C (p.Gln74Pro)	DCTN1	Q74P, Q57P	Normal	Perry syndrome|not provided	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, single submitter	VCV000008407	2	74605185	2	74378058	8407	23446	rs72466487	NC_000002.12:74378057:T:G	T	G	CLINICAL
NM_003896.4(ST3GAL5):c.584G>C (p.Cys195Ser)	ST3GAL5	C195S, C167S, C172S, C67S	Normal	GM3 synthase deficiency	Pathogenic(Last reviewed: Sep 16, 2016)	no assertion criteria provided	VCV000254245	2	86075062	2	85847939	254245	248759	rs886037930	NC_000002.12:85847938:C:G	C	G	CLINICAL
NM_015575.4(GIGYF2):c.167A>G (p.Asn56Ser)	GIGYF2	N56S	Normal	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000753	2	233612450	2	232747740	753	15792	rs72554080	NC_000002.12:232747739:A:G	A	G	CLINICAL
NM_015575.4(GIGYF2):c.832A>G (p.Ile278Val)	GIGYF2	I278V, I272V, I300V	Normal	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000756	2	233655527	2	232790817	756	15795	rs118203904	NC_000002.12:232790816:A:G	A	G	CLINICAL
NM_015575.4(GIGYF2):c.1262A>G (p.Lys421Arg)	GIGYF2	K421R, K415R, K442R	Normal	Parkinson disease 11	risk factor(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000757	2	233656136	2	232791426	757	15796	rs115735611	NC_000002.12:232791425:A:G	A	G	CLINICAL
NM_015575.4(GIGYF2):c.1818C>G (p.Asp606Glu)	GIGYF2	D606E, D627E, D600E	Normal	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000755	2	233674441	2	232809731	755	15794	rs118203903	NC_000002.12:232809730:C:G	C	G	CLINICAL
NM_013247.4(HTRA2):c.427C>G (p.Pro143Ala)	HTRA2	P143A	Normal	Parkinson disease 13	risk factor(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030583	2	74757560	2	74530433	30583	39540	rs387906942	NC_000002.12:74530432:C:G	C	G	CLINICAL
NM_020919.4(ALS2):c.4022G>A (p.Arg1341His)	ALS2	R1341H	Normal	Amyotrophic lateral sclerosis type 2|Peripheral axonal neuropathy	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374111	2	202575814	2	201711091	374111	360832	rs761291489	NC_000002.12:201711090:C:T	C	T	CLINICAL
NM_005235.3(ERBB4):c.3814G>A (p.Gly1272Arg)	ERBB4	G1256R, G1272R	Normal	Amyotrophic lateral sclerosis	Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV000976654	2	212248453	2	211383728	976654	964789	rs371332509	NC_000002.12:211383727:C:T	C	T	CLINICAL
NM_005235.3(ERBB4):c.2780G>A (p.Arg927Gln)	ERBB4	R927Q	Normal	Amyotrophic lateral sclerosis 19|not provided	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000064625	2	212288966	2	211424241	64625	75589	rs397514262	NC_000002.12:211424240:C:T	C	T	CLINICAL
NM_005235.3(ERBB4):c.2207T>A (p.Ile736Asn)	ERBB4	I736N	Normal	Amyotrophic lateral sclerosis 19	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801872	2	212483996	2	211619271	801872	790172	rs1574867228	NC_000002.12:211619270:A:T	A	T	CLINICAL
NM_006000.3(TUBA4A):c.1220G>A (p.Trp407Ter)	TUBA4A	W407*, W392*	Normal	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180184	2	220115201	2	219250479	180184	178367	rs730880027	NC_000002.12:219250478:C:T	C	T	CLINICAL
NM_006000.3(TUBA4A):c.1147G>A (p.Ala383Thr)	TUBA4A	A383T, A368T	Normal	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180186	2	220115274	2	219250552	180186	178369	rs368743618	NC_000002.12:219250551:C:T	C	T	CLINICAL
NM_006000.3(TUBA4A):c.959G>A (p.Arg320His)	TUBA4A	R320H, R305H	Normal	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180183	2	220115462	2	219250740	180183	178366	rs730880026	NC_000002.12:219250739:C:T	C	T	CLINICAL
NM_022893.4(BCL11A):c.198C>A (p.His66Gln)	BCL11A	H66Q	Normal	Intellectual developmental disorder with persistence of fetal hemoglobin	Pathogenic(Last reviewed: Sep 8, 2016)	no assertion criteria provided	VCV000253302	2	60773293	2	60546158	253302	247745	rs886037866	NC_000002.12:60546157:G:T	G	T	CLINICAL
NM_001374353.1(GLI2):c.4603A>T (p.Thr1535Ser)	GLI2	T1552S, T1535S, T1410S	Normal	Holoprosencephaly 9	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	VCV000374267	2	121748144	2	120990568	374267	361165	rs1057518657	NC_000002.12:120990567:A:T	A	T	CLINICAL
NM_018328.4(MBD5):c.973C>T (p.Arg325Ter)	MBD5	R325*	Normal	Intellectual disability|Inborn genetic diseases|Autism spectrum disorder	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521004	2	149226485	2	148468916	521004	511323	rs1553518509	NC_000002.12:148468915:C:T	C	T	CLINICAL
NM_013450.4(BAZ2B):c.2126G>A (p.Cys709Tyr)	BAZ2B	C646Y, C707Y, C709Y	Normal	Neurodevelopmental disorder	Pathogenic(Last reviewed: Sep 12, 2017)	no assertion criteria provided	VCV000800362	2	160287442	2	159430931	800362	788959	rs1576949430	NC_000002.12:159430930:C:T	C	T	CLINICAL
NM_006593.4(TBR1):c.813G>T (p.Trp271Cys)	TBR1	W271C	Normal	Autism 5	Pathogenic(Last reviewed: Jan 2, 2019)	no assertion criteria provided	VCV000599052	2	162274307	2	161417796	599052	590229	rs1559060428	NC_000002.12:161417795:G:T	G	T	CLINICAL
NM_001040142.2(SCN2A):c.1747C>T (p.Arg583Ter)	SCN2A	R583*	Normal	not provided	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000620152	2	166179741	2	165323231	620152	611535	rs1553571901	NC_000002.12:165323230:C:T	C	T	CLINICAL
NM_001040142.2(SCN2A):c.4303C>T (p.Arg1435Ter)	SCN2A	R1435*	Normal	Intellectual disability|Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11|not provided|Early infantile epileptic encephalopathy 11	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419721	2	166234155	2	165377645	419721	405354	rs796053138	NC_000002.12:165377644:C:T	C	T	CLINICAL
NM_001040142.2(SCN2A):c.5318C>T (p.Ala1773Val)	SCN2A	A1773V	Normal	Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11|Complex neurodevelopmental disorder|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000520893	2	166245634	2	165389124	520893	511350	rs1553463602	NC_000002.12:165389123:C:T	C	T	CLINICAL
NM_001039523.3(CHRNA1):c.1396G>A (p.Gly466Arg)	CHRNA1	G441R, G466R	Normal	not provided|Lethal multiple pterygium syndrome|Autistic disorder of childhood onset|Seizures	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449923	2	175612905	2	174748177	449923	443058	rs768407867	NC_000002.12:174748176:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.10549C>T (p.Gln3517Ter)	ALMS1	Q3517*	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000551455	2	73799550	2	73572423	551455	542720	rs375019820	NC_000002.12:73572422:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.5146A>T (p.Arg1716Ter)	ALMS1	R1716*	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000488175	2	73678797	2	73451670	488175	481124	rs773513360	NC_000002.12:73451669:A:T	A	T	CLINICAL
NM_015120.4(ALMS1):c.12114+1G>T	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000555419	2	73828564	2	73601437	555419	542851	rs376719320	NC_000002.12:73601436:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.1432+1G>T	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000556522	2	73659420	2	73432292	556522	542355	rs1553401634	NC_000002.12:73432291:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.9539+1G>T	ALMS1		Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000552716	2	73718626	2	73491499	552716	542702	rs1553409901	NC_000002.12:73491498:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.5243A>T (p.Gln1748Leu)	ALMS1	Q1748L	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812222	2	73678894	2	73451767	812222	800475	rs1572936360	NC_000002.12:73451766:A:T	A	T	CLINICAL
NM_015120.4(ALMS1):c.3784G>T (p.Glu1262Ter)	ALMS1	E1262*	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225295	2	73677435	2	73450308	225295	227247	rs1085307054	NC_000002.12:73450307:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.10G>T (p.Glu4Ter)	ALMS1	E4*	Normal	Alstrom syndrome	Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000554597	2	73613006	2	73385878	554597	542207	rs1553396092	NC_000002.12:73385877:G:T	G	T	CLINICAL
NM_001378454.1(ALMS1):c.1897C>T (p.Gln633Ter)	ALMS1	Q634*, Q633*	Normal	not provided|Alstrom syndrome	Pathogenic	criteria provided, single submitter	VCV000092240	2	73675551	2	73448424	92240	98152	rs398122995	NC_000002.12:73448423:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.4183C>T (p.Gln1395Ter)	ALMS1	Q1395*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	VCV000459866	2	73677834	2	73450707	459866	451643	rs969786171	NC_000002.12:73450706:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.11449C>T (p.Gln3817Ter)	ALMS1	Q3817*	Normal	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620477	2	73800450	2	73573323	620477	611575	rs940576720	NC_000002.12:73573322:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.8008C>T (p.Arg2670Ter)	ALMS1	R2670*	Normal	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000529386	2	73717091	2	73489964	529386	518587	rs549857076	NC_000002.12:73489963:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.10945G>T (p.Glu3649Ter)	ALMS1	E3649*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000039748	2	73799946	2	73572819	39748	48347	rs397514576	NC_000002.12:73572818:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.10885C>T (p.Arg3629Ter)	ALMS1	R3629*	Normal	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434136	2	73799886	2	73572759	434136	428097	rs1473611414	NC_000002.12:73572758:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.6436C>T (p.Arg2146Ter)	ALMS1	R2146*	Normal	Alstrom syndrome|Retinal dystrophy	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210129	2	73680087	2	73452960	210129	207022	rs770558150	NC_000002.12:73452959:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.10483C>T (p.Gln3495Ter)	ALMS1	Q3495*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000210122	2	73799484	2	73572357	210122	207024	rs772624348	NC_000002.12:73572356:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.808C>T (p.Arg270Ter)	ALMS1	R270*	Normal	Cone-rod degeneration|Alstrom syndrome	Pathogenic(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000812221	2	73651598	2	73424470	812221	800474	rs1426009756	NC_000002.12:73424469:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.9541C>T (p.Arg3181Ter)	ALMS1	R3181*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000583154	2	73718624	2	73491497	583154	558277	rs563393715	NC_000002.12:73491496:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.301G>T (p.Glu101Ter)	ALMS1	E101*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000661135	2	73613294	2	73386166	661135	630481	rs1254495717	NC_000002.12:73386165:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.8164C>T (p.Arg2722Ter)	ALMS1	R2722*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV000003975	2	73717247	2	73490120	3975	19014	rs193919340	NC_000002.12:73490119:C:T	C	T	CLINICAL
NM_003597.5(KLF11):c.1039G>T (p.Ala347Ser)	KLF11	A330S, A347S	Normal	Maturity-onset diabetes of the young type 7	Pathogenic(Last reviewed: Mar 29, 2005)	no assertion criteria provided	VCV000006498	2	10188503	2	10048376	6498	21537	rs121912645	NC_000002.12:10048375:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.8383C>T (p.Gln2795Ter)	ALMS1	Q2795*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000003970	2	73717466	2	73490339	3970	19009	rs193919338	NC_000002.12:73490338:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.1054C>T (p.Arg352Ter)	ALMS1	R352*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459845	2	73651844	2	73424716	459845	451767	rs1275113273	NC_000002.12:73424715:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.2329C>T (p.Gln777Ter)	ALMS1	Q777*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801721	2	73675980	2	73448853	801721	790291	rs758195453	NC_000002.12:73448852:C:T	C	T	CLINICAL
NM_152384.3(BBS5):c.265C>T (p.Arg89Ter)	BBS5	R89*	Normal	not provided|Bardet-Biedl syndrome 5|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000531823	2	170344503	2	169487993	531823	516815	rs772757329	NC_000002.12:169487992:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.4393C>T (p.Gln1465Ter)	ALMS1	Q1465*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000529397	2	73678044	2	73450917	529397	518655	rs904289501	NC_000002.12:73450916:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.10825C>T (p.Arg3609Ter)	ALMS1	R3609*	Normal	not provided|Alstrom syndrome	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488677	2	73799826	2	73572699	488677	481663	rs1192396248	NC_000002.12:73572698:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.5590C>T (p.Gln1864Ter)	ALMS1	Q1864*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000403915	2	73679241	2	73452114	403915	393456	rs769440001	NC_000002.12:73452113:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.1819G>T (p.Gly607Ter)	ALMS1	G607*	Normal	Alstrom syndrome	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000459853	2	73675470	2	73448343	459853	451845	rs1553403321	NC_000002.12:73448342:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.712G>T (p.Glu238Ter)	ALMS1	E238*	Normal	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000555777	2	73650047	2	73422919	555777	542190	rs989080548	NC_000002.12:73422918:G:T	G	T	CLINICAL
NM_015120.4(ALMS1):c.5200C>T (p.Gln1734Ter)	ALMS1	Q1734*	Normal	Alstrom syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000529398	2	73678851	2	73451724	529398	518733	rs750136202	NC_000002.12:73451723:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.430C>T (p.Gln144Ter)	ALMS1	Q144*	Normal	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551028	2	73635852	2	73408724	551028	542158	rs150825781	NC_000002.12:73408723:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.286C>T (p.Gln96Ter)	ALMS1	Q96*	Normal	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556723	2	73613279	2	73386151	556723	542151	rs750326619	NC_000002.12:73386150:C:T	C	T	CLINICAL
NM_015120.4(ALMS1):c.358C>T (p.Gln120Ter)	ALMS1	Q120*	Normal	Alstrom syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550543	2	73635780	2	73408652	550543	542438	rs751804613	NC_000002.12:73408651:C:T	C	T	CLINICAL
NM_005544.2(IRS1):c.2911G>A (p.Gly971Arg)	IRS1	G971R	Normal	Insulin resistance, susceptibility to|Coronary artery disease, susceptibility to	risk factor(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000029761	2	227660544	2	226795828	29761	38716	rs1801278	NC_000002.12:226795827:C:T	C	T	CLINICAL
NM_012233.3(RAB3GAP1):c.71A>T (p.Glu24Val)	RAB3GAP1	E24V	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000100772	2	135810052	2	135052482	100772	106638	rs587777155	NC_000002.12:135052481:A:T	A	T	CLINICAL
NM_012233.3(RAB3GAP1):c.469G>T (p.Gly157Ter)	RAB3GAP1	G157*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561095	2	135870827	2	135113257	561095	552048	rs1558782178	NC_000002.12:135113256:G:T	G	T	CLINICAL
NM_012233.3(RAB3GAP1):c.559C>T (p.Arg187Ter)	RAB3GAP1	R187*	Normal	Warburg micro syndrome 1	Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800891	2	135872862	2	135115292	800891	788741	rs764260054	NC_000002.12:135115291:C:T	C	T	CLINICAL
NM_012233.3(RAB3GAP1):c.1009C>T (p.Arg337Ter)	RAB3GAP1	R337*	Normal	not provided|Warburg micro syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000191126	2	135887600	2	135130030	191126	188929	rs766629205	NC_000002.12:135130029:C:T	C	T	CLINICAL
NM_012233.3(RAB3GAP1):c.1039C>T (p.Arg347Ter)	RAB3GAP1	R347*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000545410	2	135887630	2	135130060	545410	535675	rs532964185	NC_000002.12:135130059:C:T	C	T	CLINICAL
NM_012233.3(RAB3GAP1):c.2011C>T (p.Arg671Ter)	RAB3GAP1	R671*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000007059	2	135908026	2	135150456	7059	22098	rs137853052	NC_000002.12:135150455:C:T	C	T	CLINICAL
NM_012233.3(RAB3GAP1):c.2491G>T (p.Glu831Ter)	RAB3GAP1	E831*	Normal	Warburg micro syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623319	2	135920556	2	135162986	623319	612347	rs1558805900	NC_000002.12:135162985:G:T	G	T	CLINICAL
NM_014795.4(ZEB2):c.3200C>A (p.Ser1067Ter)	ZEB2	S1067*, S1043*	Normal	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547837	2	145147463	2	144389896	547837	537690	rs1423851170	NC_000002.12:144389895:G:T	G	T	CLINICAL
NM_014795.4(ZEB2):c.3170G>A (p.Cys1057Tyr)	ZEB2	C1057Y, C1033Y	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431116	2	145147493	2	144389926	431116	424640	rs1135401790	NC_000002.12:144389925:C:T	C	T	CLINICAL
NM_014795.4(ZEB2):c.3137C>A (p.Ser1046Ter)	ZEB2	S1046*, S1022*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000212636	2	145147526	2	144389959	212636	206846	rs797046121	NC_000002.12:144389958:G:T	G	T	CLINICAL
NM_014795.4(ZEB2):c.2894T>A (p.Leu965Ter)	ZEB2	L965*, L941*	Normal	Mowat-Wilson syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212635	2	145154152	2	144396585	212635	206847	rs797046120	NC_000002.12:144396584:A:T	A	T	CLINICAL
NM_014795.4(ZEB2):c.2072G>A (p.Trp691Ter)	ZEB2	W691*, W667*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000437332	2	145156682	2	144399115	437332	427887	rs1553961610	NC_000002.12:144399114:C:T	C	T	CLINICAL
NM_014795.4(ZEB2):c.1956C>A (p.Tyr652Ter)	ZEB2	Y652*, Y628*	Normal	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000589324	2	145156798	2	144399231	589324	578959	rs587784563	NC_000002.12:144399230:G:T	G	T	CLINICAL
NM_014795.4(ZEB2):c.1749C>A (p.Cys583Ter)	ZEB2	C583*, C559*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189274	2	145157005	2	144399438	189274	187158	rs786204808	NC_000002.12:144399437:G:T	G	T	CLINICAL
NM_014795.4(ZEB2):c.1106T>A (p.Leu369Ter)	ZEB2	L369*, L345*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000212632	2	145157648	2	144400081	212632	206850	rs797046117	NC_000002.12:144400080:A:T	A	T	CLINICAL
NM_014795.4(ZEB2):c.674C>A (p.Ser225Ter)	ZEB2	S225*, S201*	Normal	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212637	2	145161616	2	144404049	212637	206852	rs797046122	NC_000002.12:144404048:G:T	G	T	CLINICAL
NM_014795.4(ZEB2):c.351T>A (p.Tyr117Ter)	ZEB2	Y117*	Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000567647	2	145182415	2	144424848	567647	557526	rs1560618505	NC_000002.12:144424847:A:T	A	T	CLINICAL
NM_014795.4(ZEB2):c.-69-1G>A	ZEB2		Normal	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000004767	2	145274987	2	144517420	4767	19806	rs587776612	NC_000002.12:144517419:C:T	C	T	CLINICAL
NM_018328.4(MBD5):c.114-2A>T	MBD5		Normal	Mental retardation, autosomal dominant 1	Likely pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000658842	2	149220149	2	148462580	658842	650826	rs1574451881	NC_000002.12:148462579:A:T	A	T	CLINICAL
NM_018328.4(MBD5):c.973C>T (p.Arg325Ter)	MBD5	R325*	Normal	Intellectual disability|Inborn genetic diseases|Autism spectrum disorder	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521004	2	149226485	2	148468916	521004	511323	rs1553518509	NC_000002.12:148468915:C:T	C	T	CLINICAL
NM_018328.4(MBD5):c.2437C>T (p.Gln813Ter)	MBD5	Q813*	Normal	not provided|Mental retardation, autosomal dominant 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000393195	2	149227949	2	148470380	393195	365798	rs1057524832	NC_000002.12:148470379:C:T	C	T	CLINICAL
NM_001206744.2(TPO):c.1558C>T (p.His520Tyr)	TPO	H520Y, H347Y	Normal	Deficiency of iodide peroxidase|Global developmental delay|Delayed speech and language development|Intellectual disability, severe|Protruding tongue|Delayed gross motor development|Short stature|Congenital hypothyroidism	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374178	2	1488587	2	1484815	374178	360819	rs1057518950	NC_000002.12:1484814:C:T	C	T	CLINICAL
NM_005378.6(MYCN):c.217G>T (p.Glu73Ter)	MYCN|MYCNOS	E73*	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000013896	2	16082403	2	15942281	13896	28935	rs113994115	NC_000002.12:15942280:G:T	G	T	CLINICAL
NM_005378.6(MYCN):c.964C>T (p.Arg322Ter)	MYCN	R322*, R111*	Normal	Feingold syndrome 1	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000433151	2	16085788	2	15945666	433151	426709	rs759103701	NC_000002.12:15945665:C:T	C	T	CLINICAL
NM_005378.6(MYCN):c.1117C>T (p.Arg373Ter)	MYCN	R373*, R162*	Normal	not provided|Feingold syndrome 1	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000545970	2	16085941	2	15945819	545970	536234	rs754137452	NC_000002.12:15945818:C:T	C	T	CLINICAL
NM_005378.6(MYCN):c.1181G>T (p.Arg394Leu)	MYCN	R394L, R183L	Normal	Feingold syndrome 1	Likely pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000433153	2	16086005	2	15945883	433153	426712	rs104893648	NC_000002.12:15945882:G:T	G	T	CLINICAL
NM_022168.4(IFIH1):c.2336G>A (p.Arg779His)	IFIH1	R779H	Normal	not provided|Aicardi-Goutieres syndrome 7|Singleton-Merten syndrome 1|Aicardi-Goutieres syndrome 7|Abnormality of the basal ganglia|Neonatal hypotonia|Developmental regression|Abnormality of the cerebral white matter|Hyperreflexia|Abnormal upper motor neuron morphology|Clonus	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137622	2	163130423	2	162273913	137622	141325	rs587777446	NC_000002.12:162273912:C:T	C	T	CLINICAL
NM_001040142.2(SCN2A):c.719C>T (p.Ala240Val)	SCN2A	A240V	Normal	Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449164	2	166166854	2	165310344	449164	442985	rs1553567864	NC_000002.12:165310343:C:T	C	T	CLINICAL
NM_001040142.2(SCN2A):c.1270G>T (p.Val424Leu)	SCN2A	V424L	Normal	Movement disorder|Seizures|Global developmental delay	Likely pathogenic	no assertion criteria provided	VCV000812987	2	166170505	2	165313995	812987	800991	rs1574567728	NC_000002.12:165313994:G:T	G	T	CLINICAL
NM_001040142.2(SCN2A):c.3697G>T (p.Glu1233Ter)	SCN2A	E1233*	Normal	Mental retardation, autosomal dominant	Pathogenic(Last reviewed: Mar 16, 2015)	no assertion criteria provided	VCV000377394	2	166226657	2	165370147	377394	364279	rs1057519617	NC_000002.12:165370146:G:T	G	T	CLINICAL
NM_001040142.2(SCN2A):c.4303C>T (p.Arg1435Ter)	SCN2A	R1435*	Normal	Intellectual disability|Seizures, benign familial infantile, 3|Early infantile epileptic encephalopathy 11|not provided|Early infantile epileptic encephalopathy 11	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419721	2	166234155	2	165377645	419721	405354	rs796053138	NC_000002.12:165377644:C:T	C	T	CLINICAL
NM_001165963.4(SCN1A):c.4907G>A (p.Arg1636Gln)	LOC102724058|SCN1A	R1625Q, R1636Q, R1607Q, R1624Q, R1608Q, R822Q	Normal	Inborn genetic diseases|Early infantile epileptic encephalopathy with suppression bursts|Epileptic encephalopathy Lennox-Gastaut type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000068557	2	166848878	2	165992368	68557	79449	rs121917995	NC_000002.12:165992367:C:T	C	T	CLINICAL
NM_001165963.4(SCN1A):c.4441G>A (p.Val1481Ile)	SCN1A|LOC102724058	V1470I, V1481I, V667I, V1452I, V1453I, V1469I	Normal	Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426175	2	166854583	2	165998073	426175	414841	rs1085307484	NC_000002.12:165998072:C:T	C	T	CLINICAL
NM_001165963.4(SCN1A):c.3852G>A (p.Trp1284Ter)	SCN1A|LOC102724058	W1273*, W1284*, W1255*, W470*, W1272*, W1256*	Normal	not provided	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000523783	2	166868646	2	166012136	523783	514442	rs1553531178	NC_000002.12:166012135:C:T	C	T	CLINICAL
NM_025000.4(DCAF17):c.85C>T (p.Gln29Ter)	METTL8|DCAF17	Q29*	Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000571994	2	172291172	2	171434662	571994	557694	rs868533593	NC_000002.12:171434661:C:T	C	T	CLINICAL
NM_025000.4(DCAF17):c.580C>T (p.Arg194Ter)	DCAF17	R194*	Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804389	2	172309676	2	171453166	804389	792723	rs1470826074	NC_000002.12:171453165:C:T	C	T	CLINICAL
NM_025000.4(DCAF17):c.1422+5G>T	DCAF17		Normal	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000000532	2	172336708	2	171480198	532	15571	rs1314048356	NC_000002.12:171480197:G:T	G	T	CLINICAL
NM_001822.7(CHN1):c.667G>A (p.Ala223Thr)	CHN1	A223T, A98T, A197T, A240T	Normal	Dandy-Walker syndrome|Global developmental delay|Abnormality of the diaphragm|Arachnodactyly|Micrognathia|Abnormality of the vertebral column|Cerebellar vermis hypoplasia|Feeding difficulties|Nyctalopia|Cleft palate|Sensorineural hearing loss|Microglossia|Hydronephrosis|Duane anomaly|Diaphragmatic eventration|Abnormality of the cervical spine|Laryngomalacia|Small hand|Hydroureter	Likely pathogenic	criteria provided, single submitter	VCV000598971	2	175689207	2	174824479	598971	590040	rs1558939623	NC_000002.12:174824478:C:T	C	T	CLINICAL
NM_001303052.2(MYT1L):c.2642+1G>A	MYT1L		Normal	Mental retardation, autosomal dominant 39|not provided	Pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000208428	2	1891259	2	1887487	208428	204646	rs869320675	NC_000002.12:1887486:C:T	C	T	CLINICAL
NM_001303052.2(MYT1L):c.1706G>A (p.Arg569Gln)	MYT1L	R567Q, R569Q	Normal	Mental retardation, autosomal dominant 39|not provided|Intellectual disability	Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235469	2	1915795	2	1912023	235469	237152	rs878853045	NC_000002.12:1912022:C:T	C	T	CLINICAL
NM_001303052.2(MYT1L):c.1585G>A (p.Gly529Arg)	MYT1L	G529R, G527R	Normal	Mental retardation, autosomal dominant 39	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000592088	2	1921010	2	1917238	592088	583083	rs1275489527	NC_000002.12:1917237:C:T	C	T	CLINICAL
NM_024989.4(PGAP1):c.2204T>A (p.Leu735Ter)	PGAP1	L735*, L561*, L346*	Normal	Mental retardation, autosomal recessive 42	Likely pathogenic(Last reviewed: Aug 5, 2016)	criteria provided, single submitter	VCV000436298	2	197710688	2	196845964	436298	427971	rs1361547443	NC_000002.12:196845963:A:T	A	T	CLINICAL
NM_024989.4(PGAP1):c.1572T>A (p.Tyr524Ter)	PGAP1	Y524*, Y135*, Y350*	Normal	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: May 24, 2021)	no assertion criteria provided	VCV000222977	2	197737731	2	196873007	222977	224698	rs869025578	NC_000002.12:196873006:A:T	A	T	CLINICAL
NM_024989.4(PGAP1):c.927+1G>A	PGAP1		Normal	Mental retardation, autosomal recessive 42	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000436299	2	197761854	2	196897130	436299	427977	rs750079325	NC_000002.12:196897129:C:T	C	T	CLINICAL
NM_005006.7(NDUFS1):c.1855G>A (p.Asp619Asn)	NDUFS1	D619N, D583N, D562N, D633N, D508N	Normal	Mitochondrial complex 1 deficiency, nuclear type 5	Pathogenic(Last reviewed: Jul 1, 2010)	no assertion criteria provided	VCV000050922	2	206992550	2	206127826	50922	65581	rs397515447	NC_000002.12:206127825:C:T	C	T	CLINICAL
NM_003709.4(KLF7):c.790G>A (p.Asp264Asn)	KLF7	D264N, D236N, D231N	Normal	KLF7-related disorder|intellectual deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374233	2	207953249	2	207088525	374233	361122	rs1057518995	NC_000002.12:207088524:C:T	C	T	CLINICAL
NM_000784.4(CYP27A1):c.1016C>T (p.Thr339Met)	CYP27A1	T339M	Normal	Cholestanol storage disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004266	2	219677818	2	218813095	4266	19305	rs121908102	NC_000002.12:218813094:C:T	C	T	CLINICAL
NM_000784.4(CYP27A1):c.1183C>T (p.Arg395Cys)	CYP27A1	R395C	Normal	not provided|Cholestanol storage disease|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004255	2	219678909	2	218814186	4255	19294	rs121908096	NC_000002.12:218814185:C:T	C	T	CLINICAL
NM_013335.4(GMPPA):c.295C>T (p.Arg99Ter)	GMPPA|ASIC4-AS1	R99*	Normal	Alacrima, achalasia, and mental retardation syndrome	Pathogenic(Last reviewed: Oct 3, 2013)	no assertion criteria provided	VCV000088691	2	220366625	2	219501903	88691	94271	rs397518460	NC_000002.12:219501902:C:T	C	T	CLINICAL
NM_001277062.2(MFF):c.112C>T (p.Gln38Ter)	MFF	Q64*, Q38*	Normal	Encephalopathy due to defective mitochondrial and peroxisomal fission 2|Mitochondrial encephalomyopathy|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000039831	2	228195493	2	227330777	39831	48430	rs397514615	NC_000002.12:227330776:C:T	C	T	CLINICAL
NM_001284214.2(TRIP12):c.4928G>A (p.Arg1643Gln)	TRIP12	R1628Q, R1643Q, R1325Q, R1596Q, R1665Q, R1595Q, R1623Q, R1636Q, R1666Q, R1644Q, R1670Q, R1671Q	Normal	Intellectual disability, autosomal dominant 49	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446138	2	230650558	2	229785842	446138	439485	rs1553602821	NC_000002.12:229785841:C:T	C	T	CLINICAL
NM_001284214.2(TRIP12):c.4905T>A (p.Asp1635Glu)	TRIP12	D1635E, D1657E, D1662E, D1663E, D1588E, D1615E, D1628E, D1658E, D1587E, D1317E, D1620E, D1636E	Normal	Intellectual disability, autosomal dominant 49	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801906	2	230652230	2	229787514	801906	790206	rs1468657712	NC_000002.12:229787513:A:T	A	T	CLINICAL
NM_001284214.2(TRIP12):c.3887+1G>A	TRIP12		Normal	Intellectual disability, autosomal dominant 49	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446141	2	230659894	2	229795178	446141	439488	rs1553612358	NC_000002.12:229795177:C:T	C	T	CLINICAL
NM_001284214.2(TRIP12):c.3401+1G>A	TRIP12		Normal	Intellectual disability, autosomal dominant 49	Pathogenic(Last reviewed: Apr 15, 2020)	no assertion criteria provided	VCV000446137	2	230663590	2	229798874	446137	439484	rs1553616463	NC_000002.12:229798873:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.1394+2T>A	KIF1A		Normal	Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive	Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000532873	2	241709042	2	240769625	532873	518045	rs751051049	NC_000002.12:240769624:A:T	A	T	CLINICAL
NM_004321.7(KIF1A):c.920G>A (p.Arg307Gln)	KIF1A	R307Q	Normal	not provided|Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000418275	2	241715306	2	240775889	418275	405684	rs1064793161	NC_000002.12:240775888:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.761G>A (p.Arg254Gln)	KIF1A	R254Q	Normal	Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|not provided|Intellectual disability, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280500	2	241723193	2	240783776	280500	264094	rs886041692	NC_000002.12:240783775:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.757G>A (p.Glu253Lys)	KIF1A	E253K	Normal	not provided|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000162059	2	241723197	2	240783780	162059	171772	rs672601369	NC_000002.12:240783779:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.749C>A (p.Ala250Asp)	KIF1A	A250D	Normal	Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000580199	2	241723205	2	240783788	580199	558330	rs1559526692	NC_000002.12:240783787:G:T	G	T	CLINICAL
NM_004321.7(KIF1A):c.746T>A (p.Leu249Gln)	KIF1A	L249Q	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV000162061	2	241723208	2	240783791	162061	171773	rs672601371	NC_000002.12:240783790:A:T	A	T	CLINICAL
NM_004321.7(KIF1A):c.647G>A (p.Arg216His)	KIF1A	R216H	Normal	not provided|Intellectual disability, autosomal dominant 9|PEHO syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208161	2	241724479	2	240785062	208161	204420	rs672601368	NC_000002.12:240785061:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.609-1G>A	KIF1A		Normal	Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000574529	2	241724518	2	240785101	574529	560549	rs1559527796	NC_000002.12:240785100:C:T	C	T	CLINICAL
NM_001244008.2(KIF1A):c.595G>A (p.Gly199Arg)	KIF1A	G199R	Normal	not provided|Intellectual disability, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449043	2	241725765	2	240786348	449043	443215	rs1553638614	NC_000002.12:240786347:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.305G>A (p.Gly102Asp)	KIF1A	G102D	Normal	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV000162053	2	241727526	2	240788109	162053	171779	rs672601363	NC_000002.12:240788108:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.304G>A (p.Gly102Ser)	KIF1A	G102S	Normal	not provided|Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000422067	2	241727527	2	240788110	422067	405686	rs1064795534	NC_000002.12:240788109:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.38G>A (p.Arg13His)	KIF1A	R13H	Normal	Spastic paraplegia|Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209165	2	241737132	2	240797715	209165	205730	rs797045050	NC_000002.12:240797714:C:T	C	T	CLINICAL
NM_004321.7(KIF1A):c.32G>A (p.Arg11Gln)	KIF1A	R11Q	Normal	Spastic paraplegia 30, autosomal recessive|Intellectual disability, autosomal dominant 9|Hereditary sensory and autonomic neuropathy type IIC|Intellectual disability, autosomal dominant 9|Spastic paraplegia 30, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000654820	2	241737138	2	240797721	654820	629744	rs1575654528	NC_000002.12:240797720:C:T	C	T	CLINICAL
NM_001287491.2(TET3):c.2722G>T (p.Val908Leu)	TET3	V908L, V815L	Normal	TET3 deficiency|Intellectual disability|Beck-Fahrner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2020)	no assertion criteria provided	VCV000816634	2	74314999	2	74087872	816634	804839	rs1227643933	NC_000002.12:74087871:G:T	G	T	CLINICAL
NM_004082.4(DCTN1):c.212G>A (p.Gly71Glu)	DCTN1	G71E, G54E	Normal	Perry syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, single submitter	VCV000021390	2	74605194	2	74378067	21390	34242	rs67586389	NC_000002.12:74378066:C:T	C	T	CLINICAL
NM_004082.5(DCTN1):c.211G>A (p.Gly71Arg)	DCTN1	G71R, G54R	Normal	Perry syndrome	Pathogenic(Last reviewed: Jul 29, 2021)	no assertion criteria provided	VCV000008406	2	74605195	2	74378068	8406	23445	rs72466485	NC_000002.12:74378067:C:T	C	T	CLINICAL
NM_004082.4(DCTN1):c.175G>A (p.Gly59Ser)	DCTN1	G59S, G42S	Normal	Distal hereditary motor neuronopathy type 7B|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1|Hereditary motor neuron disease	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000008401	2	74605231	2	74378104	8401	23440	rs121909342	NC_000002.12:74378103:C:T	C	T	CLINICAL
NM_003896.4(ST3GAL5):c.1024G>A (p.Gly342Ser)	ST3GAL5	G101S, G319S, G214S, G289S, G342S, G314S	Normal	GM3 synthase deficiency	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828145	2	86067500	2	85840377	828145	816446	rs367638648	NC_000002.12:85840376:C:T	C	T	CLINICAL
NM_003896.4(ST3GAL5):c.740G>A (p.Gly247Asp)	ST3GAL5	G219D, G6D, G119D, G224D, G247D	Normal	Intellectual disability|GM3 synthase deficiency	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000666332	2	86073609	2	85846486	666332	653855	rs1573589807	NC_000002.12:85846485:C:T	C	T	CLINICAL
NM_003896.4(ST3GAL5):c.601G>A (p.Gly201Arg)	ST3GAL5	G201R, G178R, G173R, G73R	Normal	GM3 synthase deficiency	Likely pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000254246	2	86075045	2	85847922	254246	248760	rs771732955	NC_000002.12:85847921:C:T	C	T	CLINICAL
NM_003896.4(ST3GAL5):c.147G>A (p.Trp49Ter)	ST3GAL5	W49*, W21*, W26*	Normal	GM3 synthase deficiency	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000572904	2	86090544	2	85863421	572904	559191	rs778265926	NC_000002.12:85863420:C:T	C	T	CLINICAL
NM_004836.7(EIF2AK3):c.2985+1G>A	EIF2AK3|LOC101928371		Normal	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Sep 1, 2003)	no assertion criteria provided	VCV000005876	2	88870391	2	88570873	5876	20915	rs869025179	NC_000002.12:88570872:C:T	C	T	CLINICAL
NM_004836.7(EIF2AK3):c.1763G>A (p.Arg588Gln)	EIF2AK3	R588Q, R437Q	Normal	Wolcott-Rallison dysplasia	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000005875	2	88882948	2	88583430	5875	20914	rs121908569	NC_000002.12:88583429:C:T	C	T	CLINICAL
NM_001322346.1(LMAN2L):c.-195G>A	LMAN2L	R53Q	Normal	Mental retardation, autosomal recessive 52	Pathogenic(Last reviewed: Apr 1, 2016)	no assertion criteria provided	VCV000224890	2	97405620	2	96739883	224890	226736	rs869320632	NC_000002.12:96739882:C:T	C	T	CLINICAL
NM_001134225.2(INPP4A):c.115C>T (p.Gln39Ter)	INPP4A	Q39*	Normal	Intellectual disability	Pathogenic(Last reviewed: Dec 1, 2019)	no assertion criteria provided	VCV000801338	2	99137158	2	98520695	801338	789720	rs1574887674	NC_000002.12:98520694:C:T	C	T	CLINICAL
NM_015575.4(GIGYF2):c.2378C>T (p.Ala793Val)	GIGYF2	A793V, A814V, A787V	Normal	Parkinson disease 11	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000216934	2	233684544	2	232819834	216934	213536	rs748538823	NC_000002.12:232819833:C:T	C	T	CLINICAL
NM_000158.4(GBE1):c.784C>T (p.Arg262Cys)	GBE1	R262C	Normal	Glycogen storage disease IV, congenital neuromuscular|Adult polyglucosan body disease	Pathogenic(Last reviewed: Nov 15, 2016)	criteria provided, single submitter	VCV000002791	3	81692140	3	81642989	2791	17830	rs137852893	NC_000003.12:81642988:G:A	G	A	CLINICAL
NM_001289080.2(CNTN6):c.566C>A (p.Ser189Ter)	CNTN6	S189*, S117*	Normal	Autistic behavior	Likely pathogenic(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000548950	3	1337396	3	1295712	548950	539432	rs773080572	NC_000003.12:1295711:C:A	C	A	CLINICAL
NM_001068.3(TOP2B):c.172C>T (p.His58Tyr)	TOP2B	H58Y, H63Y	Normal	Autism spectrum disorder	Likely pathogenic(Last reviewed: Oct 11, 2016)	no assertion criteria provided	VCV000265791	3	25686844	3	25645353	265791	260481	rs886039770	NC_000003.12:25645352:G:A	G	A	CLINICAL
NM_018297.4(NGLY1):c.1405C>T (p.Arg469Ter)	NGLY1	R427*, R469*, R451*	Normal	not provided|Congenital disorder of deglycosylation|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488990	3	25773830	3	25732339	488990	481686	rs768131676	NC_000003.12:25732338:G:A	G	A	CLINICAL
NM_001128840.3(CACNA1D):c.2245G>A (p.Ala749Thr)	CACNA1D	A769T, A749T	Normal	not provided	Likely pathogenic(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000421144	3	53764492	3	53730465	421144	406349	rs1064794938	NC_000003.12:53730464:G:A	G	A	CLINICAL
NM_001354604.2(MITF):c.1273G>A (p.Glu425Lys)	MITF	E318K, E419K, E312K, E403K, E402K, E256K, E418K, E425K, E367K, E424K	Normal	Melanoma|Tietz syndrome|Cutaneous malignant melanoma 8|Waardenburg syndrome type 2A|not provided|Cutaneous malignant melanoma 8|Waardenburg syndrome type 2A|not specified|Hereditary cancer-predisposing syndrome|Cutaneous malignant melanoma 8	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029792	3	70014091	3	69964940	29792	38747	rs149617956	NC_000003.12:69964939:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.1573C>T (p.Arg525Ter)	FOXP1	R525*, R424*, R425*, R524*, R449*	Normal	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018428	3	71021785	3	70972634	18428	33467	rs112795301	NC_000003.12:70972633:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.1540C>T (p.Arg514Cys)	FOXP1	R514C, R413C, R414C, R438C, R513C	Normal	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217265	3	71021818	3	70972667	217265	213912	rs869025203	NC_000003.12:70972666:G:A	G	A	CLINICAL
NM_001164342.2(ZBTB20):c.1955A>T (p.His652Leu)	ZBTB20	H652L, H579L	Normal	Clinodactyly of the 4th toe|Moderate global developmental delay|Autistic behavior|Clinodactyly of the 5th finger|Abnormal facial shape	Likely pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000585297	3	114058123	3	114339276	585297	576328	rs1560092224	NC_000003.12:114339275:T:A	T	A	CLINICAL
NM_173653.4(SLC9A9):c.1267C>T (p.Arg423Ter)	SLC9A9	R423*	Normal	Autism 16	risk factor(Last reviewed: Jul 11, 2008)	no assertion criteria provided	VCV000002363	3	143212543	3	143493701	2363	17402	rs121912597	NC_000003.12:143493700:G:A	G	A	CLINICAL
NM_000340.2(SLC2A2):c.1250C>T (p.Pro417Leu)	SLC2A2	P417L, P244L, P298L	Normal	Fanconi-Bickel syndrome	Likely pathogenic	criteria provided, single submitter	VCV000016095	3	170716106	3	170998317	16095	31134	rs121909744	NC_000003.12:170998316:G:A	G	A	CLINICAL
NM_001321142.2(CIDEC):c.556G>T (p.Glu186Ter)	CIDEC	E186*, E196*, E112*, E199*	Normal	Familial partial lipodystrophy 5	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000050400	3	9908979	3	9867295	50400	59522	rs587776968	NC_000003.12:9867294:C:A	C	A	CLINICAL
NM_001330615.1(PPARG):c.735+10967T>A	PPARG	F388L, F360L, F149L	Normal	Familial partial lipodystrophy 3	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000008141	3	12458547	3	12417048	8141	23180	rs72551363	NC_000003.12:12417047:T:A	T	A	CLINICAL
NM_001330615.1(PPARG):c.735+10755G>A	PPARG	V290M, V318M, V79M	Normal	Familial partial lipodystrophy 3	Pathogenic(Last reviewed: Dec 23, 1999)	no assertion criteria provided	VCV000008137	3	12458335	3	12416836	8137	23176	rs72551362	NC_000003.12:12416835:G:A	G	A	CLINICAL
NM_014415.4(ZBTB11):c.2185C>T (p.His729Tyr)	ZBTB11	H729Y	Normal	Intellectual developmental disorder, autosomal recessive 69	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625185	3	101374954	3	101656110	625185	613528	rs1559982532	NC_000003.12:101656109:G:A	G	A	CLINICAL
NM_001164342.2(ZBTB20):c.1861C>T (p.Leu621Phe)	ZBTB20	L621F, L548F	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139449	3	114058217	3	114339370	139449	143141	rs483353070	NC_000003.12:114339369:G:A	G	A	CLINICAL
NM_001164342.2(ZBTB20):c.1837C>T (p.Arg613Cys)	ZBTB20	R613C, R540C	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638658	3	114058241	3	114339394	638658	626436	rs1576220876	NC_000003.12:114339393:G:A	G	A	CLINICAL
NM_001164342.2(ZBTB20):c.1802C>T (p.Thr601Ile)	ZBTB20	T601I, T528I	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000139446	3	114069123	3	114350276	139446	143138	rs483353067	NC_000003.12:114350275:G:A	G	A	CLINICAL
NM_001164342.2(ZBTB20):c.1786C>T (p.His596Tyr)	ZBTB20	H596Y, H523Y	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000375372	3	114069139	3	114350292	375372	362137	rs1057519435	NC_000003.12:114350291:G:A	G	A	CLINICAL
NM_001354689.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	S257L, S224L, S143L, S176L	Normal	Lung adenocarcinoma|LEOPARD syndrome 2|Noonan syndrome 5|Cardiomyopathy, dilated, 1NN|Rasopathy|none provided|Noonan syndrome|Noonan syndrome with multiple lentigines|Adenocarcinoma of stomach|Noonan syndrome|not provided|Noonan syndrome 5|LEOPARD syndrome 2|Malignant melanoma of skin|Noonan syndrome with multiple lentigines|Noonan syndrome 1|Inborn genetic diseases|Neoplasm of the large intestine	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013957	3	12645699	3	12604200	13957	28996	rs80338796	NC_000003.12:12604199:G:A	G	A	CLINICAL
NM_144639.3(UROC1):c.1348C>T (p.Arg450Cys)	UROC1	R450C, R510C	Normal	Urocanate hydratase deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000407	3	126216984	3	126498141	407	15446	rs137852795	NC_000003.12:126498140:G:A	G	A	CLINICAL
NM_005862.3(STAG1):c.1129C>T (p.Arg377Cys)	STAG1	R377C	Normal	Intellectual disability, autosomal dominant 47	Likely pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000523187	3	136191331	3	136472489	523187	513813	rs1559824939	NC_000003.12:136472488:G:A	G	A	CLINICAL
NM_003412.4(ZIC1):c.1163C>A (p.Ser388Ter)	ZIC1	S388*	Normal	Structural brain anomalies with impaired intellectual development and craniosynostosis	Pathogenic(Last reviewed: Jan 14, 2020)	no assertion criteria provided	VCV000372161	3	147131157	3	147413370	372161	359066	rs1057517667	NC_000003.12:147413369:C:A	C	A	CLINICAL
NM_022788.5(P2RY12):c.-180+4576C>T	MED12L|P2RY12	M1459I	Normal	Intellectual disability	Pathogenic	no assertion criteria provided	VCV000598930	3	151097904	3	151380116	598930	590017	rs1560103306	NC_000003.12:151380115:G:A	G	A	CLINICAL
NM_022788.5(P2RY12):c.-180+610C>T	P2RY12|MED12L		Normal	Nizon-Isidor syndrome|Intellectual disability	Pathogenic(Last reviewed: May 5, 2020)	no assertion criteria provided	VCV000592166	3	151101870	3	151384082	592166	583202	rs1560108090	NC_000003.12:151384081:G:A	G	A	CLINICAL
NM_015028.4(TNIK):c.538C>T (p.Arg180Ter)	TNIK	R180*	Normal	Mental retardation, autosomal recessive 54	Pathogenic(Last reviewed: Jul 26, 2016)	no assertion criteria provided	VCV000243022	3	170906592	3	171188803	243022	244104	rs886037841	NC_000003.12:171188802:G:A	G	A	CLINICAL
NM_024665.6(TBL1XR1):c.977G>T (p.Ser326Ile)	TBL1XR1	S326I, S239I	Normal	Mental retardation, autosomal dominant 41	Likely pathogenic(Last reviewed: Aug 1, 2017)	no assertion criteria provided	VCV000431083	3	176756171	3	177038383	431083	424606	rs1135401760	NC_000003.12:177038382:C:A	C	A	CLINICAL
NM_024665.7(TBL1XR1):c.799G>T (p.Gly267Cys)	TBL1XR1	G180C, G267C	Normal	Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000807509	3	176765153	3	177047365	807509	798524	rs1577017863	NC_000003.12:177047364:C:A	C	A	CLINICAL
NM_001622.4(AHSG):c.950G>A (p.Arg317His)	AHSG	R317H, R289H, R316H, R318H	Normal	Alopecia-intellectual disability syndrome 1	Pathogenic(Last reviewed: Aug 23, 2021)	no assertion criteria provided	VCV000488189	3	186338565	3	186620776	488189	481154	rs201849460	NC_000003.12:186620775:G:A	G	A	CLINICAL
NM_015560.2(OPA1):c.1204G>A (p.Val402Met)	OPA1	V402M, V457M, V366M, V420M, V279M, V439M, V278M, V384M, V403M, V421M	Normal	Abortive cerebellar ataxia	Pathogenic(Last reviewed: Aug 18, 2016)	no assertion criteria provided	VCV000225122	3	193361225	3	193643436	225122	227008	rs879255594	NC_000003.12:193643435:G:A	G	A	CLINICAL
NM_001367321.1(TRNT1):c.*433G>A	TRNT1|CRBN	R419*, R418*	Normal	Mental retardation, autosomal recessive 2|not provided	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000001821	3	3192623	3	3150939	1821	16860	rs121918368	NC_000003.12:3150938:G:A	G	A	CLINICAL
NM_001904.4(CTNNB1):c.198G>A (p.Trp66Ter)	CTNNB1	W66*, W59*	Normal	not provided|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000280325	3	41266201	3	41224710	280325	264159	rs886041553	NC_000003.12:41224709:G:A	G	A	CLINICAL
NM_015466.4(PTPN23):c.695G>A (p.Arg232Gln)	PTPN23	R232Q, R106Q	Normal	Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000636322	3	47448038	3	47406548	636322	624127	rs577689618	NC_000003.12:47406547:G:A	G	A	CLINICAL
NM_015466.4(PTPN23):c.3748G>A (p.Glu1250Lys)	PTPN23	E1250K, E1124K	Normal	Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000636315	3	47453036	3	47411546	636315	624136	rs148689441	NC_000003.12:47411545:G:A	G	A	CLINICAL
NM_002222.6(ITPR1):c.7471G>A (p.Gly2491Arg)	ITPR1	G2539R, G2491R, G2506R	Normal	Anterior segment dysgenesis|Inborn genetic diseases|Spinocerebellar ataxia type 29|not provided|Gillespie syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235922	3	4856205	3	4814521	235922	237580	rs752281590	NC_000003.12:4814520:G:A	G	A	CLINICAL
NM_002222.6(ITPR1):c.7604T>A (p.Ile2535Asn)	ITPR1	I2550N, I2583N, I2535N	Normal	Gillespie syndrome	Pathogenic(Last reviewed: Apr 18, 2018)	no assertion criteria provided	VCV000522562	3	4856828	3	4815144	522562	513174	rs1553758021	NC_000003.12:4815143:T:A	T	A	CLINICAL
NM_198880.3(QRICH1):c.1954C>T (p.Arg652Ter)	QRICH1	R652*	Normal	Intellectual disability|Ververi-Brady syndrome	Pathogenic(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV000523657	3	49070148	3	49032715	523657	514305	rs1236702036	NC_000003.12:49032714:G:A	G	A	CLINICAL
NM_021971.4(GMPPB):c.859C>T (p.Arg287Trp)	GMPPB	R287W	Normal	Muscular dystrophy|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|not provided	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225925	3	49759490	3	49722057	225925	227736	rs142908436	NC_000003.12:49722056:G:A	G	A	CLINICAL
NM_021971.4(GMPPB):c.790C>T (p.Gln264Ter)	GMPPB	Q264*	Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000571713	3	49759559	3	49722126	571713	561685	rs763971677	NC_000003.12:49722125:G:A	G	A	CLINICAL
NM_021971.4(GMPPB):c.553C>T (p.Arg185Cys)	GMPPB	R185C	Normal	Inborn genetic diseases|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060543	3	49760037	3	49722604	60543	75124	rs397509425	NC_000003.12:49722603:G:A	G	A	CLINICAL
NM_021971.4(GMPPB):c.458C>T (p.Thr153Ile)	GMPPB	T153I	Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638638	3	49760132	3	49722699	638638	626413	rs202013297	NC_000003.12:49722698:G:A	G	A	CLINICAL
NM_021971.4(GMPPB):c.109C>T (p.Gln37Ter)	GMPPB	Q37*	Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000647358	3	49761051	3	49723618	647358	631585	rs1348189028	NC_000003.12:49723617:G:A	G	A	CLINICAL
NM_005879.3(TRAIP):c.553C>T (p.Arg185Ter)	TRAIP	R185*	Normal	Seckel syndrome 9	Pathogenic(Last reviewed: May 22, 2019)	no assertion criteria provided	VCV000221232	3	49879323	3	49841890	221232	222930	rs767664526	NC_000003.12:49841889:G:A	G	A	CLINICAL
NM_052859.4(RFT1):c.199C>T (p.Arg67Cys)	RFT1	R67C	Normal	not provided|Congenital disorder of glycosylation type 1N	Likely pathogenic(Last reviewed: Dec 22, 2020)	criteria provided, single submitter	VCV000000785	3	53157807	3	53123791	785	15824	rs118203913	NC_000003.12:53123790:G:A	G	A	CLINICAL
NM_000925.4(PDHB):c.1030C>T (p.Pro344Ser)	PDHB	P344S, P326S	Normal	Pyruvate dehydrogenase E1-beta deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000013189	3	58413811	3	58428084	13189	28228	rs28933391	NC_000003.12:58428083:G:A	G	A	CLINICAL
NM_032682.5(FOXP1):c.1653-2A>T	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561014	3	71019958	3	70970807	561014	552076	rs1559596756	NC_000003.12:70970806:T:A	T	A	CLINICAL
NM_032682.6(FOXP1):c.1630C>T (p.Arg544Ter)	FOXP1	R543*, R544*, R443*, R444*, R468*	Normal	Rare genetic intellectual disability|Seizures|Intellectual disability|Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000626283	3	71021728	3	70972577	626283	614601	rs1559602356	NC_000003.12:70972576:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.1573C>T (p.Arg525Ter)	FOXP1	R525*, R424*, R425*, R524*, R449*	Normal	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018428	3	71021785	3	70972634	18428	33467	rs112795301	NC_000003.12:70972633:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.1540C>T (p.Arg514Cys)	FOXP1	R514C, R413C, R414C, R438C, R513C	Normal	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217265	3	71021818	3	70972667	217265	213912	rs869025203	NC_000003.12:70972666:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.1507C>T (p.Arg503Ter)	FOXP1	R503*, R402*, R502*, R427*, R403*	Normal	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000211038	3	71026115	3	70976964	211038	207085	rs797045584	NC_000003.12:70976963:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.1489C>T (p.Arg497Ter)	FOXP1	R497*, R397*, R396*, R421*, R496*	Normal	Mental retardation with language impairment and with or without autistic features|not provided	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379850	3	71026133	3	70976982	379850	367721	rs775136381	NC_000003.12:70976981:G:A	G	A	CLINICAL
NM_032682.6(FOXP1):c.622C>T (p.Gln208Ter)	FOXP1	Q208*, Q108*, Q132*, Q207*, Q107*	Normal	Congenital cerebellar hypoplasia|Mental retardation with language impairment and with or without autistic features|Cerebellar vermis hypoplasia|not provided	Pathogenic(Last reviewed: Nov 28, 2016)	criteria provided, single submitter	VCV000498786	3	71096135	3	71046984	498786	490210	rs1553709881	NC_000003.12:71046983:G:A	G	A	CLINICAL
NM_000844.4(GRM7):c.2024C>A (p.Thr675Lys)	GRM7	T675K	Normal	Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities|Brain atrophy|Seizures|CNS hypomyelination|Muscular hypotonia|Intellectual disability|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	no assertion criteria provided	VCV000242901	3	7620617	3	7578930	242901	243983	rs1114167301	NC_000003.12:7578929:C:A	C	A	CLINICAL
NM_198241.3(EIF4G1):c.3614G>A (p.Arg1205His)	EIF4G1	R1205H, R1206H, R1165H, R1010H, R1041H, R1118H, R1212H	Normal	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030072	3	184045189	3	184327401	30072	39027	rs112176450	NC_000003.12:184327400:G:A	G	A	CLINICAL
NM_004366.6(CLCN2):c.2386C>T (p.Gln796Ter)	CLCN2	Q796*, Q752*, Q779*	Normal	not provided|Leukoencephalopathy with ataxia	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000217796	3	184069830	3	184352042	217796	214419	rs376823689	NC_000003.12:184352041:G:A	G	A	CLINICAL
NM_004366.6(CLCN2):c.1957A>T (p.Arg653Ter)	CLCN2	R653*, R636*, R609*	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217795	3	184071109	3	184353321	217795	214426	rs863225256	NC_000003.12:184353320:T:A	T	A	CLINICAL
NM_004366.6(CLCN2):c.1499C>T (p.Ala500Val)	CLCN2	A500V, A483V, A456V	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000100631	3	184072344	3	184354556	100631	106503	rs587777111	NC_000003.12:184354555:G:A	G	A	CLINICAL
NM_004366.6(CLCN2):c.925C>T (p.Arg309Ter)	CLCN2	R309*, R265*	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217785	3	184075028	3	184357240	217785	214439	rs863225250	NC_000003.12:184357239:G:A	G	A	CLINICAL
NM_014043.4(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	Q206H, Q165H	Normal	not provided|Amyotrophic lateral sclerosis 17	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001654	3	87302948	3	87253798	1654	16693	rs63751126	NC_000003.12:87253797:A:C	A	C	CLINICAL
NM_032682.6(FOXP1):c.1393A>G (p.Arg465Gly)	FOXP1	R465G, R464G, R389G, R364G, R365G	Normal	Mental retardation with language impairment and with or without autistic features|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217264	3	71026829	3	70977678	217264	213913	rs869025202	NC_000003.12:70977677:T:C	T	C	CLINICAL
NM_015869.4(PPARG):c.1352T>C (p.Leu451Pro)	PPARG	L423P, L451P, L212P	Normal	Familial partial lipodystrophy 3	Likely pathogenic(Last reviewed: Dec 27, 2016)	criteria provided, single submitter	VCV000436404	3	12475478	3	12433979	436404	428124	rs1553653993	NC_000003.12:12433978:T:C	T	C	CLINICAL
NM_001278293.3(ARL6):c.272T>C (p.Ile91Thr)	ARL6	I91T	Normal	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000068064	3	97503816	3	97784972	68064	78955	rs137854907	NC_000003.12:97784971:T:C	T	C	CLINICAL
NM_000551.3(VHL):c.452T>C (p.Ile151Thr)	VHL|LOC107303340	I151T	Normal	Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428803	3	10188309	3	10146625	428803	420449	rs869025655	NC_000003.12:10146624:T:C	T	C	CLINICAL
NM_014415.4(ZBTB11):c.2640T>G (p.His880Gln)	ZBTB11	H880Q	Normal	Intellectual developmental disorder, autosomal recessive 69	Pathogenic(Last reviewed: Apr 10, 2019)	no assertion criteria provided	VCV000625186	3	101371344	3	101652500	625186	613529	rs1559981249	NC_000003.12:101652499:A:C	A	C	CLINICAL
NM_001164342.2(ZBTB20):c.1955A>G (p.His652Arg)	ZBTB20	H652R, H579R	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638659	3	114058123	3	114339276	638659	626433	rs1560092224	NC_000003.12:114339275:T:C	T	C	CLINICAL
NM_015642.6(ZBTB20):c.1581C>G (p.His527Gln)	ZBTB20	H600Q, H527Q	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000618973	3	114069125	3	114350278	618973	610373	rs1560110565	NC_000003.12:114350277:G:C	G	C	CLINICAL
NM_001164342.2(ZBTB20):c.1787A>G (p.His596Arg)	ZBTB20	H596R, H523R	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139438	3	114069138	3	114350291	139438	143130	rs483353066	NC_000003.12:114350290:T:C	T	C	CLINICAL
NM_001164342.2(ZBTB20):c.1771C>G (p.Gln591Glu)	ZBTB20	Q591E, Q518E	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000139437	3	114069154	3	114350307	139437	143129	rs483353065	NC_000003.12:114350306:G:C	G	C	CLINICAL
NM_001164342.2(ZBTB20):c.1760T>G (p.Phe587Cys)	ZBTB20	F587C, F514C	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000638657	3	114069165	3	114350318	638657	626438	rs1576280892	NC_000003.12:114350317:A:C	A	C	CLINICAL
NM_005862.3(STAG1):c.2936A>G (p.Lys979Arg)	STAG1	K979R	Normal	STAG1-related disorder|Intellectual disability, autosomal dominant 47	Likely pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000440451	3	136077990	3	136359148	440451	434077	rs1471479119	NC_000003.12:136359147:T:C	T	C	CLINICAL
NM_005862.3(STAG1):c.646A>G (p.Arg216Gly)	STAG1	R216G	Normal	STAG1-related disorder|Intellectual disability, autosomal dominant 47	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437898	3	136240085	3	136521243	437898	431520	rs1553738686	NC_000003.12:136521242:T:C	T	C	CLINICAL
NM_001370658.1(BTD):c.1308A>C (p.Gln436His)	BTD	Q436H	Normal	not provided|Biotinidase deficiency|Intellectual disability	Pathogenic(Last reviewed: Jun 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001902	3	15686731	3	15645224	1902	16941	rs80338685	NC_000003.12:15645223:A:C	A	C	CLINICAL
NM_000340.2(SLC2A2):c.109-2A>G	SLC2A2		Normal	Fanconi-Bickel syndrome	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000016102	3	170732522	3	171014733	16102	31141	rs1576838294	NC_000003.12:171014732:T:C	T	C	CLINICAL
NM_024665.6(TBL1XR1):c.1043A>G (p.His348Arg)	TBL1XR1	H261R, H348R	Normal	Mental retardation, autosomal dominant 41|See cases	Likely pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000666259	3	176756105	3	177038317	666259	653815	rs1576994053	NC_000003.12:177038316:T:C	T	C	CLINICAL
NM_024665.6(TBL1XR1):c.734A>G (p.Tyr245Cys)	TBL1XR1	Y245C, Y158C	Normal	Mental retardation, autosomal dominant 41|Pierpont syndrome|not provided	Pathogenic(Last reviewed: Jun 22, 2021)	criteria provided, single submitter	VCV000225873	3	176765306	3	177047518	225873	227686	rs878854401	NC_000003.12:177047517:T:C	T	C	CLINICAL
NM_020166.5(MCCC1):c.1380T>G (p.Ile460Met)	MCCC1	I460M, I343M, I351M	Normal	3 Methylcrotonyl-CoA carboxylase 1 deficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001935	3	182755220	3	183037432	1935	16974	rs119103218	NC_000003.12:183037431:A:C	A	C	CLINICAL
NM_016302.3(CRBN):c.641C>G (p.Ser214Ter)	CRBN	S213*, S214*	Normal	Mental retardation, autosomal recessive 2|not provided	Likely pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000816985	3	3209364	3	3167680	816985	805340	rs1575094649	NC_000003.12:3167679:G:C	G	C	CLINICAL
NM_001904.4(CTNNB1):c.495+1G>C	CTNNB1		Normal	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560987	3	41266699	3	41225208	560987	552074	rs1559468403	NC_000003.12:41225207:G:C	G	C	CLINICAL
NM_001904.4(CTNNB1):c.2076G>C (p.Glu692Asp)	CTNNB1	E692D, E685D	Normal	Mental retardation, autosomal dominant 19	Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000562195	3	41278200	3	41236709	562195	553377	rs1559477241	NC_000003.12:41236708:G:C	G	C	CLINICAL
NM_002222.6(ITPR1):c.7471G>C (p.Gly2491Arg)	ITPR1	G2539R, G2506R, G2491R	Normal	not provided|Gillespie syndrome	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV000235923	3	4856205	3	4814521	235923	237581	rs752281590	NC_000003.12:4814520:G:C	G	C	CLINICAL
NM_021971.4(GMPPB):c.395C>G (p.Ser132Cys)	GMPPB	S132C	Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Likely pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000640100	3	49760412	3	49722979	640100	631580	rs145535498	NC_000003.12:49722978:G:C	G	C	CLINICAL
NM_000925.4(PDHB):c.395A>G (p.Tyr132Cys)	PDHB	Y132C, Y114C	Normal	Pyruvate dehydrogenase E1-beta deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000013188	3	58416578	3	58430851	13188	28227	rs28935769	NC_000003.12:58430850:T:C	T	C	CLINICAL
NM_000844.4(GRM7):c.461T>C (p.Ile154Thr)	GRM7	I154T	Normal	Muscular hypotonia|Brain atrophy|Hypoplasia of the corpus callosum|Seizures|Global developmental delay|Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	no assertion criteria provided	VCV000242895	3	6903536	3	6861849	242895	243981	rs1114167298	NC_000003.12:6861848:T:C	T	C	CLINICAL
NM_032682.6(FOXP1):c.1550T>G (p.Leu517Arg)	FOXP1	L416R, L441R, L417R, L517R, L516R	Normal	Mental retardation with language impairment and with or without autistic features	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801983	3	71021808	3	70972657	801983	790417	rs1575757812	NC_000003.12:70972656:A:C	A	C	CLINICAL
NM_032682.6(FOXP1):c.1396C>G (p.Pro466Ala)	FOXP1	P466A, P465A, P366A, P365A, P390A	Normal	Anterior creases of earlobe|Delayed speech and language development|Glabellar hemangioma|Intellectual disability|Strabismus	Likely pathogenic(Last reviewed: Nov 21, 2014)	criteria provided, single submitter	VCV000374144	3	71026826	3	70977675	374144	360857	rs1057518926	NC_000003.12:70977674:G:C	G	C	CLINICAL
NM_032682.6(FOXP1):c.1393A>G (p.Arg465Gly)	FOXP1	R465G, R464G, R389G, R364G, R365G	Normal	Mental retardation with language impairment and with or without autistic features|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217264	3	71026829	3	70977678	217264	213913	rs869025202	NC_000003.12:70977677:T:C	T	C	CLINICAL
NM_032682.6(FOXP1):c.1317C>G (p.Tyr439Ter)	FOXP1	Y439*, Y338*, Y363*, Y438*, Y339*	Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000217266	3	71027010	3	70977859	217266	213914	rs794727155	NC_000003.12:70977858:G:C	G	C	CLINICAL
NM_032682.5(FOXP1):c.1147-2A>G	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Likely pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000619979	3	71027182	3	70978031	619979	611463	rs1559621862	NC_000003.12:70978030:T:C	T	C	CLINICAL
NM_001080517.3(SETD5):c.1783-1G>C	SETD5		Normal	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: May 24, 2017)	no assertion criteria provided	VCV000488444	3	9489369	3	9447685	488444	481310	rs1553625691	NC_000003.12:9447684:G:C	G	C	CLINICAL
NM_014043.4(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	Q206H, Q165H	Normal	not provided|Amyotrophic lateral sclerosis 17	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001654	3	87302948	3	87253798	1654	16693	rs63751126	NC_000003.12:87253797:A:C	A	C	CLINICAL
NM_000158.4(GBE1):c.986A>C (p.Tyr329Ser)	GBE1	Y329S	Normal	Adult polyglucosan body neuropathy|Glycogen storage disease, type IV|Adult polyglucosan body disease|GBE1-Related Disorders|Adult polyglucosan body disease|not provided|Glycogen storage disease IV, nonprogressive hepatic|Glycogen storage disease, type IV|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic	Pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002777	3	81691938	3	81642787	2777	17816	rs80338671	NC_000003.12:81642786:T:G	T	G	CLINICAL
NM_000158.4(GBE1):c.691+2T>C	GBE1		Normal	GBE1-Related Disorders|Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Adult polyglucosan body disease|Glycogen storage disease, type IV|not provided|Glycogen storage disease	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208584	3	81698005	3	81648854	208584	205142	rs192044702	NC_000003.12:81648853:A:G	A	G	CLINICAL
NM_001080517.3(SETD5):c.2347-7A>G	SETD5		Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 23|See cases|not provided	Pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280376	3	9495416	3	9453732	280376	264172	rs886041593	NC_000003.12:9453731:A:G	A	G	CLINICAL
NM_001349253.2(SCN11A):c.1187T>C (p.Leu396Pro)	SCN11A	L396P	Normal	not provided|Neuropathy, hereditary sensory and autonomic, type VII	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000426113	3	38950600	3	38909109	426113	414717	rs1085307142	NC_000003.12:38909108:A:G	A	G	CLINICAL
NM_001244810.1(FOXP1):c.1348+2T>C	FOXP1		Normal	Autistic disorder of childhood onset	Likely pathogenic	no assertion criteria provided	VCV000374237	3	71026977	3	70977826	374237	361123	rs1057518999	NC_000003.12:70977825:A:G	A	G	CLINICAL
NM_032682.5(FOXP1):c.1348+1G>C	FOXP1		Normal	Autistic disorder of childhood onset|Intellectual disability	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000587696	3	71026978	3	70977827	587696	578654	rs1559619762	NC_000003.12:70977826:C:G	C	G	CLINICAL
NM_001354669.1(PPARG):c.-400C>G	PPARG	P12A, P40A	Normal	Diabetes mellitus, noninsulin-dependent, modifier of|Obesity, modifier of|Body mass index, modifier of|Intimal medial thickness of internal carotid artery, modifier of	risk factor(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000008131	3	12421238	3	12379739	8131	23170	rs1805192	NC_000003.12:12379738:C:G	C	G	CLINICAL
NM_024548.4(CEP97):c.1148A>G (p.His383Arg)	CEP97	H383R	Normal	Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	VCV000402141	3	101476598	3	101757754	402141	389117	rs1060499739	NC_000003.12:101757753:A:G	A	G	CLINICAL
NM_001164342.2(ZBTB20):c.1939A>C (p.Ser647Arg)	ZBTB20	S647R, S574R	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000638662	3	114058139	3	114339292	638662	626434	rs1576220405	NC_000003.12:114339291:T:G	T	G	CLINICAL
NM_001164342.2(ZBTB20):c.1862T>C (p.Leu621Pro)	ZBTB20	L621P, L548P	Normal	Marfanoid habitus and intellectual disability|Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000638663	3	114058216	3	114339369	638663	626435	rs1576220750	NC_000003.12:114339368:A:G	A	G	CLINICAL
NM_001348803.2(ZBTB20):c.1817A>C (p.His606Pro)	ZBTB20	H606P, H533P	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000638660	3	114058261	3	114339414	638660	626437	rs1576220938	NC_000003.12:114339413:T:G	T	G	CLINICAL
NM_001164342.2(ZBTB20):c.1811A>C (p.Lys604Thr)	ZBTB20	K604T, K531T	Normal	Inborn genetic diseases|Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139448	3	114058267	3	114339420	139448	143140	rs483353069	NC_000003.12:114339419:T:G	T	G	CLINICAL
NM_001164342.2(ZBTB20):c.1805G>C (p.Gly602Ala)	ZBTB20	G602A, G529A	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139447	3	114058273	3	114339426	139447	143139	rs483353068	NC_000003.12:114339425:C:G	C	G	CLINICAL
NM_001164342.2(ZBTB20):c.1768A>C (p.Lys590Gln)	ZBTB20	K590Q, K517Q	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic(Last reviewed: Aug 1, 2014)	no assertion criteria provided	VCV000139436	3	114069157	3	114350310	139436	143128	rs483353064	NC_000003.12:114350309:T:G	T	G	CLINICAL
NM_144639.3(UROC1):c.209T>C (p.Leu70Pro)	UROC1	L70P	Normal	Urocanate hydratase deficiency	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000408	3	126229555	3	126510712	408	15447	rs137852796	NC_000003.12:126510711:A:G	A	G	CLINICAL
NM_005862.3(STAG1):c.1433A>C (p.His478Pro)	STAG1	H478P	Normal	STAG1-related disorder|Intellectual disability, autosomal dominant 47	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2017)	no assertion criteria provided	VCV000437897	3	136162242	3	136443400	437897	431519	rs1553722309	NC_000003.12:136443399:T:G	T	G	CLINICAL
NM_024665.6(TBL1XR1):c.1336T>C (p.Tyr446His)	TBL1XR1	Y446H, Y359H	Normal	Mental retardation, autosomal dominant 41|Pierpont syndrome	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000627550	3	176750839	3	177033051	627550	615905	rs1553808301	NC_000003.12:177033050:A:G	A	G	CLINICAL
NM_024665.6(TBL1XR1):c.1000T>C (p.Cys334Arg)	TBL1XR1	C334R, C247R	Normal	Mental retardation, autosomal dominant 41	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666258	3	176756148	3	177038360	666258	653810	rs1576994101	NC_000003.12:177038359:A:G	A	G	CLINICAL
NM_016302.3(CRBN):c.1171T>C (p.Cys391Arg)	TRNT1|CRBN	C391R, C390R	Normal	not provided|Mental retardation, autosomal recessive 2	Likely pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, multiple submitters, no conflicts	VCV000209144	3	3192707	3	3151023	209144	205733	rs797045036	NC_000003.12:3151022:A:G	A	G	CLINICAL
NM_001904.4(CTNNB1):c.1271T>G (p.Leu424Arg)	CTNNB1	L424R, L417R	Normal	Mental retardation, autosomal dominant 19	Likely pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000216915	3	41275105	3	41233614	216915	213551	rs863224864	NC_000003.12:41233613:T:G	T	G	CLINICAL
NM_015466.4(PTPN23):c.1748A>G (p.Lys583Arg)	PTPN23	K583R, K457R	Normal	Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000636323	3	47450758	3	47409268	636323	624129	rs147293860	NC_000003.12:47409267:A:G	A	G	CLINICAL
NM_002222.6(ITPR1):c.6137A>G (p.Glu2046Gly)	ITPR1	E2094G, E2061G, E2046G	Normal	Gillespie syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	no assertion criteria provided	VCV000235921	3	4821268	3	4779584	235921	237579	rs878853177	NC_000003.12:4779583:A:G	A	G	CLINICAL
NM_138615.3(DHX30):c.1685A>G (p.His562Arg)	DHX30	H562R, H523R, H534R	Normal	Neurodevelopmental disorder with severe motor impairment and absent language|Abnormality of the cerebral white matter|Intellectual disability|Autistic disorder of childhood onset|Microcephaly|Delayed speech and language development|Sleep disturbance|Hearing impairment|Muscular hypotonia of the trunk|Strabismus|Global developmental delay	Pathogenic	criteria provided, single submitter	VCV000402130	3	47888247	3	47846757	402130	389102	rs1060499733	NC_000003.12:47846756:A:G	A	G	CLINICAL
NM_002222.6(ITPR1):c.7614T>G (p.Phe2538Leu)	ITPR1	F2553L, F2586L, F2538L	Normal	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235920	3	4856838	3	4815154	235920	237578	rs878853176	NC_000003.12:4815153:T:G	T	G	CLINICAL
NM_021971.4(GMPPB):c.656T>C (p.Ile219Thr)	GMPPB	I219T	Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV000575991	3	49759776	3	49722343	575991	559054	rs761714818	NC_000003.12:49722342:A:G	A	G	CLINICAL
NM_021971.4(GMPPB):c.79G>C (p.Asp27His)	GMPPB	D27H	Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|not provided|Muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000060546	3	49761081	3	49723648	60546	75127	rs142336618	NC_000003.12:49723647:C:G	C	G	CLINICAL
NM_004947.5(DOCK3):c.1038-2A>G	DOCK3		Normal	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia|Muscular hypotonia|Global developmental delay	Pathogenic(Last reviewed: Aug 12, 2020)	no assertion criteria provided	VCV000599269	3	51246203	3	51208772	599269	583203	rs1560212751	NC_000003.12:51208771:A:G	A	G	CLINICAL
NM_032682.6(FOXP1):c.1600T>C (p.Trp534Arg)	FOXP1	W534R, W458R, W533R, W433R, W434R	Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000156541	3	71021758	3	70972607	156541	166312	rs587777855	NC_000003.12:70972606:A:G	A	G	CLINICAL
NM_032682.6(FOXP1):c.1394G>C (p.Arg465Thr)	FOXP1	R465T, R365T, R364T, R464T, R389T	Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000559905	3	71026828	3	70977677	559905	550596	rs1553668196	NC_000003.12:70977676:C:G	C	G	CLINICAL
NM_001244810.1(FOXP1):c.1348+2T>C	FOXP1		Normal	Autistic disorder of childhood onset	Likely pathogenic	no assertion criteria provided	VCV000374237	3	71026977	3	70977826	374237	361123	rs1057518999	NC_000003.12:70977825:A:G	A	G	CLINICAL
NM_032682.5(FOXP1):c.1348+1G>C	FOXP1		Normal	Autistic disorder of childhood onset|Intellectual disability	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000587696	3	71026978	3	70977827	587696	578654	rs1559619762	NC_000003.12:70977826:C:G	C	G	CLINICAL
NM_032682.5(FOXP1):c.1146+1G>C	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Likely pathogenic(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000633220	3	71037144	3	70987993	633220	621730	rs1559650552	NC_000003.12:70987992:C:G	C	G	CLINICAL
NM_032682.5(FOXP1):c.1000G>C (p.Asp334His)	FOXP1	D233H, D234H, D258H, D333H, D334H	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000691264	3	71050185	3	71001034	691264	678938	rs1576028676	NC_000003.12:71001033:C:G	C	G	CLINICAL
NM_032682.5(FOXP1):c.975-2A>C	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Sep 21, 2016)	no assertion criteria provided	VCV000438294	3	71050212	3	71001061	438294	431906	rs1553685707	NC_000003.12:71001060:T:G	T	G	CLINICAL
NM_032682.6(FOXP1):c.870-1G>C	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801985	3	71064805	3	71015654	801985	790419	rs1576175491	NC_000003.12:71015653:C:G	C	G	CLINICAL
NM_001080517.3(SETD5):c.988A>G (p.Lys330Glu)	SETD5	K232E, K330E	Normal	Mental retardation, autosomal dominant 23	Likely pathogenic(Last reviewed: Sep 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000666294	3	9483840	3	9442156	666294	653863	rs1575430613	NC_000003.12:9442155:A:G	A	G	CLINICAL
NM_001080517.3(SETD5):c.1931C>G (p.Ser644Ter)	SETD5	S644*, S546*	Normal	Mental retardation, autosomal dominant 23	Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000520418	3	9489518	3	9447834	520418	511024	rs1553625881	NC_000003.12:9447833:C:G	C	G	CLINICAL
NM_001080517.3(SETD5):c.2347-7A>G	SETD5		Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 23|See cases|not provided	Pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280376	3	9495416	3	9453732	280376	264172	rs886041593	NC_000003.12:9453731:A:G	A	G	CLINICAL
NM_004366.6(CLCN2):c.1015G>C (p.Val339Leu)	CLCN2	V339L, V295L	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217786	3	184074851	3	184357063	217786	214438	rs532632165	NC_000003.12:184357062:C:G	C	G	CLINICAL
NM_004366.6(CLCN2):c.292G>C (p.Gly98Arg)	CLCN2	G98R	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217784	3	184076530	3	184358742	217784	214442	rs863225249	NC_000003.12:184358741:C:G	C	G	CLINICAL
NM_001354689.3(RAF1):c.786T>A (p.Asn262Lys)	RAF1	N262K, N148K, N229K, N181K	Normal	Noonan syndrome|not provided	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044634	3	12645683	3	12604184	44634	53801	rs397516829	NC_000003.12:12604183:A:T	A	T	CLINICAL
NM_006070.6(TFG):c.854C>T (p.Pro285Leu)	TFG	P285L, P281L	Normal	Amyotrophic Lateral Sclerosis with Sensory Neuropathy|not provided|Hereditary motor and sensory neuropathy, Okinawa type|Hereditary motor and sensory neuropathy, Okinawa type|Spastic paraplegia 57, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000037089	3	100467026	3	100748182	37089	45764	rs207482230	NC_000003.12:100748181:C:T	C	T	CLINICAL
NM_001080517.3(SETD5):c.922C>T (p.Arg308Ter)	SETD5	R308*, R210*	Normal	not provided|Mental retardation, autosomal dominant 23	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620169	3	9483388	3	9441704	620169	611599	rs1421204500	NC_000003.12:9441703:C:T	C	T	CLINICAL
NM_001003694.2(BRPF1):c.2497C>T (p.Arg833Ter)	BRPF1	R833*, R827*, R826*	Normal	Intellectual developmental disorder with dysmorphic facies and ptosis|not provided	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000375487	3	9785447	3	9743763	375487	362297	rs1057519512	NC_000003.12:9743762:C:T	C	T	CLINICAL
NM_003042.4(SLC6A1):c.863C>T (p.Ala288Val)	SLC6A1	A288V, A110V, A168V	Normal	Myoclonic-atonic epilepsy|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000192372	3	11067472	3	11025786	192372	190159	rs794726860	NC_000003.12:11025785:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.337C>T (p.Gln113Ter)	CTNNB1	Q113*, Q106*	Normal	not provided|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451713	3	41266540	3	41225049	451713	443452	rs1553630279	NC_000003.12:41225048:C:T	C	T	CLINICAL
NM_004113.6(FGF12):c.148G>A (p.Gly50Ser)	FGF12	G112S, G50S	Normal	Epileptic encephalopathy, early infantile, 47	Likely pathogenic(Last reviewed: Dec 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522854	3	192053230	3	192335441	522854	513415	rs1553798675	NC_000003.12:192335440:C:T	C	T	CLINICAL
NM_000340.2(SLC2A2):c.1246G>A (p.Gly416Ser)	SLC2A2	G416S, G243S, G297S	Normal	Fanconi-Bickel syndrome	Likely pathogenic(Last reviewed: Feb 1, 2016)	criteria provided, single submitter	VCV000445147	3	170716110	3	170998321	445147	438543	rs1553785033	NC_000003.12:170998320:C:T	C	T	CLINICAL
NM_000340.2(SLC2A2):c.963+1G>A	SLC2A2		Normal	Fanconi-Bickel syndrome|Type 2 diabetes mellitus	Pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000444008	3	170723073	3	171005284	444008	437669	rs371977235	NC_000003.12:171005283:C:T	C	T	CLINICAL
NM_000096.4(CP):c.2630G>A (p.Trp877Ter)	CP	W877*	Normal	not provided|Hypoceruloplasminemia|Deficiency of ferroxidase	Pathogenic(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000017562	3	148897374	3	149179587	17562	32601	rs121909579	NC_000003.12:149179586:C:T	C	T	CLINICAL
NM_005037.5(PPARG):c.496C>T (p.Arg166Trp)	PPARG	R194W, R166W	Normal	Familial partial lipodystrophy 3	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000008144	3	12434212	3	12392713	8144	23183	rs121909246	NC_000003.12:12392712:C:T	C	T	CLINICAL
NM_000551.4(VHL):c.481C>T (p.Arg161Ter)	VHL|LOC107303340	R161*, R120*	Normal	Familial infantile myasthenia|Renal cell carcinoma, papillary, 1|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002217	3	10191488	3	10149804	2217	17256	rs5030818	NC_000003.12:10149803:C:T	C	T	CLINICAL
NM_000340.2(SLC2A2):c.775+1G>A	SLC2A2		Normal	not provided|Fanconi-Bickel syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000502268	3	170723731	3	171005942	502268	493692	rs756874949	NC_000003.12:171005941:C:T	C	T	CLINICAL
NM_003042.4(SLC6A1):c.167C>T (p.Ser56Phe)	SLC6A1|SLC6A1-AS1	S56F	Normal	Global developmental delay|Seizures	Likely pathogenic	no assertion criteria provided	VCV000812761	3	11059064	3	11017378	812761	801070	rs1574891108	NC_000003.12:11017377:C:T	C	T	CLINICAL
NM_001164342.2(ZBTB20):c.1876G>A (p.Val626Met)	ZBTB20	V626M, V553M	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Pathogenic	no assertion criteria provided	VCV000139450	3	114058202	3	114339355	139450	143142	rs483353063	NC_000003.12:114339354:C:T	C	T	CLINICAL
NM_001348800.3(ZBTB20):c.1734T>A (p.Tyr578Ter)	ZBTB20	Y505*, Y578*	Normal	Intellectual disability-cataracts-calcified pinnae-myopathy syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801992	3	114069191	3	114350344	801992	790316	rs1576280941	NC_000003.12:114350343:A:T	A	T	CLINICAL
NM_005862.3(STAG1):c.1118G>A (p.Arg373Gln)	STAG1	R373Q	Normal	Inborn genetic diseases|STAG1-related disorder|Intellectual disability, autosomal dominant 47	Likely pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437899	3	136192388	3	136473546	437899	431521	rs1376334317	NC_000003.12:136473545:C:T	C	T	CLINICAL
NM_053002.5(MED12L):c.5371C>T (p.Arg1791Ter)	MED12L	R1791*	Normal	Intellectual disability	Pathogenic(Last reviewed: Nov 27, 2018)	no assertion criteria provided	VCV000592153	3	151107791	3	151390003	592153	583142	rs1560115921	NC_000003.12:151390002:C:T	C	T	CLINICAL
NM_004733.4(SLC33A1):c.963+1G>A	SLC33A1		Normal	Hypothyroidism|Global developmental delay|Failure to thrive	Likely pathogenic	no assertion criteria provided	VCV000812763	3	155560220	3	155842431	812763	801072	rs1266904735	NC_000003.12:155842430:C:T	C	T	CLINICAL
NM_001271838.2(RSRC1):c.205C>T (p.Arg69Ter)	RSRC1	R69*	Normal	Intellectual developmental disorder, autosomal recessive 70	Pathogenic(Last reviewed: Apr 26, 2019)	no assertion criteria provided	VCV000626266	3	157841665	3	158123876	626266	614570	rs868818936	NC_000003.12:158123875:C:T	C	T	CLINICAL
NM_001271838.2(RSRC1):c.268C>T (p.Arg90Ter)	RSRC1	R90*	Normal	Intellectual developmental disorder, autosomal recessive 70	Pathogenic(Last reviewed: Apr 26, 2019)	no assertion criteria provided	VCV000626265	3	157841728	3	158123939	626265	614569	rs1183090232	NC_000003.12:158123938:C:T	C	T	CLINICAL
NM_024665.6(TBL1XR1):c.1108G>A (p.Asp370Asn)	TBL1XR1	D370N, D283N	Normal	Inborn genetic diseases|Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372701	3	176755900	3	177038112	372701	359406	rs1057517933	NC_000003.12:177038111:C:T	C	T	CLINICAL
NM_001321195.2(TBL1XR1):c.-53G>A	TBL1XR1	G70D	Normal	Mental retardation, autosomal dominant 41	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000191371	3	176769510	3	177051722	191371	189176	rs786205859	NC_000003.12:177051721:C:T	C	T	CLINICAL
NM_003907.3(EIF2B5):c.943C>T (p.Arg315Cys)	EIF2B5	R315C	Normal	Dystonia|Leukodystrophy|Developmental regression|Abnormality of the cerebral white matter	Pathogenic	criteria provided, single submitter	VCV000598970	3	183858305	3	184140517	598970	590049	rs113994063	NC_000003.12:184140516:C:T	C	T	CLINICAL
NM_004068.4(AP2M1):c.508C>T (p.Arg170Trp)	AP2M1	R170W, R168W, R195W	Normal	Intellectual disability|Seizures|Autistic disorder of childhood onset|Intellectual developmental disorder 60 with seizures	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000689722	3	183898715	3	184180927	689722	677400	rs1577059692	NC_000003.12:184180926:C:T	C	T	CLINICAL
NM_015560.2(OPA1):c.1705+1G>T	OPA1		Normal	Abortive cerebellar ataxia	Pathogenic(Last reviewed: Jan 2, 2018)	no assertion criteria provided	VCV000225123	3	193364970	3	193647181	225123	227009	rs879255595	NC_000003.12:193647180:G:T	G	T	CLINICAL
NM_015560.2(OPA1):c.2470C>T (p.Arg824Ter)	OPA1	R824*, R879*, R701*, R788*, R806*, R842*, R700*, R825*, R843*, R861*	Normal	Abortive cerebellar ataxia|Retinal dystrophy	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000225121	3	193380725	3	193662936	225121	227007	rs879255593	NC_000003.12:193662935:C:T	C	T	CLINICAL
NM_001354712.2(THRB):c.1302C>A (p.Cys434Ter)	THRB	C434*, C403*	Normal	not provided|Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000012565	3	24164459	3	24122968	12565	27604	rs121918705	NC_000003.12:24122967:G:T	G	T	CLINICAL
NM_001904.4(CTNNB1):c.268C>T (p.Arg90Ter)	CTNNB1	R90*, R83*	Normal	Mental retardation, autosomal dominant 19|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000253000	3	41266471	3	41224980	253000	247398	rs1369821061	NC_000003.12:41224979:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.283C>T (p.Arg95Ter)	CTNNB1	R95*, R88*	Normal	not provided|Medulloblastoma|Hepatocellular carcinoma|Carcinoma of colon|Pilomatrixoma|Exudative vitreoretinopathy 7|Mental retardation, autosomal dominant 19|Neoplasm of ovary|Mental retardation, autosomal dominant 19|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265443	3	41266486	3	41224995	265443	259764	rs775104326	NC_000003.12:41224994:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.337C>T (p.Gln113Ter)	CTNNB1	Q113*, Q106*	Normal	not provided|Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451713	3	41266540	3	41225049	451713	443452	rs1553630279	NC_000003.12:41225048:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.925C>T (p.Gln309Ter)	CTNNB1	Q309*, Q302*	Normal	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Nov 15, 2012)	no assertion criteria provided	VCV000039656	3	41267341	3	41225850	39656	48255	rs376393123	NC_000003.12:41225849:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1297A>T (p.Lys433Ter)	CTNNB1	K433*, K426*	Normal	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000560707	3	41275131	3	41233640	560707	551769	rs1559474364	NC_000003.12:41233639:A:T	A	T	CLINICAL
NM_001904.4(CTNNB1):c.1420C>T (p.Arg474Ter)	CTNNB1	R474*, R467*	Normal	Mental retardation, autosomal dominant 19|Neurodevelopmental disorder|Intellectual disability|not provided	Pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000559636	3	41275254	3	41233763	559636	550356	rs1553631860	NC_000003.12:41233762:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1543C>T (p.Arg515Ter)	CTNNB1	R515*, R508*	Normal	Mental retardation, autosomal dominant 19|not provided	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039655	3	41275648	3	41234157	39655	48254	rs397514554	NC_000003.12:41234156:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1588C>T (p.Gln530Ter)	CTNNB1	Q530*, Q523*	Normal	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000598768	3	41275693	3	41234202	598768	589831	rs1559474966	NC_000003.12:41234201:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1603C>T (p.Arg535Ter)	CTNNB1	R535*, R528*	Normal	not provided|Mental retardation, autosomal dominant 19|Abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity|Exudative vitreoretinopathy 7|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265085	3	41275708	3	41234217	265085	259765	rs886039332	NC_000003.12:41234216:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1672C>T (p.Gln558Ter)	CTNNB1	Q558*, Q551*	Normal	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Mar 18, 2019)	no assertion criteria provided	VCV000430707	3	41275777	3	41234286	430707	424246	rs1131692181	NC_000003.12:41234285:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1759C>T (p.Arg587Ter)	CTNNB1	R587*, R580*	Normal	Mental retardation, autosomal dominant 19|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423482	3	41277290	3	41235799	423482	406301	rs1064796453	NC_000003.12:41235798:C:T	C	T	CLINICAL
NM_001904.4(CTNNB1):c.1876G>T (p.Glu626Ter)	CTNNB1	E626*, E619*	Normal	Microcephaly|Imperforate anus|Teratoma|Global developmental delay|Absent speech	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523403	3	41277912	3	41236421	523403	513945	rs1553632357	NC_000003.12:41236420:G:T	G	T	CLINICAL
NM_001904.4(CTNNB1):c.1900G>T (p.Glu634Ter)	CTNNB1	E634*, E627*	Normal	Mental retardation, autosomal dominant 19	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000807588	3	41277936	3	41236445	807588	798532	rs1575334103	NC_000003.12:41236444:G:T	G	T	CLINICAL
NM_001904.4(CTNNB1):c.1981C>T (p.Arg661Ter)	CTNNB1	R661*, R654*	Normal	Mental retardation, autosomal dominant 19|not provided	Pathogenic(Last reviewed: Apr 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429824	3	41278105	3	41236614	429824	421442	rs748294403	NC_000003.12:41236613:C:T	C	T	CLINICAL
NM_001378452.1(ITPR1):c.805C>T (p.Arg269Trp)	ITPR1	R269W	Normal	Spinocerebellar ataxia type 29|not provided|Spinocerebellar ataxia type 29|Spinocerebellar Ataxia Type 15|Gillespie syndrome|Gillespie syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265201	3	4687362	3	4645678	265201	259766	rs886039392	NC_000003.12:4645677:C:T	C	T	CLINICAL
NM_001099952.3(ITPR1):c.1252-2A>T	ITPR1		Normal	Gillespie syndrome	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617623	3	4703764	3	4662080	617623	609019	rs1559638068	NC_000003.12:4662079:A:T	A	T	CLINICAL
NM_002222.6(ITPR1):c.2137C>T (p.Arg713Ter)	ITPR1	R728*, R713*	Normal	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235916	3	4712588	3	4670904	235916	237574	rs878853172	NC_000003.12:4670903:C:T	C	T	CLINICAL
NM_002222.6(ITPR1):c.4627C>T (p.Gln1543Ter)	ITPR1	Q1558*, Q1552*, Q1543*	Normal	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235915	3	4747892	3	4706208	235915	237573	rs878853171	NC_000003.12:4706207:C:T	C	T	CLINICAL
NM_015466.4(PTPN23):c.1291C>T (p.Arg431Trp)	PTPN23	R431W, R305W	Normal	Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000636317	3	47449941	3	47408451	636317	624128	rs150712932	NC_000003.12:47408450:C:T	C	T	CLINICAL
NM_015466.4(PTPN23):c.2486C>T (p.Pro829Leu)	PTPN23	P829L, P703L	Normal	Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000636318	3	47451774	3	47410284	636318	624130	rs138076291	NC_000003.12:47410283:C:T	C	T	CLINICAL
NM_015466.4(PTPN23):c.2680C>T (p.His894Tyr)	PTPN23	H894Y, H768Y	Normal	Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Feb 15, 2019)	no assertion criteria provided	VCV000636313	3	47451968	3	47410478	636313	624132	rs967738491	NC_000003.12:47410477:C:T	C	T	CLINICAL
NM_015466.4(PTPN23):c.3995G>T (p.Arg1332Leu)	PTPN23	R1332L, R1206L	Normal	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity|Global developmental delay|Seizures|Brain atrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2015)	no assertion criteria provided	VCV000183326	3	47453379	3	47411889	183326	181409	rs730882229	NC_000003.12:47411888:G:T	G	T	CLINICAL
NM_002222.6(ITPR1):c.6321+3A>T	ITPR1		Normal	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235917	3	4824428	3	4782744	235917	237575	rs878853173	NC_000003.12:4782743:A:T	A	T	CLINICAL
NM_138615.3(DHX30):c.2344C>T (p.Arg782Trp)	DHX30	R782W, R743W, R754W	Normal	Neurodevelopmental disorder with severe motor impairment and absent language|Global developmental delay|Failure to thrive|Short stature|EEG abnormality|Generalized hypotonia|Hirsutism|Intellectual disability|Microcephaly	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375373	3	47889727	3	47848237	375373	362139	rs753242774	NC_000003.12:47848236:C:T	C	T	CLINICAL
NM_002222.6(ITPR1):c.6619+5G>T	ITPR1		Normal	Gillespie syndrome	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000235918	3	4829828	3	4788144	235918	237576	rs878853174	NC_000003.12:4788143:G:T	G	T	CLINICAL
NM_021971.4(GMPPB):c.1070G>A (p.Arg357His)	GMPPB	R384H, R357H	Normal	Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14	Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000581597	3	49759198	3	49721765	581597	559048	rs771861177	NC_000003.12:49721764:C:T	C	T	CLINICAL
NM_021971.2(GMPPB):c.1000G>A	GMPPB	D334N, D361N	Normal	not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Likely pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000060540	3	49759268	3	49721835	60540	75121	rs397509422	NC_000003.12:49721834:C:T	C	T	CLINICAL
NM_021971.4(GMPPB):c.988G>A (p.Val330Ile)	GMPPB	V330I, V357I	Normal	Inborn genetic diseases|Muscular dystrophy-dystroglycanopathy|Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|not provided	Likely pathogenic(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000060547	3	49759280	3	49721847	60547	75128	rs199922550	NC_000003.12:49721846:C:T	C	T	CLINICAL
NM_021971.4(GMPPB):c.640+1G>A	GMPPB		Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|not provided	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000640954	3	49759864	3	49722431	640954	651209	rs141588721	NC_000003.12:49722430:C:T	C	T	CLINICAL
NM_021971.4(GMPPB):c.402+1G>A	GMPPB		Normal	Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type b, 14|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 14|Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14	Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	VCV000570106	3	49760404	3	49722971	570106	563104	rs145564018	NC_000003.12:49722970:C:T	C	T	CLINICAL
NM_032682.5(FOXP1):c.1653-1G>A	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000691269	3	71019957	3	70970806	691269	678956	rs1575741313	NC_000003.12:70970805:C:T	C	T	CLINICAL
NM_032682.6(FOXP1):c.1541G>A (p.Arg514His)	FOXP1	R514H, R413H, R513H, R414H, R438H	Normal	Mental retardation with language impairment and with or without autistic features|Intellectual disability|not provided|See cases|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000211040	3	71021817	3	70972666	211040	207083	rs797045586	NC_000003.12:70972665:C:T	C	T	CLINICAL
NM_032682.5(FOXP1):c.1146+1G>A	FOXP1		Normal	not provided|Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000691271	3	71037144	3	70987993	691271	678957	rs1559650552	NC_000003.12:70987992:C:T	C	T	CLINICAL
NM_001244808.2(FOXP1):c.869+1G>A	FOXP1		Normal	Mental retardation with language impairment and with or without autistic features	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	VCV000433178	3	71090478	3	71041327	433178	426741	rs763837297	NC_000003.12:71041326:C:T	C	T	CLINICAL
NM_000844.4(GRM7):c.1972C>T (p.Arg658Trp)	GRM7	R658W	Normal	Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities|Brain atrophy|Seizures|CNS hypomyelination|Muscular hypotonia|Intellectual disability|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	no assertion criteria provided	VCV000242900	3	7620565	3	7578878	242900	243982	rs1114167300	NC_000003.12:7578877:C:T	C	T	CLINICAL
NM_000158.4(GBE1):c.1571G>A (p.Arg524Gln)	GBE1	R524Q	Normal	Glycogen storage disease, type IV|Glycogen storage disease IV, classic hepatic|Glycogen storage disease, type IV|Adult polyglucosan body neuropathy|Glycogen storage disease IV, combined hepatic and myopathic	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000002782	3	81627123	3	81577972	2782	17821	rs80338673	NC_000003.12:81577971:C:T	C	T	CLINICAL
NM_001080517.3(SETD5):c.670C>T (p.Gln224Ter)	SETD5	Q224*, Q126*	Normal	Mental retardation, autosomal dominant 23	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666304	3	9482242	3	9440558	666304	653862	rs1575421295	NC_000003.12:9440557:C:T	C	T	CLINICAL
NM_001080517.3(SETD5):c.922C>T (p.Arg308Ter)	SETD5	R308*, R210*	Normal	not provided|Mental retardation, autosomal dominant 23	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620169	3	9483388	3	9441704	620169	611599	rs1421204500	NC_000003.12:9441703:C:T	C	T	CLINICAL
NM_001080517.3(SETD5):c.1195A>T (p.Lys399Ter)	SETD5	K399*, K301*	Normal	Mental retardation, autosomal dominant 23	Pathogenic(Last reviewed: Apr 3, 2014)	no assertion criteria provided	VCV000127102	3	9486739	3	9445055	127102	132611	rs587777325	NC_000003.12:9445054:A:T	A	T	CLINICAL
NM_001080517.3(SETD5):c.2302C>T (p.Arg768Ter)	SETD5	R768*, R670*	Normal	Mental retardation, autosomal dominant 23|Neurodevelopmental disorder|not provided	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000219198	3	9490270	3	9448586	219198	217224	rs864321657	NC_000003.12:9448585:C:T	C	T	CLINICAL
NM_001080517.3(SETD5):c.3631+1G>T	SETD5		Normal	Mental retardation, autosomal dominant 23	Likely pathogenic(Last reviewed: Dec 30, 2016)	criteria provided, single submitter	VCV000436694	3	9516267	3	9474583	436694	428233	rs1553640838	NC_000003.12:9474582:G:T	G	T	CLINICAL
NM_198241.3(EIF4G1):c.1505C>T (p.Ala502Val)	EIF4G1	A502V, A306V, A338V, A415V, A462V, A509V	Normal	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030073	3	184039877	3	184322089	30073	39028	rs111290936	NC_000003.12:184322088:C:T	C	T	CLINICAL
NM_004366.6(CLCN2):c.1709G>A (p.Trp570Ter)	CLCN2	W570*, W553*, W526*	Normal	Leukoencephalopathy with ataxia|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000100629	3	184071901	3	184354113	100629	106501	rs201330912	NC_000003.12:184354112:C:T	C	T	CLINICAL
NM_004366.6(CLCN2):c.1507G>A (p.Gly503Arg)	CLCN2	G503R, G459R, G486R	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217793	3	184072336	3	184354548	217793	214431	rs777105668	NC_000003.12:184354547:C:T	C	T	CLINICAL
NM_004366.6(CLCN2):c.1412G>A (p.Arg471His)	CLCN2	R471H, R427H	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217791	3	184072431	3	184354643	217791	214433	rs771507094	NC_000003.12:184354642:C:T	C	T	CLINICAL
NM_004366.6(CLCN2):c.1397G>A (p.Gly466Glu)	CLCN2	G466E, G422E	Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000217790	3	184072446	3	184354658	217790	214434	rs863225254	NC_000003.12:184354657:C:T	C	T	CLINICAL
NM_004366.6(CLCN2):c.1397-1G>A	CLCN2		Normal	Leukoencephalopathy with ataxia	Pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000813301	3	184072447	3	184354659	813301	801547	rs1478304584	NC_000003.12:184354658:C:T	C	T	CLINICAL
NM_015009.3(PDZRN3):c.820G>A (p.Asp274Asn)	PDZRN3	D274N	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208395	3	73651603	3	73602452	208395	204614	rs748809996	NC_000003.12:73602451:C:T	C	T	CLINICAL
NM_012224.3(NEK1):c.2350A>T (p.Arg784Ter)	NEK1	R812*, R715*, R768*, R740*, R784*	Normal	Amyotrophic lateral sclerosis, susceptibility to, 24	risk factor(Last reviewed: Feb 28, 2018)	no assertion criteria provided	VCV000495118	4	170398275	4	169477124	495118	486672	rs749428135	NC_000004.12:169477123:T:A	T	A	CLINICAL
NM_006005.3(WFS1):c.2338G>A (p.Gly780Ser)	WFS1	G780S	Normal	Wolfram-like syndrome, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030559	4	6303860	4	6302133	30559	39516	rs387906931	NC_000004.12:6302132:G:A	G	A	CLINICAL
NM_000901.5(NR3C2):c.1609C>T (p.Arg537Ter)	NR3C2	R537*	Normal	Autism spectrum disorder|Autosomal dominant pseudohypoaldosteronism type 1	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000008555	4	149356404	4	148435252	8555	23594	rs121912562	NC_000004.12:148435251:G:A	G	A	CLINICAL
NM_006005.3(WFS1):c.330C>A (p.Tyr110Ter)	WFS1	Y110*	Normal	Type 2 diabetes mellitus	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523067	4	6290728	4	6289001	523067	513547	rs1553876668	NC_000004.12:6289000:C:A	C	A	CLINICAL
NM_176824.3(BBS7):c.632C>T (p.Thr211Ile)	BBS7	T211I	Normal	Bardet-Biedl syndrome 1/7, digenic|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV000003016	4	122775945	4	121854790	3016	18055	rs119466002	NC_000004.12:121854789:G:A	G	A	CLINICAL
NM_006005.3(WFS1):c.1839G>A (p.Trp613Ter)	WFS1	W613*	Normal	WFS1-Related Spectrum Disorders|Diabetes mellitus	Pathogenic(Last reviewed: Sep 20, 2016)	criteria provided, single submitter	VCV000349320	4	6303361	4	6301634	349320	299130	rs143064649	NC_000004.12:6301633:G:A	G	A	CLINICAL
NM_006005.3(WFS1):c.2590G>A (p.Glu864Lys)	WFS1	E864K	Normal	Nonsyndromic hearing loss and deafness|DFNA6/14/38 Nonsyndromic Low-Frequency Sensorineural Hearing Loss|not provided|Rare genetic deafness|Wolfram syndrome 1|Autosomal dominant nonsyndromic deafness 6|Wolfram-like syndrome, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004526	4	6304112	4	6302385	4526	19565	rs74315205	NC_000004.12:6302384:G:A	G	A	CLINICAL
NM_005112.2:c.4198C>T			Normal	Intellectual developmental disorder 61	Pathogenic(Last reviewed: Dec 14, 2020)	no assertion criteria provided	VCV000810683	4	10074197	4	10072573	810683	798969	rs540561511	NC_000004.12:10072572:G:A	G	A	CLINICAL
NM_001163435.3(TBCK):c.376C>T (p.Arg126Ter)	TBCK	R126*	Normal	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3|Generalized hypotonia|Global developmental delay|Inborn genetic diseases|Syndromic Infantile Encephalopathy|not provided	Pathogenic(Last reviewed: May 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225235	4	107183260	4	106262103	225235	227149	rs575822089	NC_000004.12:106262102:G:A	G	A	CLINICAL
NM_145207.3(SPATA5):c.251G>A (p.Arg84Gln)	SPATA5	R84Q, R83Q	Normal	not provided|Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000203534	4	123848876	4	122927721	203534	199923	rs745858366	NC_000004.12:122927720:G:A	G	A	CLINICAL
NM_145207.3(SPATA5):c.298G>A (p.Ala100Thr)	SPATA5	A100T, A99T	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 3, 2015)	no assertion criteria provided	VCV000203536	4	123850204	4	122929049	203536	199925	rs796051895	NC_000004.12:122929048:G:A	G	A	CLINICAL
NM_145207.3(SPATA5):c.446+1G>A	SPATA5		Normal	not provided|Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546179	4	123850353	4	122929198	546179	536661	rs1166181741	NC_000004.12:122929197:G:A	G	A	CLINICAL
NM_145207.3(SPATA5):c.1586G>A (p.Arg529Gln)	SPATA5	R529Q, R528Q	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV000203523	4	123868515	4	122947360	203523	199930	rs567175477	NC_000004.12:122947359:G:A	G	A	CLINICAL
NM_145207.3(SPATA5):c.1677C>A (p.Tyr559Ter)	SPATA5	Y559*, Y558*	Normal	not provided|Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV000207827	4	123868606	4	122947451	207827	204063	rs139834687	NC_000004.12:122947450:C:A	C	A	CLINICAL
NM_145207.3(SPATA5):c.1714+1G>A	SPATA5		Normal	Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207803	4	123868644	4	122947489	207803	204039	rs149688478	NC_000004.12:122947488:G:A	G	A	CLINICAL
NM_057175.5(NAA15):c.691+1G>A	NAA15		Normal	Intellectual disability, autosomal dominant 50	Likely pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800817	4	140265494	4	139344340	800817	789364	rs1579109565	NC_000004.12:139344339:G:A	G	A	CLINICAL
NM_057175.5(NAA15):c.1695T>A (p.Tyr565Ter)	NAA15	Y565*	Normal	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Jul 7, 2021)	no assertion criteria provided	VCV000446518	4	140283033	4	139361879	446518	440036	rs1553997065	NC_000004.12:139361878:T:A	T	A	CLINICAL
NM_001042424.3(NSD2):c.708G>A (p.Trp236Ter)	NSD2	W236*	Normal	4p partial monosomy syndrome|Wolf-Hirschhorn like syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000599448	4	1906053	4	1904326	599448	590769	rs1560602800	NC_000004.12:1904325:G:A	G	A	CLINICAL
NM_016955.4(SEPSECS):c.766G>T (p.Gly256Ter)	SEPSECS	G256*	Normal	not provided|Pontocerebellar hypoplasia type 2D	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620464	4	25153620	4	25151998	620464	611612	rs779387647	NC_000004.12:25151997:C:A	C	A	CLINICAL
NM_001127178.3(PIGG):c.1515G>A (p.Trp505Ter)	PIGG	W505*, W139*, W162*, W408*, W497*, W372*, W416*	Normal	not provided|Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000476318	4	515631	4	521842	476318	453992	rs150259543	NC_000004.12:521841:G:A	G	A	CLINICAL
NM_024592.5(SRD5A3):c.57G>A (p.Trp19Ter)	SRD5A3	W19*	Normal	not provided|Congenital disorder of glycosylation type 1Q|Congenital disorder of glycosylation|Kahrizi syndrome|Autistic disorder of childhood onset|Global developmental delay|Cone dystrophy	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096125	4	56212560	4	55346393	96125	102019	rs398124401	NC_000004.12:55346392:G:A	G	A	CLINICAL
NM_001098484.3(SLC4A4):c.1661G>A (p.Arg554His)	SLC4A4	R510H, R554H	Normal	Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006472	4	72338445	4	71472728	6472	21511	rs121908857	NC_000004.12:71472727:G:A	G	A	CLINICAL
NM_000669.5(ADH1C):c.232G>T (p.Gly78Ter)	ADH1C	G78*	Normal	Parkinson disease, mitochondrial	risk factor(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000018181	4	100268190	4	99347033	18181	33220	rs283413	NC_000004.12:99347032:C:A	C	A	CLINICAL
NM_006005.3(WFS1):c.2338G>A (p.Gly780Ser)	WFS1	G780S	Normal	Wolfram-like syndrome, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030559	4	6303860	4	6302133	30559	39516	rs387906931	NC_000004.12:6302132:G:A	G	A	CLINICAL
NM_001199397.3(NEK1):c.3107C>G (p.Ser1036Ter)	NEK1	S1036*, S1008*, S964*, S992*, S939*, S991*, S875*	Normal	Amyotrophic lateral sclerosis, susceptibility to, 24|Short rib-polydactyly syndrome, Majewski type|not provided|none provided|Amyotrophic lateral sclerosis, susceptibility to, 24|Short rib-polydactyly syndrome, Majewski type	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208600	4	170345819	4	169424668	208600	205144	rs199947197	NC_000004.12:169424667:G:C	G	C	CLINICAL
NM_176824.3(BBS7):c.968A>G (p.His323Arg)	BBS7	H323R	Normal	Bardet-Biedl syndrome 7|not provided|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003015	4	122768628	4	121847473	3015	18054	rs119466001	NC_000004.12:121847472:T:C	T	C	CLINICAL
NM_000944.5(PPP3CA):c.275A>G (p.His92Arg)	PPP3CA	H92R	Normal	Inborn genetic diseases|Seizures|Intellectual disability|Developmental and epileptic encephalopathy 91	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000441272	4	102030220	4	101109063	441272	434926	rs1553925558	NC_000004.12:101109062:T:C	T	C	CLINICAL
NM_145207.3(SPATA5):c.1715-1G>C	SPATA5		Normal	Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, single submitter	VCV000568380	4	123900386	4	122979231	568380	559736	rs1263369560	NC_000004.12:122979230:G:C	G	C	CLINICAL
NM_016955.4(SEPSECS):c.1001A>G (p.Tyr334Cys)	SEPSECS	Y334C	Normal	Pontocerebellar hypoplasia type 2D|not provided	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV000018400	4	25146421	4	25144799	18400	33439	rs267607036	NC_000004.12:25144798:T:C	T	C	CLINICAL
NM_001127178.3(PIGG):c.1030A>C (p.Met344Leu)	PIGG	M211L, M222L, M255L, M1L, M344L	Normal	Mental retardation, autosomal recessive 53	Likely pathogenic(Last reviewed: Dec 10, 2018)	no assertion criteria provided	VCV000807655	4	509890	4	516101	807655	798543	rs757141700	NC_000004.12:516100:A:C	A	C	CLINICAL
NM_001127178.3(PIGG):c.2261+1G>C	PIGG		Normal	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225639	4	521020	4	527231	225639	227473	rs869320773	NC_000004.12:527230:G:C	G	C	CLINICAL
NM_147127.5(EVC2):c.3797T>G (p.Leu1266Ter)	EVC2	L1266*, L1186*	Normal	Curry-Hall syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000102430	4	5564705	4	5562978	102430	108172	rs1577093161	NC_000004.12:5562977:A:C	A	C	CLINICAL
NM_001098484.3(SLC4A4):c.1026A>C (p.Arg342Ser)	SLC4A4	R298S, R342S	Normal	Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation	Pathogenic(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000006471	4	72313423	4	71447706	6471	21510	rs121908856	NC_000004.12:71447705:A:C	A	C	CLINICAL
NM_004181.5(UCHL1):c.20A>C (p.Glu7Ala)	UCHL1	E7A	Normal	Spastic paraplegia 79, autosomal recessive	Pathogenic(Last reviewed: Feb 26, 2013)	no assertion criteria provided	VCV000088635	4	41259013	4	41256996	88635	94224	rs397515634	NC_000004.12:41256995:A:C	A	C	CLINICAL
NM_015697.8(COQ2):c.1028T>C (p.Val343Ala)	COQ2	V293A	Normal	Multiple system atrophy	risk factor(Last reviewed: Jul 3, 2014)	no assertion criteria provided	VCV000060537	4	84188812	4	83267659	60537	75118	rs397514727	NC_000004.12:83267658:A:G	A	G	CLINICAL
NM_152618.3(BBS12):c.323C>G (p.Pro108Arg)	BBS12	P108R	Normal	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000068065	4	123663370	4	122742215	68065	78956	rs151344630	NC_000004.12:122742214:C:G	C	G	CLINICAL
NM_005908.4(MANBA):c.1513T>C (p.Ser505Pro)	MANBA	S505P	Normal	Beta-D-mannosidosis	Pathogenic(Last reviewed: Aug 1, 2008)	no assertion criteria provided	VCV000001679	4	103579030	4	102657873	1679	16718	rs121434334	NC_000004.12:102657872:A:G	A	G	CLINICAL
NM_014822.4(SEC24D):c.697G>C (p.Gly233Arg)	SEC24D	G233R, G234R	Normal	Seizures|Intellectual disability	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183297	4	119736287	4	118815132	183297	181411	rs730882211	NC_000004.12:118815131:C:G	C	G	CLINICAL
NM_145207.3(SPATA5):c.1883A>G (p.Asp628Gly)	SPATA5	D628G, D627G	Normal	not provided|Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000203524	4	123949354	4	123028199	203524	199931	rs768528444	NC_000004.12:123028198:A:G	A	G	CLINICAL
NM_145207.3(SPATA5):c.2384C>G (p.Pro795Arg)	SPATA5	P795R, P794R	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Likely pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000488610	4	124177214	4	123256059	488610	481478	rs1553934697	NC_000004.12:123256058:C:G	C	G	CLINICAL
NM_057175.5(NAA15):c.2322C>G (p.Tyr774Ter)	NAA15	Y774*	Normal	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000268211	4	140307306	4	139386152	268211	263827	rs886041097	NC_000004.12:139386151:C:G	C	G	CLINICAL
NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)	FGFR3	P250R	Normal	Hypochondroplasia|Muenke syndrome|Achondroplasia|not specified|not provided|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Achondroplasia|Carcinoma of colon|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Severe achondroplasia with developmental delay and acanthosis nigricans|Hypochondroplasia|Levy-Hollister syndrome|Epidermal nevus|Urinary bladder cancer|Cancer of cervix|Malignant tumor of testis|Seizures|Unilateral renal agenesis|Infantile axial hypotonia|Crouzon syndrome|Coronal craniosynostosis|Absence seizures|Facial asymmetry|Saethre-Chotzen syndrome|Inborn genetic diseases|Craniosynostosis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000016340	4	1803571	4	1801844	16340	31379	rs4647924	NC_000004.12:1801843:C:G	C	G	CLINICAL
NM_032906.5(PYURF):c.*235T>C	PYURF|PIGY	L46P	Normal	Hyperphosphatasia with mental retardation syndrome 6	Pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000222024	4	89442804	4	88521653	222024	223715	rs869025322	NC_000004.12:88521652:A:G	A	G	CLINICAL
NM_004181.5(UCHL1):c.279C>G (p.Ile93Met)	UCHL1	I93M	Normal	Parkinson disease 5	risk factor(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000012297	4	41262768	4	41260751	12297	27336	rs121917767	NC_000004.12:41260750:C:G	C	G	CLINICAL
NM_000345.4(SNCA):c.88G>C (p.Ala30Pro)	SNCA	A30P	Normal	Parkinson disease 1	Pathogenic(Last reviewed: Nov 22, 2013)	no assertion criteria provided	VCV000014008	4	90756731	4	89835580	14008	29047	rs104893878	NC_000004.12:89835579:C:G	C	G	CLINICAL
NM_000944.5(PPP3CA):c.844G>A (p.Glu282Lys)	PPP3CA	E282K	Normal	Developmental and epileptic encephalopathy 91|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000441275	4	102004359	4	101083202	441275	434929	rs1553923787	NC_000004.12:101083201:C:T	C	T	CLINICAL
NM_018392.4(ZGRF1):c.4087G>A (p.Glu1363Lys)	ZGRF1	E1363K, E1305K	Normal	Speech-language disorder 1	Likely pathogenic(Last reviewed: Apr 27, 2016)	no assertion criteria provided	VCV000617843	4	113506711	4	112585555	617843	609195	rs76187047	NC_000004.12:112585554:C:T	C	T	CLINICAL
NM_018392.4(ZGRF1):c.142C>A (p.Leu48Met)	ZGRF1	L48M	Normal	Speech-language disorder 1	Likely pathogenic(Last reviewed: Apr 27, 2016)	no assertion criteria provided	VCV000617844	4	113544993	4	112623837	617844	609196	rs61745597	NC_000004.12:112623836:G:T	G	T	CLINICAL
NM_057175.5(NAA15):c.2086A>T (p.Lys696Ter)	NAA15	K696*	Normal	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Jul 7, 2021)	no assertion criteria provided	VCV000446519	4	140299939	4	139378785	446519	440037	rs1553998565	NC_000004.12:139378784:A:T	A	T	CLINICAL
NM_152618.3(BBS12):c.1063C>T (p.Arg355Ter)	BBS12	R355*	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 12|Abnormality of cardiovascular system morphology|Visual impairment|Inability to walk|Postaxial polydactyly type A1	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001147	4	123664110	4	122742955	1147	16186	rs121918327	NC_000004.12:122742954:C:T	C	T	CLINICAL
NM_006005.3(WFS1):c.2051C>T (p.Ala684Val)	WFS1	A684V	Normal	Rare genetic deafness|Wolfram syndrome 1|Inborn genetic diseases|not provided|Autosomal dominant nonsyndromic deafness 6|Wolfram-like syndrome, autosomal dominant|Wolfram syndrome 1	Pathogenic(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030556	4	6303573	4	6301846	30556	39513	rs387906930	NC_000004.12:6301845:C:T	C	T	CLINICAL
NM_006005.3(WFS1):c.124C>T (p.Arg42Ter)	WFS1	R42*	Normal	not provided|Type 2 diabetes mellitus|Autosomal dominant nonsyndromic deafness 6|Wolfram syndrome 1|Cataract 41|Wolfram-like syndrome, autosomal dominant|Type 2 diabetes mellitus|Autosomal dominant nonsyndromic deafness 6|Wolfram syndrome 1|Wolfram-like syndrome, autosomal dominant|Wolfram syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000189251	4	6279306	4	6277579	189251	187111	rs71530923	NC_000004.12:6277578:C:T	C	T	CLINICAL
NM_005908.4(MANBA):c.1622G>A (p.Trp541Ter)	MANBA	W541*	Normal	not provided|Beta-D-mannosidosis	Pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000594436	4	103578921	4	102657764	594436	585499	rs771865668	NC_000004.12:102657763:C:T	C	T	CLINICAL
NM_001163435.3(TBCK):c.1897+1G>A	TBCK		Normal	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3|Delayed reflexes|Global developmental delay|Muscular hypotonia|Dysmorphism|Ventral septal defect|Seizures	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000183338	4	107115874	4	106194717	183338	181410	rs374319146	NC_000004.12:106194716:C:T	C	T	CLINICAL
NM_183075.3(CYP2U1):c.947A>T (p.Asp316Val)	CYP2U1	D316V	Normal	Spastic paraplegia|Spastic paraplegia 56, autosomal recessive|not provided|Neurodegeneration|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039500	4	108866582	4	107945426	39500	48099	rs397514513	NC_000004.12:107945425:A:T	A	T	CLINICAL
NM_145207.3(SPATA5):c.394C>T (p.Gln132Ter)	SPATA5	Q132*, Q131*	Normal	Epilepsy, hearing loss, and mental retardation syndrome|not provided	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000488607	4	123850300	4	122929145	488607	481475	rs1220351376	NC_000004.12:122929144:C:T	C	T	CLINICAL
NM_145207.3(SPATA5):c.556C>T (p.Arg186Ter)	SPATA5	R186*, R185*	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000204306	4	123855302	4	122934147	204306	200703	rs796052095	NC_000004.12:122934146:C:T	C	T	CLINICAL
NM_145207.3(SPATA5):c.661C>T (p.Gln221Ter)	SPATA5	Q221*, Q220*	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000542389	4	123855407	4	122934252	542389	519739	rs1553955672	NC_000004.12:122934251:C:T	C	T	CLINICAL
NM_145207.3(SPATA5):c.700C>T (p.Gln234Ter)	SPATA5	Q234*, Q233*	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000488608	4	123855446	4	122934291	488608	481476	rs775269863	NC_000004.12:122934290:C:T	C	T	CLINICAL
NM_145207.3(SPATA5):c.1528C>T (p.Arg510Ter)	SPATA5	R510*, R509*	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000075286	4	123868457	4	122947302	75286	86177	rs267600009	NC_000004.12:122947301:C:T	C	T	CLINICAL
NM_145207.3(SPATA5):c.2038G>T (p.Ala680Ser)	SPATA5	A679S, A680S	Normal	Epilepsy, hearing loss, and mental retardation syndrome	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000666562	4	123949509	4	123028354	666562	654124	rs1578710903	NC_000004.12:123028353:G:T	G	T	CLINICAL
NM_057175.5(NAA15):c.382C>T (p.Arg128Ter)	NAA15	R128*	Normal	Intellectual disability, autosomal dominant 50|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000521938	4	140262203	4	139341049	521938	511524	rs1274633498	NC_000004.12:139341048:C:T	C	T	CLINICAL
NM_057175.5(NAA15):c.913A>T (p.Lys305Ter)	NAA15	K305*	Normal	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Jul 7, 2021)	no assertion criteria provided	VCV000559847	4	140272664	4	139351510	559847	550569	rs1553996072	NC_000004.12:139351509:A:T	A	T	CLINICAL
NM_057175.5(NAA15):c.2086A>T (p.Lys696Ter)	NAA15	K696*	Normal	Intellectual disability, autosomal dominant 50	Pathogenic(Last reviewed: Jul 7, 2021)	no assertion criteria provided	VCV000446519	4	140299939	4	139378785	446519	440037	rs1553998565	NC_000004.12:139378784:A:T	A	T	CLINICAL
NM_001080522.2(CC2D2A):c.3145C>T (p.Arg1049Ter)	CC2D2A	R1049*	Normal	Meckel syndrome type 6|Joubert syndrome with hepatic defect|Joubert syndrome 9|COACH syndrome 2|not provided|Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 9/15, digenic	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000747	4	15565108	4	15563485	747	15786	rs386833750	NC_000004.12:15563484:C:T	C	T	CLINICAL
NM_000142.5(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	R248C	Normal	Lung adenocarcinoma|not provided|none provided|Squamous cell lung carcinoma|Cancer of cervix|Epidermal nevus|Thanatophoric dysplasia type 1|Skeletal dysplasia with acanthosis nigricans|Multiple myeloma|Seborrheic keratosis|Crouzon syndrome with acanthosis nigricans|Muenke syndrome|Achondroplasia|Carcinoma of colon|Thanatophoric dysplasia type 1|Thanatophoric dysplasia, type 2|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Severe achondroplasia with developmental delay and acanthosis nigricans|Hypochondroplasia|Levy-Hollister syndrome|Epidermal nevus|Urinary bladder cancer|Cancer of cervix|Malignant tumor of testis|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Short stature|Lethal short-limbed short stature|Upper limb undergrowth|Disproportionate short-limb short stature|Bowed humerus|Short ribs|Narrow chest|Femoral bowing|Small for gestational age|Bell-shaped thorax|Growth delay|Lower limb undergrowth|Skeletal dysplasia|Carcinoma|Hamartoma|Craniosynostosis syndrome	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016332	4	1803564	4	1801837	16332	31371	rs121913482	NC_000004.12:1801836:C:T	C	T	CLINICAL
NM_000142.5(FGFR3):c.1949A>T (p.Lys650Met)	FGFR3	K650M, K652M, K538M, K651M	Normal	not provided|Thanatophoric dysplasia type 1|SEVERE ACHONDRODYSPLASIA WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS	Pathogenic(Last reviewed: Jul 29, 2020)	no assertion criteria provided	VCV000016341	4	1807890	4	1806163	16341	31380	rs121913105	NC_000004.12:1806162:A:T	A	T	CLINICAL
NM_018359.5(UFSP2):c.344T>A (p.Val115Glu)	UFSP2|C4orf47	V115E	Normal	Intellectual disability|Microcephaly|Seizures	Pathogenic(Last reviewed: Dec 30, 2020)	no assertion criteria provided	VCV000932944	4	186337011	4	185415857	932944	921245	rs142500730	NC_000004.12:185415856:A:T	A	T	CLINICAL
NM_000128.3(F11):c.403G>T (p.Glu135Ter)	F11	E135*	Normal	not provided|Inborn genetic diseases|Hereditary factor XI deficiency disease|Plasma factor XI deficiency|Thrombocytopenia|Abnormal bleeding	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011891	4	187195347	4	186274193	11891	26930	rs121965063	NC_000004.12:186274192:G:T	G	T	CLINICAL
NM_001042424.3(NSD2):c.793C>T (p.Gln265Ter)	NSD2	Q265*	Normal	4p partial monosomy syndrome|Wolf-Hirschhorn like syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000599449	4	1918630	4	1916903	599449	590770	rs1560635105	NC_000004.12:1916902:C:T	C	T	CLINICAL
NM_016955.4(SEPSECS):c.715G>A (p.Ala239Thr)	SEPSECS	A239T	Normal	Pontocerebellar hypoplasia type 2D|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018401	4	25153671	4	25152049	18401	33440	rs267607035	NC_000004.12:25152048:C:T	C	T	CLINICAL
NM_016955.4(SEPSECS):c.388+5G>A	SEPSECS		Normal	Pontocerebellar hypoplasia type 2D|Kyphosis|Arthrogryposis multiplex congenita|Severe global developmental delay|Cerebral hypoplasia|Seizures|Spinal rigidity|Congenital cerebellar hypoplasia	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374085	4	25158473	4	25156851	374085	360859	rs1057518887	NC_000004.12:25156850:C:T	C	T	CLINICAL
NM_001127178.3(PIGG):c.910C>T (p.Arg304Ter)	PIGG	R215*, R171*, R182*, R304*	Normal	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000807654	4	509770	4	515981	807654	798542	rs752545577	NC_000004.12:515980:C:T	C	T	CLINICAL
NM_001127178.3(PIGG):c.928C>T (p.Gln310Ter)	PIGG	Q310*, Q188*, Q221*, Q177*	Normal	Mental retardation, autosomal recessive 53	Pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225637	4	509788	4	515999	225637	227471	rs869320772	NC_000004.12:515998:C:T	C	T	CLINICAL
NM_001127178.3(PIGG):c.2569C>T (p.Gln857Ter)	PIGG	Q724*, Q346*, Q849*, Q514*, Q491*, Q760*, Q768*, Q857*	Normal	not provided|Mental retardation, autosomal recessive 53	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000654965	4	524532	4	530743	654965	632255	rs1294683568	NC_000004.12:530742:C:T	C	T	CLINICAL
NM_024592.5(SRD5A3):c.484C>T (p.Gln162Ter)	SRD5A3	Q162*	Normal	Congenital disorder of glycosylation type 1Q|Kahrizi syndrome	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804441	4	56230360	4	55364193	804441	792750	rs1578209906	NC_000004.12:55364192:C:T	C	T	CLINICAL
NM_006005.3(WFS1):c.1999C>T (p.Gln667Ter)	WFS1	Q667*	Normal	Dandy-Walker syndrome|Global developmental delay|Abnormality of the diaphragm|Arachnodactyly|Micrognathia|Abnormality of the vertebral column|Cerebellar vermis hypoplasia|Feeding difficulties|Nyctalopia|Cleft palate|Sensorineural hearing loss|Microglossia|Hydronephrosis|Duane anomaly|Diaphragmatic eventration|Abnormality of the cervical spine|Laryngomalacia|Small hand|Hydroureter	Pathogenic	criteria provided, single submitter	VCV000598973	4	6303521	4	6301794	598973	590055	rs771409809	NC_000004.12:6301793:C:T	C	T	CLINICAL
NM_001098484.3(SLC4A4):c.254-37C>T	SLC4A4	Q29*	Normal	Renal tubular acidosis, proximal, with ocular abnormalities and mental retardation	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000006473	4	72205050	4	71339333	6473	21512	rs121908858	NC_000004.12:71339332:C:T	C	T	CLINICAL
NM_001042616.2(PIGY):c.-540G>A	PIGY		Normal	Hyperphosphatasia with mental retardation syndrome 6	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	VCV000222025	4	89444948	4	88523797	222025	223716	rs869025323	NC_000004.12:88523796:C:T	C	T	CLINICAL
NM_000345.4(SNCA):c.157G>A (p.Ala53Thr)	SNCA	A53T	Normal	Lewy body dementia|Parkinson disease 1|Parkinson disease 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000014007	4	90749300	4	89828149	14007	29046	rs104893877	NC_000004.12:89828148:C:T	C	T	CLINICAL
NM_000345.4(SNCA):c.152G>A (p.Gly51Asp)	SNCA	G51D	Normal	Parkinson disease 1	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000097000	4	90749305	4	89828154	97000	102896	rs431905511	NC_000004.12:89828153:C:T	C	T	CLINICAL
NM_145207.3(SPATA5):c.388C>T (p.Gln130Ter)	SPATA5	Q130*, Q129*	Normal	not provided	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000620157	4	123850294	4	122929139	620157	611604	rs1560786479	NC_000004.12:122929138:C:T	C	T	CLINICAL
NM_003900.5(SQSTM1):c.1165+1G>A	SQSTM1		Normal	Paget disease of bone 3|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|GNE myopathy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000008110	5	179260783	5	179833783	8110	23149	rs796051870	NC_000005.10:179833782:G:A	G	A	CLINICAL
NM_005211.3(CSF1R):c.2326C>T (p.His776Tyr)	CSF1R	H776Y	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599608	5	149435898	5	150056335	599608	590944	rs1561905293	NC_000005.10:150056334:G:A	G	A	CLINICAL
NM_007118.4(TRIO):c.4128G>A (p.Trp1376Ter)	TRIO	W1376*	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253080	5	14390409	5	14390300	253080	247491	rs879255622	NC_000005.10:14390299:G:A	G	A	CLINICAL
NM_007118.4(TRIO):c.4283G>A (p.Arg1428Gln)	TRIO	R1428Q	Normal	Mental retardation, autosomal dominant 44|not provided	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000253084	5	14394211	5	14394102	253084	247495	rs879255626	NC_000005.10:14394101:G:A	G	A	CLINICAL
NM_007118.4(TRIO):c.4381C>A (p.Pro1461Thr)	TRIO	P1461T	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000253085	5	14397221	5	14397112	253085	247496	rs879255627	NC_000005.10:14397111:C:A	C	A	CLINICAL
NM_002397.5(MEF2C):c.766C>T (p.Arg256Ter)	MEF2C	R254*, R256*, R208*, R114*, R130*, R274*	Normal	Intellectual disability|Autism spectrum disorder	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206134	5	88027590	5	88731773	206134	201908	rs796052733	NC_000005.10:88731772:G:A	G	A	CLINICAL
NM_002397.5(MEF2C):c.403-1G>T	MEF2C		Normal	Autism spectrum disorder	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562143	5	88047861	5	88752044	562143	553316	rs1561824498	NC_000005.10:88752043:C:A	C	A	CLINICAL
NM_002397.5(MEF2C):c.43C>T (p.Arg15Cys)	MEF2C	R15C	Normal	not provided|Autism spectrum disorder	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV000206129	5	88119563	5	88823746	206129	201918	rs796052728	NC_000005.10:88823745:G:A	G	A	CLINICAL
NM_005654.6(NR2F1):c.413G>A (p.Cys138Tyr)	NR2F1	C138Y	Normal	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic	no assertion criteria provided	VCV000375371	5	92921142	5	93585436	375371	362143	rs1057519434	NC_000005.10:93585435:G:A	G	A	CLINICAL
NM_000827.4(GRIA1):c.2234G>A (p.Gly745Asp)	GRIA1	G745D, G650D, G665D, G755D, G676D, G689D, G754D	Normal	Non-syndromic intellectual disability|Autism spectrum disorder	Likely pathogenic	no assertion criteria provided	VCV000585059	5	153149939	5	153770379	585059	576113	rs1561846159	NC_000005.10:153770378:G:A	G	A	CLINICAL
NM_022464.5(SIL1):c.1312C>T (p.Gln438Ter)	SIL1	Q438*	Normal	Marinesco-Sjögren syndrome|not provided	Pathogenic(Last reviewed: Nov 21, 2012)	criteria provided, single submitter	VCV000002627	5	138282880	5	138947191	2627	17666	rs119456966	NC_000005.10:138947190:G:A	G	A	CLINICAL
NM_005859.5(PURA):c.470T>A (p.Met157Lys)	PURA	M157K	Normal	Neonatal hypotonia|Global developmental delay|Intellectual disability|Delayed speech and language development	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156410	5	139494236	5	140114651	156410	166189	rs587782998	NC_000005.10:140114650:T:A	T	A	CLINICAL
NM_002109.6(HARS1):c.616G>T (p.Asp206Tyr)	HARS1	D132Y, D146Y, D166Y, D177Y, D186Y, D206Y, D92Y	Normal	Dysarthria|Spastic ataxia|Intellectual disability|Nystagmus|Cerebellar atrophy|Oculomotor apraxia|Choreoathetosis|Tremor|Peripheral neuropathy|Dysmetria	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000804285	5	140057507	5	140677922	804285	792643	rs1131040	NC_000005.10:140677921:C:A	C	A	CLINICAL
NM_005219.5(DIAPH1):c.2332C>T (p.Gln778Ter)	DIAPH1	Q769*, Q778*	Normal	Seizures, cortical blindness, and microcephaly syndrome|Global developmental delay|Seizure disorder|Microcephaly|Failure to thrive	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000183344	5	140953085	5	141573518	183344	181418	rs730882242	NC_000005.10:141573517:G:A	G	A	CLINICAL
NM_007118.4(TRIO):c.4128G>A (p.Trp1376Ter)	TRIO	W1376*	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253080	5	14390409	5	14390300	253080	247491	rs879255622	NC_000005.10:14390299:G:A	G	A	CLINICAL
NM_007118.4(TRIO):c.4283G>A (p.Arg1428Gln)	TRIO	R1428Q	Normal	Mental retardation, autosomal dominant 44|not provided	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000253084	5	14394211	5	14394102	253084	247495	rs879255626	NC_000005.10:14394101:G:A	G	A	CLINICAL
NM_007118.4(TRIO):c.4381C>A (p.Pro1461Thr)	TRIO	P1461T	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000253085	5	14397221	5	14397112	253085	247496	rs879255627	NC_000005.10:14397111:C:A	C	A	CLINICAL
NM_015981.4(CAMK2A):c.1429C>T (p.His477Tyr)	CAMK2A	H477Y, H466Y	Normal	Intellectual disability, autosomal recessive 63	Pathogenic(Last reviewed: Jul 20, 2020)	no assertion criteria provided	VCV000560170	5	149602589	5	150223026	560170	550886	rs1554119274	NC_000005.10:150223025:G:A	G	A	CLINICAL
NM_015981.4(CAMK2A):c.635C>T (p.Pro212Leu)	CAMK2A	P212L	Normal	not provided|Intellectual disability	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000430916	5	149631371	5	150251808	430916	424457	rs926027867	NC_000005.10:150251807:G:A	G	A	CLINICAL
NM_015981.4(CAMK2A):c.548A>T (p.Glu183Val)	CAMK2A	E183V	Normal	Intellectual disability|Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000430914	5	149631595	5	150252032	430914	424459	rs1554122129	NC_000005.10:150252031:T:A	T	A	CLINICAL
NM_001543.5(NDST1):c.1831G>A (p.Gly611Ser)	NDST1	G611S	Normal	Mental retardation, autosomal recessive 46	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000161412	5	149921213	5	150541651	161412	171255	rs606231459	NC_000005.10:150541650:G:A	G	A	CLINICAL
NM_001543.5(NDST1):c.2126G>A (p.Arg709Gln)	NDST1	R709Q	Normal	Mental retardation, autosomal recessive 46	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161409	5	149925029	5	150545467	161409	171252	rs606231456	NC_000005.10:150545466:G:A	G	A	CLINICAL
NM_000827.4(GRIA1):c.1906G>A (p.Ala636Thr)	GRIA1	A636T, A556T, A645T, A646T, A541T, A567T, A580T	Normal	Variant of unknown significance|Intellectual disability|not provided	Likely pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, single submitter	VCV000039966	5	153144076	5	153764516	39966	48486	rs587776937	NC_000005.10:153764515:G:A	G	A	CLINICAL
NM_000827.4(GRIA1):c.2234G>A (p.Gly745Asp)	GRIA1	G745D, G650D, G665D, G755D, G676D, G689D, G754D	Normal	Non-syndromic intellectual disability|Autism spectrum disorder	Likely pathogenic	no assertion criteria provided	VCV000585059	5	153149939	5	153770379	585059	576113	rs1561846159	NC_000005.10:153770378:G:A	G	A	CLINICAL
NM_021911.2(GABRB2):c.895A>T (p.Ile299Phe)	GABRB2	I299F	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000647339	5	160758072	5	161331065	647339	633693	rs1580984895	NC_000005.10:161331064:T:A	T	A	CLINICAL
NM_022455.4(NSD1):c.3839G>A (p.Trp1280Ter)	NSD1	W1280*, W1011*	Normal	Sotos syndrome 1|Cleft palate|Cleft uvula|Overfolding of the superior helices|Patent foramen ovale|Highly arched eyebrow|Seizures|Prominent supraorbital ridges|Scoliosis|Hypertelorism|Cryptorchidism|Midface retrusion|Pectus carinatum|Chronic lung disease|Disproportionate tall stature|Hypermetropia|Talipes valgus|Autistic disorder of childhood onset|Cognitive impairment	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159315	5	176662864	5	177235863	159315	168168	rs587784105	NC_000005.10:177235862:G:A	G	A	CLINICAL
NM_022455.4(NSD1):c.6050G>A (p.Arg2017Gln)	NSD1	R2017Q, R1748Q	Normal	High forehead|Increased body weight|Osteopenia|Preeclampsia|Pointed chin|Overgrowth|Macrocephalus|Tall stature|Delayed speech and language development|not provided|Beckwith-Wiedemann syndrome|Hypoplasia of the corpus callosum|Global developmental delay|Scoliosis|Hypertelorism|High anterior hairline|Delayed speech and language development|Delayed gross motor development|Sotos syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159398	5	176710828	5	177283827	159398	168250	rs587784177	NC_000005.10:177283826:G:A	G	A	CLINICAL
NM_133433.4(NIPBL):c.6635T>A (p.Val2212Glu)	NIPBL	V2212E	Normal	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000446367	5	37048649	5	37048547	446367	439808	rs1554032789	NC_000005.10:37048546:T:A	T	A	CLINICAL
NM_000082.3(ERCC8):c.37G>T (p.Glu13Ter)	ERCC8|NDUFAF2	E13*	Normal	Cockayne syndrome|not provided|Cockayne syndrome type A	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001716	5	60240799	5	60944972	1716	16755	rs121434324	NC_000005.10:60944971:C:A	C	A	CLINICAL
NM_005869.4(CWC27):c.495G>A (p.Glu165=)	CWC27		Normal	Retinitis pigmentosa with or without skeletal anomalies	Pathogenic(Last reviewed: May 11, 2017)	no assertion criteria provided	VCV000426071	5	64081406	5	64785579	426071	414475	rs1085307446	NC_000005.10:64785578:G:A	G	A	CLINICAL
NM_017755.6(NSUN2):c.1114C>T (p.Gln372Ter)	NSUN2	Q372*, Q337*	Normal	Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031676	5	6611180	5	6611067	31676	40338	rs387907191	NC_000005.10:6611066:G:A	G	A	CLINICAL
NM_017755.6(NSUN2):c.679C>T (p.Gln227Ter)	NSUN2	Q227*, Q192*	Normal	Inborn genetic diseases|Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000031675	5	6620355	5	6620242	31675	40337	rs387907190	NC_000005.10:6620241:G:A	G	A	CLINICAL
NM_001130105.1(CERT1):c.271G>T (p.Glu91Ter)	CERT1	E91*	Normal	Mental retardation, autosomal dominant 34	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548566	5	74807146	5	75511321	548566	538988	rs1554048616	NC_000005.10:75511320:C:A	C	A	CLINICAL
NM_002397.5(MEF2C):c.766C>T (p.Arg256Ter)	MEF2C	R254*, R256*, R208*, R114*, R130*, R274*	Normal	Intellectual disability|Autism spectrum disorder	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206134	5	88027590	5	88731773	206134	201908	rs796052733	NC_000005.10:88731772:G:A	G	A	CLINICAL
NM_002397.5(MEF2C):c.565C>T (p.Arg189Ter)	MEF2C	R187*, R189*, R141*, R207*, R63*, R47*	Normal	not provided|Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158886	5	88047698	5	88751881	158886	168543	rs587783747	NC_000005.10:88751880:G:A	G	A	CLINICAL
NM_002397.5(MEF2C):c.9A>T (p.Arg3Ser)	MEF2C	R3S	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000218315	5	88119597	5	88823780	218315	215010	rs876661308	NC_000005.10:88823779:T:A	T	A	CLINICAL
NM_024577.4(SH3TC2):c.2860C>T (p.Arg954Ter)	SH3TC2	R954*	Normal	Charcot-Marie-Tooth disease|Mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease, type 4C|Mononeuropathy of the median nerve, mild|Charcot-Marie-Tooth disease type 4|none provided|SH3TC2-Related Disorders|Charcot-Marie-Tooth disease, type 4C|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002482	5	148406435	5	149026872	2482	17521	rs80338933	NC_000005.10:149026871:G:A	G	A	CLINICAL
NM_005859.5(PURA):c.563T>C (p.Ile188Thr)	PURA	I188T	Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000192334	5	139494329	5	140114744	192334	190129	rs793888527	NC_000005.10:140114743:T:C	T	C	CLINICAL
NM_001104631.2(PDE4D):c.677T>G (p.Phe226Cys)	PDE4D	F226C, F165C, F104C, F162C, F90C, F116C, F155C, F96C	Normal	Acrodysostosis 2, with or without hormone resistance	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000101052	5	58489333	5	59193507	101052	106816	rs397514465	NC_000005.10:59193506:A:C	A	C	CLINICAL
NM_001999.4(FBN2):c.3759T>G (p.Cys1253Trp)	FBN2	C1253W	Normal	Congenital contractural arachnodactyly	Pathogenic(Last reviewed: May 1, 2000)	no assertion criteria provided	VCV000000527	5	127671235	5	128335543	527	15566	rs28931602	NC_000005.10:128335542:A:C	A	C	CLINICAL
NM_005859.5(PURA):c.265G>C (p.Ala89Pro)	PURA	A89P	Normal	Seizures|Neonatal hypotonia|Global developmental delay|Intellectual disability|Delayed speech and language development	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156411	5	139494031	5	140114446	156411	166190	rs587782999	NC_000005.10:140114445:G:C	G	C	CLINICAL
NM_005859.5(PURA):c.299T>C (p.Leu100Pro)	PURA	L100P	Normal	Delayed speech and language development|Neonatal hypotonia|Seizures|Global developmental delay|Intellectual disability|Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Aug 5, 2017)	criteria provided, single submitter	VCV000156407	5	139494065	5	140114480	156407	166186	rs587782995	NC_000005.10:140114479:T:C	T	C	CLINICAL
NM_005859.5(PURA):c.503T>C (p.Leu168Pro)	PURA	L168P	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000690372	5	139494269	5	140114684	690372	678061	rs1581036449	NC_000005.10:140114683:T:C	T	C	CLINICAL
NM_005859.5(PURA):c.563T>C (p.Ile188Thr)	PURA	I188T	Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000192334	5	139494329	5	140114744	192334	190129	rs793888527	NC_000005.10:140114743:T:C	T	C	CLINICAL
NM_005859.5(PURA):c.565G>C (p.Ala189Pro)	PURA	A189P	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Aug 8, 2019)	no assertion criteria provided	VCV000807477	5	139494331	5	140114746	807477	798551	rs1581036496	NC_000005.10:140114745:G:C	G	C	CLINICAL
NM_005859.5(PURA):c.596G>C (p.Arg199Pro)	PURA	R199P	Normal	not provided|Neonatal hypotonia|Intellectual disability|Delayed speech and language development|Seizures|Global developmental delay|Mental retardation, autosomal dominant 31	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000156413	5	139494362	5	140114777	156413	166192	rs587783001	NC_000005.10:140114776:G:C	G	C	CLINICAL
NM_005859.5(PURA):c.605T>C (p.Leu202Pro)	PURA	L202P	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000560683	5	139494371	5	140114786	560683	551772	rs1561793336	NC_000005.10:140114785:T:C	T	C	CLINICAL
NM_005859.5(PURA):c.614T>C (p.Leu205Pro)	PURA	L205P	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802159	5	139494380	5	140114795	802159	790519	rs1581036537	NC_000005.10:140114794:T:C	T	C	CLINICAL
NM_005859.5(PURA):c.734G>C (p.Arg245Pro)	PURA	R245P	Normal	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000545025	5	139494500	5	140114915	545025	535289	rs1554129118	NC_000005.10:140114914:G:C	G	C	CLINICAL
NM_015981.4(CAMK2A):c.845A>G (p.His282Arg)	CAMK2A	H282R	Normal	Intellectual disability|Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000430917	5	149629844	5	150250281	430917	424456	rs1554121875	NC_000005.10:150250280:T:C	T	C	CLINICAL
NM_001543.5(NDST1):c.1918T>C (p.Phe640Leu)	NDST1	F640L	Normal	Mental retardation, autosomal recessive 46	Likely pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV000161411	5	149922481	5	150542919	161411	171254	rs606231458	NC_000005.10:150542918:T:C	T	C	CLINICAL
NM_000171.4(GLRA1):c.777C>G (p.Ser259Arg)	GLRA1	S259R, S176R	Normal	Hyperekplexia 1	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000016071	5	151231086	5	151851525	16071	31110	rs121918417	NC_000005.10:151851524:G:C	G	C	CLINICAL
NM_021911.2(GABRB2):c.902A>G (p.Tyr301Cys)	GABRB2	Y301C	Normal	not provided|Intellectual disability	Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000421234	5	160758065	5	161331058	421234	406673	rs1064794996	NC_000005.10:161331057:T:C	T	C	CLINICAL
NM_133433.4(NIPBL):c.6242G>C (p.Gly2081Ala)	NIPBL	G2081A	Normal	Abnormal facial shape|Intellectual disability|Brachydactyly|Global developmental delay	Likely pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000374158	5	37044582	5	37044480	374158	360870	rs587784000	NC_000005.10:37044479:G:C	G	C	CLINICAL
NM_002397.5(MEF2C):c.683C>G (p.Ser228Ter)	MEF2C	S228*, S180*, S226*, S246*, S86*, S102*	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000008947	5	88027673	5	88731856	8947	23986	rs267607233	NC_000005.10:88731855:G:C	G	C	CLINICAL
NM_002397.5(MEF2C):c.194T>G (p.Val65Gly)	MEF2C	V65G	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Likely pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000827823	5	88100479	5	88804662	827823	815982	rs1580988074	NC_000005.10:88804661:A:C	A	C	CLINICAL
NM_002397.5(MEF2C):c.68A>G (p.Lys23Arg)	MEF2C	K23R	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Likely pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	VCV000209171	5	88100605	5	88804788	209171	205746	rs797045053	NC_000005.10:88804787:T:C	T	C	CLINICAL
NM_018834.6(MATR3):c.254C>G (p.Ser85Cys)	MATR3	S85C	Normal	not provided|Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014002	5	138643358	5	139307669	14002	29041	rs121434591	NC_000005.10:139307668:C:G	C	G	CLINICAL
NM_018834.6(MATR3):c.1864A>G (p.Thr622Ala)	MATR3	T622A, T284A, T334A	Normal	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126562	5	138658372	5	139322683	126562	132072	rs587777301	NC_000005.10:139322682:A:G	A	G	CLINICAL
NM_003900.5(SQSTM1):c.995C>G (p.Ser332Ter)	SQSTM1	S248*, S332*	Normal	Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Pathogenic(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000642133	5	179260612	5	179833612	642133	633844	rs1185406298	NC_000005.10:179833611:C:G	C	G	CLINICAL
NM_005211.3(CSF1R):c.2671G>C (p.Ala891Pro)	CSF1R	A891P	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599607	5	149433977	5	150054414	599607	590943	rs1561901881	NC_000005.10:150054413:C:G	C	G	CLINICAL
NM_007118.4(TRIO):c.4406A>G (p.His1469Arg)	TRIO	H1469R	Normal	not provided|Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000545083	5	14397246	5	14397137	545083	535302	rs1554070777	NC_000005.10:14397136:A:G	A	G	CLINICAL
NM_007118.4(TRIO):c.4860-2A>G	TRIO		Normal	Mental retardation, autosomal dominant 44	Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000666589	5	14406680	5	14406571	666589	654149	rs1579564431	NC_000005.10:14406570:A:G	A	G	CLINICAL
NM_005859.5(PURA):c.289A>G (p.Lys97Glu)	PURA	K97E	Normal	Neonatal hypotonia|Intellectual disability|Delayed speech and language development|Seizures|Global developmental delay|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000156406	5	139494055	5	140114470	156406	166185	rs587782994	NC_000005.10:140114469:A:G	A	G	CLINICAL
NM_005859.5(PURA):c.339C>G (p.Tyr113Ter)	PURA	Y113*	Normal	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000656180	5	139494105	5	140114520	656180	633504	rs1581036318	NC_000005.10:140114519:C:G	C	G	CLINICAL
NM_005859.5(PURA):c.363C>G (p.Tyr121Ter)	PURA	Y121*	Normal	Seizures|Neonatal hypotonia|Global developmental delay|Intellectual disability|Delayed speech and language development|not provided	Pathogenic(Last reviewed: Dec 23, 2016)	criteria provided, single submitter	VCV000156408	5	139494129	5	140114544	156408	166187	rs587782996	NC_000005.10:140114543:C:G	C	G	CLINICAL
NM_005859.5(PURA):c.430A>G (p.Lys144Glu)	PURA	K144E	Normal	Mental retardation, autosomal dominant 31|Intellectual disability	Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000666300	5	139494196	5	140114611	666300	653866	rs1581036396	NC_000005.10:140114610:A:G	A	G	CLINICAL
NM_005859.5(PURA):c.511C>G (p.Arg171Gly)	PURA	R171G	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Sep 14, 2016)	criteria provided, single submitter	VCV000496677	5	139494277	5	140114692	496677	488154	rs1554129100	NC_000005.10:140114691:C:G	C	G	CLINICAL
NM_005859.5(PURA):c.783C>G (p.Tyr261Ter)	PURA	Y261*	Normal	Seizures|Neonatal hypotonia|Global developmental delay|Intellectual disability|Delayed speech and language development	Pathogenic(Last reviewed: Sep 15, 2014)	no assertion criteria provided	VCV000156409	5	139494549	5	140114964	156409	166188	rs587782997	NC_000005.10:140114963:C:G	C	G	CLINICAL
NM_007118.4(TRIO):c.4406A>G (p.His1469Arg)	TRIO	H1469R	Normal	not provided|Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000545083	5	14397246	5	14397137	545083	535302	rs1554070777	NC_000005.10:14397136:A:G	A	G	CLINICAL
NM_007118.4(TRIO):c.4860-2A>G	TRIO		Normal	Mental retardation, autosomal dominant 44	Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000666589	5	14406680	5	14406571	666589	654149	rs1579564431	NC_000005.10:14406570:A:G	A	G	CLINICAL
NM_015981.4(CAMK2A):c.856A>C (p.Thr286Pro)	CAMK2A	T286P	Normal	Intellectual disability|Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000430918	5	149629833	5	150250270	430918	424455	rs1554121872	NC_000005.10:150250269:T:G	T	G	CLINICAL
NM_015981.4(CAMK2A):c.327G>C (p.Glu109Asp)	CAMK2A	E109D	Normal	Intellectual disability|Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000430913	5	149636340	5	150256777	430913	424460	rs1287121256	NC_000005.10:150256776:C:G	C	G	CLINICAL
NM_015981.4(CAMK2A):c.293T>C (p.Phe98Ser)	CAMK2A	F98S	Normal	Intellectual disability|Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	VCV000430912	5	149636374	5	150256811	430912	424461	rs1554122526	NC_000005.10:150256810:A:G	A	G	CLINICAL
NM_198903.2(GABRG2):c.529C>G (p.Arg177Gly)	GABRG2	R177G	Normal	Familial febrile seizures 8	Pathogenic(Last reviewed: Aug 22, 2006)	no assertion criteria provided	VCV000016211	5	161524845	5	162097839	16211	31250	rs267606837	NC_000005.10:162097838:C:G	C	G	CLINICAL
NM_022762.5(RMND5B):c.*1728A>G	NHP2|RMND5B	Y139H	Normal	Dyskeratosis congenita, autosomal recessive 2|Dyskeratosis congenita autosomal recessive 1	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000004280	5	177576761	5	178149760	4280	19319	rs121908089	NC_000005.10:178149759:A:G	A	G	CLINICAL
NM_017755.6(NSUN2):c.538-1G>C	NSUN2		Normal	Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: Jun 1, 2012)	no assertion criteria provided	VCV000037005	5	6622214	5	6622101	37005	45671	rs1560982564	NC_000005.10:6622100:C:G	C	G	CLINICAL
NM_022132.5(MCCC2):c.569A>G (p.His190Arg)	MCCC2	H190R	Normal	3-methylcrotonyl CoA carboxylase 2 deficiency	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000001926	5	70900240	5	71604413	1926	16965	rs119103225	NC_000005.10:71604412:A:G	A	G	CLINICAL
NM_002397.5(MEF2C):c.638-2A>C	MEF2C		Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Nov 3, 2017)	no assertion criteria provided	VCV000488545	5	88027720	5	88731903	488545	481413	rs1554102556	NC_000005.10:88731902:T:G	T	G	CLINICAL
NM_002397.5(MEF2C):c.80G>C (p.Gly27Ala)	MEF2C	G27A	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000040216	5	88100593	5	88804776	40216	48701	rs397514656	NC_000005.10:88804775:C:G	C	G	CLINICAL
NM_002397.5(MEF2C):c.2T>C (p.Met1Thr)	MEF2C	M1T	Normal	not provided|Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211494	5	88119604	5	88823787	211494	207288	rs545185248	NC_000005.10:88823786:A:G	A	G	CLINICAL
NM_018834.6(MATR3):c.460C>T (p.Pro154Ser)	MATR3	P154S	Normal	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126563	5	138643564	5	139307875	126563	132073	rs587777302	NC_000005.10:139307874:C:T	C	T	CLINICAL
NM_003900.5(SQSTM1):c.286C>T (p.Arg96Ter)	SQSTM1	R96*, R12*	Normal	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV000265782	5	179250038	5	179823038	265782	260472	rs886039782	NC_000005.10:179823037:C:T	C	T	CLINICAL
NM_004168.4(SDHA):c.91C>T (p.Arg31Ter)	SDHA	R31*	Normal	not provided|Paragangliomas 5|Pilocytic astrocytoma|Leigh syndrome|Rhabdomyosarcoma (disease)|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1|Carney triad|Paragangliomas 5|Dilated cardiomyopathy 1GG|Leigh syndrome|Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142601	5	223624	5	223509	142601	152315	rs142441643	NC_000005.10:223508:C:T	C	T	CLINICAL
NM_001044.5(SLC6A3):c.1269+1G>A	SLC6A3		Normal	not provided|Parkinsonism-dystonia, infantile, 1	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029685	5	1411357	5	1411242	29685	38640	rs431905504	NC_000005.10:1411241:C:T	C	T	CLINICAL
NM_007118.4(TRIO):c.634G>T (p.Glu212Ter)	TRIO	E212*	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000369657	5	14290918	5	14290809	369657	353885	rs1057516029	NC_000005.10:14290808:G:T	G	T	CLINICAL
NM_007118.4(TRIO):c.649A>T (p.Arg217Ter)	TRIO	R217*	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253082	5	14290933	5	14290824	253082	247493	rs879255624	NC_000005.10:14290823:A:T	A	T	CLINICAL
NM_007118.4(TRIO):c.3239A>T (p.Asn1080Ile)	TRIO	N1080I	Normal	Mental retardation, autosomal dominant 44|Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000253086	5	14374360	5	14374251	253086	247497	rs879255628	NC_000005.10:14374250:A:T	A	T	CLINICAL
NM_007118.4(TRIO):c.4276G>T (p.Val1426Phe)	TRIO	V1426F	Normal	Mental retardation, autosomal dominant 44	Likely pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000807714	5	14394204	5	14394095	807714	798552	rs1579522661	NC_000005.10:14394094:G:T	G	T	CLINICAL
NM_005909.5(MAP1B):c.3094G>T (p.Glu1032Ter)	MAP1B	E1032*, E906*	Normal	Periventricular nodular heterotopia 9|Periventricular nodular heterotopia|Cognitive impairment|Hypoplasia of the corpus callosum|White matter deficit|Autism spectrum disorder	Pathogenic, risk factor(Last reviewed: Jun 29, 2020)	no assertion criteria provided	VCV000800721	5	71492276	5	72196449	800721	789342	rs1561315170	NC_000005.10:72196448:G:T	G	T	CLINICAL
NM_005909.5(MAP1B):c.4990C>T (p.Arg1664Ter)	MAP1B	R1538*, R1664*	Normal	Neurodevelopmental disorder|Periventricular nodular heterotopia 9|Periventricular nodular heterotopia|Cognitive impairment|Hypoplasia of the corpus callosum|White matter deficit|Autism spectrum disorder	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000800722	5	71494172	5	72198345	800722	789343	rs1580026238	NC_000005.10:72198344:C:T	C	T	CLINICAL
NM_005909.5(MAP1B):c.5368C>T (p.Arg1790Ter)	MAP1B	R1790*, R1664*	Normal	Global developmental delay|Pyloric stenosis|Metopic synostosis|Muscular hypotonia|Abnormal facial shape|Attention deficit hyperactivity disorder	Pathogenic(Last reviewed: Feb 5, 2019)	no assertion criteria provided	VCV000638688	5	71494550	5	72198723	638688	626461	rs1580027036	NC_000005.10:72198722:C:T	C	T	CLINICAL
NM_001145805.1(IRGM):c.313C>T (p.Leu105=)	IRGM		Normal	Inflammatory bowel disease 19	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030716	5	150227998	5	150848436	30716	39673	rs10065172	NC_000005.10:150848435:C:T	C	T	CLINICAL
NM_181523.3(PIK3R1):c.1425+1G>T	PIK3R1		Normal	Immunodeficiency 36|not provided|Agammaglobulinemia 7, autosomal recessive|Immunodeficiency 36|SHORT syndrome	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156008	5	67589663	5	68293835	156008	165812	rs587777709	NC_000005.10:68293834:G:T	G	T	CLINICAL
NM_014402.5(UQCRQ):c.134C>T (p.Ser45Phe)	UQCRQ	S45F	Normal	not provided|Mitochondrial complex III deficiency, nuclear type 4	Pathogenic(Last reviewed: Jun 16, 2015)	criteria provided, single submitter	VCV000000729	5	132202707	5	132867015	729	15768	rs11544803	NC_000005.10:132867014:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.1A>T (p.Met1Leu)	PURA	M1L	Normal	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV000192337	5	139493767	5	140114182	192337	190122	rs793888530	NC_000005.10:140114181:A:T	A	T	CLINICAL
NM_005859.5(PURA):c.10C>T (p.Arg4Ter)	PURA	R4*	Normal	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000571407	5	139493776	5	140114191	571407	564817	rs1561792945	NC_000005.10:140114190:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.163C>T (p.Gln55Ter)	PURA	Q55*	Normal	Mental retardation, autosomal dominant 31|not provided	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000426145	5	139493929	5	140114344	426145	414991	rs1085307472	NC_000005.10:140114343:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.175C>T (p.Gln59Ter)	PURA	Q59*	Normal	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000582890	5	139493941	5	140114356	582890	562878	rs1561793115	NC_000005.10:140114355:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.205C>T (p.Gln69Ter)	PURA	Q69*	Normal	not provided|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489041	5	139493971	5	140114386	489041	481725	rs1554129045	NC_000005.10:140114385:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.487C>T (p.Gln163Ter)	PURA	Q163*	Normal	not provided|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451895	5	139494253	5	140114668	451895	443692	rs1554129091	NC_000005.10:140114667:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.496C>T (p.Arg166Cys)	PURA	R166C	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Jun 1, 2017)	no assertion criteria provided	VCV000488450	5	139494262	5	140114677	488450	481311	rs1554129096	NC_000005.10:140114676:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.556C>T (p.Gln186Ter)	PURA	Q186*	Normal	Delayed speech and language development|Neonatal hypotonia|Seizures|Global developmental delay|Intellectual disability|Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Nov 6, 2014)	no assertion criteria provided	VCV000156405	5	139494322	5	140114737	156405	166184	rs587782993	NC_000005.10:140114736:C:T	C	T	CLINICAL
NM_005859.5(PURA):c.616A>T (p.Ile206Phe)	PURA	I206F	Normal	Mental retardation, autosomal dominant 31	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000189318	5	139494382	5	140114797	189318	187206	rs786204834	NC_000005.10:140114796:A:T	A	T	CLINICAL
NM_005859.5(PURA):c.640G>T (p.Glu214Ter)	PURA	E214*	Normal	Limb dystonia|Apnea|Generalized hypotonia|Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV000635405	5	139494406	5	140114821	635405	623231	rs1581036558	NC_000005.10:140114820:G:T	G	T	CLINICAL
NM_005859.5(PURA):c.710C>T (p.Ser237Phe)	PURA	S237F	Normal	Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Aug 11, 2016)	criteria provided, single submitter	VCV000266027	5	139494476	5	140114891	266027	260850	rs886039899	NC_000005.10:140114890:C:T	C	T	CLINICAL
NM_007118.4(TRIO):c.634G>T (p.Glu212Ter)	TRIO	E212*	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000369657	5	14290918	5	14290809	369657	353885	rs1057516029	NC_000005.10:14290808:G:T	G	T	CLINICAL
NM_007118.4(TRIO):c.649A>T (p.Arg217Ter)	TRIO	R217*	Normal	Mental retardation, autosomal dominant 44	Pathogenic(Last reviewed: Mar 31, 2020)	no assertion criteria provided	VCV000253082	5	14290933	5	14290824	253082	247493	rs879255624	NC_000005.10:14290823:A:T	A	T	CLINICAL
NM_007118.4(TRIO):c.3239A>T (p.Asn1080Ile)	TRIO	N1080I	Normal	Mental retardation, autosomal dominant 44|Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000253086	5	14374360	5	14374251	253086	247497	rs879255628	NC_000005.10:14374250:A:T	A	T	CLINICAL
NM_007118.4(TRIO):c.4276G>T (p.Val1426Phe)	TRIO	V1426F	Normal	Mental retardation, autosomal dominant 44	Likely pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000807714	5	14394204	5	14394095	807714	798552	rs1579522661	NC_000005.10:14394094:G:T	G	T	CLINICAL
NM_015981.4(CAMK2A):c.1237+1G>A	CAMK2A		Normal	Intellectual disability	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000430919	5	149607754	5	150228191	430919	424454	rs113331868	NC_000005.10:150228190:C:T	C	T	CLINICAL
NM_015981.4(CAMK2A):c.817-1G>A	CAMK2A		Normal	Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560173	5	149629873	5	150250310	560173	550889	rs1554121878	NC_000005.10:150250309:C:T	C	T	CLINICAL
NM_015981.4(CAMK2A):c.635C>A (p.Pro212Gln)	CAMK2A	P212Q	Normal	Intellectual disability, autosomal dominant 53	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560171	5	149631371	5	150251808	560171	550887	rs926027867	NC_000005.10:150251807:G:T	G	T	CLINICAL
NM_015981.4(CAMK2A):c.49G>A (p.Glu17Lys)	CAMK2A	E17K	Normal	Intellectual disability, autosomal dominant 53|Global developmental delay	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000666572	5	149669140	5	150289577	666572	654125	rs1580966945	NC_000005.10:150289576:C:T	C	T	CLINICAL
NM_001543.5(NDST1):c.1926G>T (p.Glu642Asp)	NDST1	E642D	Normal	Mental retardation, autosomal recessive 46	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000161410	5	149922489	5	150542927	161410	171253	rs606231457	NC_000005.10:150542926:G:T	G	T	CLINICAL
NM_001012339.3(DNAJC21):c.544C>T (p.Arg182Ter)	DNAJC21	R182*	Normal	Acute myeloid leukemia|Cognitive impairment|Pectus excavatum|Pancytopenia|Abnormality of the tongue|Short stature|Webbed neck	Pathogenic	criteria provided, single submitter	VCV000598950	5	34937536	5	34937431	598950	590056	rs771063992	NC_000005.10:34937430:C:T	C	T	CLINICAL
NM_023073.3(CPLANE1):c.7817T>A (p.Leu2606Ter)	CPLANE1	L2606*	Normal	Joubert syndrome 17|Global developmental delay|Jaundice|Joubert syndrome 17|Orofaciodigital syndrome type 6|not provided|Orofaciodigital syndrome type 6	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217575	5	37157912	5	37157810	217575	214208	rs749523755	NC_000005.10:37157809:A:T	A	T	CLINICAL
NM_002495.4(NDUFS4):c.316C>T (p.Arg106Ter)	NDUFS4	R106*	Normal	Mitochondrial complex I deficiency, nuclear type 1|Mitochondrial complex I deficiency	Pathogenic	criteria provided, single submitter	VCV000006889	5	52942201	5	53646371	6889	21928	rs104893898	NC_000005.10:53646370:C:T	C	T	CLINICAL
NM_017755.6(NSUN2):c.2035G>A (p.Gly679Arg)	NSUN2	G679R, G644R	Normal	Mental retardation, autosomal recessive 5	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031678	5	6600308	5	6600195	31678	40340	rs587776908	NC_000005.10:6600194:C:T	C	T	CLINICAL
NM_005909.5(MAP1B):c.3094G>T (p.Glu1032Ter)	MAP1B	E1032*, E906*	Normal	Periventricular nodular heterotopia 9|Periventricular nodular heterotopia|Cognitive impairment|Hypoplasia of the corpus callosum|White matter deficit|Autism spectrum disorder	Pathogenic, risk factor(Last reviewed: Jun 29, 2020)	no assertion criteria provided	VCV000800721	5	71492276	5	72196449	800721	789342	rs1561315170	NC_000005.10:72196448:G:T	G	T	CLINICAL
NM_005909.5(MAP1B):c.4990C>T (p.Arg1664Ter)	MAP1B	R1538*, R1664*	Normal	Neurodevelopmental disorder|Periventricular nodular heterotopia 9|Periventricular nodular heterotopia|Cognitive impairment|Hypoplasia of the corpus callosum|White matter deficit|Autism spectrum disorder	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000800722	5	71494172	5	72198345	800722	789343	rs1580026238	NC_000005.10:72198344:C:T	C	T	CLINICAL
NM_005909.5(MAP1B):c.5368C>T (p.Arg1790Ter)	MAP1B	R1790*, R1664*	Normal	Global developmental delay|Pyloric stenosis|Metopic synostosis|Muscular hypotonia|Abnormal facial shape|Attention deficit hyperactivity disorder	Pathogenic(Last reviewed: Feb 5, 2019)	no assertion criteria provided	VCV000638688	5	71494550	5	72198723	638688	626461	rs1580027036	NC_000005.10:72198722:C:T	C	T	CLINICAL
NM_000521.4(HEXB):c.1250C>T (p.Pro417Leu)	HEXB	P417L, P192L	Normal	Sandhoff disease|Sandhoff disease, juvenile type|Sandhoff disease, adult type|not provided	Pathogenic(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003878	5	74014629	5	74718804	3878	18917	rs28942073	NC_000005.10:74718803:C:T	C	T	CLINICAL
NM_002397.5(MEF2C):c.113T>A (p.Leu38Gln)	MEF2C	L38Q	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000040214	5	88100560	5	88804743	40214	48699	rs397514655	NC_000005.10:88804742:A:T	A	T	CLINICAL
NM_002397.5(MEF2C):c.71G>A (p.Arg24Lys)	MEF2C	R24K	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic/Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224136	5	88100602	5	88804785	224136	225866	rs869312698	NC_000005.10:88804784:C:T	C	T	CLINICAL
NM_002397.5(MEF2C):c.44G>A (p.Arg15His)	MEF2C	R15H	Normal	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000620015	5	88119562	5	88823745	620015	611389	rs1202957297	NC_000005.10:88823744:C:T	C	T	CLINICAL
NM_001145805.1(IRGM):c.313C>T (p.Leu105=)	IRGM		Normal	Inflammatory bowel disease 19	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030716	5	150227998	5	150848436	30716	39673	rs10065172	NC_000005.10:150848435:C:T	C	T	CLINICAL
NM_014845.5(FIG4):c.737G>A (p.Trp246Ter)	FIG4	W246*	Normal	not provided|Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis type 11|Yunis-Varon syndrome|Charcot-Marie-Tooth disease, type 4J|Polymicrogyria, bilateral temporooccipital	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420149	6	110059618	6	109738415	420149	406786	rs776005417	NC_000006.12:109738414:G:A	G	A	CLINICAL
NM_001080.3(ALDH5A1):c.727-3298G>A	ALDH5A1		Normal	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000001356	6	24512097	6	24511869	1356	16395	rs1561872640	NC_000006.12:24511868:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.509G>A (p.Arg170Gln)	SYNGAP1	R170Q	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375528	6	33400583	6	33432806	375528	362330	rs1057519546	NC_000006.12:33432805:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.1269T>A (p.Tyr423Ter)	SYNGAP1	Y423*	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800803	6	33405951	6	33438174	800803	788800	rs1561785045	NC_000006.12:33438173:T:A	T	A	CLINICAL
NM_006772.3(SYNGAP1):c.1403T>A (p.Met468Lys)	SYNGAP1|MIR5004	M468K	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000642691	6	33406212	6	33438435	642691	634848	rs763770519	NC_000006.12:33438434:T:A	T	A	CLINICAL
NM_006772.3(SYNGAP1):c.2147G>A (p.Arg716Gln)	SYNGAP1	R716Q	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000411585	6	33409389	6	33441612	411585	395101	rs1060503384	NC_000006.12:33441611:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.2294+1G>A	SYNGAP1		Normal	Intellectual disability|Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000041460	6	33409537	6	33441760	41460	49896	rs1554121970	NC_000006.12:33441759:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.3583-9G>A	SYNGAP1		Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000537000	6	33414343	6	33446566	537000	521972	rs1554122689	NC_000006.12:33446565:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.589G>A (p.Glu197Lys)	MEA1|PPP2R5D	E197K, E165K, E91K, E46K	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000217913	6	42975000	6	43007262	217913	214562	rs863225081	NC_000006.12:43007261:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.598G>A (p.Glu200Lys)	MEA1|PPP2R5D	E200K, E168K, E94K, E49K	Normal	Mental retardation, autosomal dominant 35|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217456	6	42975009	6	43007271	217456	214097	rs863225079	NC_000006.12:43007270:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.619T>A (p.Trp207Arg)	MEA1|PPP2R5D	W207R, W101R, W56R, W175R	Normal	Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000217457	6	42975030	6	43007292	217457	214098	rs869320691	NC_000006.12:43007291:T:A	T	A	CLINICAL
NM_006245.4(PPP2R5D):c.1258G>A (p.Glu420Lys)	PPP2R5D|MEA1	E420K, E388K, E269K, E314K	Normal	Mental retardation, autosomal dominant 35|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217912	6	42977066	6	43009328	217912	214565	rs863225080	NC_000006.12:43009327:G:A	G	A	CLINICAL
NM_001134831.2(AHI1):c.985C>T (p.Arg329Ter)	AHI1	R329*	Normal	Retinal dystrophy|Joubert syndrome|not provided|Joubert syndrome with ocular defect|Joubert syndrome 3	Pathogenic(Last reviewed: Mar 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030760	6	135778798	6	135457660	30760	39717	rs201391050	NC_000006.12:135457659:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.6964C>T (p.Gln2322Ter)	HIVEP2	Q2322*	Normal	Mental retardation, autosomal dominant 43|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000520986	6	143074621	6	142753484	520986	511628	rs1554274371	NC_000006.12:142753483:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.6667C>T (p.Arg2223Ter)	HIVEP2	R2223*	Normal	not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000620226	6	143074918	6	142753781	620226	611646	rs1562493608	NC_000006.12:142753780:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.6475G>T (p.Gly2159Ter)	HIVEP2	G2159*	Normal	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000224793	6	143080950	6	142759813	224793	226609	rs761993070	NC_000006.12:142759812:C:A	C	A	CLINICAL
NM_006734.4(HIVEP2):c.5935C>T (p.Arg1979Ter)	HIVEP2	R1979*	Normal	not provided|Angelman syndrome-like|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523775	6	143081490	6	142760353	523775	514525	rs1554275163	NC_000006.12:142760352:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.3742C>T (p.Gln1248Ter)	HIVEP2	Q1248*	Normal	not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000620259	6	143092134	6	142770997	620259	611647	rs1562505335	NC_000006.12:142770996:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.3556C>T (p.Gln1186Ter)	HIVEP2	Q1186*	Normal	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000236212	6	143092320	6	142771183	236212	237780	rs878853269	NC_000006.12:142771182:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.2905C>T (p.Gln969Ter)	HIVEP2	Q969*	Normal	not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000224792	6	143092971	6	142771834	224792	226611	rs869312842	NC_000006.12:142771833:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.2857G>T (p.Glu953Ter)	HIVEP2	E953*	Normal	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000224794	6	143093019	6	142771882	224794	226612	rs869312843	NC_000006.12:142771881:C:A	C	A	CLINICAL
NM_006734.4(HIVEP2):c.2827C>T (p.Arg943Ter)	HIVEP2	R943*	Normal	Mental retardation, autosomal dominant 43|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224791	6	143093049	6	142771912	224791	226613	rs869312841	NC_000006.12:142771911:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.1189G>T (p.Asp397Tyr)	HIVEP2	D397Y	Normal	HIVEP2-Related Disorder|Mental retardation, autosomal dominant 43|not provided	Likely pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000224798	6	143094687	6	142773550	224798	226614	rs869312847	NC_000006.12:142773549:C:A	C	A	CLINICAL
NM_020732.3(ARID1B):c.3737C>A (p.Ser1246Ter)	ARID1B	S1246*, S1286*, S536*, S1233*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560951	6	157511219	6	157190085	560951	552100	rs772973856	NC_000006.12:157190084:C:A	C	A	CLINICAL
NM_001002255.2(SUMO4):c.163G>A (p.Val55Met)	TAB2|SUMO4	V55M	Normal	Diabetes mellitus, insulin-dependent, 5	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000002062	6	149721690	6	149400554	2062	17101	rs237025	NC_000006.12:149400553:G:A	G	A	CLINICAL
NM_000410.3(HFE):c.506G>A (p.Trp169Ter)	HFE	W169*, W81*, W146*	Normal	Hemochromatosis type 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000208985	6	26091707	6	26091479	208985	205545	rs797045145	NC_000006.12:26091478:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.598G>A (p.Glu200Lys)	MEA1|PPP2R5D	E200K, E168K, E94K, E49K	Normal	Mental retardation, autosomal dominant 35|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217456	6	42975009	6	43007271	217456	214097	rs863225079	NC_000006.12:43007270:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.1258G>A (p.Glu420Lys)	PPP2R5D|MEA1	E420K, E388K, E269K, E314K	Normal	Mental retardation, autosomal dominant 35|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217912	6	42977066	6	43009328	217912	214565	rs863225080	NC_000006.12:43009327:G:A	G	A	CLINICAL
NM_020771.4(HACE1):c.805C>T (p.Arg269Ter)	HACE1	R269*, R235*, R225*, R101*, R172*, R75*, R8*, R107*, R191*	Normal	Seizures|Generalized hypotonia|Global developmental delay|Spastic paraplegia and psychomotor retardation with or without seizures	Pathogenic(Last reviewed: Feb 4, 2016)	no assertion criteria provided	VCV000221295	6	105244541	6	104796666	221295	223024	rs750371878	NC_000006.12:104796665:G:A	G	A	CLINICAL
NM_032730.5(RTN4IP1):c.601A>T (p.Lys201Ter)	RTN4IP1	K201*, K101*	Normal	Optic atrophy 10 with or without ataxia, mental retardation, and seizures|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000218933	6	107067096	6	106619221	218933	215759	rs200457692	NC_000006.12:106619220:T:A	T	A	CLINICAL
NM_032730.5(RTN4IP1):c.313C>T (p.Pro105Ser)	RTN4IP1	P105S, P5S	Normal	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	Likely pathogenic(Last reviewed: Aug 14, 2018)	no assertion criteria provided	VCV000807479	6	107070806	6	106622931	807479	798566	rs1582392486	NC_000006.12:106622930:G:A	G	A	CLINICAL
NM_014797.2(ZBTB24):c.958C>T (p.Arg320Ter)	ZBTB24	R320*	Normal	not provided|Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000031093	6	109798128	6	109476925	31093	40050	rs387907104	NC_000006.12:109476924:G:A	G	A	CLINICAL
NM_003931.3(WASF1):c.1558C>T (p.Gln520Ter)	WASF1	Q520*	Normal	Intellectual disability|Epileptic encephalopathy|Neurodevelopmental disorder with absent language and variable seizures	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000561981	6	110421847	6	110100644	561981	553119	rs1562159088	NC_000006.12:110100643:G:A	G	A	CLINICAL
NM_003931.3(WASF1):c.1516C>T (p.Arg506Ter)	WASF1	R506*	Normal	Intellectual disability|Neurodevelopmental disorder with absent language and variable seizures	Pathogenic(Last reviewed: Dec 20, 2019)	no assertion criteria provided	VCV000561980	6	110422797	6	110101594	561980	553120	rs1562159562	NC_000006.12:110101593:G:A	G	A	CLINICAL
NM_003931.3(WASF1):c.136A>T (p.Lys46Ter)	WASF1	K46*	Normal	Intellectual disability	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801360	6	110434661	6	110113458	801360	789740	rs778229060	NC_000006.12:110113457:T:A	T	A	CLINICAL
NM_004830.4(MED23):c.3988C>T (p.Arg1330Ter)	MED23	R1330*, R1336*	Normal	Mental retardation, autosomal recessive 18|not provided	Pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, single submitter	VCV000143193	6	131908938	6	131587798	143193	152911	rs527236036	NC_000006.12:131587797:G:A	G	A	CLINICAL
NM_004830.4(MED23):c.3982C>T (p.Arg1328Cys)	MED23	R1271C, R1281C, R1310C, R1328C, R1243C, R1282C, R1334C, R1199C	Normal	Mental retardation, autosomal recessive 18	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802270	6	131908944	6	131587804	802270	790588	rs766478634	NC_000006.12:131587803:G:A	G	A	CLINICAL
NM_001134831.2(AHI1):c.985C>T (p.Arg329Ter)	AHI1	R329*	Normal	Retinal dystrophy|Joubert syndrome|not provided|Joubert syndrome with ocular defect|Joubert syndrome 3	Pathogenic(Last reviewed: Mar 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030760	6	135778798	6	135457660	30760	39717	rs201391050	NC_000006.12:135457659:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.6964C>T (p.Gln2322Ter)	HIVEP2	Q2322*	Normal	Mental retardation, autosomal dominant 43|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 11, 2016)	criteria provided, single submitter	VCV000520986	6	143074621	6	142753484	520986	511628	rs1554274371	NC_000006.12:142753483:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.6667C>T (p.Arg2223Ter)	HIVEP2	R2223*	Normal	not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000620226	6	143074918	6	142753781	620226	611646	rs1562493608	NC_000006.12:142753780:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.6475G>T (p.Gly2159Ter)	HIVEP2	G2159*	Normal	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000224793	6	143080950	6	142759813	224793	226609	rs761993070	NC_000006.12:142759812:C:A	C	A	CLINICAL
NM_006734.4(HIVEP2):c.5935C>T (p.Arg1979Ter)	HIVEP2	R1979*	Normal	not provided|Angelman syndrome-like|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523775	6	143081490	6	142760353	523775	514525	rs1554275163	NC_000006.12:142760352:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.3742C>T (p.Gln1248Ter)	HIVEP2	Q1248*	Normal	not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000620259	6	143092134	6	142770997	620259	611647	rs1562505335	NC_000006.12:142770996:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.3556C>T (p.Gln1186Ter)	HIVEP2	Q1186*	Normal	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000236212	6	143092320	6	142771183	236212	237780	rs878853269	NC_000006.12:142771182:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.2905C>T (p.Gln969Ter)	HIVEP2	Q969*	Normal	not provided|Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000224792	6	143092971	6	142771834	224792	226611	rs869312842	NC_000006.12:142771833:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.2857G>T (p.Glu953Ter)	HIVEP2	E953*	Normal	Mental retardation, autosomal dominant 43	Pathogenic(Last reviewed: Jun 28, 2017)	no assertion criteria provided	VCV000224794	6	143093019	6	142771882	224794	226612	rs869312843	NC_000006.12:142771881:C:A	C	A	CLINICAL
NM_006734.4(HIVEP2):c.2827C>T (p.Arg943Ter)	HIVEP2	R943*	Normal	Mental retardation, autosomal dominant 43|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224791	6	143093049	6	142771912	224791	226613	rs869312841	NC_000006.12:142771911:G:A	G	A	CLINICAL
NM_006734.4(HIVEP2):c.1189G>T (p.Asp397Tyr)	HIVEP2	D397Y	Normal	HIVEP2-Related Disorder|Mental retardation, autosomal dominant 43|not provided	Likely pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000224798	6	143094687	6	142773550	224798	226614	rs869312847	NC_000006.12:142773549:C:A	C	A	CLINICAL
NM_017519.2(ARID1B):c.17G>A (p.Gly6Asp)	ARID1B|LOC115308161	G6D	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy	Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000374256	6	157099080	6	156777946	374256	361185	rs1057518648	NC_000006.12:156777945:G:A	G	A	CLINICAL
NM_020732.3(ARID1B):c.2371G>A (p.Gly791Ser)	ARID1B	G778S, G791S, G28S	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy|not provided	Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372882	6	157431695	6	157110561	372882	359764	rs1057518045	NC_000006.12:157110560:G:A	G	A	CLINICAL
NM_001374828.1(ARID1B):c.3345G>A (p.Lys1115=)	ARID1B		Normal	Coffin-Siris syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694701	6	157495251	6	157174117	694701	682803	rs1583451360	NC_000006.12:157174116:G:A	G	A	CLINICAL
NM_020732.3(ARID1B):c.3737C>A (p.Ser1246Ter)	ARID1B	S1246*, S1286*, S536*, S1233*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560951	6	157511219	6	157190085	560951	552100	rs772973856	NC_000006.12:157190084:C:A	C	A	CLINICAL
NM_001374828.1(ARID1B):c.4299C>A (p.Tyr1433Ter)	ARID1B	Y1433*, Y1380*, Y1393*, Y600*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802286	6	157517366	6	157196232	802286	790604	rs1583491515	NC_000006.12:157196231:C:A	C	A	CLINICAL
NM_020732.3(ARID1B):c.4014-1G>A	ARID1B		Normal	not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000291011	6	157519944	6	157198810	291011	275248	rs886044620	NC_000006.12:157198809:G:A	G	A	CLINICAL
NM_017519.2(ARID1B):c.3999T>A (p.Tyr1333Ter)	ARID1B	Y1346*, Y1386*, Y636*, Y1333*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031212	6	157519969	6	157198835	31212	40169	rs748363079	NC_000006.12:157198834:T:A	T	A	CLINICAL
NM_020732.3(ARID1B):c.4536G>A (p.Trp1512Ter)	ARID1B	W1512*, W1552*, W1499*, W802*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560952	6	157522264	6	157201130	560952	552101	rs1554235834	NC_000006.12:157201129:G:A	G	A	CLINICAL
NM_020732.3(ARID1B):c.5025+1G>A	ARID1B		Normal	Coffin-Siris syndrome	Likely pathogenic	no assertion criteria provided	VCV000374222	6	157525131	6	157203997	374222	361126	rs1057518984	NC_000006.12:157203996:G:A	G	A	CLINICAL
NM_020732.3(ARID1B):c.5482G>A (p.Glu1828Lys)	ARID1B	E1828K, E1868K, E1118K, E1815K	Normal	Coffin-Siris syndrome 1	Likely pathogenic	no assertion criteria provided	VCV000632549	6	157527757	6	157206623	632549	620936	rs1451259945	NC_000006.12:157206622:G:A	G	A	CLINICAL
NM_003107.3(SOX4):c.198C>A (p.Phe66Leu)	SOX4	F66L	Normal	Intellectual disability, mild|Developmental delay|Intellectual disability|Mild facial and digital morphological abnormalities|Coffin-Siris syndrome 10	Likely pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000548142	6	21594963	6	21594732	548142	538627	rs1334099693	NC_000006.12:21594731:C:A	C	A	CLINICAL
NM_003587.5(DHX16):c.2021C>T (p.Thr674Met)	DHX16	T193M, T614M, T674M	Normal	Seizures|Neurodevelopmental delay|Intellectual disability|Neuromuscular disease and ocular or auditory anomalies with or without seizures|Neurodevelopmental disorders	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	no assertion criteria provided	VCV000691934	6	30624856	6	30657079	691934	679673	rs1582931908	NC_000006.12:30657078:G:A	G	A	CLINICAL
NM_178014.4(TUBB):c.1057G>A (p.Val353Ile)	TUBB	V353I, V281I, V309I, V151I, V373I	Normal	Cortical dysplasia, complex, with other brain malformations 6	Pathogenic(Last reviewed: Dec 27, 2012)	no assertion criteria provided	VCV000127190	6	30691896	6	30724119	127190	132674	rs587777356	NC_000006.12:30724118:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.509G>A (p.Arg170Gln)	SYNGAP1	R170Q	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000375528	6	33400583	6	33432806	375528	362330	rs1057519546	NC_000006.12:33432805:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.1269T>A (p.Tyr423Ter)	SYNGAP1	Y423*	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800803	6	33405951	6	33438174	800803	788800	rs1561785045	NC_000006.12:33438173:T:A	T	A	CLINICAL
NM_006772.3(SYNGAP1):c.1403T>A (p.Met468Lys)	SYNGAP1|MIR5004	M468K	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000642691	6	33406212	6	33438435	642691	634848	rs763770519	NC_000006.12:33438434:T:A	T	A	CLINICAL
NM_006772.3(SYNGAP1):c.2115G>A (p.Lys705=)	SYNGAP1		Normal	Global developmental delay|Generalized hypotonia|Stereotypy|Preauricular skin tag|Delayed speech and language development	Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	VCV000373940	6	33409151	6	33441374	373940	360877	rs1057518786	NC_000006.12:33441373:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.2147G>A (p.Arg716Gln)	SYNGAP1	R716Q	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000411585	6	33409389	6	33441612	411585	395101	rs1060503384	NC_000006.12:33441611:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.2294+1G>A	SYNGAP1		Normal	Intellectual disability|Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000041460	6	33409537	6	33441760	41460	49896	rs1554121970	NC_000006.12:33441759:G:A	G	A	CLINICAL
NM_006772.3(SYNGAP1):c.3583-9G>A	SYNGAP1		Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Sep 29, 2018)	criteria provided, single submitter	VCV000537000	6	33414343	6	33446566	537000	521972	rs1554122689	NC_000006.12:33446565:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.589G>A (p.Glu197Lys)	MEA1|PPP2R5D	E197K, E165K, E91K, E46K	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Oct 11, 2016)	criteria provided, single submitter	VCV000217913	6	42975000	6	43007262	217913	214562	rs863225081	NC_000006.12:43007261:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.598G>A (p.Glu200Lys)	MEA1|PPP2R5D	E200K, E168K, E94K, E49K	Normal	Mental retardation, autosomal dominant 35|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217456	6	42975009	6	43007271	217456	214097	rs863225079	NC_000006.12:43007270:G:A	G	A	CLINICAL
NM_006245.4(PPP2R5D):c.619T>A (p.Trp207Arg)	MEA1|PPP2R5D	W207R, W101R, W56R, W175R	Normal	Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000217457	6	42975030	6	43007292	217457	214098	rs869320691	NC_000006.12:43007291:T:A	T	A	CLINICAL
NM_006245.4(PPP2R5D):c.1258G>A (p.Glu420Lys)	PPP2R5D|MEA1	E420K, E388K, E269K, E314K	Normal	Mental retardation, autosomal dominant 35|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217912	6	42977066	6	43009328	217912	214565	rs863225080	NC_000006.12:43009327:G:A	G	A	CLINICAL
NM_019842.3(KCNQ5):c.1021C>A (p.Leu341Ile)	KCNQ5	L341I	Normal	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431386	6	73815082	6	73105359	431386	424909	rs1135401956	NC_000006.12:73105358:C:A	C	A	CLINICAL
NM_001160133.1(KCNQ5):c.1039G>A (p.Gly347Ser)	KCNQ5	G347S	Normal	Inborn genetic diseases|Global developmental delay	Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000521883	6	73821040	6	73111317	521883	511686	rs1554210415	NC_000006.12:73111316:G:A	G	A	CLINICAL
NM_019842.4(KCNQ5):c.1106C>A (p.Pro369Gln)	KCNQ5	P369Q	Normal	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802242	6	73821107	6	73111384	802242	790657	rs1135401958	NC_000006.12:73111383:C:A	C	A	CLINICAL
NM_012123.4(MTO1):c.1282G>A (p.Ala428Thr)	MTO1	A428T, A453T, A468T	Normal	Global developmental delay|not provided|Combined oxidative phosphorylation deficiency 10|Mitochondrial oxidative phosphorylation disorder	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035496	6	74191784	6	73482061	35496	44169	rs143747297	NC_000006.12:73482060:G:A	G	A	CLINICAL
NM_022726.4(ELOVL4):c.646C>T (p.Arg216Ter)	ELOVL4	R216*	Normal	Ichthyosis, spastic quadriplegia, and mental retardation|not provided	Likely pathogenic(Last reviewed: Jun 11, 2017)	criteria provided, single submitter	VCV000030494	6	80629160	6	79919443	30494	39451	rs387906916	NC_000006.12:79919442:G:A	G	A	CLINICAL
NM_001278716.2(FBXL4):c.1444C>T (p.Arg482Trp)	FBXL4	R482W	Normal	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)|Global developmental delay|Mitochondrial encephalomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000066093	6	99323549	6	98875673	66093	76995	rs398123061	NC_000006.12:98875672:G:A	G	A	CLINICAL
NM_004562.3(PRKN):c.1292G>T (p.Cys431Phe)	PRKN	C431F, C403F, C282F	Normal	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000050354	6	161771237	6	161350205	50354	59479	rs397514694	NC_000006.12:161350204:C:A	C	A	CLINICAL
NM_004562.3(PRKN):c.931C>T (p.Gln311Ter)	PRKN	Q311*, Q162*, Q283*	Normal	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007037	6	161990389	6	161569357	7037	22076	rs137853055	NC_000006.12:161569356:G:A	G	A	CLINICAL
NM_004562.3(PRKN):c.823C>T (p.Arg275Trp)	PRKN	R275W, R126W, R247W	Normal	Parkinson disease 2|Lung carcinoma|Neoplasm of ovary|Leprosy 2|Parkinson disease 2|not provided|See cases|Young-onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007050	6	162206852	6	161785820	7050	22089	rs34424986	NC_000006.12:161785819:G:A	G	A	CLINICAL
NM_004562.3(PRKN):c.633A>T (p.Lys211Asn)	PRKN	K211N, K62N, K183N	Normal	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007051	6	162394435	6	161973403	7051	22090	rs137853060	NC_000006.12:161973402:T:A	T	A	CLINICAL
NM_004562.3(PRKN):c.483A>T (p.Lys161Asn)	PRKN	K161N	Normal	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007043	6	162622214	6	162201182	7043	22082	rs137853057	NC_000006.12:162201181:T:A	T	A	CLINICAL
NM_004562.3(PRKN):c.7+1G>T	PRKN|PACRG		Normal	Parkinson disease 2	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000007053	6	163148693	6	162727661	7053	22092	rs397518439	NC_000006.12:162727660:C:A	C	A	CLINICAL
NM_032538.3(TTBK1):c.773G>A (p.Arg258Gln)	TTBK1	R258Q	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208398	6	43223506	6	43255768	208398	204615	rs759748655	NC_000006.12:43255767:G:A	G	A	CLINICAL
NM_002114.4(HIVEP1):c.4089G>C (p.Met1363Ile)	HIVEP1	M1363I	Normal	Attention deficit hyperactivity disorder|Hearing impairment|Seizures|Obsessive-compulsive behavior	Pathogenic	no assertion criteria provided	VCV000375377	6	12124117	6	12123884	375377	362144	rs776300630	NC_000006.12:12123883:G:C	G	C	CLINICAL
NM_006772.3(SYNGAP1):c.844T>C (p.Cys282Arg)	SYNGAP1	C282R	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000635755	6	33405526	6	33437749	635755	623587	rs1581987022	NC_000006.12:33437748:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.878G>C (p.Arg293Pro)	SYNGAP1	R293P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000571092	6	33405560	6	33437783	571092	565590	rs1561784553	NC_000006.12:33437782:G:C	G	C	CLINICAL
NM_006772.3(SYNGAP1):c.980T>C (p.Leu327Pro)	SYNGAP1	L327P	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000660421	6	33405662	6	33437885	660421	634845	rs1581987268	NC_000006.12:33437884:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.1084T>C (p.Trp362Arg)	SYNGAP1	W362R	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000041461	6	33405766	6	33437989	41461	49897	rs1581987445	NC_000006.12:33437988:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.1631G>C (p.Arg544Pro)	SYNGAP1	R544P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: May 6, 2016)	no assertion criteria provided	VCV000438305	6	33406651	6	33438874	438305	431915	rs1480178032	NC_000006.12:33438873:G:C	G	C	CLINICAL
NM_006772.3(SYNGAP1):c.1652T>C (p.Leu551Pro)	SYNGAP1	L551P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000547942	6	33406672	6	33438895	547942	538386	rs1554121453	NC_000006.12:33438894:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.1925A>C (p.Lys642Thr)	SYNGAP1	K642T	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000437411	6	33408961	6	33441184	437411	430962	rs1485749468	NC_000006.12:33441183:A:C	A	C	CLINICAL
NM_006772.3(SYNGAP1):c.2071A>C (p.Thr691Pro)	SYNGAP1	T691P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000648126	6	33409107	6	33441330	648126	634851	rs1581992998	NC_000006.12:33441329:A:C	A	C	CLINICAL
NM_006245.4(PPP2R5D):c.619T>C (p.Trp207Arg)	MEA1|PPP2R5D	W207R, W101R, W175R, W56R	Normal	Mental retardation, autosomal dominant 35|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280435	6	42975030	6	43007292	280435	264294	rs869320691	NC_000006.12:43007291:T:C	T	C	CLINICAL
NM_006245.4(PPP2R5D):c.752A>C (p.Asp251Ala)	MEA1|PPP2R5D	D251A, D100A, D219A, D145A	Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521616	6	42975698	6	43007960	521616	511680	rs1064794719	NC_000006.12:43007959:A:C	A	C	CLINICAL
NM_139003.3(HFE):c.340+250A>C	HFE	Q127H, Q104H, Q39H	Normal	Hemochromatosis type 1	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000000017	6	26091582	6	26091354	17	15056	rs28934595	NC_000006.12:26091353:A:C	A	C	CLINICAL
NM_139011.3(HFE):c.77-203A>C	HFE	Q283P, Q191P, Q269P, Q103P, Q177P, Q195P, Q260P, Q181P	Normal	Hereditary hemochromatosis|Hemochromatosis type 1	Pathogenic(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV000000019	6	26093144	6	26092916	19	15058	rs111033563	NC_000006.12:26092915:A:C	A	C	CLINICAL
NM_139007.3(HFE):c.77-273G>C	HFE	G93R, G70R	Normal	Hemochromatosis type 1	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000000013	6	26091269	6	26091041	13	15052	rs28934597	NC_000006.12:26091040:G:C	G	C	CLINICAL
NM_014797.2(ZBTB24):c.833C>G (p.Ser278Ter)	ZBTB24	S278*	Normal	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Jun 10, 2011)	no assertion criteria provided	VCV000031095	6	109802397	6	109481194	31095	40052	rs1582683374	NC_000006.12:109481193:G:C	G	C	CLINICAL
NM_014797.2(ZBTB24):c.47C>G (p.Ser16Ter)	ZBTB24	S16*	Normal	not provided|Immunodeficiency-centromeric instability-facial anomalies syndrome 2	Pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, single submitter	VCV000598541	6	109803183	6	109481980	598541	589602	rs370370334	NC_000006.12:109481979:G:C	G	C	CLINICAL
NM_000165.5(GJA1):c.440T>C (p.Met147Thr)	GJA1	M147T	Normal	Anteverted nares|Cutaneous finger syndactyly|Intellectual disability|Bilateral microphthalmos	Pathogenic(Last reviewed: Jul 2, 2014)	criteria provided, single submitter	VCV000374068	6	121768433	6	121447287	374068	360871	rs1057518872	NC_000006.12:121447286:T:C	T	C	CLINICAL
NM_004830.4(MED23):c.3638A>G (p.His1213Arg)	MED23	H1213R, H1219R	Normal	Mental retardation, autosomal recessive 18	Pathogenic	no assertion criteria provided	VCV000143192	6	131912501	6	131591361	143192	152910	rs527236035	NC_000006.12:131591360:T:C	T	C	CLINICAL
NM_004830.4(MED23):c.3353C>G (p.Ser1118Ter)	MED23	S1124*, S1118*	Normal	Mental retardation, autosomal recessive 18|not provided	Likely pathogenic(Last reviewed: Jan 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000620500	6	131914191	6	131593051	620500	611643	rs769471341	NC_000006.12:131593050:G:C	G	C	CLINICAL
NM_004830.4(MED23):c.670C>G (p.Arg224Gly)	MED23	R224G	Normal	Mental retardation, autosomal recessive 18	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437437	6	131939657	6	131618517	437437	430994	rs1293450628	NC_000006.12:131618516:G:C	G	C	CLINICAL
NM_020732.3(ARID1B):c.3689+1G>C	ARID1B		Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000374317	6	157510915	6	157189781	374317	361264	rs1057518691	NC_000006.12:157189780:G:C	G	C	CLINICAL
NM_020732.3(ARID1B):c.5026-2A>C	ARID1B		Normal	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000620062	6	157527299	6	157206165	620062	611465	rs1562350940	NC_000006.12:157206164:A:C	A	C	CLINICAL
NM_006661.4(PDE10A):c.290A>G (p.Tyr97Cys)	PDE10A	Y107C, Y97C	Normal	Dyskinesia, limb and orofacial, infantile-onset|Global developmental delay|Generalized hypotonia	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2016)	no assertion criteria provided	VCV000225633	6	165863756	6	165450268	225633	227467	rs778899140	NC_000006.12:165450267:T:C	T	C	CLINICAL
NM_003107.3(SOX4):c.334G>C (p.Ala112Pro)	SOX4	A112P	Normal	Developmental delay|Intellectual disability|Mild facial and digital morphological abnormalities|Coffin-Siris syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635852	6	21595099	6	21594868	635852	623665	rs1464282327	NC_000006.12:21594867:G:C	G	C	CLINICAL
NM_006772.3(SYNGAP1):c.844T>C (p.Cys282Arg)	SYNGAP1	C282R	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000635755	6	33405526	6	33437749	635755	623587	rs1581987022	NC_000006.12:33437748:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.878G>C (p.Arg293Pro)	SYNGAP1	R293P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000571092	6	33405560	6	33437783	571092	565590	rs1561784553	NC_000006.12:33437782:G:C	G	C	CLINICAL
NM_006772.3(SYNGAP1):c.980T>C (p.Leu327Pro)	SYNGAP1	L327P	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 22, 2018)	criteria provided, single submitter	VCV000660421	6	33405662	6	33437885	660421	634845	rs1581987268	NC_000006.12:33437884:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.1084T>C (p.Trp362Arg)	SYNGAP1	W362R	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000041461	6	33405766	6	33437989	41461	49897	rs1581987445	NC_000006.12:33437988:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.1631G>C (p.Arg544Pro)	SYNGAP1	R544P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: May 6, 2016)	no assertion criteria provided	VCV000438305	6	33406651	6	33438874	438305	431915	rs1480178032	NC_000006.12:33438873:G:C	G	C	CLINICAL
NM_006772.3(SYNGAP1):c.1652T>C (p.Leu551Pro)	SYNGAP1	L551P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000547942	6	33406672	6	33438895	547942	538386	rs1554121453	NC_000006.12:33438894:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.1925A>C (p.Lys642Thr)	SYNGAP1	K642T	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000437411	6	33408961	6	33441184	437411	430962	rs1485749468	NC_000006.12:33441183:A:C	A	C	CLINICAL
NM_006772.3(SYNGAP1):c.2071A>C (p.Thr691Pro)	SYNGAP1	T691P	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000648126	6	33409107	6	33441330	648126	634851	rs1581992998	NC_000006.12:33441329:A:C	A	C	CLINICAL
NM_032340.4(UQCC2):c.214-3C>G	UQCC2		Normal	Mitochondrial complex III deficiency, nuclear type 7	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000133295	6	33668293	6	33700516	133295	137034	rs587777410	NC_000006.12:33700515:G:C	G	C	CLINICAL
NM_182548.4(LHFPL5):c.575T>C (p.Leu192Pro)	LHFPL5	L192P	Normal	Deafness, autosomal recessive 67|Autosomal recessive non-syndromic intellectual disability	Pathogenic(Last reviewed: Feb 12, 2017)	criteria provided, single submitter	VCV000375705	6	35782485	6	35814708	375705	362595	rs1554147220	NC_000006.12:35814707:T:C	T	C	CLINICAL
NM_006245.4(PPP2R5D):c.619T>C (p.Trp207Arg)	MEA1|PPP2R5D	W207R, W101R, W175R, W56R	Normal	Mental retardation, autosomal dominant 35|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280435	6	42975030	6	43007292	280435	264294	rs869320691	NC_000006.12:43007291:T:C	T	C	CLINICAL
NM_006245.4(PPP2R5D):c.752A>C (p.Asp251Ala)	MEA1|PPP2R5D	D251A, D100A, D219A, D145A	Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521616	6	42975698	6	43007960	521616	511680	rs1064794719	NC_000006.12:43007959:A:C	A	C	CLINICAL
NM_022726.4(ELOVL4):c.289-2A>G	ELOVL4		Normal	Ichthyosis, spastic quadriplegia, and mental retardation	Likely pathogenic(Last reviewed: Jul 6, 2017)	no assertion criteria provided	VCV000433192	6	80634751	6	79925034	433192	426755	rs1554162524	NC_000006.12:79925033:T:C	T	C	CLINICAL
NM_004562.3(PRKN):c.719C>G (p.Thr240Arg)	PRKN	T240R, T212R, T91R	Normal	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007036	6	162394349	6	161973317	7036	22075	rs137853054	NC_000006.12:161973316:G:C	G	C	CLINICAL
NM_004562.3(PRKN):c.1A>G (p.Met1Val)	PRKN|PACRG	M1V	Normal	Young-onset Parkinson disease|not provided	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493448	6	163148700	6	162727668	493448	486411	rs772786691	NC_000006.12:162727667:T:C	T	C	CLINICAL
NM_006772.3(SYNGAP1):c.388-2A>G	SYNGAP1		Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 9, 2014)	no assertion criteria provided	VCV000208499	6	33400460	6	33432683	208499	205012	rs797045012	NC_000006.12:33432682:A:G	A	G	CLINICAL
NM_006772.3(SYNGAP1):c.1205T>G (p.Leu402Arg)	SYNGAP1	L402R	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jun 15, 2018)	no assertion criteria provided	VCV000559657	6	33405887	6	33438110	559657	550360	rs1554121265	NC_000006.12:33438109:T:G	T	G	CLINICAL
NM_006245.4(PPP2R5D):c.602C>G (p.Pro201Arg)	MEA1|PPP2R5D	P201R, P50R, P95R, P169R	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000190287	6	42975013	6	43007275	190287	188115	rs876657383	NC_000006.12:43007274:C:G	C	G	CLINICAL
NM_173560.4(RFX6):c.224-12A>G	RFX6		Normal	Mitchell-Riley syndrome|Diabetes mellitus	Pathogenic(Last reviewed: Feb 11, 2010)	no assertion criteria provided	VCV000000497	6	117198947	6	116877784	497	15536	rs587776515	NC_000006.12:116877783:A:G	A	G	CLINICAL
NM_206809.4(MOG):c.398C>G (p.Ser133Cys)	MOG	S133C	Normal	Narcolepsy 7	Pathogenic(Last reviewed: Sep 9, 2011)	no assertion criteria provided	VCV000029798	6	29627405	6	29659628	29798	38753	rs387906655	NC_000006.12:29659627:C:G	C	G	CLINICAL
NM_001025366.3(VEGFA):c.-94C>G	VEGFA|POLR1C		Normal	Microvascular complications of diabetes 1	risk factor(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000012223	6	43738350	6	43770613	12223	27262	rs2010963	NC_000006.12:43770612:C:G	C	G	CLINICAL
NM_020732.3(ARID1B):c.3228C>G (p.Tyr1076Ter)	ARID1B	Y1076*, Y1116*, Y366*, Y1063*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560949	6	157502195	6	157181061	560949	552098	rs1562328526	NC_000006.12:157181060:C:G	C	G	CLINICAL
NM_020732.3(ARID1B):c.3345+2T>G	ARID1B		Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 28, 2017)	no assertion criteria provided	VCV000438281	6	157502314	6	157181180	438281	431912	rs1404726383	NC_000006.12:157181179:T:G	T	G	CLINICAL
NM_020732.3(ARID1B):c.3401C>G (p.Ser1134Ter)	ARID1B	S1134*, S1174*, S1121*, S424*	Normal	Coffin-Siris syndrome 1	Likely pathogenic	no assertion criteria provided	VCV000636329	6	157505420	6	157184286	636329	624152	rs1583469292	NC_000006.12:157184285:C:G	C	G	CLINICAL
NM_020732.3(ARID1B):c.4140C>G (p.Tyr1380Ter)	ARID1B	Y1380*, Y1420*, Y1367*, Y670*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000585304	6	157521868	6	157200734	585304	576349	rs377021700	NC_000006.12:157200733:C:G	C	G	CLINICAL
NM_003107.3(SOX4):c.176T>G (p.Ile59Ser)	SOX4	I59S	Normal	Developmental delay|Intellectual disability|Mild facial and digital morphological abnormalities|Coffin-Siris syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635853	6	21594941	6	21594710	635853	623666	rs1582601669	NC_000006.12:21594709:T:G	T	G	CLINICAL
NM_178012.5(TUBB2B):c.793T>C (p.Phe265Leu)	TUBB2B	F265L	Normal	Polymicrogyria, asymmetric	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000000428	6	3225530	6	3225296	428	15467	rs137853196	NC_000006.12:3225295:A:G	A	G	CLINICAL
NM_178012.5(TUBB2B):c.350T>C (p.Leu117Pro)	TUBB2B	L117P	Normal	not provided|Polymicrogyria, asymmetric	Likely pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000039722	6	3225973	6	3225739	39722	48321	rs397514569	NC_000006.12:3225738:A:G	A	G	CLINICAL
NM_006772.3(SYNGAP1):c.388-2A>G	SYNGAP1		Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 9, 2014)	no assertion criteria provided	VCV000208499	6	33400460	6	33432683	208499	205012	rs797045012	NC_000006.12:33432682:A:G	A	G	CLINICAL
NM_006772.3(SYNGAP1):c.1205T>G (p.Leu402Arg)	SYNGAP1	L402R	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jun 15, 2018)	no assertion criteria provided	VCV000559657	6	33405887	6	33438110	559657	550360	rs1554121265	NC_000006.12:33438109:T:G	T	G	CLINICAL
NM_006245.4(PPP2R5D):c.602C>G (p.Pro201Arg)	MEA1|PPP2R5D	P201R, P50R, P95R, P169R	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000190287	6	42975013	6	43007275	190287	188115	rs876657383	NC_000006.12:43007274:C:G	C	G	CLINICAL
NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	FARS2	Y144C	Normal	not provided|Combined oxidative phosphorylation deficiency 14|Global developmental delay|Mitochondrial encephalomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039824	6	5369234	6	5369001	39824	48423	rs397514610	NC_000006.12:5369000:A:G	A	G	CLINICAL
NM_019842.3(KCNQ5):c.434T>G (p.Val145Gly)	KCNQ5	V145G	Normal	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431385	6	73713666	6	73003943	431385	424908	rs1135401955	NC_000006.12:73003942:T:G	T	G	CLINICAL
NM_019842.3(KCNQ5):c.1106C>G (p.Pro369Arg)	KCNQ5	P369R	Normal	Intellectual disability, autosomal dominant 46	Pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	VCV000431388	6	73821107	6	73111384	431388	424911	rs1135401958	NC_000006.12:73111383:C:G	C	G	CLINICAL
NM_014165.4(NDUFAF4):c.194T>C (p.Leu65Pro)	NDUFAF4	L65P	Normal	Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000000790	6	97344666	6	96896790	790	15829	rs63751061	NC_000006.12:96896789:A:G	A	G	CLINICAL
NM_004562.3(PRKN):c.1301T>C (p.Met434Thr)	PRKN	M285T, M406T, M434T	Normal	Parkinson disease 2	Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000810783	6	161771228	6	161350196	810783	799032	rs1582953433	NC_000006.12:161350195:A:G	A	G	CLINICAL
NM_014845.5(FIG4):c.157G>T (p.Asp53Tyr)	FIG4	D53Y	Normal	Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001728	6	110036371	6	109715168	1728	16767	rs121908290	NC_000006.12:109715167:G:T	G	T	CLINICAL
NM_014845.5(FIG4):c.547C>T (p.Arg183Ter)	FIG4	R183*	Normal	not provided|Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease, type 4J	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001723	6	110056402	6	109735199	1723	16762	rs121908288	NC_000006.12:109735198:C:T	C	T	CLINICAL
NM_000594.3(TNF):c.-1037C>T	TNF		Normal	Alzheimer disease, susceptibility to|Vascular dementia, susceptibility to	risk factor(Last reviewed: Jul 1, 2005)	no assertion criteria provided	VCV000012389	6	31542482	6	31574705	12389	27428	rs1799724	NC_000006.12:31574704:C:T	C	T	CLINICAL
NM_001080.3(ALDH5A1):c.1343+1G>T	ALDH5A1		Normal	Succinate-semialdehyde dehydrogenase deficiency	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000001355	6	24528395	6	24528167	1355	16394	rs1561879380	NC_000006.12:24528166:G:T	G	T	CLINICAL
NM_006772.3(SYNGAP1):c.403C>T (p.Arg135Ter)	SYNGAP1	R135*	Normal	Inborn genetic diseases|not provided|Mental retardation, autosomal recessive 5|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000430834	6	33400477	6	33432700	430834	424377	rs1131692154	NC_000006.12:33432699:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.412A>T (p.Lys138Ter)	SYNGAP1	K138*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000006392	6	33400486	6	33432709	6392	21431	rs121918315	NC_000006.12:33432708:A:T	A	T	CLINICAL
NM_006772.3(SYNGAP1):c.427C>T (p.Arg143Ter)	SYNGAP1	R143*	Normal	not provided|Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060716	6	33400501	6	33432724	60716	75278	rs397514741	NC_000006.12:33432723:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.484C>T (p.Arg162Cys)	SYNGAP1	R162C	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Dec 9, 2016)	no assertion criteria provided	VCV000438306	6	33400558	6	33432781	438306	431914	rs1554120589	NC_000006.12:33432780:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.490C>T (p.Arg164Ter)	SYNGAP1	R164*	Normal	not provided|Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373327	6	33400564	6	33432787	373327	359770	rs1057518352	NC_000006.12:33432786:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.739C>T (p.Gln247Ter)	SYNGAP1	Q247*	Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000496672	6	33403367	6	33435590	496672	488156	rs1554120978	NC_000006.12:33435589:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.762+1G>T	SYNGAP1		Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000212358	6	33403391	6	33435614	212358	207403	rs797046031	NC_000006.12:33435613:G:T	G	T	CLINICAL
NM_006772.3(SYNGAP1):c.937G>T (p.Glu313Ter)	SYNGAP1	E313*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000648805	6	33405619	6	33437842	648805	634844	rs1554121207	NC_000006.12:33437841:G:T	G	T	CLINICAL
NM_006772.3(SYNGAP1):c.1618C>T (p.Gln540Ter)	SYNGAP1	Q540*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802201	6	33406638	6	33438861	802201	790616	rs1554121438	NC_000006.12:33438860:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1630C>T (p.Arg544Ter)	SYNGAP1	R544*	Normal	not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522845	6	33406650	6	33438873	522845	513422	rs1554121443	NC_000006.12:33438872:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1717C>T (p.Arg573Trp)	SYNGAP1	R573W	Normal	not provided|Intellectual disability|Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421734	6	33408546	6	33440769	421734	406862	rs1064795331	NC_000006.12:33440768:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1735C>T (p.Arg579Ter)	SYNGAP1	R579*	Normal	not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006393	6	33408564	6	33440787	6393	21432	rs121918316	NC_000006.12:33440786:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1861C>T (p.Arg621Ter)	SYNGAP1	R621*	Normal	Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411589	6	33408690	6	33440913	411589	395450	rs1060503386	NC_000006.12:33440912:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.2059C>T (p.Arg687Ter)	SYNGAP1	R687*	Normal	not provided|Aggressive behavior|High forehead|Bulbous tips of toes|Downslanted palpebral fissures|Abnormality of the sternum|Delayed speech and language development|Triangular face|Motor delay|Behavioral abnormality|Wide nasal bridge|Ptosis|Pointed chin|Infantile muscular hypotonia|Mental retardation, autosomal dominant 5	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411584	6	33409095	6	33441318	411584	395696	rs1060503383	NC_000006.12:33441317:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.2755C>T (p.Gln919Ter)	SYNGAP1	Q919*, Q905*	Normal	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655800	6	33411084	6	33443307	655800	634859	rs1554122242	NC_000006.12:33443306:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.2899C>T (p.Arg967Ter)	SYNGAP1	R967*, R953*	Normal	Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000436928	6	33411228	6	33443451	436928	428626	rs749188610	NC_000006.12:33443450:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3073C>T (p.Gln1025Ter)	SYNGAP1	Q1025*, Q1011*	Normal	not provided|Mental retardation, autosomal dominant 5	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000581705	6	33411402	6	33443625	581705	560694	rs1554122296	NC_000006.12:33443624:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3124C>T (p.Gln1042Ter)	SYNGAP1	Q1042*, Q1028*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000575167	6	33411453	6	33443676	575167	563544	rs1554122305	NC_000006.12:33443675:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3190C>T (p.Gln1064Ter)	SYNGAP1	Q1064*, Q1050*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431134	6	33411519	6	33443742	431134	424650	rs1135401805	NC_000006.12:33443741:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3277C>T (p.Gln1093Ter)	SYNGAP1	Q1093*, Q1079*	Normal	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488875	6	33411606	6	33443829	488875	481762	rs1554122363	NC_000006.12:33443828:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3494C>T (p.Ser1165Leu)	SYNGAP1	S1165L, S1151L	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000225899	6	33412306	6	33444529	225899	227706	rs875989808	NC_000006.12:33444528:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3706C>T (p.Gln1236Ter)	SYNGAP1	Q1236*, Q1220*	Normal	Mental retardation, autosomal dominant 5|Inborn genetic diseases	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521432	6	33414475	6	33446698	521432	511676	rs1554122729	NC_000006.12:33446697:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3718C>T (p.Arg1240Ter)	SYNGAP1	R1240*, R1224*	Normal	Inborn genetic diseases|Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225077	6	33414487	6	33446710	225077	226901	rs869312955	NC_000006.12:33446709:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3811G>T (p.Glu1271Ter)	SYNGAP1	E1271*, E1255*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000576831	6	33415636	6	33447859	576831	565623	rs1554122888	NC_000006.12:33447858:G:T	G	T	CLINICAL
NM_006245.4(PPP2R5D):c.157C>T (p.Pro53Ser)	MEA1|PPP2R5D	P53S	Normal	Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000217455	6	42974252	6	43006514	217455	214096	rs757369209	NC_000006.12:43006513:C:T	C	T	CLINICAL
NM_006245.4(PPP2R5D):c.752A>T (p.Asp251Val)	MEA1|PPP2R5D	D251V, D145V, D219V, D100V	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420814	6	42975698	6	43007960	420814	406872	rs1064794719	NC_000006.12:43007959:A:T	A	T	CLINICAL
NM_020732.3(ARID1B):c.1828C>T (p.Gln610Ter)	ARID1B	Q597*, Q610*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560948	6	157222561	6	156901427	560948	552097	rs1554265271	NC_000006.12:156901426:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.2653C>T (p.Arg885Ter)	ARID1B	R898*, R885*, R135*	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy|not provided|Autism spectrum disorder	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000199160	6	157469898	6	157148764	199160	196319	rs794727977	NC_000006.12:157148763:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.3223C>T (p.Arg1075Ter)	ARID1B	R1075*, R1115*, R365*, R1062*	Normal	Coffin-Siris syndrome 1|not provided|ARID1B-related BAFopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031216	6	157502190	6	157181056	31216	40173	rs387907144	NC_000006.12:157181055:C:T	C	T	CLINICAL
NM_032122.5(DTNBP1):c.177G>A (p.Trp59Ter)	DTNBP1	W59*, W24*, W42*	Normal	Hermansky-Pudlak syndrome 1|Hermansky-Pudlak syndrome 7	Pathogenic(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000162098	6	15638020	6	15637789	162098	171814	rs727502866	NC_000006.12:15637788:C:T	C	T	CLINICAL
NM_000410.3(HFE):c.989G>T (p.Arg330Met)	HFE	R330M, R150M, R242M, R316M, R224M, R228M, R238M, R307M, R58M	Normal	Hemochromatosis type 1	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000000018	6	26093443	6	26093215	18	15057	rs111033558	NC_000006.12:26093214:G:T	G	T	CLINICAL
NM_000410.3(HFE):c.502G>T (p.Glu168Ter)	HFE	E168*, E145*, E80*	Normal	Hemochromatosis type 1|Hereditary hemochromatosis	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000088946	6	26091703	6	26091475	88946	94503	rs146519482	NC_000006.12:26091474:G:T	G	T	CLINICAL
NM_000410.3(HFE):c.892G>T (p.Glu298Ter)	HFE	E298*, E118*, E196*, E275*, E284*, E192*, E210*, E206*	Normal	Hemochromatosis type 1	Pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000407073	6	26093188	6	26092960	407073	395090	rs749553271	NC_000006.12:26092959:G:T	G	T	CLINICAL
NM_006772.3(SYNGAP1):c.490C>T (p.Arg164Ter)	SYNGAP1	R164*	Normal	not provided|Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373327	6	33400564	6	33432787	373327	359770	rs1057518352	NC_000006.12:33432786:C:T	C	T	CLINICAL
NM_006245.4(PPP2R5D):c.752A>T (p.Asp251Val)	MEA1|PPP2R5D	D251V, D145V, D219V, D100V	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420814	6	42975698	6	43007960	420814	406872	rs1064794719	NC_000006.12:43007959:A:T	A	T	CLINICAL
NM_021956.4(GRIK2):c.592C>T (p.Arg198Ter)	GRIK2	R198*	Normal	Mental retardation, autosomal recessive 6	Pathogenic(Last reviewed: Mar 1, 2015)	no assertion criteria provided	VCV000189252	6	102124548	6	101676673	189252	187134	rs749995448	NC_000006.12:101676672:C:T	C	T	CLINICAL
NM_021956.4(GRIK2):c.808C>T (p.Arg270Ter)	GRIK2	R270*	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000637968	6	102134085	6	101686210	637968	625797	rs1265340906	NC_000006.12:101686209:C:T	C	T	CLINICAL
NM_032730.5(RTN4IP1):c.308G>A (p.Arg103His)	RTN4IP1	R103H, R3H	Normal	Optic atrophy 10 with or without ataxia, mental retardation, and seizures	Pathogenic(Last reviewed: Nov 5, 2015)	no assertion criteria provided	VCV000218932	6	107070811	6	106622936	218932	215758	rs372054380	NC_000006.12:106622935:C:T	C	T	CLINICAL
NM_018013.4(SOBP):c.1981C>T (p.Arg661Ter)	SOBP	R661*	Normal	Mental retardation, anterior maxillary protrusion, and strabismus	Pathogenic(Last reviewed: Nov 12, 2010)	no assertion criteria provided	VCV000018392	6	107956029	6	107634825	18392	33431	rs267607078	NC_000006.12:107634824:C:T	C	T	CLINICAL
NM_000426.3(LAMA2):c.4645C>T (p.Arg1549Ter)	LAMA2	R1549*	Normal	Merosin deficient congenital muscular dystrophy|Laminin alpha 2-related dystrophy|Congenital muscular dystrophy due to partial LAMA2 deficiency	Pathogenic(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014299	6	129674430	6	129353285	14299	29338	rs121913575	NC_000006.12:129353284:C:T	C	T	CLINICAL
NM_004830.4(MED23):c.1832G>A (p.Arg611Gln)	MED23	R617Q, R611Q	Normal	not provided|Mental retardation, autosomal recessive 18	Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000030442	6	131924269	6	131603129	30442	39399	rs370667926	NC_000006.12:131603128:C:T	C	T	CLINICAL
NM_001134831.2(AHI1):c.1484G>A (p.Arg495His)	AHI1	R495H	Normal	Joubert syndrome 3	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000030761	6	135769570	6	135448432	30761	39718	rs387907003	NC_000006.12:135448431:C:T	C	T	CLINICAL
NM_001134831.2(AHI1):c.1328T>A (p.Val443Asp)	AHI1	V443D	Normal	Joubert syndrome 3|Typical Joubert syndrome MRI findings|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000002012	6	135776888	6	135455750	2012	17051	rs121434350	NC_000006.12:135455749:A:T	A	T	CLINICAL
NM_001278064.2(GRM1):c.889C>T (p.Arg297Ter)	GRM1	R297*	Normal	Spinocerebellar ataxia, autosomal recessive 13|Global developmental delay	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000626248	6	146480672	6	146159536	626248	614542	rs774214806	NC_000006.12:146159535:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.850C>T (p.Gln284Ter)	ARID1B	Q284*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000635838	6	157099913	6	156778779	635838	623652	rs1583025138	NC_000006.12:156778778:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.1483C>T (p.Gln495Ter)	ARID1B	Q495*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000434378	6	157100546	6	156779412	434378	428558	rs1554248236	NC_000006.12:156779411:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.1612C>T (p.Gln538Ter)	ARID1B	Q538*	Normal	Global developmental delay|Hypertrichosis|Neonatal hypotonia|Nail dysplasia|Corpus callosum, agenesis of|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374179	6	157150430	6	156829296	374179	360874	rs1057518951	NC_000006.12:156829295:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.1618C>T (p.Gln540Ter)	ARID1B	Q540*	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000520639	6	157150436	6	156829302	520639	511635	rs1554256703	NC_000006.12:156829301:C:T	C	T	CLINICAL
NM_001374828.1(ARID1B):c.1870C>T (p.Gln624Ter)	ARID1B	Q624*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Nov 2, 2018)	no assertion criteria provided	VCV000807540	6	157150439	6	156829305	807540	798571	rs754167205	NC_000006.12:156829304:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.1735C>T (p.Gln579Ter)	ARID1B	Q579*	Normal	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	VCV000397537	6	157150553	6	156829419	397537	384434	rs1060499668	NC_000006.12:156829418:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.1762G>T (p.Glu588Ter)	ARID1B	E588*	Normal	Inborn genetic diseases|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520728	6	157192772	6	156871638	520728	511636	rs201653711	NC_000006.12:156871637:G:T	G	T	CLINICAL
NM_020732.3(ARID1B):c.1828C>T (p.Gln610Ter)	ARID1B	Q597*, Q610*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000560948	6	157222561	6	156901427	560948	552097	rs1554265271	NC_000006.12:156901426:C:T	C	T	CLINICAL
NM_001374828.1(ARID1B):c.2107C>T (p.Gln703Ter)	ARID1B	Q716*, Q703*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828172	6	157222630	6	156901496	828172	816458	rs1554265316	NC_000006.12:156901495:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.1864C>T (p.Gln622Ter)	ARID1B	Q635*, Q622*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000031213	6	157222636	6	156901502	31213	40170	rs387907142	NC_000006.12:156901501:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.1960C>T (p.Gln654Ter)	ARID1B	Q641*, Q654*	Normal	Coffin-Siris syndrome 1|not provided	Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000438282	6	157256633	6	156935499	438282	431910	rs1554270809	NC_000006.12:156935498:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.2077G>T (p.Glu693Ter)	ARID1B	E680*, E693*	Normal	Coffin-Siris syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620011	6	157405835	6	157084701	620011	611392	rs1554294593	NC_000006.12:157084700:G:T	G	T	CLINICAL
NM_020732.3(ARID1B):c.2149C>T (p.Gln717Ter)	ARID1B	Q717*, Q704*	Normal	Coffin-Siris syndrome 1|not provided	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210275	6	157405907	6	157084773	210275	207363	rs753933273	NC_000006.12:157084772:C:T	C	T	CLINICAL
NM_001363725.2(ARID1B):c.-48C>T	ARID1B	Q748*, Q735*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224158	6	157406000	6	157084866	224158	225886	rs869312712	NC_000006.12:157084865:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.2248C>T (p.Arg750Ter)	ARID1B	R750*, R737*	Normal	Coffin-Siris syndrome 1|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000210277	6	157406006	6	157084872	210277	207365	rs797045272	NC_000006.12:157084871:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.2653C>T (p.Arg885Ter)	ARID1B	R898*, R885*, R135*	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy|not provided|Autism spectrum disorder	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000199160	6	157469898	6	157148764	199160	196319	rs794727977	NC_000006.12:157148763:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.2902C>T (p.Gln968Ter)	ARID1B	Q981*, Q968*, Q218*	Normal	Intellectual disability, moderate|Absent speech|Thick lower lip vermilion|Blepharophimosis|Long eyelashes|Thin upper lip vermilion	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	VCV000242867	6	157488235	6	157167101	242867	243971	rs879253747	NC_000006.12:157167100:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.3223C>T (p.Arg1075Ter)	ARID1B	R1075*, R1115*, R365*, R1062*	Normal	Coffin-Siris syndrome 1|not provided|ARID1B-related BAFopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031216	6	157502190	6	157181056	31216	40173	rs387907144	NC_000006.12:157181055:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.3304C>T (p.Arg1102Ter)	ARID1B	R1102*, R1142*, R1089*, R392*	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy|not provided	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000031210	6	157502271	6	157181137	31210	40167	rs387907141	NC_000006.12:157181136:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.3430C>T (p.Gln1144Ter)	ARID1B	Q1144*, Q1184*, Q1131*, Q434*	Normal	Coffin-Siris syndrome 1|Intellectual disability	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000434384	6	157505449	6	157184315	434384	428569	rs1554231836	NC_000006.12:157184314:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.3568C>T (p.Gln1190Ter)	ARID1B	Q1190*, Q1230*, Q1177*, Q1273*, Q480*	Normal	ARID1B-related BAFopathy|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000689741	6	157510793	6	157189659	689741	677423	rs1554232919	NC_000006.12:157189658:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.3898C>T (p.Gln1300Ter)	ARID1B	Q1300*, Q1340*, Q1287*, Q590*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000434386	6	157517334	6	157196200	434386	428571	rs1554234341	NC_000006.12:157196199:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.3880C>T (p.Gln1294Ter)	ARID1B	Q1307*, Q1347*, Q1294*, Q597*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000031208	6	157517355	6	157196221	31208	40165	rs387907140	NC_000006.12:157196220:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.4009C>T (p.Arg1337Ter)	ARID1B	R1337*, R1377*, R1324*, R627*	Normal	Inborn genetic diseases|not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488469	6	157517445	6	157196311	488469	481337	rs773740590	NC_000006.12:157196310:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.4336C>T (p.Gln1446Ter)	ARID1B	Q1446*, Q1486*, Q1433*, Q736*	Normal	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Nov 12, 2014)	criteria provided, single submitter	VCV000210293	6	157522064	6	157200930	210293	207375	rs797045278	NC_000006.12:157200929:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.4870C>T (p.Arg1624Ter)	ARID1B	R1624*, R1664*, R914*, R1611*	Normal	not provided|Coffin-Siris syndrome 1|ARID1B-related BAFopathy	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503753	6	157522598	6	157201464	503753	495270	rs1554236040	NC_000006.12:157201463:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.5290A>T (p.Lys1764Ter)	ARID1B	K1777*, K1817*, K1764*, K1067*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000031215	6	157527604	6	157206470	31215	40172	rs387907143	NC_000006.12:157206469:A:T	A	T	CLINICAL
NM_020732.3(ARID1B):c.5404C>T (p.Arg1802Ter)	ARID1B	R1802*, R1842*, R1092*, R1789*	Normal	not provided|Coffin-Siris syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000210302	6	157527679	6	157206545	210302	207384	rs797045282	NC_000006.12:157206544:C:T	C	T	CLINICAL
NM_001346813.1(ARID1B):c.5602G>T (p.Glu1868Ter)	ARID1B	E1828*, E1868*, E1815*, E1118*	Normal	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Jul 9, 2018)	no assertion criteria provided	VCV000592129	6	157527757	6	157206623	592129	583100	rs1451259945	NC_000006.12:157206622:G:T	G	T	CLINICAL
NM_017519.2(ARID1B):c.5737C>T (p.Arg1913Ter)	ARID1B	R1926*, R1966*, R1913*, R1216*	Normal	Coffin-Siris syndrome 1|ARID1B-related BAFopathy|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000488678	6	157528051	6	157206917	488678	481755	rs1554237658	NC_000006.12:157206916:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.5830C>T (p.Arg1944Ter)	ARID1B	R1944*, R1984*, R1931*, R1234*	Normal	not provided|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431136	6	157528105	6	157206971	431136	424649	rs1028186690	NC_000006.12:157206970:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.5968C>T (p.Arg1990Ter)	ARID1B	R1990*, R2030*, R1280*, R1977*	Normal	Coffin-Siris syndrome 1|not provided|Global developmental delay|Generalized hypotonia|Relative macrocephaly|Premature birth|Congenital talipes calcaneovalgus|Dysphagia|Capillary hemangiomas|Short stature|Torticollis|Joint hypermobility	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210306	6	157528243	6	157207109	210306	207388	rs797045283	NC_000006.12:157207108:C:T	C	T	CLINICAL
NM_017519.2(ARID1B):c.6061C>T (p.Gln2021Ter)	ARID1B	Q2034*, Q2021*, Q2074*, Q1324*	Normal	Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 4, 2015)	criteria provided, single submitter	VCV000224135	6	157528375	6	157207241	224135	225865	rs869312697	NC_000006.12:157207240:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.6382C>T (p.Arg2128Ter)	ARID1B	R2128*, R2168*, R2115*, R1418*	Normal	not provided|History of neurodevelopmental disorder|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448984	6	157528657	6	157207523	448984	443928	rs1554238072	NC_000006.12:157207522:C:T	C	T	CLINICAL
NM_020732.3(ARID1B):c.6526C>T (p.Gln2176Ter)	ARID1B	Q2176*, Q2216*, Q1466*, Q2163*	Normal	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: May 25, 2016)	no assertion criteria provided	VCV000438283	6	157528801	6	157207667	438283	431913	rs758120346	NC_000006.12:157207666:C:T	C	T	CLINICAL
NM_003107.3(SOX4):c.315G>T (p.Lys105Asn)	SOX4	K105N	Normal	Developmental delay|Intellectual disability|Mild facial and digital morphological abnormalities|Coffin-Siris syndrome 10	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	no assertion criteria provided	VCV000635854	6	21595080	6	21594849	635854	623667	rs1582601747	NC_000006.12:21594848:G:T	G	T	CLINICAL
NM_003587.5(DHX16):c.1744T>A (p.Phe582Ile)	DHX16	F101I, F522I, F582I	Normal	Periventricular gray matter heterotopia|Seizures|Chorioretinal lacunae|Neurodevelopmental delay|Intellectual disability|Corpus callosum, agenesis of|Neuromuscular disease and ocular or auditory anomalies with or without seizures|Neurodevelopmental disorders	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	no assertion criteria provided	VCV000691931	6	30627820	6	30660043	691931	679674	rs1582940678	NC_000006.12:30660042:A:T	A	T	CLINICAL
NM_003587.5(DHX16):c.1280G>A (p.Gly427Glu)	DHX16	G367E, G427E	Normal	Neurodevelopmental delay|Intellectual disability|Neuromuscular disease and ocular or auditory anomalies with or without seizures|Neurodevelopmental disorders	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	no assertion criteria provided	VCV000691933	6	30632615	6	30664838	691933	679675	rs1582953009	NC_000006.12:30664837:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.403C>T (p.Arg135Ter)	SYNGAP1	R135*	Normal	Inborn genetic diseases|not provided|Mental retardation, autosomal recessive 5|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jun 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000430834	6	33400477	6	33432700	430834	424377	rs1131692154	NC_000006.12:33432699:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.412A>T (p.Lys138Ter)	SYNGAP1	K138*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000006392	6	33400486	6	33432709	6392	21431	rs121918315	NC_000006.12:33432708:A:T	A	T	CLINICAL
NM_006772.3(SYNGAP1):c.427C>T (p.Arg143Ter)	SYNGAP1	R143*	Normal	not provided|Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060716	6	33400501	6	33432724	60716	75278	rs397514741	NC_000006.12:33432723:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.484C>T (p.Arg162Cys)	SYNGAP1	R162C	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Dec 9, 2016)	no assertion criteria provided	VCV000438306	6	33400558	6	33432781	438306	431914	rs1554120589	NC_000006.12:33432780:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.490C>T (p.Arg164Ter)	SYNGAP1	R164*	Normal	not provided|Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373327	6	33400564	6	33432787	373327	359770	rs1057518352	NC_000006.12:33432786:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.739C>T (p.Gln247Ter)	SYNGAP1	Q247*	Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000496672	6	33403367	6	33435590	496672	488156	rs1554120978	NC_000006.12:33435589:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.762+1G>T	SYNGAP1		Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Dec 16, 2014)	criteria provided, single submitter	VCV000212358	6	33403391	6	33435614	212358	207403	rs797046031	NC_000006.12:33435613:G:T	G	T	CLINICAL
NM_006772.3(SYNGAP1):c.937G>T (p.Glu313Ter)	SYNGAP1	E313*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000648805	6	33405619	6	33437842	648805	634844	rs1554121207	NC_000006.12:33437841:G:T	G	T	CLINICAL
NM_006772.3(SYNGAP1):c.1618C>T (p.Gln540Ter)	SYNGAP1	Q540*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802201	6	33406638	6	33438861	802201	790616	rs1554121438	NC_000006.12:33438860:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1630C>T (p.Arg544Ter)	SYNGAP1	R544*	Normal	not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522845	6	33406650	6	33438873	522845	513422	rs1554121443	NC_000006.12:33438872:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1717C>T (p.Arg573Trp)	SYNGAP1	R573W	Normal	not provided|Intellectual disability|Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421734	6	33408546	6	33440769	421734	406862	rs1064795331	NC_000006.12:33440768:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1735C>T (p.Arg579Ter)	SYNGAP1	R579*	Normal	not provided|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006393	6	33408564	6	33440787	6393	21432	rs121918316	NC_000006.12:33440786:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.1861C>T (p.Arg621Ter)	SYNGAP1	R621*	Normal	Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411589	6	33408690	6	33440913	411589	395450	rs1060503386	NC_000006.12:33440912:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.2059C>T (p.Arg687Ter)	SYNGAP1	R687*	Normal	not provided|Aggressive behavior|High forehead|Bulbous tips of toes|Downslanted palpebral fissures|Abnormality of the sternum|Delayed speech and language development|Triangular face|Motor delay|Behavioral abnormality|Wide nasal bridge|Ptosis|Pointed chin|Infantile muscular hypotonia|Mental retardation, autosomal dominant 5	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411584	6	33409095	6	33441318	411584	395696	rs1060503383	NC_000006.12:33441317:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.2755C>T (p.Gln919Ter)	SYNGAP1	Q919*, Q905*	Normal	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655800	6	33411084	6	33443307	655800	634859	rs1554122242	NC_000006.12:33443306:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.2899C>T (p.Arg967Ter)	SYNGAP1	R967*, R953*	Normal	Mental retardation, autosomal dominant 5|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000436928	6	33411228	6	33443451	436928	428626	rs749188610	NC_000006.12:33443450:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3073C>T (p.Gln1025Ter)	SYNGAP1	Q1025*, Q1011*	Normal	not provided|Mental retardation, autosomal dominant 5	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000581705	6	33411402	6	33443625	581705	560694	rs1554122296	NC_000006.12:33443624:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3124C>T (p.Gln1042Ter)	SYNGAP1	Q1042*, Q1028*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000575167	6	33411453	6	33443676	575167	563544	rs1554122305	NC_000006.12:33443675:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3190C>T (p.Gln1064Ter)	SYNGAP1	Q1064*, Q1050*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431134	6	33411519	6	33443742	431134	424650	rs1135401805	NC_000006.12:33443741:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3277C>T (p.Gln1093Ter)	SYNGAP1	Q1093*, Q1079*	Normal	Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488875	6	33411606	6	33443829	488875	481762	rs1554122363	NC_000006.12:33443828:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3494C>T (p.Ser1165Leu)	SYNGAP1	S1165L, S1151L	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000225899	6	33412306	6	33444529	225899	227706	rs875989808	NC_000006.12:33444528:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3706C>T (p.Gln1236Ter)	SYNGAP1	Q1236*, Q1220*	Normal	Mental retardation, autosomal dominant 5|Inborn genetic diseases	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521432	6	33414475	6	33446698	521432	511676	rs1554122729	NC_000006.12:33446697:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3718C>T (p.Arg1240Ter)	SYNGAP1	R1240*, R1224*	Normal	Inborn genetic diseases|Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5|not provided	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225077	6	33414487	6	33446710	225077	226901	rs869312955	NC_000006.12:33446709:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3811G>T (p.Glu1271Ter)	SYNGAP1	E1271*, E1255*	Normal	Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000576831	6	33415636	6	33447859	576831	565623	rs1554122888	NC_000006.12:33447858:G:T	G	T	CLINICAL
NM_006245.4(PPP2R5D):c.157C>T (p.Pro53Ser)	MEA1|PPP2R5D	P53S	Normal	Mental retardation, autosomal dominant 35	Pathogenic(Last reviewed: Nov 15, 2018)	no assertion criteria provided	VCV000217455	6	42974252	6	43006514	217455	214096	rs757369209	NC_000006.12:43006513:C:T	C	T	CLINICAL
NM_006245.4(PPP2R5D):c.752A>T (p.Asp251Val)	MEA1|PPP2R5D	D251V, D145V, D219V, D100V	Normal	not provided|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420814	6	42975698	6	43007960	420814	406872	rs1064794719	NC_000006.12:43007959:A:T	A	T	CLINICAL
NM_016277.5(RAB23):c.434T>A (p.Leu145Ter)	RAB23	L145*	Normal	not provided|Carpenter syndrome 1|Inborn genetic diseases|Carpenter syndrome	Pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004591	6	57059615	6	57194817	4591	19630	rs121908171	NC_000006.12:57194816:A:T	A	T	CLINICAL
NM_001160133.1(KCNQ5):c.532C>T (p.Arg178Ter)	KCNQ5	R178*	Normal	not provided|Intellectual disability, autosomal dominant 46	Likely pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523807	6	73751701	6	73041978	523807	514537	rs1554201137	NC_000006.12:73041977:C:T	C	T	CLINICAL
NM_001160134.1(KCNQ5):c.1247+8947G>T	KCNQ5	S448I, S429I, S420I, S439I	Normal	Intellectual disability, autosomal dominant 46|not provided	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000431387	6	73843182	6	73133459	431387	424910	rs1135401957	NC_000006.12:73133458:G:T	G	T	CLINICAL
NM_004370.6(COL12A1):c.8453G>A (p.Gly2818Glu)	COL12A1	G2818E, G1654E	Normal	Global developmental delay|Inborn genetic diseases	Likely pathogenic(Last reviewed: Feb 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000521418	6	75811731	6	75102015	521418	511689	rs1554168326	NC_000006.12:75102014:C:T	C	T	CLINICAL
NM_022726.4(ELOVL4):c.670-1G>A	ELOVL4		Normal	Ichthyosis, spastic quadriplegia, and mental retardation	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561003	6	80626601	6	79916884	561003	552107	rs1561982219	NC_000006.12:79916883:C:T	C	T	CLINICAL
NM_004562.3(PRKN):c.1358G>A (p.Trp453Ter)	PRKN	W453*, W304*, W425*	Normal	Parkinson disease 2|not provided	Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000007042	6	161771171	6	161350139	7042	22081	rs137853056	NC_000006.12:161350138:C:T	C	T	CLINICAL
NM_004562.3(PRKN):c.1289G>A (p.Gly430Asp)	PRKN	G430D, G281D, G402D	Normal	not provided|Parkinson disease 2|Young-onset Parkinson disease	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000356016	6	161771240	6	161350208	356016	306532	rs191486604	NC_000006.12:161350207:C:T	C	T	CLINICAL
NM_004562.3(PRKN):c.758G>A (p.Cys253Tyr)	PRKN	C253Y, C104Y, C225Y	Normal	not provided|Parkinson disease 2	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000645725	6	162206917	6	161785885	645725	634768	rs747427602	NC_000006.12:161785884:C:T	C	T	CLINICAL
NM_004562.3(PRKN):c.734+1G>A	PRKN		Normal	not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000571536	6	162394333	6	161973301	571536	565522	rs1562430103	NC_000006.12:161973300:C:T	C	T	CLINICAL
NM_004562.3(PRKN):c.635G>A (p.Cys212Tyr)	PRKN	C212Y, C184Y, C63Y	Normal	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000007046	6	162394433	6	161973401	7046	22085	rs137853058	NC_000006.12:161973400:C:T	C	T	CLINICAL
NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)	PRKN	R33Q	Normal	Young-onset Parkinson disease|Parkinson disease 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578186	6	162864415	6	162443383	578186	560658	rs147757966	NC_000006.12:162443382:C:T	C	T	CLINICAL
NM_006772.3(SYNGAP1):c.3494C>T (p.Ser1165Leu)	SYNGAP1	S1165L, S1151L	Normal	Mental retardation, autosomal dominant 5	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000225899	6	33412306	6	33444529	225899	227706	rs875989808	NC_000006.12:33444528:C:T	C	T	CLINICAL
NM_000823.4(GHRHR):c.57+1G>A	GHRHR		Normal	not provided|Isolated growth hormone deficiency, type 4	Pathogenic(Last reviewed: Jul 24, 2019)	no assertion criteria provided	VCV000015990	7	31003741	7	30964126	15990	31029	rs2302022	NC_000007.14:30964125:G:A	G	A	CLINICAL
NM_003718.5(CDK13):c.2149G>A (p.Gly717Arg)	CDK13	G717R	Normal	Autism spectrum disorder|Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000375737	7	40039066	7	39999467	375737	362622	rs1057519632	NC_000007.14:39999466:G:A	G	A	CLINICAL
NM_003718.5(CDK13):c.2194G>A (p.Ala732Thr)	CDK13	A732T	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Likely pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000827814	7	40041471	7	40001872	827814	815987	rs1583972803	NC_000007.14:40001871:G:A	G	A	CLINICAL
NM_003718.5(CDK13):c.2246C>A (p.Ala749Glu)	CDK13	A749E	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Likely pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000625525	7	40041523	7	40001924	625525	613829	rs1562722163	NC_000007.14:40001923:C:A	C	A	CLINICAL
NM_003718.5(CDK13):c.2252G>A (p.Arg751Gln)	CDK13	R751Q	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000375739	7	40041529	7	40001930	375739	362624	rs1057519634	NC_000007.14:40001929:G:A	G	A	CLINICAL
NM_003718.5(CDK13):c.2570G>A (p.Gly857Glu)	CDK13	G857E	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689751	7	40087446	7	40047847	689751	677426	rs1584035995	NC_000007.14:40047846:G:A	G	A	CLINICAL
NM_003496.3(TRRAP):c.3127G>A (p.Ala1043Thr)	TRRAP	A1043T	Normal	Developmental delay with or without dysmorphic facies and autism	Pathogenic(Last reviewed: Jun 13, 2019)	no assertion criteria provided	VCV000634849	7	98524941	7	98927318	634849	622718	rs1562945106	NC_000007.14:98927317:G:A	G	A	CLINICAL
NM_003496.3(TRRAP):c.5542T>A (p.Trp1848Arg)	TRRAP	W1866R, W1848R	Normal	Developmental delay with or without dysmorphic facies and autism	Pathogenic(Last reviewed: Feb 18, 2020)	no assertion criteria provided	VCV000634850	7	98550943	7	98953320	634850	622719	rs1562957569	NC_000007.14:98953319:T:A	T	A	CLINICAL
NM_003496.3(TRRAP):c.5957G>A (p.Arg1986Gln)	TRRAP	R1986Q, R2004Q	Normal	Developmental delay with or without dysmorphic facies and autism	Pathogenic(Last reviewed: Jun 13, 2019)	no assertion criteria provided	VCV000634847	7	98553863	7	98956240	634847	622716	rs1562959030	NC_000007.14:98956239:G:A	G	A	CLINICAL
NM_014491.4(FOXP2):c.1658G>A (p.Arg553His)	FOXP2	R553H, R578H, R552H, R570H	Normal	Speech-language disorder 1	Pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	VCV000005067	7	114302130	7	114662075	5067	20106	rs121908377	NC_000007.14:114662074:G:A	G	A	CLINICAL
NM_012281.3(KCND2):c.1210G>A (p.Val404Met)	KCND2	V404M	Normal	Early myoclonic encephalopathy|not provided	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV000144007	7	120373051	7	120732997	144007	153738	rs587777631	NC_000007.14:120732996:G:A	G	A	CLINICAL
NM_173569.4(UBN2):c.2024+1G>A	UBN2		Normal	Autism spectrum disorder	Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689795	7	138960894	7	139276148	689795	677425	rs1585016242	NC_000007.14:139276147:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.1175G>T (p.Arg392Leu)	GCK	R392L, R393L, R391L, R12L, R55L, R70L	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036185	7	44185174	7	44145575	36185	44849	rs193922269	NC_000007.14:44145574:C:A	C	A	CLINICAL
NM_000162.5(GCK):c.1124C>T (p.Ser375Phe)	GCK	S375F, S376F, S374F, S38F, S53F	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036175	7	44185225	7	44145626	36175	44839	rs193922263	NC_000007.14:44145625:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.1114G>T (p.Glu372Ter)	GCK	E372*, E373*, E35*, E50*, E371*	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036174	7	44185235	7	44145636	36174	44838	rs193922262	NC_000007.14:44145635:C:A	C	A	CLINICAL
NM_000162.5(GCK):c.1042A>T (p.Ile348Phe)	GCK	I348F, I349F, I26F, I347F, I11F	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036172	7	44185307	7	44145708	36172	44836	rs193922260	NC_000007.14:44145707:T:A	T	A	CLINICAL
NM_000162.5(GCK):c.952G>T (p.Gly318Trp)	GCK	G318W, G319W, G317W	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036268	7	44186129	7	44146530	36268	44932	rs193922340	NC_000007.14:44146529:C:A	C	A	CLINICAL
NM_000162.5(GCK):c.630G>T (p.Met210Ile)	GCK	M210I, M211I, M209I	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036236	7	44189408	7	44149809	36236	44900	rs193922313	NC_000007.14:44149808:C:A	C	A	CLINICAL
NM_000162.5(GCK):c.563C>T (p.Ala188Val)	GCK	A188V, A189V, A187V	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036229	7	44189584	7	44149985	36229	44893	rs193922307	NC_000007.14:44149984:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.509G>T (p.Gly170Val)	GCK	G170V, G171V, G169V	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036225	7	44189638	7	44150039	36225	44889	rs193922303	NC_000007.14:44150038:C:A	C	A	CLINICAL
NM_000162.5(GCK):c.304A>T (p.Lys102Ter)	GCK	K102*, K103*, K101*	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036211	7	44191929	7	44152330	36211	44875	rs193922291	NC_000007.14:44152329:T:A	T	A	CLINICAL
NM_000162.5(GCK):c.253A>T (p.Arg85Trp)	GCK	R85W, R86W, R84W	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036210	7	44191980	7	44152381	36210	44874	rs193922290	NC_000007.14:44152380:T:A	T	A	CLINICAL
NM_000162.5(GCK):c.103A>T (p.Arg35Ter)	GCK	R35*, R36*, R34*	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036171	7	44193005	7	44153406	36171	44835	rs193922259	NC_000007.14:44153405:T:A	T	A	CLINICAL
NM_004333.6(BRAF):c.1592G>T (p.Trp531Leu)	BRAF	W531L	Normal	Cardiofaciocutaneous syndrome 1	Likely pathogenic(Last reviewed: Aug 6, 2017)	criteria provided, single submitter	VCV000040379	7	140476814	7	140777014	40379	48849	rs397507478	NC_000007.14:140777013:C:A	C	A	CLINICAL
NM_000443.4(ABCB4):c.2869C>T (p.Arg957Ter)	ABCB4	R957*	Normal	Cholestasis, intrahepatic, of pregnancy 3|Low phospholipid associated cholelithiasis|Progressive familial intrahepatic cholestasis 3	Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000013687	7	87041264	7	87411948	13687	28726	rs121918440	NC_000007.14:87411947:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.1160C>T (p.Ala387Val)	GCK	A387V, A388V, A50V, A386V, A65V, A7V	Normal	Monogenic diabetes|Maturity-onset diabetes of the young, type 2|not provided	Likely pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036182	7	44185189	7	44145590	36182	44846	rs193921338	NC_000007.14:44145589:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.1358C>T (p.Ser453Leu)	GCK	S453L, S454L, S452L, S73L, S131L, S116L	Normal	Hyperinsulinism due to glucokinase deficiency|Type 2 diabetes mellitus|Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young, type 2|Maturity-onset diabetes of the young, type 2|not provided	Likely pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036200	7	44184775	7	44145176	36200	44864	rs193922283	NC_000007.14:44145175:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.907C>T (p.Arg303Trp)	GCK	R303W, R304W, R302W	Normal	not provided|Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036264	7	44186174	7	44146575	36264	44928	rs193922336	NC_000007.14:44146574:G:A	G	A	CLINICAL
NM_000443.4(ABCB4):c.3136C>T (p.Arg1046Ter)	ABCB4	R1046*, R999*	Normal	Cholestasis, intrahepatic, of pregnancy 3|not provided|Progressive familial intrahepatic cholestasis 3|Low phospholipid associated cholelithiasis	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000587488	7	87037496	7	87408180	587488	578462	rs759202962	NC_000007.14:87408179:G:A	G	A	CLINICAL
NM_001366110.1(PAX4):c.385C>T (p.Arg129Trp)	PAX4	R129W	Normal	Type 2 diabetes mellitus	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000013790	7	127254587	7	127614533	13790	28829	rs114202595	NC_000007.14:127614532:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.45+1G>T	GCK		Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619964	7	44228507	7	44188908	619964	611361	rs781260712	NC_000007.14:44188907:C:A	C	A	CLINICAL
NM_001366110.1(PAX4):c.514C>T (p.Arg172Trp)	PAX4	R172W	Normal	Maturity-onset diabetes of the young type 9	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000013793	7	127253858	7	127613804	13793	28832	rs121917718	NC_000007.14:127613803:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.683C>T (p.Thr228Met)	GCK	T228M, T229M, T227M	Normal	Permanent neonatal diabetes mellitus 1|not provided|Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016134	7	44187429	7	44147830	16134	31173	rs80356655	NC_000007.14:44147829:G:A	G	A	CLINICAL
NM_003227.4(TFR2):c.949C>T (p.Gln317Ter)	TFR2	Q317*, Q146*	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021379	7	100229722	7	100632099	21379	34231	rs80338881	NC_000007.14:100632098:G:A	G	A	CLINICAL
NM_003227.4(TFR2):c.313C>T (p.Arg105Ter)	TFR2	R105*	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021375	7	100238469	7	100640846	21375	34227	rs80338878	NC_000007.14:100640845:G:A	G	A	CLINICAL
NM_003227.4(TFR2):c.1186C>T (p.Arg396Ter)	TFR2	R396*, R225*	Normal	Hemochromatosis type 3|Hereditary hemochromatosis	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV000021362	7	100228596	7	100630973	21362	34214	rs80338882	NC_000007.14:100630972:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.871A>T (p.Lys291Ter)	GCK	K291*, K292*, K290*	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036263	7	44186210	7	44146611	36263	44927	rs193922335	NC_000007.14:44146610:T:A	T	A	CLINICAL
NM_003227.4(TFR2):c.2101C>T (p.Arg701Ter)	TFR2|LOC113687175	R530*, R701*	Normal	Hemochromatosis type 1|Hereditary hemochromatosis	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000802342	7	100224421	7	100626798	802342	790670	rs946552921	NC_000007.14:100626797:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.76C>T (p.Gln26Ter)	GCK	Q26*, Q27*, Q25*	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036256	7	44193032	7	44153433	36256	44920	rs193922329	NC_000007.14:44153432:G:A	G	A	CLINICAL
NM_000162.5(GCK):c.175C>T (p.Pro59Ser)	GCK	P59S, P60S, P58S	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000036205	7	44192933	7	44153334	36205	44869	rs193922287	NC_000007.14:44153333:G:A	G	A	CLINICAL
NM_000799.3(EPO):c.-1306C>A	EPO		Normal	Microvascular complications of diabetes 2	risk factor(Last reviewed: May 13, 2008)	no assertion criteria provided	VCV000016602	7	100317298	7	100719675	16602	31641	rs1617640	NC_000007.14:100719674:C:A	C	A	CLINICAL
NM_000474.4(TWIST1):c.563C>T (p.Ser188Leu)	TWIST1	S188L	Normal	Craniosynostosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007986	7	19156382	7	19116759	7986	23025	rs121909191	NC_000007.14:19116758:G:A	G	A	CLINICAL
NM_005402.4(RALA):c.73G>A (p.Val25Met)	RALA	V25M	Normal	Intellectual disability|HIATT-NEU-COOPER NEURODEVELOPMENTAL SYNDROME|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521019	7	39726339	7	39686740	521019	511709	rs1554297905	NC_000007.14:39686739:G:A	G	A	CLINICAL
NM_003718.5(CDK13):c.2141G>A (p.Gly714Asp)	CDK13	G714D	Normal	Global developmental delay|not provided	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, single submitter	VCV000449224	7	40039058	7	39999459	449224	444125	rs1554326755	NC_000007.14:39999458:G:A	G	A	CLINICAL
NM_001220.5(CAMK2B):c.852A>T (p.Arg284Ser)	CAMK2B	R284S	Normal	Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560180	7	44281350	7	44241751	560180	550896	rs1554385203	NC_000007.14:44241750:T:A	T	A	CLINICAL
NM_001220.5(CAMK2B):c.638C>T (p.Pro213Leu)	CAMK2B	P213L	Normal	Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Aug 28, 2018)	no assertion criteria provided	VCV000560179	7	44282217	7	44242618	560179	550895	rs1554387293	NC_000007.14:44242617:G:A	G	A	CLINICAL
NM_001220.5(CAMK2B):c.416C>T (p.Pro139Leu)	CAMK2B	P139L	Normal	Intellectual disability, autosomal dominant 54|Intellectual disability|not provided|Inborn genetic diseases|Global developmental delay|Apnea|Dystonia|Agitation|Microcephaly|Hyperventilation	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000430922	7	44283125	7	44243526	430922	424467	rs1554389088	NC_000007.14:44243525:G:A	G	A	CLINICAL
NM_001220.5(CAMK2B):c.85C>T (p.Arg29Ter)	CAMK2B	R29*	Normal	Intellectual disability|not provided|Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000430920	7	44323805	7	44284206	430920	424469	rs1554434435	NC_000007.14:44284205:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.1117A>T (p.Lys373Ter)	ACTB	K373*	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Mar 8, 2018)	no assertion criteria provided	VCV000495295	7	5567390	7	5527759	495295	486792	rs1554329068	NC_000007.14:5527758:T:A	T	A	CLINICAL
NM_001101.5(ACTB):c.1043C>T (p.Ser348Leu)	ACTB	S348L	Normal	Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279997	7	5567464	7	5527833	279997	264354	rs886041309	NC_000007.14:5527832:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.1013C>T (p.Ser338Phe)	ACTB	S338F	Normal	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Nov 24, 2016)	no assertion criteria provided	VCV000438273	7	5567494	7	5527863	438273	431916	rs1554329113	NC_000007.14:5527862:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.628C>T (p.Arg210Cys)	ACTB	R210C	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 26, 2019)	no assertion criteria provided	VCV000807362	7	5568086	7	5528455	807362	798586	rs1584261979	NC_000007.14:5528454:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.586C>T (p.Arg196Cys)	ACTB	R196C	Normal	Baraitser-Winter syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029600	7	5568128	7	5528497	29600	38554	rs281875333	NC_000007.14:5528496:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.547C>T (p.Arg183Trp)	ACTB	R183W	Normal	Developmental malformations-deafness-dystonia syndrome|Baraitser-Winter syndrome 1|not provided|ACTB-related BAFopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000018275	7	5568167	7	5528536	18275	33314	rs104894003	NC_000007.14:5528535:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.446C>T (p.Thr149Ile)	ACTB	T149I	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000127169	7	5568268	7	5528637	127169	132667	rs587779775	NC_000007.14:5528636:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.359C>T (p.Thr120Ile)	ACTB	T120I	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000127168	7	5568796	7	5529165	127168	132666	rs587779774	NC_000007.14:5529164:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.351G>T (p.Glu117Asp)	ACTB	E117D	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431099	7	5568804	7	5529173	431099	424622	rs765265404	NC_000007.14:5529172:C:A	C	A	CLINICAL
NM_001101.5(ACTB):c.350A>T (p.Glu117Val)	ACTB	E117V	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Jun 1, 2016)	no assertion criteria provided	VCV000438274	7	5568805	7	5529174	438274	431917	rs1554329516	NC_000007.14:5529173:T:A	T	A	CLINICAL
NM_001101.5(ACTB):c.217C>T (p.His73Tyr)	ACTB	H73Y	Normal	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000520411	7	5568938	7	5529307	520411	511009	rs786205585	NC_000007.14:5529306:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.209C>T (p.Pro70Leu)	ACTB	P70L	Normal	not provided|Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000127162	7	5568946	7	5529315	127162	132660	rs587779769	NC_000007.14:5529314:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.193C>T (p.Leu65Phe)	ACTB	L65F	Normal	Baraitser-Winter syndrome 1|Intellectual disability	Pathogenic(Last reviewed: Dec 1, 2018)	no assertion criteria provided	VCV000127161	7	5568962	7	5529331	127161	132659	rs281875332	NC_000007.14:5529330:G:A	G	A	CLINICAL
NM_001101.5(ACTB):c.113C>T (p.Pro38Leu)	ACTB	P38L	Normal	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000466230	7	5569176	7	5529545	466230	457811	rs1554329646	NC_000007.14:5529544:G:A	G	A	CLINICAL
NM_006908.5(RAC1):c.53G>A (p.Cys18Tyr)	RAC1	C18Y	Normal	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445280	7	6426860	7	6387229	445280	438552	rs1554263326	NC_000007.14:6387228:G:A	G	A	CLINICAL
NM_006908.5(RAC1):c.151G>A (p.Val51Met)	RAC1	V51M	Normal	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445284	7	6431598	7	6391967	445284	438556	rs1554263625	NC_000007.14:6391966:G:A	G	A	CLINICAL
NM_006908.5(RAC1):c.470G>A (p.Cys157Tyr)	RAC1	C157Y, C176Y	Normal	Intellectual disability, autosomal dominant 48|not provided	Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000445282	7	6441968	7	6402337	445282	438554	rs1554264268	NC_000007.14:6402336:G:A	G	A	CLINICAL
NM_000181.4(GUSB):c.1856C>T (p.Ala619Val)	GUSB	A619V, A400V, A429V, A473V	Normal	Mucopolysaccharidosis type 7	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000000893	7	65425984	7	65960997	893	15932	rs121918172	NC_000007.14:65960996:G:A	G	A	CLINICAL
NM_016038.4(SBDS):c.184A>T (p.Lys62Ter)	SBDS	K62*	Normal	Shwachman-Diamond syndrome 1|Intellectual disability|not provided|Splenomegaly|Deeply set eye|Microcephaly|Short stature|Agenesis of permanent teeth	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449095	7	66459273	7	66994286	449095	444151	rs120074160	NC_000007.14:66994285:T:A	T	A	CLINICAL
NM_015570.4(AUTS2):c.742+1G>A	AUTS2		Normal	not provided|Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000546070	7	70163607	7	70698621	546070	536739	rs1554464807	NC_000007.14:70698620:G:A	G	A	CLINICAL
NM_012431.3(SEMA3E):c.2108C>T (p.Ser703Leu)	SEMA3E	S703L, S643L	Normal	CHARGE association	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000002505	7	82997122	7	83367806	2505	17544	rs121918341	NC_000007.14:83367805:G:A	G	A	CLINICAL
NM_016203.4(PRKAG2):c.1463A>T (p.Asn488Ile)	PRKAG2	N488I, N247I, N363I, N364I, N444I	Normal	Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006850	7	151261285	7	151564199	6850	21889	rs121908989	NC_000007.14:151564198:T:A	T	A	CLINICAL
NM_002137.4(HNRNPA2B1):c.869A>T (p.Asp290Val)	HNRNPA2B1	D290V, D302V	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065454	7	26232966	7	26193346	65454	76371	rs397515326	NC_000007.14:26193345:T:A	T	A	CLINICAL
NM_016139.4(CHCHD2):c.182C>T (p.Thr61Ile)	CHCHD2	T61I	Normal	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218882	7	56172037	7	56104344	218882	215639	rs864309650	NC_000007.14:56104343:G:A	G	A	CLINICAL
NM_000441.2(SLC26A4):c.2T>C (p.Met1Thr)	SLC26A4|SLC26A4-AS1	M1T	Normal	not provided|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Rare genetic deafness|Pendred syndrome	Pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000043553	7	107302088	7	107661643	43553	52722	rs111033302	NC_000007.14:107661642:T:C	T	C	CLINICAL
NM_003718.5(CDK13):c.2140G>C (p.Gly714Arg)	CDK13	G714R	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic(Last reviewed: Feb 24, 2017)	no assertion criteria provided	VCV000375738	7	40039057	7	39999458	375738	362623	rs1057519633	NC_000007.14:39999457:G:C	G	C	CLINICAL
NM_014491.4(FOXP2):c.1591T>C (p.Tyr531His)	FOXP2	Y531H, Y556H, Y530H, Y548H	Normal	Speech-language disorder 1	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000242975	7	114299672	7	114659617	242975	244062	rs879253772	NC_000007.14:114659616:T:C	T	C	CLINICAL
NM_014491.4(FOXP2):c.1769+2T>C	FOXP2		Normal	Speech-language disorder 1	Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431153	7	114302243	7	114662188	431153	424654	rs1135401820	NC_000007.14:114662187:T:C	T	C	CLINICAL
NM_014141.6(CNTNAP2):c.1778-1G>C	CNTNAP2		Normal	Autism spectrum disorder	Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562153	7	147259229	7	147562137	562153	553317	rs1396313317	NC_000007.14:147562136:G:C	G	C	CLINICAL
NM_170606.3(KMT2C):c.560C>G (p.Ser187Ter)	KMT2C	S187*	Normal	Intellectual disability	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561045	7	152012253	7	152315168	561045	552115	rs1563831738	NC_000007.14:152315167:G:C	G	C	CLINICAL
NM_000162.5(GCK):c.1142T>G (p.Met381Arg)	GCK	M381R, M382R, M1R, M380R, M59R, M44R	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036178	7	44185207	7	44145608	36178	44842	rs193922266	NC_000007.14:44145607:A:C	A	C	CLINICAL
NM_000162.5(GCK):c.1018A>G (p.Ser340Gly)	GCK	S340G, S341G, S339G	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036167	7	44186063	7	44146464	36167	44831	rs193922255	NC_000007.14:44146463:T:C	T	C	CLINICAL
NM_000162.5(GCK):c.758T>G (p.Val253Gly)	GCK	V253G, V254G, V252G	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036253	7	44187354	7	44147755	36253	44917	rs193921400	NC_000007.14:44147754:A:C	A	C	CLINICAL
NM_000162.5(GCK):c.615C>G (p.Asp205Glu)	GCK	D205E, D206E, D204E	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036234	7	44189423	7	44149824	36234	44898	rs193922312	NC_000007.14:44149823:G:C	G	C	CLINICAL
NM_000162.5(GCK):c.604A>G (p.Met202Val)	GCK	M202V, M203V, M201V	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036232	7	44189434	7	44149835	36232	44896	rs193922310	NC_000007.14:44149834:T:C	T	C	CLINICAL
NM_000162.5(GCK):c.587A>G (p.Glu196Gly)	GCK	E196G, E197G, E195G	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036231	7	44189451	7	44149852	36231	44895	rs193922309	NC_000007.14:44149851:T:C	T	C	CLINICAL
NM_000162.5(GCK):c.527C>G (p.Ala176Gly)	GCK	A176G, A177G, A175G	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036226	7	44189620	7	44150021	36226	44890	rs193922304	NC_000007.14:44150020:G:C	G	C	CLINICAL
NM_000162.5(GCK):c.463A>G (p.Arg155Gly)	GCK	R155G, R156G, R154G	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036223	7	44190575	7	44150976	36223	44887	rs193922301	NC_000007.14:44150975:T:C	T	C	CLINICAL
NM_000162.5(GCK):c.322T>G (p.Tyr108Asp)	GCK	Y108D, Y109D, Y107D	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036212	7	44191911	7	44152312	36212	44876	rs193922292	NC_000007.14:44152311:A:C	A	C	CLINICAL
NM_000162.5(GCK):c.74T>G (p.Leu25Arg)	GCK	L25R, L26R, L24R	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036250	7	44193034	7	44153435	36250	44914	rs193922325	NC_000007.14:44153434:A:C	A	C	CLINICAL
NM_000162.5(GCK):c.57C>G (p.Ile19Met)	GCK	I19M, I20M, I18M	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036230	7	44193051	7	44153452	36230	44894	rs193922308	NC_000007.14:44153451:G:C	G	C	CLINICAL
NM_000162.5(GCK):c.1339C>G (p.Arg447Gly)	GCK	R447G, R448G, R67G, R125G, R110G, R446G	Normal	Maturity-onset diabetes of the young, type 2|not provided	Likely pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036198	7	44184794	7	44145195	36198	44862	rs193922281	NC_000007.14:44145194:G:C	G	C	CLINICAL
NM_000443.4(ABCB4):c.1633C>G (p.Arg545Gly)	ABCB4	R545G	Normal	Low phospholipid associated cholelithiasis	Pathogenic(Last reviewed: Jul 1, 2008)	no assertion criteria provided	VCV000039841	7	87069081	7	87439765	39841	48440	rs397514620	NC_000007.14:87439764:G:C	G	C	CLINICAL
NM_003227.4(TFR2):c.1469T>G (p.Leu490Arg)	TFR2	L490R, L319R	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021366	7	100225851	7	100628228	21366	34218	rs80338886	NC_000007.14:100628227:A:C	A	C	CLINICAL
NM_003227.4(TFR2):c.750C>G (p.Tyr250Ter)	TFR2	Y250*, Y79*	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000005380	7	100230723	7	100633100	5380	20419	rs80338880	NC_000007.14:100633099:G:C	G	C	CLINICAL
NM_000162.5(GCK):c.645C>G (p.Tyr215Ter)	GCK	Y215*, Y216*, Y214*	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036238	7	44189393	7	44149794	36238	44902	rs144723656	NC_000007.14:44149793:G:C	G	C	CLINICAL
NM_000162.5(GCK):c.1240A>G (p.Lys414Glu)	GCK	K414E, K415E, K92E, K34E, K77E, K413E	Normal	Monogenic diabetes|Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036188	7	44185109	7	44145510	36188	44852	rs193922272	NC_000007.14:44145509:T:C	T	C	CLINICAL
NM_006348.5(COG5):c.1576-15A>G	COG5		Normal	Congenital disorder of glycosylation type 2i	Pathogenic(Last reviewed: Nov 15, 2009)	no assertion criteria provided	VCV000004001	7	106898843	7	107258398	4001	19040	rs1562937199	NC_000007.14:107258397:T:C	T	C	CLINICAL
NM_018718.3(CEP41):c.33+2T>G	CEP41		Normal	Joubert syndrome 15	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030838	7	130080773	7	130440932	30838	39795	rs1584916464	NC_000007.14:130440931:A:C	A	C	CLINICAL
NM_001374258.1(BRAF):c.770A>G (p.Gln257Arg)	BRAF	Q257R, Q205R, Q223R, Q260R, Q169R	Normal	not provided|Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Cardio-facio-cutaneous syndrome|not specified|Rasopathy|Inborn genetic diseases|Cardiofaciocutaneous syndrome 1|LEOPARD syndrome 3|Noonan syndrome 7	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013973	7	140501302	7	140801502	13973	29012	rs180177035	NC_000007.14:140801501:T:C	T	C	CLINICAL
NM_170606.3(KMT2C):c.560C>G (p.Ser187Ter)	KMT2C	S187*	Normal	Intellectual disability	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561045	7	152012253	7	152315168	561045	552115	rs1563831738	NC_000007.14:152315167:G:C	G	C	CLINICAL
NM_130797.4(DPP6):c.1153A>C (p.Met385Leu)	DPP6	M385L, M321L, M278L, M323L, M324L	Normal	Mental retardation, autosomal dominant 33	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000189389	7	154585805	7	154794095	189389	187269	rs786205143	NC_000007.14:154794094:A:C	A	C	CLINICAL
NM_000162.5(GCK):c.641A>G (p.Tyr214Cys)	GCK	Y214C, Y215C, Y213C	Normal	Hyperinsulinism due to glucokinase deficiency	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000016144	7	44189397	7	44149798	16144	31183	rs104894015	NC_000007.14:44149797:T:C	T	C	CLINICAL
NM_001220.5(CAMK2B):c.901A>G (p.Lys301Glu)	CAMK2B	K301E	Normal	Inborn genetic diseases|Intellectual disability, autosomal dominant 54|Intellectual disability	Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000430925	7	44281301	7	44241702	430925	424464	rs1554385111	NC_000007.14:44241701:T:C	T	C	CLINICAL
NM_001101.5(ACTB):c.611C>G (p.Ala204Gly)	ACTB	A204G	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 20, 2017)	criteria provided, single submitter	VCV000127171	7	5568103	7	5528472	127171	132669	rs587779776	NC_000007.14:5528471:G:C	G	C	CLINICAL
NM_001101.5(ACTB):c.193C>G (p.Leu65Val)	ACTB	L65V	Normal	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029601	7	5568962	7	5529331	29601	38555	rs281875332	NC_000007.14:5529330:G:C	G	C	CLINICAL
NM_001101.5(ACTB):c.34A>G (p.Asn12Asp)	ACTB	N12D	Normal	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000029602	7	5569255	7	5529624	29602	38556	rs281875331	NC_000007.14:5529623:T:C	T	C	CLINICAL
NM_006908.5(RAC1):c.151G>C (p.Val51Leu)	RAC1	V51L	Normal	Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Oct 31, 2017)	no assertion criteria provided	VCV000445285	7	6431598	7	6391967	445285	438557	rs1554263625	NC_000007.14:6391966:G:C	G	C	CLINICAL
NM_015570.4(AUTS2):c.1600A>C (p.Thr534Pro)	AUTS2	T534P	Normal	Congenital cerebellar hypoplasia|Corpus callosum, agenesis of|Mental retardation, autosomal dominant 26|Multiple congenital anomalies	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632598	7	70231231	7	70766245	632598	621025	rs1563183469	NC_000007.14:70766244:A:C	A	C	CLINICAL
NM_015570.4(AUTS2):c.1604A>C (p.His535Pro)	AUTS2	H535P	Normal	Mental retardation, autosomal dominant 26	Likely pathogenic(Last reviewed: Jul 4, 2019)	no assertion criteria provided	VCV000807382	7	70231235	7	70766249	807382	798590	rs1585653240	NC_000007.14:70766248:A:C	A	C	CLINICAL
NM_000441.2(SLC26A4):c.85G>C (p.Glu29Gln)	SLC26A4|SLC26A4-AS1	E29Q	Normal	Pendred syndrome|Wolff-Parkinson-White pattern|SLC26A4-Related Disorders|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Rare genetic deafness|not provided	Pathogenic(Last reviewed: Mar 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004839	7	107302171	7	107661726	4839	19878	rs111033205	NC_000007.14:107661725:G:C	G	C	CLINICAL
NM_016203.4(PRKAG2):c.1591C>G (p.Arg531Gly)	PRKAG2	R531G, R290G, R407G, R406G, R487G	Normal	Wolff-Parkinson-White syndrome, childhood-onset	Pathogenic(Last reviewed: Dec 18, 2001)	no assertion criteria provided	VCV000006851	7	151257697	7	151560611	6851	21890	rs121908990	NC_000007.14:151560610:G:C	G	C	CLINICAL
NM_016203.4(PRKAG2):c.1589A>G (p.His530Arg)	PRKAG2	H530R, H406R, H289R, H486R, H405R	Normal	not provided|Familial hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy|Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006854	7	151257699	7	151560613	6854	21893	rs267606977	NC_000007.14:151560612:T:C	T	C	CLINICAL
NM_152701.5(ABCA13):c.11473+2T>C	ABCA13		Normal	Schizophrenia	Likely pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000210065	7	48427558	7	48387961	210065	207488	rs797045205	NC_000007.14:48387960:T:C	T	C	CLINICAL
NM_003718.5(CDK13):c.2200A>G (p.Lys734Glu)	CDK13	K734E	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder|not provided	Likely pathogenic(Last reviewed: Oct 14, 2016)	criteria provided, single submitter	VCV000422362	7	40041477	7	40001878	422362	407131	rs1064795731	NC_000007.14:40001877:A:G	A	G	CLINICAL
NM_003718.5(CDK13):c.2524A>G (p.Asn842Asp)	CDK13	N842D	Normal	not provided|Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522794	7	40085605	7	40046006	522794	513425	rs1554333853	NC_000007.14:40046005:A:G	A	G	CLINICAL
NM_003718.5(CDK13):c.2525A>G (p.Asn842Ser)	CDK13	N842S	Normal	Global developmental delay|Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder|Inborn genetic diseases|not provided|Marfanoid habitus and intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235887	7	40085606	7	40046007	235887	237522	rs878853160	NC_000007.14:40046006:A:G	A	G	CLINICAL
NM_182931.3(KMT2E):c.3554C>G (p.Ser1185Ter)	KMT2E	S1185*	Normal	O'Donnell-Luria-Rodan syndrome|See cases	Likely pathogenic(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000638172	7	104749474	7	105109027	638172	625994	rs186916831	NC_000007.14:105109026:C:G	C	G	CLINICAL
NM_004333.6(BRAF):c.1593G>C (p.Trp531Cys)	BRAF	W531C	Normal	Rasopathy|Noonan syndrome 7|Noonan syndrome 1	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000029808	7	140476813	7	140777013	29808	38763	rs606231228	NC_000007.14:140777012:C:G	C	G	CLINICAL
NM_014141.6(CNTNAP2):c.2099-26267A>G	CNTNAP2		Normal	Autism 15	risk factor(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000005491	7	147574390	7	147877298	5491	20530	rs2710102	NC_000007.14:147877297:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.1157T>C (p.Leu386Pro)	GCK	L386P, L387P, L385P, L49P, L64P, L6P	Normal	not provided|Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036180	7	44185192	7	44145593	36180	44844	rs193922268	NC_000007.14:44145592:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.1289T>C (p.Leu430Pro)	GCK	L430P, L431P, L108P, L93P, L50P, L429P	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036194	7	44184844	7	44145245	36194	44858	rs193922277	NC_000007.14:44145244:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.1169T>C (p.Ile390Thr)	GCK	I390T, I391T, I10T, I389T, I53T, I68T	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036184	7	44185180	7	44145581	36184	44848	rs193921340	NC_000007.14:44145580:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.1020-1G>C	GCK		Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036170	7	44185330	7	44145731	36170	44834	rs193922258	NC_000007.14:44145730:C:G	C	G	CLINICAL
NM_000162.5(GCK):c.971T>C (p.Leu324Pro)	GCK	L324P, L325P, L323P	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036270	7	44186110	7	44146511	36270	44934	rs193922341	NC_000007.14:44146510:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.812T>C (p.Leu271Pro)	GCK	L271P, L272P, L270P	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036259	7	44187300	7	44147701	36259	44923	rs193922332	NC_000007.14:44147700:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.779T>C (p.Phe260Ser)	GCK	F260S, F261S, F259S	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036257	7	44187333	7	44147734	36257	44921	rs193922330	NC_000007.14:44147733:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.768G>C (p.Glu256Asp)	GCK	E256D, E257D, E255D	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036255	7	44187344	7	44147745	36255	44919	rs193922328	NC_000007.14:44147744:C:G	C	G	CLINICAL
NM_000162.5(GCK):c.758T>C (p.Val253Ala)	GCK	V253A, V254A, V252A	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036252	7	44187354	7	44147755	36252	44916	rs193921400	NC_000007.14:44147754:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.752T>C (p.Met251Thr)	GCK	M251T, M252T, M250T	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036251	7	44187360	7	44147761	36251	44915	rs193922326	NC_000007.14:44147760:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.704T>C (p.Met235Thr)	GCK	M235T, M236T, M234T	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036248	7	44187408	7	44147809	36248	44912	rs193922323	NC_000007.14:44147808:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.677T>C (p.Val226Ala)	GCK	V226A, V227A, V225A	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036244	7	44189361	7	44149762	36244	44908	rs193922319	NC_000007.14:44149761:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.658T>C (p.Cys220Arg)	GCK	C220R, C221R, C219R	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036239	7	44189380	7	44149781	36239	44903	rs193922315	NC_000007.14:44149780:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.107G>C (p.Arg36Pro)	GCK	R36P, R37P, R35P	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036173	7	44193001	7	44153402	36173	44837	rs193922261	NC_000007.14:44153401:C:G	C	G	CLINICAL
NM_000162.5(GCK):c.787T>C (p.Ser263Pro)	GCK	S263P, S264P, S262P	Normal	Maturity-onset diabetes of the young, type 2|Gestational diabetes|Maturity onset diabetes mellitus in young|not provided	Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000036258	7	44187325	7	44147726	36258	44922	rs193922331	NC_000007.14:44147725:A:G	A	G	CLINICAL
NM_000162.5(GCK):c.760A>C (p.Asn254His)	GCK	N254H, N255H, N253H	Normal	not provided|Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000036254	7	44187352	7	44147753	36254	44918	rs193922327	NC_000007.14:44147752:T:G	T	G	CLINICAL
NM_000443.4(ABCB4):c.2932T>C (p.Ser978Pro)	ABCB4	S978P, S931P	Normal	Low phospholipid associated cholelithiasis	Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000599183	7	87038701	7	87409385	599183	590360	rs1051861187	NC_000007.14:87409384:A:G	A	G	CLINICAL
NM_003227.4(TFR2):c.2069A>C (p.Gln690Pro)	TFR2|LOC113687175	Q690P, Q519P	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000005384	7	100224453	7	100626830	5384	20423	rs80338889	NC_000007.14:100626829:T:G	T	G	CLINICAL
NM_000162.5(GCK):c.895G>C (p.Gly299Arg)	GCK	G299R, G300R, G298R	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000016136	7	44186186	7	44146587	16136	31175	rs104894009	NC_000007.14:44146586:C:G	C	G	CLINICAL
NM_000162.5(GCK):c.449T>C (p.Phe150Ser)	GCK	F150S, F151S, F149S	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, multiple submitters, no conflicts	VCV000036218	7	44190589	7	44150990	36218	44882	rs193922297	NC_000007.14:44150989:A:G	A	G	CLINICAL
NM_139315.3(TAF6):c.212T>C (p.Ile71Thr)	TAF6	I108T, I71T, I117T, I61T	Normal	Syndromic intellectual disability|Alazami-Yuan syndrome|Inborn genetic diseases|Global developmental delay|Abnormal facial shape	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000180204	7	99711522	7	100113899	180204	178380	rs374993554	NC_000007.14:100113898:A:G	A	G	CLINICAL
NM_001283.5(AP1S1):c.183-2A>G	AP1S1		Normal	Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000039854	7	100800656	7	101157375	39854	48453	rs751430853	NC_000007.14:101157374:A:G	A	G	CLINICAL
NM_001369598.1(ST7):c.489T>G (p.Tyr163Ter)	ST7|ST7-AS2	Y163*, Y117*, Y113*, Y120*	Normal	Intractable seizure|Global developmental delay|Brain atrophy	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183291	7	116770584	7	117130530	183291	181424	rs550492993	NC_000007.14:117130529:T:G	T	G	CLINICAL
NM_018718.3(CEP41):c.423-2A>C	CEP41		Normal	Joubert syndrome 15	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030840	7	130042642	7	130402801	30840	39797	rs781815473	NC_000007.14:130402800:T:G	T	G	CLINICAL
NM_004333.6(BRAF):c.755G>C (p.Arg252Pro)	BRAF	R252P	Normal	Global developmental delay|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000451504	7	140501317	7	140801517	451504	444072	rs1325951163	NC_000007.14:140801516:C:G	C	G	CLINICAL
NM_003718.5(CDK13):c.2525A>G (p.Asn842Ser)	CDK13	N842S	Normal	Global developmental delay|Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder|Inborn genetic diseases|not provided|Marfanoid habitus and intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235887	7	40085606	7	40046007	235887	237522	rs878853160	NC_000007.14:40046006:A:G	A	G	CLINICAL
NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)	GLI3	A934P	Normal	Greig cephalopolysyndactyly syndrome, severe	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000013825	7	42005871	7	41966273	13825	28864	rs28933372	NC_000007.14:41966272:C:G	C	G	CLINICAL
NM_001101.5(ACTB):c.802G>C (p.Gly268Arg)	ACTB	G268R	Normal	Baraitser-Winter syndrome 1	Pathogenic	no assertion criteria provided	VCV000264642	7	5567912	7	5528281	264642	259236	rs1554329269	NC_000007.14:5528280:C:G	C	G	CLINICAL
NM_001101.5(ACTB):c.527T>C (p.Leu176Pro)	ACTB	L176P	Normal	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000446430	7	5568187	7	5528556	446430	439880	rs1554329331	NC_000007.14:5528555:A:G	A	G	CLINICAL
NM_001101.5(ACTB):c.356T>C (p.Met119Thr)	ACTB	M119T	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000127167	7	5568799	7	5529168	127167	132665	rs587779773	NC_000007.14:5529167:A:G	A	G	CLINICAL
NM_001101.5(ACTB):c.224T>C (p.Ile75Thr)	ACTB	I75T	Normal	not provided|Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000127164	7	5568931	7	5529300	127164	132662	rs587779771	NC_000007.14:5529299:A:G	A	G	CLINICAL
NM_001101.5(ACTB):c.34A>C (p.Asn12His)	ACTB	N12H	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000127166	7	5569255	7	5529624	127166	132664	rs281875331	NC_000007.14:5529623:T:G	T	G	CLINICAL
NM_006908.5(RAC1):c.116A>G (p.Asn39Ser)	RAC1	N39S	Normal	Global developmental delay|Intellectual disability, autosomal dominant 48	Pathogenic/Likely pathogenic(Last reviewed: May 20, 2021)	no assertion criteria provided	VCV000445281	7	6431563	7	6391932	445281	438553	rs1554263624	NC_000007.14:6391931:A:G	A	G	CLINICAL
NM_006908.5(RAC1):c.190T>G (p.Tyr64Asp)	RAC1	Y64D	Normal	not provided|Intellectual disability, autosomal dominant 48	Pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000445283	7	6431637	7	6392006	445283	438555	rs1554263626	NC_000007.14:6392005:T:G	T	G	CLINICAL
NM_015570.4(AUTS2):c.1605C>G (p.His535Gln)	AUTS2	H535Q	Normal	Pierre Robin-like syndrome	Likely pathogenic	no assertion criteria provided	VCV000374224	7	70231236	7	70766250	374224	361129	rs1057518986	NC_000007.14:70766249:C:G	C	G	CLINICAL
NM_016203.4(PRKAG2):c.1646A>C (p.Asp549Ala)	PRKAG2	D549A, D505A, D308A, D424A, D425A	Normal	not provided	Likely pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000181481	7	151257642	7	151560556	181481	179112	rs730880982	NC_000007.14:151560555:T:G	T	G	CLINICAL
NM_000162.5(GCK):c.645C>A (p.Tyr215Ter)	GCK	Y215*, Y216*, Y214*	Normal	not provided|Maturity onset diabetes mellitus in young	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000453007	7	44189393	7	44149794	453007	444135	rs144723656	NC_000007.14:44149793:G:T	G	T	CLINICAL
NM_003718.5(CDK13):c.2209C>T (p.Arg737Cys)	CDK13	R737C	Normal	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder|not provided	Pathogenic(Last reviewed: Apr 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000423480	7	40041486	7	40001887	423480	407132	rs1064796451	NC_000007.14:40001886:C:T	C	T	CLINICAL
NM_003496.3(TRRAP):c.2413C>T (p.Leu805Phe)	TRRAP	L805F	Normal	Developmental delay with or without dysmorphic facies and autism	Pathogenic(Last reviewed: Jun 13, 2019)	no assertion criteria provided	VCV000634848	7	98515093	7	98917470	634848	622717	rs1562940289	NC_000007.14:98917469:C:T	C	T	CLINICAL
NM_003496.3(TRRAP):c.5544G>T (p.Trp1848Cys)	TRRAP	W1866C, W1848C	Normal	Developmental delay with or without dysmorphic facies and autism	Pathogenic(Last reviewed: Jun 13, 2019)	no assertion criteria provided	VCV000634851	7	98550945	7	98953322	634851	622720	rs1562957576	NC_000007.14:98953321:G:T	G	T	CLINICAL
NM_014491.4(FOXP2):c.553C>T (p.Gln185Ter)	FOXP2	Q210*, Q185*, Q202*	Normal	Speech-language disorder 1	Pathogenic(Last reviewed: Oct 22, 2019)	no assertion criteria provided	VCV000807606	7	114270016	7	114629961	807606	798581	rs1584969672	NC_000007.14:114629960:C:T	C	T	CLINICAL
NM_014491.4(FOXP2):c.982C>T (p.Arg328Ter)	FOXP2	R328*, R353*, R327*, R345*	Normal	not provided|Speech-language disorder 1	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV000005068	7	114282671	7	114642616	5068	20107	rs121908378	NC_000007.14:114642615:C:T	C	T	CLINICAL
NM_014491.4(FOXP2):c.1426C>T (p.Arg476Ter)	FOXP2	R475*, R476*, R493*, R501*	Normal	Speech-language disorder 1	Pathogenic(Last reviewed: Sep 13, 2018)	no assertion criteria provided	VCV000617625	7	114298280	7	114658225	617625	609022	rs1178491246	NC_000007.14:114658224:C:T	C	T	CLINICAL
NM_014141.6(CNTNAP2):c.208+18133A>T	CNTNAP2		Normal	Autism 15	risk factor(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000005492	7	146489606	7	146792514	5492	20531	rs7794745	NC_000007.14:146792513:A:T	A	T	CLINICAL
NM_014141.6(CNTNAP2):c.1447C>T (p.Arg483Ter)	CNTNAP2	R483*	Normal	not provided|Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000205244	7	146997331	7	147300239	205244	202058	rs752550849	NC_000007.14:147300238:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.1345G>A (p.Ala449Thr)	GCK	A449T, A450T, A448T, A69T, A112T, A127T	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036199	7	44184788	7	44145189	36199	44863	rs193922282	NC_000007.14:44145188:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.1307T>A (p.Ile436Asn)	GCK	I436N, I437N, I56N, I99N, I114N, I435N	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036195	7	44184826	7	44145227	36195	44859	rs193922278	NC_000007.14:44145226:A:T	A	T	CLINICAL
NM_000162.5(GCK):c.1268T>A (p.Phe423Tyr)	GCK	F423Y, F424Y, F86Y, F101Y, F43Y, F422Y	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036189	7	44184865	7	44145266	36189	44853	rs193922273	NC_000007.14:44145265:A:T	A	T	CLINICAL
NM_000162.5(GCK):c.1169T>A (p.Ile390Asn)	GCK	I390N, I391N, I68N, I53N, I10N, I389N	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036183	7	44185180	7	44145581	36183	44847	rs193921340	NC_000007.14:44145580:A:T	A	T	CLINICAL
NM_000162.5(GCK):c.1160C>A (p.Ala387Glu)	GCK	A387E, A388E, A65E, A386E, A50E, A7E	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036181	7	44185189	7	44145590	36181	44845	rs193921338	NC_000007.14:44145589:G:T	G	T	CLINICAL
NM_000162.5(GCK):c.1153G>A (p.Gly385Arg)	GCK	G385R, G386R, G384R, G5R, G48R, G63R	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036179	7	44185196	7	44145597	36179	44843	rs193922267	NC_000007.14:44145596:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.947T>A (p.Phe316Tyr)	GCK	F316Y, F317Y, F315Y	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036267	7	44186134	7	44146535	36267	44931	rs193922339	NC_000007.14:44146534:A:T	A	T	CLINICAL
NM_000162.5(GCK):c.694G>A (p.Ala232Thr)	GCK	A232T, A233T, A231T	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036247	7	44187418	7	44147819	36247	44911	rs193922322	NC_000007.14:44147818:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.659G>A (p.Cys220Tyr)	GCK	C220Y, C221Y, C219Y	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036240	7	44189379	7	44149780	36240	44904	rs193922316	NC_000007.14:44149779:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.532G>A (p.Gly178Arg)	GCK	G178R, G179R, G177R	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036227	7	44189615	7	44150016	36227	44891	rs193922305	NC_000007.14:44150015:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.483G>A (p.Lys161=)	GCK		Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036224	7	44190555	7	44150956	36224	44888	rs193922302	NC_000007.14:44150955:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.440G>A (p.Gly147Asp)	GCK	G147D, G148D, G146D	Normal	Monogenic diabetes|Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036217	7	44190598	7	44150999	36217	44881	rs193922296	NC_000007.14:44150998:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.146C>A (p.Thr49Asn)	GCK	T49N, T50N, T48N	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036204	7	44192962	7	44153363	36204	44868	rs193922286	NC_000007.14:44153362:G:T	G	T	CLINICAL
NM_000162.5(GCK):c.131G>A (p.Gly44Asp)	GCK	G44D, G45D, G43D	Normal	Maturity-onset diabetes of the young, type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036196	7	44192977	7	44153378	36196	44860	rs193922279	NC_000007.14:44153377:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.128G>A (p.Arg43His)	GCK	R43H, R44H, R42H	Normal	not provided|Monogenic diabetes	Likely pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000393453	7	44192980	7	44153381	393453	380272	rs764232985	NC_000007.14:44153380:C:T	C	T	CLINICAL
NM_003227.4(TFR2):c.2374G>A (p.Gly792Arg)	TFR2	G792R, G621R	Normal	not provided|Hemochromatosis type 3|Hereditary hemochromatosis	Likely pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021374	7	100218512	7	100620889	21374	34226	rs80338891	NC_000007.14:100620888:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.944T>A (p.Leu315His)	GCK	L315H, L316H, L314H	Normal	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036266	7	44186137	7	44146538	36266	44930	rs193922338	NC_000007.14:44146537:A:T	A	T	CLINICAL
NM_001366110.1(PAX4):c.772-1G>A	PAX4		Normal	Maturity-onset diabetes of the young type 9	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000013794	7	127251731	7	127611677	13794	28833	rs371715169	NC_000007.14:127611676:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.629T>A (p.Met210Lys)	GCK	M210K, M211K, M209K	Normal	Permanent neonatal diabetes mellitus 1|Maturity-onset diabetes of the young, type 2|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000016141	7	44189409	7	44149810	16141	31180	rs80356654	NC_000007.14:44149809:A:T	A	T	CLINICAL
NM_003227.4(TFR2):c.1330G>A (p.Ala444Thr)	TFR2	A444T, A273T	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000021364	7	100226936	7	100629313	21364	34216	rs80338884	NC_000007.14:100629312:C:T	C	T	CLINICAL
NM_003227.4(TFR2):c.515T>A (p.Met172Lys)	TFR2	M172K, M1K	Normal	Hemochromatosis type 3	Pathogenic(Last reviewed: Jun 9, 2011)	no assertion criteria provided	VCV000005382	7	100231138	7	100633515	5382	20421	rs80338879	NC_000007.14:100633514:A:T	A	T	CLINICAL
NM_000162.5(GCK):c.1015G>A (p.Glu339Lys)	GCK	E339K, E340K, E338K	Normal	Maturity-onset diabetes of the young, type 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000039759	7	44186066	7	44146467	39759	48358	rs397514580	NC_000007.14:44146466:C:T	C	T	CLINICAL
NM_000230.3(LEP):c.313C>T (p.Arg105Trp)	LEP	R105W	Normal	Leptin deficiency or dysfunction	Pathogenic(Last reviewed: Mar 30, 2004)	no assertion criteria provided	VCV000013987	7	127894625	7	128254572	13987	29026	rs104894023	NC_000007.14:128254571:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.562G>A (p.Ala188Thr)	GCK	A187T, A188T, A189T	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000804849	7	44189585	7	44149986	804849	793237	rs751279776	NC_000007.14:44149985:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.214G>A (p.Gly72Arg)	GCK	G72R, G73R, G71R	Normal	Monogenic diabetes|Maturity-onset diabetes of the young, type 2|not provided	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036209	7	44192019	7	44152420	36209	44873	rs193922289	NC_000007.14:44152419:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.661G>A (p.Glu221Lys)	GCK	E221K, E222K, E220K	Normal	Maturity-onset diabetes of the young, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000036241	7	44189377	7	44149778	36241	44905	rs193922317	NC_000007.14:44149777:C:T	C	T	CLINICAL
NM_000162.5(GCK):c.645C>A (p.Tyr215Ter)	GCK	Y215*, Y216*, Y214*	Normal	not provided|Maturity onset diabetes mellitus in young	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000453007	7	44189393	7	44149794	453007	444135	rs144723656	NC_000007.14:44149793:G:T	G	T	CLINICAL
NM_000162.5(GCK):c.676G>A (p.Val226Met)	GCK	V226M, V227M, V225M	Normal	Maturity-onset diabetes of the young, type 2|not provided|Hyperinsulinism due to glucokinase deficiency|Maturity-onset diabetes of the young, type 2|Type 2 diabetes mellitus|Permanent neonatal diabetes mellitus|Maturity onset diabetes mellitus in young	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036243	7	44189362	7	44149763	36243	44907	rs148311934	NC_000007.14:44149762:C:T	C	T	CLINICAL
NM_001540.5(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	R136L	Normal	Inborn genetic diseases|not provided|Charcot-Marie-Tooth disease axonal type 2F|Charcot-Marie-Tooth disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217230	7	75933161	7	76303844	217230	213813	rs863225022	NC_000007.14:76303843:G:T	G	T	CLINICAL
NM_004722.4(AP4M1):c.916C>T (p.Arg306Ter)	AP4M1	R306*, R313*	Normal	Spastic paraplegia 50, autosomal recessive|not provided|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000561150	7	99703149	7	100105526	561150	552111	rs369459721	NC_000007.14:100105525:C:T	C	T	CLINICAL
NM_004722.4(AP4M1):c.952C>T (p.Arg318Ter)	AP4M1	R318*, R325*	Normal	Spastic paraplegia 50, autosomal recessive|Hypoplasia of the corpus callosum|Global developmental delay|Brain atrophy|Microcephaly|CNS hypomyelination|not provided	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183357	7	99703604	7	100105981	183357	181423	rs730882249	NC_000007.14:100105980:C:T	C	T	CLINICAL
NM_016188.5(ACTL6B):c.893G>A (p.Arg298Gln)	ACTL6B	R298Q	Normal	Developmental and epileptic encephalopathy, 76|Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	VCV000402140	7	100244637	7	100647014	402140	389133	rs1060499738	NC_000007.14:100647013:C:T	C	T	CLINICAL
NM_001283.5(AP1S1):c.220C>T (p.Gln74Ter)	AP1S1	Q74*	Normal	Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804403	7	100800695	7	101157414	804403	792763	rs1584203922	NC_000007.14:101157413:C:T	C	T	CLINICAL
NM_018718.3(CEP41):c.83C>A (p.Ser28Ter)	CEP41	S28*	Normal	Joubert syndrome 15	Pathogenic(Last reviewed: Jan 15, 2012)	no assertion criteria provided	VCV000030844	7	130067810	7	130427969	30844	39801	rs1584901211	NC_000007.14:130427968:G:T	G	T	CLINICAL
NM_014141.6(CNTNAP2):c.1671-1G>T	CNTNAP2		Normal	not provided|Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Sep 13, 2012)	criteria provided, single submitter	VCV000005495	7	147183026	7	147485934	5495	20534	rs730880276	NC_000007.14:147485933:G:T	G	T	CLINICAL
NM_000474.4(TWIST1):c.556G>A (p.Ala186Thr)	TWIST1	A186T	Normal	Craniosynostosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000007985	7	19156389	7	19116766	7985	23024	rs121909190	NC_000007.14:19116765:C:T	C	T	CLINICAL
NM_001220.5(CAMK2B):c.903+1G>A	CAMK2B		Normal	not provided|Intellectual disability	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000430926	7	44281298	7	44241699	430926	424463	rs1554385102	NC_000007.14:44241698:C:T	C	T	CLINICAL
NM_001220.5(CAMK2B):c.820-1G>A	CAMK2B		Normal	Intellectual disability	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000430924	7	44281383	7	44241784	430924	424465	rs1554385305	NC_000007.14:44241783:C:T	C	T	CLINICAL
NM_001220.5(CAMK2B):c.709G>A (p.Glu237Lys)	CAMK2B	E237K	Normal	Intellectual disability|Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000430923	7	44281927	7	44242328	430923	424466	rs1554386687	NC_000007.14:44242327:C:T	C	T	CLINICAL
NM_001220.5(CAMK2B):c.328G>A (p.Glu110Lys)	CAMK2B	E110K	Normal	Intellectual disability|Intellectual disability, autosomal dominant 54	Pathogenic(Last reviewed: Dec 8, 2017)	no assertion criteria provided	VCV000430921	7	44294154	7	44254555	430921	424468	rs1554402092	NC_000007.14:44254554:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.1090G>A (p.Glu364Lys)	ACTB	E364K	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000218132	7	5567417	7	5527786	218132	214776	rs368352689	NC_000007.14:5527785:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.625G>A (p.Val209Met)	ACTB	V209M	Normal	Baraitser-Winter syndrome 1|not provided|ACTB-related BAFopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000127172	7	5568089	7	5528458	127172	132670	rs587779777	NC_000007.14:5528457:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.587G>A (p.Arg196His)	ACTB	R196H	Normal	Baraitser-Winter syndrome 1|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029599	7	5568127	7	5528496	29599	38553	rs281875334	NC_000007.14:5528495:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.586C>A (p.Arg196Ser)	ACTB	R196S	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Apr 15, 2014)	no assertion criteria provided	VCV000127170	7	5568128	7	5528497	127170	132668	rs281875333	NC_000007.14:5528496:G:T	G	T	CLINICAL
NM_001101.5(ACTB):c.349G>A (p.Glu117Lys)	ACTB	E117K	Normal	Baraitser-Winter syndrome 1	Pathogenic(Last reviewed: Sep 17, 2015)	no assertion criteria provided	VCV000066051	7	5568806	7	5529175	66051	76956	rs397515470	NC_000007.14:5529174:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.220G>A (p.Gly74Ser)	ACTB	G74S	Normal	Baraitser-Winter syndrome 1|not provided	Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000127163	7	5568935	7	5529304	127163	132661	rs587779770	NC_000007.14:5529303:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.64G>A (p.Ala22Thr)	ACTB	A22T	Normal	Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	VCV000128262	7	5569225	7	5529594	128262	133711	rs587780273	NC_000007.14:5529593:C:T	C	T	CLINICAL
NM_001101.5(ACTB):c.19G>A (p.Ala7Thr)	ACTB	A7T	Normal	Intellectual disability|Baraitser-Winter syndrome 1	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000577358	7	5569270	7	5529639	577358	561995	rs1562720119	NC_000007.14:5529638:C:T	C	T	CLINICAL
NM_153033.4(KCTD7):c.295C>T (p.Arg99Ter)	KCTD7	R99*	Normal	Epilepsy, progressive myoclonic 3	Pathogenic(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000000843	7	66098412	7	66633425	843	15882	rs267607199	NC_000007.14:66633424:C:T	C	T	CLINICAL
NM_015570.4(AUTS2):c.784C>T (p.Gln262Ter)	AUTS2	Q262*	Normal	Mental retardation, autosomal dominant 26	Likely pathogenic(Last reviewed: May 21, 2019)	no assertion criteria provided	VCV000827791	7	70227897	7	70762911	827791	815988	rs1585645384	NC_000007.14:70762910:C:T	C	T	CLINICAL
NM_015570.4(AUTS2):c.901C>T (p.Gln301Ter)	AUTS2	Q301*	Normal	Mental retardation, autosomal dominant 26	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000666574	7	70228014	7	70763028	666574	654130	rs1585645641	NC_000007.14:70763027:C:T	C	T	CLINICAL
NM_015570.4(AUTS2):c.946C>T (p.Arg316Ter)	AUTS2	R316*	Normal	Mental retardation, autosomal dominant 26|not provided	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000489014	7	70228059	7	70763073	489014	481792	rs1554480537	NC_000007.14:70763072:C:T	C	T	CLINICAL
NM_015570.4(AUTS2):c.1603C>T (p.His535Tyr)	AUTS2	H535Y	Normal	Mental retardation, autosomal dominant 26	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000584456	7	70231234	7	70766248	584456	575490	rs1563183492	NC_000007.14:70766247:C:T	C	T	CLINICAL
NM_016203.4(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	T400N, T275N, T276N, T159N, T356N	Normal	Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 6	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000006849	7	151265836	7	151568750	6849	21888	rs28938173	NC_000007.14:151568749:G:T	G	T	CLINICAL
NM_016203.4(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	R302Q, R61Q, R178Q, R177Q, R258Q	Normal	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|not provided|Cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006846	7	151273498	7	151576412	6846	21885	rs121908987	NC_000007.14:151576411:C:T	C	T	CLINICAL
NM_016139.4(CHCHD2):c.434G>A (p.Arg145Gln)	CHCHD2	R145Q	Normal	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218883	7	56170571	7	56102878	218883	215640	rs752169833	NC_000007.14:56102877:C:T	C	T	CLINICAL
NM_016139.4(CHCHD2):c.300+5G>A	CHCHD2		Normal	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218884	7	56171914	7	56104221	218884	215641	rs750014782	NC_000007.14:56104220:C:T	C	T	CLINICAL
NM_002402.4(MEST):c.559C>T (p.Pro187Ser)	MEST	P178S, P187S, P173S	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208394	7	130139739	7	130499898	208394	204616	rs863223353	NC_000007.14:130499897:C:T	C	T	CLINICAL
NM_014141.6(CNTNAP2):c.1447C>T (p.Arg483Ter)	CNTNAP2	R483*	Normal	not provided|Pitt-Hopkins-like syndrome 1	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000205244	7	146997331	7	147300239	205244	202058	rs752550849	NC_000007.14:147300238:C:T	C	T	CLINICAL
NM_005685.4(GTF2IRD1):c.973C>T (p.Arg325Cys)	GTF2IRD1	R325C, R357C	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208388	7	73935594	7	74521264	208388	204617	rs863223350	NC_000007.14:74521263:C:T	C	T	CLINICAL
NM_000492.4(CFTR):c.1657C>T (p.Arg553Ter)	CFTR|LOC111674475	R553*	Normal	not provided|not specified|Bronchiectasis with or without elevated sweat chloride 1|Hereditary pancreatitis|Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|none provided|Congenital bilateral aplasia of vas deferens from CFTR mutation|Cystic fibrosis|Cystic fibrosis|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 3, 2004)	practice guideline	VCV000007122	7	117227865	7	117587811	7122	22161	rs74597325	NC_000007.14:117587810:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.164T>A (p.Leu55Ter)	HGSNAT	L55*	Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000651853	8	43002136	8	43146993	651853	637223	rs1586698317	NC_000008.11:43146992:T:A	T	A	CLINICAL
NM_152419.3(HGSNAT):c.234+1G>A	HGSNAT		Normal	Sanfilippo syndrome|Retinal dystrophy|not provided|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Sep 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030832	8	43002207	8	43147064	30832	39789	rs483352908	NC_000008.11:43147063:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.493+1G>A	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome	Pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001230	8	43014188	8	43159045	1230	16269	rs193066451	NC_000008.11:43159044:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.518G>A (p.Gly173Asp)	HGSNAT	G173D	Normal	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000252961	8	43016605	8	43161462	252961	247363	rs370717845	NC_000008.11:43161461:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.851+1G>A	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000552286	8	43028887	8	43173744	552286	544734	rs1554532283	NC_000008.11:43173743:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.852-1G>A	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic(Last reviewed: Feb 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000556501	8	43033216	8	43178073	556501	544779	rs1447092074	NC_000008.11:43178072:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.887C>A (p.Ser296Ter)	HGSNAT	S296*, S8*	Normal	Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000542424	8	43033252	8	43178109	542424	523582	rs372933126	NC_000008.11:43178108:C:A	C	A	CLINICAL
NM_152419.3(HGSNAT):c.947G>A (p.Trp316Ter)	HGSNAT	W316*, W28*	Normal	Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553494	8	43033312	8	43178169	553494	544781	rs1554533211	NC_000008.11:43178168:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.1031G>A (p.Arg344His)	HGSNAT	R344H, R280H, R56H	Normal	Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551378	8	43037306	8	43182163	551378	544783	rs766835582	NC_000008.11:43182162:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.1250+1G>A	HGSNAT		Normal	Sanfilippo syndrome|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Retinal dystrophy|not provided|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096500	8	43046739	8	43191596	96500	102394	rs398124544	NC_000008.11:43191595:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.1411G>A (p.Glu471Lys)	HGSNAT	E471K, E183K, E407K	Normal	Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Sanfilippo syndrome|not provided|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Aug 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265483	8	43048933	8	43193790	265483	259899	rs753355844	NC_000008.11:43193789:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.1445T>A (p.Met482Lys)	HGSNAT	M482K, M418K, M194K	Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV000001234	8	43048967	8	43193824	1234	16273	rs121908284	NC_000008.11:43193823:T:A	T	A	CLINICAL
NM_152419.3(HGSNAT):c.1464+1G>A	HGSNAT		Normal	not provided|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096502	8	43048987	8	43193844	96502	102396	rs398124545	NC_000008.11:43193843:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.1542+1G>A	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000558433	8	43052169	8	43197026	558433	544430	rs1554537612	NC_000008.11:43197025:G:A	G	A	CLINICAL
NM_014112.5(TRPS1):c.1630C>T (p.Arg544Ter)	TRPS1	R544*, R535*, R531*, R537*	Normal	Trichorhinophalangeal dysplasia type I|Trichorhinophalangeal syndrome, type III|not provided|Langer-Giedion syndrome|Trichorhinophalangeal dysplasia type I	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267746	8	116616566	8	115604339	267746	263045	rs886040971	NC_000008.11:115604338:G:A	G	A	CLINICAL
NM_004519.4(KCNQ3):c.688C>T (p.Arg230Cys)	KCNQ3	R230C, R110C	Normal	Benign familial neonatal seizures|not provided|Seizures, benign familial infantile, 5|Autistic behavior|Intellectual disability|Severe neurodevelopmental delay|Intellectual disability|Benign familial neonatal seizures|Lennox-Gastaut syndrome|Benign familial neonatal seizures 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205963	8	133192493	8	132180246	205963	202181	rs796052676	NC_000008.11:132180245:G:A	G	A	CLINICAL
NM_023110.2(FGFR1):c.1097C>T (p.Pro366Leu)	FGFR1	P366L, P358L, P275L, P397L, P277L, P364L	Normal	Trigonocephaly 1|Jackson-Weiss syndrome|Hartsfield syndrome|Osteoglophonic dysplasia|Hypogonadotropic hypogonadism 2 with or without anosmia|Pfeiffer syndrome|Encephalocraniocutaneous lipomatosis|Hypogonadotropic hypogonadism 2 with anosmia|Hypogonadotropic hypogonadism 7 with or without anosmia	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000016299	8	38277238	8	38419720	16299	31338	rs121909641	NC_000008.11:38419719:G:A	G	A	CLINICAL
NC_000008.9:g.11369157G>A	BLK|FAM167A		Normal	Maturity-onset diabetes of the young, type 11	Pathogenic(Last reviewed: Aug 25, 2009)	no assertion criteria provided	VCV000012322	8	11331747	8	11474238	12322	27361	rs886037620	NC_000008.11:11474237:G:A	G	A	CLINICAL
NM_000237.3(LPL):c.249+1G>A	LPL		Normal	not provided|Hyperlipoproteinemia, type I|Hyperlipidemia, familial combined, LPL related	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001535	8	19805852	8	19948341	1535	16574	rs1563569634	NC_000008.11:19948340:G:A	G	A	CLINICAL
NM_001979.6(EPHX2):c.860G>A (p.Arg287Gln)	EPHX2	R287Q, R234Q, R221Q	Normal	Familial hypercholesterolemia 1	risk factor(Last reviewed: May 27, 2005)	no assertion criteria provided	VCV000016603	8	27373865	8	27516348	16603	31642	rs751141	NC_000008.11:27516347:G:A	G	A	CLINICAL
NM_003184.4(TAF2):c.2531C>T (p.Pro844Leu)	TAF2	P844L	Normal	Mental retardation, autosomal recessive 40	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666328	8	120774682	8	119762442	666328	653875	rs750451843	NC_000008.11:119762441:G:A	G	A	CLINICAL
NM_004519.4(KCNQ3):c.688C>T (p.Arg230Cys)	KCNQ3	R230C, R110C	Normal	Benign familial neonatal seizures|not provided|Seizures, benign familial infantile, 5|Autistic behavior|Intellectual disability|Severe neurodevelopmental delay|Intellectual disability|Benign familial neonatal seizures|Lennox-Gastaut syndrome|Benign familial neonatal seizures 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205963	8	133192493	8	132180246	205963	202181	rs796052676	NC_000008.11:132180245:G:A	G	A	CLINICAL
NM_001160372.4(TRAPPC9):c.2854G>T (p.Glu952Ter)	TRAPPC9	E1050*, E952*, E943*	Normal	not provided|Mental retardation, autosomal recessive 13	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000446015	8	140922501	8	139910257	446015	439287	rs766614772	NC_000008.11:139910256:C:A	C	A	CLINICAL
NM_001160372.4(TRAPPC9):c.1414C>T (p.Arg472Ter)	TRAPPC9	R570*, R472*, R463*	Normal	not provided|Mental retardation, autosomal recessive 13	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000759	8	141370230	8	140360131	759	15798	rs267607137	NC_000008.11:140360130:G:A	G	A	CLINICAL
NM_001160372.4(TRAPPC9):c.1129C>T (p.Arg377Ter)	TRAPPC9	R475*, R377*, R368*	Normal	Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV000000758	8	141407724	8	140397625	758	15797	rs267607136	NC_000008.11:140397624:G:A	G	A	CLINICAL
NM_001160372.4(TRAPPC9):c.367G>T (p.Glu123Ter)	TRAPPC9	E221*, E123*	Normal	Mental retardation, autosomal recessive 13|not provided	Pathogenic(Last reviewed: May 7, 2015)	criteria provided, multiple submitters, no conflicts	VCV000130637	8	141461106	8	140451007	130637	136083	rs587780486	NC_000008.11:140451006:C:A	C	A	CLINICAL
NM_025115.4(TTI2):c.1100C>T (p.Pro367Leu)	TTI2	P367L, P336L	Normal	Mental retardation, autosomal recessive 39	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000088867	8	33361281	8	33503763	88867	94436	rs398122366	NC_000008.11:33503762:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.518G>A (p.Gly173Asp)	HGSNAT	G173D	Normal	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000252961	8	43016605	8	43161462	252961	247363	rs370717845	NC_000008.11:43161461:G:A	G	A	CLINICAL
NM_004056.6(CA8):c.475A>T (p.Lys159Ter)	CA8	K159*	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3	Likely pathogenic(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	VCV000522600	8	61144881	8	60232322	522600	513213	rs79267946	NC_000008.11:60232321:T:A	T	A	CLINICAL
NM_017780.4(CHD7):c.378C>A (p.Tyr126Ter)	CHD7	Y126*	Normal	CHARGE association	Likely pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000599450	8	61654369	8	60741810	599450	590780	rs1563559596	NC_000008.11:60741809:C:A	C	A	CLINICAL
NM_017780.4(CHD7):c.2520G>A (p.Trp840Ter)	CHD7	W840*	Normal	CHARGE association	Pathogenic	criteria provided, single submitter	VCV000694697	8	61728967	8	60816408	694697	682811	rs1586379156	NC_000008.11:60816407:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.2613+1G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158283	8	61729061	8	60816502	158283	168599	rs587783432	NC_000008.11:60816501:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.2836-1G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000665863	8	61734582	8	60822023	665863	651906	rs1586389929	NC_000008.11:60822022:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.2858G>A (p.Trp953Ter)	CHD7	W953*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 8, 2017)	no assertion criteria provided	VCV000488479	8	61734605	8	60822046	488479	481347	rs1554597465	NC_000008.11:60822045:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.2957+5G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802408	8	61734709	8	60822150	802408	790808	rs1586390236	NC_000008.11:60822149:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.3623T>A (p.Val1208Asp)	CHD7	V1208D	Normal	Inborn genetic diseases|not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267427	8	61742981	8	60830422	267427	262652	rs886040988	NC_000008.11:60830421:T:A	T	A	CLINICAL
NM_017780.4(CHD7):c.4185+1G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000689639	8	61749572	8	60837013	689639	677321	rs1586418093	NC_000008.11:60837012:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.4533+1G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000816902	8	61750815	8	60838256	816902	805138	rs1586420419	NC_000008.11:60838255:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5050G>A (p.Gly1684Ser)	CHD7	G1684S	Normal	not provided|Inborn genetic diseases|CHARGE association	Pathogenic(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520773	8	61757622	8	60845063	520773	511761	rs1554602465	NC_000008.11:60845062:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5051-1G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802410	8	61757808	8	60845249	802410	790810	rs1586432203	NC_000008.11:60845248:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5355G>A (p.Trp1785Ter)	CHD7	W1785*	Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488363	8	61761664	8	60849105	488363	481221	rs1554603276	NC_000008.11:60849104:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5389G>A (p.Gly1797Arg)	CHD7	G1797R	Normal	CHARGE association	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000581739	8	61761698	8	60849139	581739	563014	rs1563656016	NC_000008.11:60849138:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5404G>A (p.Gly1802Ser)	CHD7	G1802S	Normal	CHARGE association	Likely pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000488387	8	61761713	8	60849154	488387	481235	rs1554603293	NC_000008.11:60849153:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5405-18C>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000428609	8	61763034	8	60850475	428609	420428	rs199981784	NC_000008.11:60850474:C:A	C	A	CLINICAL
NM_017780.4(CHD7):c.5405-17G>A	CHD7		Normal	not provided|CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|Inborn genetic diseases|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195978	8	61763035	8	60850476	195978	193139	rs794727423	NC_000008.11:60850475:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5405-13G>A	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 11, 2017)	criteria provided, single submitter	VCV000428610	8	61763039	8	60850480	428610	420429	rs1131690787	NC_000008.11:60850479:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5405-7G>A	CHD7		Normal	Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000095795	8	61763045	8	60850486	95795	101692	rs398124321	NC_000008.11:60850485:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.5607+1G>A	CHD7		Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000547194	8	61763664	8	60851105	547194	537834	rs1554603672	NC_000008.11:60851104:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.6322G>A (p.Gly2108Arg)	CHD7	G2108R	Normal	CHARGE association	Pathogenic(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000002032	8	61765606	8	60853047	2032	17071	rs121434343	NC_000008.11:60853046:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.6473C>A (p.Ser2158Ter)	CHD7	S2158*	Normal	CHARGE association	Pathogenic(Last reviewed: Apr 23, 2017)	criteria provided, single submitter	VCV000459559	8	61765757	8	60853198	459559	458569	rs376056567	NC_000008.11:60853197:C:A	C	A	CLINICAL
NM_017780.4(CHD7):c.6561T>A (p.Cys2187Ter)	CHD7	C2187*	Normal	CHARGE association	Likely pathogenic(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000692084	8	61765845	8	60853286	692084	679762	rs1586446578	NC_000008.11:60853285:T:A	T	A	CLINICAL
NM_017780.4(CHD7):c.6955C>A (p.Arg2319Ser)	CHD7	R2319S	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002027	8	61768552	8	60855993	2027	17066	rs121434341	NC_000008.11:60855992:C:A	C	A	CLINICAL
NM_017780.4(CHD7):c.6995G>A (p.Trp2332Ter)	CHD7	W2332*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Jun 17, 2014)	criteria provided, single submitter	VCV000196870	8	61768592	8	60856033	196870	194031	rs794727569	NC_000008.11:60856032:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.7781G>A (p.Trp2594Ter)	CHD7	W2594*	Normal	CHARGE association	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000651792	8	61773635	8	60861076	651792	637348	rs748126701	NC_000008.11:60861075:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.8015G>A (p.Trp2672Ter)	CHD7	W2672*, W623*	Normal	CHARGE association	Pathogenic	no assertion criteria provided	VCV000625860	8	61775150	8	60862591	625860	614164	rs1563670964	NC_000008.11:60862590:G:A	G	A	CLINICAL
NM_017780.4(CHD7):c.8055G>A (p.Trp2685Ter)	CHD7	W2685*, W636*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158322	8	61775190	8	60862631	158322	168638	rs587783459	NC_000008.11:60862630:G:A	G	A	CLINICAL
NM_024596.5(MCPH1):c.278C>A (p.Ala93Glu)	MCPH1	A93E, A59E, A91E	Normal	Primary autosomal recessive microcephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158867	8	6289064	8	6431543	158867	168645	rs587783741	NC_000008.11:6431542:C:A	C	A	CLINICAL
NM_017866.6(TMEM70):c.336T>A (p.Tyr112Ter)	TMEM70	Y112*	Normal	Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Mar 1, 2011)	no assertion criteria provided	VCV000030957	8	74893409	8	73981174	30957	39914	rs1586636643	NC_000008.11:73981173:T:A	T	A	CLINICAL
NM_000067.3(CA2):c.232+1G>A	CA2		Normal	Osteopetrosis with renal tubular acidosis|not provided	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000288909	8	86377699	8	85465470	288909	273146	rs573750741	NC_000008.11:85465469:G:A	G	A	CLINICAL
NM_017890.4(VPS13B):c.4820+1G>A	VPS13B		Normal	Global developmental delay|Severe Myopia|Retinal dystrophy|Joint laxity|Myopia (disease)|Intellectual disability|Mild hearing impairment|Optic disc pallor|Retinal dystrophy	Likely pathogenic	no assertion criteria provided	VCV000812992	8	100533239	8	99521011	812992	801103	rs1469729130	NC_000008.11:99521010:G:A	G	A	CLINICAL
NM_152419.3(HGSNAT):c.836A>C (p.Asp279Ala)	HGSNAT	D279A	Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Jan 11, 2017)	no assertion criteria provided	VCV000425553	8	43028871	8	43173728	425553	413894	rs1085307112	NC_000008.11:43173727:A:C	A	C	CLINICAL
NM_152419.3(HGSNAT):c.852-2A>C	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504466	8	43033215	8	43178072	504466	495386	rs755710040	NC_000008.11:43178071:A:C	A	C	CLINICAL
NM_152419.3(HGSNAT):c.1542+1G>C	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000552646	8	43052169	8	43197026	552646	544443	rs1554537612	NC_000008.11:43197025:G:C	G	C	CLINICAL
NM_023110.2(FGFR1):c.1869C>G (p.Asp623Glu)	FGFR1	D623E, D613E, D534E, D621E, D619E, D530E, D532E, D654E	Normal	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000522553	8	38272405	8	38414887	522553	513166	rs780009859	NC_000008.11:38414886:G:C	G	C	CLINICAL
NM_000553.6(WRN):c.3139-1G>C	WRN		Normal	not provided|Werner syndrome	Pathogenic(Last reviewed: May 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005447	8	30999196	8	31141680	5447	20486	rs113993961	NC_000008.11:31141679:G:C	G	C	CLINICAL
NM_153704.6(TMEM67):c.1046T>C (p.Leu349Ser)	TMEM67	L268S, L349S	Normal	TMEM67-Related Disorders|not provided|Meckel syndrome, type 3|Joubert syndrome 6|Meckel-Gruber syndrome|Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 6|Bardet-Biedl syndrome|Bardet-Biedl syndrome 14|Nephronophthisis 11|Joubert syndrome with hepatic defect|Meckel syndrome, type 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056762	8	94793953	8	93781725	56762	71401	rs386834180	NC_000008.11:93781724:T:C	T	C	CLINICAL
NM_153704.6(TMEM67):c.1843T>C (p.Cys615Arg)	TMEM67	C615R, C534R	Normal	Meckel-Gruber syndrome|Joubert syndrome|Nephronophthisis|not provided|Nephronophthisis 11|TMEM67-Related Disorders|Inborn genetic diseases|Joubert syndrome 6|RHYNS syndrome|Kidney damage|Infantile muscular hypotonia|Absent speech|Nystagmus|Intellectual disability, severe|Barrel-shaped chest|Visual impairment|Peritonitis|Cerebellar malformation|Pancreatitis|Cerebellar vermis hypoplasia|Tremor|Global developmental delay|Congenital ocular coloboma|Oligohydramnios|Renal cyst|Joubert syndrome|Bardet-Biedl syndrome 14|Meckel syndrome, type 3|Joubert syndrome 6|Joubert syndrome with hepatic defect|Nephronophthisis 11	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001383	8	94808198	8	93795970	1383	16422	rs201893408	NC_000008.11:93795969:T:C	T	C	CLINICAL
NM_001160372.4(TRAPPC9):c.2890A>G (p.Lys964Glu)	TRAPPC9	K964E, K927E, K916E, K955E, K971E	Normal	Mental retardation, autosomal recessive 13	Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800898	8	140922465	8	139910221	800898	788823	rs1357591960	NC_000008.11:139910220:T:C	T	C	CLINICAL
NM_015214.3(DDHD2):c.1978G>C (p.Asp660His)	DDHD2	D660H, D630H	Normal	Spastic paraplegia 54, autosomal recessive|not provided|Global developmental delay|Obesity|Generalized epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Sep 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039679	8	38111160	8	38253642	39679	48278	rs375168720	NC_000008.11:38253641:G:C	G	C	CLINICAL
NM_001257180.2(SLC20A2):c.1802C>G (p.Ser601Trp)	SLC20A2	S601W	Normal	Idiopathic basal ganglia calcification 1	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000029794	8	42275478	8	42417960	29794	38749	rs387906652	NC_000008.11:42417959:G:C	G	C	CLINICAL
NM_017780.4(CHD7):c.2097-1G>C	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000411182	8	61707544	8	60794985	411182	396666	rs1060503182	NC_000008.11:60794984:G:C	G	C	CLINICAL
NM_017780.4(CHD7):c.2442+5G>C	CHD7		Normal	Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic	criteria provided, single submitter	VCV000002034	8	61714157	8	60801598	2034	17073	rs387906271	NC_000008.11:60801597:G:C	G	C	CLINICAL
NM_017780.4(CHD7):c.3093G>C (p.Trp1031Cys)	CHD7	W1031C	Normal	CHARGE association	Pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, single submitter	VCV000411188	8	61735197	8	60822638	411188	396259	rs1060503187	NC_000008.11:60822637:G:C	G	C	CLINICAL
NM_017780.4(CHD7):c.3295T>C (p.Trp1099Arg)	CHD7	W1099R	Normal	CHARGE association	Likely pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000638145	8	61736492	8	60823933	638145	625966	rs1586393514	NC_000008.11:60823932:T:C	T	C	CLINICAL
NM_017780.4(CHD7):c.3301T>C (p.Cys1101Arg)	CHD7	C1101R	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000690306	8	61736498	8	60823939	690306	677982	rs1586393556	NC_000008.11:60823938:T:C	T	C	CLINICAL
NM_017780.4(CHD7):c.3379-2A>C	CHD7		Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000220434	8	61741220	8	60828661	220434	221761	rs864622523	NC_000008.11:60828660:A:C	A	C	CLINICAL
NM_017780.4(CHD7):c.3881T>C (p.Leu1294Pro)	CHD7	L1294P	Normal	CHARGE association|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218745	8	61748734	8	60836175	218745	215385	rs864309609	NC_000008.11:60836174:T:C	T	C	CLINICAL
NM_017780.4(CHD7):c.3905T>C (p.Leu1302Pro)	CHD7	L1302P	Normal	CHARGE association	Pathogenic(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000626915	8	61748758	8	60836199	626915	615268	rs1563643394	NC_000008.11:60836198:T:C	T	C	CLINICAL
NM_017780.4(CHD7):c.5210+2T>C	CHD7		Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488368	8	61757970	8	60845411	488368	481220	rs1554602587	NC_000008.11:60845410:T:C	T	C	CLINICAL
NM_017780.4(CHD7):c.5211-1G>C	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 22, 2016)	criteria provided, single submitter	VCV000411179	8	61761073	8	60848514	411179	396667	rs1060503180	NC_000008.11:60848513:G:C	G	C	CLINICAL
NM_017780.4(CHD7):c.5666-2A>C	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 3, 2013)	criteria provided, single submitter	VCV000158304	8	61764576	8	60852017	158304	168620	rs587783448	NC_000008.11:60852016:A:C	A	C	CLINICAL
NM_017780.4(CHD7):c.8076+1G>C	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000598779	8	61775212	8	60862653	598779	589840	rs1563671108	NC_000008.11:60862652:G:C	G	C	CLINICAL
NM_017780.4(CHD7):c.8077-1G>C	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000656743	8	61777574	8	60865015	656743	651995	rs1586466948	NC_000008.11:60865014:G:C	G	C	CLINICAL
NM_024596.5(MCPH1):c.2453-1G>C	MCPH1|MCPH1-AS1		Normal	not provided|Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Nov 29, 2012)	criteria provided, single submitter	VCV000158863	8	6500514	8	6642993	158863	168702	rs587783739	NC_000008.11:6642992:G:C	G	C	CLINICAL
NM_153704.6(TMEM67):c.1843T>C (p.Cys615Arg)	TMEM67	C615R, C534R	Normal	Meckel-Gruber syndrome|Joubert syndrome|Nephronophthisis|not provided|Nephronophthisis 11|TMEM67-Related Disorders|Inborn genetic diseases|Joubert syndrome 6|RHYNS syndrome|Kidney damage|Infantile muscular hypotonia|Absent speech|Nystagmus|Intellectual disability, severe|Barrel-shaped chest|Visual impairment|Peritonitis|Cerebellar malformation|Pancreatitis|Cerebellar vermis hypoplasia|Tremor|Global developmental delay|Congenital ocular coloboma|Oligohydramnios|Renal cyst|Joubert syndrome|Bardet-Biedl syndrome 14|Meckel syndrome, type 3|Joubert syndrome 6|Joubert syndrome with hepatic defect|Nephronophthisis 11	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001383	8	94808198	8	93795970	1383	16422	rs201893408	NC_000008.11:93795969:T:C	T	C	CLINICAL
NM_153704.6(TMEM67):c.2498T>C (p.Ile833Thr)	TMEM67	I833T, I752T	Normal	Joubert syndrome with hepatic defect|RHYNS syndrome|Meckel syndrome, type 3|Joubert syndrome 6|Nephronophthisis 11|Bardet-Biedl syndrome 14|Meckel syndrome, type 3|Joubert syndrome 6|Meckel-Gruber syndrome|Joubert syndrome|not provided|Joubert syndrome with hepatic defect	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001378	8	94821126	8	93808898	1378	16417	rs267607119	NC_000008.11:93808897:T:C	T	C	CLINICAL
NM_014754.3(PTDSS1):c.794T>C (p.Leu265Pro)	PTDSS1	L265P, L119P	Normal	Lenz-Majewski hyperostosis syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097036	8	97316309	8	96304081	97036	102941	rs587777090	NC_000008.11:96304080:T:C	T	C	CLINICAL
NM_017890.4(VPS13B):c.9406-1G>C	VPS13B		Normal	Cohen syndrome	Pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000189197	8	100844596	8	99832368	189197	187088	rs386834119	NC_000008.11:99832367:G:C	G	C	CLINICAL
NM_152419.3(HGSNAT):c.372-2A>G	HGSNAT		Normal	Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001236	8	43014064	8	43158921	1236	16275	rs483352896	NC_000008.11:43158920:A:G	A	G	CLINICAL
NM_152419.3(HGSNAT):c.744-2A>G	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000555096	8	43027451	8	43172308	555096	544774	rs762402992	NC_000008.11:43172307:A:G	A	G	CLINICAL
NM_152419.3(HGSNAT):c.962T>G (p.Leu321Ter)	HGSNAT	L321*, L33*	Normal	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Nov 1, 2006)	no assertion criteria provided	VCV000001233	8	43033327	8	43178184	1233	16272	rs121908283	NC_000008.11:43178183:T:G	T	G	CLINICAL
NM_152419.3(HGSNAT):c.1542+2T>G	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000556118	8	43052170	8	43197027	556118	544789	rs1554537613	NC_000008.11:43197026:T:G	T	G	CLINICAL
NM_152419.3(HGSNAT):c.1674C>G (p.Tyr558Ter)	HGSNAT	Y558*, Y587*, Y270*, Y494*	Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000553553	8	43053043	8	43197900	553553	544792	rs1554537841	NC_000008.11:43197899:C:G	C	G	CLINICAL
NM_000025.3(ADRB3):c.190T>C (p.Trp64Arg)	ADRB3	W64R	Normal	Obesity	risk factor(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000017741	8	37823798	8	37966280	17741	32780	rs4994	NC_000008.11:37966279:A:G	A	G	CLINICAL
NM_003184.4(TAF2):c.1945T>C (p.Trp649Arg)	TAF2	W649R	Normal	Mental retardation, autosomal recessive 40	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000092249	8	120795788	8	119783548	92249	98160	rs398124645	NC_000008.11:119783547:A:G	A	G	CLINICAL
NM_001282534.2(KCNK9):c.706G>C (p.Gly236Arg)	KCNK9	G236R	Normal	Birk-Barel syndrome	Pathogenic(Last reviewed: Dec 12, 2016)	no assertion criteria provided	VCV000397636	8	140630920	8	139618677	397636	384602	rs121908332	NC_000008.11:139618676:C:G	C	G	CLINICAL
NM_001160372.4(TRAPPC9):c.2557-2A>C	TRAPPC9		Normal	Mental retardation, autosomal recessive 13	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000041419	8	141034178	8	140024081	41419	49854	rs1587520018	NC_000008.11:140024080:T:G	T	G	CLINICAL
NM_018941.3(CLN8):c.70C>G (p.Arg24Gly)	CLN8	R24G	Normal	Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 8|Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002802	8	1719290	8	1771124	2802	17841	rs104894064	NC_000008.11:1771123:C:G	C	G	CLINICAL
NM_004674.5(ASH2L):c.1726A>G (p.Ile576Val)	ASH2L	I482V, I437V, I449V, I576V	Normal	Intellectual disability|Global developmental delay	Likely pathogenic	criteria provided, single submitter	VCV000402148	8	37996340	8	38138822	402148	389134	rs1060499744	NC_000008.11:38138821:A:G	A	G	CLINICAL
NM_004056.6(CA8):c.298T>C (p.Ser100Pro)	CA8	S100P	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000017604	8	61178603	8	60266044	17604	32643	rs267606695	NC_000008.11:60266043:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.1170T>G (p.Tyr390Ter)	CHD7	Y390*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379836	8	61655161	8	60742602	379836	371928	rs554737227	NC_000008.11:60742601:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.2643T>G (p.Tyr881Ter)	CHD7	Y881*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158284	8	61732595	8	60820036	158284	168601	rs587783433	NC_000008.11:60820035:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.2915A>G (p.Gln972Arg)	CHD7	Q972R	Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488372	8	61734662	8	60822103	488372	481215	rs1554597512	NC_000008.11:60822102:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.3082A>G (p.Ile1028Val)	CHD7	I1028V	Normal	CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association|not provided	Pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000002022	8	61735186	8	60822627	2022	17061	rs121434338	NC_000008.11:60822626:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.3202-3T>G	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Nov 30, 2016)	criteria provided, single submitter	VCV000411184	8	61736396	8	60823837	411184	396262	rs1060503183	NC_000008.11:60823836:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.3768C>G (p.Tyr1256Ter)	CHD7	Y1256*	Normal	CHARGE association	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000241192	8	61743126	8	60830567	241192	240395	rs878855032	NC_000008.11:60830566:C:G	C	G	CLINICAL
NM_017780.4(CHD7):c.3770T>G (p.Leu1257Arg)	CHD7	L1257R	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002023	8	61743128	8	60830569	2023	17062	rs121434339	NC_000008.11:60830568:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.4195A>G (p.Arg1399Gly)	CHD7	R1399G	Normal	CHARGE association	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802409	8	61750236	8	60837677	802409	790809	rs1586419356	NC_000008.11:60837676:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.4247C>G (p.Thr1416Arg)	CHD7	T1416R	Normal	not provided|CHARGE association	Likely pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391856	8	61750288	8	60837729	391856	370299	rs770166812	NC_000008.11:60837728:C:G	C	G	CLINICAL
NM_017780.4(CHD7):c.4353+3A>G	CHD7		Normal	CHARGE association|not provided	Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158295	8	61750397	8	60837838	158295	168610	rs587783441	NC_000008.11:60837837:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.5210+3A>G	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547193	8	61757971	8	60845412	547193	537833	rs1554602588	NC_000008.11:60845411:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.5238C>G (p.Tyr1746Ter)	CHD7	Y1746*	Normal	CHARGE association	Pathogenic(Last reviewed: Mar 25, 2017)	criteria provided, single submitter	VCV000459551	8	61761101	8	60848542	459551	458496	rs1554603151	NC_000008.11:60848541:C:G	C	G	CLINICAL
NM_017780.4(CHD7):c.5405-2A>G	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	VCV000430832	8	61763050	8	60850491	430832	424375	rs1131692153	NC_000008.11:60850490:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.5409T>G (p.Tyr1803Ter)	CHD7	Y1803*	Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488370	8	61763056	8	60850497	488370	481222	rs1021645395	NC_000008.11:60850496:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.5418C>G (p.Tyr1806Ter)	CHD7	Y1806*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002024	8	61763065	8	60850506	2024	17063	rs121434340	NC_000008.11:60850505:C:G	C	G	CLINICAL
NM_017780.4(CHD7):c.5450T>G (p.Phe1817Cys)	CHD7	F1817C	Normal	CHARGE association	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158301	8	61763097	8	60850538	158301	168617	rs587783445	NC_000008.11:60850537:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.5706C>G (p.Tyr1902Ter)	CHD7	Y1902*	Normal	CHARGE association	Pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000431034	8	61764618	8	60852059	431034	424563	rs1131692325	NC_000008.11:60852058:C:G	C	G	CLINICAL
NM_017780.4(CHD7):c.6287A>G (p.His2096Arg)	CHD7	H2096R	Normal	CHARGE association	Likely pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158309	8	61765571	8	60853012	158309	168625	rs587783451	NC_000008.11:60853011:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.6937-2A>G	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000651945	8	61768532	8	60855973	651945	651795	rs1586451506	NC_000008.11:60855972:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.7165-4A>G	CHD7		Normal	CHARGE association	Pathogenic(Last reviewed: Sep 19, 2017)	no assertion criteria provided	VCV000444870	8	61769000	8	60856441	444870	438510	rs1554604915	NC_000008.11:60856440:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.7312C>G (p.Gln2438Glu)	CHD7	Q2438E	Normal	CHARGE association	Likely pathogenic(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000626218	8	61769151	8	60856592	626218	614514	rs1060503188	NC_000008.11:60856591:C:G	C	G	CLINICAL
NM_017780.4(CHD7):c.7763A>G (p.Asn2588Ser)	CHD7	N2588S	Normal	CHARGE association	Likely pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000459563	8	61773617	8	60861058	459563	458501	rs1554606033	NC_000008.11:60861057:A:G	A	G	CLINICAL
NM_017780.4(CHD7):c.7824T>G (p.Tyr2608Ter)	CHD7	Y2608*	Normal	CHARGE association	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000655421	8	61773678	8	60861119	655421	637349	rs1586460329	NC_000008.11:60861118:T:G	T	G	CLINICAL
NM_017780.4(CHD7):c.8063T>G (p.Ile2688Arg)	CHD7	I2688R, I639R	Normal	CHARGE association	Likely pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000374318	8	61775198	8	60862639	374318	361191	rs755066542	NC_000008.11:60862638:T:G	T	G	CLINICAL
NM_024596.5(MCPH1):c.74C>G (p.Ser25Ter)	MCPH1	S25*, S23*	Normal	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000003454	8	6266851	8	6409330	3454	18493	rs121434305	NC_000008.11:6409329:C:G	C	G	CLINICAL
NM_024596.5(MCPH1):c.80C>G (p.Thr27Arg)	MCPH1	T27R, T25R	Normal	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000021704	8	6266857	8	6409336	21704	34556	rs199422124	NC_000008.11:6409335:C:G	C	G	CLINICAL
NM_024596.5(MCPH1):c.147C>G (p.His49Gln)	MCPH1	H49Q, H15Q, H47Q	Normal	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030640	8	6272318	8	6414797	30640	39597	rs1488084787	NC_000008.11:6414796:C:G	C	G	CLINICAL
NM_024596.5(MCPH1):c.302C>G (p.Ser101Ter)	MCPH1	S101*, S67*, S99*	Normal	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000030642	8	6289088	8	6431567	30642	39599	rs755862917	NC_000008.11:6431566:C:G	C	G	CLINICAL
NM_024596.5(MCPH1):c.1625T>G (p.Leu542Ter)	MCPH1	L542*, L540*, L494*, L508*	Normal	not provided|Primary autosomal recessive microcephaly 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586140	8	6302868	8	6445347	586140	577066	rs748011724	NC_000008.11:6445346:T:G	T	G	CLINICAL
NM_024596.5(MCPH1):c.1974-2A>G	MCPH1		Normal	Primary autosomal recessive microcephaly 1|not provided	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420681	8	6338233	8	6480712	420681	407440	rs541042265	NC_000008.11:6480711:A:G	A	G	CLINICAL
NM_017866.6(TMEM70):c.317-2A>G	TMEM70		Normal	not provided|Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000540	8	74893388	8	73981153	540	15579	rs183973249	NC_000008.11:73981152:A:G	A	G	CLINICAL
NM_000067.3(CA2):c.120T>G (p.Tyr40Ter)	CA2	Y40*	Normal	Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Jan 1, 1995)	no assertion criteria provided	VCV000000919	8	86377586	8	85465357	919	15958	rs118203934	NC_000008.11:85465356:T:G	T	G	CLINICAL
NM_016023.5(OTUD6B):c.83-2A>G	OTUD6B		Normal	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Dysmorphic features|Intellectual disability|Epilepsy	Pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000375703	8	92083364	8	91071136	375703	362593	rs1064797102	NC_000008.11:91071135:A:G	A	G	CLINICAL
NM_016023.5(OTUD6B):c.557A>G (p.Tyr186Cys)	OTUD6B	Y85C, Y186C	Normal	Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Dysmorphic features|Intellectual disability|Epilepsy	Likely pathogenic(Last reviewed: Jan 9, 2017)	criteria provided, single submitter	VCV000375704	8	92090825	8	91078597	375704	362594	rs1064797103	NC_000008.11:91078596:A:G	A	G	CLINICAL
NM_153704.6(TMEM67):c.313-3T>G	TMEM67		Normal	Joubert syndrome 6	Likely pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000692261	8	94770708	8	93758480	692261	680065	rs1586336362	NC_000008.11:93758479:T:G	T	G	CLINICAL
NM_152416.4(NDUFAF6):c.841C>G (p.Pro281Ala)	NDUFAF6	P281A, P189A, P129A, P170A, P229A	Normal	Developmental regression	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523560	8	96064426	8	95052198	523560	513981	rs1224421127	NC_000008.11:95052197:C:G	C	G	CLINICAL
NM_014754.3(PTDSS1):c.1058A>G (p.Gln353Arg)	PTDSS1	Q353R, Q207R	Normal	Lenz-Majewski hyperostosis syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097034	8	97321835	8	96309607	97034	102939	rs587777088	NC_000008.11:96309606:A:G	A	G	CLINICAL
NM_152419.3(HGSNAT):c.607C>T (p.Arg203Ter)	HGSNAT	R203*	Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Sanfilippo syndrome	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569138	8	43024359	8	43169216	569138	562427	rs1563366896	NC_000008.11:43169215:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.848C>T (p.Pro283Leu)	HGSNAT	P283L	Normal	Retinal dystrophy|Mucopolysaccharidosis, MPS-III-C|not provided|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001232	8	43028883	8	43173740	1232	16271	rs121908282	NC_000008.11:43173739:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.851+1G>T	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000557165	8	43028887	8	43173744	557165	544826	rs1554532283	NC_000008.11:43173743:G:T	G	T	CLINICAL
NM_152419.3(HGSNAT):c.1030C>T (p.Arg344Cys)	HGSNAT	R344C, R280C, R56C	Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001237	8	43037305	8	43182162	1237	16276	rs121908285	NC_000008.11:43182161:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.1048C>T (p.Gln350Ter)	HGSNAT	Q350*, Q286*, Q62*	Normal	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638471	8	43037323	8	43182180	638471	626178	rs752939204	NC_000008.11:43182179:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.1102A>T (p.Lys368Ter)	HGSNAT	K368*, K80*, K304*	Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373465	8	43037377	8	43182234	373465	359858	rs954238515	NC_000008.11:43182233:A:T	A	T	CLINICAL
NM_152419.3(HGSNAT):c.1129-2A>T	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000554389	8	43046615	8	43191472	554389	544833	rs749568919	NC_000008.11:43191471:A:T	A	T	CLINICAL
NM_152419.3(HGSNAT):c.1150C>T (p.Arg384Ter)	HGSNAT	R384*, R96*, R320*	Normal	Mucopolysaccharidosis, MPS-III-C|Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Sanfilippo syndrome	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000549921	8	43046638	8	43191495	549921	544423	rs775078211	NC_000008.11:43191494:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.1360C>T (p.Gln454Ter)	HGSNAT	Q454*, Q390*, Q166*	Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000374408	8	43047556	8	43192413	374408	361294	rs1057518644	NC_000008.11:43192412:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.1516C>T (p.Arg506Ter)	HGSNAT	R506*, R218*, R535*, R442*	Normal	Mucopolysaccharidosis, MPS-III-C|Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|not provided	Pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552134	8	43052142	8	43196999	552134	544843	rs747240928	NC_000008.11:43196998:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.1553C>T (p.Ser518Phe)	HGSNAT	S518F, S230F, S454F, S547F	Normal	Mucopolysaccharidosis, MPS-III-C	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000001238	8	43052825	8	43197682	1238	16277	rs121908286	NC_000008.11:43197681:C:T	C	T	CLINICAL
NM_152419.3(HGSNAT):c.1614-2A>T	HGSNAT		Normal	Mucopolysaccharidosis, MPS-III-C	Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000556780	8	43052981	8	43197838	556780	544447	rs1554537807	NC_000008.11:43197837:A:T	A	T	CLINICAL
NM_152419.3(HGSNAT):c.1622C>T (p.Ser541Leu)	HGSNAT	S541L, S477L, S253L, S570L	Normal	Retinitis pigmentosa 73|Mucopolysaccharidosis, MPS-III-C|Retinal dystrophy|Mucopolysaccharidosis, MPS-III-C	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000569073	8	43052991	8	43197848	569073	567933	rs756310864	NC_000008.11:43197847:C:T	C	T	CLINICAL
NM_017890.4(VPS13B):c.1219C>T (p.Gln407Ter)	VPS13B	Q407*	Normal	not provided|Cohen syndrome|Unsteady gait|Intellectual disability|Global developmental delay|Generalized joint laxity|Microcephaly|Muscular hypotonia|Carious teeth|Attention deficit hyperactivity disorder	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056645	8	100146872	8	99134644	56645	71284	rs386834070	NC_000008.11:99134643:C:T	C	T	CLINICAL
NM_001385.3(DPYS):c.905G>A (p.Arg302Gln)	DPYS	R302Q	Normal	Dihydropyrimidinase deficiency	Likely pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000631543	8	105441818	8	104429590	631543	619920	rs200913682	NC_000008.11:104429589:C:T	C	T	CLINICAL
NM_001715.2(BLK):c.*505G>T	BLK		Normal	Maturity-onset diabetes of the young, type 11	Pathogenic(Last reviewed: Aug 25, 2009)	no assertion criteria provided	VCV000012323	8	11422122	8	11564613	12323	27362	rs886037621	NC_000008.11:11564612:G:T	G	T	CLINICAL
NM_000553.6(WRN):c.3913C>T (p.Arg1305Ter)	WRN	R1305*	Normal	Werner syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005444	8	31014977	8	31157461	5444	20483	rs121908446	NC_000008.11:31157460:C:T	C	T	CLINICAL
NM_023110.2(FGFR1):c.1604T>A (p.Met535Lys)	FGFR1	M535K, M525K, M531K, M533K, M566K, M442K, M444K, M446K	Normal	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000496784	8	38274883	8	38417365	496784	488207	rs1554551667	NC_000008.11:38417364:A:T	A	T	CLINICAL
NM_023110.2(FGFR1):c.1460G>A (p.Gly487Asp)	FGFR1	G487D, G394D, G477D, G483D, G396D, G398D, G485D, G518D	Normal	Hartsfield syndrome|Hypogonadotropic hypogonadism 2 with or without anosmia	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000132647	8	38275480	8	38417962	132647	136395	rs515726224	NC_000008.11:38417961:C:T	C	T	CLINICAL
NM_000553.6(WRN):c.1105C>T (p.Arg369Ter)	WRN	R369*	Normal	not provided|Medulloblastoma|Werner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005449	8	30938648	8	31081132	5449	20488	rs17847577	NC_000008.11:31081131:C:T	C	T	CLINICAL
NM_173851.3(SLC30A8):c.973C>T (p.Arg325Trp)	SLC30A8	R325W, R276W	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jun 1, 2007)	no assertion criteria provided	VCV000001000	8	118184783	8	117172544	1000	16039	rs13266634	NC_000008.11:117172543:C:T	C	T	CLINICAL
NM_003301.7(TRHR):c.49C>T (p.Arg17Ter)	TRHR	R17*	Normal	Hypothyroidism, congenital, nongoitrous, 7	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000012682	8	110099790	8	109087561	12682	27721	rs121917847	NC_000008.11:109087560:C:T	C	T	CLINICAL
NM_001282534.2(KCNK9):c.706G>A (p.Gly236Arg)	KCNK9	G236R	Normal	not provided|Birk-Barel syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004741	8	140630920	8	139618677	4741	19780	rs121908332	NC_000008.11:139618676:C:T	C	T	CLINICAL
NM_001960.6(EEF1D):c.-7-2282G>A	EEF1D	W316*	Normal	Autosomal recessive non-syndromic intellectual disability	Pathogenic(Last reviewed: Sep 26, 2018)	no assertion criteria provided	VCV000599374	8	144671304	8	143589134	599374	590712	rs1563978827	NC_000008.11:143589133:C:T	C	T	CLINICAL
NM_078480.3(PUF60):c.389G>A (p.Arg130His)	PUF60	R130H, R101H, R129H, R87H, R150H, R70H, R112H, R113H, R167H, R84H	Normal	CHARGE association|Verheij syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488376	8	144900664	8	143818494	488376	481211	rs1554643584	NC_000008.11:143818493:C:T	C	T	CLINICAL
NM_006765.4(TUSC3):c.163C>T (p.Gln55Ter)	TUSC3	Q55*	Normal	Mental retardation, autosomal recessive 7	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000030177	8	15480613	8	15623104	30177	39133	rs387906804	NC_000008.11:15623103:C:T	C	T	CLINICAL
NM_018941.3(CLN8):c.610C>T (p.Arg204Cys)	CLN8	R204C	Normal	Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant|Neuronal ceroid lipofuscinosis 8|Neuronal ceroid lipofuscinosis|Neuronal ceroid lipofuscinosis 8	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002804	8	1728482	8	1780316	2804	17843	rs104894060	NC_000008.11:1780315:C:T	C	T	CLINICAL
NM_001693.4(ATP6V1B2):c.1516C>T (p.Arg506Ter)	ATP6V1B2	R506*	Normal	Deafness, congenital, with onychodystrophy, autosomal dominant	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000203442	8	20077893	8	20220382	203442	199855	rs794729667	NC_000008.11:20220381:C:T	C	T	CLINICAL
NM_032509.4(MAK16):c.*1814A>T	TTI2|MAK16	I436N, I405N	Normal	Mental retardation, autosomal recessive 39	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000088868	8	33357961	8	33500443	88868	94437	rs398122367	NC_000008.11:33500442:A:T	A	T	CLINICAL
NM_004056.6(CA8):c.710G>A (p.Arg237Gln)	CA8	R237Q, R205Q	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000029620	8	61135236	8	60222677	29620	38574	rs387906598	NC_000008.11:60222676:C:T	C	T	CLINICAL
NM_004056.6(CA8):c.100+1G>A	CA8		Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3	Likely pathogenic(Last reviewed: Aug 25, 2018)	no assertion criteria provided	VCV000560540	8	61193606	8	60281047	560540	551618	rs1563390893	NC_000008.11:60281046:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.469C>T (p.Arg157Ter)	CHD7	R157*	Normal	not provided|CHARGE association|not specified	Pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195321	8	61654460	8	60741901	195321	192482	rs794727293	NC_000008.11:60741900:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.496C>T (p.Gln166Ter)	CHD7	Q166*	Normal	CHARGE association	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000267414	8	61654487	8	60741928	267414	262639	rs886040978	NC_000008.11:60741927:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.511C>T (p.Gln171Ter)	CHD7	Q171*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Aug 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620120	8	61654502	8	60741943	620120	611702	rs1563560018	NC_000008.11:60741942:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.538C>T (p.Gln180Ter)	CHD7	Q180*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000618017	8	61654529	8	60741970	618017	609700	rs1563560149	NC_000008.11:60741969:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.604C>T (p.Gln202Ter)	CHD7	Q202*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000459557	8	61654595	8	60742036	459557	458971	rs1554581277	NC_000008.11:60742035:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.862C>T (p.Gln288Ter)	CHD7	Q288*	Normal	CHARGE association	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547189	8	61654853	8	60742294	547189	537829	rs1554581399	NC_000008.11:60742293:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.889C>T (p.Gln297Ter)	CHD7	Q297*	Normal	CHARGE association	Pathogenic(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000661514	8	61654880	8	60742321	661514	637309	rs1586249808	NC_000008.11:60742320:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.925C>T (p.Gln309Ter)	CHD7	Q309*	Normal	CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488371	8	61654916	8	60742357	488371	481212	rs1436515577	NC_000008.11:60742356:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.1246G>T (p.Gly416Ter)	CHD7	G416*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158278	8	61655237	8	60742678	158278	168593	rs587783428	NC_000008.11:60742677:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.1300C>T (p.Gln434Ter)	CHD7	Q434*	Normal	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000653661	8	61655291	8	60742732	653661	637313	rs1586251038	NC_000008.11:60742731:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.1312C>T (p.Gln438Ter)	CHD7	Q438*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000529121	8	61655303	8	60742744	529121	524254	rs1554581657	NC_000008.11:60742743:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.1480C>T (p.Arg494Ter)	CHD7	R494*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000158279	8	61655471	8	60742912	158279	168594	rs587783429	NC_000008.11:60742911:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.1513C>T (p.Gln505Ter)	CHD7	Q505*	Normal	Retinal coloboma|Pulmonary artery atresia|Chorioretinal coloboma|Hearing impairment|CHARGE association	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523521	8	61655504	8	60742945	523521	513977	rs1554581757	NC_000008.11:60742944:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.1552C>T (p.Gln518Ter)	CHD7	Q518*	Normal	CHARGE association	Pathogenic	no assertion criteria provided	VCV000375575	8	61655543	8	60742984	375575	362385	rs1057519423	NC_000008.11:60742983:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.1735C>T (p.Gln579Ter)	CHD7	Q579*	Normal	CHARGE association	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000459542	8	61693628	8	60781069	459542	458486	rs780953224	NC_000008.11:60781068:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.2215G>T (p.Glu739Ter)	CHD7	E739*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267419	8	61707663	8	60795104	267419	262644	rs886040981	NC_000008.11:60795103:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.2257C>T (p.Gln753Ter)	CHD7	Q753*	Normal	not specified|CHARGE association	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000660551	8	61712965	8	60800406	660551	637319	rs1586350727	NC_000008.11:60800405:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.2440C>T (p.Gln814Ter)	CHD7	Q814*	Normal	CHARGE association	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000488369	8	61714150	8	60801591	488369	481214	rs1554593049	NC_000008.11:60801590:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.2501C>T (p.Ser834Phe)	CHD7	S834F	Normal	Hypogonadotropic hypogonadism 5 without anosmia|CHARGE association	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002033	8	61728948	8	60816389	2033	17072	rs121434344	NC_000008.11:60816388:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.2572C>T (p.Arg858Ter)	CHD7	R858*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000620086	8	61729019	8	60816460	620086	611703	rs1563625351	NC_000008.11:60816459:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.2815G>T (p.Glu939Ter)	CHD7	E939*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158285	8	61734466	8	60821907	158285	168602	rs587783434	NC_000008.11:60821906:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.2836-2A>T	CHD7		Normal	not provided|CHARGE association	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000241191	8	61734581	8	60822022	241191	240394	rs878855031	NC_000008.11:60822021:A:T	A	T	CLINICAL
NM_017780.4(CHD7):c.2839C>T (p.Arg947Ter)	CHD7	R947*	Normal	not provided|CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095781	8	61734586	8	60822027	95781	101678	rs200220845	NC_000008.11:60822026:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.2959C>T (p.Arg987Ter)	CHD7	R987*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267421	8	61735063	8	60822504	267421	262646	rs886040983	NC_000008.11:60822503:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3106C>T (p.Arg1036Ter)	CHD7	R1036*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488373	8	61735210	8	60822651	488373	481216	rs1554597716	NC_000008.11:60822650:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3205C>T (p.Arg1069Ter)	CHD7	R1069*	Normal	not provided|CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000267423	8	61736402	8	60823843	267423	262648	rs886040985	NC_000008.11:60823842:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3241A>T (p.Ile1081Phe)	CHD7	I1081F	Normal	Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267424	8	61736438	8	60823879	267424	262649	rs768184220	NC_000008.11:60823878:A:T	A	T	CLINICAL
NM_017780.4(CHD7):c.3379G>T (p.Glu1127Ter)	CHD7	E1127*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000573842	8	61741222	8	60828663	573842	565194	rs1563636399	NC_000008.11:60828662:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.3412C>T (p.Gln1138Ter)	CHD7	Q1138*	Normal	CHARGE association	Pathogenic(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000548946	8	61741255	8	60828696	548946	539430	rs1554599035	NC_000008.11:60828695:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3490C>T (p.Gln1164Ter)	CHD7	Q1164*	Normal	CHARGE association	Pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000459546	8	61741333	8	60828774	459546	458489	rs1554599065	NC_000008.11:60828773:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3526C>T (p.Gln1176Ter)	CHD7	Q1176*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, single submitter	VCV000267425	8	61742884	8	60830325	267425	262650	rs886040986	NC_000008.11:60830324:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3655C>T (p.Arg1219Ter)	CHD7	R1219*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279759	8	61743013	8	60830454	279759	264411	rs372174845	NC_000008.11:60830453:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.3811G>T (p.Glu1271Ter)	CHD7	E1271*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000002028	8	61748664	8	60836105	2028	17067	rs121434342	NC_000008.11:60836104:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.4318C>T (p.Gln1440Ter)	CHD7	Q1440*	Normal	CHARGE association	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158294	8	61750359	8	60837800	158294	168609	rs587783440	NC_000008.11:60837799:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.4393C>T (p.Arg1465Ter)	CHD7	R1465*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000267430	8	61750674	8	60838115	267430	262655	rs886040991	NC_000008.11:60838114:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.4480C>T (p.Arg1494Ter)	CHD7	R1494*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158296	8	61750761	8	60838202	158296	168611	rs587783442	NC_000008.11:60838201:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.4795C>T (p.Gln1599Ter)	CHD7	Q1599*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	VCV000002038	8	61754556	8	60841997	2038	17077	rs267606724	NC_000008.11:60841996:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.5023C>T (p.Gln1675Ter)	CHD7	Q1675*	Normal	CHARGE association	Pathogenic(Last reviewed: Mar 2, 2015)	criteria provided, single submitter	VCV000210719	8	61757595	8	60845036	210719	207558	rs797045467	NC_000008.11:60845035:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.5029C>T (p.Arg1677Ter)	CHD7	R1677*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Apr 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000279762	8	61757601	8	60845042	279762	264397	rs777652245	NC_000008.11:60845041:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.5428C>T (p.Arg1810Ter)	CHD7	R1810*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000459555	8	61763075	8	60850516	459555	458975	rs1554603552	NC_000008.11:60850515:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.5458C>T (p.Arg1820Ter)	CHD7	R1820*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158302	8	61763105	8	60850546	158302	168618	rs587783446	NC_000008.11:60850545:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.5551G>T (p.Glu1851Ter)	CHD7	E1851*	Normal	CHARGE association	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158303	8	61763607	8	60851048	158303	168619	rs587783447	NC_000008.11:60851047:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.5833C>T (p.Arg1945Ter)	CHD7	R1945*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000267434	8	61764745	8	60852186	267434	262659	rs757160222	NC_000008.11:60852185:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.5944G>T (p.Gly1982Trp)	CHD7	G1982W	Normal	CHARGE association	Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000626914	8	61765106	8	60852547	626914	615267	rs1563659678	NC_000008.11:60852546:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter)	CHD7	R2024*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547195	8	61765232	8	60852673	547195	537835	rs1360515765	NC_000008.11:60852672:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6079C>T (p.Arg2027Ter)	CHD7	R2027*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267435	8	61765241	8	60852682	267435	262660	rs886040995	NC_000008.11:60852681:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6148C>T (p.Arg2050Ter)	CHD7	R2050*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Apr 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000267436	8	61765432	8	60852873	267436	262661	rs886040996	NC_000008.11:60852872:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6157C>T (p.Arg2053Ter)	CHD7	R2053*	Normal	not provided|CHARGE association|Hypogonadotropic hypogonadism 5 with or without anosmia|CHARGE association	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158307	8	61765441	8	60852882	158307	168623	rs587783450	NC_000008.11:60852881:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6199C>T (p.Gln2067Ter)	CHD7	Q2067*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488803	8	61765483	8	60852924	488803	481823	rs766862122	NC_000008.11:60852923:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6292C>T (p.Arg2098Ter)	CHD7	R2098*	Normal	not provided|CHARGE association|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000226115	8	61765576	8	60853017	226115	227917	rs875989879	NC_000008.11:60853016:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6850C>T (p.Arg2284Ter)	CHD7	R2284*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158313	8	61766996	8	60854437	158313	168629	rs587783454	NC_000008.11:60854436:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.6955C>T (p.Arg2319Cys)	CHD7	R2319C	Normal	CHARGE association	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235889	8	61768552	8	60855993	235889	237524	rs121434341	NC_000008.11:60855992:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7132G>T (p.Glu2378Ter)	CHD7	E2378*	Normal	CHARGE association	Pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000529132	8	61768729	8	60856170	529132	524267	rs878975068	NC_000008.11:60856169:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.7222G>T (p.Glu2408Ter)	CHD7	E2408*	Normal	CHARGE association	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000619296	8	61769061	8	60856502	619296	610694	rs1341064149	NC_000008.11:60856501:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.7246A>T (p.Lys2416Ter)	CHD7	K2416*	Normal	CHARGE association	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802412	8	61769085	8	60856526	802412	790812	rs1586452965	NC_000008.11:60856525:A:T	A	T	CLINICAL
NM_017780.4(CHD7):c.7252C>T (p.Arg2418Ter)	CHD7	R2418*	Normal	CHARGE association|not specified|not provided	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158314	8	61769091	8	60856532	158314	168630	rs587783455	NC_000008.11:60856531:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7282C>T (p.Arg2428Ter)	CHD7	R2428*	Normal	CHARGE association	Pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523619	8	61769121	8	60856562	523619	514270	rs1320897198	NC_000008.11:60856561:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7285G>T (p.Glu2429Ter)	CHD7	E2429*	Normal	CHARGE association	Pathogenic(Last reviewed: Oct 18, 2016)	criteria provided, single submitter	VCV000411189	8	61769124	8	60856565	411189	396545	rs773047607	NC_000008.11:60856564:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.7312C>T (p.Gln2438Ter)	CHD7	Q2438*	Normal	CHARGE association	Pathogenic(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000411190	8	61769151	8	60856592	411190	396674	rs1060503188	NC_000008.11:60856591:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7648G>T (p.Glu2550Ter)	CHD7	E2550*	Normal	CHARGE association	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547196	8	61773502	8	60860943	547196	537836	rs1554605973	NC_000008.11:60860942:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.7879C>T (p.Arg2627Ter)	CHD7	R2627*, R578*	Normal	CHARGE association|not provided	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418655	8	61774803	8	60862244	418655	407437	rs1064793346	NC_000008.11:60862243:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7891C>T (p.Arg2631Ter)	CHD7	R2631*, R582*	Normal	CHARGE association|none provided|not provided	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158320	8	61774815	8	60862256	158320	168636	rs587783457	NC_000008.11:60862255:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7957C>T (p.Arg2653Ter)	CHD7	R2653*, R604*	Normal	Inborn genetic diseases|CHARGE association|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158321	8	61774881	8	60862322	158321	168637	rs587783458	NC_000008.11:60862321:C:T	C	T	CLINICAL
NM_017780.4(CHD7):c.7971+1G>T	CHD7		Normal	CHARGE association	Likely pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000529117	8	61774896	8	60862337	529117	523672	rs1554606274	NC_000008.11:60862336:G:T	G	T	CLINICAL
NM_017780.4(CHD7):c.8023G>T (p.Glu2675Ter)	CHD7	E2675*, E626*	Normal	not provided|CHARGE association	Pathogenic(Last reviewed: Jul 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000504190	8	61775158	8	60862599	504190	495395	rs748504264	NC_000008.11:60862598:G:T	G	T	CLINICAL
NM_024596.5(MCPH1):c.215C>T (p.Ser72Leu)	MCPH1	S72L, S38L, S70L	Normal	Primary autosomal recessive microcephaly 1	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000030641	8	6272386	8	6414865	30641	39598	rs387906961	NC_000008.11:6414864:C:T	C	T	CLINICAL
NM_017866.6(TMEM70):c.238C>T (p.Arg80Ter)	TMEM70	R80*	Normal	Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 2|not provided	Pathogenic(Last reviewed: Feb 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030958	8	74891018	8	73978783	30958	39915	rs387907070	NC_000008.11:73978782:C:T	C	T	CLINICAL
NM_000067.3(CA2):c.319C>T (p.His107Tyr)	CA2	H107Y	Normal	Osteopetrosis with renal tubular acidosis	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000000916	8	86386008	8	85473779	916	15955	rs118203933	NC_000008.11:85473778:C:T	C	T	CLINICAL
NM_016023.5(OTUD6B):c.343C>T (p.Arg115Ter)	OTUD6B	R14*, R115*	Normal	not provided|Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies|Dysmorphic features|Intellectual disability|Epilepsy|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000375701	8	92090611	8	91078383	375701	362591	rs368313959	NC_000008.11:91078382:C:T	C	T	CLINICAL
NM_153704.6(TMEM67):c.622A>T (p.Arg208Ter)	TMEM67	R208*, R127*	Normal	Meckel-Gruber syndrome|Joubert syndrome|Meckel syndrome, type 3|Joubert syndrome 6|RHYNS syndrome|not provided|TMEM67-Related Disorders	Pathogenic(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001376	8	94777845	8	93765617	1376	16415	rs137853108	NC_000008.11:93765616:A:T	A	T	CLINICAL
NM_153704.6(TMEM67):c.1321C>T (p.Arg441Cys)	TMEM67	R360C, R441C	Normal	Joubert syndrome 6|Joubert syndrome|Renal cyst|Oligohydramnios|Global developmental delay|Congenital ocular coloboma|Absent speech|Cerebellar malformation|Nystagmus|Pancreatitis|Infantile muscular hypotonia|Intellectual disability, severe|Barrel-shaped chest|Tremor|Visual impairment|Peritonitis|Kidney damage|Cerebellar vermis hypoplasia|Inborn genetic diseases|Nephronophthisis 11|Joubert syndrome with hepatic defect|Joubert syndrome 6|Bardet-Biedl syndrome 14|Meckel syndrome, type 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217725	8	94798483	8	93786255	217725	214282	rs752362727	NC_000008.11:93786254:C:T	C	T	CLINICAL
NM_014754.3(PTDSS1):c.805C>T (p.Pro269Ser)	PTDSS1	P269S, P123S	Normal	Lenz-Majewski hyperostosis syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000097035	8	97316320	8	96304092	97035	102940	rs587777089	NC_000008.11:96304091:C:T	C	T	CLINICAL
NM_017890.4(VPS13B):c.1219C>T (p.Gln407Ter)	VPS13B	Q407*	Normal	not provided|Cohen syndrome|Unsteady gait|Intellectual disability|Global developmental delay|Generalized joint laxity|Microcephaly|Muscular hypotonia|Carious teeth|Attention deficit hyperactivity disorder	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000056645	8	100146872	8	99134644	56645	71284	rs386834070	NC_000008.11:99134643:C:T	C	T	CLINICAL
NM_017890.4(VPS13B):c.11314C>T (p.Gln3772Ter)	VPS13B	Q3772*, Q3747*	Normal	Cohen syndrome|Retinal dystrophy|Small hand|Intellectual disability|Progressive visual loss|Short stature|Microcephaly|Neutropenia|Short foot|Recurrent aphthous stomatitis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000056635	8	100880540	8	99868312	56635	71274	rs386834061	NC_000008.11:99868311:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	Normal	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	NC_000009.12:35065351:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.283C>T (p.Arg95Cys)	VCP	R95C, R50C	Normal	not provided|Amyotrophic lateral sclerosis|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280124	9	35067907	9	35067910	280124	264531	rs121909332	NC_000009.12:35067909:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.271A>T (p.Asn91Tyr)	VCP	N91Y, N46Y	Normal	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|INCLUSION BODY MYOPATHY WITHOUT EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2020)	no assertion criteria provided	VCV000217877	9	35067919	9	35067922	217877	214539	rs863225291	NC_000009.12:35067921:T:A	T	A	CLINICAL
NM_007126.5(VCP):c.409C>T (p.Pro137Ser)	VCP	P137S, P92S	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599629	9	35066708	9	35066711	599629	590945	rs866101707	NC_000009.12:35066710:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.169+1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000006731	9	130416076	9	127653797	6731	21770	rs587776641	NC_000009.12:127653796:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.251T>A (p.Val84Asp)	STXBP1	V84D	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006729	9	130422313	9	127660034	6729	21768	rs121918320	NC_000009.12:127660033:T:A	T	A	CLINICAL
NM_001032221.6(STXBP1):c.430-1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802511	9	130425483	9	127663204	802511	790838	rs796053354	NC_000009.12:127663203:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.539G>A (p.Cys180Tyr)	STXBP1	C180Y	Normal	History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	VCV000006727	9	130425593	9	127663314	6727	21766	rs121918318	NC_000009.12:127663313:G:A	G	A	CLINICAL
NM_003165.6(STXBP1):c.578+1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561119	9	130425633	9	127663354	561119	552131	rs796053357	NC_000009.12:127663353:G:A	G	A	CLINICAL
NM_001032221.6(STXBP1):c.579-1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802512	9	130427525	9	127665246	802512	790839	rs1588317190	NC_000009.12:127665245:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.704G>A (p.Arg235Gln)	STXBP1	R235Q	Normal	not provided|Congenital cerebellar hypoplasia|Infantile epilepsy syndrome|Early infantile epileptic encephalopathy 4|Cerebellar vermis hypoplasia|Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000199083	9	130428485	9	127666206	199083	196242	rs794727970	NC_000009.12:127666205:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.847G>A (p.Glu283Lys)	STXBP1	E283K	Normal	Early infantile epileptic encephalopathy with suppression bursts|not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	VCV000127076	9	130430411	9	127668132	127076	132587	rs587777310	NC_000009.12:127668131:G:A	G	A	CLINICAL
NM_003165.6(STXBP1):c.875G>A	STXBP1	R292H	Normal	Infantile epilepsy syndrome|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207424	9	130430439	9	127668160	207424	202301	rs796053361	NC_000009.12:127668159:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.902+1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 9, 2016)	no assertion criteria provided	VCV000375214	9	130430467	9	127668188	375214	361912	rs886041978	NC_000009.12:127668187:G:A	G	A	CLINICAL
NM_001032221.6(STXBP1):c.1217G>A (p.Arg406His)	STXBP1	R406H, R370H, R403H, R392H	Normal	Early infantile epileptic encephalopathy with suppression bursts|not provided|Infantile epilepsy syndrome|Inborn genetic diseases|Early infantile epileptic encephalopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279904	9	130438189	9	127675910	279904	264306	rs886041246	NC_000009.12:127675909:G:A	G	A	CLINICAL
NM_001032221.6(STXBP1):c.1427C>A (p.Ser476Ter)	STXBP1	S440*, S462*, S473*, S476*	Normal	Early infantile epileptic encephalopathy 4	Pathogenic	no assertion criteria provided	VCV000812664	9	130440777	9	127678498	812664	800915	rs1564355614	NC_000009.12:127678497:C:A	C	A	CLINICAL
NM_003165.4(STXBP1):c.1557T>A (p.Tyr519Ter)	STXBP1	Y519*	Normal	Early infantile epileptic encephalopathy 4	Pathogenic	no assertion criteria provided	VCV000590289	9	130444694	9	127682415	590289	581230	rs1564357089	NC_000009.12:127682414:T:A	T	A	CLINICAL
NM_003165.4(STXBP1):c.1631G>A (p.Gly544Asp)	STXBP1	G544D	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006726	9	130444768	9	127682489	6726	21765	rs121918317	NC_000009.12:127682488:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.1651C>A (p.Arg551Ser)	STXBP1	R551S	Normal	not provided|Early infantile epileptic encephalopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207439	9	130444788	9	127682509	207439	202327	rs796053373	NC_000009.12:127682508:C:A	C	A	CLINICAL
NM_003165.4(STXBP1):c.1652G>A (p.Arg551His)	STXBP1	R551H	Normal	Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000566474	9	130444789	9	127682510	566474	562736	rs796053374	NC_000009.12:127682509:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.1702+1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4|not provided|Infantile epilepsy syndrome|STXBP1-associated neurodevelopmental disorder|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207444	9	130444840	9	127682561	207444	202332	rs796053377	NC_000009.12:127682560:G:A	G	A	CLINICAL
NM_024757.5(EHMT1):c.3413G>A (p.Trp1138Ter)	EHMT1	W1138*, W1131*	Normal	Kleefstra syndrome 1|Autism spectrum disorder	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000221980	9	140711929	9	137817477	221980	223668	rs886037776	NC_000009.12:137817476:G:A	G	A	CLINICAL
NM_006412.4(AGPAT2):c.676C>T (p.Gln226Ter)	AGPAT2	Q226*, Q194*	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372111	9	139568365	9	136673913	372111	359011	rs1057517655	NC_000009.12:136673912:G:A	G	A	CLINICAL
NM_006412.4(AGPAT2):c.202C>T (p.Arg68Ter)	AGPAT2	R68*	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000006624	9	139571989	9	136677537	6624	21663	rs104894093	NC_000009.12:136677536:G:A	G	A	CLINICAL
NM_001365068.1(ASTN2):c.2806+26570C>T	TRIM32|ASTN2	D487N	Normal	Sarcotubular myopathy|Bardet-Biedl syndrome 11|Bardet-Biedl syndrome|Myopathy	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007350	9	119461480	9	116699201	7350	22389	rs111033570	NC_000009.12:116699200:G:A	G	A	CLINICAL
NM_006412.4(AGPAT2):c.643A>T (p.Lys215Ter)	AGPAT2	K215*, K183*	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000006629	9	139569205	9	136674753	6629	21668	rs121908925	NC_000009.12:136674752:T:A	T	A	CLINICAL
NM_000155.4(GALT):c.524G>A (p.Gly175Asp)	GALT	G175D, G66D	Normal	Galactosemia|not specified|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Feb 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000025203	9	34648128	9	34648131	25203	36537	rs111033718	NC_000009.12:34648130:G:A	G	A	CLINICAL
NM_000155.4(GALT):c.747G>A (p.Trp249Ter)	GALT	W249*, W140*	Normal	Galactosemia|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025252	9	34648818	9	34648821	25252	36586	rs111033758	NC_000009.12:34648820:G:A	G	A	CLINICAL
NM_000155.4(GALT):c.564+1G>A	GALT		Normal	Galactosemia|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025215	9	34648169	9	34648172	25215	36549	rs111033723	NC_000009.12:34648171:G:A	G	A	CLINICAL
NM_000155.4(GALT):c.983G>A (p.Arg328His)	GALT	R328H, R219H	Normal	Galactosemia|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000025309	9	34649485	9	34649488	25309	36643	rs111033802	NC_000009.12:34649487:G:A	G	A	CLINICAL
NM_054012.4(ASS1):c.787G>A (p.Val263Met)	ASS1	V263M	Normal	not provided|Citrullinemia|Citrullinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092372	9	133355785	9	130480398	92372	98283	rs192838388	NC_000009.12:130480397:G:A	G	A	CLINICAL
NM_001079802.2(FKTN):c.411C>A (p.Cys137Ter)	FKTN	C137*, C5*, C114*	Normal	not provided|Fukuyama congenital muscular dystrophy|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167069	9	108366537	9	105604256	167069	177258	rs537001725	NC_000009.12:105604255:C:A	C	A	CLINICAL
NM_001079802.2(FKTN):c.509C>A (p.Ala170Glu)	FKTN	A170E, A38E, A147E	Normal	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000003214	9	108366635	9	105604354	3214	18253	rs119464997	NC_000009.12:105604353:C:A	C	A	CLINICAL
NM_006731.2(FKTN):c.780+1G>A	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	VCV000370420	9	108370233	9	105607952	370420	357768	rs370819786	NC_000009.12:105607951:G:A	G	A	CLINICAL
NM_001079802.2(FKTN):c.920G>A (p.Arg307Gln)	FKTN	R307Q, R284Q, R175Q	Normal	not provided|Fukuyama congenital muscular dystrophy|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4|Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003208	9	108380249	9	105617968	3208	18247	rs119463992	NC_000009.12:105617967:G:A	G	A	CLINICAL
NM_006731.2(FKTN):c.1172+1G>A	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000558161	9	108382343	9	105620062	558161	545156	rs1554761462	NC_000009.12:105620061:G:A	G	A	CLINICAL
NM_006731.2(FKTN):c.1173-1G>A	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000552964	9	108397331	9	105635050	552964	545158	rs557699482	NC_000009.12:105635049:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.169+1G>A	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2009)	no assertion criteria provided	VCV000006731	9	130416076	9	127653797	6731	21770	rs587776641	NC_000009.12:127653796:G:A	G	A	CLINICAL
NM_003165.4(STXBP1):c.251T>A (p.Val84Asp)	STXBP1	V84D	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006729	9	130422313	9	127660034	6729	21768	rs121918320	NC_000009.12:127660033:T:A	T	A	CLINICAL
NM_003165.4(STXBP1):c.569G>A (p.Arg190Gln)	STXBP1	R190Q	Normal	not provided|Autistic disorder of childhood onset|Neurodegeneration|Photosensitive tonic-clonic seizures|Intellectual disability, severe|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Apr 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207418	9	130425623	9	127663344	207418	202291	rs796053356	NC_000009.12:127663343:G:A	G	A	CLINICAL
NM_004408.4(DNM1):c.139G>A (p.Val47Met)	DNM1|CIZ1	V47M	Normal	Epileptic encephalopathy, early infantile, 31|Muscular hypotonia|Global developmental delay|Cerebellar ataxia|Seizures|Epileptic encephalopathy|Stereotypy	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000224142	9	130965888	9	128203609	224142	225871	rs869312702	NC_000009.12:128203608:G:A	G	A	CLINICAL
NM_001077365.2(POMT1):c.193G>A (p.Gly65Arg)	POMT1	G65R, G11R	Normal	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003244	9	134381571	9	131506184	3244	18283	rs119462983	NC_000009.12:131506183:G:A	G	A	CLINICAL
NM_001077365.2(POMT1):c.443C>A (p.Thr148Asn)	POMT1	T148N, T94N, T118N, T31N	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000562183	9	134384313	9	131508926	562183	553357	rs1564341846	NC_000009.12:131508925:C:A	C	A	CLINICAL
NM_001077365.2(POMT1):c.699+67G>A	POMT1		Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000593922	9	134385450	9	131510063	593922	584985	rs776061161	NC_000009.12:131510062:G:A	G	A	CLINICAL
NM_001077365.2(POMT1):c.978C>A (p.Tyr326Ter)	POMT1	Y231*, Y209*, Y272*, Y294*, Y296*, Y348*, Y174*, Y326*, P321T, Y196*	Normal	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000658622	9	134386846	9	131511459	658622	637794	rs1588391612	NC_000009.12:131511458:C:A	C	A	CLINICAL
NM_001077365.2(POMT1):c.990T>A (p.Tyr330Ter)	POMT1	Y352*, Y330*, Y213*, Y178*, Y276*, Y298*, Y235*, Y300*, Y326*, Y200*	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000502224	9	134387431	9	131512044	502224	493648	rs765230689	NC_000009.12:131512043:T:A	T	A	CLINICAL
NM_001077365.2(POMT1):c.1175+1G>A	POMT1		Normal	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000003251	9	134388719	9	131513332	3251	18290	rs1051679985	NC_000009.12:131513331:G:A	G	A	CLINICAL
NM_001077365.2(POMT1):c.1939G>A (p.Ala647Thr)	POMT1	A669T, A552T, A593T, A617T, A647T, A495T, A615T, A530T, A574T, A517T, A643T	Normal	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1|not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003250	9	134397547	9	131522160	3250	18289	rs119462987	NC_000009.12:131522159:G:A	G	A	CLINICAL
NM_015160.3(PMPCA):c.554G>A (p.Arg185Gln)	PMPCA	R185Q, R54Q, R85Q	Normal	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic	no assertion criteria provided	VCV000375401	9	139310764	9	136416312	375401	362150	rs573267388	NC_000009.12:136416311:G:A	G	A	CLINICAL
NM_015160.3(PMPCA):c.1129G>A (p.Ala377Thr)	PMPCA	A377T, A277T, A246T	Normal	Spinocerebellar ataxia, autosomal recessive 2|Normal pressure hydrocephalus|Hypertrophic cardiomyopathy|Bilateral ptosis|Optic atrophy|Diffuse cerebellar atrophy|Failure to thrive|Blindness|Severe global developmental delay|Infantile muscular hypotonia|Chronic lactic acidosis|Global brain atrophy|Restrictive external ophthalmoplegia|Hypoventilation	Pathogenic(Last reviewed: Feb 10, 2016)	no assertion criteria provided	VCV000221552	9	139313299	9	136418847	221552	223282	rs753611141	NC_000009.12:136418846:G:A	G	A	CLINICAL
NM_015160.3(PMPCA):c.1543G>A (p.Gly515Arg)	PMPCA	G515R, G415R, G384R	Normal	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic(Last reviewed: Oct 12, 2016)	no assertion criteria provided	VCV000221565	9	139317681	9	136423229	221565	223294	rs869025293	NC_000009.12:136423228:G:A	G	A	CLINICAL
NM_019892.6(INPP5E):c.1879C>T (p.Gln627Ter)	INPP5E	Q627*, Q626*	Normal	MORM syndrome	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000396	9	139324183	9	136429731	396	15435	rs121918127	NC_000009.12:136429730:G:A	G	A	CLINICAL
NM_019892.6(INPP5E):c.1303C>T (p.Arg435Trp)	INPP5E	R435W, R434W	Normal	Joubert syndrome and related disorders	Likely pathogenic(Last reviewed: May 16, 2016)	no assertion criteria provided	VCV000375472	9	139327015	9	136432563	375472	362277	rs756789619	NC_000009.12:136432562:G:A	G	A	CLINICAL
NM_016219.5(MAN1B1):c.1189G>A (p.Glu397Lys)	MAN1B1	E397K	Normal	not provided|Mental retardation, autosomal recessive 15	Likely pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	VCV000030413	9	139996059	9	137101607	30413	39370	rs387906885	NC_000009.12:137101606:G:A	G	A	CLINICAL
NM_016219.5(MAN1B1):c.1418G>A (p.Trp473Ter)	MAN1B1	W473*	Normal	Mental retardation, autosomal recessive 15	Pathogenic(Last reviewed: Jul 15, 2011)	no assertion criteria provided	VCV000030414	9	140000740	9	137106288	30414	39371	rs1564311909	NC_000009.12:137106287:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.352G>A (p.Val118Met)	GRIN1	V118M	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000807608	9	140036558	9	137142106	807608	798617	rs1588686286	NC_000009.12:137142105:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.1656C>A (p.Asp552Glu)	GRIN1	D552E, D573E	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487501	9	140056647	9	137162195	487501	480552	rs1554770054	NC_000009.12:137162194:C:A	C	A	CLINICAL
NM_007327.4(GRIN1):c.1858G>A (p.Gly620Arg)	GRIN1	G620R, G641R	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000487508	9	140056962	9	137162510	487508	480559	rs797045047	NC_000009.12:137162509:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.1923G>A (p.Met641Ile)	GRIN1	M641I, M662I	Normal	GRIN1-Related Disorder|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000403957	9	140057101	9	137162649	403957	397398	rs1060500046	NC_000009.12:137162648:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.1984G>A (p.Glu662Lys)	GRIN1	E662K, E683K	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000029725	9	140057162	9	137162710	29725	38680	rs387906635	NC_000009.12:137162709:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.2231G>A (p.Cys744Tyr)	GRIN1	C744Y, C765Y	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000539840	9	140057680	9	137163228	539840	524446	rs1554770444	NC_000009.12:137163227:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.2381G>A (p.Arg794Gln)	GRIN1	R794Q, R815Q	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Dec 28, 2016)	criteria provided, single submitter	VCV000435376	9	140058058	9	137163606	435376	428970	rs781053477	NC_000009.12:137163605:G:A	G	A	CLINICAL
NM_007327.4(GRIN1):c.2417C>A (p.Ala806Glu)	GRIN1	A806E, A827E	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522682	9	140058094	9	137163642	522682	513298	rs1554770589	NC_000009.12:137163641:C:A	C	A	CLINICAL
NM_024757.5(EHMT1):c.2712+1G>A	EHMT1		Normal	not provided|Kleefstra syndrome 1|Global developmental delay|Difficulty walking|Polymicrogyria|Abnormal facial shape	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374034	9	140695437	9	137800985	374034	360912	rs1057518849	NC_000009.12:137800984:G:A	G	A	CLINICAL
NM_001190737.2(NFIB):c.109C>T (p.Arg37Ter)	NFIB	R37*, R28*, R32*, R59*, R33*, R63*	Normal	Macrocephalus|Intellectual disability|Macrocephaly, acquired, with impaired intellectual development	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560024	9	14307441	9	14307442	560024	550740	rs1554709792	NC_000009.12:14307441:G:A	G	A	CLINICAL
NM_003070.5(SMARCA2):c.1574G>A (p.Arg525His)	SMARCA2	R525H	Normal	Intellectual disability|BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000829814	9	2060868	9	2060868	829814	818150	rs1586660381	NC_000009.12:2060867:G:A	G	A	CLINICAL
NM_003070.5(SMARCA2):c.1600G>A (p.Asp534Asn)	SMARCA2	D534N	Normal	Intellectual disability	Likely pathogenic	no assertion criteria provided	VCV000827769	9	2060894	9	2060894	827769	815967	rs863224922	NC_000009.12:2060893:G:A	G	A	CLINICAL
NM_003070.5(SMARCA2):c.2648C>A (p.Pro883Gln)	SMARCA2	P883Q	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000436804	9	2086950	9	2086950	436804	428991	rs281875188	NC_000009.12:2086949:C:A	C	A	CLINICAL
NM_003070.5(SMARCA2):c.3395G>A (p.Gly1132Asp)	SMARCA2	G1132D, G1074D	Normal	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000031687	9	2110356	9	2110356	31687	40347	rs387907194	NC_000009.12:2110355:G:A	G	A	CLINICAL
NM_003070.5(SMARCA2):c.3476G>A (p.Arg1159Gln)	SMARCA2	R1159Q, R1101Q	Normal	Nicolaides-Baraitser syndrome|SMARCA2-related BAFopathy|not provided	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030010	9	2115841	9	2115841	30010	38965	rs281875187	NC_000009.12:2115840:G:A	G	A	CLINICAL
NM_003070.5(SMARCA2):c.3485G>A (p.Arg1162His)	SMARCA2	R1162H, R1104H	Normal	Nicolaides-Baraitser syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030014	9	2115850	9	2115850	30014	38969	rs281875186	NC_000009.12:2115849:G:A	G	A	CLINICAL
NM_003070.5(SMARCA2):c.3493C>A (p.Gln1165Lys)	SMARCA2	Q1165K, Q1107K	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Oct 24, 2014)	criteria provided, single submitter	VCV000212227	9	2115858	9	2115858	212227	207703	rs797045976	NC_000009.12:2115857:C:A	C	A	CLINICAL
NM_003070.5(SMARCA2):c.3562G>A (p.Ala1188Thr)	SMARCA2	A1188T, A1130T	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000369656	9	2115927	9	2115927	369656	353884	rs281875196	NC_000009.12:2115926:G:A	G	A	CLINICAL
NM_003383.5(VLDLR):c.83-1G>A	VLDLR		Normal	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	Pathogenic(Last reviewed: Nov 11, 2014)	criteria provided, single submitter	VCV000212565	9	2635452	9	2635452	212565	207707	rs770269674	NC_000009.12:2635451:G:A	G	A	CLINICAL
NM_032634.4(PIGO):c.2869C>T (p.Leu957Phe)	PIGO	L957F, L540F	Normal	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000035599	9	35090263	9	35090266	35599	44264	rs142164373	NC_000009.12:35090265:G:A	G	A	CLINICAL
NM_032634.4(PIGO):c.2404C>T (p.Arg802Ter)	PIGO	R802*	Normal	Hyperphosphatasia with mental retardation syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620478	9	35091480	9	35091483	620478	611719	rs1199247059	NC_000009.12:35091482:G:A	G	A	CLINICAL
NM_032634.4(PIGO):c.511G>T (p.Gly171Ter)	PIGO	G171*	Normal	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000647724	9	35095052	9	35095055	647724	638271	rs1247927038	NC_000009.12:35095054:C:A	C	A	CLINICAL
NM_032634.4(PIGO):c.196C>T (p.Arg66Ter)	PIGO	R66*	Normal	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: May 12, 2019)	criteria provided, single submitter	VCV000651005	9	35095367	9	35095370	651005	638276	rs763992668	NC_000009.12:35095369:G:A	G	A	CLINICAL
NM_001286715.1(AGTPBP1):c.2998C>T (p.Arg1000Ter)	AGTPBP1	R1000*, R948*, R908*, R960*	Normal	Aplasia/Hypoplasia of the cerebellum|Global developmental delay	Pathogenic	no assertion criteria provided	VCV000599381	9	88203274	9	85588359	599381	590718	rs943824159	NC_000009.12:85588358:G:A	G	A	CLINICAL
NM_001698.2(AUH):c.589C>T (p.Arg197Ter)	AUH	R197*, R168*, R88*	Normal	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000009056	9	94060275	9	91297993	9056	24095	rs121434636	NC_000009.12:91297992:G:A	G	A	CLINICAL
NM_001698.2(AUH):c.373C>T (p.Arg125Trp)	AUH	R125W, R16W	Normal	3-Methylglutaconic aciduria type 1	Likely pathogenic(Last reviewed: May 25, 2014)	no assertion criteria provided	VCV000208151	9	94118210	9	91355928	208151	204412	rs200030276	NC_000009.12:91355927:G:A	G	A	CLINICAL
NM_006415.4(SPTLC1):c.992C>T (p.Ser331Phe)	SPTLC1	S331F, S176F, S209F	Normal	Neuropathy, hereditary sensory and autonomic, type IA, severe	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000004804	9	94809543	9	92047261	4804	19843	rs267607087	NC_000009.12:92047260:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	Normal	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	NC_000009.12:35065351:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.463C>T (p.Arg155Cys)	VCP	R155C, R110C	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008469	9	35065361	9	35065364	8469	23508	rs121909330	NC_000009.12:35065363:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.283C>T (p.Arg95Cys)	VCP	R95C, R50C	Normal	not provided|Amyotrophic lateral sclerosis|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280124	9	35067907	9	35067910	280124	264531	rs121909332	NC_000009.12:35067909:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.277C>T (p.Arg93Cys)	VCP	R93C, R48C	Normal	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000593071	9	35067913	9	35067916	593071	584135	rs1554669087	NC_000009.12:35067915:G:A	G	A	CLINICAL
NM_007126.5(VCP):c.271A>T (p.Asn91Tyr)	VCP	N91Y, N46Y	Normal	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|INCLUSION BODY MYOPATHY WITHOUT EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2020)	no assertion criteria provided	VCV000217877	9	35067919	9	35067922	217877	214539	rs863225291	NC_000009.12:35067921:T:A	T	A	CLINICAL
NM_007126.5(VCP):c.475C>G (p.Arg159Gly)	VCP	R159G, R114G	Normal	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030152	9	35065349	9	35065352	30152	39108	rs387906789	NC_000009.12:35065351:G:C	G	C	CLINICAL
NM_001032221.4(STXBP1):c.87+2T>C	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000436894	9	130413933	9	127651654	436894	428915	rs1554775960	NC_000009.12:127651653:T:C	T	C	CLINICAL
NM_001032221.6(STXBP1):c.308A>C (p.His103Pro)	STXBP1	H89P, H103P	Normal	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Jan 14, 2019)	no assertion criteria provided	VCV000807505	9	130422370	9	127660091	807505	798611	rs1588306948	NC_000009.12:127660090:A:C	A	C	CLINICAL
NM_003165.4(STXBP1):c.433T>C (p.Tyr145His)	STXBP1	Y145H	Normal	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	VCV000160073	9	130425487	9	127663208	160073	168751	rs587784455	NC_000009.12:127663207:T:C	T	C	CLINICAL
NM_001032221.6(STXBP1):c.862T>C (p.Trp288Arg)	STXBP1	W274R, W285R, W288R	Normal	Intellectual disability|Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000802513	9	130430426	9	127668147	802513	790840	rs1588324025	NC_000009.12:127668146:T:C	T	C	CLINICAL
NM_003165.4(STXBP1):c.1029+1G>C	STXBP1		Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 13, 2014)	criteria provided, single submitter	VCV000212326	9	130434396	9	127672117	212326	207613	rs727504173	NC_000009.12:127672116:G:C	G	C	CLINICAL
NM_003165.4(STXBP1):c.1652G>C (p.Arg551Pro)	STXBP1	R551P	Normal	not provided	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000207441	9	130444789	9	127682510	207441	202329	rs796053374	NC_000009.12:127682509:G:C	G	C	CLINICAL
NM_007327.4(GRIN1):c.1858G>C (p.Gly620Arg)	GRIN1	G620R, G641R	Normal	not provided|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|Seizures|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209159	9	140056962	9	137162510	209159	205760	rs797045047	NC_000009.12:137162509:G:C	G	C	CLINICAL
NM_006412.4(AGPAT2):c.713C>G (p.Ala238Gly)	AGPAT2	A238G, A206G	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372112	9	139568328	9	136673876	372112	359010	rs200656731	NC_000009.12:136673875:G:C	G	C	CLINICAL
NM_006412.4(AGPAT2):c.661+2T>G	AGPAT2		Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372110	9	139569185	9	136674733	372110	359012	rs1057517654	NC_000009.12:136674732:A:C	A	C	CLINICAL
NM_006412.4(AGPAT2):c.183-2A>G	AGPAT2		Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372102	9	139572010	9	136677558	372102	359018	rs1057517649	NC_000009.12:136677557:T:C	T	C	CLINICAL
NM_006412.4(AGPAT2):c.589-2A>G	AGPAT2		Normal	not provided|Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006625	9	139569261	9	136674809	6625	21664	rs116807569	NC_000009.12:136674808:T:C	T	C	CLINICAL
NM_003165.4(STXBP1):c.1277T>C (p.Leu426Pro)	STXBP1	L426P	Normal	not provided|Early infantile epileptic encephalopathy with suppression bursts|Infantile epilepsy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265263	9	130438950	9	127676671	265263	259912	rs886039435	NC_000009.12:127676670:T:C	T	C	CLINICAL
NM_006731.2(FKTN):c.1173-1G>C	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000553352	9	108397331	9	105635050	553352	545160	rs557699482	NC_000009.12:105635049:G:C	G	C	CLINICAL
NM_001032221.6(STXBP1):c.862T>C (p.Trp288Arg)	STXBP1	W274R, W285R, W288R	Normal	Intellectual disability|Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000802513	9	130430426	9	127668147	802513	790840	rs1588324025	NC_000009.12:127668146:T:C	T	C	CLINICAL
NM_054012.4(ASS1):c.535T>C (p.Trp179Arg)	ASS1	W179R	Normal	Citrullinemia, mild|not provided|Citrullinemia|Citrullinemia type I	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006335	9	133346260	9	130470873	6335	21374	rs121908646	NC_000009.12:130470872:T:C	T	C	CLINICAL
NM_001077365.2(POMT1):c.132A>C (p.Glu44Asp)	POMT1	E44D	Normal	not provided|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095456	9	134381510	9	131506123	95456	101355	rs398124244	NC_000009.12:131506122:A:C	A	C	CLINICAL
NM_001077365.2(POMT1):c.598G>C (p.Ala200Pro)	POMT1	A200P, A170P, A48P, A146P, A83P	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003243	9	134385188	9	131509801	3243	18282	rs119462982	NC_000009.12:131509800:G:C	G	C	CLINICAL
NM_001077365.2(POMT1):c.605+1G>C	POMT1		Normal	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000538720	9	134385196	9	131509809	538720	524381	rs766648827	NC_000009.12:131509808:G:C	G	C	CLINICAL
NM_001077365.2(POMT1):c.987-2A>C	POMT1		Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000580822	9	134387426	9	131512039	580822	565589	rs1453773610	NC_000009.12:131512038:A:C	A	C	CLINICAL
NM_001077365.2(POMT1):c.1272+2T>C	POMT1		Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000580081	9	134390911	9	131515524	580081	563582	rs1564365317	NC_000009.12:131515523:T:C	T	C	CLINICAL
NM_000368.4(TSC1):c.671T>G (p.Met224Arg)	TSC1	M224R, M103R, M173R	Normal	Tuberous sclerosis 1|Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Aug 11, 2019)	criteria provided, single submitter	VCV000005104	9	135796816	9	132921429	5104	20143	rs118203426	NC_000009.12:132921428:A:C	A	C	CLINICAL
NM_007327.4(GRIN1):c.1858G>C (p.Gly620Arg)	GRIN1	G620R, G641R	Normal	not provided|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|Seizures|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209159	9	140056962	9	137162510	209159	205760	rs797045047	NC_000009.12:137162509:G:C	G	C	CLINICAL
NM_007327.4(GRIN1):c.1922T>C (p.Met641Thr)	GRIN1	M641T, M662T	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV000828036	9	140057100	9	137162648	828036	816364	rs1588732344	NC_000009.12:137162647:T:C	T	C	CLINICAL
NM_007327.4(GRIN1):c.2449T>C (p.Phe817Leu)	GRIN1	F817L, F838L	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487504	9	140058216	9	137163764	487504	480555	rs1554770624	NC_000009.12:137163763:T:C	T	C	CLINICAL
NM_007327.4(GRIN1):c.2452A>C (p.Met818Leu)	GRIN1	M818L, M839L	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000472576	9	140058219	9	137163767	472576	459909	rs1554770628	NC_000009.12:137163766:A:C	A	C	CLINICAL
NM_024757.5(EHMT1):c.1647+2T>C	EHMT1	V519A, V550A	Normal	Synophrys|Anteverted nares|Coarse facial features|Schizophrenia|Intellectual disability|Global developmental delay|Kleefstra syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000374120	9	140657274	9	137762822	374120	360911	rs1057518913	NC_000009.12:137762821:T:C	T	C	CLINICAL
NM_001190737.2(NFIB):c.376A>G (p.Lys126Glu)	NFIB	K126E, K122E, K117E, K148E, K152E, K121E, K78E	Normal	Macrocephalus|Intellectual disability|Marfanoid habitus and intellectual disability|Macrocephaly, acquired, with impaired intellectual development	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560026	9	14307174	9	14307175	560026	550742	rs1554709662	NC_000009.12:14307174:T:C	T	C	CLINICAL
NM_003070.5(SMARCA2):c.2255G>C (p.Gly752Ala)	SMARCA2	G752A	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030019	9	2081902	9	2081902	30019	38974	rs281875198	NC_000009.12:2081901:G:C	G	C	CLINICAL
NM_003070.5(SMARCA2):c.2853G>C (p.Lys951Asn)	SMARCA2	K951N, K893N	Normal	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Sep 7, 2016)	criteria provided, single submitter	VCV000436805	9	2088583	9	2088583	436805	428992	rs1554624100	NC_000009.12:2088582:G:C	G	C	CLINICAL
NM_003070.5(SMARCA2):c.3587A>C (p.Gln1196Pro)	SMARCA2	Q1138P, Q1196P	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802455	9	2115952	9	2115952	802455	790885	rs1586721515	NC_000009.12:2115951:A:C	A	C	CLINICAL
NM_003383.5(VLDLR):c.2T>C (p.Met1Thr)	VLDLR|VLDLR-AS1	M1T	Normal	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	Likely pathogenic(Last reviewed: Apr 5, 2015)	criteria provided, single submitter	VCV000212557	9	2622191	9	2622191	212557	207705	rs797046092	NC_000009.12:2622190:T:C	T	C	CLINICAL
NM_003383.5(VLDLR):c.1962+2T>C	VLDLR		Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000635065	9	2648349	9	2648349	635065	622893	rs1563764078	NC_000009.12:2648348:T:C	T	C	CLINICAL
NM_138691.2(TMC1):c.530T>C (p.Ile177Thr)	TMC1	I177T	Normal	Bilateral sensorineural hearing impairment|Delayed speech and language development|Intellectual disability, moderate	Pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000690365	9	75357436	9	72742520	690365	678050	rs747645067	NC_000009.12:72742519:T:C	T	C	CLINICAL
NM_001286715.1(AGTPBP1):c.2351A>G (p.Tyr784Cys)	AGTPBP1	Y784C, Y692C, Y744C, Y732C	Normal	Aplasia/Hypoplasia of the cerebellum|Global developmental delay	Likely pathogenic	no assertion criteria provided	VCV000599380	9	88234038	9	85619123	599380	590717	rs1564069651	NC_000009.12:85619122:T:C	T	C	CLINICAL
NM_015239.2(AGTPBP1):c.2066+2T>G	AGTPBP1		Normal	Aplasia/Hypoplasia of the cerebellum|Global developmental delay|Motor polyneuropathy	Likely pathogenic	no assertion criteria provided	VCV000599379	9	88234128	9	85619213	599379	590716	rs1564069807	NC_000009.12:85619212:A:C	A	C	CLINICAL
NM_001698.2(AUH):c.943-2A>G	AUH		Normal	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000009060	9	93976709	9	91214427	9060	24099	rs730880312	NC_000009.12:91214426:T:C	T	C	CLINICAL
NM_001698.2(AUH):c.599-2A>G	AUH		Normal	3-Methylglutaconic aciduria type 1	Likely pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000642421	9	94058361	9	91296079	642421	652055	rs1587799880	NC_000009.12:91296078:T:C	T	C	CLINICAL
NM_001698.2(AUH):c.263-2A>G	AUH		Normal	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Dec 1, 2005)	no assertion criteria provided	VCV000009059	9	94118439	9	91356157	9059	24098	rs730880311	NC_000009.12:91356156:T:C	T	C	CLINICAL
NM_007126.5(VCP):c.283C>G (p.Arg95Gly)	VCP	R95G, R50G	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000008471	9	35067907	9	35067910	8471	23510	rs121909332	NC_000009.12:35067909:G:C	G	C	CLINICAL
NM_024757.5(EHMT1):c.1647+2T>C	EHMT1	V519A, V550A	Normal	Synophrys|Anteverted nares|Coarse facial features|Schizophrenia|Intellectual disability|Global developmental delay|Kleefstra syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2015)	criteria provided, multiple submitters, no conflicts	VCV000374120	9	140657274	9	137762822	374120	360911	rs1057518913	NC_000009.12:137762821:T:C	T	C	CLINICAL
NM_005866.4(SIGMAR1):c.304G>C (p.Glu102Gln)	SIGMAR1	E102Q, E82Q	Normal	Amyotrophic lateral sclerosis 16, juvenile	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030238	9	34637265	9	34637268	30238	39194	rs387906829	NC_000009.12:34637267:C:G	C	G	CLINICAL
NM_003165.4(STXBP1):c.170-2A>G	STXBP1		Normal	Infantile epilepsy syndrome|not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jan 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488800	9	130420652	9	127658373	488800	481837	rs1554776674	NC_000009.12:127658372:A:G	A	G	CLINICAL
NM_001032221.6(STXBP1):c.1111-2A>G	STXBP1		Normal	Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000461286	9	130438081	9	127675802	461286	458775	rs1554778417	NC_000009.12:127675801:A:G	A	G	CLINICAL
NM_003165.4(STXBP1):c.1328T>G (p.Met443Arg)	STXBP1	M443R	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000006728	9	130439001	9	127676722	6728	21767	rs121918319	NC_000009.12:127676721:T:G	T	G	CLINICAL
NM_003165.4(STXBP1):c.1427C>G (p.Ser476Ter)	STXBP1	S476*	Normal	not provided|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000620472	9	130440777	9	127678498	620472	611714	rs1564355614	NC_000009.12:127678497:C:G	C	G	CLINICAL
NM_006412.4(AGPAT2):c.493-1G>C	AGPAT2		Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	VCV000006630	9	139571133	9	136676681	6630	21669	rs606231168	NC_000009.12:136676680:C:G	C	G	CLINICAL
NM_006412.4(AGPAT2):c.683T>C (p.Leu228Pro)	AGPAT2	L228P, L196P	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000006627	9	139568358	9	136673906	6627	21666	rs104894100	NC_000009.12:136673905:A:G	A	G	CLINICAL
NM_000118.3(ENG):c.816+6T>C	ENG		Normal	Hereditary hemorrhagic telangiectasia type 1|Systemic lupus erythematosus	Pathogenic(Last reviewed: Mar 20, 2017)	no assertion criteria provided	VCV000453308	9	130587504	9	127825225	453308	446888	rs759191907	NC_000009.12:127825224:A:G	A	G	CLINICAL
NM_006731.2(FKTN):c.106-2A>G	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000552263	9	108358877	9	105596596	552263	545040	rs1554748292	NC_000009.12:105596595:A:G	A	G	CLINICAL
NM_006731.2(FKTN):c.370-2A>G	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000551769	9	108366494	9	105604213	551769	545052	rs1554752805	NC_000009.12:105604212:A:G	A	G	CLINICAL
NM_006731.2(FKTN):c.1173-2A>G	FKTN		Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000558611	9	108397330	9	105635049	558611	544924	rs1554766808	NC_000009.12:105635048:A:G	A	G	CLINICAL
NM_003011.4(SET):c.244T>G (p.Trp82Gly)	SET	W95G, W73G, W71G, W82G	Normal	Intellectual disability, autosomal dominant 58	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000560206	9	131454249	9	128691970	560206	551258	rs1554776500	NC_000009.12:128691969:T:G	T	G	CLINICAL
NM_001077365.2(POMT1):c.1361T>G (p.Leu454Ter)	POMT1	L476*, L302*, L400*, L454*, L424*, L337*, L359*, L422*, L324*, L450*	Normal	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000471374	9	134393920	9	131518533	471374	458491	rs1554780670	NC_000009.12:131518532:T:G	T	G	CLINICAL
NM_007327.4(GRIN1):c.1656C>G (p.Asp552Glu)	GRIN1	D552E, D573E	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Feb 22, 2018)	no assertion criteria provided	VCV000487500	9	140056647	9	137162195	487500	480551	rs1554770054	NC_000009.12:137162194:C:G	C	G	CLINICAL
NM_007327.4(GRIN1):c.1670C>G (p.Pro557Arg)	GRIN1	P557R, P578R	Normal	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235846	9	140056661	9	137162209	235846	237500	rs878853143	NC_000009.12:137162208:C:G	C	G	CLINICAL
NM_007327.4(GRIN1):c.1847A>G (p.Asn616Ser)	GRIN1	N616S, N637S	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000567084	9	140056951	9	137162499	567084	563099	rs1564363665	NC_000009.12:137162498:A:G	A	G	CLINICAL
NM_007327.4(GRIN1):c.1950C>G (p.Asn650Lys)	GRIN1	N650K, N671K	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Jan 9, 2018)	no assertion criteria provided	VCV000487502	9	140057128	9	137162676	487502	480553	rs771610568	NC_000009.12:137162675:C:G	C	G	CLINICAL
NM_007327.4(GRIN1):c.1961T>G (p.Phe654Cys)	GRIN1	F654C, F675C	Normal	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000559643	9	140057139	9	137162687	559643	550363	rs1554770262	NC_000009.12:137162686:T:G	T	G	CLINICAL
NM_001190737.2(NFIB):c.395T>C (p.Leu132Pro)	NFIB	L132P, L128P, L84P, L123P, L127P, L158P, L154P	Normal	Macrocephalus|Intellectual disability|Macrocephaly, acquired, with impaired intellectual development	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560027	9	14307155	9	14307156	560027	550743	rs1554709654	NC_000009.12:14307155:A:G	A	G	CLINICAL
NM_001190737.2(NFIB):c.341A>C (p.Lys114Thr)	NFIB	K114T, K105T, K136T, K140T, K66T, K109T, K110T	Normal	Macrocephalus|Intellectual disability|Macrocephaly, acquired, with impaired intellectual development	Pathogenic	criteria provided, single submitter	VCV000560025	9	14307209	9	14307210	560025	550741	rs1554709683	NC_000009.12:14307209:T:G	T	G	CLINICAL
NM_003070.5(SMARCA2):c.1585C>G (p.Leu529Val)	SMARCA2	L529V	Normal	Intellectual disability|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV000829810	9	2060879	9	2060879	829810	818146	rs1586660389	NC_000009.12:2060878:C:G	C	G	CLINICAL
NM_003070.5(SMARCA2):c.2348C>G (p.Ser783Trp)	SMARCA2	S783W	Normal	Intellectual disability|Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000436803	9	2081995	9	2081995	436803	428990	rs1554623112	NC_000009.12:2081994:C:G	C	G	CLINICAL
NM_003070.5(SMARCA2):c.2552A>G (p.Asp851Gly)	SMARCA2	D851G	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	VCV000267266	9	2086854	9	2086854	267266	262269	rs886041045	NC_000009.12:2086853:A:G	A	G	CLINICAL
NM_003070.5(SMARCA2):c.2563C>G (p.Arg855Gly)	SMARCA2	R855G	Normal	Nicolaides-Baraitser syndrome|not provided	Pathogenic	no assertion criteria provided	VCV000068765	9	2086865	9	2086865	68765	79657	rs281875207	NC_000009.12:2086864:C:G	C	G	CLINICAL
NM_003070.5(SMARCA2):c.3475C>G (p.Arg1159Gly)	SMARCA2	R1159G, R1101G	Normal	Nicolaides-Baraitser syndrome|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000030012	9	2115840	9	2115840	30012	38967	rs281875184	NC_000009.12:2115839:C:G	C	G	CLINICAL
NM_003070.5(SMARCA2):c.3482A>G (p.His1161Arg)	SMARCA2	H1161R, H1103R	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000217001	9	2115847	9	2115847	217001	213591	rs863224921	NC_000009.12:2115846:A:G	A	G	CLINICAL
NM_032634.4(PIGO):c.3069+2T>C	PIGO		Normal	not provided|Hyperphosphatasia with mental retardation syndrome 2	Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000422406	9	35090061	9	35090064	422406	407693	rs1064795758	NC_000009.12:35090063:A:G	A	G	CLINICAL
NM_032634.4(PIGO):c.2397A>C (p.Gln799His)	PIGO	Q799H	Normal	Hyperphosphatasia with mental retardation syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694694	9	35091487	9	35091490	694694	682814	rs1587162510	NC_000009.12:35091489:T:G	T	G	CLINICAL
NM_000170.2(GLDC):c.1545G>C (p.Arg515Ser)	GLDC	R515S	Normal	Non-ketotic hyperglycinemia|Global developmental delay|Generalized epilepsy|Obesity	Pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011985	9	6589230	9	6589230	11985	27024	rs121964976	NC_000009.12:6589229:C:G	C	G	CLINICAL
NM_007126.5(VCP):c.464G>C (p.Arg155Pro)	VCP	R155P, R110P	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000008472	9	35065360	9	35065363	8472	23511	rs121909329	NC_000009.12:35065362:C:G	C	G	CLINICAL
NM_005866.4(SIGMAR1):c.194T>A (p.Leu65Gln)	SIGMAR1	L65Q, L45Q	Normal	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Likely pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000575556	9	34637375	9	34637378	575556	563214	rs140376902	NC_000009.12:34637377:A:T	A	T	CLINICAL
NM_007126.5(VCP):c.1774G>A (p.Asp592Asn)	VCP	D592N, D547N	Normal	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030153	9	35059720	9	35059723	30153	39109	rs387906790	NC_000009.12:35059722:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	NC_000009.12:35065254:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	Normal	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	NC_000009.12:35065350:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	NC_000009.12:35065362:C:T	C	T	CLINICAL
NM_198252.3(GSN):c.487G>T (p.Asp163Tyr)	GSN	D187Y, D174Y, D214Y, D163Y, D171Y, D180Y, D199Y	Normal	Meretoja syndrome	Pathogenic(Last reviewed: Nov 10, 2017)	no assertion criteria provided	VCV000016181	9	124073097	9	121310819	16181	31220	rs121909715	NC_000009.12:121310818:G:T	G	T	CLINICAL
NM_001039803.2(CDK20):c.564G>A (p.Trp188Ter)	CDK20	W188*	Normal	Attention deficit hyperactivity disorder|Hearing impairment|Seizures|Obsessive-compulsive behavior	Pathogenic	no assertion criteria provided	VCV000375376	9	90584834	9	87969919	375376	362151	rs1057519438	NC_000009.12:87969918:C:T	C	T	CLINICAL
NM_005458.8(GABBR2):c.1699G>A (p.Ala567Thr)	GABBR2	A567T	Normal	Inborn genetic diseases|Rett syndrome|Neurodevelopmental disorder with poor language and loss of hand skills|Epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446211	9	101133817	9	98371535	446211	439573	rs922847767	NC_000009.12:98371534:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.79G>T (p.Glu27Ter)	STXBP1	E27*	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561120	9	130413923	9	127651644	561120	552129	rs1564346538	NC_000009.12:127651643:G:T	G	T	CLINICAL
NM_001032221.6(STXBP1):c.236C>T (p.Pro79Leu)	STXBP1	P65L, P79L	Normal	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802507	9	130420720	9	127658441	802507	790834	rs1588302912	NC_000009.12:127658440:C:T	C	T	CLINICAL
NM_001032221.6(STXBP1):c.241G>T (p.Glu81Ter)	STXBP1	E67*, E81*	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802508	9	130420725	9	127658446	802508	790835	rs1461664423	NC_000009.12:127658445:G:T	G	T	CLINICAL
NM_003165.4(STXBP1):c.326-1G>T	STXBP1		Normal	Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000461293	9	130423380	9	127661101	461293	458771	rs1554776948	NC_000009.12:127661100:G:T	G	T	CLINICAL
NM_003165.4(STXBP1):c.364C>T (p.Arg122Ter)	STXBP1	R122*	Normal	Intellectual disability|not provided|Infantile epilepsy syndrome|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|Global developmental delay|Generalized hypotonia|Horizontal nystagmus|Strabismus|Muscular hypotonia of the trunk|Delayed speech and language development|Infantile spasms	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198157	9	130423419	9	127661140	198157	195318	rs794727792	NC_000009.12:127661139:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.416C>T (p.Pro139Leu)	STXBP1	P139L	Normal	Intellectual disability|Seizures|Intellectual disability|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207415	9	130423471	9	127661192	207415	202287	rs796053353	NC_000009.12:127661191:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.703C>T (p.Arg235Ter)	STXBP1	R235*	Normal	Infantile epilepsy syndrome|Early infantile epileptic encephalopathy 4|not provided|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000207422	9	130428484	9	127666205	207422	202297	rs796053359	NC_000009.12:127666204:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1006C>T (p.Gln336Ter)	STXBP1	Q336*	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000375464	9	130434372	9	127672093	375464	362229	rs1057519501	NC_000009.12:127672092:C:T	C	T	CLINICAL
NM_001032221.6(STXBP1):c.1099C>T (p.Arg367Ter)	STXBP1	R367*, R331*, R353*, R364*	Normal	Infantile epilepsy syndrome|Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy with suppression bursts|Epileptic encephalopathy|Intellectual disability|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207429	9	130435529	9	127673250	207429	202308	rs796053366	NC_000009.12:127673249:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1162C>T (p.Arg388Ter)	STXBP1	R388*	Normal	not provided|Infantile epilepsy syndrome|Inborn genetic diseases|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006730	9	130438134	9	127675855	6730	21769	rs121918321	NC_000009.12:127675854:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1216C>T (p.Arg406Cys)	STXBP1	R406C	Normal	Early infantile epileptic encephalopathy with suppression bursts|Infantile epilepsy syndrome|Early infantile epileptic encephalopathy 4|not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207431	9	130438188	9	127675909	207431	202311	rs796053367	NC_000009.12:127675908:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1217G>T (p.Arg406Leu)	STXBP1	R406L	Normal	not provided|Early infantile epileptic encephalopathy 4	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419223	9	130438189	9	127675910	419223	407541	rs886041246	NC_000009.12:127675909:G:T	G	T	CLINICAL
NM_001032221.6(STXBP1):c.1261G>T (p.Glu421Ter)	STXBP1	E418*, E407*, E421*, E385*	Normal	Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Jul 9, 2019)	no assertion criteria provided	VCV000807506	9	130438934	9	127676655	807506	798612	rs1588341629	NC_000009.12:127676654:G:T	G	T	CLINICAL
NM_003165.4(STXBP1):c.1439C>T (p.Pro480Leu)	STXBP1	P480L	Normal	Early infantile epileptic encephalopathy with suppression bursts|Intellectual disability|Early infantile epileptic encephalopathy 4|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207432	9	130440789	9	127678510	207432	202320	rs796053368	NC_000009.12:127678509:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1631G>T (p.Gly544Val)	STXBP1	G544V	Normal	Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy with suppression bursts|not provided	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429757	9	130444768	9	127682489	429757	421698	rs121918317	NC_000009.12:127682488:G:T	G	T	CLINICAL
NM_003165.4(STXBP1):c.1651C>T (p.Arg551Cys)	STXBP1	R551C	Normal	Infantile epilepsy syndrome|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|See cases|not provided	Pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000207440	9	130444788	9	127682509	207440	202328	rs796053373	NC_000009.12:127682508:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.406G>A (p.Gly136Arg)	AGPAT2	G136R	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	VCV000210104	9	139571499	9	136677047	210104	207660	rs797045222	NC_000009.12:136677046:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.492+1G>A	AGPAT2		Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372106	9	139571412	9	136676960	372106	359015	rs933422777	NC_000009.12:136676959:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.194G>A (p.Trp65Ter)	AGPAT2	W65*	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372104	9	139571997	9	136677545	372104	359017	rs1057517651	NC_000009.12:136677544:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.182+1G>A	AGPAT2		Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000372103	9	139581627	9	136687175	372103	359019	rs1057517650	NC_000009.12:136687174:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.570C>A (p.Tyr190Ter)	AGPAT2	Y190*	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000006631	9	139571055	9	136676603	6631	21670	rs121908926	NC_000009.12:136676602:G:T	G	T	CLINICAL
NM_006412.4(AGPAT2):c.299G>A (p.Ser100Asn)	AGPAT2	S100N	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	VCV000372105	9	139571892	9	136677440	372105	359016	rs764260414	NC_000009.12:136677439:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.503G>A (p.Trp168Ter)	AGPAT2	W168*	Normal	Congenital generalized lipodystrophy type 1	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374338	9	139571122	9	136676670	374338	361196	rs1057518714	NC_000009.12:136676669:C:T	C	T	CLINICAL
NM_001365068.1(ASTN2):c.2806+27641G>A	TRIM32|ASTN2	P130S	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 11	Pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	VCV000007351	9	119460409	9	116698130	7351	22390	rs111033571	NC_000009.12:116698129:C:T	C	T	CLINICAL
NM_006412.4(AGPAT2):c.514G>A (p.Glu172Lys)	AGPAT2	E172K	Normal	Congenital generalized lipodystrophy type 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372108	9	139571111	9	136676659	372108	359014	rs748157664	NC_000009.12:136676658:C:T	C	T	CLINICAL
NM_000155.4(GALT):c.377+1G>T	GALT		Normal	Galactosemia|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic	criteria provided, single submitter	VCV000025164	9	34647703	9	34647706	25164	36498	rs111033681	NC_000009.12:34647705:G:T	G	T	CLINICAL
NM_003165.4(STXBP1):c.1651C>T (p.Arg551Cys)	STXBP1	R551C	Normal	Infantile epilepsy syndrome|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|See cases|not provided	Pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000207440	9	130444788	9	127682509	207440	202328	rs796053373	NC_000009.12:127682508:C:T	C	T	CLINICAL
NM_000155.4(GALT):c.601C>T (p.Arg201Cys)	GALT	R201C, R92C	Normal	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia|not specified|not provided	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000025226	9	34648367	9	34648370	25226	36560	rs111033739	NC_000009.12:34648369:C:T	C	T	CLINICAL
NM_000155.4(GALT):c.367C>T (p.Arg123Ter)	GALT	R123*	Normal	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|Galactosemia|not provided	Pathogenic(Last reviewed: Mar 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000203734	9	34647692	9	34647695	203734	200182	rs111033674	NC_000009.12:34647694:C:T	C	T	CLINICAL
NM_001079802.2(FKTN):c.109G>T (p.Gly37Ter)	FKTN	G37*	Normal	Fukuyama congenital muscular dystrophy	Likely pathogenic(Last reviewed: Apr 8, 2016)	criteria provided, single submitter	VCV000370768	9	108358882	9	105596601	370768	357764	rs773884973	NC_000009.12:105596600:G:T	G	T	CLINICAL
NM_001079802.2(FKTN):c.139C>T (p.Arg47Ter)	FKTN	R47*	Normal	Fukuyama congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4|not provided|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003200	9	108358912	9	105596631	3200	18239	rs119463990	NC_000009.12:105596630:C:T	C	T	CLINICAL
NM_001079802.2(FKTN):c.607C>T (p.Arg203Ter)	FKTN	R203*, R180*, R71*	Normal	Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4|Fukuyama congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4|Fukuyama congenital muscular dystrophy|Walker-Warburg congenital muscular dystrophy|not provided	Pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225359	9	108366733	9	105604452	225359	227329	rs746763506	NC_000009.12:105604451:C:T	C	T	CLINICAL
NM_006731.2(FKTN):c.647+2084G>T	FKTN		Normal	Walker-Warburg congenital muscular dystrophy|Fukuyama congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C4|Dilated cardiomyopathy 1X|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy without mental retardation, type B4|Fukuyama congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000496331	9	108368857	9	105606576	496331	487362	rs1554754182	NC_000009.12:105606575:G:T	G	T	CLINICAL
NM_001079802.2(FKTN):c.919C>T (p.Arg307Ter)	FKTN	R307*, R284*, R175*	Normal	Walker-Warburg congenital muscular dystrophy|not provided|Fukuyama congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003216	9	108380248	9	105617967	3216	18255	rs267606814	NC_000009.12:105617966:C:T	C	T	CLINICAL
NM_021224.6(ZNF462):c.3787C>T (p.Arg1263Ter)	ZNF462	R1263*	Normal	Weiss-kruszka syndrome|Mental retardation, autosomal dominant|Craniosynostosis syndrome	Pathogenic(Last reviewed: Oct 14, 2019)	no assertion criteria provided	VCV000402116	9	109689980	9	106927699	402116	389089	rs1060499549	NC_000009.12:106927698:C:T	C	T	CLINICAL
NM_018249.6(CDK5RAP2):c.246T>A (p.Tyr82Ter)	CDK5RAP2	Y82*	Normal	Primary autosomal recessive microcephaly 3	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000002488	9	123313130	9	120550852	2488	17527	rs199422126	NC_000009.12:120550851:A:T	A	T	CLINICAL
NM_003165.4(STXBP1):c.364C>T (p.Arg122Ter)	STXBP1	R122*	Normal	Intellectual disability|not provided|Infantile epilepsy syndrome|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|Global developmental delay|Generalized hypotonia|Horizontal nystagmus|Strabismus|Muscular hypotonia of the trunk|Delayed speech and language development|Infantile spasms	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198157	9	130423419	9	127661140	198157	195318	rs794727792	NC_000009.12:127661139:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.416C>T (p.Pro139Leu)	STXBP1	P139L	Normal	Intellectual disability|Seizures|Intellectual disability|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207415	9	130423471	9	127661192	207415	202287	rs796053353	NC_000009.12:127661191:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1082C>T (p.Thr361Ile)	STXBP1	T361I	Normal	Epileptic encephalopathy	Likely pathogenic	no assertion criteria provided	VCV000374223	9	130435512	9	127673233	374223	361132	rs1057518985	NC_000009.12:127673232:C:T	C	T	CLINICAL
NM_001032221.6(STXBP1):c.1099C>T (p.Arg367Ter)	STXBP1	R367*, R331*, R353*, R364*	Normal	Infantile epilepsy syndrome|Early infantile epileptic encephalopathy 4|Early infantile epileptic encephalopathy with suppression bursts|Epileptic encephalopathy|Intellectual disability|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207429	9	130435529	9	127673250	207429	202308	rs796053366	NC_000009.12:127673249:C:T	C	T	CLINICAL
NM_003165.4(STXBP1):c.1162C>T (p.Arg388Ter)	STXBP1	R388*	Normal	not provided|Infantile epilepsy syndrome|Inborn genetic diseases|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 4	Pathogenic(Last reviewed: Dec 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006730	9	130438134	9	127675855	6730	21769	rs121918321	NC_000009.12:127675854:C:T	C	T	CLINICAL
NM_001032221.6(STXBP1):c.1359+1G>T	STXBP1		Normal	Global developmental delay|Autistic disorder of childhood onset	Pathogenic	no assertion criteria provided	VCV000812770	9	130439033	9	127676754	812770	801109	rs796053370	NC_000009.12:127676753:G:T	G	T	CLINICAL
NM_003165.4(STXBP1):c.1439C>T (p.Pro480Leu)	STXBP1	P480L	Normal	Early infantile epileptic encephalopathy with suppression bursts|Intellectual disability|Early infantile epileptic encephalopathy 4|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207432	9	130440789	9	127678510	207432	202320	rs796053368	NC_000009.12:127678509:C:T	C	T	CLINICAL
NM_001032221.4(STXBP1):c.1706C>T (p.Ser569Phe)	STXBP1|MIR3911	S569F	Normal	Non-syndromic intellectual disability	Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431152	9	130453057	9	127690778	431152	424655	rs1135401819	NC_000009.12:127690777:C:T	C	T	CLINICAL
NM_003011.4(SET):c.313C>T (p.His105Tyr)	SET	H118Y, H105Y, H96Y, H94Y	Normal	Intellectual disability, autosomal dominant 58	Pathogenic(Last reviewed: Aug 31, 2018)	no assertion criteria provided	VCV000560207	9	131454979	9	128692700	560207	551259	rs1564360978	NC_000009.12:128692699:C:T	C	T	CLINICAL
NM_001077365.2(POMT1):c.1087C>T (p.Gln363Ter)	POMT1	Q385*, Q211*, Q246*, Q309*, Q331*, Q333*, Q363*, Q268*, Q233*, Q359*	Normal	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|not provided	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095452	9	134388630	9	131513243	95452	101351	rs200056620	NC_000009.12:131513242:C:T	C	T	CLINICAL
NM_001077365.2(POMT1):c.1798C>T (p.Arg600Ter)	POMT1	R622*, R483*, R568*, R600*, R448*, R570*, R505*, R546*, R470*, R596*, R527*	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194859	9	134396832	9	131521445	194859	192022	rs794727208	NC_000009.12:131521444:C:T	C	T	CLINICAL
NM_001077365.2(POMT1):c.1892C>T (p.Pro631Leu)	POMT1	P653L, P479L, P514L, P536L, P577L, P601L, P599L, P631L, P501L, P558L, P627L	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1|Walker-Warburg congenital muscular dystrophy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000194962	9	134397500	9	131522113	194962	192124	rs149682171	NC_000009.12:131522112:C:T	C	T	CLINICAL
NM_001077365.2(POMT1):c.1921C>T (p.Leu641Phe)	POMT1	L663F, L587F, L641F, L524F, L546F, L611F, L489F, L609F, L511F, L637F, L568F	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B1	Pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000488581	9	134397529	9	131522142	488581	481449	rs777437871	NC_000009.12:131522141:C:T	C	T	CLINICAL
NM_015160.3(PMPCA):c.64C>T (p.Arg22Trp)	PMPCA	R22W	Normal	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic	no assertion criteria provided	VCV000375400	9	139305184	9	136410732	375400	362149	rs1057519454	NC_000009.12:136410731:C:T	C	T	CLINICAL
NM_015160.3(PMPCA):c.287C>T (p.Ser96Leu)	PMPCA	S96L	Normal	Spinocerebellar ataxia, autosomal recessive 2	Pathogenic(Last reviewed: Oct 12, 2016)	no assertion criteria provided	VCV000221564	9	139306954	9	136412502	221564	223293	rs869025292	NC_000009.12:136412501:C:T	C	T	CLINICAL
NM_016219.5(MAN1B1):c.172G>T (p.Glu58Ter)	MAN1B1	E58*	Normal	Mental retardation, autosomal recessive 15|not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000816942	9	139981623	9	137087171	816942	805616	rs753503405	NC_000009.12:137087170:G:T	G	T	CLINICAL
NM_016219.5(MAN1B1):c.1000C>T (p.Arg334Cys)	MAN1B1	R334C	Normal	MAN1B1-Related Disorders|Mental retardation, autosomal recessive 15	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030415	9	139995540	9	137101088	30415	39372	rs387906886	NC_000009.12:137101087:C:T	C	T	CLINICAL
NM_016219.5(MAN1B1):c.1942C>T (p.Gln648Ter)	MAN1B1	Q648*	Normal	Mental retardation, autosomal recessive 15	Likely pathogenic(Last reviewed: Jul 15, 2017)	criteria provided, single submitter	VCV000495322	9	140002885	9	137108433	495322	486814	rs1164484724	NC_000009.12:137108432:C:T	C	T	CLINICAL
NM_007327.4(GRIN1):c.2530C>T (p.Arg844Cys)	GRIN1	R844C, R865C	Normal	not provided|Inborn genetic diseases|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive|Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521354	9	140058297	9	137163845	521354	511828	rs1554770667	NC_000009.12:137163844:C:T	C	T	CLINICAL
NM_024757.5(EHMT1):c.871C>T (p.Arg291Ter)	EHMT1	R260*, R291*, R284*	Normal	Kleefstra syndrome 1	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000003608	9	140637870	9	137743418	3608	18647	rs137852714	NC_000009.12:137743417:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.1538G>T (p.Gly513Val)	SMARCA2	G513V	Normal	Intellectual disability	Likely pathogenic	no assertion criteria provided	VCV000829812	9	2060832	9	2060832	829812	818148	rs1586660338	NC_000009.12:2060831:G:T	G	T	CLINICAL
NM_003070.5(SMARCA2):c.1573C>T (p.Arg525Cys)	SMARCA2	R525C	Normal	Intellectual disability|BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2021)	no assertion criteria provided	VCV000829811	9	2060867	9	2060867	829811	818147	rs1586660370	NC_000009.12:2060866:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.1600G>T (p.Asp534Tyr)	SMARCA2	D534Y	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	VCV000217002	9	2060894	9	2060894	217002	213590	rs863224922	NC_000009.12:2060893:G:T	G	T	CLINICAL
NM_003070.5(SMARCA2):c.2486C>T (p.Thr829Ile)	SMARCA2	T829I	Normal	Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Oct 13, 2017)	criteria provided, single submitter	VCV000212225	9	2084156	9	2084156	212225	207701	rs797045974	NC_000009.12:2084155:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.2642G>T (p.Gly881Val)	SMARCA2	G881V	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030013	9	2086944	9	2086944	30013	38968	rs281875185	NC_000009.12:2086943:G:T	G	T	CLINICAL
NM_003070.5(SMARCA2):c.2648C>T (p.Pro883Leu)	SMARCA2	P883L	Normal	Nicolaides-Baraitser syndrome|not provided|SMARCA2-related BAFopathy	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV000030016	9	2086950	9	2086950	30016	38971	rs281875188	NC_000009.12:2086949:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.2786A>T (p.Glu929Val)	SMARCA2	E871V, E929V	Normal	BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME|Intellectual disability	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000827770	9	2088516	9	2088516	827770	815968	rs1586692481	NC_000009.12:2088515:A:T	A	T	CLINICAL
NM_003070.5(SMARCA2):c.2809C>T (p.Arg937Cys)	SMARCA2	R879C, R937C	Normal	Intellectual disability	Likely pathogenic	no assertion criteria provided	VCV000827771	9	2088539	9	2088539	827771	815969	rs1586692548	NC_000009.12:2088538:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.2810G>T (p.Arg937Leu)	SMARCA2	R879L, R937L	Normal	Intellectual disability|BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME	Pathogenic/Likely pathogenic(Last reviewed: Apr 30, 2021)	no assertion criteria provided	VCV000827773	9	2088540	9	2088540	827773	815971	rs1586692551	NC_000009.12:2088539:G:T	G	T	CLINICAL
NM_003070.5(SMARCA2):c.2815C>T (p.His939Tyr)	SMARCA2	H939Y, H881Y	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030018	9	2088545	9	2088545	30018	38973	rs281875190	NC_000009.12:2088544:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.3473A>T (p.Asp1158Val)	SMARCA2	D1158V, D1100V	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030011	9	2115838	9	2115838	30011	38966	rs281875240	NC_000009.12:2115837:A:T	A	T	CLINICAL
NM_003070.5(SMARCA2):c.3476G>T (p.Arg1159Leu)	SMARCA2	R1159L, R1101L	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030015	9	2115841	9	2115841	30015	38970	rs281875187	NC_000009.12:2115840:G:T	G	T	CLINICAL
NM_003070.5(SMARCA2):c.3602C>T (p.Ala1201Val)	SMARCA2	A1201V, A1143V	Normal	not provided|Intellectual disability|Hirsutism|Nicolaides-Baraitser syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030017	9	2115967	9	2115967	30017	38972	rs281875189	NC_000009.12:2115966:C:T	C	T	CLINICAL
NM_003070.5(SMARCA2):c.3604G>T (p.Gly1202Cys)	SMARCA2	G1202C, G1144C	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030009	9	2115969	9	2115969	30009	38964	rs281875239	NC_000009.12:2115968:G:T	G	T	CLINICAL
NM_003070.5(SMARCA2):c.3637C>T (p.Arg1213Trp)	SMARCA2	R1213W, R1155W	Normal	not provided|Nicolaides-Baraitser syndrome	Pathogenic(Last reviewed: Feb 26, 2012)	no assertion criteria provided	VCV000030008	9	2116002	9	2116002	30008	38963	rs281875238	NC_000009.12:2116001:C:T	C	T	CLINICAL
NM_003383.5(VLDLR):c.769C>T (p.Arg257Ter)	VLDLR	R257*, R216*	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1|Cerebellar ataxia and mental retardation with quadrupedal locomotion 1	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000012201	9	2643480	9	2643480	12201	27240	rs80338907	NC_000009.12:2643479:C:T	C	T	CLINICAL
NM_003383.5(VLDLR):c.1342C>T (p.Arg448Ter)	VLDLR	R448*, R407*	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Aug 26, 2008)	no assertion criteria provided	VCV000021381	9	2645603	9	2645603	21381	34233	rs80338905	NC_000009.12:2645602:C:T	C	T	CLINICAL
NM_003383.5(VLDLR):c.2117G>T (p.Cys706Phe)	VLDLR	C706F, C665F	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1	Pathogenic(Last reviewed: Sep 14, 2012)	no assertion criteria provided	VCV000064373	9	2650382	9	2650382	64373	75338	rs397514750	NC_000009.12:2650381:G:T	G	T	CLINICAL
NM_001031689.3(PLAA):c.1487-1G>A	PLAA		Normal	Inborn genetic diseases|Combined T and B cell immunodeficiency|Lymphadenopathy|Global developmental delay|Lymphoproliferative disorder|Split foot|Growth delay|Split hand|Microcephaly	Likely pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000598964	9	26913946	9	26913948	598964	590062	rs1426488816	NC_000009.12:26913947:C:T	C	T	CLINICAL
NM_000155.4(GALT):c.997C>T (p.Arg333Trp)	GALT	R333W, R224W	Normal	not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003610	9	34649499	9	34649502	3610	18649	rs111033800	NC_000009.12:34649501:C:T	C	T	CLINICAL
NM_032634.4(PIGO):c.2648-1G>A	PIGO		Normal	Hyperphosphatasia with mental retardation syndrome 2|not provided	Likely pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000451522	9	35090670	9	35090673	451522	444482	rs755750516	NC_000009.12:35090672:C:T	C	T	CLINICAL
NM_032634.4(PIGO):c.2007G>A (p.Trp669Ter)	PIGO	W669*	Normal	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000581964	9	35091877	9	35091880	581964	563243	rs1563996824	NC_000009.12:35091879:C:T	C	T	CLINICAL
NM_032634.4(PIGO):c.1959G>A (p.Trp653Ter)	PIGO	W653*	Normal	Hyperphosphatasia with mental retardation syndrome 2	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	VCV000565791	9	35091925	9	35091928	565791	569050	rs1391418639	NC_000009.12:35091927:C:T	C	T	CLINICAL
NM_014806.5(RUSC2):c.2596C>T (p.Arg866Ter)	RUSC2	R866*	Normal	Intellectual disability, autosomal recessive 61	Pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000446385	9	35555638	9	35555641	446385	439840	rs1402086660	NC_000009.12:35555640:C:T	C	T	CLINICAL
NM_014806.5(RUSC2):c.3952C>T (p.Arg1318Ter)	RUSC2	R1318*, R440*	Normal	Intellectual disability, autosomal recessive 61	Pathogenic(Last reviewed: Nov 27, 2017)	no assertion criteria provided	VCV000446386	9	35560589	9	35560592	446386	439841	rs1554645052	NC_000009.12:35560591:C:T	C	T	CLINICAL
NM_004972.3(JAK2):c.1849G>T (p.Val617Phe)	JAK2|INSL6	V617F, V212F, V468F	Normal	not provided|Primary familial polycythemia due to EPO receptor mutation|Myeloproliferative disorder|Myelofibrosis|Splenomegaly|Subacute lymphoid leukemia|Thrombocythemia 3|Myelofibrosis|Chronic myelogenous leukemia, BCR-ABL1 positive|Polycythemia vera|Polycythemia (disease)|Budd-Chiari syndrome, susceptibility to, somatic|Thrombocythemia 3|Myelofibrosis|Polycythemia vera|Primary familial polycythemia due to EPO receptor mutation|Budd-Chiari syndrome|Acute myeloid leukemia|Acute myeloid leukemia	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014662	9	5073770	9	5073770	14662	29701	rs77375493	NC_000009.12:5073769:G:T	G	T	CLINICAL
NM_001366145.2(TRPM3):c.3004G>A (p.Val1002Met)	TRPM3|KLF9-DT	V837M, V990M, V1002M, V1017M, V827M, V1027M, V849M, V1004M, V862M, V980M, V839M, V852M, V992M	Normal	Intellectual disability|Global developmental delay|Seizures|Mulibrey nanism syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000585073	9	73213379	9	70598463	585073	576134	rs1564493599	NC_000009.12:70598462:C:T	C	T	CLINICAL
NM_001698.2(AUH):c.895-1G>A	AUH		Normal	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Nov 28, 2006)	no assertion criteria provided	VCV000009057	9	93978389	9	91216107	9057	24096	rs730880309	NC_000009.12:91216106:C:T	C	T	CLINICAL
NM_001698.2(AUH):c.650G>A (p.Gly217Asp)	AUH	G217D, G108D, G188D	Normal	3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Sep 21, 2010)	no assertion criteria provided	VCV000030080	9	94058308	9	91296026	30080	39035	rs387906756	NC_000009.12:91296025:C:T	C	T	CLINICAL
NM_001698.2(AUH):c.559G>A (p.Gly187Ser)	AUH	G187S, G158S, G78S	Normal	not provided|3-Methylglutaconic aciduria type 1	Pathogenic(Last reviewed: Jun 30, 2014)	criteria provided, single submitter	VCV000030079	9	94060305	9	91298023	30079	39034	rs387906755	NC_000009.12:91298022:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.695C>A (p.Ala232Glu)	VCP	A232E, A187E	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000008470	9	35064164	9	35064167	8470	23509	rs121909331	NC_000009.12:35064166:G:T	G	T	CLINICAL
NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	NC_000009.12:35065254:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	Normal	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	NC_000009.12:35065350:C:T	C	T	CLINICAL
NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Normal	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	NC_000009.12:35065362:C:T	C	T	CLINICAL
NM_016628.5(WAC):c.374C>A (p.Ser125Ter)	WAC	S125*, S80*	Normal	Desanto-shinawi syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000219142	10	28872427	10	28583498	219142	216948	rs864321692	NC_000010.11:28583497:C:A	C	A	CLINICAL
NM_016628.5(WAC):c.1437+1G>A	WAC		Normal	not provided|Desanto-shinawi syndrome	Likely pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000438308	10	28900852	10	28611923	438308	431919	rs1554791124	NC_000010.11:28611922:G:A	G	A	CLINICAL
NM_016628.5(WAC):c.1721G>A (p.Trp574Ter)	WAC	W574*, W529*, W471*	Normal	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219140	10	28905266	10	28616337	219140	216946	rs864321690	NC_000010.11:28616336:G:A	G	A	CLINICAL
NM_016628.5(WAC):c.1746+1G>A	WAC		Normal	Desanto-shinawi syndrome	Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522961	10	28905292	10	28616363	522961	513592	rs1554791975	NC_000010.11:28616362:G:A	G	A	CLINICAL
NM_000314.7(PTEN):c.131G>A (p.Gly44Asp)	PTEN	G44D, G217D	Normal	PTEN hamartoma tumor syndrome|not provided	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427582	10	89653833	10	87894076	427582	416935	rs1085308042	NC_000010.11:87894075:G:A	G	A	CLINICAL
NM_000314.7(PTEN):c.253+2T>A	PTEN		Normal	PTEN hamartoma tumor syndrome|Glioma susceptibility 2|Macrocephaly/autism syndrome|Meningioma, familial|VACTERL association with hydrocephalus|PTEN hamartoma tumor syndrome|Malignant tumor of prostate|Cowden syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468676	10	89690848	10	87931091	468676	460360	rs1224040268	NC_000010.11:87931090:T:A	T	A	CLINICAL
NM_000314.7(PTEN):c.404T>A (p.Ile135Lys)	PTEN	I135K, I308K	Normal	Macrocephaly/autism syndrome|Malignant tumor of prostate|Meningioma, familial|Glioma susceptibility 2|Cowden syndrome 1|VACTERL association with hydrocephalus|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000428235	10	89692920	10	87933163	428235	419728	rs370795352	NC_000010.11:87933162:T:A	T	A	CLINICAL
NM_000314.7(PTEN):c.437T>A (p.Leu146Ter)	PTEN	L146*, L319*	Normal	not provided	Pathogenic(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	VCV000189488	10	89692953	10	87933196	189488	187356	rs786204933	NC_000010.11:87933195:T:A	T	A	CLINICAL
NM_001304718.2(PTEN):c.-92C>A	PTEN	T167N, T340N	Normal	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Nov 28, 2018)	reviewed by expert panel	VCV000039668	10	89711882	10	87952125	39668	48267	rs397514559	NC_000010.11:87952124:C:A	C	A	CLINICAL
NM_000314.8(PTEN):c.518G>A (p.Arg173His)	PTEN	R173H, R346H	Normal	Neoplasm of brain|not provided|PTEN hamartoma tumor syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376032	10	89711900	10	87952143	376032	362911	rs121913294	NC_000010.11:87952142:G:A	G	A	CLINICAL
NM_000314.8(PTEN):c.802-1G>A	PTEN		Normal	not provided|Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689447	10	89720650	10	87960893	689447	677041	rs1257124719	NC_000010.11:87960892:G:A	G	A	CLINICAL
NM_000314.7(PTEN):c.1004G>A (p.Arg335Gln)	PTEN	R335Q, R508Q, R138Q	Normal	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000427580	10	89720853	10	87961096	427580	416953	rs1085308040	NC_000010.11:87961095:G:A	G	A	CLINICAL
NM_020975.6(RET):c.1901G>A (p.Cys634Tyr)	RET	C634Y, C380Y	Normal	Medullary thyroid carcinoma|not provided|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not specified|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 4|Neoplasm	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013909	10	43609949	10	43114501	13909	28948	rs75996173	NC_000010.11:43114500:G:A	G	A	CLINICAL
NM_020975.6(RET):c.1826G>A (p.Cys609Tyr)	RET	C609Y, C355Y	Normal	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Hereditary cancer-predisposing syndrome|none provided|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE|Multiple endocrine neoplasia, type 2b|not provided|Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013933	10	43609070	10	43113622	13933	28972	rs77939446	NC_000010.11:43113621:G:A	G	A	CLINICAL
NC_000010.11:g.6072697C>A	IL2RA		Normal	TYPE 1 DIABETES MELLITUS, INSULIN-DEPENDENT, 10	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000014669	10	6114660	10	6072697	14669	29708	rs41295061	NC_000010.11:6072696:C:A	C	A	CLINICAL
NC_000010.10:g.6122009T>A	IL2RA		Normal	Diabetes mellitus, insulin-dependent, 10	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000014670	10	6122009	10	6080046	14670	29709	rs11594656	NC_000010.11:6080045:T:A	T	A	CLINICAL
NM_017649.5(CNNM2):c.364G>A (p.Glu122Lys)	CNNM2	E122K	Normal	Hypomagnesemia, seizures, and mental retardation 1	Pathogenic(Last reviewed: Oct 12, 2017)	no assertion criteria provided	VCV000192323	10	104678601	10	102918844	192323	190115	rs786205909	NC_000010.11:102918843:G:A	G	A	CLINICAL
NM_017649.5(CNNM2):c.1069G>A (p.Glu357Lys)	CNNM2	E357K	Normal	Hypomagnesemia, seizures, and mental retardation 1	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000192324	10	104679306	10	102919549	192324	190116	rs786205910	NC_000010.11:102919548:G:A	G	A	CLINICAL
NM_000141.5(FGFR2):c.870G>T (p.Trp290Cys)	FGFR2	W290C, W175C, W62C, W201C	Normal	not provided|FGFR2 related craniosynostosis|Craniofacial-skeletal-dermatologic dysplasia|Pfeiffer syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013293	10	123279562	10	121520048	13293	28332	rs121918499	NC_000010.11:121520047:C:A	C	A	CLINICAL
NM_001375380.1(EBF3):c.488G>T (p.Arg163Leu)	EBF3	R163L	Normal	Hypotonia, ataxia, and delayed development syndrome|Global developmental delay|Muscular hypotonia|Intellectual disability|Ataxia|Expressive language delay|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000268155	10	131755588	10	129957324	268155	263782	rs1057519389	NC_000010.11:129957323:C:A	C	A	CLINICAL
NM_004092.4(ECHS1):c.5C>T (p.Ala2Val)	ECHS1	A2V	Normal	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency|not provided|Leigh syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156434	10	135186833	10	133373329	156434	166207	rs587776498	NC_000010.11:133373328:G:A	G	A	CLINICAL
NM_006624.5(ZMYND11):c.1262G>A (p.Ser421Asn)	ZMYND11	S421N, S336N, S345N, S399N, S264N, S366N, S404N, S420N, S327N, S367N, S372N, S390N, S302N, S319N, S381N, S398N	Normal	not provided|Mental retardation, autosomal dominant 30|Intellectual disability	Likely pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000225254	10	294310	10	248370	225254	227161	rs869320713	NC_000010.11:248369:G:A	G	A	CLINICAL
NM_020987.5(ANK3):c.2659C>T (p.Gln887Ter)	ANK3	Q21*, Q887*, Q881*, Q888*	Normal	Mental retardation, autosomal recessive 37	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802576	10	61898801	10	60139043	802576	790967	rs1590691724	NC_000010.11:60139042:G:A	G	A	CLINICAL
NM_001083116.3(PRF1):c.673C>T (p.Arg225Trp)	PRF1	R225W	Normal	Familial hemophagocytic lymphohistiocytosis 2	Pathogenic(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000013711	10	72358804	10	70599048	13711	28750	rs28933973	NC_000010.11:70599047:G:A	G	A	CLINICAL
NM_006721.4(ADK):c.89G>A (p.Gly30Glu)	ADK	G13E, G30E	Normal	Adenosine kinase deficiency	Pathogenic(Last reviewed: Oct 7, 2011)	no assertion criteria provided	VCV000029605	10	75960545	10	74200787	29605	38559	rs397514454	NC_000010.11:74200786:G:A	G	A	CLINICAL
NM_006721.4(ADK):c.953C>A (p.Ala318Glu)	ADK	A301E, A318E, A261E, A244E, H280N, A283E	Normal	Adenosine kinase deficiency	Pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000029603	10	76430016	10	74670258	29603	38557	rs397514452	NC_000010.11:74670257:C:A	C	A	CLINICAL
NM_012330.4(KAT6B):c.3147G>A (p.Pro1049=)	KAT6B		Normal	Blepharophimosis - intellectual disability syndrome, SBBYS type|not provided|Intellectual disability	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279815	10	76781764	10	75022006	279815	264349	rs886041207	NC_000010.11:75022005:G:A	G	A	CLINICAL
NM_012330.4(KAT6B):c.3664+1G>A	KAT6B		Normal	Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: May 5, 2015)	criteria provided, single submitter	VCV000369663	10	76785008	10	75025250	369663	353900	rs1057516033	NC_000010.11:75025249:G:A	G	A	CLINICAL
NM_000314.7(PTEN):c.634+5G>A	PTEN		Normal	Intellectual disability|not provided|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Mar 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280031	10	89712021	10	87952264	280031	264490	rs138336847	NC_000010.11:87952263:G:A	G	A	CLINICAL
NM_004523.4(KIF11):c.381G>A (p.Trp127Ter)	KIF11	W127*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation|Syndromic retinitis pigmentosa	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	no assertion criteria provided	VCV000810629	10	94366988	10	92607231	810629	798919	rs1589590737	NC_000010.11:92607230:G:A	G	A	CLINICAL
NM_004523.4(KIF11):c.790-1G>A	KIF11		Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Nov 1, 2014)	no assertion criteria provided	VCV000183017	10	94373133	10	92613376	183017	181168	rs730882122	NC_000010.11:92613375:G:A	G	A	CLINICAL
NM_004523.4(KIF11):c.1305+1G>A	KIF11		Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Likely pathogenic(Last reviewed: Jan 4, 2018)	no assertion criteria provided	VCV000807619	10	94388653	10	92628896	807619	798628	rs1589600695	NC_000010.11:92628895:G:A	G	A	CLINICAL
NM_004523.4(KIF11):c.2548-1G>A	KIF11		Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000435615	10	94407968	10	92648211	435615	429148	rs1554863016	NC_000010.11:92648210:G:A	G	A	CLINICAL
NM_002860.4(ALDH18A1):c.2350C>T (p.His784Tyr)	ALDH18A1	H784Y, H671Y, H572Y, H673Y, H749Y, H782Y	Normal	Cutis laxa, autosomal recessive IIIA	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000016086	10	97366557	10	95606800	16086	31125	rs121434583	NC_000010.11:95606799:G:A	G	A	CLINICAL
NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	R334Q	Normal	Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Infantile onset spinocerebellar ataxia|Mitochondrial diseases|not provided	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004623	10	102748968	10	100989211	4623	19662	rs28937887	NC_000010.11:100989210:G:A	G	A	CLINICAL
NM_145868.2(ANXA11):c.119A>G (p.Asp40Gly)	ANXA11	D40G, D7G	Normal	Amyotrophic lateral sclerosis type 23	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000488353	10	81930608	10	80170852	488353	481193	rs1247392012	NC_000010.11:80170851:T:C	T	C	CLINICAL
NM_004521.3(KIF5B):c.2252A>G (p.His751Arg)	KIF5B	H751R	Normal	Attention deficit hyperactivity disorder|Global developmental delay|Brain atrophy|Hypoplasia of the corpus callosum|Seizures	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242891	10	32308840	10	32019912	242891	243987	rs1114167297	NC_000010.11:32019911:T:C	T	C	CLINICAL
NM_032776.3(JMJD1C):c.5863-6T>G	JMJD1C		Normal	not provided	Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000804311	10	64952917	10	63193157	804311	792681	rs1589111139	NC_000010.11:63193156:A:C	A	C	CLINICAL
NM_000314.7(PTEN):c.35A>C (p.Asn12Thr)	PTEN	N12T, N185T	Normal	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000427586	10	89624261	10	87864504	427586	416933	rs1085308044	NC_000010.11:87864503:A:C	A	C	CLINICAL
NM_000314.7(PTEN):c.45A>C (p.Arg15Ser)	PTEN	R15S, R188S	Normal	Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428194	10	89624271	10	87864514	428194	419693	rs1064794096	NC_000010.11:87864513:A:C	A	C	CLINICAL
NM_000314.7(PTEN):c.164+1G>C	PTEN		Normal	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000427583	10	89653867	10	87894110	427583	416936	rs1554893835	NC_000010.11:87894109:G:C	G	C	CLINICAL
NM_000314.7(PTEN):c.202T>C (p.Tyr68His)	PTEN	Y68H, Y241H	Normal	not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189474	10	89685307	10	87925550	189474	187338	rs398123317	NC_000010.11:87925549:T:C	T	C	CLINICAL
NM_000314.8(PTEN):c.302T>C (p.Ile101Thr)	PTEN	I101T, I274T	Normal	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000822660	10	89692818	10	87933061	822660	810095	rs1339631701	NC_000010.11:87933060:T:C	T	C	CLINICAL
NM_000314.7(PTEN):c.401T>C (p.Met134Thr)	PTEN	M134T, M307T	Normal	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	VCV000427588	10	89692917	10	87933160	427588	416941	rs1085308046	NC_000010.11:87933159:T:C	T	C	CLINICAL
NM_000314.8(PTEN):c.406T>C (p.Cys136Arg)	PTEN	C136R, C309R	Normal	Mediastinal germ cell tumor|Acute megakaryoblastic leukemia|Neoplasm of ovary|Cowden syndrome|Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Sep 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183726	10	89692922	10	87933165	183726	183028	rs786201044	NC_000010.11:87933164:T:C	T	C	CLINICAL
NM_000314.7(PTEN):c.722T>C (p.Phe241Ser)	PTEN	F241S, F414S, F44S	Normal	PTEN hamartoma tumor syndrome|Macrocephaly/autism syndrome	Likely pathogenic(Last reviewed: Nov 28, 2018)	reviewed by expert panel	VCV000007850	10	89717697	10	87957940	7850	22889	rs121909240	NC_000010.11:87957939:T:C	T	C	CLINICAL
NM_000314.7(PTEN):c.740T>C (p.Leu247Ser)	PTEN	L247S, L50S, L420S	Normal	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Jun 25, 2019)	reviewed by expert panel	VCV000223142	10	89717715	10	87957958	223142	224868	rs1057519368	NC_000010.11:87957957:T:C	T	C	CLINICAL
NM_005445.3(SMC3):c.587T>C (p.Ile196Thr)	SMC3	I196T	Normal	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Aug 30, 2014)	criteria provided, single submitter	VCV000209193	10	112341720	10	110581962	209193	205764	rs797045070	NC_000010.11:110581961:T:C	T	C	CLINICAL
NM_020975.6(RET):c.1900T>C (p.Cys634Arg)	RET	C634R, C380R	Normal	Pheochromocytoma|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 4|not specified|Multiple endocrine neoplasia, type 2|Thyroid carcinoma|not provided|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013917	10	43609948	10	43114500	13917	28956	rs75076352	NC_000010.11:43114499:T:C	T	C	CLINICAL
NM_001146274.2(TCF7L2):c.552+7162G>C	TCF7L2		Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007415	10	114807047	10	113047288	7415	22454	rs11196205	NC_000010.11:113047287:G:C	G	C	CLINICAL
NM_000141.5(FGFR2):c.1576A>G (p.Lys526Glu)	FGFR2	K526E, K527E, K437E, K298E, K409E, K414E, K438E, K410E, K411E, K524E	Normal	Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000013295	10	123258105	10	121498591	13295	28334	rs121918507	NC_000010.11:121498590:T:C	T	C	CLINICAL
NM_000141.5(FGFR2):c.1124A>G (p.Tyr375Cys)	FGFR2	Y375C, Y376C, Y263C, Y147C, Y286C, Y287C, Y260C	Normal	Crouzon syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Neoplasm of stomach|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Bent bone dysplasia syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Levy-Hollister syndrome|not provided|Beare-Stevenson cutis gyrata syndrome|FGFR2 related craniosynostosis|Endometrial neoplasm|Endometrial carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013277	10	123274794	10	121515280	13277	28316	rs121913478	NC_000010.11:121515279:T:C	T	C	CLINICAL
NM_000141.5(FGFR2):c.758C>G (p.Pro253Arg)	FGFR2	P253R, P138R, P164R, P25R	Normal	not provided|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Pfeiffer syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Levy-Hollister syndrome|Bent bone dysplasia syndrome|Neoplasm of stomach|Acrocephalosyndactyly type I|Head and Neck Neoplasms|FGFR2 related craniosynostosis|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Acrocephalosyndactyly type I	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013273	10	123279674	10	121520160	13273	28312	rs77543610	NC_000010.11:121520159:G:C	G	C	CLINICAL
NM_000141.5(FGFR2):c.755C>G (p.Ser252Trp)	FGFR2	S252W, S137W, S163W, S24W	Normal	not provided|Acrocephalosyndactyly type I|Endometrial carcinoma|Acrocephalosyndactyly|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation|Endometrial neoplasm|FGFR2 related craniosynostosis|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm of stomach|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Levy-Hollister syndrome|Acrocephalosyndactyly type I|Bent bone dysplasia syndrome|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013272	10	123279677	10	121520163	13272	28311	rs79184941	NC_000010.11:121520162:G:C	G	C	CLINICAL
NM_022970.3(FGFR2):c.314A>G (p.Tyr105Cys)	FGFR2	Y105C	Normal	not provided|FGFR2 related craniosynostosis|Bent bone dysplasia syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Neoplasm of stomach	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449024	10	123325014	10	121565500	449024	444566	rs1434545235	NC_000010.11:121565499:T:C	T	C	CLINICAL
NM_004092.4(ECHS1):c.2T>G (p.Met1Arg)	ECHS1	M1R	Normal	Mitochondrial short-chain enoyl-coa hydratase 1 deficiency|Leigh syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2015)	no assertion criteria provided	VCV000156433	10	135186836	10	133373332	156433	166206	rs587776497	NC_000010.11:133373331:A:C	A	C	CLINICAL
NM_004521.3(KIF5B):c.2252A>G (p.His751Arg)	KIF5B	H751R	Normal	Attention deficit hyperactivity disorder|Global developmental delay|Brain atrophy|Hypoplasia of the corpus callosum|Seizures	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242891	10	32308840	10	32019912	242891	243987	rs1114167297	NC_000010.11:32019911:T:C	T	C	CLINICAL
NM_006721.4(ADK):c.704A>C (p.Asp235Ala)	ADK|LOC102723439	D218A, D235A, D200A	Normal	Adenosine kinase deficiency	Pathogenic(Last reviewed: Oct 7, 2011)	no assertion criteria provided	VCV000029604	10	76285162	10	74525404	29604	38558	rs397514453	NC_000010.11:74525403:A:C	A	C	CLINICAL
NM_004523.4(KIF11):c.1634T>C (p.Met545Thr)	KIF11	M545T	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Likely pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666590	10	94392382	10	92632625	666590	654135	rs1564713037	NC_000010.11:92632624:T:C	T	C	CLINICAL
NM_004523.4(KIF11):c.2547+2T>C	KIF11		Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029772	10	94405401	10	92645644	29772	38727	rs730882063	NC_000010.11:92645643:T:C	T	C	CLINICAL
NM_016628.5(WAC):c.498-2A>G	WAC		Normal	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431093	10	28879647	10	28590718	431093	424616	rs1135401769	NC_000010.11:28590717:A:G	A	G	CLINICAL
NM_000314.7(PTEN):c.1A>G (p.Met1Val)	PTEN	M1V, M174V	Normal	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Nov 22, 2019)	reviewed by expert panel	VCV000484600	10	89624227	10	87864470	484600	475363	rs1554890324	NC_000010.11:87864469:A:G	A	G	CLINICAL
NM_000314.7(PTEN):c.40A>G (p.Arg14Gly)	PTEN	R14G, R187G	Normal	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000427589	10	89624266	10	87864509	427589	416934	rs1085308047	NC_000010.11:87864508:A:G	A	G	CLINICAL
NM_000314.7(PTEN):c.165-2A>G	PTEN		Normal	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000427584	10	89685268	10	87925511	427584	416937	rs1085308043	NC_000010.11:87925510:A:G	A	G	CLINICAL
NM_000314.7(PTEN):c.278A>G (p.His93Arg)	PTEN	H93R, H266R	Normal	PTEN hamartoma tumor syndrome|Macrocephaly/autism syndrome	Pathogenic(Last reviewed: Nov 28, 2018)	reviewed by expert panel	VCV000007848	10	89692794	10	87933037	7848	22887	rs121909238	NC_000010.11:87933036:A:G	A	G	CLINICAL
NM_000314.7(PTEN):c.369C>G (p.His123Gln)	PTEN	H123Q, H296Q	Normal	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000427587	10	89692885	10	87933128	427587	416940	rs1085308045	NC_000010.11:87933127:C:G	C	G	CLINICAL
NM_000314.7(PTEN):c.416T>G (p.Leu139Ter)	PTEN	L139*, L312*	Normal	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000427590	10	89692932	10	87933175	427590	416942	rs1085308048	NC_000010.11:87933174:T:G	T	G	CLINICAL
NM_000314.8(PTEN):c.635-3C>G	PTEN		Normal	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 22, 2019)	reviewed by expert panel	VCV000427599	10	89717607	10	87957850	427599	416949	rs1085308056	NC_000010.11:87957849:C:G	C	G	CLINICAL
NM_000314.7(PTEN):c.755A>G (p.Asp252Gly)	PTEN	D252G, D55G, D425G	Normal	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Likely pathogenic(Last reviewed: Jul 25, 2018)	reviewed by expert panel	VCV000007849	10	89717730	10	87957973	7849	22888	rs121909239	NC_000010.11:87957972:A:G	A	G	CLINICAL
NM_000314.7(PTEN):c.860C>G (p.Ser287Ter)	PTEN	S287*, S90*, S460*	Normal	Bannayan-Riley-Ruvalcaba syndrome|Cowden syndrome 1|Macrocephaly/autism syndrome|VACTERL association with hydrocephalus|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|Meningioma, familial|Malignant tumor of prostate|Cowden syndrome 1|Macrocephaly/autism syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000216987	10	89720709	10	87960952	216987	213602	rs863224909	NC_000010.11:87960951:C:G	C	G	CLINICAL
NM_000314.7(PTEN):c.959T>G (p.Leu320Ter)	PTEN	L320*, L123*, L493*	Normal	Hereditary cancer-predisposing syndrome|Macrocephaly/autism syndrome	Pathogenic(Last reviewed: Jan 15, 2015)	criteria provided, single submitter	VCV000428253	10	89720808	10	87961051	428253	419766	rs1114167667	NC_000010.11:87961050:T:G	T	G	CLINICAL
NM_017649.5(CNNM2):c.806C>G (p.Ser269Trp)	CNNM2	S269W	Normal	Hypomagnesemia, seizures, and mental retardation 1	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000192325	10	104679043	10	102919286	192325	190117	rs794726858	NC_000010.11:102919285:C:G	C	G	CLINICAL
NM_014023.4(WDR37):c.386C>G (p.Ser129Cys)	WDR37	S129C	Normal	Dysmorphism|Developmental delay|Intellectual disability|Congenital cerebellar hypoplasia|Epilepsy|Congenital ocular coloboma|Neurooculocardiogenitourinary syndrome	Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000633616	10	1126406	10	1080466	633616	622049	rs1589088702	NC_000010.11:1080465:C:G	C	G	CLINICAL
NM_005445.3(SMC3):c.1942A>G (p.Met648Val)	SMC3	M648V	Normal	not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279893	10	112352960	10	110593202	279893	264423	rs886041239	NC_000010.11:110593201:A:G	A	G	CLINICAL
NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	SHOC2	S2G	Normal	Inborn genetic diseases|not provided|Noonan syndrome|not specified|Noonan syndrome-like disorder with loose anagen hair 1|Rasopathy|Noonan syndrome-like disorder with loose anagen hair	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000006821	10	112724120	10	110964362	6821	21860	rs267607048	NC_000010.11:110964361:A:G	A	G	CLINICAL
NM_014317.5(PDSS1):c.924T>G (p.Asp308Glu)	PDSS1	D308E, D138E	Normal	Coenzyme Q10 deficiency, primary, 2	Pathogenic(Last reviewed: Jun 7, 2016)	no assertion criteria provided	VCV000003237	10	27024406	10	26735477	3237	18276	rs119463988	NC_000010.11:26735476:T:G	T	G	CLINICAL
NM_001367534.1(CAMK2G):c.875G>C (p.Arg292Pro)	CAMK2G	R292P, R210P, R284P, R188P, R41P, R70P	Normal	Intellectual disability, severe|Generalized hypotonia|Intellectual disability, severe|Autistic disorder of childhood onset|Global developmental delay	Likely pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000039975	10	75602244	10	73842486	39975	48495	rs397514627	NC_000010.11:73842485:C:G	C	G	CLINICAL
NM_012330.4(KAT6B):c.4993A>G (p.Ser1665Gly)	KAT6B|DUSP29	S1319G, S1665G, S1102G, S1310G, S884G, S1482G, S970G, S1373G	Normal	Genitopatellar syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802592	10	76789575	10	75029817	802592	790984	rs1589844927	NC_000010.11:75029816:A:G	A	G	CLINICAL
NM_007055.4(POLR3A):c.2471A>C (p.His824Pro)	POLR3A	H824P	Normal	Leukodystrophy, hypomyelinating, 4	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000590969	10	79760741	10	78000983	590969	581913	rs1564617866	NC_000010.11:78000982:T:G	T	G	CLINICAL
NM_000314.7(PTEN):c.203A>G (p.Tyr68Cys)	PTEN	Y68C, Y241C	Normal	Cowden syndrome 1|Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome|Developmental regression|Microcephaly|Seizures|Infantile spasms|Cortical visual impairment|Global developmental delay|Autistic disorder of childhood onset|Cognitive impairment	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233777	10	89685308	10	87925551	233777	233846	rs876660634	NC_000010.11:87925550:A:G	A	G	CLINICAL
NM_002860.4(ALDH18A1):c.359T>C (p.Val120Ala)	ALDH18A1	V120A, V9A	Normal	de Barsy syndrome|Cutis laxa, autosomal dominant 3|Hereditary spastic paraplegia 9A|Hereditary spastic paraplegia 9A	Pathogenic(Last reviewed: Jan 15, 2019)	criteria provided, single submitter	VCV000217118	10	97397138	10	95637381	217118	213763	rs863224945	NC_000010.11:95637380:A:G	A	G	CLINICAL
NM_001001412.3(CALHM1):c.461G>A (p.Arg154His)	CALHM1	R154H	Normal	not provided	Likely pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000381737	10	105218048	10	103458291	381737	371133	rs371900329	NC_000010.11:103458290:C:T	C	T	CLINICAL
NM_016628.5(WAC):c.1537C>T (p.Arg513Ter)	WAC	R513*, R468*, R410*	Normal	not provided|Desanto-shinawi syndrome	Pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000584445	10	28903595	10	28614666	584445	575493	rs1564421528	NC_000010.11:28614665:C:T	C	T	CLINICAL
NM_016628.5(WAC):c.1648C>T (p.Arg550Ter)	WAC	R505*, R550*, R447*	Normal	not provided|Desanto-shinawi syndrome	Pathogenic(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000496763	10	28905193	10	28616264	496763	488205	rs1554791943	NC_000010.11:28616263:C:T	C	T	CLINICAL
NM_016628.5(WAC):c.1852C>T (p.Gln618Ter)	WAC	Q618*, Q573*, Q515*	Normal	Desanto-shinawi syndrome	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219143	10	28906691	10	28617762	219143	216949	rs864321634	NC_000010.11:28617761:C:T	C	T	CLINICAL
NM_000314.7(PTEN):c.320A>T (p.Asp107Val)	PTEN	D107V, D280V	Normal	PTEN hamartoma tumor syndrome|not provided	Pathogenic(Last reviewed: Jun 25, 2019)	reviewed by expert panel	VCV000372481	10	89692836	10	87933079	372481	359885	rs786204858	NC_000010.11:87933078:A:T	A	T	CLINICAL
NM_000314.7(PTEN):c.388C>T (p.Arg130Ter)	PTEN	R130*, R303*	Normal	Macrocephaly/autism syndrome|Glioma susceptibility 2|Cowden syndrome 1|Abnormality of cardiovascular system morphology|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of brain|PTEN hamartoma tumor syndrome|Rhabdomyosarcoma (disease)|none provided|Neoplasm of ovary	Pathogenic(Last reviewed: Jan 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007819	10	89692904	10	87933147	7819	22858	rs121909224	NC_000010.11:87933146:C:T	C	T	CLINICAL
NM_001304718.2(PTEN):c.-359C>T	PTEN	T131I, T304I	Normal	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Nov 28, 2018)	reviewed by expert panel	VCV000039669	10	89692908	10	87933151	39669	48268	rs397514560	NC_000010.11:87933150:C:T	C	T	CLINICAL
NM_000314.7(PTEN):c.517C>T (p.Arg173Cys)	PTEN	R173C, R346C	Normal	not provided|Neoplasm of brain|PTEN hamartoma tumor syndrome|not specified|Hereditary cancer-predisposing syndrome|Macrocephaly/autism syndrome|Cowden syndrome 1|VACTERL association with hydrocephalus|Macrocephaly/autism syndrome|Meningioma, familial|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Glioma susceptibility 2|VACTERL association with hydrocephalus|Malignant tumor of prostate	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	VCV000189500	10	89711899	10	87952142	189500	187363	rs121913293	NC_000010.11:87952141:C:T	C	T	CLINICAL
NM_000314.7(PTEN):c.640C>T (p.Gln214Ter)	PTEN	Q214*, Q387*, Q17*	Normal	Inborn genetic diseases|not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Macrocephaly/autism syndrome|Cowden syndrome 1	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007827	10	89717615	10	87957858	7827	22866	rs121909227	NC_000010.11:87957857:C:T	C	T	CLINICAL
NM_000314.7(PTEN):c.697C>T (p.Arg233Ter)	PTEN	R233*, R406*, R36*	Normal	Glioblastoma|Cowden syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of ovary|Abnormality of cardiovascular system morphology|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Macrocephaly/autism syndrome|Non-small cell lung cancer|none provided|Neoplasm of the large intestine	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007813	10	89717672	10	87957915	7813	22852	rs121909219	NC_000010.11:87957914:C:T	C	T	CLINICAL
NM_000314.8(PTEN):c.737C>T (p.Pro246Leu)	PTEN	P246L, P49L, P419L	Normal	Breast and/or ovarian cancer|PTEN hamartoma tumor syndrome|not provided|Cowden syndrome 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	VCV000142269	10	89717712	10	87957955	142269	151983	rs587782350	NC_000010.11:87957954:C:T	C	T	CLINICAL
NM_000314.8(PTEN):c.1003C>T (p.Arg335Ter)	PTEN	R335*, R508*, R138*	Normal	Macrocephaly/autism syndrome|Proteus-like syndrome|Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Inborn genetic diseases|Cowden syndrome|PTEN hamartoma tumor syndrome|VACTERL association with hydrocephalus|Glioma susceptibility 2|Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome|Meningioma, familial|Cowden syndrome 1|Malignant tumor of prostate|PTEN-related disorder|Macrocephaly/autism syndrome|Cowden syndrome 1|Neoplasm of ovary	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007833	10	89720852	10	87961095	7833	22872	rs121909231	NC_000010.11:87961094:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.247C>T (p.Arg83Ter)	KIF11	R83*	Normal	not provided|Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424002	10	94366412	10	92606655	424002	408021	rs1064796738	NC_000010.11:92606654:C:T	C	T	CLINICAL
NM_018344.6(SLC29A3):c.1330G>T (p.Glu444Ter)	SLC29A3	E444*, E366*	Normal	not provided|Histiocytosis-lymphadenopathy plus syndrome	Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000564	10	73122267	10	71362510	564	15603	rs267607056	NC_000010.11:71362509:G:T	G	T	CLINICAL
NM_020975.6(RET):c.1891G>T (p.Asp631Tyr)	RET	D631Y, D377Y	Normal	Multiple endocrine neoplasia, type 2a|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 8, 2015)	criteria provided, single submitter	VCV000024914	10	43609939	10	43114491	24914	36255	rs377767406	NC_000010.11:43114490:G:T	G	T	CLINICAL
NM_001146274.2(TCF7L2):c.552+9017G>T	TCF7L2		Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jan 1, 2008)	no assertion criteria provided	VCV000007414	10	114808902	10	113049143	7414	22453	rs12255372	NC_000010.11:113049142:G:T	G	T	CLINICAL
NM_014023.4(WDR37):c.356C>T (p.Ser119Phe)	WDR37	S119F	Normal	Dysmorphism|Developmental delay|Intellectual disability|Congenital cerebellar hypoplasia|Epilepsy|Congenital ocular coloboma|Neurooculocardiogenitourinary syndrome	Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000633617	10	1126376	10	1080436	633617	622048	rs1589088690	NC_000010.11:1080435:C:T	C	T	CLINICAL
NM_014023.4(WDR37):c.374C>T (p.Thr125Ile)	WDR37	T125I	Normal	Neurooculocardiogenitourinary syndrome|Congenital ocular coloboma|Dysmorphism|Intellectual disability|Epilepsy|Developmental delay|Congenital cerebellar hypoplasia|Congenital cerebellar hypoplasia|Cerebellar vermis hypoplasia|Ventriculomegaly|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000440948	10	1126394	10	1080454	440948	434634	rs1554823375	NC_000010.11:1080453:C:T	C	T	CLINICAL
NM_014023.4(WDR37):c.389C>T (p.Thr130Ile)	WDR37	T130I	Normal	Dysmorphism|Developmental delay|Intellectual disability|Congenital cerebellar hypoplasia|Epilepsy|Congenital ocular coloboma|Neurooculocardiogenitourinary syndrome	Likely pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000633618	10	1126409	10	1080469	633618	622050	rs1589088703	NC_000010.11:1080468:C:T	C	T	CLINICAL
NM_000141.5(FGFR2):c.1150G>A (p.Gly384Arg)	FGFR2	G384R, G385R, G156R, G295R, G269R, G296R, G272R	Normal	FGFR2 related craniosynostosis|Bent bone dysplasia syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Neoplasm of stomach	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000478046	10	123274768	10	121515254	478046	459906	rs1554927408	NC_000010.11:121515253:C:T	C	T	CLINICAL
NM_000141.5(FGFR2):c.1032G>A (p.Ala344=)	FGFR2		Normal	not provided|Beare-Stevenson cutis gyrata syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Jackson-Weiss syndrome|Saethre-Chotzen syndrome|Crouzon syndrome|Pfeiffer syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Levy-Hollister syndrome|Bent bone dysplasia syndrome|Neoplasm of stomach|Acrocephalosyndactyly type I|Craniosynostosis syndrome|FGFR2 related craniosynostosis|Crouzon syndrome|Craniosynostosis, nonclassifiable autosomal dominant|Scaphocephaly and axenfeld-rieger anomaly	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013268	10	123276885	10	121517371	13268	28307	rs121918491	NC_000010.11:121517370:C:T	C	T	CLINICAL
NM_000141.5(FGFR2):c.1025G>A (p.Cys342Tyr)	FGFR2	C342Y, C253Y, C227Y, C114Y	Normal	Crouzon syndrome|Pfeiffer syndrome|not provided|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|FGFR2 related craniosynostosis|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Neoplasm of stomach|Pfeiffer syndrome|Acrocephalosyndactyly type I|Beare-Stevenson cutis gyrata syndrome|Bent bone dysplasia syndrome|Levy-Hollister syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Jackson-Weiss syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013263	10	123276892	10	121517378	13263	28302	rs121918487	NC_000010.11:121517377:C:T	C	T	CLINICAL
NM_000141.5(FGFR2):c.1013G>A (p.Gly338Glu)	FGFR2	G338E, G249E, G110E, G223E	Normal	FGFR2 related craniosynostosis|Bent bone dysplasia syndrome|Beare-Stevenson cutis gyrata syndrome|Pfeiffer syndrome|Jackson-Weiss syndrome|Levy-Hollister syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Crouzon syndrome|Saethre-Chotzen syndrome|Acrocephalosyndactyly type I|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Neoplasm of stomach|Crouzon syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374817	10	123276904	10	121517390	374817	361713	rs1057519044	NC_000010.11:121517389:C:T	C	T	CLINICAL
NM_002775.5(HTRA1):c.904C>T (p.Arg302Ter)	HTRA1	R302*	Normal	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2|CARASIL syndrome|Small vessel cerebrovascular disease|Personality changes|Seizures|Cognitive impairment	Likely pathogenic(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000007488	10	124266333	10	122506817	7488	22527	rs113993970	NC_000010.11:122506816:C:T	C	T	CLINICAL
NM_001375380.1(EBF3):c.512G>A (p.Gly171Asp)	EBF3	G171D	Normal	Hypotonia, ataxia, and delayed development syndrome|Renal dysplasia|Broad-based gait|Developmental regression|Neurogenic bladder|Generalized hypotonia	Pathogenic(Last reviewed: May 4, 2021)	no assertion criteria provided	VCV000375375	10	131755564	10	129957300	375375	362152	rs1057519437	NC_000010.11:129957299:C:T	C	T	CLINICAL
NM_001375380.1(EBF3):c.488G>A (p.Arg163Gln)	EBF3	R163Q	Normal	Hypotonia, ataxia, and delayed development syndrome|Ataxia|Intellectual disability|Global developmental delay|Muscular hypotonia|Expressive language delay|Inborn genetic diseases|Robin sequence	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000268156	10	131755588	10	129957324	268156	263783	rs1057519389	NC_000010.11:129957323:C:T	C	T	CLINICAL
NM_006624.5(ZMYND11):c.22C>T (p.Arg8Ter)	ZMYND11	R8*	Normal	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000393552	10	225974	10	180034	393552	380443	rs1060499626	NC_000010.11:180033:C:T	C	T	CLINICAL
NM_006624.5(ZMYND11):c.76C>T (p.Arg26Trp)	ZMYND11	R26W	Normal	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431123	10	226028	10	180088	431123	424656	rs1135401797	NC_000010.11:180087:C:T	C	T	CLINICAL
NM_006624.5(ZMYND11):c.82C>T (p.Gln28Ter)	ZMYND11	Q28*	Normal	Mental retardation, autosomal dominant 30|not provided	Pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000451936	10	226034	10	180094	451936	444578	rs1554767754	NC_000010.11:180093:C:T	C	T	CLINICAL
NM_006624.5(ZMYND11):c.976C>T (p.Gln326Ter)	ZMYND11	Q326*, Q232*, Q286*, Q304*, Q169*, Q241*, Q300*, Q309*, Q207*, Q224*, Q250*, Q271*, Q272*, Q295*, Q325*	Normal	Mental retardation, autosomal dominant 30	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157552	10	292731	10	246791	157552	167415	rs672601340	NC_000010.11:246790:C:T	C	T	CLINICAL
NM_006624.5(ZMYND11):c.1798C>T (p.Arg600Trp)	ZMYND11	R600W, R481W, R498W, R506W, R515W, R569W, R577W, R545W, R551W, R578W, R560W, R599W, R443W, R524W, R546W, R583W	Normal	Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 30|Global developmental delay	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208648	10	298399	10	252459	208648	205263	rs797044854	NC_000010.11:252458:C:T	C	T	CLINICAL
NM_006721.4(ADK):c.1031C>T (p.Ala344Val)	ADK	A327V, A270V, A287V, A309V, A344V	Normal	Adenosine kinase deficiency	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802589	10	76468145	10	74708387	802589	790981	rs1589387419	NC_000010.11:74708386:C:T	C	T	CLINICAL
NM_012330.4(KAT6B):c.2299C>T (p.His767Tyr)	KAT6B	H126Y, H412Y, H475Y, H584Y, H767Y	Normal	Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Dec 26, 2019)	no assertion criteria provided	VCV000828179	10	76741612	10	74981854	828179	816515	rs1589750251	NC_000010.11:74981853:C:T	C	T	CLINICAL
NM_012330.4(KAT6B):c.3172C>T (p.Arg1058Ter)	KAT6B	R1058*, R277*, R495*, R712*, R363*, R703*, R766*, R875*	Normal	Genitopatellar syndrome|Blepharophimosis - intellectual disability syndrome, SBBYS type|Genitopatellar syndrome|not provided|Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Sep 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523902	10	76781789	10	75022031	523902	514612	rs1554843815	NC_000010.11:75022030:C:T	C	T	CLINICAL
NM_012330.4(KAT6B):c.3256G>T (p.Glu1086Ter)	KAT6B	E1086*, E903*, E391*, E740*, E305*, E523*, E731*, E794*	Normal	Blepharophimosis - intellectual disability syndrome, SBBYS type	Likely pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000559862	10	76781873	10	75022115	559862	550617	rs751215527	NC_000010.11:75022114:G:T	G	T	CLINICAL
NM_012330.4(KAT6B):c.3349C>T (p.Gln1117Ter)	KAT6B	Q1117*, Q762*, Q771*, Q934*, Q336*, Q422*, Q554*, Q825*	Normal	Intellectual disability|not provided	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000450178	10	76781966	10	75022208	450178	444652	rs1554843977	NC_000010.11:75022207:C:T	C	T	CLINICAL
NM_012330.4(KAT6B):c.3802G>T (p.Gly1268Ter)	KAT6B|DUSP29	G1268*, G573*, G1085*, G922*, G487*, G705*, G913*, G976*	Normal	not provided|Genitopatellar syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030533	10	76788384	10	75028626	30533	39490	rs199470473	NC_000010.11:75028625:G:T	G	T	CLINICAL
NM_012330.4(KAT6B):c.3892G>T (p.Gly1298Ter)	KAT6B|DUSP29	G1298*, G517*, G1115*, G952*, G1006*, G603*, G943*, G735*	Normal	not provided|Genitopatellar syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030532	10	76788474	10	75028716	30532	39489	rs199470475	NC_000010.11:75028715:G:T	G	T	CLINICAL
NM_012330.4(KAT6B):c.4069G>T (p.Glu1357Ter)	KAT6B|DUSP29	E1357*, E1011*, E1065*, E576*, E1002*, E1174*, E662*, E794*	Normal	not provided|Blepharophimosis - intellectual disability syndrome, SBBYS type	Pathogenic(Last reviewed: Nov 11, 2011)	no assertion criteria provided	VCV000030528	10	76788651	10	75028893	30528	39485	rs199470476	NC_000010.11:75028892:G:T	G	T	CLINICAL
NM_012330.4(KAT6B):c.4072G>T (p.Glu1358Ter)	KAT6B|DUSP29	E1003*, E1175*, E663*, E795*, E1012*, E1066*, E1358*, E577*	Normal	Genitopatellar syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802590	10	76788654	10	75028896	802590	790982	rs774508465	NC_000010.11:75028895:G:T	G	T	CLINICAL
NM_012330.4(KAT6B):c.5213C>T (p.Thr1738Ile)	KAT6B|DUSP29	T1738I, T1383I, T957I, T1446I, T1043I, T1555I, T1175I, T1392I	Normal	Cryptorchidism|Short nose|Clubfoot|Spinal deformities|Abnormal facial shape|Hypertelorism|Short distal phalanx of toe|Tapered finger|Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523500	10	76789795	10	75030037	523500	514001	rs1554846212	NC_000010.11:75030036:C:T	C	T	CLINICAL
NM_012330.4(KAT6B):c.5290C>T (p.Gln1764Ter)	KAT6B|DUSP29	Q1764*, Q1418*, Q1409*, Q983*, Q1069*, Q1201*, Q1472*, Q1581*	Normal	Genitopatellar syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000567140	10	76789872	10	75030114	567140	566503	rs1564632652	NC_000010.11:75030113:C:T	C	T	CLINICAL
NM_012330.4(KAT6B):c.5389C>T (p.Arg1797Ter)	KAT6B|DUSP29	R1797*, R1234*, R1442*, R1505*, R1016*, R1451*, R1614*, R1102*	Normal	Blepharophimosis - intellectual disability syndrome, SBBYS type|Genitopatellar syndrome|not provided	Pathogenic(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV000050357	10	76789971	10	75030213	50357	59482	rs199470484	NC_000010.11:75030212:C:T	C	T	CLINICAL
NM_000314.7(PTEN):c.697C>T (p.Arg233Ter)	PTEN	R233*, R406*, R36*	Normal	Glioblastoma|Cowden syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of ovary|Abnormality of cardiovascular system morphology|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Macrocephaly/autism syndrome|Non-small cell lung cancer|none provided|Neoplasm of the large intestine	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007813	10	89717672	10	87957915	7813	22852	rs121909219	NC_000010.11:87957914:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.139C>T (p.Arg47Ter)	KIF11	R47*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation|not provided	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000488844	10	94366083	10	92606326	488844	481972	rs1227480400	NC_000010.11:92606325:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.247C>T (p.Arg83Ter)	KIF11	R83*	Normal	not provided|Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424002	10	94366412	10	92606655	424002	408021	rs1064796738	NC_000010.11:92606654:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.436A>T (p.Lys146Ter)	KIF11	K146*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	VCV000211274	10	94368825	10	92609068	211274	207800	rs797045650	NC_000010.11:92609067:A:T	A	T	CLINICAL
NM_004523.4(KIF11):c.790-1G>T	KIF11		Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation|Microcephaly with or without chorioretinopathy, lymphedema or intellectual disability (MCLID)	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000192301	10	94373133	10	92613376	192301	190094	rs730882122	NC_000010.11:92613375:G:T	G	T	CLINICAL
NM_004523.4(KIF11):c.868C>T (p.Gln290Ter)	KIF11	Q290*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000435617	10	94373212	10	92613455	435617	429140	rs1554859966	NC_000010.11:92613454:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.1159C>T (p.Arg387Ter)	KIF11	R387*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000029768	10	94381172	10	92621415	29768	38723	rs387906641	NC_000010.11:92621414:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.1408G>T (p.Glu470Ter)	KIF11	E470*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000192300	10	94390035	10	92630278	192300	190093	rs786205900	NC_000010.11:92630277:G:T	G	T	CLINICAL
NM_004523.4(KIF11):c.2160+1G>T	KIF11		Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000435613	10	94397303	10	92637546	435613	429146	rs1554862218	NC_000010.11:92637545:G:T	G	T	CLINICAL
NM_004523.4(KIF11):c.2230C>T (p.Gln744Ter)	KIF11	Q744*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: Dec 18, 2017)	no assertion criteria provided	VCV000453264	10	94399620	10	92639863	453264	446859	rs1554862427	NC_000010.11:92639862:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.2341C>T (p.Gln781Ter)	KIF11	Q781*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic	no assertion criteria provided	VCV000369969	10	94405193	10	92645436	369969	354170	rs1057516208	NC_000010.11:92645435:C:T	C	T	CLINICAL
NM_004523.4(KIF11):c.2782C>T (p.Gln928Ter)	KIF11	Q928*	Normal	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802621	10	94409603	10	92649846	802621	791015	rs1589608594	NC_000010.11:92649845:C:T	C	T	CLINICAL
NM_005343.4(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	G12C	Normal	Costello syndrome|Epidermal nevus syndrome|Urinary bladder cancer|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Large congenital melanocytic nevus|Costello syndrome|Glioblastoma|Myelodysplastic syndrome|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Multiple myeloma|Breast neoplasm|not provided|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Carcinoma of esophagus|Rasopathy|Hepatocellular carcinoma|Nevus sebaceous|Bladder carcinoma|Squamous cell carcinoma of the head and neck|Malignant melanoma of skin|Acute myeloid leukemia|Squamous cell carcinoma of the skin|Epidermal nevus|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Neoplasm of uterine cervix|Adenoid cystic carcinoma|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Nasopharyngeal Neoplasms|Neoplasm of the large intestine	Pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012613	11	534289	11	534289	12613	27652	rs104894229	NC_000011.10:534288:C:A	C	A	CLINICAL
NM_019040.5(ELP4):c.1143+14176C>A	PAX6DRR|ELP4		Normal	Aniridia 1	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000120328	11	31685945	11	31664397	120328	125923	rs606231388	NC_000011.10:31664396:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.1183G>T (p.Gly395Ter)	PAX6	G395*, G259*, G328*, G409*, G476*, G434*, G342*, G194*, G420*	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000431008	11	31812258	11	31790710	431008	424511	rs1131692318	NC_000011.10:31790709:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.949C>T (p.Arg317Ter)	PAX6	R317*, R116*, R342*, R181*, R356*, R250*, R264*, R331*, R332*, R398*	Normal	not provided|Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372444	11	31815069	11	31793521	372444	359933	rs1057517785	NC_000011.10:31793520:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.916+1G>T	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800463	11	31815199	11	31793651	800463	789062	rs1057517783	NC_000011.10:31793650:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.829C>T (p.Gln277Ter)	PAX6	Q292*, Q358*, Q224*, Q302*, Q76*, Q141*, Q210*, Q277*, Q291*, Q316*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800460	11	31815287	11	31793739	800460	788993	rs1592415563	NC_000011.10:31793738:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.820C>T (p.Gln274Ter)	PAX6	Q274*, Q355*, Q207*, Q73*, Q138*, Q288*, Q289*, Q313*, Q221*, Q299*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000492995	11	31815296	11	31793748	492995	485941	rs1554983229	NC_000011.10:31793747:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.781C>T (p.Arg261Ter)	PAX6	R261*, R125*, R208*, R276*, R300*, R342*, R60*, R194*, R275*, R286*	Normal	Congenital ocular coloboma|Foveal hypoplasia and presenile cataract syndrome|Aniridia 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Optic nerve hypoplasia, bilateral|Coloboma of optic nerve (disease)|Keratitis, hereditary|Irido-corneo-trabecular dysgenesis|Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1|not provided	Pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279862	11	31815335	11	31793787	279862	264422	rs886041222	NC_000011.10:31793786:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.718C>T (p.Arg240Ter)	PAX6	R240*, R254*, R187*, R39*, R104*, R173*, R279*, R255*, R265*, R321*	Normal	not provided|Irido-corneo-trabecular dysgenesis|Aniridia 1|Aniridia 1	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003467	11	31815627	11	31794079	3467	18506	rs121907917	NC_000011.10:31794078:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.661C>T (p.Gln221Ter)	PAX6	Q221*, Q235*, Q154*, Q168*, Q246*, Q302*, Q20*, Q236*, Q260*, Q85*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000430999	11	31816199	11	31794651	430999	424520	rs1131692309	NC_000011.10:31794650:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.622C>T (p.Arg208Trp)	PAX6	R208W, R247W, R223W, R141W, R222W, R72W, R7W, R155W, R233W, R289W	Normal	Aniridia 1|not provided|Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372441	11	31816238	11	31794690	372441	360004	rs757259413	NC_000011.10:31794689:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.613C>T (p.Gln205Ter)	PAX6	Q205*, Q219*, Q152*, Q286*, Q4*, Q69*, Q244*, Q138*, Q220*, Q230*	Normal	Irido-corneo-trabecular dysgenesis|Aniridia 1|not provided|Optic nerve hypoplasia, bilateral	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003476	11	31816247	11	31794699	3476	18515	rs121907924	NC_000011.10:31794698:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.607C>T (p.Arg203Ter)	PAX6	R203*, R217*, R136*, R228*, R284*, R67*, R150*, R2*, R218*, R242*	Normal	not provided|Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003466	11	31816253	11	31794705	3466	18505	rs121907916	NC_000011.10:31794704:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.538C>T (p.Gln180Ter)	PAX6	Q180*, Q127*, Q194*, Q261*, Q113*, Q195*, Q219*, Q205*, Q44*	Normal	Aniridia 1	Pathogenic(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000492994	11	31816322	11	31794774	492994	485942	rs1554983571	NC_000011.10:31794773:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.511C>T (p.Gln171Ter)	PAX6	Q171*, Q118*, Q186*, Q252*, Q185*, Q210*, Q104*, Q196*, Q35*	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000430998	11	31822251	11	31800703	430998	424521	rs1131692308	NC_000011.10:31800702:G:A	G	A	CLINICAL
NM_001310160.1(PAX6):c.-3C>T	PAX6	Q136*, Q150*, Q151*, Q217*, Q83*, Q69*, Q161*, Q175*	Normal	Aniridia 1	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000003461	11	31822356	11	31800808	3461	18500	rs121907912	NC_000011.10:31800807:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.403C>T (p.Gln135Ter)	PAX6	Q135*, Q149*, Q150*, Q160*, Q174*, Q216*, Q68*, Q82*	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000430994	11	31822359	11	31800811	430994	424525	rs1131692304	NC_000011.10:31800810:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.383G>T (p.Arg128Leu)	PAX6	R128L, R142L, R75L, R143L, R61L, R153L, R167L, R209L	Normal	Aniridia 1|not provided	Likely pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV000800436	11	31822379	11	31800831	800436	789010	rs1592531953	NC_000011.10:31800830:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.382C>T (p.Arg128Cys)	PAX6	R128C, R142C, R143C, R167C, R75C, R153C, R209C, R61C	Normal	Foveal hypoplasia and presenile cataract syndrome|Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000003470	11	31822380	11	31800832	3470	18509	rs121907918	NC_000011.10:31800831:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.357+4A>T	PAX6		Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000460459	11	31823105	11	31801557	460459	461523	rs1554985282	NC_000011.10:31801556:T:A	T	A	CLINICAL
NM_000280.4(PAX6):c.325G>T (p.Glu109Ter)	PAX6	E109*, E123*, E124*, E190*, E134*, E148*	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000492993	11	31823141	11	31801593	492993	485943	rs1554985305	NC_000011.10:31801592:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.307C>T (p.Arg103Ter)	PAX6	R103*, R117*, R128*, R118*, R184*, R142*	Normal	not provided|Aniridia 1	Pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000003464	11	31823159	11	31801611	3464	18503	rs121907914	NC_000011.10:31801610:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.265C>T (p.Gln89Ter)	PAX6	Q89*, Q103*, Q104*, Q114*, Q170*, Q128*	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430986	11	31823201	11	31801653	430986	424533	rs1131692297	NC_000011.10:31801652:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.255C>T (p.Ser85=)	PAX6		Normal	not provided|Aniridia 1	Likely pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, single submitter	VCV000418399	11	31823211	11	31801663	418399	408334	rs1064793223	NC_000011.10:31801662:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.244G>T (p.Glu82Ter)	PAX6	E82*, E121*, E163*, E97*, E107*, E96*	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430985	11	31823222	11	31801674	430985	424534	rs1131692296	NC_000011.10:31801673:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.214G>T (p.Gly72Cys)	PAX6	G111C, G153C, G87C, G72C, G97C, G86C	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800414	11	31823252	11	31801704	800414	789028	rs759557055	NC_000011.10:31801703:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.191G>T (p.Gly64Val)	PAX6	G64V, G78V, G89V, G103V, G79V, G145V	Normal	Foveal hypoplasia 1 with cataract|Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000003472	11	31823275	11	31801727	3472	18511	rs121907920	NC_000011.10:31801726:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.184G>T (p.Glu62Ter)	PAX6	E62*, E143*, E76*, E101*, E77*, E87*	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430984	11	31823282	11	31801734	430984	424535	rs1131692295	NC_000011.10:31801733:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.174C>T (p.Gly58=)	PAX6		Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800410	11	31823292	11	31801744	800410	789032	rs763807196	NC_000011.10:31801743:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.163A>T (p.Lys55Ter)	PAX6	K55*, K136*, K70*, K80*, K94*, K69*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000800407	11	31823303	11	31801755	800407	789035	rs1592546120	NC_000011.10:31801754:T:A	T	A	CLINICAL
NM_000280.4(PAX6):c.141+4A>T	PAX6	I49F	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800401	11	31824248	11	31802700	800401	789078	rs1131692290	NC_000011.10:31802699:T:A	T	A	CLINICAL
NM_000280.4(PAX6):c.139C>T (p.Gln47Ter)	PAX6	Q47*, Q48*, Q128*	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000529892	11	31824254	11	31802706	529892	526626	rs1554985716	NC_000011.10:31802705:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.130C>T (p.Arg44Ter)	PAX6	R44*, R125*, R45*	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430976	11	31824263	11	31802715	430976	424543	rs141873759	NC_000011.10:31802714:G:A	G	A	CLINICAL
NM_001310160.1(PAX6):c.-670C>T	PAX6	R38W, R119W, R39W	Normal	Aniridia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000040090	11	31824281	11	31802733	40090	48596	rs397514640	NC_000011.10:31802732:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.107G>T (p.Gly36Val)	PAX6	G36V, G117V, G37V	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800393	11	31824286	11	31802738	800393	789046	rs1592563636	NC_000011.10:31802737:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.76C>T (p.Arg26Trp)	PAX6	R27W, R26W, R107W	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800389	11	31824317	11	31802769	800389	789049	rs121907913	NC_000011.10:31802768:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.19G>T (p.Gly7Ter)	PAX6	G8*, G7*, G88*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800383	11	31824374	11	31802826	800383	789055	rs1131692285	NC_000011.10:31802825:C:A	C	A	CLINICAL
NM_000280.4(PAX6):c.3G>T (p.Met1Ile)	PAX6	M1I, A35S	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000492990	11	31827957	11	31806409	492990	485946	rs1554986754	NC_000011.10:31806408:C:A	C	A	CLINICAL
NM_024426.6(WT1):c.1447+4C>T	WT1		Normal	not provided|Nephrotic range proteinuria|Wilms tumor 1|Frasier syndrome|Nephrotic syndrome, type 4|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Frasier syndrome|Drash syndrome|Familial idiopathic steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003500	11	32413514	11	32391968	3500	18539	rs587776577	NC_000011.10:32391967:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1399C>T (p.Arg467Trp)	WT1	R250W, R467W, R233W, R450W, R71W	Normal	Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Steroid-resistant nephrotic syndrome|Nephrotic range proteinuria|not provided|Nephrotic syndrome, type 4|Drash syndrome|Meacham syndrome|Wilms tumor 1	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003487	11	32413566	11	32392020	3487	18526	rs121907900	NC_000011.10:32392019:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1387C>T (p.Arg463Ter)	WT1	R246*, R229*, R446*, R463*, R67*	Normal	not provided|Wilms tumor 1|Wilms tumor 1|Frasier syndrome|Drash syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003494	11	32413578	11	32392032	3494	18533	rs121907909	NC_000011.10:32392031:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1303C>T (p.Arg435Ter)	WT1	R218*, R201*, R39*, R418*, R435*	Normal	Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Frasier syndrome|Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Mesothelioma, malignant|Nephrotic syndrome, type 4|Meacham syndrome|Drash syndrome|Aniridia 1|Frasier syndrome|Drash syndrome|Wilms tumor 1|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003497	11	32414263	11	32392717	3497	18536	rs121907906	NC_000011.10:32392716:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1120C>T (p.Arg374Ter)	WT1	R157*, R374*, R357*, R140*	Normal	Wilms tumor 1|Drash syndrome|not provided|Wilms tumor 1|Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449416	11	32417947	11	32396401	449416	444795	rs1423753702	NC_000011.10:32396400:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.512G>T (p.Gly171Val)	WT1|LOC107982234	G171V	Normal	Nephrotic syndrome, type 4|Wilms tumor 1|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome	Likely pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000438653	11	32456395	11	32434849	438653	432306	rs1554946480	NC_000011.10:32434848:C:A	C	A	CLINICAL
NM_024426.6(WT1):c.478C>T (p.Gln160Ter)	WT1|LOC107982234	Q160*	Normal	Drash syndrome|Wilms tumor 1|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000543125	11	32456429	11	32434883	543125	526172	rs1554946500	NC_000011.10:32434882:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.472G>T (p.Glu158Ter)	WT1|LOC107982234	E158*	Normal	Wilms tumor 1|Drash syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000584762	11	32456435	11	32434889	584762	575847	rs1565001383	NC_000011.10:32434888:C:A	C	A	CLINICAL
NM_001382.4(DPAGT1):c.1123C>T (p.His375Tyr)	DPAGT1	H375Y	Normal	not provided	Likely pathogenic(Last reviewed: Nov 1, 2015)	criteria provided, single submitter	VCV000429774	11	118967890	11	119097180	429774	421831	rs759542218	NC_000011.10:119097179:G:A	G	A	CLINICAL
NM_014619.4(GRIK4):c.1856G>A (p.Arg619His)	GRIK4|LOC101929208	R619H	Normal	not provided	Likely pathogenic(Last reviewed: Oct 9, 2015)	criteria provided, single submitter	VCV000224137	11	120827644	11	120956935	224137	225867	rs534517447	NC_000011.10:120956934:G:A	G	A	CLINICAL
NM_152722.5(HEPACAM):c.442C>T (p.Pro148Ser)	HEPACAM	P148S	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation|Megalencephalic leukoencephalopathy with subcortical cysts 2a	Likely pathogenic	no assertion criteria provided	VCV000433199	11	124793892	11	124923996	433199	426773	rs1555055028	NC_000011.10:124923995:G:A	G	A	CLINICAL
NM_152722.5(HEPACAM):c.292C>T (p.Arg98Cys)	HEPACAM	R98C	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030918	11	124794759	11	124924863	30918	39875	rs387907052	NC_000011.10:124924862:G:A	G	A	CLINICAL
NM_152722.5(HEPACAM):c.274C>T (p.Arg92Trp)	HEPACAM	R92W	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a|Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000030921	11	124794777	11	124924881	30921	39878	rs387907055	NC_000011.10:124924880:G:A	G	A	CLINICAL
NM_000352.6(ABCC8):c.4136G>T (p.Arg1379Leu)	ABCC8	R1379L, R1380L, R1378L, R1401L	Normal	Neonatal diabetes mellitus	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000035615	11	17417461	11	17395914	35615	44280	rs193922401	NC_000011.10:17395913:C:A	C	A	CLINICAL
NM_000525.3(KCNJ11):c.697C>T (p.Leu233Phe)	KCNJ11	L233F, L146F	Normal	Maturity-onset diabetes of the young, type 13	Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000617651	11	17408942	11	17387395	617651	609051	rs1564865302	NC_000011.10:17387394:G:A	G	A	CLINICAL
NM_000207.3(INS):c.16C>T (p.Arg6Cys)	INS|INS-IGF2	R6C	Normal	Maturity-onset diabetes of the young, type 10	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000013390	11	2182186	11	2160956	13390	28429	rs121908278	NC_000011.10:2160955:G:A	G	A	CLINICAL
NM_000244.3(MEN1):c.1A>T (p.Met1Leu)	MEN1	M1L	Normal	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428034	11	64577581	11	64810109	428034	419865	rs386134250	NC_000011.10:64810108:T:A	T	A	CLINICAL
NM_000244.3(MEN1):c.85C>T (p.Arg29Ter)	MEN1	R29*	Normal	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200970	11	64577497	11	64810025	200970	197564	rs794728615	NC_000011.10:64810024:G:A	G	A	CLINICAL
NM_000244.3(MEN1):c.1675C>T (p.Gln559Ter)	MEN1	Q554*, Q559*, Q519*, Q596*	Normal	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000200988	11	64571979	11	64804507	200988	197519	rs794728631	NC_000011.10:64804506:G:A	G	A	CLINICAL
NM_000352.6(ABCC8):c.4135C>T (p.Arg1379Cys)	ABCC8	R1379C, R1380C, R1378C, R1401C	Normal	Transient neonatal diabetes mellitus 2|Permanent neonatal diabetes mellitus|Monogenic diabetes|Type 2 diabetes mellitus	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	VCV000009105	11	17417462	11	17395915	9105	24144	rs137852673	NC_000011.10:17395914:G:A	G	A	CLINICAL
NM_000207.3(INS):c.265C>T (p.Arg89Cys)	INS|INS-IGF2	R89C	Normal	Permanent neonatal diabetes mellitus 4|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	VCV000021117	11	2181150	11	2159920	21117	33969	rs80356669	NC_000011.10:2159919:G:A	G	A	CLINICAL
NM_001310160.1(PAX6):c.-670C>T	PAX6	R38W, R119W, R39W	Normal	Aniridia 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000040090	11	31824281	11	31802733	40090	48596	rs397514640	NC_000011.10:31802732:G:A	G	A	CLINICAL
NM_001371904.1(APOA5):c.415C>T (p.Gln139Ter)	APOA5	Q139*	Normal	Familial type 5 hyperlipoproteinemia	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000004404	11	116661530	11	116790814	4404	19443	rs121917821	NC_000011.10:116790813:G:A	G	A	CLINICAL
NM_000207.3(INS):c.163C>T (p.Arg55Cys)	INS|INS-IGF2	R55C	Normal	Diabetes mellitus, insulin-dependent, 2|not provided	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000013392	11	2182039	11	2160809	13392	28431	rs121908261	NC_000011.10:2160808:G:A	G	A	CLINICAL
NM_024649.5(BBS1):c.432+1G>A	BBS1		Normal	Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012145	11	66282150	11	66514679	12145	27184	rs587777829	NC_000011.10:66514678:G:A	G	A	CLINICAL
NM_000352.6(ABCC8):c.4306C>T (p.Arg1436Ter)	ABCC8	R1436*, R1437*, R1458*, R1435*	Normal	Hyperinsulinemic hypoglycemia, familial, 1|Type 2 diabetes mellitus|Permanent neonatal diabetes mellitus|Hyperinsulinemic hypoglycemia, familial, 1|Transient neonatal diabetes mellitus 2|Leucine-induced hypoglycemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035617	11	17417158	11	17395611	35617	44282	rs193922402	NC_000011.10:17395610:G:A	G	A	CLINICAL
NM_000525.3(KCNJ11):c.881C>T (p.Thr294Met)	KCNJ11	T294M, T207M	Normal	Transient neonatal diabetes mellitus 3|Hyperinsulinemic hypoglycemia, familial, 2|Transient neonatal diabetes mellitus 3|Hyperinsulinemic hypoglycemia, familial, 2|Permanent neonatal diabetes mellitus 2|Type 2 diabetes mellitus|Maturity-onset diabetes of the young, type 13|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000211230	11	17408758	11	17387211	211230	207832	rs780957825	NC_000011.10:17387210:G:A	G	A	CLINICAL
NM_024649.5(BBS1):c.479G>A (p.Arg160Gln)	BBS1	R160Q	Normal	Bardet-Biedl syndrome 1|not provided|Retinitis pigmentosa|Bardet-Biedl syndrome|Retinal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370228	11	66283057	11	66515586	370228	358036	rs376894444	NC_000011.10:66515585:G:A	G	A	CLINICAL
NM_000352.6(ABCC8):c.2506C>T (p.Arg836Ter)	ABCC8	R836*, R837*, R835*, R858*	Normal	not provided|Hyperinsulinemic hypoglycemia, familial, 1|Hereditary hyperinsulinism|Permanent neonatal diabetes mellitus|Type 2 diabetes mellitus|Transient neonatal diabetes mellitus 2|Hyperinsulinemic hypoglycemia, familial, 1|Leucine-induced hypoglycemia	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188915	11	17434263	11	17412716	188915	186816	rs72559722	NC_000011.10:17412715:G:A	G	A	CLINICAL
NM_024649.5(BBS1):c.951+1G>A	BBS1|ZDHHC24		Normal	Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370919	11	66291048	11	66523577	370919	358043	rs746875134	NC_000011.10:66523576:G:A	G	A	CLINICAL
NM_005456.4(MAPK8IP1):c.176G>A (p.Ser59Asn)	MAPK8IP1	S59N	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000005419	11	45919710	11	45898159	5419	20458	rs119489103	NC_000011.10:45898158:G:A	G	A	CLINICAL
NM_001377.3(DYNC2H1):c.10100G>A (p.Arg3367His)	DYNC2H1	R3374H, R3367H	Normal	Intellectual disability|Short-rib thoracic dysplasia 3 with or without polydactyly	Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000369660	11	103124071	11	103253342	369660	353901	rs759549373	NC_000011.10:103253341:G:A	G	A	CLINICAL
NM_138775.3(ALKBH8):c.1651C>T (p.Arg551Ter)	ALKBH8	R554*, R551*	Normal	Intellectual developmental disorder, autosomal recessive 71	Pathogenic(Last reviewed: Jul 19, 2019)	no assertion criteria provided	VCV000636271	11	107375728	11	107505002	636271	624083	rs375189195	NC_000011.10:107505001:G:A	G	A	CLINICAL
NM_000019.4(ACAT1):c.2T>A (p.Met1Lys)	ACAT1	M1K	Normal	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000002838	11	107992335	11	108121608	2838	17877	rs120074142	NC_000011.10:108121607:T:A	T	A	CLINICAL
NM_000019.4(ACAT1):c.435+1G>A	ACAT1		Normal	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666483	11	108005970	11	108135243	666483	654084	rs1591363834	NC_000011.10:108135242:G:A	G	A	CLINICAL
NM_001931.5(DLAT):c.976-1G>A	DLAT		Normal	not provided|Pyruvate dehydrogenase E2 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432212	11	111909967	11	112039243	432212	425901	rs367875541	NC_000011.10:112039242:G:A	G	A	CLINICAL
NM_001931.5(DLAT):c.1728C>A (p.Phe576Leu)	DLAT|PIH1D2	F576L, F435L, F582L, F449L, F483L, F520L, F540L, F574L, F471L, F534L, F569L, F422L, F565L	Normal	Pyruvate dehydrogenase E2 deficiency	Pathogenic(Last reviewed: Aug 1, 2005)	no assertion criteria provided	VCV000002110	11	111931812	11	112061088	2110	17149	rs119103240	NC_000011.10:112061087:C:A	C	A	CLINICAL
NM_001197104.2(KMT2A):c.502+1G>A	KMT2A		Normal	Wiedemann-Steiner syndrome|Intellectual disability	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000802796	11	118339560	11	118468845	802796	791104	rs1591371152	NC_000011.10:118468844:G:A	G	A	CLINICAL
NM_001197104.2(KMT2A):c.572C>A (p.Ser191Ter)	KMT2A	S191*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000816873	11	118342446	11	118471731	816873	805092	rs1591373553	NC_000011.10:118471730:C:A	C	A	CLINICAL
NM_001197104.1(KMT2A):c.3334+1G>A	KMT2A		Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431178	11	118347698	11	118476983	431178	424701	rs1135401764	NC_000011.10:118476982:G:A	G	A	CLINICAL
NM_001197104.1(KMT2A):c.3341C>A (p.Ser1114Ter)	KMT2A	S1114*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000488383	11	118348688	11	118477973	488383	481237	rs1555038029	NC_000011.10:118477972:C:A	C	A	CLINICAL
NM_001197104.2(KMT2A):c.3455C>A (p.Ser1152Ter)	KMT2A	S1152*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802797	11	118348802	11	118478087	802797	791105	rs1591381084	NC_000011.10:118478086:C:A	C	A	CLINICAL
NM_005933.4(KMT2A):c.3464G>A (p.Cys1155Tyr)	KMT2A	C1155Y	Normal	not provided|Wiedemann-Steiner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372920	11	118348811	11	118478096	372920	359911	rs1057518074	NC_000011.10:118478095:G:A	G	A	CLINICAL
NM_001197104.1(KMT2A):c.3473G>A (p.Cys1158Tyr)	KMT2A	C1158Y	Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Oct 14, 2015)	criteria provided, single submitter	VCV000435658	11	118348820	11	118478105	435658	429172	rs1131691503	NC_000011.10:118478104:G:A	G	A	CLINICAL
NM_005933.4(KMT2A):c.3566G>A (p.Cys1189Tyr)	KMT2A	C1189Y	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Apr 27, 2018)	no assertion criteria provided	VCV000523095	11	118348913	11	118478198	523095	513719	rs1555038125	NC_000011.10:118478197:G:A	G	A	CLINICAL
NM_005933.4(KMT2A):c.4012+2T>A	KMT2A		Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689770	11	118352809	11	118482094	689770	677432	rs1591385183	NC_000011.10:118482093:T:A	T	A	CLINICAL
NM_001197104.1(KMT2A):c.4086+1G>A	KMT2A		Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Jun 4, 2013)	criteria provided, single submitter	VCV000216953	11	118353211	11	118482496	216953	213606	rs863224889	NC_000011.10:118482495:G:A	G	A	CLINICAL
NM_001197104.1(KMT2A):c.4343G>A (p.Cys1448Tyr)	KMT2A	C1448Y	Normal	not provided|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426928	11	118359339	11	118488624	426928	415250	rs1085307857	NC_000011.10:118488623:G:A	G	A	CLINICAL
NM_001197104.1(KMT2A):c.4696+1G>A	KMT2A		Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jun 10, 2020)	no assertion criteria provided	VCV000375623	11	118360965	11	118490250	375623	362437	rs1057519407	NC_000011.10:118490249:G:A	G	A	CLINICAL
NM_001197104.1(KMT2A):c.5494C>A (p.Pro1832Thr)	KMT2A	P1832T, P1829T	Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	VCV000209168	11	118366545	11	118495830	209168	205767	rs797045051	NC_000011.10:118495829:C:A	C	A	CLINICAL
NM_001197104.1(KMT2A):c.6080G>A (p.Gly2027Glu)	KMT2A	G2027E, G2024E	Normal	Wiedemann-Steiner syndrome	Likely pathogenic	no assertion criteria provided	VCV000375619	11	118370550	11	118499835	375619	362433	rs1057519403	NC_000011.10:118499834:G:A	G	A	CLINICAL
NM_001197104.1(KMT2A):c.11071+1G>A	KMT2A		Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000446424	11	118380834	11	118510119	446424	439883	rs1555049702	NC_000011.10:118510118:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.77G>A (p.Arg26His)	HMBS	R26H, R9H	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV000001443	11	118959008	11	119088298	1443	16482	rs118204103	NC_000011.10:119088297:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.91G>A (p.Ala31Thr)	HMBS	A31T, A14T	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001454	11	118959348	11	119088638	1454	16493	rs118204104	NC_000011.10:119088637:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.100C>A (p.Gln34Lys)	HMBS	Q34K, Q17K	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Sep 1, 1992)	no assertion criteria provided	VCV000001455	11	118959357	11	119088647	1455	16494	rs118204105	NC_000011.10:119088646:C:A	C	A	CLINICAL
NM_000190.4(HMBS):c.211-1G>A	HMBS		Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001461	11	118959926	11	119089216	1461	16500	rs1565754452	NC_000011.10:119089215:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.331G>A (p.Gly111Arg)	HMBS	G111R, G94R	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Apr 22, 2020)	criteria provided, single submitter	VCV000001464	11	118960457	11	119089747	1464	16503	rs118204107	NC_000011.10:119089746:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.446G>A (p.Arg149Gln)	HMBS	R149Q, R132Q	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Oct 8, 1999)	no assertion criteria provided	VCV000001449	11	118960923	11	119090213	1449	16488	rs118204098	NC_000011.10:119090212:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.499-1G>A	HMBS		Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV000001465	11	118962122	11	119091412	1465	16504	rs1565756481	NC_000011.10:119091411:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	HMBS	R167Q, R150Q	Normal	Acute intermittent porphyria|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001446	11	118962124	11	119091414	1446	16485	rs118204095	NC_000011.10:119091413:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.518G>A (p.Arg173Gln)	HMBS	R173Q, R156Q	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1992)	no assertion criteria provided	VCV000001447	11	118962142	11	119091432	1447	16486	rs118204096	NC_000011.10:119091431:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.593G>A (p.Trp198Ter)	HMBS	W198*, W181*	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1991)	no assertion criteria provided	VCV000001453	11	118962217	11	119091507	1453	16492	rs118204100	NC_000011.10:119091506:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.647G>A (p.Gly216Asp)	HMBS	G216D, G199D	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000001478	11	118962869	11	119092159	1478	16517	rs118204116	NC_000011.10:119092158:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.748G>A (p.Glu250Lys)	HMBS	E250K, E233K	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001471	11	118963210	11	119092500	1471	16510	rs118204112	NC_000011.10:119092499:G:A	G	A	CLINICAL
NM_000190.4(HMBS):c.766C>A (p.His256Asn)	HMBS	H256N, H239N	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001474	11	118963228	11	119092518	1474	16513	rs118204115	NC_000011.10:119092517:C:A	C	A	CLINICAL
NM_000190.4(HMBS):c.849G>A (p.Trp283Ter)	HMBS	W283*, W266*, W226*, W243*	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001483	11	118963668	11	119092958	1483	16522	rs118204117	NC_000011.10:119092957:G:A	G	A	CLINICAL
NM_152722.5(HEPACAM):c.442C>T (p.Pro148Ser)	HEPACAM	P148S	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation|Megalencephalic leukoencephalopathy with subcortical cysts 2a	Likely pathogenic	no assertion criteria provided	VCV000433199	11	124793892	11	124923996	433199	426773	rs1555055028	NC_000011.10:124923995:G:A	G	A	CLINICAL
NM_152722.5(HEPACAM):c.292C>T (p.Arg98Cys)	HEPACAM	R98C	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030918	11	124794759	11	124924863	30918	39875	rs387907052	NC_000011.10:124924862:G:A	G	A	CLINICAL
NM_152722.5(HEPACAM):c.274C>T (p.Arg92Trp)	HEPACAM	R92W	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a|Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation	Pathogenic(Last reviewed: Nov 3, 2011)	no assertion criteria provided	VCV000030921	11	124794777	11	124924881	30921	39878	rs387907055	NC_000011.10:124924880:G:A	G	A	CLINICAL
NM_031307.4(PUS3):c.1303C>T (p.Arg435Ter)	PUS3|HYLS1	R435*, R227*	Normal	Mental retardation, autosomal recessive 55	Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2020)	no assertion criteria provided	VCV000253169	11	125763823	11	125893928	253169	247581	rs774005569	NC_000011.10:125893927:G:A	G	A	CLINICAL
NM_001112741.1(KCNC1):c.959G>A (p.Arg320His)	KCNC1	R320H	Normal	Epilepsy, progressive myoclonic 7	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162519	11	17793600	11	17772053	162519	172192	rs727502818	NC_000011.10:17772052:G:A	G	A	CLINICAL
NM_152316.3(ARL14EP):c.653G>A (p.Gly218Glu)	ARL14EP	G218E	Normal	Microcephaly|Truncal obesity|Abnormal facial shape|Global developmental delay|not provided	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183284	11	30358212	11	30336665	183284	181431	rs730882201	NC_000011.10:30336664:G:A	G	A	CLINICAL
NM_000280.4(PAX6):c.781C>T (p.Arg261Ter)	PAX6	R261*, R125*, R208*, R276*, R300*, R342*, R60*, R194*, R275*, R286*	Normal	Congenital ocular coloboma|Foveal hypoplasia and presenile cataract syndrome|Aniridia 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Optic nerve hypoplasia, bilateral|Coloboma of optic nerve (disease)|Keratitis, hereditary|Irido-corneo-trabecular dysgenesis|Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1|not provided	Pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279862	11	31815335	11	31793787	279862	264422	rs886041222	NC_000011.10:31793786:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1447+4C>T	WT1		Normal	not provided|Nephrotic range proteinuria|Wilms tumor 1|Frasier syndrome|Nephrotic syndrome, type 4|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Frasier syndrome|Drash syndrome|Familial idiopathic steroid-resistant nephrotic syndrome	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003500	11	32413514	11	32391968	3500	18539	rs587776577	NC_000011.10:32391967:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1399C>T (p.Arg467Trp)	WT1	R250W, R467W, R233W, R450W, R71W	Normal	Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Steroid-resistant nephrotic syndrome|Nephrotic range proteinuria|not provided|Nephrotic syndrome, type 4|Drash syndrome|Meacham syndrome|Wilms tumor 1	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003487	11	32413566	11	32392020	3487	18526	rs121907900	NC_000011.10:32392019:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1387C>T (p.Arg463Ter)	WT1	R246*, R229*, R446*, R463*, R67*	Normal	not provided|Wilms tumor 1|Wilms tumor 1|Frasier syndrome|Drash syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Frasier syndrome	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003494	11	32413578	11	32392032	3494	18533	rs121907909	NC_000011.10:32392031:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1303C>T (p.Arg435Ter)	WT1	R218*, R201*, R39*, R418*, R435*	Normal	Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Frasier syndrome|Wilms tumor 1|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Mesothelioma, malignant|Nephrotic syndrome, type 4|Meacham syndrome|Drash syndrome|Aniridia 1|Frasier syndrome|Drash syndrome|Wilms tumor 1|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000003497	11	32414263	11	32392717	3497	18536	rs121907906	NC_000011.10:32392716:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.1120C>T (p.Arg374Ter)	WT1	R157*, R374*, R357*, R140*	Normal	Wilms tumor 1|Drash syndrome|not provided|Wilms tumor 1|Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449416	11	32417947	11	32396401	449416	444795	rs1423753702	NC_000011.10:32396400:G:A	G	A	CLINICAL
NM_024426.6(WT1):c.512G>T (p.Gly171Val)	WT1|LOC107982234	G171V	Normal	Nephrotic syndrome, type 4|Wilms tumor 1|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome	Likely pathogenic(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000438653	11	32456395	11	32434849	438653	432306	rs1554946480	NC_000011.10:32434848:C:A	C	A	CLINICAL
NM_024426.6(WT1):c.478C>T (p.Gln160Ter)	WT1|LOC107982234	Q160*	Normal	Drash syndrome|Wilms tumor 1|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000543125	11	32456429	11	32434883	543125	526172	rs1554946500	NC_000011.10:32434882:G:A	G	A	CLINICAL
NM_003477.3(PDHX):c.134G>A (p.Trp45Ter)	PDHX	W45*	Normal	not provided|Pyruvate dehydrogenase E3-binding protein deficiency	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424121	11	34938336	11	34916789	424121	408337	rs1064796807	NC_000011.10:34916788:G:A	G	A	CLINICAL
NM_003477.3(PDHX):c.641+1G>A	PDHX		Normal	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000002114	11	34982066	11	34960519	2114	17153	rs724159829	NC_000011.10:34960518:G:A	G	A	CLINICAL
NM_003477.3(PDHX):c.1024-1G>A	PDHX		Normal	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000002115	11	35006116	11	34984569	2115	17154	rs724159830	NC_000011.10:34984568:G:A	G	A	CLINICAL
NM_021926.4(ALX4):c.793C>T (p.Arg265Ter)	ALX4	R265*	Normal	Frontonasal dysplasia 2|Inborn genetic diseases	Pathogenic(Last reviewed: May 15, 2015)	criteria provided, single submitter	VCV000005020	11	44289157	11	44267607	5020	20059	rs267606653	NC_000011.10:44267606:G:A	G	A	CLINICAL
NM_004551.3(NDUFS3):c.374G>A (p.Arg125His)	NDUFS3	R125H	Normal	Mitochondrial complex I deficiency|not provided	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000418381	11	47602529	11	47580977	418381	408382	rs138867882	NC_000011.10:47580976:G:A	G	A	CLINICAL
NM_005343.4(HRAS):c.37G>T (p.Gly13Cys)	HRAS|LRRC56	G13C	Normal	Lung adenocarcinoma|not provided|Breast neoplasm|Chronic lymphocytic leukemia|Neoplasm of uterine cervix|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Costello syndrome|Squamous cell lung carcinoma|Noonan syndrome|Multiple myeloma|Malignant melanoma of skin|Pancreatic adenocarcinoma|Rasopathy|Thyroid cancer, nonmedullary, 2|Costello syndrome|Epidermal nevus syndrome|Epidermal nevus|Urinary bladder cancer|Large congenital melanocytic nevus|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Acute myeloid leukemia|Neoplasm|Neoplasm of the large intestine	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012606	11	534286	11	534286	12606	27645	rs104894228	NC_000011.10:534285:C:A	C	A	CLINICAL
NM_000543.5(SMPD1):c.880C>A (p.Gln294Lys)	SMPD1	Q294K, Q293K	Normal	not specified|Niemann-Pick disease, type B|Niemann-Pick disease, type B|Niemann-Pick disease, type A|Sphingomyelin/cholesterol lipidosis|Niemann-pick disease, intermediate, protracted neurovisceral|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002994	11	6413175	11	6391945	2994	18033	rs120074128	NC_000011.10:6391944:C:A	C	A	CLINICAL
NM_033310.3(KCNK4):c.515C>A (p.Ala172Glu)	KCNK4|KCNK4-TEX40	A172E	Normal	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome|Abnormal facial shape|Generalized hypertrichosis|Gingival enlargement|Seizures|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000560221	11	64064979	11	64297507	560221	551271	rs1565369746	NC_000011.10:64297506:C:A	C	A	CLINICAL
NM_005186.4(CAPN1):c.338-1G>A	CAPN1		Normal	Spastic paraplegia 76, autosomal recessive	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000617483	11	64950944	11	65183473	617483	608845	rs1590847310	NC_000011.10:65183472:G:A	G	A	CLINICAL
NM_007103.4(NDUFV1):c.383G>A (p.Arg128Gln)	NDUFV1	R119Q, R128Q	Normal	Mitochondrial complex I deficiency	Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000692023	11	67376979	11	67609508	692023	679783	rs778295360	NC_000011.10:67609507:G:A	G	A	CLINICAL
NM_017635.5(KMT5B):c.856C>T (p.Arg286Ter)	KMT5B	R114*, R263*, R215*, R286*, R46*	Normal	Intellectual disability, autosomal dominant 51	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000666575	11	67938603	11	68171136	666575	654136	rs1590954686	NC_000011.10:68171135:G:A	G	A	CLINICAL
NM_017635.5(KMT5B):c.559C>T (p.Arg187Ter)	KMT5B	R187*, R116*, R15*, R164*	Normal	Intellectual disability, autosomal dominant 51|Neural tube defect	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560606	11	67941365	11	68173898	560606	551681	rs114727354	NC_000011.10:68173897:G:A	G	A	CLINICAL
NM_001293634.1(DEAF1):c.664+919C>T	DEAF1	R224W	Normal	Mental retardation, autosomal dominant 24|not provided	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV000133293	11	686992	11	686992	133293	137032	rs587777408	NC_000011.10:686991:G:A	G	A	CLINICAL
NM_002599.5(PDE2A):c.1180C>T (p.Gln394Ter)	PDE2A	Q387*, Q394*, Q373*, Q385*	Normal	Intellectual developmental disorder with paroxysmal dyskinesia or seizures|Chorea|Interictal EEG abnormality|EEG abnormality|Paroxysmal dystonia|Intellectual disability, moderate|Generalized hypotonia	Pathogenic	criteria provided, single submitter	VCV000689477	11	72297116	11	72586072	689477	677070	rs1591023585	NC_000011.10:72586071:G:A	G	A	CLINICAL
NM_001128922.2(LRRC32):c.1630C>T (p.Arg544Ter)	LRRC32	R544*, R434*, R522*	Normal	Cleft palate, proliferative retinopathy, and developmental delay|Cleft palate|Vitreoretinopathy|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2020)	no assertion criteria provided	VCV000545640	11	76371007	11	76659963	545640	536136	rs369867819	NC_000011.10:76659962:G:A	G	A	CLINICAL
NM_181798.1(KCNQ1):c.343G>A (p.Asp115Asn)	KCNQ1	D242N, D115N	Normal	Long QT syndrome|Congenital long QT syndrome|not provided|Wolff-Parkinson-White pattern	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053090	11	2593283	11	2572053	53090	67758	rs199472712	NC_000011.10:2572052:G:A	G	A	CLINICAL
NM_021008.3(DEAF1):c.664+2T>G	DEAF1		Normal	Autism spectrum disorder	Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562152	11	687909	11	687909	562152	553321	rs1564950387	NC_000011.10:687908:A:C	A	C	CLINICAL
NM_000280.4(PAX6):c.1062C>G (p.Tyr354Ter)	PAX6	Y435*, Y153*, Y301*, Y368*, Y379*, Y393*, Y218*, Y287*, Y354*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800474	11	31812379	11	31790831	800474	788985	rs1592369500	NC_000011.10:31790830:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.1058C>G (p.Ser353Ter)	PAX6	S353*, S367*, S217*, S286*, S434*, S300*, S392*, S152*, S378*	Normal	Cataracts, congenital, with late-onset corneal dystrophy|Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000003462	11	31812383	11	31790835	3462	18501	rs121907915	NC_000011.10:31790834:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.1033-2A>G	PAX6		Normal	not provided|Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003468	11	31812410	11	31790862	3468	18507	rs794726661	NC_000011.10:31790861:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.1032+6T>G	PAX6	S346R	Normal	Aniridia 1	Likely pathogenic	no assertion criteria provided	VCV000431006	11	31814980	11	31793432	431006	424513	rs1131692316	NC_000011.10:31793431:A:C	A	C	CLINICAL
NM_000280.4(PAX6):c.683-9C>G	PAX6		Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800449	11	31815671	11	31794123	800449	789067	rs1592422097	NC_000011.10:31794122:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.681A>G (p.Lys227=)	PAX6		Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800448	11	31816179	11	31794631	800448	789001	rs1592433022	NC_000011.10:31794630:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.640A>G (p.Arg214Gly)	PAX6	R147G, R161G, R214G, R229G, R295G, R228G, R239G, R13G, R253G, R78G	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800447	11	31816220	11	31794672	800447	789002	rs1592433545	NC_000011.10:31794671:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.632A>G (p.Gln211Arg)	PAX6	Q144R, Q226R, Q75R, Q158R, Q225R, Q236R, Q211R, Q10R, Q250R, Q292R	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis	Likely pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000648737	11	31816228	11	31794680	648737	639954	rs1592433640	NC_000011.10:31794679:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.524-2A>G	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800442	11	31816338	11	31794790	800442	789070	rs1592435653	NC_000011.10:31794789:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.489T>G (p.Tyr163Ter)	PAX6	Y163*, Y27*, Y110*, Y178*, Y202*, Y244*, Y177*, Y188*, Y96*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800439	11	31822273	11	31800725	800439	789007	rs1592530126	NC_000011.10:31800724:A:C	A	C	CLINICAL
NM_000280.4(PAX6):c.365C>G (p.Ser122Ter)	PAX6	S137*, S136*, S122*, S203*, S69*, S147*, S161*, S55*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800432	11	31822397	11	31800849	800432	789014	rs1554985100	NC_000011.10:31800848:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.358-2A>G	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800430	11	31822406	11	31800858	800430	789072	rs1592532580	NC_000011.10:31800857:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.357C>G (p.Ser119Arg)	PAX6	S119R, S133R, S158R, S134R, S144R, S200R	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430991	11	31823109	11	31801561	430991	424528	rs121907928	NC_000011.10:31801560:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.183C>G (p.Tyr61Ter)	PAX6	Y100*, Y75*, Y86*, Y142*, Y61*, Y76*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000800411	11	31823283	11	31801735	800411	789031	rs760490431	NC_000011.10:31801734:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.158T>G (p.Val53Gly)	PAX6	V92G, V67G, V68G, V78G, V134G, V53G	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800406	11	31823308	11	31801760	800406	789037	rs1592546273	NC_000011.10:31801759:A:C	A	C	CLINICAL
NM_000280.4(PAX6):c.142-2A>G	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800404	11	31823326	11	31801778	800404	789077	rs1592546589	NC_000011.10:31801777:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.142-5T>G	PAX6		Normal	Aniridia 1	Likely pathogenic	no assertion criteria provided	VCV000430981	11	31823329	11	31801781	430981	424538	rs1131692292	NC_000011.10:31801780:A:C	A	C	CLINICAL
NM_000280.4(PAX6):c.142-14C>G	PAX6		Normal	Aniridia 1	Likely pathogenic	no assertion criteria provided	VCV000430980	11	31823338	11	31801790	430980	424539	rs1131692291	NC_000011.10:31801789:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.141+4A>G	PAX6	I49V	Normal	Aniridia 1	Likely pathogenic	no assertion criteria provided	VCV000430979	11	31824248	11	31802700	430979	424540	rs1131692290	NC_000011.10:31802699:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.140A>G (p.Gln47Arg)	PAX6	Q47R, Q48R, Q128R	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430978	11	31824253	11	31802705	430978	424542	rs1131692289	NC_000011.10:31802704:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.125T>G (p.Ile42Ser)	PAX6	I43S, I123S, I42S	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800398	11	31824268	11	31802720	800398	789041	rs1592562910	NC_000011.10:31802719:A:C	A	C	CLINICAL
NM_000280.4(PAX6):c.112C>G (p.Arg38Gly)	PAX6	R38G, R119G, R39G	Normal	Foveal hypoplasia and presenile cataract syndrome|not provided|Aniridia 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000637045	11	31824281	11	31802733	637045	624856	rs397514640	NC_000011.10:31802732:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.94C>G (p.Leu32Val)	PAX6	L113V, L33V, L32V	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800390	11	31824299	11	31802751	800390	789048	rs1592563721	NC_000011.10:31802750:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.76C>G (p.Arg26Gly)	PAX6	R26G, R107G, R27G	Normal	Aniridia 1|ANTERIOR SEGMENT DYSGENESIS 5, PETERS ANOMALY SUBTYPE	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000003463	11	31824317	11	31802769	3463	18502	rs121907913	NC_000011.10:31802768:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.51C>G (p.Asn17Lys)	PAX6	N17K, N18K, N98K	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800385	11	31824342	11	31802794	800385	789054	rs1388158419	NC_000011.10:31802793:G:C	G	C	CLINICAL
NM_000280.4(PAX6):c.11-2A>G	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800382	11	31824384	11	31802836	800382	789079	rs1592564908	NC_000011.10:31802835:T:C	T	C	CLINICAL
NM_000280.4(PAX6):c.1A>G (p.Met1Val)	PAX6	M1V, H34R	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430971	11	31827959	11	31806411	430971	424547	rs1131692284	NC_000011.10:31806410:T:C	T	C	CLINICAL
NM_024426.6(WT1):c.1406A>G (p.Asp469Gly)	WT1	D252G, D452G, D469G, D73G, D235G	Normal	Drash syndrome|Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1	Likely pathogenic(Last reviewed: May 28, 2017)	criteria provided, single submitter	VCV000003489	11	32413559	11	32392013	3489	18528	rs121907902	NC_000011.10:32392012:T:C	T	C	CLINICAL
NM_152722.5(HEPACAM):c.359A>G (p.Tyr120Cys)	HEPACAM	Y120C	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000590970	11	124794692	11	124924796	590970	581914	rs1565339091	NC_000011.10:124924795:T:C	T	C	CLINICAL
NM_024649.5(BBS1):c.48-2A>C	BBS1		Normal	Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Likely pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371141	11	66278482	11	66511011	371141	358031	rs764245266	NC_000011.10:66511010:A:C	A	C	CLINICAL
NM_000352.6(ABCC8):c.1744C>G (p.Leu582Val)	ABCC8	L582V, L581V	Normal	Type 2 diabetes mellitus|Transient neonatal diabetes mellitus 2	Pathogenic(Last reviewed: Aug 3, 2006)	no assertion criteria provided	VCV000009106	11	17452434	11	17430887	9106	24145	rs137852674	NC_000011.10:17430886:G:C	G	C	CLINICAL
NM_000207.3(INS):c.127T>G (p.Cys43Gly)	INS|INS-IGF2	C43G	Normal	Neonatal diabetes mellitus|Permanent neonatal diabetes mellitus 4|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000021114	11	2182075	11	2160845	21114	33966	rs80356666	NC_000011.10:2160844:A:C	A	C	CLINICAL
NM_024649.5(BBS1):c.724-1G>C	BBS1|ZDHHC24		Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552356	11	66288740	11	66521269	552356	546150	rs748523268	NC_000011.10:66521268:G:C	G	C	CLINICAL
NM_005959.3(MTNR1B):c.124G>C (p.Ala42Pro)	MTNR1B	A42P	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jan 29, 2012)	no assertion criteria provided	VCV000030127	11	92703015	11	92969849	30127	39083	rs387906779	NC_000011.10:92969848:G:C	G	C	CLINICAL
NM_005959.3(MTNR1B):c.923A>C (p.Tyr308Ser)	MTNR1B	Y308S	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jan 29, 2012)	no assertion criteria provided	VCV000030130	11	92715312	11	92982146	30130	39086	rs184917682	NC_000011.10:92982145:A:C	A	C	CLINICAL
NM_000829.4(GRIA4):c.2090G>C (p.Arg697Pro)	GRIA4	R697P	Normal	Neurodevelopmental disorder with or without seizures and gait abnormalities|Intellectual disability	Likely pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000446210	11	105804491	11	105933765	446210	439572	rs765556214	NC_000011.10:105933764:G:C	G	C	CLINICAL
NM_000019.4(ACAT1):c.2T>C (p.Met1Thr)	ACAT1	M1T	Normal	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000666461	11	107992335	11	108121608	666461	654020	rs120074142	NC_000011.10:108121607:T:C	T	C	CLINICAL
NM_000019.4(ACAT1):c.431A>C (p.His144Pro)	ACAT1	H144P	Normal	Deficiency of acetyl-CoA acetyltransferase	Likely pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666482	11	108005965	11	108135238	666482	654038	rs1025180934	NC_000011.10:108135237:A:C	A	C	CLINICAL
NM_000019.4(ACAT1):c.1168T>C (p.Ser390Pro)	ACAT1	S390P	Normal	Deficiency of acetyl-CoA acetyltransferase	Likely pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666532	11	108018001	11	108147274	666532	654076	rs1184088336	NC_000011.10:108147273:T:C	T	C	CLINICAL
NM_001330368.2(C11orf65):c.641-24854A>G	ATM|C11orf65	L2656P	Normal	Ataxia-telangiectasia without immunodeficiency	Pathogenic(Last reviewed: Jan 13, 1998)	no assertion criteria provided	VCV000003028	11	108204652	11	108333925	3028	18067	rs121434218	NC_000011.10:108333924:T:C	T	C	CLINICAL
NM_001197104.1(KMT2A):c.3565T>C (p.Cys1189Arg)	KMT2A	C1189R	Normal	not provided|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280722	11	118348912	11	118478197	280722	264447	rs886041875	NC_000011.10:118478196:T:C	T	C	CLINICAL
NM_001197104.1(KMT2A):c.4342T>C (p.Cys1448Arg)	KMT2A	C1448R	Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	VCV000216962	11	118359338	11	118488623	216962	213607	rs863224895	NC_000011.10:118488622:T:C	T	C	CLINICAL
NM_001197104.1(KMT2A):c.6158+6T>C	KMT2A		Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000435659	11	118370634	11	118499919	435659	429173	rs1555045177	NC_000011.10:118499918:T:C	T	C	CLINICAL
NM_001197104.1(KMT2A):c.8543T>C (p.Leu2848Pro)	KMT2A	L2848P, L2845P	Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000435661	11	118375150	11	118504435	435661	429174	rs1555047266	NC_000011.10:118504434:T:C	T	C	CLINICAL
NM_001197104.2(KMT2A):c.11785A>C (p.Ile3929Leu)	KMT2A|TTC36-AS1	I3926L, I3929L	Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802805	11	118392753	11	118522038	802805	791113	rs1591312430	NC_000011.10:118522037:A:C	A	C	CLINICAL
NM_000190.4(HMBS):c.160+5G>C	HMBS		Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Mar 17, 2019)	criteria provided, single submitter	VCV000694280	11	118959422	11	119088712	694280	682125	rs1592213590	NC_000011.10:119088711:G:C	G	C	CLINICAL
NM_000190.4(HMBS):c.242T>C (p.Leu81Pro)	HMBS	L81P, L64P	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000001485	11	118959958	11	119089248	1485	16524	rs118204119	NC_000011.10:119089247:T:C	T	C	CLINICAL
NM_000190.4(HMBS):c.266+1G>C	HMBS		Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jul 1, 1997)	no assertion criteria provided	VCV000001477	11	118959983	11	119089273	1477	16516	rs1565754565	NC_000011.10:119089272:G:C	G	C	CLINICAL
NM_000190.4(HMBS):c.739T>C (p.Cys247Arg)	HMBS	C247R, C230R	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001469	11	118963201	11	119092491	1469	16508	rs118204111	NC_000011.10:119092490:T:C	T	C	CLINICAL
NM_000190.4(HMBS):c.771+1G>C	HMBS		Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001475	11	118963234	11	119092524	1475	16514	rs1565758008	NC_000011.10:119092523:G:C	G	C	CLINICAL
NM_152722.5(HEPACAM):c.359A>G (p.Tyr120Cys)	HEPACAM	Y120C	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000590970	11	124794692	11	124924796	590970	581914	rs1565339091	NC_000011.10:124924795:T:C	T	C	CLINICAL
NM_031307.4(PUS3):c.1A>G (p.Met1Val)	PUS3|HYLS1	M1V	Normal	Mental retardation, autosomal recessive 55	Likely pathogenic(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000692029	11	125766179	11	125896284	692029	679775	rs543614309	NC_000011.10:125896283:T:C	T	C	CLINICAL
NM_000525.3(KCNJ11):c.176T>G (p.Val59Gly)	KCNJ11	V59G	Normal	Permanent neonatal diabetes mellitus 2|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000008669	11	17409463	11	17387916	8669	23708	rs80356617	NC_000011.10:17387915:A:C	A	C	CLINICAL
NM_024426.6(WT1):c.1406A>G (p.Asp469Gly)	WT1	D252G, D452G, D469G, D73G, D235G	Normal	Drash syndrome|Drash syndrome|Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1	Likely pathogenic(Last reviewed: May 28, 2017)	criteria provided, single submitter	VCV000003489	11	32413559	11	32392013	3489	18528	rs121907902	NC_000011.10:32392012:T:C	T	C	CLINICAL
NM_014489.4(PGAP2):c.449T>C (p.Phe150Ser)	PGAP2	F146S, F129S, F89S, F107S, F140S, F207S, F150S	Normal	Hyperphosphatasia with mental retardation syndrome 3	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802653	11	3845213	11	3823983	802653	791138	rs1590416370	NC_000011.10:3823982:T:C	T	C	CLINICAL
NM_014489.4(PGAP2):c.563T>C (p.Leu188Ser)	PGAP2	L127S, L145S, L167S, L178S, L184S, L188S, L245S	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050504	11	3845327	11	3824097	50504	59543	rs879255233	NC_000011.10:3824096:T:C	T	C	CLINICAL
NM_014489.4(PGAP2):c.713G>C (p.Arg238Pro)	PGAP2	R177P, R195P, R230P, R173P, R217P, R234P, R295P, R228P, R238P	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic	criteria provided, single submitter	VCV000050503	11	3846254	11	3825024	50503	59542	rs774843232	NC_000011.10:3825023:G:C	G	C	CLINICAL
NM_000256.3(MYBPC3):c.26-2A>G	MYBPC3		Normal	Cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Intellectual disability|not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042644	11	47373058	11	47351507	42644	51814	rs376395543	NC_000011.10:47351506:T:C	T	C	CLINICAL
NM_005343.4(HRAS):c.350A>G (p.Lys117Arg)	HRAS|LRRC56	K117R, S11G	Normal	not provided|Costello syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012605	11	533553	11	533553	12605	27644	rs104894227	NC_000011.10:533552:T:C	T	C	CLINICAL
NM_033310.3(KCNK4):c.730G>C (p.Ala244Pro)	KCNK4|KCNK4-TEX40	A244P	Normal	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome|Abnormal facial shape|Generalized hypertrichosis|Gingival enlargement|Seizures|Intellectual disability	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000560222	11	64065650	11	64298178	560222	551272	rs1189909394	NC_000011.10:64298177:G:C	G	C	CLINICAL
NM_000391.4(TPP1):c.687+2T>G	TPP1		Normal	Ceroid lipofuscinosis neuronal 2|Developmental regression	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000371022	11	6638204	11	6616973	371022	358027	rs1057516945	NC_000011.10:6616972:A:C	A	C	CLINICAL
NM_007103.4(NDUFV1):c.1118T>C (p.Phe373Ser)	NDUFV1	F373S, F364S	Normal	Mitochondrial complex I deficiency	Pathogenic	no assertion criteria provided	VCV000431452	11	67379405	11	67611934	431452	424968	rs1135402749	NC_000011.10:67611933:T:C	T	C	CLINICAL
NM_001293634.1(DEAF1):c.664+932T>G	DEAF1	I228S	Normal	Mental retardation, autosomal dominant 24	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000133291	11	686979	11	686979	133291	137030	rs587777406	NC_000011.10:686978:A:C	A	C	CLINICAL
NM_001293634.1(DEAF1):c.664+986G>C	DEAF1	R246T, R4T	Normal	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000437396	11	686925	11	686925	437396	430956	rs1554944271	NC_000011.10:686924:C:G	C	G	CLINICAL
NM_019040.5(ELP4):c.*6412A>G	PAX6|ELP4		Normal	Aniridia 1|not provided	Pathogenic(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV000800482	11	31811484	11	31789936	800482	788978	rs750848278	NC_000011.10:31789935:A:G	A	G	CLINICAL
NM_019040.5(ELP4):c.*6496C>G	PAX6|ELP4		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800478	11	31811568	11	31790020	800478	789057	rs1592350356	NC_000011.10:31790019:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.1183+2T>C	PAX6		Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000431009	11	31812256	11	31790708	431009	424510	rs1131692319	NC_000011.10:31790707:A:G	A	G	CLINICAL
NM_000280.4(PAX6):c.1183G>C (p.Gly395Arg)	PAX6	G434R, G328R, G342R, G194R, G476R, G259R, G395R, G409R, G420R	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000003465	11	31812258	11	31790710	3465	18504	rs1131692318	NC_000011.10:31790709:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.917-1G>C	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800467	11	31815102	11	31793554	800467	789060	rs1592412022	NC_000011.10:31793553:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.916+1G>C	PAX6		Normal	Aniridia 1|not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000372442	11	31815199	11	31793651	372442	359935	rs1057517783	NC_000011.10:31793650:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.766-1G>C	PAX6		Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000800453	11	31815351	11	31793803	800453	789064	rs1592416538	NC_000011.10:31793802:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.765G>C (p.Gln255His)	PAX6	Q188H, Q270H, Q280H, Q255H, Q54H, Q202H, Q294H, Q336H, Q119H, Q269H	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000800452	11	31815580	11	31794032	800452	788999	rs1592420967	NC_000011.10:31794031:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.725G>C (p.Arg242Thr)	PAX6	R242T, R256T, R41T, R175T, R257T, R267T, R281T, R106T, R189T, R323T	Normal	Aniridia 1	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000003480	11	31815620	11	31794072	3480	18519	rs121907927	NC_000011.10:31794071:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.683-1G>C	PAX6		Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000431000	11	31815663	11	31794115	431000	424518	rs1131692310	NC_000011.10:31794114:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.683-5T>C	PAX6		Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800450	11	31815667	11	31794119	800450	789066	rs1592421981	NC_000011.10:31794118:A:G	A	G	CLINICAL
NM_000280.4(PAX6):c.275G>C (p.Arg92Pro)	PAX6	R106P, R173P, R131P, R117P, R107P, R92P	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800417	11	31823191	11	31801643	800417	789025	rs769095184	NC_000011.10:31801642:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.170T>C (p.Leu57Pro)	PAX6	L71P, L96P, L138P, L57P, L72P, L82P	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800409	11	31823296	11	31801748	800409	789033	rs1592545972	NC_000011.10:31801747:A:G	A	G	CLINICAL
NM_000280.4(PAX6):c.164A>C (p.Lys55Thr)	PAX6	K55T, K136T, K70T, K80T, K94T, K69T	Normal	Aniridia 1	Likely pathogenic	no assertion criteria provided	VCV000430983	11	31823302	11	31801754	430983	424536	rs1131692294	NC_000011.10:31801753:T:G	T	G	CLINICAL
NM_000280.4(PAX6):c.141+1G>C	PAX6	V48L	Normal	Aniridia 1	Pathogenic(Last reviewed: Apr 20, 2017)	no assertion criteria provided	VCV000438712	11	31824251	11	31802703	438712	432305	rs1554985714	NC_000011.10:31802702:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.140A>C (p.Gln47Pro)	PAX6	Q128P, Q48P, Q47P	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800400	11	31824253	11	31802705	800400	789038	rs1131692289	NC_000011.10:31802704:T:G	T	G	CLINICAL
NM_000280.4(PAX6):c.53G>C (p.Gly18Ala)	PAX6	G19A, G99A, G18A	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800386	11	31824340	11	31802792	800386	789053	rs1592564366	NC_000011.10:31802791:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.52G>C (p.Gly18Arg)	PAX6	G18R, G99R, G19R	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000289849	11	31824341	11	31802793	289849	274086	rs886044289	NC_000011.10:31802792:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.19G>C (p.Gly7Arg)	PAX6	G7R, G8R, G88R	Normal	Aniridia 1	Likely pathogenic	no assertion criteria provided	VCV000430973	11	31824374	11	31802826	430973	424546	rs1131692285	NC_000011.10:31802825:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.1A>C (p.Met1Leu)	PAX6	M1L, H34P	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000430972	11	31827959	11	31806411	430972	424548	rs1131692284	NC_000011.10:31806410:T:G	T	G	CLINICAL
NM_001360.3(DHCR7):c.964-1G>C	DHCR7		Normal	Smith-Lemli-Opitz syndrome|not provided|Global developmental delay|History of neurodevelopmental disorder|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093725	11	71146886	11	71435840	93725	99628	rs138659167	NC_000011.10:71435839:C:G	C	G	CLINICAL
NM_000352.5(ABCC8):c.290+2T>C	ABCC8		Normal	Hyperinsulinemic hypoglycemia, familial, 1|Leucine-induced hypoglycemia|Permanent neonatal diabetes mellitus|Hyperinsulinemic hypoglycemia, familial, 1|Transient neonatal diabetes mellitus 2|Type 2 diabetes mellitus	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552247	11	17496431	11	17474884	552247	546326	rs1554948310	NC_000011.10:17474883:A:G	A	G	CLINICAL
NM_032667.6(BSCL2):c.634G>C (p.Ala212Pro)	BSCL2|HNRNPUL2-BSCL2	A212P, A276P	Normal	Congenital generalized lipodystrophy type 2	Pathogenic(Last reviewed: Dec 8, 2016)	no assertion criteria provided	VCV000004539	11	62459885	11	62692413	4539	19578	rs137852971	NC_000011.10:62692412:C:G	C	G	CLINICAL
NM_000525.3(KCNJ11):c.124T>C (p.Cys42Arg)	KCNJ11	C42R	Normal	Maturity-onset diabetes of the young, type 13|Transient neonatal diabetes mellitus 3|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000008676	11	17409515	11	17387968	8676	23715	rs80356610	NC_000011.10:17387967:A:G	A	G	CLINICAL
NM_024649.5(BBS1):c.1125C>G (p.Ser375Arg)	BBS1|ZDHHC24	S375R	Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585170	11	66293608	11	66526137	585170	576227	rs1565287512	NC_000011.10:66526136:C:G	C	G	CLINICAL
NM_024649.5(BBS1):c.831-2A>G	BBS1|ZDHHC24		Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371517	11	66290925	11	66523454	371517	358040	rs1057517332	NC_000011.10:66523453:A:G	A	G	CLINICAL
NM_024649.5(BBS1):c.1169T>G (p.Met390Arg)	BBS1|ZDHHC24	M390R	Normal	Retinal dystrophy|Bardet-Biedl syndrome 1|Retinitis pigmentosa|not provided|Bardet-Biedl syndrome|Usher syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012143	11	66293652	11	66526181	12143	27182	rs113624356	NC_000011.10:66526180:T:G	T	G	CLINICAL
NM_005959.3(MTNR1B):c.179T>G (p.Leu60Arg)	MTNR1B	L60R	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jan 29, 2012)	no assertion criteria provided	VCV000030128	11	92703070	11	92969904	30128	39084	rs141804752	NC_000011.10:92969903:T:G	T	G	CLINICAL
NM_000829.4(GRIA4):c.1921A>G (p.Asn641Asp)	GRIA4	N641D	Normal	Inborn genetic diseases|Neurodevelopmental disorder with or without seizures and gait abnormalities|Intellectual disability	Likely pathogenic(Last reviewed: Feb 8, 2016)	criteria provided, single submitter	VCV000446207	11	105797540	11	105926814	446207	439569	rs1555050165	NC_000011.10:105926813:A:G	A	G	CLINICAL
NM_000829.4(GRIA4):c.1928C>G (p.Ala643Gly)	GRIA4	A643G	Normal	Intellectual disability|Neurodevelopmental disorder with or without seizures and gait abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446208	11	105797547	11	105926821	446208	439570	rs1555050171	NC_000011.10:105926820:C:G	C	G	CLINICAL
NM_000019.4(ACAT1):c.1A>G (p.Met1Val)	ACAT1	M1V	Normal	Deficiency of acetyl-CoA acetyltransferase	Pathogenic(Last reviewed: May 5, 2019)	criteria provided, single submitter	VCV000666460	11	107992334	11	108121607	666460	654019	rs1305448140	NC_000011.10:108121606:A:G	A	G	CLINICAL
NM_001931.5(DLAT):c.470T>G (p.Val157Gly)	DLAT	V157G, V115G, V101G, F2V, V146G	Normal	Inborn genetic diseases|Pyruvate dehydrogenase E2 deficiency	Likely pathogenic(Last reviewed: Sep 4, 2014)	criteria provided, single submitter	VCV000208790	11	111899327	11	112028603	208790	205266	rs797044957	NC_000011.10:112028602:T:G	T	G	CLINICAL
NM_006006.6(ZBTB16):c.1849A>G (p.Met617Val)	ZBTB16	M617V, M588V	Normal	Skeletal defects, genital hypoplasia, and mental retardation	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000013376	11	114121104	11	114250382	13376	28415	rs121434606	NC_000011.10:114250381:A:G	A	G	CLINICAL
NM_001197104.1(KMT2A):c.458C>G (p.Ser153Ter)	KMT2A	S153*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	VCV000158704	11	118339515	11	118468800	158704	168851	rs587783678	NC_000011.10:118468799:C:G	C	G	CLINICAL
NM_001197104.1(KMT2A):c.3521T>G (p.Leu1174Ter)	KMT2A	L1174*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000522805	11	118348868	11	118478153	522805	513437	rs1555038111	NC_000011.10:118478152:T:G	T	G	CLINICAL
NM_001197104.1(KMT2A):c.4367A>G (p.His1456Arg)	KMT2A	H1456R	Normal	Wiedemann-Steiner syndrome|not provided	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429523	11	118359363	11	118488648	429523	421828	rs1131691433	NC_000011.10:118488647:A:G	A	G	CLINICAL
NM_001197104.1(KMT2A):c.11084C>G (p.Ser3695Ter)	KMT2A|TTC36-AS1	S3695*, S3692*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 3, 2015)	criteria provided, single submitter	VCV000211312	11	118382678	11	118511963	211312	207817	rs782477344	NC_000011.10:118511962:C:G	C	G	CLINICAL
NM_000190.4(HMBS):c.530T>G (p.Leu177Arg)	HMBS	L177R, L160R	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000001466	11	118962154	11	119091444	1466	16505	rs118204108	NC_000011.10:119091443:T:G	T	G	CLINICAL
NM_000190.4(HMBS):c.734T>G (p.Leu245Arg)	HMBS	L245R, L228R	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Oct 8, 1999)	no assertion criteria provided	VCV000001450	11	118963196	11	119092486	1450	16489	rs118204099	NC_000011.10:119092485:T:G	T	G	CLINICAL
NM_000525.3(KCNJ11):c.510G>C (p.Lys170Asn)	KCNJ11	K170N, K83N	Normal	Permanent neonatal diabetes mellitus 2|Permanent neonatal diabetes mellitus	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000008672	11	17409129	11	17387582	8672	23711	rs80356622	NC_000011.10:17387581:C:G	C	G	CLINICAL
NM_000280.4(PAX6):c.773T>C (p.Phe258Ser)	PAX6	F258S, F272S, F122S, F205S, F339S, F191S, F297S, F273S, F283S, F57S	Normal	Coloboma of optic nerve (disease)|Congenital ocular coloboma	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000003477	11	31815343	11	31793795	3477	18516	rs121907925	NC_000011.10:31793794:A:G	A	G	CLINICAL
NM_014489.4(PGAP2):c.2T>G (p.Met1Arg)	PGAP2	C13G, M1R, M52R, M58R	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic	criteria provided, single submitter	VCV000694699	11	3832491	11	3811261	694699	682817	rs1590215915	NC_000011.10:3811260:T:G	T	G	CLINICAL
NM_014489.4(PGAP2):c.479A>G (p.Tyr160Cys)	PGAP2	Y99C, Y117C, Y156C, Y217C, Y139C, Y150C, Y160C	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV000050502	11	3845243	11	3824013	50502	59541	rs879255232	NC_000011.10:3824012:A:G	A	G	CLINICAL
NM_018389.4(SLC35C1):c.923C>G (p.Thr308Arg)	SLC35C1	T308R, T295R	Normal	Leukocyte adhesion deficiency type II	Pathogenic(Last reviewed: Jun 15, 2002)	no assertion criteria provided	VCV000004740	11	45832714	11	45811163	4740	19779	rs28937886	NC_000011.10:45811162:C:G	C	G	CLINICAL
NM_000543.5(SMPD1):c.1177T>G (p.Trp393Gly)	SMPD1	W393G, W86G, W392G	Normal	Niemann-pick disease, intermediate, protracted neurovisceral|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|Niemann-Pick disease, type B|Niemann-Pick disease, type A	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000002991	11	6414531	11	6393301	2991	18030	rs120074125	NC_000011.10:6393300:T:G	T	G	CLINICAL
NM_021008.3(DEAF1):c.997+4A>C	DEAF1		Normal	Dyskinesia, seizures, and intellectual developmental disorder|Mental retardation, autosomal dominant 24	Pathogenic(Last reviewed: Jun 1, 2020)	no assertion criteria provided	VCV000267316	11	680959	11	680959	267316	262391	rs886040972	NC_000011.10:680958:T:G	T	G	CLINICAL
NM_021008.4(DEAF1):c.880G>C (p.Val294Leu)	DEAF1	V52L, V294L	Normal	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802645	11	681080	11	681080	802645	791163	rs1590008294	NC_000011.10:681079:C:G	C	G	CLINICAL
NM_001293634.1(DEAF1):c.664+1011A>C	DEAF1	R254S, R12S	Normal	Mental retardation, autosomal dominant 24	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000133294	11	686900	11	686900	133294	137033	rs587777409	NC_000011.10:686899:T:G	T	G	CLINICAL
NM_001293634.1(DEAF1):c.664+986G>C	DEAF1	R246T, R4T	Normal	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000437396	11	686925	11	686925	437396	430956	rs1554944271	NC_000011.10:686924:C:G	C	G	CLINICAL
NM_001360.3(DHCR7):c.964-1G>C	DHCR7		Normal	Smith-Lemli-Opitz syndrome|not provided|Global developmental delay|History of neurodevelopmental disorder|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093725	11	71146886	11	71435840	93725	99628	rs138659167	NC_000011.10:71435839:C:G	C	G	CLINICAL
NM_000256.3(MYBPC3):c.1591G>C (p.Gly531Arg)	MYBPC3	G531R	Normal	Wolff-Parkinson-White syndrome|Hypertrophic cardiomyopathy|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042550	11	47364162	11	47342611	42550	51720	rs397515912	NC_000011.10:47342610:C:G	C	G	CLINICAL
NM_021975.4(RELA):c.329T>C (p.Ile110Thr)	RELA	I110T	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208401	11	65429164	11	65661693	208401	204618	rs863223356	NC_000011.10:65661692:A:G	A	G	CLINICAL
NM_138706.5(B3GNT6):c.552C>G (p.Asp184Glu)	B3GNT6	D184E	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208399	11	76751147	11	77040103	208399	204619	rs781821239	NC_000011.10:77040102:C:G	C	G	CLINICAL
NM_170601.5(SIAE):c.1211T>C (p.Phe404Ser)	SIAE	F404S, F369S	Normal	Autoimmune disease 6	risk factor(Last reviewed: Jul 8, 2010)	no assertion criteria provided	VCV000001353	11	124508547	11	124638651	1353	16392	rs201877149	NC_000011.10:124638650:A:G	A	G	CLINICAL
NM_021008.3(DEAF1):c.634G>A (p.Gly212Ser)	DEAF1	G212S	Normal	Mental retardation, autosomal dominant 24|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375554	11	687941	11	687941	375554	362364	rs1057519565	NC_000011.10:687940:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.1183+5G>A	PAX6		Normal	Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000658957	11	31812253	11	31790705	658957	652188	rs1592366898	NC_000011.10:31790704:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.1183+1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	VCV000492996	11	31812257	11	31790709	492996	485940	rs1554982537	NC_000011.10:31790708:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.1088C>A (p.Ser363Ter)	PAX6	S363*, S162*, S296*, S377*, S402*, S227*, S310*, S444*, S388*	Normal	not provided|Aniridia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546663	11	31812353	11	31790805	546663	537152	rs1411880763	NC_000011.10:31790804:G:T	G	T	CLINICAL
NM_000280.4(PAX6):c.1033-1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800470	11	31812409	11	31790861	800470	789059	rs1592370265	NC_000011.10:31790860:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.917-1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800466	11	31815102	11	31793554	800466	789061	rs1592412022	NC_000011.10:31793553:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.916+1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000800462	11	31815199	11	31793651	800462	789063	rs1057517783	NC_000011.10:31793650:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.794G>A (p.Trp265Ter)	PAX6	W265*, W129*, W346*, W198*, W212*, W304*, W64*, W279*, W280*, W290*	Normal	Aniridia 1|not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000431004	11	31815322	11	31793774	431004	424515	rs1131692314	NC_000011.10:31793773:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.771G>A (p.Trp257Ter)	PAX6	W257*, W271*, W121*, W190*, W204*, W272*, W282*, W296*, W56*, W338*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000003483	11	31815345	11	31793797	3483	18522	rs121907929	NC_000011.10:31793796:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.770G>A (p.Trp257Ter)	PAX6	W282*, W296*, W272*, W56*, W204*, W338*, W121*, W190*, W257*, W271*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800455	11	31815346	11	31793798	800455	788998	rs1592416453	NC_000011.10:31793797:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.766-1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800454	11	31815351	11	31793803	800454	789065	rs1592416538	NC_000011.10:31793802:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.524-1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800443	11	31816337	11	31794789	800443	789069	rs1592435632	NC_000011.10:31794788:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.500C>A (p.Ser167Ter)	PAX6	S192*, S248*, S114*, S167*, S206*, S100*, S182*, S31*, S181*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800440	11	31822262	11	31800714	800440	789006	rs151086737	NC_000011.10:31800713:G:T	G	T	CLINICAL
NM_000280.4(PAX6):c.486G>A (p.Trp162Ter)	PAX6	W162*, W109*, W176*, W187*, W177*, W201*, W243*, W26*, W95*	Normal	not provided|Irido-corneo-trabecular dysgenesis|Aniridia 1	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379847	11	31822276	11	31800728	379847	371403	rs1057520755	NC_000011.10:31800727:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.468G>A (p.Trp156Ter)	PAX6	W156*, W170*, W171*, W181*, W237*, W103*, W20*, W89*, W195*	Normal	Inborn genetic diseases|Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521078	11	31822294	11	31800746	521078	511911	rs1554985028	NC_000011.10:31800745:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.467G>A (p.Trp156Ter)	PAX6	W156*, W181*, W20*, W237*, W103*, W195*, W170*, W171*, W89*	Normal	Aniridia 1	Pathogenic	no assertion criteria provided	VCV000430996	11	31822295	11	31800747	430996	424523	rs1131692306	NC_000011.10:31800746:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.383G>A (p.Arg128His)	PAX6	R128H, R153H, R142H, R167H, R209H, R75H, R143H, R61H	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800435	11	31822379	11	31800831	800435	789011	rs1592531953	NC_000011.10:31800830:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.358-1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800431	11	31822405	11	31800857	800431	789071	rs1592532561	NC_000011.10:31800856:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.357+5G>A	PAX6		Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800429	11	31823104	11	31801556	800429	789073	rs1592542002	NC_000011.10:31801555:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.357+1G>A	PAX6		Normal	not provided|Irido-corneo-trabecular dysgenesis|Aniridia 1|Aniridia 1	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092758	11	31823108	11	31801560	92758	98665	rs398123295	NC_000011.10:31801559:C:T	C	T	CLINICAL
NM_001310160.1(PAX6):c.-383C>A	PAX6	S119R, S133R, S134R, S144R, S158R, S200R	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000003481	11	31823109	11	31801561	3481	18520	rs121907928	NC_000011.10:31801560:G:T	G	T	CLINICAL
NM_000280.4(PAX6):c.333C>A (p.Val111=)	PAX6		Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800425	11	31823133	11	31801585	800425	789017	rs1592542705	NC_000011.10:31801584:G:T	G	T	CLINICAL
NM_001604.5(PAX6):c.347T>A (p.Ile116Asn)	PAX6	I102N, I116N, I127N, I183N, I141N, I117N	Normal	Aniridia 1	Pathogenic(Last reviewed: Jan 18, 2019)	no assertion criteria provided	VCV000617617	11	31823161	11	31801613	617617	609013	rs1565238322	NC_000011.10:31801612:A:T	A	T	CLINICAL
NM_000280.4(PAX6):c.300G>A (p.Trp100Ter)	PAX6	W100*, W115*, W114*, W125*, W181*, W139*	Normal	Aniridia 1|not provided	Pathogenic(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000430989	11	31823166	11	31801618	430989	424530	rs1131692300	NC_000011.10:31801617:C:T	C	T	CLINICAL
NM_001310160.1(PAX6):c.-441G>A	PAX6	W100*, W139*, W114*, W125*, W181*, W115*	Normal	Aniridia 1	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000559407	11	31823167	11	31801619	559407	550137	rs1554985320	NC_000011.10:31801618:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.151G>A (p.Gly51Arg)	PAX6	G51R, G90R, G132R, G65R, G66R, G76R	Normal	not provided|Aniridia 1	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000430982	11	31823315	11	31801767	430982	424537	rs1131692293	NC_000011.10:31801766:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.142-1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800402	11	31823325	11	31801777	800402	789076	rs1592546566	NC_000011.10:31801776:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.120C>A (p.Cys40Ter)	PAX6	C40*, C121*, C41*	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000460456	11	31824273	11	31802725	460456	461056	rs1329112134	NC_000011.10:31802724:G:T	G	T	CLINICAL
NM_000280.4(PAX6):c.107G>A (p.Gly36Glu)	PAX6	G37E, G117E, G36E	Normal	Aniridia 1	Likely pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000800392	11	31824286	11	31802738	800392	789047	rs1592563636	NC_000011.10:31802737:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.3G>A (p.Met1Ile)	PAX6	M1I, A35T	Normal	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000460461	11	31827957	11	31806409	460461	461848	rs1554986754	NC_000011.10:31806408:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.-52+1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000800380	11	31828396	11	31806848	800380	789080	rs1592614756	NC_000011.10:31806847:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.-129+2T>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 15, 2019)	no assertion criteria provided	VCV000003482	11	31832374	11	31810826	3482	18521	rs878852979	NC_000011.10:31810825:A:T	A	T	CLINICAL
NM_000280.4(PAX6):c.-129+1G>A	PAX6		Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000559615	11	31832375	11	31810827	559615	550342	rs1565277245	NC_000011.10:31810826:C:T	C	T	CLINICAL
NM_024426.6(WT1):c.1447+5G>A	WT1		Normal	Wilms tumor 1|Frasier syndrome|Drash syndrome|not provided|Familial idiopathic steroid-resistant nephrotic syndrome|Nephrotic syndrome, type 4|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Frasier syndrome|Drash syndrome	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003493	11	32413513	11	32391967	3493	18532	rs587776576	NC_000011.10:32391966:C:T	C	T	CLINICAL
NM_024426.6(WT1):c.1316G>A (p.Arg439His)	WT1	R222H, R422H, R439H, R205H, R43H	Normal	Wilms tumor 1|Nephrotic syndrome, type 4|Frasier syndrome|Drash syndrome|not provided|Drash syndrome	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003488	11	32414250	11	32392704	3488	18527	rs121907901	NC_000011.10:32392703:C:T	C	T	CLINICAL
NM_024426.6(WT1):c.965+1G>A	WT1		Normal	Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Wilms tumor 1	Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000661942	11	32439122	11	32417576	661942	652119	rs771527206	NC_000011.10:32417575:C:T	C	T	CLINICAL
NM_024426.6(WT1):c.882C>A (p.Tyr294Ter)	WT1	Y294*, Y77*	Normal	Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Drash syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645008	11	32449507	11	32427961	645008	639969	rs1554945031	NC_000011.10:32427960:G:T	G	T	CLINICAL
NM_024426.6(WT1):c.546C>A (p.Tyr182Ter)	WT1|LOC107982234	Y182*	Normal	Wilms tumor 1	Pathogenic(Last reviewed: Sep 15, 2008)	no assertion criteria provided	VCV000003506	11	32456361	11	32434815	3506	18545	rs121907911	NC_000011.10:32434814:G:T	G	T	CLINICAL
NM_006019.4(TCIRG1):c.2008C>T (p.Arg670Ter)	TCIRG1	R670*, R372*, R454*	Normal	not provided|Osteopetrosis|Autosomal recessive osteopetrosis 1	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551284	11	67817250	11	68049783	551284	546277	rs371263807	NC_000011.10:68049782:C:T	C	T	CLINICAL
NM_000372.5(TYR):c.229C>T (p.Arg77Trp)	TYR	R77W	Normal	not provided|Tyrosinase-negative oculocutaneous albinism	Pathogenic(Last reviewed: Jun 15, 2021)	criteria provided, single submitter	VCV000099553	11	88911350	11	89178182	99553	105442	rs61753184	NC_000011.10:89178181:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.803+1G>A	HEPACAM		Normal	Autism spectrum disorder	Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562146	11	124793235	11	124923339	562146	553320	rs375712202	NC_000011.10:124923338:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.631G>A (p.Asp211Asn)	HEPACAM	D211N	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030917	11	124793703	11	124923807	30917	39874	rs387907051	NC_000011.10:124923806:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.587C>A (p.Ser196Tyr)	HEPACAM	S196Y	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a|not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000030914	11	124793747	11	124923851	30914	39871	rs387907049	NC_000011.10:124923850:G:T	G	T	CLINICAL
NM_152722.5(HEPACAM):c.275G>A (p.Arg92Gln)	HEPACAM	R92Q	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000030916	11	124794776	11	124924880	30916	39873	rs387907050	NC_000011.10:124924879:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.265G>A (p.Gly89Ser)	HEPACAM	G89S	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a|Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation|not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000030919	11	124794786	11	124924890	30919	39876	rs387907053	NC_000011.10:124924889:C:T	C	T	CLINICAL
NM_001558.4(IL10RA):c.301C>T (p.Arg101Trp)	IL10RA	R101W	Normal	Inflammatory bowel disease 28, autosomal recessive	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV000039432	11	117860269	11	117989554	39432	48031	rs368287711	NC_000011.10:117989553:C:T	C	T	CLINICAL
NM_000244.3(MEN1):c.1296T>A (p.Ser432Arg)	MEN1	S427R, S432R, S392R, S469R	Normal	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Likely pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428072	11	64572575	11	64805103	428072	419794	rs1114167528	NC_000011.10:64805102:A:T	A	T	CLINICAL
NM_181798.1(KCNQ1):c.1207C>T (p.Gln403Ter)	KCNQ1	Q530*, Q403*	Normal	Short QT syndrome 2|Long QT syndrome 1|Jervell and Lange-Nielsen syndrome 1|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Arrhythmia|Long QT syndrome|Long QT syndrome 1|Cardiovascular phenotype|not provided	Pathogenic(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000052996	11	2790147	11	2768917	52996	67664	rs397508097	NC_000011.10:2768916:C:T	C	T	CLINICAL
NM_000525.3(KCNJ11):c.679G>A (p.Glu227Lys)	KCNJ11	E227K, E140K	Normal	Transient neonatal diabetes mellitus 3|Maturity-onset diabetes of the young, type 13|not provided|Diabetes mellitus	Pathogenic(Last reviewed: Jun 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158682	11	17408960	11	17387413	158682	168869	rs587783672	NC_000011.10:17387412:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.1240G>T (p.Glu414Ter)	BBS1|ZDHHC24	E414*	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000412287	11	66294179	11	66526708	412287	398348	rs1060503690	NC_000011.10:66526707:G:T	G	T	CLINICAL
NM_000207.3(INS):c.94G>A (p.Gly32Ser)	INS|INS-IGF2	G32S	Normal	Neonatal diabetes mellitus|Permanent neonatal diabetes mellitus 4|Permanent neonatal diabetes mellitus|Diabetes mellitus, insulin-dependent, 2	Pathogenic(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	VCV000021122	11	2182108	11	2160878	21122	33974	rs80356664	NC_000011.10:2160877:C:T	C	T	CLINICAL
NM_000244.3(MEN1):c.843C>A (p.Tyr281Ter)	MEN1	Y276*, Y281*, Y241*	Normal	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418292	11	64574567	11	64807095	418292	408406	rs1060503789	NC_000011.10:64807094:G:T	G	T	CLINICAL
NM_000352.6(ABCC8):c.3641G>A (p.Arg1214Gln)	ABCC8	R1214Q, R1215Q, R1213Q, R1236Q	Normal	Hereditary hyperinsulinism|Hyperinsulinemic hypoglycemia, familial, 1|not provided|Familial hyperinsulinism	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000632619	11	17424217	11	17402670	632619	621346	rs367850779	NC_000011.10:17402669:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.871C>T (p.Gln291Ter)	BBS1|ZDHHC24	Q291*	Normal	Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371274	11	66290967	11	66523496	371274	358042	rs1057517143	NC_000011.10:66523495:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.1447C>T (p.Arg483Ter)	BBS1|ZDHHC24	R483*	Normal	Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000649714	11	66297397	11	66529926	649714	640364	rs745656125	NC_000011.10:66529925:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.1012C>T (p.Gln338Ter)	ZDHHC24|BBS1	Q338*	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 1	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000217433	11	66291255	11	66523784	217433	214074	rs869025205	NC_000011.10:66523783:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.1177C>T (p.Arg393Ter)	BBS1|ZDHHC24	R393*	Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585171	11	66293660	11	66526189	585171	576228	rs1160669210	NC_000011.10:66526188:C:T	C	T	CLINICAL
NM_000218.3(KCNQ1):c.1096C>T (p.Arg366Trp)	KCNQ1	R366W, R239W	Normal	Long QT syndrome|Long QT syndrome 1|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000052955	11	2606505	11	2585275	52955	67623	rs199473411	NC_000011.10:2585274:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.1285C>T (p.Arg429Ter)	BBS1|ZDHHC24	R429*	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188983	11	66294224	11	66526753	188983	186838	rs768443448	NC_000011.10:66526752:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.1645G>T (p.Glu549Ter)	BBS1|ZDHHC24	E549*	Normal	not provided|Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012144	11	66299163	11	66531692	12144	27183	rs121917777	NC_000011.10:66531691:G:T	G	T	CLINICAL
NM_024649.5(BBS1):c.1318C>T (p.Arg440Ter)	ZDHHC24|BBS1	R440*	Normal	Bardet-Biedl syndrome 1|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551887	11	66294257	11	66526786	551887	546459	rs1014835928	NC_000011.10:66526785:C:T	C	T	CLINICAL
NM_000352.6(ABCC8):c.4432G>A (p.Gly1478Arg)	ABCC8	G1478R, G1479R, G1477R, G1500R	Normal	not provided|Transient neonatal diabetes mellitus 2|Permanent neonatal diabetes mellitus|Type 2 diabetes mellitus|Hyperinsulinemic hypoglycemia, familial, 1|Leucine-induced hypoglycemia|Hyperinsulinemic hypoglycemia, familial, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000434045	11	17415926	11	17394379	434045	429199	rs72559715	NC_000011.10:17394378:C:T	C	T	CLINICAL
NM_000525.3(KCNJ11):c.844G>A (p.Glu282Lys)	KCNJ11	E282K, E195K	Normal	Permanent neonatal diabetes mellitus|Hyperinsulinemic hypoglycemia, familial, 2|Maturity-onset diabetes of the young, type 13|Transient neonatal diabetes mellitus 3|Type 2 diabetes mellitus|Hyperinsulinemic hypoglycemia, familial, 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008686	11	17408795	11	17387248	8686	23725	rs267607196	NC_000011.10:17387247:C:T	C	T	CLINICAL
NM_024649.5(BBS1):c.436C>T (p.Arg146Ter)	BBS1	R146*	Normal	Bardet-Biedl syndrome 1|not provided|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000188752	11	66283014	11	66515543	188752	186836	rs786204444	NC_000011.10:66515542:C:T	C	T	CLINICAL
NM_000352.6(ABCC8):c.221G>A (p.Arg74Gln)	ABCC8	R74Q	Normal	Hyperinsulinemic hypoglycemia, familial, 1|Leucine-induced hypoglycemia|Type 2 diabetes mellitus|Hyperinsulinemic hypoglycemia, familial, 1|Permanent neonatal diabetes mellitus|Transient neonatal diabetes mellitus 2|Familial hyperinsulinism|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495834	11	17496502	11	17474955	495834	487507	rs72559734	NC_000011.10:17474954:C:T	C	T	CLINICAL
NM_003355.2(UCP2):c.-1245G>A	UCP2		Normal	Body mass index quantitative trait locus 4	risk factor(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000007865	11	73694754	11	73983709	7865	22904	rs659366	NC_000011.10:73983708:C:T	C	T	CLINICAL
NM_005959.3(MTNR1B):c.284C>T (p.Pro95Leu)	MTNR1B	P95L	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Jan 29, 2012)	no assertion criteria provided	VCV000030129	11	92714673	11	92981507	30129	39085	rs182349376	NC_000011.10:92981506:C:T	C	T	CLINICAL
NM_018026.4(PACS1):c.607C>T (p.Arg203Trp)	PACS1	R203W	Normal	Intellectual disability|not provided|Global developmental delay|Schuurs-hoeijmakers syndrome|Multiple congenital anomalies|Neurodevelopmental disorder|PACS1-related syndrome|Inborn genetic diseases|Hypotelorism|Mitral valve prolapse|Horseshoe kidney|Aortic root dilatation|Optic disc pallor	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039581	11	65978677	11	66211206	39581	48180	rs398123009	NC_000011.10:66211205:C:T	C	T	CLINICAL
NM_001130145.3(YAP1):c.1066G>T (p.Glu356Ter)	YAP1	E356*, E302*, E306*, E322*, E344*, E340*, E360*, E178*, E318*	Normal	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000120327	11	102094386	11	102223655	120327	125922	rs587777250	NC_000011.10:102223654:G:T	G	T	CLINICAL
NM_000829.4(GRIA4):c.1915A>T (p.Thr639Ser)	GRIA4	T639S	Normal	Intellectual disability|Neurodevelopmental disorder with or without seizures and gait abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446206	11	105797534	11	105926808	446206	439568	rs1555050158	NC_000011.10:105926807:A:T	A	T	CLINICAL
NM_000829.4(GRIA4):c.1931C>T (p.Ala644Val)	GRIA4	A644V	Normal	Intellectual disability|Neurodevelopmental disorder with or without seizures and gait abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Feb 7, 2018)	no assertion criteria provided	VCV000446209	11	105797550	11	105926824	446209	439571	rs1555050174	NC_000011.10:105926823:C:T	C	T	CLINICAL
NM_024740.2(ALG9):c.[1173+2T>A];[1173+2T>A]	ALG9		Normal	Gillessen-Kaesbach-Nishimura syndrome|Gillessen-Kaesbach-Nishimura dysplasia	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000162619	11	111711376	11	111840653	162619	172295	rs786205134	NC_000011.10:111840652:A:T	A	T	CLINICAL
NM_001197104.1(KMT2A):c.478C>T (p.Arg160Ter)	KMT2A	R160*	Normal	Wiedemann-Steiner syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000504304	11	118339535	11	118468820	504304	495699	rs1555034779	NC_000011.10:118468819:C:T	C	T	CLINICAL
NM_001197104.1(KMT2A):c.2896A>T (p.Arg966Ter)	KMT2A	R966*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522659	11	118344770	11	118474055	522659	513312	rs1555036801	NC_000011.10:118474054:A:T	A	T	CLINICAL
NM_001197104.1(KMT2A):c.3301C>T (p.Arg1101Ter)	KMT2A	R1101*	Normal	not provided|Inborn genetic diseases|intellectual deficiency|Wiedemann-Steiner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280699	11	118347664	11	118476949	280699	264585	rs886041856	NC_000011.10:118476948:C:T	C	T	CLINICAL
NM_005933.4(KMT2A):c.3460C>T (p.Arg1154Trp)	KMT2A	R1154W	Normal	not provided|Wiedemann-Steiner syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431895	11	118348807	11	118478092	431895	425906	rs1555038090	NC_000011.10:118478091:C:T	C	T	CLINICAL
NM_001197104.2(KMT2A):c.3592C>T (p.Gln1198Ter)	KMT2A	Q1198*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802798	11	118350911	11	118480196	802798	791106	rs1591383060	NC_000011.10:118480195:C:T	C	T	CLINICAL
NM_001197104.1(KMT2A):c.3790C>T (p.Arg1264Ter)	KMT2A	R1264*	Normal	not provided|Hirsutism|Intellectual disability|Rare genetic intellectual disability|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522088	11	118352585	11	118481870	522088	511891	rs1555039343	NC_000011.10:118481869:C:T	C	T	CLINICAL
NM_001197104.2(KMT2A):c.4906C>T (p.Arg1636Ter)	KMT2A	R1633*, R1636*	Normal	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666288	11	118362545	11	118491830	666288	653878	rs1591266263	NC_000011.10:118491829:C:T	C	T	CLINICAL
NM_001197104.2(KMT2A):c.5431C>T (p.Arg1811Ter)	KMT2A	R1808*, R1811*	Normal	Wiedemann-Steiner syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000802801	11	118366482	11	118495767	802801	791109	rs1555043796	NC_000011.10:118495766:C:T	C	T	CLINICAL
NM_005933.4(KMT2A):c.7135C>T (p.Arg2379Ter)	KMT2A	R2382*, R2379*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037074	11	118373751	11	118503036	37074	45750	rs387907275	NC_000011.10:118503035:C:T	C	T	CLINICAL
NM_005933.4(KMT2A):c.7429C>T (p.Arg2477Ter)	KMT2A	R2480*, R2477*	Normal	Wiedemann-Steiner syndrome|not provided	Pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449960	11	118374045	11	118503330	449960	444733	rs1555046568	NC_000011.10:118503329:C:T	C	T	CLINICAL
NM_001197104.1(KMT2A):c.7831G>T (p.Glu2611Ter)	KMT2A	E2611*, E2608*	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	VCV000158708	11	118374438	11	118503723	158708	168858	rs587783679	NC_000011.10:118503722:G:T	G	T	CLINICAL
NM_005933.4(KMT2A):c.8086C>T (p.Arg2696Ter)	KMT2A	R2699*, R2696*	Normal	not provided|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158709	11	118374702	11	118503987	158709	168859	rs587783680	NC_000011.10:118503986:C:T	C	T	CLINICAL
NM_001197104.1(KMT2A):c.11110C>T (p.Arg3704Ter)	KMT2A|TTC36-AS1	R3704*, R3701*	Normal	not provided|Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000523802	11	118382704	11	118511989	523802	514622	rs1555050211	NC_000011.10:118511988:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.104C>T (p.Thr35Met)	HMBS	T18M, T35M	Normal	Acute intermittent porphyria|not provided	Likely pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000449465	11	118959361	11	119088651	449465	444737	rs974712040	NC_000011.10:119088650:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.163G>T (p.Ala55Ser)	HMBS	A55S, A38S	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Jan 1, 1994)	no assertion criteria provided	VCV000001458	11	118959794	11	119089084	1458	16497	rs118204106	NC_000011.10:119089083:G:T	G	T	CLINICAL
NM_000190.4(HMBS):c.346C>T (p.Arg116Trp)	HMBS	R116W, R99W	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000001445	11	118960701	11	119089991	1445	16484	rs118204094	NC_000011.10:119089990:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.445C>T (p.Arg149Ter)	HMBS	R149*, R132*	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001486	11	118960922	11	119090212	1486	16525	rs118204120	NC_000011.10:119090211:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.463C>T (p.Gln155Ter)	HMBS	Q155*, Q138*	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Oct 1, 1990)	no assertion criteria provided	VCV000001448	11	118960940	11	119090230	1448	16487	rs118204097	NC_000011.10:119090229:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.499C>T (p.Arg167Trp)	HMBS	R167W, R150W	Normal	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001456	11	118962123	11	119091413	1456	16495	rs118204101	NC_000011.10:119091412:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.500G>T (p.Arg167Leu)	HMBS	R167L, R150L	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Apr 15, 1991)	no assertion criteria provided	VCV000001457	11	118962124	11	119091414	1457	16496	rs118204095	NC_000011.10:119091413:G:T	G	T	CLINICAL
NM_000190.4(HMBS):c.517C>T (p.Arg173Trp)	HMBS	R173W, R156W	Normal	not provided|Acute intermittent porphyria	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000649348	11	118962141	11	119091431	649348	639782	rs575222284	NC_000011.10:119091430:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.583C>T (p.Arg195Cys)	HMBS	R178C, R195C	Normal	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV000161251	11	118962207	11	119091497	161251	171129	rs34413634	NC_000011.10:119091496:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.601C>T (p.Arg201Trp)	HMBS	R201W, R184W	Normal	not provided|Acute intermittent porphyria	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001462	11	118962225	11	119091515	1462	16501	rs118204109	NC_000011.10:119091514:C:T	C	T	CLINICAL
NM_000190.4(HMBS):c.655G>T (p.Ala219Ser)	HMBS	A219S, A202S	Normal	Acute intermittent porphyria	Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000689731	11	118963117	11	119092407	689731	677433	rs767103817	NC_000011.10:119092406:G:T	G	T	CLINICAL
NM_000190.4(HMBS):c.755C>T (p.Ala252Val)	HMBS	A252V, A235V	Normal	Acute intermittent porphyria	Pathogenic(Last reviewed: Dec 1, 1993)	no assertion criteria provided	VCV000001473	11	118963217	11	119092507	1473	16512	rs118204114	NC_000011.10:119092506:C:T	C	T	CLINICAL
NM_002855.5(NECTIN1):c.554G>A (p.Trp185Ter)	NECTIN1	W185*	Normal	Orofacial cleft 7|Cleft lip/palate-ectodermal dysplasia syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000008969	11	119548444	11	119677734	8969	24008	rs104894281	NC_000011.10:119677733:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.631G>A (p.Asp211Asn)	HEPACAM	D211N	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030917	11	124793703	11	124923807	30917	39874	rs387907051	NC_000011.10:124923806:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.587C>A (p.Ser196Tyr)	HEPACAM	S196Y	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a|not provided	Pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, single submitter	VCV000030914	11	124793747	11	124923851	30914	39871	rs387907049	NC_000011.10:124923850:G:T	G	T	CLINICAL
NM_152722.5(HEPACAM):c.275G>A (p.Arg92Gln)	HEPACAM	R92Q	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a	Pathogenic(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000030916	11	124794776	11	124924880	30916	39873	rs387907050	NC_000011.10:124924879:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.266G>A (p.Gly89Asp)	HEPACAM	G89D	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with mental retardation	Pathogenic(Last reviewed: Apr 8, 2011)	no assertion criteria provided	VCV000030920	11	124794785	11	124924889	30920	39877	rs387907054	NC_000011.10:124924888:C:T	C	T	CLINICAL
NM_152722.5(HEPACAM):c.265G>A (p.Gly89Ser)	HEPACAM	G89S	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 2a|Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation|not provided	Pathogenic(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000030919	11	124794786	11	124924890	30919	39876	rs387907053	NC_000011.10:124924889:C:T	C	T	CLINICAL
NM_031307.4(PUS3):c.578G>A (p.Arg193Gln)	PUS3|HYLS1	R193Q	Normal	Dandy-Walker syndrome|Genetic syndrome with a Dandy-Walker malformation as major feature|Mental retardation, autosomal recessive 55	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632593	11	125765485	11	125895590	632593	621029	rs576405108	NC_000011.10:125895589:C:T	C	T	CLINICAL
NM_031307.4(PUS3):c.497G>A (p.Arg166Gln)	PUS3|HYLS1	R166Q	Normal	Dandy-Walker syndrome|Genetic syndrome with a Dandy-Walker malformation as major feature|Mental retardation, autosomal recessive 55	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632594	11	125765566	11	125895671	632594	621030	rs200876642	NC_000011.10:125895670:C:T	C	T	CLINICAL
NM_017547.4(FOXRED1):c.406C>T (p.Arg136Trp)	FOXRED1	R136W	Normal	not provided|Mitochondrial complex I deficiency	Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, single submitter	VCV000372745	11	126142963	11	126273068	372745	360002	rs373075574	NC_000011.10:126273067:C:T	C	T	CLINICAL
NM_032531.4(KIRREL3):c.2019G>A (p.Met673Ile)	KIRREL3	M673I, M661I	Normal	Mental retardation, autosomal dominant 4	Likely pathogenic(Last reviewed: Nov 19, 2015)	criteria provided, single submitter	VCV000375632	11	126294793	11	126424898	375632	362444	rs1057519593	NC_000011.10:126424897:C:T	C	T	CLINICAL
NM_000525.3(KCNJ11):c.175G>A (p.Val59Met)	KCNJ11	V59M	Normal	not provided|Permanent neonatal diabetes mellitus|Permanent neonatal diabetes mellitus 2|Neonatal insulin-dependent diabetes mellitus	Pathogenic(Last reviewed: Apr 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000008667	11	17409464	11	17387917	8667	23706	rs80356616	NC_000011.10:17387916:C:T	C	T	CLINICAL
NM_001277269.1(OTOG):c.2500C>T (p.Gln834Ter)	OTOG	Q834*, Q822*	Normal	Deafness, autosomal recessive 18b|not provided|Seizures|Intellectual disability|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000417941	11	17596437	11	17574890	417941	404799	rs554847663	NC_000011.10:17574889:C:T	C	T	CLINICAL
NM_000280.4(PAX6):c.771G>A (p.Trp257Ter)	PAX6	W257*, W271*, W121*, W190*, W204*, W272*, W282*, W296*, W56*, W338*	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000003483	11	31815345	11	31793797	3483	18522	rs121907929	NC_000011.10:31793796:C:T	C	T	CLINICAL
NM_001310160.1(PAX6):c.-383C>A	PAX6	S119R, S133R, S134R, S144R, S158R, S200R	Normal	Aniridia 1	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000003481	11	31823109	11	31801561	3481	18520	rs121907928	NC_000011.10:31801560:G:T	G	T	CLINICAL
NM_024426.6(WT1):c.1447+5G>A	WT1		Normal	Wilms tumor 1|Frasier syndrome|Drash syndrome|not provided|Familial idiopathic steroid-resistant nephrotic syndrome|Nephrotic syndrome, type 4|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Frasier syndrome|Drash syndrome	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003493	11	32413513	11	32391967	3493	18532	rs587776576	NC_000011.10:32391966:C:T	C	T	CLINICAL
NM_024426.6(WT1):c.965+1G>A	WT1		Normal	Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Drash syndrome|Wilms tumor 1	Likely pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000661942	11	32439122	11	32417576	661942	652119	rs771527206	NC_000011.10:32417575:C:T	C	T	CLINICAL
NM_024426.6(WT1):c.882C>A (p.Tyr294Ter)	WT1	Y294*, Y77*	Normal	Frasier syndrome|Wilms tumor, aniridia, genitourinary anomalies, and mental retardation syndrome|Wilms tumor 1|Drash syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000645008	11	32449507	11	32427961	645008	639969	rs1554945031	NC_000011.10:32427960:G:T	G	T	CLINICAL
NM_003477.3(PDHX):c.742C>T (p.Gln248Ter)	PDHX	Q248*, Q233*	Normal	Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000002118	11	34988287	11	34966740	2118	17157	rs113309941	NC_000011.10:34966739:C:T	C	T	CLINICAL
NM_003477.3(PDHX):c.1336C>T (p.Arg446Ter)	PDHX	R446*, R219*, R431*	Normal	not provided|Pyruvate dehydrogenase E3-binding protein deficiency	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162202	11	35016549	11	34995002	162202	171910	rs1135402725	NC_000011.10:34995001:C:T	C	T	CLINICAL
NM_014489.4(PGAP2):c.46C>T (p.Arg16Trp)	PGAP2	R16W, R73W, R67W	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050505	11	3832535	11	3811305	50505	59544	rs773359554	NC_000011.10:3811304:C:T	C	T	CLINICAL
NM_014489.4(PGAP2):c.391G>T (p.Glu131Ter)	PGAP2	E110*, E121*, E127*, E131*, E188*, E70*, E88*, G111V, G73V	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Aug 23, 2019)	no assertion criteria provided	VCV000827783	11	3845155	11	3823925	827783	815994	rs1590414630	NC_000011.10:3823924:G:T	G	T	CLINICAL
NM_014489.4(PGAP2):c.491C>T (p.Thr164Ile)	PGAP2	T160I, T121I, T221I, T103I, T154I, T164I, T143I	Normal	Hyperphosphatasia with mental retardation syndrome 3	Pathogenic(Last reviewed: Apr 4, 2013)	no assertion criteria provided	VCV000050506	11	3845255	11	3824025	50506	59545	rs587776970	NC_000011.10:3824024:C:T	C	T	CLINICAL
NM_014489.4(PGAP2):c.881C>T (p.Thr294Met)	PGAP2	T229M, T233M, T251M, T273M, T284M, T286M, T290M, T294M, T351M	Normal	Hyperphosphatasia with mental retardation syndrome 3	Likely pathogenic(Last reviewed: Aug 23, 2019)	no assertion criteria provided	VCV000827784	11	3846621	11	3825391	827784	815995	rs747658866	NC_000011.10:3825390:C:T	C	T	CLINICAL
NM_021926.4(ALX4):c.620C>A (p.Ser207Ter)	ALX4	S207*	Normal	Parietal foramina 2	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000005018	11	44297055	11	44275505	5018	20057	rs104894197	NC_000011.10:44275504:G:T	G	T	CLINICAL
NM_005343.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS|LRRC56	G12S	Normal	Carcinoma of esophagus|Lung adenocarcinoma|Glioblastoma|not provided|Rhabdomyosarcoma (disease)|Breast neoplasm|none provided|Uterine Carcinosarcoma|Neoplasm of uterine cervix|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Neoplasm of the thyroid gland|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Costello syndrome|Myopathy, congenital, with excess of muscle spindles|Nevus sebaceous|Epidermal nevus with urothelial cancer, somatic|Nevus, woolly hair|Multiple myeloma|Myelodysplastic syndrome|Malignant melanoma of skin|Pancreatic adenocarcinoma|Rasopathy|Hepatocellular carcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Lip and oral cavity carcinoma|Inborn genetic diseases|Neoplasm of the large intestine	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012602	11	534289	11	534289	12602	27641	rs104894229	NC_000011.10:534288:C:T	C	T	CLINICAL
NM_001173990.3(TMEM216):c.218G>T (p.Arg73Leu)	TMEM216	R73L, R12L	Normal	Joubert syndrome 2|not provided|Meckel syndrome, type 2|Joubert syndrome|Joubert syndrome 2|Meckel syndrome, type 2|TMEM216-Related Disorders|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000197	11	61161437	11	61393965	197	15236	rs201108965	NC_000011.10:61393964:G:T	G	T	CLINICAL
NM_006268.5(DPF2):c.827G>T (p.Cys276Phe)	DPF2	C276F, C290F	Normal	Coffin-Siris syndrome 7|Coffin-Siris syndrome 1	Pathogenic(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000438643	11	65113452	11	65345981	438643	432263	rs1555031372	NC_000011.10:65345980:G:T	G	T	CLINICAL
NM_018026.4(PACS1):c.607C>T (p.Arg203Trp)	PACS1	R203W	Normal	Intellectual disability|not provided|Global developmental delay|Schuurs-hoeijmakers syndrome|Multiple congenital anomalies|Neurodevelopmental disorder|PACS1-related syndrome|Inborn genetic diseases|Hypotelorism|Mitral valve prolapse|Horseshoe kidney|Aortic root dilatation|Optic disc pallor	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039581	11	65978677	11	66211206	39581	48180	rs398123009	NC_000011.10:66211205:C:T	C	T	CLINICAL
NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met)	NDUFV1	T423M, T414M	Normal	Mitochondrial complex I deficiency|not provided|Mitochondrial complex 1 deficiency, nuclear type 4|Mitochondrial complex I deficiency, nuclear type 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014056	11	67379696	11	67612225	14056	29095	rs121913659	NC_000011.10:67612224:C:T	C	T	CLINICAL
NM_002335.4(LRP5):c.1145C>T (p.Pro382Leu)	LRP5	P382L	Normal	not provided|Osteoporosis with pseudoglioma	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000040288	11	68153913	11	68386445	40288	48771	rs397514664	NC_000011.10:68386444:C:T	C	T	CLINICAL
NM_021008.4(DEAF1):c.700T>A (p.Trp234Arg)	DEAF1	W234R	Normal	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000437398	11	686962	11	686962	437398	430958	rs1057524157	NC_000011.10:686961:A:T	A	T	CLINICAL
NM_021008.3(DEAF1):c.634G>A (p.Gly212Ser)	DEAF1	G212S	Normal	Mental retardation, autosomal dominant 24|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375554	11	687941	11	687941	375554	362364	rs1057519565	NC_000011.10:687940:C:T	C	T	CLINICAL
NM_031157.4(HNRNPA1):c.940G>A (p.Asp314Asn)	HNRNPA1	D314N, D262N	Normal	Amyotrophic lateral sclerosis 20	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065452	12	54677628	12	54283844	65452	76369	rs397518453	NC_000012.12:54283843:G:A	G	A	CLINICAL
NM_004984.4(KIF5A):c.3020+1G>A	KIF5A		Normal	Amyotrophic lateral sclerosis, susceptibility to, 25	risk factor(Last reviewed: Mar 29, 2018)	no assertion criteria provided	VCV000504478	12	57976413	12	57582630	504478	495918	rs1555179091	NC_000012.12:57582629:G:A	G	A	CLINICAL
NM_013254.4(TBK1):c.1340+1G>A	TBK1		Normal	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000203439	12	64879798	12	64486018	203439	199852	rs767898276	NC_000012.12:64486017:G:A	G	A	CLINICAL
NM_013254.4(TBK1):c.2086G>A (p.Glu696Lys)	TBK1	E696K	Normal	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000203440	12	64891767	12	64497987	203440	199853	rs748112833	NC_000012.12:64497986:G:A	G	A	CLINICAL
NM_001917.5(DAO):c.250G>A (p.Ala84Thr)	DAO	A84T	Normal	Amyotrophic lateral sclerosis	Likely pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV000976656	12	109281281	12	108887505	976656	964791	rs781658657	NC_000012.12:108887504:G:A	G	A	CLINICAL
NM_198578.4(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	G2019S	Normal	not provided|Inborn genetic diseases|Parkinson disease 8, autosomal dominant|Hereditary late onset Parkinson disease|Young-onset Parkinson disease	Pathogenic, risk factor(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001940	12	40734202	12	40340400	1940	16979	rs34637584	NC_000012.12:40340399:G:A	G	A	CLINICAL
NM_000719.7(CACNA1C):c.1113G>A (p.Trp371Ter)	CACNA1C	W368*, W371*	Normal	Timothy syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802809	12	2602552	12	2493386	802809	791223	rs1555672574	NC_000012.12:2493385:G:A	G	A	CLINICAL
NM_000719.7(CACNA1C):c.1114-304G>A	CACNA1C	G406R	Normal	Long QT syndrome|not provided|Timothy syndrome	Pathogenic(Last reviewed: Aug 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190633	12	2613704	12	2504538	190633	188541	rs786205745	NC_000012.12:2504537:G:A	G	A	CLINICAL
NM_000719.7(CACNA1C):c.1204G>A (p.Gly402Ser)	CACNA1C	G402S, G399S	Normal	not provided|Timothy syndrome|Congenital long QT syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000017633	12	2614098	12	2504932	17633	32672	rs80315385	NC_000012.12:2504931:G:A	G	A	CLINICAL
NM_000719.7(CACNA1C):c.1216G>A (p.Gly406Arg)	CACNA1C	G406R, G403R	Normal	not provided|Timothy syndrome|CACNA1C-Related Disorders|Long QT syndrome|Congenital long QT syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017632	12	2614110	12	2504944	17632	32671	rs79891110	NC_000012.12:2504943:G:A	G	A	CLINICAL
NM_000719.7(CACNA1C):c.2573G>A (p.Arg858His)	CACNA1C	R858H, R855H	Normal	none provided|Long QT syndrome|not provided|Long QT syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Jan 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000190653	12	2702421	12	2593255	190653	188572	rs786205753	NC_000012.12:2593254:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.3944C>T (p.Ala1315Val)	GRIN2B	A1315V	Normal	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000655974	12	13716228	12	13563294	655974	640994	rs1591605514	NC_000012.12:13563293:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.2539C>T (p.Arg847Ter)	GRIN2B	R847*	Normal	Mental retardation, autosomal dominant 6|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27|Complex neurodevelopmental disorder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245756	12	13720018	12	13567084	245756	244793	rs879253931	NC_000012.12:13567083:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.2459G>T (p.Gly820Val)	GRIN2B	G820V	Normal	Mental retardation, autosomal dominant 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234635	12	13720098	12	13567164	234635	231836	rs797044849	NC_000012.12:13567163:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.2201C>T (p.Ala734Val)	GRIN2B	A734V	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234527	12	13722922	12	13569988	234527	231840	rs876661064	NC_000012.12:13569987:G:A	G	A	CLINICAL
NM_000834.5(GRIN2B):c.2044C>T	GRIN2B	R682C	Normal	Mental retardation, autosomal dominant 6|not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029730	12	13724865	12	13571931	29730	38685	rs387906636	NC_000012.12:13571930:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.2002G>T (p.Asp668Tyr)	GRIN2B	D668Y	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234668	12	13761545	12	13608611	234668	231841	rs876661151	NC_000012.12:13608610:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.1966C>T (p.Gln656Ter)	GRIN2B	Q656*	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431127	12	13761581	12	13608647	431127	424660	rs1135401799	NC_000012.12:13608646:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1916C>T (p.Ala639Val)	GRIN2B	A639V	Normal	Mental retardation, autosomal dominant 6|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208749	12	13761631	12	13608697	208749	205274	rs797044930	NC_000012.12:13608696:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1844A>T (p.Asn615Ile)	GRIN2B	N615I	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000162086	12	13761703	12	13608769	162086	171802	rs672601377	NC_000012.12:13608768:T:A	T	A	CLINICAL
NM_000834.4(GRIN2B):c.1658C>T (p.Pro553Leu)	GRIN2B	P553L	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000039661	12	13764781	12	13611847	39661	48260	rs397514556	NC_000012.12:13611846:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1555C>T (p.Arg519Ter)	GRIN2B	R519*	Normal	Complex neurodevelopmental disorder|Intellectual disability|not provided|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391757	12	13768147	12	13615213	391757	372867	rs774592932	NC_000012.12:13615212:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1345G>T (p.Glu449Ter)	GRIN2B	E449*	Normal	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000544230	12	13768582	12	13615648	544230	527240	rs1555112186	NC_000012.12:13615647:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.1280G>T (p.Gly427Val)	GRIN2B	G427V	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000663217	12	13769437	12	13616503	663217	641005	rs1591643530	NC_000012.12:13616502:C:A	C	A	CLINICAL
NM_020297.3(ABCC9):c.3460C>T (p.Arg1154Trp)	ABCC9	R1154W	Normal	Hypertrichotic osteochondrodysplasia Cantu type|Dilated cardiomyopathy 1O|not provided|Coarse facial features|Macrocephalus|Epicanthus|Depressed nasal bridge|Bulbous nose|Abnormality of the face|Left ventricular hypertrophy|Joint hypermobility|Micrognathia|Tapered finger|Abnormal facial shape|Thick upper lip vermilion|Patent ductus arteriosus|Large hands|Low anterior hairline	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031946	12	21995261	12	21842327	31946	40611	rs387907208	NC_000012.12:21842326:G:A	G	A	CLINICAL
NM_005691.3(ABCC9):c.3346C>T (p.Arg1116Cys)	ABCC9	R1116C	Normal	Dilated cardiomyopathy 1O|Kleefstra syndrome 1|Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000035534	12	21995375	12	21842441	35534	44205	rs387907228	NC_000012.12:21842440:G:A	G	A	CLINICAL
NM_005691.3(ABCC9):c.1703C>T (p.Pro568Leu)	ABCC9	P568L	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666318	12	22047065	12	21894131	666318	653882	rs1592166720	NC_000012.12:21894130:G:A	G	A	CLINICAL
NM_005691.3(ABCC9):c.1433C>T (p.Ala478Val)	ABCC9	A478V	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000031949	12	22061033	12	21908099	31949	40614	rs387907211	NC_000012.12:21908098:G:A	G	A	CLINICAL
NM_005691.3(ABCC9):c.178C>T (p.His60Tyr)	ABCC9	H60Y	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic(Last reviewed: May 18, 2012)	no assertion criteria provided	VCV000035536	12	22086822	12	21933888	35536	44207	rs387907230	NC_000012.12:21933887:G:A	G	A	CLINICAL
NM_002076.4(GNS):c.1168C>T (p.Gln390Ter)	GNS	Q390*	Normal	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000002934	12	65122768	12	64728988	2934	17973	rs119461975	NC_000012.12:64728987:G:A	G	A	CLINICAL
NM_002076.4(GNS):c.1063C>T (p.Arg355Ter)	GNS	R355*	Normal	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000002932	12	65130819	12	64737039	2932	17971	rs119461974	NC_000012.12:64737038:G:A	G	A	CLINICAL
NM_002076.4(GNS):c.814C>T (p.Gln272Ter)	GNS	Q272*	Normal	Mucopolysaccharidosis, MPS-III-D	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000638094	12	65134447	12	64740667	638094	625883	rs1365770233	NC_000012.12:64740666:G:A	G	A	CLINICAL
NM_024312.5(GNPTAB):c.832C>T (p.Gln278Ter)	GNPTAB	Q278*	Normal	Mucopolysaccharidosis, MPS-III-A|Mucolipidosis type II|Pseudo-Hurler polydystrophy	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV000038433	12	102164875	12	101771097	38433	46992	rs35878526	NC_000012.12:101771096:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.441C>A (p.His147Gln)	HNF1A	H147Q	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036821	12	121426750	12	120988947	36821	45482	rs193922597	NC_000012.12:120988946:C:A	C	A	CLINICAL
NM_000545.6(HNF1A):c.608G>A (p.Arg203His)	HNF1A	R203H	Normal	not provided|Diabetes mellitus type 1	Likely pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000129235	12	121431404	12	120993601	129235	134681	rs587780357	NC_000012.12:120993600:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.827C>A (p.Ala276Asp)	HNF1A	A276D	Normal	Monogenic diabetes|not provided|Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000014945	12	121432080	12	120994277	14945	29984	rs137853245	NC_000012.12:120994276:C:A	C	A	CLINICAL
NM_000545.6(HNF1A):c.1501+1G>A	HNF1A		Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000430837	12	121435469	12	120997666	430837	424382	rs1131692182	NC_000012.12:120997665:G:A	G	A	CLINICAL
NM_000486.5(AQP2):c.450T>A (p.Asp150Glu)	AQP2|AQP5-AS1	D150E	Normal	not provided|Nephrogenic diabetes insipidus, autosomal	Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000441134	12	50348027	12	49954244	441134	434768	rs770932012	NC_000012.12:49954243:T:A	T	A	CLINICAL
NM_000545.6(HNF1A):c.812G>A (p.Arg271Gln)	HNF1A	R271Q	Normal	Diabetes mellitus|not provided	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000449403	12	121432065	12	120994262	449403	444937	rs779184183	NC_000012.12:120994261:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.815G>A (p.Arg272His)	HNF1A	R272H	Normal	Monogenic diabetes|not provided|Diabetes mellitus, insulin-dependent, 20	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014931	12	121432068	12	120994265	14931	29970	rs137853238	NC_000012.12:120994264:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.714-1G>A	HNF1A		Normal	Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000014941	12	121431966	12	120994163	14941	29980	rs1463923467	NC_000012.12:120994162:G:A	G	A	CLINICAL
NM_000552.4(VWF):c.1533+1G>T	VWF		Normal	Inborn genetic diseases	Pathogenic(Last reviewed: Feb 10, 2017)	criteria provided, single submitter	VCV000521600	12	6172119	12	6062953	521600	512032	rs1555198839	NC_000012.12:6062952:C:A	C	A	CLINICAL
NM_000545.6(HNF1A):c.392G>A (p.Arg131Gln)	HNF1A	R131Q	Normal	not provided|Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000562373	12	121426701	12	120988898	562373	553557	rs753998395	NC_000012.12:120988897:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.476G>A (p.Arg159Gln)	HNF1A	R159Q	Normal	Maturity-onset diabetes of the young, type 3|not provided	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586792	12	121426785	12	120988982	586792	577242	rs1172328722	NC_000012.12:120988981:G:A	G	A	CLINICAL
NM_024685.4(BBS10):c.145C>T (p.Arg49Trp)	BBS10	R49W	Normal	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|not provided|Retinal dystrophy|High-frequency hearing impairment|Macular degeneration|Postaxial hand polydactyly|Intellectual disability|Retinal dystrophy|Foot polydactyly|Inborn genetic diseases	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000225010	12	76741994	12	76348214	225010	226933	rs768933093	NC_000012.12:76348213:G:A	G	A	CLINICAL
NM_000486.5(AQP2):c.190G>A (p.Gly64Arg)	AQP2	G64R	Normal	not provided|Nephrogenic diabetes insipidus, autosomal|Nephrogenic diabetes insipidus	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000017830	12	50344803	12	49951020	17830	32869	rs104894326	NC_000012.12:49951019:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.599G>A (p.Arg200Gln)	HNF1A	R200Q	Normal	not provided|Diabetes mellitus	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381588	12	121431395	12	120993592	381588	372861	rs893256143	NC_000012.12:120993591:G:A	G	A	CLINICAL
NM_000545.6(HNF1A):c.955G>A (p.Gly319Ser)	HNF1A	G319S	Normal	Diabetes mellitus type 2, susceptibility to	risk factor(Last reviewed: Apr 2, 2002)	no assertion criteria provided	VCV000014934	12	121432208	12	120994405	14934	29973	rs137853240	NC_000012.12:120994404:G:A	G	A	CLINICAL
NM_024312.5(GNPTAB):c.3539C>T (p.Ser1180Phe)	GNPTAB	S1180F	Normal	Mucolipidosis type II|Pseudo-Hurler polydystrophy	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000397574	12	102147213	12	101753435	397574	384452	rs1060499689	NC_000012.12:101753434:G:A	G	A	CLINICAL
NM_024312.5(GNPTAB):c.1408+1G>T	GNPTAB		Normal	Mucolipidosis type II|Pseudo-Hurler polydystrophy|Mucolipidosis type II	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000397559	12	102161814	12	101768036	397559	384466	rs1060499680	NC_000012.12:101768035:C:A	C	A	CLINICAL
NM_000618.5(IGF1):c.292C>T (p.Arg98Trp)	IGF1	R98W, R82W	Normal	Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic	no assertion criteria provided	VCV000127243	12	102813397	12	102419619	127243	132700	rs587779350	NC_000012.12:102419618:G:A	G	A	CLINICAL
NM_130466.4(UBE3B):c.2568+1G>A	UBE3B		Normal	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000488631	12	109962309	12	109524504	488631	481499	rs1555269815	NC_000012.12:109524503:G:A	G	A	CLINICAL
NM_001291424.1(SH2B3):c.577G>A (p.Glu193Lys)	SH2B3	E193K, E395K	Normal	Primary familial polycythemia due to EPO receptor mutation|Thrombocythemia 1	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000619973	12	111885295	12	111447491	619973	611368	rs148636776	NC_000012.12:111447490:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.6556C>T (p.Gln2186Ter)	MED13L	Q2186*	Normal	Mental retardation and distinctive facial features with or without cardiac defects|not provided	Likely pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000451351	12	116399148	12	115961343	451351	444923	rs1555239555	NC_000012.12:115961342:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.6488C>T (p.Ser2163Leu)	MED13L	S2163L	Normal	not provided|Mental retardation and distinctive facial features with or without cardiac defects|Transposition of the great arteries, dextro-looped 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620012	12	116401224	12	115963419	620012	611408	rs1565981137	NC_000012.12:115963418:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.6485C>T (p.Thr2162Met)	MED13L	T2162M	Normal	Mental retardation and distinctive facial features with or without cardiac defects|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224153	12	116401227	12	115963422	224153	225881	rs869312707	NC_000012.12:115963421:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.5965C>T (p.Gln1989Ter)	MED13L	Q1989*	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000559865	12	116408501	12	115970696	559865	550620	rs1555241166	NC_000012.12:115970695:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.5278C>T (p.Arg1760Ter)	MED13L	R1760*	Normal	not provided|Intellectual disability	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280198	12	116418641	12	115980836	280198	264462	rs886041448	NC_000012.12:115980835:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.5173C>T (p.Gln1725Ter)	MED13L	Q1725*	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000431108	12	116420191	12	115982386	431108	424631	rs1135401765	NC_000012.12:115982385:G:A	G	A	CLINICAL
NM_015335.5(MED13L):c.3482C>T (p.Thr1161Ile)	MED13L	T1161I	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Likely pathogenic(Last reviewed: May 10, 2019)	no assertion criteria provided	VCV000827796	12	116429277	12	115991472	827796	815996	rs1592923871	NC_000012.12:115991471:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.3469C>T (p.Gln1157Ter)	MED13L	Q1157*	Normal	Mental retardation and distinctive facial features with or without cardiac defects|not provided	Pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000489304	12	116429290	12	115991485	489304	482012	rs1555245108	NC_000012.12:115991484:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.2600C>T (p.Thr867Ile)	MED13L	T867I	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Likely pathogenic(Last reviewed: Nov 8, 2017)	no assertion criteria provided	VCV000488544	12	116435005	12	115997200	488544	481412	rs1555246143	NC_000012.12:115997199:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.2597C>T (p.Pro866Leu)	MED13L	P866L	Normal	Mental retardation and distinctive facial features with or without cardiac defects|not provided|Kabuki-like syndrome	Likely pathogenic(Last reviewed: Oct 17, 2015)	criteria provided, single submitter	VCV000431916	12	116435008	12	115997203	431916	425950	rs1555246145	NC_000012.12:115997202:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.2107C>T (p.Gln703Ter)	MED13L	Q703*	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000545567	12	116445347	12	116007542	545567	536069	rs1555247672	NC_000012.12:116007541:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.2065C>T (p.Gln689Ter)	MED13L	Q689*	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Likely pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000666327	12	116445389	12	116007584	666327	653881	rs1592940794	NC_000012.12:116007583:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.2059C>T (p.Gln687Ter)	MED13L	Q687*	Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: May 9, 2016)	criteria provided, single submitter	VCV000433184	12	116445395	12	116007590	433184	426745	rs1555247699	NC_000012.12:116007589:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.1690C>T (p.Arg564Ter)	MED13L	R564*	Normal	Mental retardation and distinctive facial features with or without cardiac defects|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 16, 2016)	criteria provided, single submitter	VCV000521154	12	116446528	12	116008723	521154	511972	rs1555247936	NC_000012.12:116008722:G:A	G	A	CLINICAL
NM_015335.4(MED13L):c.480-1G>T	MED13L		Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000221557	12	116460407	12	116022602	221557	223286	rs869025288	NC_000012.12:116022601:C:A	C	A	CLINICAL
NM_001414.4(EIF2B1):c.547G>T (p.Val183Phe)	EIF2B1	V183F	Normal	Leukoencephalopathy with vanishing white matter	Pathogenic(Last reviewed: Aug 19, 2015)	no assertion criteria provided	VCV000217277	12	124110976	12	123626429	217277	213924	rs863225048	NC_000012.12:123626428:C:A	C	A	CLINICAL
NM_032656.4(DHX37):c.3281C>T (p.Thr1094Met)	DHX37	T1094M	Normal	Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691930	12	125434541	12	124949995	691930	679681	rs1277857720	NC_000012.12:124949994:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.3944C>T (p.Ala1315Val)	GRIN2B	A1315V	Normal	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000655974	12	13716228	12	13563294	655974	640994	rs1591605514	NC_000012.12:13563293:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.2539C>T (p.Arg847Ter)	GRIN2B	R847*	Normal	Mental retardation, autosomal dominant 6|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27|Complex neurodevelopmental disorder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245756	12	13720018	12	13567084	245756	244793	rs879253931	NC_000012.12:13567083:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.2459G>T (p.Gly820Val)	GRIN2B	G820V	Normal	Mental retardation, autosomal dominant 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234635	12	13720098	12	13567164	234635	231836	rs797044849	NC_000012.12:13567163:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.2225G>T (p.Arg742Ile)	GRIN2B	R742I	Normal	Autistic behavior|Behavioral abnormality|Seizures|Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523382	12	13722898	12	13569964	523382	514017	rs1555103646	NC_000012.12:13569963:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.2201C>T (p.Ala734Val)	GRIN2B	A734V	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234527	12	13722922	12	13569988	234527	231840	rs876661064	NC_000012.12:13569987:G:A	G	A	CLINICAL
NM_000834.5(GRIN2B):c.2044C>T	GRIN2B	R682C	Normal	Mental retardation, autosomal dominant 6|not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029730	12	13724865	12	13571931	29730	38685	rs387906636	NC_000012.12:13571930:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.2002G>T (p.Asp668Tyr)	GRIN2B	D668Y	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234668	12	13761545	12	13608611	234668	231841	rs876661151	NC_000012.12:13608610:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.1966C>T (p.Gln656Ter)	GRIN2B	Q656*	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431127	12	13761581	12	13608647	431127	424660	rs1135401799	NC_000012.12:13608646:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1916C>T (p.Ala639Val)	GRIN2B	A639V	Normal	Mental retardation, autosomal dominant 6|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208749	12	13761631	12	13608697	208749	205274	rs797044930	NC_000012.12:13608696:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1844A>T (p.Asn615Ile)	GRIN2B	N615I	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000162086	12	13761703	12	13608769	162086	171802	rs672601377	NC_000012.12:13608768:T:A	T	A	CLINICAL
NM_000834.4(GRIN2B):c.1658C>T (p.Pro553Leu)	GRIN2B	P553L	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000039661	12	13764781	12	13611847	39661	48260	rs397514556	NC_000012.12:13611846:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1555C>T (p.Arg519Ter)	GRIN2B	R519*	Normal	Complex neurodevelopmental disorder|Intellectual disability|not provided|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391757	12	13768147	12	13615213	391757	372867	rs774592932	NC_000012.12:13615212:G:A	G	A	CLINICAL
NM_000834.4(GRIN2B):c.1345G>T (p.Glu449Ter)	GRIN2B	E449*	Normal	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000544230	12	13768582	12	13615648	544230	527240	rs1555112186	NC_000012.12:13615647:C:A	C	A	CLINICAL
NM_000834.4(GRIN2B):c.1280G>T (p.Gly427Val)	GRIN2B	G427V	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000663217	12	13769437	12	13616503	663217	641005	rs1591643530	NC_000012.12:13616502:C:A	C	A	CLINICAL
NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	KRAS	K5N	Normal	Cardiofaciocutaneous syndrome 2|Inborn genetic diseases|Noonan syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012594	12	25398304	12	25245370	12594	27633	rs104894361	NC_000012.12:25245369:T:A	T	A	CLINICAL
NM_001173464.2(KIF21A):c.2860C>T (p.Arg954Trp)	KIF21A	R954W, R941W, R918W	Normal	Fibrosis of extraocular muscles, congenital, 3b|not provided|Fibrosis of extraocular muscles, congenital, 1	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002436	12	39726207	12	39332405	2436	17475	rs121912585	NC_000012.12:39332404:G:A	G	A	CLINICAL
NM_020374.4(C12orf4):c.1360C>T (p.Arg454Ter)	C12orf4	R454*, R170*, R238*, R281*, R411*	Normal	Intellectual disability, autosomal recessive 66	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000592164	12	4609384	12	4500218	592164	583170	rs749969789	NC_000012.12:4500217:G:A	G	A	CLINICAL
NM_003482.3(KMT2D):c.6295C>T (p.Arg2099Ter)	KMT2D	R2099*	Normal	Inborn genetic diseases|Intellectual disability|not provided|Kabuki syndrome 1	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521015	12	49435258	12	49041475	521015	512013	rs1452715535	NC_000012.12:49041474:G:A	G	A	CLINICAL
NM_006009.4(TUBA1A):c.1256C>T (p.Ser419Leu)	TUBA1A	S419L, S384L	Normal	Lissencephaly 3|Tubulinopathies	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000007074	12	49578893	12	49185110	7074	22113	rs137853047	NC_000012.12:49185109:G:A	G	A	CLINICAL
NM_006009.4(TUBA1A):c.790C>T (p.Arg264Cys)	TUBA1A	R264C, R229C	Normal	not provided|Lissencephaly|Lissencephaly 3|Tubulinopathies|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007070	12	49579359	12	49185576	7070	22109	rs137853043	NC_000012.12:49185575:G:A	G	A	CLINICAL
NM_006009.4(TUBA1A):c.180G>T (p.Lys60Asn)	TUBA1A	K60N, K25N	Normal	Congenital cerebellar hypoplasia|Corpus callosum, agenesis of|Lissencephaly 3|Cerebellar vermis hypoplasia	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632599	12	49580440	12	49186657	632599	621031	rs1565627707	NC_000012.12:49186656:C:A	C	A	CLINICAL
NM_001273.5(CHD4):c.3518G>T (p.Arg1173Leu)	CHD4	R1173L, R1166L, R1160L	Normal	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266127	12	6697063	12	6587897	266127	260982	rs886039918	NC_000012.12:6587896:C:A	C	A	CLINICAL
NM_001273.5(CHD4):c.3443G>T (p.Trp1148Leu)	CHD4	W1148L, W1135L, W1141L	Normal	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266128	12	6697486	12	6588320	266128	260983	rs886039919	NC_000012.12:6588319:C:A	C	A	CLINICAL
NM_020401.4(NUP107):c.303G>A (p.Met101Ile)	NUP107	M101I, M72I	Normal	Early onset focal segmental glomerulosclerosis|Light complexion|Global developmental delay|Galloway-Mowat syndrome 7|not provided	Pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000183304	12	69084526	12	68690746	183304	181435	rs730882216	NC_000012.12:68690745:G:A	G	A	CLINICAL
NM_138425.4(C12orf57):c.53-1G>A	C12orf57		Normal	Temtamy syndrome	Likely pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000534668	12	7053638	12	6944475	534668	527347	rs374836404	NC_000012.12:6944474:G:A	G	A	CLINICAL
NM_138425.4(C12orf57):c.152T>A (p.Leu51Gln)	C12orf57	L51Q, L16Q, L38Q	Normal	Temtamy syndrome	Pathogenic(Last reviewed: Mar 7, 2013)	no assertion criteria provided	VCV000041943	12	7053738	12	6944575	41943	51109	rs587776955	NC_000012.12:6944574:T:A	T	A	CLINICAL
NM_173353.4(TPH2):c.1322G>A (p.Arg441His)	TPH2	R441H	Normal	Unipolar depression, susceptibility to	risk factor(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000003162	12	72425324	12	72031544	3162	18201	rs120074175	NC_000012.12:72031543:G:A	G	A	CLINICAL
NM_024685.4(BBS10):c.145C>T (p.Arg49Trp)	BBS10	R49W	Normal	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|not provided|Retinal dystrophy|High-frequency hearing impairment|Macular degeneration|Postaxial hand polydactyly|Intellectual disability|Retinal dystrophy|Foot polydactyly|Inborn genetic diseases	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000225010	12	76741994	12	76348214	225010	226933	rs768933093	NC_000012.12:76348213:G:A	G	A	CLINICAL
NM_025114.4(CEP290):c.5704G>T (p.Glu1902Ter)	CEP290	E1902*	Normal	Joubert syndrome 5|Bardet-Biedl syndrome 14|Meckel syndrome type 6	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000001345	12	88471004	12	88077227	1345	16384	rs267606719	NC_000012.12:88077226:C:A	C	A	CLINICAL
NM_025114.4(CEP290):c.4882C>T (p.Gln1628Ter)	CEP290	Q1628*	Normal	Nephronophthisis|Meckel-Gruber syndrome|Joubert syndrome|Senior-Loken syndrome 6|Meckel syndrome, type 4|Bardet-Biedl syndrome 14|Joubert syndrome 5|Leber congenital amaurosis 10|Joubert syndrome 5|Global developmental delay|Blindness|Occipital encephalocele|Cystic renal dysplasia|not provided|Leber congenital amaurosis	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000217635	12	88476938	12	88083161	217635	214327	rs376493409	NC_000012.12:88083160:G:A	G	A	CLINICAL
NM_003805.5(CRADD):c.509G>A (p.Arg170His)	CRADD	R170H	Normal	Intellectual disability|Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000372191	12	94243956	12	93850180	372191	359096	rs141179774	NC_000012.12:93850179:G:A	G	A	CLINICAL
NM_005996.4(TBX3):c.991C>T (p.Gln331Ter)	TBX3	Q331*, Q351*	Normal	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000031909	12	115114166	12	114676361	31909	40565	rs397514484	NC_000012.12:114676360:G:A	G	A	CLINICAL
NM_198578.4(LRRK2):c.4321C>A (p.Arg1441Ser)	LRRK2	R1441S	Normal	Parkinson disease 8, autosomal dominant|Parkinson disease, late-onset	Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000225276	12	40704236	12	40310434	225276	227175	rs33939927	NC_000012.12:40310433:C:A	C	A	CLINICAL
NM_198578.4(LRRK2):c.4322G>A (p.Arg1441His)	LRRK2	R1441H	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001942	12	40704237	12	40310435	1942	16981	rs34995376	NC_000012.12:40310434:G:A	G	A	CLINICAL
NM_198578.4(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	G2019S	Normal	not provided|Inborn genetic diseases|Parkinson disease 8, autosomal dominant|Hereditary late onset Parkinson disease|Young-onset Parkinson disease	Pathogenic, risk factor(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001940	12	40734202	12	40340400	1940	16979	rs34637584	NC_000012.12:40340399:G:A	G	A	CLINICAL
NM_003774.5(GALNT4):c.1194C>T (p.Asn398=)	GALNT4|POC1B|POC1B-GALNT4		Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208386	12	89917133	12	89523356	208386	204620	rs863223348	NC_000012.12:89523355:G:A	G	A	CLINICAL
NM_000365.6(TPI1):c.315G>C (p.Glu105Asp)	TPI1	E142D, E105D, E23D	Normal	Triosephosphate isomerase deficiency	Pathogenic(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012468	12	6978338	12	6869174	12468	27507	rs121964845	NC_000012.12:6869173:G:C	G	C	CLINICAL
NM_000719.7(CACNA1C):c.1114-304G>C	CACNA1C	G406R	Normal	Timothy syndrome|not provided	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190634	12	2613704	12	2504538	190634	188542	rs786205745	NC_000012.12:2504537:G:C	G	C	CLINICAL
NM_000834.4(GRIN2B):c.2360-2A>G	GRIN2B		Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000029731	12	13720199	12	13567265	29731	38686	rs1057519612	NC_000012.12:13567264:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2196T>G (p.Asp732Glu)	GRIN2B	D732E	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802822	12	13722927	12	13569993	802822	791216	rs1591611001	NC_000012.12:13569992:A:C	A	C	CLINICAL
NM_000834.4(GRIN2B):c.2172-2A>G	GRIN2B		Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039659	12	13722953	12	13570019	39659	48258	rs398122824	NC_000012.12:13570018:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2116A>G (p.Met706Val)	GRIN2B	M706V	Normal	Ataxia|intellectual deficiency|Epilepsy|Mental retardation, autosomal dominant 6|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374226	12	13724793	12	13571859	374226	361140	rs1057518988	NC_000012.12:13571858:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2081A>G (p.Asn694Ser)	GRIN2B	N694S	Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802823	12	13724828	12	13571894	802823	791217	rs1591612317	NC_000012.12:13571893:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.1970A>G (p.Glu657Gly)	GRIN2B	E657G	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234479	12	13761577	12	13608643	234479	231842	rs876661041	NC_000012.12:13608642:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.1853T>G (p.Val618Gly)	GRIN2B	V618G	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000162085	12	13761694	12	13608760	162085	171801	rs672601376	NC_000012.12:13608759:A:C	A	C	CLINICAL
NM_000834.4(GRIN2B):c.1238A>G (p.Glu413Gly)	GRIN2B	E413G	Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000143189	12	13769479	12	13616545	143189	152907	rs527236034	NC_000012.12:13616544:T:C	T	C	CLINICAL
NM_024312.5(GNPTAB):c.3335+6T>G	GNPTAB		Normal	Mucolipidosis type II|Pseudo-Hurler polydystrophy|Mucolipidosis type II|Pseudo-Hurler polydystrophy|Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002773	12	102151344	12	101757566	2773	17812	rs34788341	NC_000012.12:101757565:A:C	A	C	CLINICAL
NM_000545.6(HNF1A):c.803T>C (p.Phe268Ser)	HNF1A	F268S	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036831	12	121432056	12	120994253	36831	45492	rs193922605	NC_000012.12:120994252:T:C	T	C	CLINICAL
NM_000545.6(HNF1A):c.1265T>C (p.Leu422Pro)	HNF1A	L422P	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036797	12	121434501	12	120996698	36797	45458	rs193922577	NC_000012.12:120996697:T:C	T	C	CLINICAL
NM_000486.5(AQP2):c.170A>C (p.Gln57Pro)	AQP2	Q57P	Normal	not provided|Nephrogenic diabetes insipidus, autosomal	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV000017842	12	50344783	12	49951000	17842	32881	rs28931580	NC_000012.12:49950999:A:C	A	C	CLINICAL
NM_000376.3(VDR):c.915C>G (p.His305Gln)	VDR	H305Q, H355Q	Normal	Vitamin D-dependent rickets type II with alopecia	Pathogenic(Last reviewed: Jan 15, 1997)	no assertion criteria provided	VCV000007754	12	48240227	12	47846444	7754	22793	rs121909798	NC_000012.12:47846443:G:C	G	C	CLINICAL
NM_000545.6(HNF1A):c.956-1G>C	HNF1A		Normal	Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000617646	12	121434064	12	120996261	617646	609053	rs1565886545	NC_000012.12:120996260:G:C	G	C	CLINICAL
NM_024685.4(BBS10):c.273C>G (p.Cys91Trp)	BBS10	C91W	Normal	Bardet-Biedl syndrome 10|Bardet-Biedl syndrome|not provided	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030818	12	76741492	12	76347712	30818	39775	rs148374859	NC_000012.12:76347711:G:C	G	C	CLINICAL
NM_000834.4(GRIN2B):c.2081A>G (p.Asn694Ser)	GRIN2B	N694S	Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802823	12	13724828	12	13571894	802823	791217	rs1591612317	NC_000012.12:13571893:T:C	T	C	CLINICAL
NM_130466.4(UBE3B):c.1741+2T>C	UBE3B		Normal	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050234	12	109947521	12	109509716	50234	59388	rs398123020	NC_000012.12:109509715:T:C	T	C	CLINICAL
NM_130466.4(UBE3B):c.2180A>C (p.Gln727Pro)	UBE3B	Q727P	Normal	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050237	12	109959056	12	109521251	50237	59391	rs398123023	NC_000012.12:109521250:A:C	A	C	CLINICAL
NM_130466.4(UBE3B):c.2990G>C (p.Arg997Pro)	UBE3B	R997P	Normal	Inborn genetic diseases|Kaufman oculocerebrofacial syndrome	Likely pathogenic(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000208729	12	109971338	12	109533533	208729	205272	rs539407162	NC_000012.12:109533532:G:C	G	C	CLINICAL
NM_002834.5(PTPN11):c.417G>C (p.Glu139Asp)	PTPN11	E139D, E138D	Normal	Noonan syndrome 1|Metachondromatosis|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|not specified|not provided|Noonan syndrome|Noonan syndrome 1|Rasopathy|Cardiovascular phenotype|Noonan syndrome 3|Inborn genetic diseases|Juvenile myelomonocytic leukemia|Noonan syndrome|Global developmental delay|Microcephaly|Brachycephaly|Ptosis|Pectus excavatum|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040513	12	112891083	12	112453279	40513	48983	rs397507520	NC_000012.12:112453278:G:C	G	C	CLINICAL
NM_024072.4(DDX54):c.647A>G (p.Asn216Ser)	DDX54	N216S	Normal	Seizures|Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691936	12	113614866	12	113177061	691936	679679	rs764707570	NC_000012.12:113177060:T:C	T	C	CLINICAL
NM_015335.4(MED13L):c.2579A>G (p.Asp860Gly)	MED13L	D860G	Normal	Transposition of the great arteries, dextro-looped 1|Mental retardation and distinctive facial features with or without cardiac defects|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000427897	12	116435026	12	115997221	427897	418971	rs1555246154	NC_000012.12:115997220:T:C	T	C	CLINICAL
NM_015335.4(MED13L):c.2345-3C>G	MED13L		Normal	Intellectual disability	Likely pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000691263	12	116443801	12	116005996	691263	678960	rs1592939069	NC_000012.12:116005995:G:C	G	C	CLINICAL
NM_015335.4(MED13L):c.1A>G (p.Met1Val)	MED13L	M1V	Normal	Mental retardation and distinctive facial features with or without cardiac defects|MED13L-Related Disorder|not provided	Pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000430179	12	116714936	12	116277131	430179	421904	rs1131691818	NC_000012.12:116277130:T:C	T	C	CLINICAL
NM_002150.3(HPD):c.600C>G (p.Tyr200Ter)	HPD	Y200*, Y161*	Normal	Tyrosinemia type 3	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000001575	12	122285117	12	121847211	1575	16614	rs137852867	NC_000012.12:121847210:G:C	G	C	CLINICAL
NM_032656.4(DHX37):c.1145A>G (p.Asp382Gly)	DHX37	D382G	Normal	Seizures|Chorioretinal lacunae|Choreoathetosis|Neurodevelopmental delay|Intellectual disability|Coloboma of optic nerve (disease)|Abnormality of neuronal migration|Polymicrogyria|Cerebellar dysplasia|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691929	12	125455894	12	124971348	691929	679684	rs1424699115	NC_000012.12:124971347:T:C	T	C	CLINICAL
NM_006231.3(POLE):c.1270C>G (p.Leu424Val)	POLE	L424V	Normal	Hereditary cancer-predisposing syndrome|Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation|not provided|Colorectal cancer, susceptibility to, 12|Facial dysmorphism, immunodeficiency, livedo, and short stature|Colorectal cancer, susceptibility to, 12	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000040046	12	133250250	12	132673664	40046	48560	rs483352909	NC_000012.12:132673663:G:C	G	C	CLINICAL
NM_000834.4(GRIN2B):c.2360-2A>G	GRIN2B		Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000029731	12	13720199	12	13567265	29731	38686	rs1057519612	NC_000012.12:13567264:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2216T>G (p.Met739Arg)	GRIN2B	M739R	Normal	Scoliosis|Microcephaly|Behavioral abnormality|Absent speech|Intrauterine growth retardation|Seizures|Craniosynostosis syndrome|Self-injurious behavior|Abnormal facial shape|Intellectual disability, severe|Difficulty walking	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523381	12	13722907	12	13569973	523381	514018	rs1555103652	NC_000012.12:13569972:A:C	A	C	CLINICAL
NM_000834.4(GRIN2B):c.2196T>G (p.Asp732Glu)	GRIN2B	D732E	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802822	12	13722927	12	13569993	802822	791216	rs1591611001	NC_000012.12:13569992:A:C	A	C	CLINICAL
NM_000834.4(GRIN2B):c.2172-2A>G	GRIN2B		Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039659	12	13722953	12	13570019	39659	48258	rs398122824	NC_000012.12:13570018:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2171+3A>G	GRIN2B		Normal	Intellectual disability	Pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000691253	12	13724735	12	13571801	691253	678961	rs1591612223	NC_000012.12:13571800:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2116A>G (p.Met706Val)	GRIN2B	M706V	Normal	Ataxia|intellectual deficiency|Epilepsy|Mental retardation, autosomal dominant 6|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374226	12	13724793	12	13571859	374226	361140	rs1057518988	NC_000012.12:13571858:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.2081A>G (p.Asn694Ser)	GRIN2B	N694S	Normal	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802823	12	13724828	12	13571894	802823	791217	rs1591612317	NC_000012.12:13571893:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.1970A>G (p.Glu657Gly)	GRIN2B	E657G	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234479	12	13761577	12	13608643	234479	231842	rs876661041	NC_000012.12:13608642:T:C	T	C	CLINICAL
NM_000834.4(GRIN2B):c.1853T>G (p.Val618Gly)	GRIN2B	V618G	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000162085	12	13761694	12	13608760	162085	171801	rs672601376	NC_000012.12:13608759:A:C	A	C	CLINICAL
NM_000834.4(GRIN2B):c.1238A>G (p.Glu413Gly)	GRIN2B	E413G	Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000143189	12	13769479	12	13616545	143189	152907	rs527236034	NC_000012.12:13616544:T:C	T	C	CLINICAL
NM_033360.4(KRAS):c.*22C>G	KRAS	F156L	Normal	Rasopathy|Cardiofaciocutaneous syndrome 2|not provided	Pathogenic(Last reviewed: Sep 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012595	12	25362828	12	25209894	12595	27634	rs104894362	NC_000012.12:25209893:G:C	G	C	CLINICAL
NM_001330260.2(SCN8A):c.800T>C (p.Leu267Ser)	SCN8A	L267S	Normal	Early infantile epileptic encephalopathy with suppression bursts|Global developmental delay|Developmental stagnation at onset of seizures|Intellectual disability, severe|Developmental regression|Generalized tonic seizures|Epileptic encephalopathy	Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000236207	12	52093447	12	51699663	236207	237762	rs878853250	NC_000012.12:51699662:T:C	T	C	CLINICAL
NM_001330260.2(SCN8A):c.1258G>C (p.Ala420Pro)	SCN8A	A420P	Normal	Seizures|Intellectual disability	Likely pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000691260	12	52099324	12	51705540	691260	678942	rs1592392873	NC_000012.12:51705539:G:C	G	C	CLINICAL
NM_001330260.2(SCN8A):c.4892T>C (p.Ile1631Thr)	SCN8A	I1590T, I1631T	Normal	Seizures|Intellectual disability|Autistic disorder of childhood onset	Likely pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000691254	12	52200162	12	51806378	691254	678945	rs1085307999	NC_000012.12:51806377:T:C	T	C	CLINICAL
NM_002206.3(ITGA7):c.1506-2A>G	ITGA7		Normal	Muscular dystrophy, congenital, due to integrin alpha-7 deficiency	Pathogenic(Last reviewed: May 1, 1998)	no assertion criteria provided	VCV000009049	12	56091063	12	55697279	9049	24088	rs1565627745	NC_000012.12:55697278:T:C	T	C	CLINICAL
NM_001273.5(CHD4):c.3745T>G (p.Tyr1249Asp)	CHD4	Y1249D, Y1236D, Y1242D	Normal	Sifrim-Hitz-Weiss syndrome	Likely pathogenic(Last reviewed: Apr 27, 2016)	no assertion criteria provided	VCV000417890	12	6696684	12	6587518	417890	404809	rs1060499583	NC_000012.12:6587517:A:C	A	C	CLINICAL
NM_001273.5(CHD4):c.3403C>G (p.Leu1135Val)	CHD4	L1122V, L1135V, L1128V	Normal	Sifrim-Hitz-Weiss syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802815	12	6697526	12	6588360	802815	791272	rs1592270989	NC_000012.12:6588359:G:C	G	C	CLINICAL
NM_001273.5(CHD4):c.2978A>G (p.Asn993Ser)	CHD4	N980S, N993S, N986S	Normal	Sifrim-Hitz-Weiss syndrome	Likely pathogenic(Last reviewed: Sep 4, 2019)	criteria provided, single submitter	VCV000828192	12	6701194	12	6592028	828192	816525	rs1592273799	NC_000012.12:6592027:T:C	T	C	CLINICAL
NM_025114.4(CEP290):c.2991+1655A>G	CEP290		Normal	Joubert syndrome 1|Bardet-Biedl syndrome 14|Joubert syndrome 5|Senior-Loken syndrome 6|Meckel syndrome, type 4|Leber congenital amaurosis 10|Retinal dystrophy|not provided|Leber congenital amaurosis 10|Intellectual disability|Joubert syndrome 5|Retinitis pigmentosa|Joubert syndrome|Nephronophthisis|Meckel-Gruber syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001337	12	88494960	12	88101183	1337	16376	rs281865192	NC_000012.12:88101182:T:C	T	C	CLINICAL
NM_003805.5(CRADD):c.382G>C (p.Gly128Arg)	CRADD	G128R	Normal	Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Jan 1, 2012)	no assertion criteria provided	VCV000030360	12	94243829	12	93850053	30360	39317	rs387906861	NC_000012.12:93850052:G:C	G	C	CLINICAL
NM_198578.4(LRRK2):c.4309A>C (p.Asn1437His)	LRRK2	N1437H	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039183	12	40703027	12	40309225	39183	47789	rs74163686	NC_000012.12:40309224:A:C	A	C	CLINICAL
NM_198578.4(LRRK2):c.6059T>C (p.Ile2020Thr)	LRRK2	I2020T	Normal	not provided|Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000001941	12	40734206	12	40340404	1941	16980	rs35870237	NC_000012.12:40340403:T:C	T	C	CLINICAL
NM_031157.4(HNRNPA1):c.956A>G (p.Asn319Ser)	HNRNPA1	N319S, N267S	Normal	Amyotrophic lateral sclerosis 20	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065453	12	54677644	12	54283860	65453	76370	rs397518454	NC_000012.12:54283859:A:G	A	G	CLINICAL
NM_002834.5(PTPN11):c.855T>G (p.Phe285Leu)	PTPN11	F285L, F284L	Normal	Noonan syndrome|Noonan syndrome 3|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044615	12	112915456	12	112477652	44615	53782	rs397516810	NC_000012.12:112477651:T:G	T	G	CLINICAL
NM_013254.4(TBK1):c.1201A>G (p.Lys401Glu)	TBK1	K401E	Normal	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000203441	12	64879246	12	64485466	203441	199854	rs756751089	NC_000012.12:64485465:A:G	A	G	CLINICAL
NM_000719.7(CACNA1C):c.4418C>G (p.Ala1473Gly)	CACNA1C	A1473G, A1521G, A1460G, A1462G, A1490G, A1493G, A1495G, A1501G, A1470G	Normal	not provided|Timothy syndrome	Likely pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, single submitter	VCV000196966	12	2774766	12	2665600	196966	194127	rs794727587	NC_000012.12:2665599:C:G	C	G	CLINICAL
NM_138425.4(C12orf57):c.1A>G (p.Met1Val)	C12orf57	M1V	Normal	Temtamy syndrome|not provided|Microphthalmia, isolated, with coloboma|Seizures|Abnormality of the corpus callosum|Global developmental delay	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041942	12	7053285	12	6944122	41942	51108	rs587776954	NC_000012.12:6944121:A:G	A	G	CLINICAL
NM_138425.4(C12orf57):c.53-2A>G	C12orf57		Normal	Temtamy syndrome|Attention deficit hyperactivity disorder|Vesicoureteral reflux|Hydronephrosis|Renal atrophy|Intellectual disability|Global developmental delay	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000242885	12	7053637	12	6944474	242885	243991	rs1114167293	NC_000012.12:6944473:A:G	A	G	CLINICAL
NM_000834.5(GRIN2B):c.2555G>C (p.Gly852Ala)	GRIN2B	G852A	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000827797	12	13720002	12	13567068	827797	815997	rs1168374610	NC_000012.12:13567067:C:G	C	G	CLINICAL
NM_000834.4(GRIN2B):c.2459G>C (p.Gly820Ala)	GRIN2B	G820A	Normal	not provided|Complex neurodevelopmental disorder|Inborn genetic diseases|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208643	12	13720098	12	13567164	208643	205273	rs797044849	NC_000012.12:13567163:C:G	C	G	CLINICAL
NM_000834.4(GRIN2B):c.2452A>C (p.Met818Leu)	GRIN2B	M818L	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234546	12	13720105	12	13567171	234546	231837	rs876661076	NC_000012.12:13567170:T:G	T	G	CLINICAL
NM_000834.4(GRIN2B):c.2252T>C (p.Ile751Thr)	GRIN2B	I751T	Normal	Mental retardation, autosomal dominant 6|Complex neurodevelopmental disorder|Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234500	12	13722871	12	13569937	234500	231838	rs876661055	NC_000012.12:13569936:A:G	A	G	CLINICAL
NM_000834.4(GRIN2B):c.2084T>C (p.Ile695Thr)	GRIN2B	I695T	Normal	not provided|Mental retardation, autosomal dominant 6|intellectual deficiency|Ataxia	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234790	12	13724825	12	13571891	234790	231839	rs876661219	NC_000012.12:13571890:A:G	A	G	CLINICAL
NM_000834.4(GRIN2B):c.1821G>C (p.Trp607Cys)	GRIN2B	W607C	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	VCV000374327	12	13761726	12	13608792	374327	361203	rs1057518700	NC_000012.12:13608791:C:G	C	G	CLINICAL
NM_005691.3(ABCC9):c.3058T>C (p.Ser1020Pro)	ABCC9	S1020P	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic(Last reviewed: May 18, 2012)	no assertion criteria provided	VCV000035535	12	21998575	12	21845641	35535	44206	rs387907229	NC_000012.12:21845640:A:G	A	G	CLINICAL
NM_005691.3(ABCC9):c.878T>C (p.Phe293Ser)	ABCC9	F293S	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Likely pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	VCV000369679	12	22065939	12	21913005	369679	353904	rs1057516044	NC_000012.12:21913004:A:G	A	G	CLINICAL
NM_001330260.2(SCN8A):c.5302A>G (p.Asn1768Asp)	SCN8A	N1768D, N1727D	Normal	Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 13	Pathogenic(Last reviewed: Sep 23, 2019)	criteria provided, single submitter	VCV000030123	12	52200572	12	51806788	30123	39079	rs202151337	NC_000012.12:51806787:A:G	A	G	CLINICAL
NM_024312.5(GNPTAB):c.10A>C (p.Lys4Gln)	GNPTAB	K4Q	Normal	Mucopolysaccharidosis, MPS-III-A|Pseudo-Hurler polydystrophy|Mucolipidosis type II|Pseudo-Hurler polydystrophy	Likely pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	VCV000002774	12	102224444	12	101830666	2774	17813	rs34159654	NC_000012.12:101830665:T:G	T	G	CLINICAL
NM_015335.4(MED13L):c.4956-2A>C	MED13L		Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 24, 2015)	no assertion criteria provided	VCV000374334	12	116420410	12	115982605	374334	361202	rs1057518705	NC_000012.12:115982604:T:G	T	G	CLINICAL
NM_000545.6(HNF1A):c.872C>G (p.Pro291Arg)	HNF1A	P291R	Normal	Monogenic diabetes|Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036833	12	121432125	12	120994322	36833	45494	rs193922606	NC_000012.12:120994321:C:G	C	G	CLINICAL
NM_000545.6(HNF1A):c.1745A>G (p.His582Arg)	HNF1A	H582R, H589R	Normal	Monogenic diabetes|Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036811	12	121437407	12	120999604	36811	45472	rs193922589	NC_000012.12:120999603:A:G	A	G	CLINICAL
NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly)	HNF1A	A276G	Normal	Monogenic diabetes|not provided|Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036832	12	121432080	12	120994277	36832	45493	rs137853245	NC_000012.12:120994276:C:G	C	G	CLINICAL
NM_000545.6(HNF1A):c.365A>G (p.Tyr122Cys)	HNF1A	Y122C	Normal	not provided|Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000014930	12	121426674	12	120988871	14930	29969	rs137853237	NC_000012.12:120988870:A:G	A	G	CLINICAL
NM_000486.5(AQP2):c.203A>G (p.Asn68Ser)	AQP2	N68S	Normal	Nephrogenic diabetes insipidus, autosomal	Pathogenic(Last reviewed: Feb 1, 1997)	no assertion criteria provided	VCV000017834	12	50344816	12	49951033	17834	32873	rs104894331	NC_000012.12:49951032:A:G	A	G	CLINICAL
NM_001005242.3(PKP2):c.2014-1G>C	PKP2		Normal	Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Arrhythmogenic right ventricular dysplasia 9	Pathogenic(Last reviewed: Feb 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006756	12	32955491	12	32802557	6756	21795	rs193922674	NC_000012.12:32802556:C:G	C	G	CLINICAL
NM_000486.5(AQP2):c.64C>G (p.Leu22Val)	AQP2	L22V	Normal	Nephrogenic diabetes insipidus, autosomal	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000017838	12	50344677	12	49950894	17838	32877	rs104894336	NC_000012.12:49950893:C:G	C	G	CLINICAL
NM_024685.4(BBS10):c.164T>C (p.Leu55Pro)	BBS10	L55P	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 10|Bardet-Biedl syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522272	12	76741975	12	76348195	522272	512858	rs1460517643	NC_000012.12:76348194:A:G	A	G	CLINICAL
NM_000545.6(HNF1A):c.1A>G (p.Met1Val)	HNF1A	M1V	Normal	Maturity-onset diabetes of the young, type 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2016)	criteria provided, multiple submitters, no conflicts	VCV000036814	12	121416572	12	120978769	36814	45475	rs193922592	NC_000012.12:120978768:A:G	A	G	CLINICAL
NM_015275.3(WASHC4):c.1508A>G (p.His503Arg)	WASHC4	H504R, H503R	Normal	Mental retardation, autosomal recessive 43	Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000695112	12	105534127	12	105140349	695112	683215	rs201428088	NC_000012.12:105140348:A:G	A	G	CLINICAL
NM_015275.3(WASHC4):c.3056C>G (p.Pro1019Arg)	WASHC4	P1019R, P1020R	Normal	Mental retardation, autosomal recessive 43	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000133296	12	105553922	12	105160144	133296	137035	rs587777411	NC_000012.12:105160143:C:G	C	G	CLINICAL
NM_015275.3(WASHC4):c.3236A>G (p.Lys1079Arg)	WASHC4	K1079R, K1080R	Normal	Mental retardation, autosomal recessive 43	Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000695111	12	105557967	12	105164189	695111	683216	rs748436953	NC_000012.12:105164188:A:G	A	G	CLINICAL
NM_130466.4(UBE3B):c.351T>G (p.Tyr117Ter)	UBE3B	Y117*	Normal	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000829809	12	109924284	12	109486479	829809	818141	rs1592882265	NC_000012.12:109486478:T:G	T	G	CLINICAL
NM_130466.4(UBE3B):c.545-2A>G	UBE3B		Normal	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000050236	12	109927722	12	109489917	50236	59390	rs398123022	NC_000012.12:109489916:A:G	A	G	CLINICAL
NM_001082538.3(TCTN1):c.342-2A>G	TCTN1		Normal	Joubert syndrome 13|Global developmental delay|Typical Joubert syndrome MRI findings	Pathogenic(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183312	12	111064165	12	110626360	183312	181433	rs730882221	NC_000012.12:110626359:A:G	A	G	CLINICAL
NM_015335.4(MED13L):c.4956-2A>C	MED13L		Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Aug 24, 2015)	no assertion criteria provided	VCV000374334	12	116420410	12	115982605	374334	361202	rs1057518705	NC_000012.12:115982604:T:G	T	G	CLINICAL
NM_002150.3(HPD):c.1049T>C (p.Val350Ala)	HPD	V350A, V311A	Normal	Limb dystonia|Spasticity|Global developmental delay|Hypertyrosinemia|Abnormality of the cerebral white matter|Hypokinesia	Likely pathogenic	no assertion criteria provided	VCV000812775	12	122277860	12	121839954	812775	801129	rs1592913789	NC_000012.12:121839953:A:G	A	G	CLINICAL
NM_000834.5(GRIN2B):c.2555G>C (p.Gly852Ala)	GRIN2B	G852A	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 8, 2019)	no assertion criteria provided	VCV000827797	12	13720002	12	13567068	827797	815997	rs1168374610	NC_000012.12:13567067:C:G	C	G	CLINICAL
NM_000834.4(GRIN2B):c.2459G>C (p.Gly820Ala)	GRIN2B	G820A	Normal	not provided|Complex neurodevelopmental disorder|Inborn genetic diseases|Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208643	12	13720098	12	13567164	208643	205273	rs797044849	NC_000012.12:13567163:C:G	C	G	CLINICAL
NM_000834.4(GRIN2B):c.2452A>C (p.Met818Leu)	GRIN2B	M818L	Normal	Mental retardation, autosomal dominant 6|not provided	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000234546	12	13720105	12	13567171	234546	231837	rs876661076	NC_000012.12:13567170:T:G	T	G	CLINICAL
NM_000834.4(GRIN2B):c.2252T>C (p.Ile751Thr)	GRIN2B	I751T	Normal	Mental retardation, autosomal dominant 6|Complex neurodevelopmental disorder|Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000234500	12	13722871	12	13569937	234500	231838	rs876661055	NC_000012.12:13569936:A:G	A	G	CLINICAL
NM_000834.4(GRIN2B):c.2084T>C (p.Ile695Thr)	GRIN2B	I695T	Normal	not provided|Mental retardation, autosomal dominant 6|intellectual deficiency|Ataxia	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000234790	12	13724825	12	13571891	234790	231839	rs876661219	NC_000012.12:13571890:A:G	A	G	CLINICAL
NM_000834.4(GRIN2B):c.1821G>C (p.Trp607Cys)	GRIN2B	W607C	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	VCV000374327	12	13761726	12	13608792	374327	361203	rs1057518700	NC_000012.12:13608791:C:G	C	G	CLINICAL
NM_021957.4(GYS2):c.941+1G>C	GYS2		Normal	Glycogen storage disease due to hepatic glycogen synthase deficiency	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000016050	12	21716161	12	21563227	16050	31089	rs587776831	NC_000012.12:21563226:C:G	C	G	CLINICAL
NM_020374.4(C12orf4):c.983T>C (p.Leu328Pro)	C12orf4	L328P, L155P, L44P	Normal	Intellectual disability, autosomal recessive 66	Likely pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000592163	12	4627274	12	4518108	592163	583169	rs1468772495	NC_000012.12:4518107:A:G	A	G	CLINICAL
NM_006009.4(TUBA1A):c.1226T>C (p.Val409Ala)	TUBA1A	V409A, V374A	Normal	Tubulinopathies|Corpus callosum, agenesis of|Cryptorchidism|Lissencephaly|Lissencephaly 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208490	12	49578923	12	49185140	208490	205017	rs797045005	NC_000012.12:49185139:A:G	A	G	CLINICAL
NM_001330260.2(SCN8A):c.2952C>G (p.Asn984Lys)	SCN8A	N984K	Normal	Global developmental delay|Seizures|Early infantile epileptic encephalopathy 13	Pathogenic(Last reviewed: Feb 19, 2016)	no assertion criteria provided	VCV000192317	12	52162699	12	51768915	192317	190110	rs876657399	NC_000012.12:51768914:C:G	C	G	CLINICAL
NM_138425.4(C12orf57):c.1A>G (p.Met1Val)	C12orf57	M1V	Normal	Temtamy syndrome|not provided|Microphthalmia, isolated, with coloboma|Seizures|Abnormality of the corpus callosum|Global developmental delay	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041942	12	7053285	12	6944122	41942	51108	rs587776954	NC_000012.12:6944121:A:G	A	G	CLINICAL
NM_138425.4(C12orf57):c.53-2A>G	C12orf57		Normal	Temtamy syndrome|Attention deficit hyperactivity disorder|Vesicoureteral reflux|Hydronephrosis|Renal atrophy|Intellectual disability|Global developmental delay	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, single submitter	VCV000242885	12	7053637	12	6944474	242885	243991	rs1114167293	NC_000012.12:6944473:A:G	A	G	CLINICAL
NM_172240.3(POC1B):c.317G>C (p.Arg106Pro)	POC1B	R106P, R64P	Normal	Cone-rod dystrophy 20	Pathogenic	criteria provided, single submitter	VCV000155769	12	89885848	12	89492071	155769	165521	rs76216585	NC_000012.12:89492070:C:G	C	G	CLINICAL
NM_003805.5(CRADD):c.491T>G (p.Phe164Cys)	CRADD	F164C	Normal	Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372192	12	94243938	12	93850162	372192	359097	rs370916968	NC_000012.12:93850161:T:G	T	G	CLINICAL
NM_005691.3(ABCC9):c.2019+2T>C	ABCC9		Normal	Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487597	12	22035698	12	21882764	487597	480710	rs1555100687	NC_000012.12:21882763:A:G	A	G	CLINICAL
NM_198578.4(LRRK2):c.3364A>G (p.Ile1122Val)	LRRK2	I1122V	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001939	12	40692927	12	40299125	1939	16978	rs34805604	NC_000012.12:40299124:A:G	A	G	CLINICAL
NM_198578.4(LRRK2):c.4321C>G (p.Arg1441Gly)	LRRK2	R1441G	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000001936	12	40704236	12	40310434	1936	16975	rs33939927	NC_000012.12:40310433:C:G	C	G	CLINICAL
NM_198578.4(LRRK2):c.5096A>G (p.Tyr1699Cys)	LRRK2	Y1699C	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001937	12	40714916	12	40321114	1937	16976	rs35801418	NC_000012.12:40321113:A:G	A	G	CLINICAL
NM_198578.4(LRRK2):c.5605A>G (p.Met1869Val)	LRRK2	M1869V	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039212	12	40717057	12	40323255	39212	47818	rs281865052	NC_000012.12:40323254:A:G	A	G	CLINICAL
NM_031157.4(HNRNPA1):c.1018C>G (p.Pro340Ala)	HNRNPA1	P288A, P340A	Normal	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000637023	12	54677706	12	54283922	637023	624860	rs1592173638	NC_000012.12:54283921:C:G	C	G	CLINICAL
NM_013254.4(TBK1):c.1318C>T (p.Arg440Ter)	TBK1	R440X	Normal	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Feb 21, 2020)	no assertion criteria provided	VCV000997032	12	64879775	12	64485995	997032	984744	rs142030898	NC_000012.12:64485994:C:T	C	T	CLINICAL
NM_013254.4(TBK1):c.1330C>T (p.Arg444Ter)	TBK1	R444*	Normal	Motor neuron disease|not provided	Pathogenic, other(Last reviewed: Jan 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000266072	12	64879787	12	64486007	266072	260891	rs142030898	NC_000012.12:64486006:C:T	C	T	CLINICAL
NM_013254.4(TBK1):c.2107G>T (p.Glu703Ter)	TBK1	E703*	Normal	Primary progressive non fluent aphasia|Corticobasal syndrome	Likely pathogenic	no assertion criteria provided	VCV000619188	12	64891788	12	64498008	619188	610586	rs1565825132	NC_000012.12:64498007:G:T	G	T	CLINICAL
NM_002834.5(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	R498L, R502L, R497L	Normal	not provided|Specific learning disability|Intellectual disability, mild|Scoliosis|Cafe-au-lait spot|Abnormal facial shape|Rasopathy|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome 1	Pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040554	12	112926873	12	112489069	40554	49024	rs397507542	NC_000012.12:112489068:G:T	G	T	CLINICAL
NM_000834.4(GRIN2B):c.3210T>A (p.Tyr1070Ter)	GRIN2B	Y1070*	Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802821	12	13716962	12	13564028	802821	791215	rs1591606580	NC_000012.12:13564027:A:T	A	T	CLINICAL
NM_000834.4(GRIN2B):c.2477G>A (p.Gly826Glu)	GRIN2B	G826E	Normal	not provided|Mental retardation, autosomal dominant 6|Complex neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421209	12	13720080	12	13567146	421209	408604	rs1064794979	NC_000012.12:13567145:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.2430C>A (p.Ser810Arg)	GRIN2B	S810R	Normal	Mental retardation, autosomal dominant 6|not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218471	12	13720127	12	13567193	218471	215446	rs864309560	NC_000012.12:13567192:G:T	G	T	CLINICAL
NM_000834.4(GRIN2B):c.2429G>A (p.Ser810Asn)	GRIN2B	S810N	Normal	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000800894	12	13720128	12	13567194	800894	788865	rs1591609136	NC_000012.12:13567193:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.2045G>A (p.Arg682His)	GRIN2B	R682H	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000268209	12	13724864	12	13571930	268209	263825	rs886041095	NC_000012.12:13571929:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1858G>A (p.Val620Met)	GRIN2B	V620M	Normal	Complex neurodevelopmental disorder|Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6|not provided|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000205710	12	13761689	12	13608755	205710	202669	rs796052571	NC_000012.12:13608754:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1821G>A (p.Trp607Ter)	GRIN2B	W607*	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV000574682	12	13761726	12	13608792	574682	571720	rs1057518700	NC_000012.12:13608791:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1677G>A (p.Trp559Ter)	GRIN2B	W559*	Normal	Mental retardation, autosomal dominant 6|not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039660	12	13764762	12	13611828	39660	48259	rs398122825	NC_000012.12:13611827:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1619G>A (p.Arg540His)	GRIN2B	R540H	Normal	Intellectual disability|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162087	12	13768083	12	13615149	162087	171803	rs672601378	NC_000012.12:13615148:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1598G>A (p.Gly533Asp)	GRIN2B	G533D	Normal	Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Sep 22, 2014)	criteria provided, single submitter	VCV000397525	12	13768104	12	13615170	397525	384421	rs1060499659	NC_000012.12:13615169:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1458T>A (p.His486Gln)	GRIN2B	H486Q	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802825	12	13768469	12	13615535	802825	791219	rs763436882	NC_000012.12:13615534:A:T	A	T	CLINICAL
NM_000834.4(GRIN2B):c.1367G>A (p.Cys456Tyr)	GRIN2B	C456Y	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000039658	12	13768560	12	13615626	39658	48257	rs397514555	NC_000012.12:13615625:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.411+1G>A	GRIN2B		Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000029728	12	14018731	12	13865797	29728	38683	rs1057519611	NC_000012.12:13865796:C:T	C	T	CLINICAL
NM_020297.3(ABCC9):c.3650G>A (p.Arg1217Lys)	ABCC9	R1217K	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Likely pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	VCV000545440	12	21981911	12	21828977	545440	535704	rs12298510	NC_000012.12:21828976:C:T	C	T	CLINICAL
NM_020297.3(ABCC9):c.3461G>A (p.Arg1154Gln)	ABCC9	R1154Q	Normal	Dilated cardiomyopathy 1O|not provided|Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031947	12	21995260	12	21842326	31947	40612	rs387907209	NC_000012.12:21842325:C:T	C	T	CLINICAL
NM_005691.3(ABCC9):c.3347G>A (p.Arg1116His)	ABCC9	R1116H	Normal	Dilated cardiomyopathy 1O|Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000035533	12	21995374	12	21842440	35533	44204	rs387907227	NC_000012.12:21842439:C:T	C	T	CLINICAL
NM_005691.3(ABCC9):c.3128G>A (p.Cys1043Tyr)	ABCC9	C1043Y	Normal	Hypertrichotic osteochondrodysplasia Cantu type	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000031948	12	21997818	12	21844884	31948	40613	rs387907210	NC_000012.12:21844883:C:T	C	T	CLINICAL
NM_006940.6(SOX5):c.1895C>A (p.Thr632Asn)	SOX5	T619N, T632N, T511N, T246N, T597N, T622N	Normal	Lamb-shaffer syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431148	12	23689480	12	23536546	431148	424661	rs1135401816	NC_000012.12:23536545:G:T	G	T	CLINICAL
NM_173353.4(TPH2):c.907C>T (p.Arg303Trp)	TPH2	R303W	Normal	Attention deficit-hyperactivity disorder 7	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000003163	12	72372833	12	71979053	3163	18202	rs120074176	NC_000012.12:71979052:C:T	C	T	CLINICAL
NM_173591.3(OTOGL):c.1863-1G>T	OTOGL		Normal	not provided	Likely pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000432016	12	80655748	12	80261968	432016	426021	rs777911261	NC_000012.12:80261967:G:T	G	T	CLINICAL
NM_173591.3(OTOGL):c.5422C>T (p.Arg1808Ter)	OTOGL	R1808*, R1763*	Normal	not provided	Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000432017	12	80747146	12	80353366	432017	426023	rs768620276	NC_000012.12:80353365:C:T	C	T	CLINICAL
NM_024312.5(GNPTAB):c.3435-1G>A	GNPTAB		Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 10, 2012)	no assertion criteria provided	VCV000038427	12	102147318	12	101753540	38427	46986	rs281865037	NC_000012.12:101753539:C:T	C	T	CLINICAL
NM_015335.4(MED13L):c.4077G>A (p.Trp1359Ter)	MED13L	W1359*	Normal	Transposition of the great arteries, dextro-looped 1	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000572855	12	116424951	12	115987146	572855	565058	rs1565995034	NC_000012.12:115987145:C:T	C	T	CLINICAL
NM_015335.5(MED13L):c.4076G>A (p.Trp1359Ter)	MED13L	W1359*	Normal	Mental retardation and distinctive facial features with or without cardiac defects|not provided|Autism spectrum disorder	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817519	12	116424952	12	115987147	817519	805724	rs1592919048	NC_000012.12:115987146:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.281C>T (p.Pro94Leu)	HNF1A	P94L	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036816	12	121416852	12	120979049	36816	45477	rs193922593	NC_000012.12:120979048:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.670C>T (p.Pro224Ser)	HNF1A	P224S	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036826	12	121431466	12	120993663	36826	45487	rs193922600	NC_000012.12:120993662:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.731G>T (p.Arg244Ile)	HNF1A	R244I	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036828	12	121431984	12	120994181	36828	45489	rs193922602	NC_000012.12:120994180:G:T	G	T	CLINICAL
NM_000545.6(HNF1A):c.790G>T (p.Val264Phe)	HNF1A	V264F	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036830	12	121432043	12	120994240	36830	45491	rs193922604	NC_000012.12:120994239:G:T	G	T	CLINICAL
NM_000545.6(HNF1A):c.1663C>T (p.Leu555Phe)	HNF1A	L555F, L562F	Normal	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036808	12	121437325	12	120999522	36808	45469	rs193922587	NC_000012.12:120999521:C:T	C	T	CLINICAL
NM_000224.3(KRT18):c.383A>T (p.His128Leu)	KRT18|KRT8|LOC106096416	H128L	Normal	not provided|Cirrhosis, cryptogenic|Cirrhosis, noncryptogenic, susceptibility to	Pathogenic, risk factor(Last reviewed: May 13, 2003)	no assertion criteria provided	VCV000014585	12	53343340	12	52949556	14585	29624	rs57758506	NC_000012.12:52949555:A:T	A	T	CLINICAL
NM_000545.6(HNF1A):c.335C>T (p.Pro112Leu)	HNF1A	P112L	Normal	not provided|Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000014942	12	121426644	12	120988841	14942	29981	rs137853243	NC_000012.12:120988840:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.779C>T (p.Thr260Met)	HNF1A	T260M	Normal	not provided|Maturity onset diabetes mellitus in young	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265436	12	121432032	12	120994229	265436	260011	rs886039544	NC_000012.12:120994228:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.391C>T (p.Arg131Trp)	HNF1A	R131W	Normal	Maturity-onset diabetes of the young, type 3|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014943	12	121426700	12	120988897	14943	29982	rs137853244	NC_000012.12:120988896:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.1340C>T (p.Pro447Leu)	HNF1A	P447L	Normal	Maturity onset diabetes mellitus in young|Hepatic adenomas, familial|Maturity-onset diabetes of the young, type 3|Type 2 diabetes mellitus|Diabetes mellitus type 1|Renal cell carcinoma, nonpapillary|Diabetes mellitus, insulin-dependent, 20|Maturity-onset diabetes of the young, type 3|not provided	Pathogenic(Last reviewed: May 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014928	12	121435307	12	120997504	14928	29967	rs137853236	NC_000012.12:120997503:C:T	C	T	CLINICAL
NM_000486.5(AQP2):c.559C>T (p.Arg187Cys)	AQP2|AQP5-AS1	R187C	Normal	not provided|Nephrogenic diabetes insipidus, autosomal|Nephrogenic diabetes insipidus	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000017828	12	50348446	12	49954663	17828	32867	rs104894328	NC_000012.12:49954662:C:T	C	T	CLINICAL
NM_000486.5(AQP2):c.374C>T (p.Thr125Met)	AQP2|AQP5-AS1	T125M	Normal	not provided|Nephrogenic diabetes insipidus, autosomal	Pathogenic(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV000017837	12	50347951	12	49954168	17837	32876	rs104894333	NC_000012.12:49954167:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.526C>T (p.Gln176Ter)	HNF1A	Q176*	Normal	Maturity-onset diabetes of the young, type 3|not provided|Maturity onset diabetes mellitus in young	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372380	12	121426835	12	120989032	372380	360075	rs754728827	NC_000012.12:120989031:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.814C>T (p.Arg272Cys)	HNF1A	R272C	Normal	Renal cell carcinoma, nonpapillary|Diabetes mellitus type 1|Diabetes mellitus, insulin-dependent, 20|Maturity-onset diabetes of the young, type 3|Type 2 diabetes mellitus|Hepatic adenomas, familial|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447503	12	121432067	12	120994264	447503	441526	rs1555212014	NC_000012.12:120994263:C:T	C	T	CLINICAL
NM_022895.3(C12orf43):c.*2998G>A	HNF1A|C12orf43	T620I, T627I	Normal	Maturity-onset diabetes of the young, type 3	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000014935	12	121438958	12	121001155	14935	29974	rs137853241	NC_000012.12:121001154:C:T	C	T	CLINICAL
NM_000545.6(HNF1A):c.475C>T (p.Arg159Trp)	HNF1A	R159W	Normal	Diabetes mellitus|not provided	Pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, single submitter	VCV000429750	12	121426784	12	120988981	429750	421907	rs765432081	NC_000012.12:120988980:C:T	C	T	CLINICAL
NM_024312.5(GNPTAB):c.1600G>A (p.Asp534Asn)	GNPTAB	D534N	Normal	Mucolipidosis type II|Pseudo-Hurler polydystrophy	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000397560	12	102159881	12	101766103	397560	384465	rs750240374	NC_000012.12:101766102:C:T	C	T	CLINICAL
NM_024312.5(GNPTAB):c.571G>A (p.Val191Ile)	GNPTAB	V191I	Normal	Mucolipidosis type II|Pseudo-Hurler polydystrophy	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000397556	12	102179790	12	101786012	397556	384468	rs751953529	NC_000012.12:101786011:C:T	C	T	CLINICAL
NM_000618.5(IGF1):c.285C>A (p.Cys95Ter)	IGF1	C95*, C79*	Normal	Growth delay due to insulin-like growth factor type 1 deficiency	Likely pathogenic(Last reviewed: Apr 16, 2019)	no assertion criteria provided	VCV000829837	12	102813404	12	102419626	829837	818294	rs3730193	NC_000012.12:102419625:G:T	G	T	CLINICAL
NM_000618.5(IGF1):c.274G>A (p.Val92Met)	IGF1	V76M, V92M	Normal	Growth delay due to insulin-like growth factor type 1 deficiency	Pathogenic(Last reviewed: May 1, 2005)	no assertion criteria provided	VCV000014789	12	102813415	12	102419637	14789	29828	rs121912430	NC_000012.12:102419636:C:T	C	T	CLINICAL
NM_000277.3(PAH):c.782G>A (p.Arg261Gln)	PAH	R261Q	Normal	not provided|Phenylketonuria	Pathogenic(Last reviewed: Aug 13, 2018)	reviewed by expert panel	VCV000000582	12	103246653	12	102852875	582	15621	rs5030849	NC_000012.12:102852874:C:T	C	T	CLINICAL
NM_000277.3(PAH):c.136G>A (p.Gly46Ser)	PAH	G46S	Normal	not provided|Phenylketonuria	Pathogenic(Last reviewed: Dec 22, 2019)	reviewed by expert panel	VCV000000629	12	103306601	12	102912823	629	15668	rs74603784	NC_000012.12:102912822:C:T	C	T	CLINICAL
NM_130466.4(UBE3B):c.61G>T (p.Glu21Ter)	UBE3B	E21*	Normal	not provided|Kaufman oculocerebrofacial syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000225041	12	109921417	12	109483612	225041	226931	rs775981553	NC_000012.12:109483611:G:T	G	T	CLINICAL
NM_130466.4(UBE3B):c.1852C>T (p.Arg618Ter)	UBE3B	R618*	Normal	not provided|Kaufman oculocerebrofacial syndrome	Likely pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000504153	12	109948259	12	109510454	504153	495536	rs746058354	NC_000012.12:109510453:C:T	C	T	CLINICAL
NM_130466.4(UBE3B):c.2923-1G>T	UBE3B		Normal	Kaufman oculocerebrofacial syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802889	12	109971270	12	109533465	802889	791191	rs1409120511	NC_000012.12:109533464:G:T	G	T	CLINICAL
NM_002834.5(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	R498L, R502L, R497L	Normal	not provided|Specific learning disability|Intellectual disability, mild|Scoliosis|Cafe-au-lait spot|Abnormal facial shape|Rasopathy|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome 1	Pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040554	12	112926873	12	112489069	40554	49024	rs397507542	NC_000012.12:112489068:G:T	G	T	CLINICAL
NM_024072.4(DDX54):c.1832G>A (p.Arg611Gln)	DDX54	R611Q	Normal	Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691938	12	113601978	12	113164173	691938	679676	rs777276705	NC_000012.12:113164172:C:T	C	T	CLINICAL
NM_024072.4(DDX54):c.58T>A (p.Trp20Arg)	DDX54	W20R	Normal	Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691937	12	113623199	12	113185394	691937	679680	rs774035439	NC_000012.12:113185393:A:T	A	T	CLINICAL
NM_015335.4(MED13L):c.5588+1G>A	MED13L		Normal	Mental retardation and distinctive facial features with or without cardiac defects	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431140	12	116413319	12	115975514	431140	424659	rs1135401810	NC_000012.12:115975513:C:T	C	T	CLINICAL
NM_015335.5(MED13L):c.4076G>A (p.Trp1359Ter)	MED13L	W1359*	Normal	Mental retardation and distinctive facial features with or without cardiac defects|not provided|Autism spectrum disorder	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, single submitter	VCV000817519	12	116424952	12	115987147	817519	805724	rs1592919048	NC_000012.12:115987146:C:T	C	T	CLINICAL
NM_023012.6(RSRC2):c.425G>A (p.Arg142Gln)	RSRC2	R142Q	Normal	Global developmental delay|Myopia (disease)|Autistic behavior|Strabismus|Obesity|Seizures	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242899	12	123001951	12	122517404	242899	243989	rs752134549	NC_000012.12:122517403:C:T	C	T	CLINICAL
NM_058169.6(BORCS5):c.203-1G>T	BORCS5		Normal	Polymicrogyria|Microcephaly|Seizures|Corpus callosum, agenesis of|Abnormality of the cerebral cortex|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242898	12	12588561	12	12435627	242898	243990	rs1555155556	NC_000012.12:12435626:G:T	G	T	CLINICAL
NM_032656.4(DHX37):c.2191G>A (p.Val731Met)	DHX37	V731M	Normal	Seizures|Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies|Neurodevelopmental disorders	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000691926	12	125441648	12	124957102	691926	679682	rs754186165	NC_000012.12:124957101:C:T	C	T	CLINICAL
NM_032656.4(DHX37):c.1257C>A (p.Asn419Lys)	DHX37	N419K	Normal	Abnormality of brain morphology|Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies|Neurodevelopmental disorders|Intellectual disability|Neurodevelopmental delay	Likely pathogenic	criteria provided, single submitter	VCV000402139	12	125453449	12	124968903	402139	389153	rs1060499737	NC_000012.12:124968902:G:T	G	T	CLINICAL
NM_032656.4(DHX37):c.278G>A (p.Arg93Gln)	DHX37	R93Q	Normal	Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies|Neurodevelopmental disorders	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2020)	no assertion criteria provided	VCV000691927	12	125467168	12	124982622	691927	679686	rs575837056	NC_000012.12:124982621:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.3210T>A (p.Tyr1070Ter)	GRIN2B	Y1070*	Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802821	12	13716962	12	13564028	802821	791215	rs1591606580	NC_000012.12:13564027:A:T	A	T	CLINICAL
NM_000834.4(GRIN2B):c.2515G>A (p.Glu839Lys)	GRIN2B	E839K	Normal	Complex neurodevelopmental disorder|not provided|Intellectual disability	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426296	12	13720042	12	13567108	426296	415325	rs1085307547	NC_000012.12:13567107:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.2477G>A (p.Gly826Glu)	GRIN2B	G826E	Normal	not provided|Mental retardation, autosomal dominant 6|Complex neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421209	12	13720080	12	13567146	421209	408604	rs1064794979	NC_000012.12:13567145:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.2430C>A (p.Ser810Arg)	GRIN2B	S810R	Normal	Mental retardation, autosomal dominant 6|not provided	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000218471	12	13720127	12	13567193	218471	215446	rs864309560	NC_000012.12:13567192:G:T	G	T	CLINICAL
NM_000834.4(GRIN2B):c.2429G>A (p.Ser810Asn)	GRIN2B	S810N	Normal	Mental retardation, autosomal dominant 6|Epileptic encephalopathy, early infantile, 27	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000800894	12	13720128	12	13567194	800894	788865	rs1591609136	NC_000012.12:13567193:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.2395G>A (p.Gly799Ser)	GRIN2B	G799S	Normal	Intellectual disability|Developmental delay	Likely pathogenic(Last reviewed: May 16, 2016)	no assertion criteria provided	VCV000373959	12	13720162	12	13567228	373959	360938	rs1057518800	NC_000012.12:13567227:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.2045G>A (p.Arg682His)	GRIN2B	R682H	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000268209	12	13724864	12	13571930	268209	263825	rs886041095	NC_000012.12:13571929:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1858G>A (p.Val620Met)	GRIN2B	V620M	Normal	Complex neurodevelopmental disorder|Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6|not provided|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000205710	12	13761689	12	13608755	205710	202669	rs796052571	NC_000012.12:13608754:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1821G>A (p.Trp607Ter)	GRIN2B	W607*	Normal	Epileptic encephalopathy, early infantile, 27|Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV000574682	12	13761726	12	13608792	574682	571720	rs1057518700	NC_000012.12:13608791:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1677G>A (p.Trp559Ter)	GRIN2B	W559*	Normal	Mental retardation, autosomal dominant 6|not provided	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039660	12	13764762	12	13611828	39660	48259	rs398122825	NC_000012.12:13611827:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1619G>A (p.Arg540His)	GRIN2B	R540H	Normal	Intellectual disability|Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162087	12	13768083	12	13615149	162087	171803	rs672601378	NC_000012.12:13615148:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.1458T>A (p.His486Gln)	GRIN2B	H486Q	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802825	12	13768469	12	13615535	802825	791219	rs763436882	NC_000012.12:13615534:A:T	A	T	CLINICAL
NM_000834.4(GRIN2B):c.1367G>A (p.Cys456Tyr)	GRIN2B	C456Y	Normal	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000039658	12	13768560	12	13615626	39658	48257	rs397514555	NC_000012.12:13615625:C:T	C	T	CLINICAL
NM_000834.4(GRIN2B):c.411+1G>A	GRIN2B		Normal	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000029728	12	14018731	12	13865797	29728	38683	rs1057519611	NC_000012.12:13865796:C:T	C	T	CLINICAL
NM_006940.6(SOX5):c.1895C>A (p.Thr632Asn)	SOX5	T619N, T632N, T511N, T246N, T597N, T622N	Normal	Lamb-shaffer syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431148	12	23689480	12	23536546	431148	424661	rs1135401816	NC_000012.12:23536545:G:T	G	T	CLINICAL
NM_006009.4(TUBA1A):c.1205G>A (p.Arg402His)	TUBA1A	R402H, R367H	Normal	not provided|Tubulinopathies|Lissencephaly|Lissencephaly 3	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000007071	12	49578944	12	49185161	7071	22110	rs137853044	NC_000012.12:49185160:C:T	C	T	CLINICAL
NM_006009.4(TUBA1A):c.652G>A (p.Asp218Asn)	TUBA1A	D218N, D183N	Normal	Inborn genetic diseases|Lissencephaly 3|Lissencephaly 3|Corpus callosum, agenesis of|Genetic syndrome with a Dandy-Walker malformation as major feature|Tubulinopathies|Dandy-Walker syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372561	12	49579497	12	49185714	372561	360041	rs1057517858	NC_000012.12:49185713:C:T	C	T	CLINICAL
NM_006009.4(TUBA1A):c.5G>A (p.Arg2His)	TUBA1A	R2H	Normal	not provided|Decreased head circumference|Seizures|Global developmental delay|Inborn genetic diseases|Lissencephaly 3|Tubulinopathies|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000160161	12	49580615	12	49186832	160161	169007	rs587784491	NC_000012.12:49186831:C:T	C	T	CLINICAL
NM_001330260.2(SCN8A):c.2811G>T (p.Trp937Cys)	SCN8A	W937C	Normal	Intellectual disability|Cerebellar ataxia	Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000691261	12	52159721	12	51765937	691261	678943	rs1555225835	NC_000012.12:51765936:G:T	G	T	CLINICAL
NM_001330260.2(SCN8A):c.4501C>T (p.Gln1501Ter)	SCN8A	Q1460*, Q1501*	Normal	Seizures|Intellectual disability	Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000691257	12	52184263	12	51790479	691257	678944	rs1057520149	NC_000012.12:51790478:C:T	C	T	CLINICAL
NM_004984.4(KIF5A):c.838C>T (p.Arg280Cys)	KIF5A	R280C, R191C	Normal	Hereditary spastic paraplegia 10|not provided|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006807	12	57963057	12	57569274	6807	21846	rs121434442	NC_000012.12:57569273:C:T	C	T	CLINICAL
NM_001273.5(CHD4):c.3380G>A (p.Arg1127Gln)	CHD4	R1127Q, R1114Q, R1120Q	Normal	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Aug 20, 2018)	no assertion criteria provided	VCV000266126	12	6697549	12	6588383	266126	260981	rs886039917	NC_000012.12:6588382:C:T	C	T	CLINICAL
NM_001273.5(CHD4):c.3203G>A (p.Arg1068His)	CHD4	R1068H, R1061H, R1055H	Normal	Sifrim-Hitz-Weiss syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000266124	12	6700879	12	6591713	266124	260979	rs886039915	NC_000012.12:6591712:C:T	C	T	CLINICAL
NM_001273.5(CHD4):c.2552C>A (p.Ser851Tyr)	CHD4	S851Y, S838Y, S844Y	Normal	Sifrim-Hitz-Weiss syndrome	Pathogenic(Last reviewed: Jul 12, 2021)	no assertion criteria provided	VCV000266125	12	6702357	12	6593191	266125	260980	rs886039916	NC_000012.12:6593190:G:T	G	T	CLINICAL
NM_138425.4(C12orf57):c.43C>T (p.Gln15Ter)	C12orf57	Q15*	Normal	not provided|Temtamy syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620193	12	7053327	12	6944164	620193	611776	rs1565574197	NC_000012.12:6944163:C:T	C	T	CLINICAL
NM_138425.4(C12orf57):c.52+1G>T	C12orf57		Normal	Temtamy syndrome	Likely pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV000661984	12	7053337	12	6944174	661984	652338	rs782640048	NC_000012.12:6944173:G:T	G	T	CLINICAL
NM_138425.4(C12orf57):c.184C>T (p.Gln62Ter)	C12orf57	Q62*, Q49*, Q27*	Normal	Temtamy syndrome|not provided	Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000155861	12	7053770	12	6944607	155861	165610	rs587777698	NC_000012.12:6944606:C:T	C	T	CLINICAL
NM_004426.3(PHC1):c.2974C>T (p.Leu992Phe)	PHC1	L992F	Normal	Intellectual disability|Primary microcephaly|Primary autosomal recessive microcephaly 11	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000065406	12	9092014	12	8939418	65406	76337	rs587777036	NC_000012.12:8939417:C:T	C	T	CLINICAL
NM_003805.5(CRADD):c.508C>T (p.Arg170Cys)	CRADD	R170C	Normal	Mental retardation, autosomal recessive 34	Pathogenic(Last reviewed: Dec 19, 2016)	no assertion criteria provided	VCV000372190	12	94243955	12	93850179	372190	359095	rs749655461	NC_000012.12:93850178:C:T	C	T	CLINICAL
NM_198578.4(LRRK2):c.4321C>T (p.Arg1441Cys)	LRRK2	R1441C	Normal	Hereditary late onset Parkinson disease|Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001938	12	40704236	12	40310434	1938	16977	rs33939927	NC_000012.12:40310433:C:T	C	T	CLINICAL
NM_198578.4(LRRK2):c.5620G>T (p.Glu1874Ter)	LRRK2	E1874*	Normal	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039215	12	40717072	12	40323270	39215	47821	rs281865054	NC_000012.12:40323269:G:T	G	T	CLINICAL
NM_031157.4(HNRNPA1):c.941A>T (p.Asp314Val)	HNRNPA1	D314V, D262V	Normal	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000065451	12	54677629	12	54283845	65451	76368	rs397518452	NC_000012.12:54283844:A:T	A	T	CLINICAL
NM_000059.4(BRCA2):c.92G>A (p.Trp31Ter)	BRCA2	W31*	Normal	Wilms tumor 1|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Malignant tumor of prostate|Medulloblastoma|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000052808	13	32893238	13	32319101	52808	67476	rs397508045	NC_000013.11:32319100:G:A	G	A	CLINICAL
NM_000059.4(BRCA2):c.8488-1G>A	BRCA2		Normal	Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000038164	13	32945092	13	32370955	38164	46720	rs397507404	NC_000013.11:32370954:G:A	G	A	CLINICAL
NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=)	BRCA2		Normal	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Tracheoesophageal fistula|Wilms tumor 1|Fanconi anemia, complementation group D1|Breast-ovarian cancer, familial 2|Familial cancer of breast|Pancreatic cancer 2|Malignant tumor of prostate|Glioma susceptibility 3|Medulloblastoma|not provided|Hereditary cancer-predisposing syndrome|Wilms tumor 1|Fanconi anemia, complementation group D1|Breast-ovarian cancer, familial 2|Familial cancer of breast|Pancreatic cancer 2|Malignant tumor of prostate|Glioma susceptibility 3|Medulloblastoma|Breast carcinoma	Pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000038215	13	32954050	13	32379913	38215	46771	rs28897756	NC_000013.11:32379912:G:A	G	A	CLINICAL
NM_024570.4(RNASEH2B):c.529G>A (p.Ala177Thr)	RNASEH2B	A177T	Normal	Aicardi Goutieres syndrome|Aicardi Goutieres syndrome 2|not provided|Cerebral palsy	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001262	13	51519581	13	50945445	1262	16301	rs75184679	NC_000013.11:50945444:G:A	G	A	CLINICAL
NM_000209.4(PDX1):c.532G>A (p.Glu178Lys)	PDX1	E178K	Normal	Pancreatic agenesis 1	Pathogenic(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000008865	13	28498518	13	27924381	8865	23904	rs80356662	NC_000013.11:27924380:G:A	G	A	CLINICAL
NM_014832.5(TBC1D4):c.2050C>T (p.Arg684Ter)	TBC1D4	R684*	Normal	TYPE 2 DIABETES MELLITUS 5, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 14, 2014)	no assertion criteria provided	VCV000157612	13	75898521	13	75324385	157612	167472	rs61736969	NC_000013.11:75324384:G:A	G	A	CLINICAL
NM_000209.4(PDX1):c.590G>A (p.Arg197His)	PDX1	R197H	Normal	Type 2 diabetes mellitus	risk factor(Last reviewed: Nov 1, 1999)	no assertion criteria provided	VCV000008858	13	28498576	13	27924439	8858	23897	rs137852786	NC_000013.11:27924438:G:A	G	A	CLINICAL
NM_032436.4(CHAMP1):c.1002G>A (p.Trp334Ter)	CHAMP1	W334*	Normal	CHAMP1-related syndrome|Mental retardation, autosomal dominant 40	Pathogenic(Last reviewed: May 18, 2018)	no assertion criteria provided	VCV000210049	13	115090319	13	114324844	210049	206661	rs879255261	NC_000013.11:114324843:G:A	G	A	CLINICAL
NM_018451.5(CENPJ):c.1132C>T (p.Arg378Ter)	CENPJ	R378*	Normal	not provided|Type III lissencephaly|Congenital microcephaly|Intellectual disability, moderate|Perisylvian polymicrogyria	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503611	13	25481044	13	24906906	503611	495314	rs201111299	NC_000013.11:24906905:G:A	G	A	CLINICAL
NM_016529.6(ATP8A2):c.1917T>A (p.Tyr639Ter)	ATP8A2	Y639*, Y599*	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800507	13	26153995	13	25579857	800507	789127	rs1593576872	NC_000013.11:25579856:T:A	T	A	CLINICAL
NM_012158.3(FBXL3):c.445C>T (p.Arg149Ter)	FBXL3	R149*	Normal	Mental retardation, short stature, facial anomalies, and joint dislocations	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000625419	13	77592761	13	77018626	625419	613733	rs374431043	NC_000013.11:77018625:G:A	G	A	CLINICAL
NM_207361.6(FREM2):c.8351G>A (p.Arg2784Lys)	FREM2	R2784K	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208382	13	39450228	13	38876091	208382	204621	rs863223346	NC_000013.11:38876090:G:A	G	A	CLINICAL
NM_000059.3(BRCA2):c.67+2T>C	BRCA2		Normal	not provided|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000052163	13	32890666	13	32316529	52163	66831	rs81002885	NC_000013.11:32316528:T:C	T	C	CLINICAL
NM_000059.4(BRCA2):c.8167G>C (p.Asp2723His)	BRCA2	D2723H	Normal	not provided|Hereditary breast and ovarian cancer syndrome|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Carcinoma of pancreas|Malignant tumor of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000052515	13	32937506	13	32363369	52515	67183	rs41293511	NC_000013.11:32363368:G:C	G	C	CLINICAL
NM_000209.4(PDX1):c.502A>C (p.Asn168His)	PDX1	N168H	Normal	Maturity-onset diabetes of the young type 4|Pancreatic agenesis 1	Likely pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000436282	13	28498488	13	27924351	436282	429487	rs1555241857	NC_000013.11:27924350:A:C	A	C	CLINICAL
NM_000209.4(PDX1):c.571A>C (p.Lys191Gln)	PDX1	K191Q	Normal	Maturity-onset diabetes of the young type 4	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036409	13	28498557	13	27924420	36409	45072	rs193922356	NC_000013.11:27924419:A:C	A	C	CLINICAL
NM_000209.4(PDX1):c.52T>C (p.Cys18Arg)	PDX1	C18R	Normal	not provided|Type 2 diabetes mellitus	Likely pathogenic(Last reviewed: Oct 10, 2016)	criteria provided, single submitter	VCV000008862	13	28494327	13	27920190	8862	23901	rs137852785	NC_000013.11:27920189:T:C	T	C	CLINICAL
NM_001004127.3(ALG11):c.953A>C (p.Gln318Pro)	ALG11	Q318P	Normal	Congenital disorder of glycosylation type 1P	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031647	13	52598819	13	52024683	31647	40324	rs387907184	NC_000013.11:52024682:A:C	A	C	CLINICAL
NM_001004127.3(ALG11):c.1142T>C (p.Leu381Ser)	UTP14C|ALG11	L381S	Normal	Congenital disorder of glycosylation type 1P	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000031645	13	52599008	13	52024872	31645	40322	rs387907182	NC_000013.11:52024871:T:C	T	C	CLINICAL
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter)	BRCA2	Y1655*	Normal	Familial cancer of breast|Medulloblastoma|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Malignant tumor of prostate|Wilms tumor 1|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|none provided|Breast-ovarian cancer, familial 2|not provided|not specified|Hereditary breast and ovarian cancer syndrome|Neoplasm of ovary|Fanconi anemia, complementation group D1|Malignant tumor of breast|Fanconi anemia, complementation group D1|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037936	13	32913457	13	32339320	37936	46492	rs80358721	NC_000013.11:32339319:C:G	C	G	CLINICAL
NM_000059.4(BRCA2):c.5645C>G (p.Ser1882Ter)	BRCA2	S1882*	Normal	not provided|Wilms tumor 1|Hereditary breast and ovarian cancer syndrome|Glioma susceptibility 3|Medulloblastoma|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000009346	13	32914137	13	32340000	9346	24385	rs80358785	NC_000013.11:32339999:C:G	C	G	CLINICAL
NM_000059.4(BRCA2):c.5682C>G (p.Tyr1894Ter)	BRCA2	Y1894*	Normal	Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Tracheoesophageal fistula|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Ovarian cancer|Breast and/or ovarian cancer|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000037989	13	32914174	13	32340037	37989	46545	rs41293497	NC_000013.11:32340036:C:G	C	G	CLINICAL
NM_000059.4(BRCA2):c.6656C>G (p.Ser2219Ter)	BRCA2	S2219*	Normal	Hereditary breast and ovarian cancer syndrome|not provided|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000052149	13	32915148	13	32341011	52149	66817	rs80358893	NC_000013.11:32341010:C:G	C	G	CLINICAL
NM_000059.4(BRCA2):c.9294C>G (p.Tyr3098Ter)	BRCA2	Y3098*	Normal	Hereditary breast and ovarian cancer syndrome|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000038229	13	32968863	13	32394726	38229	46785	rs80359200	NC_000013.11:32394725:C:G	C	G	CLINICAL
NM_000209.4(PDX1):c.442C>G (p.Arg148Gly)	PDX1	R148G	Normal	Maturity-onset diabetes of the young type 4	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036407	13	28498428	13	27924291	36407	45070	rs193922355	NC_000013.11:27924290:C:G	C	G	CLINICAL
NM_000209.4(PDX1):c.773A>G (p.Glu258Gly)	PDX1	E258G	Normal	Maturity-onset diabetes of the young type 4	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036413	13	28498759	13	27924622	36413	45076	rs193922360	NC_000013.11:27924621:A:G	A	G	CLINICAL
NM_000209.4(PDX1):c.533A>G (p.Glu178Gly)	PDX1	E178G	Normal	Permanent neonatal diabetes mellitus|Pancreatic agenesis 1|Maturity-onset diabetes of the young type 4|Pancreatic agenesis 1	Pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	VCV000030124	13	28498519	13	27924382	30124	39080	rs387906777	NC_000013.11:27924381:A:G	A	G	CLINICAL
NM_004004.6(GJB2):c.101T>C (p.Met34Thr)	GJB2	M34T	Normal	Nonsyndromic Deafness|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|none provided|Rare genetic deafness|Deafness, autosomal recessive 1A|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|not specified|not provided|Knuckle pads, deafness AND leukonychia syndrome|Palmoplantar keratoderma-deafness syndrome|Deafness, autosomal dominant 3a|Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Hystrix-like ichthyosis with deafness|Mutilating keratoderma|Deafness, autosomal recessive 1A|Hearing impairment|Hystrix-like ichthyosis with deafness|Hearing loss|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 24, 2019)	reviewed by expert panel	VCV000017000	13	20763620	13	20189481	17000	32039	rs35887622	NC_000013.11:20189480:A:G	A	G	CLINICAL
NM_016529.6(ATP8A2):c.1128C>G (p.Ile376Met)	ATP8A2	I376M, I336M	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000050946	13	26128001	13	25553863	50946	65609	rs546968533	NC_000013.11:25553862:C:G	C	G	CLINICAL
NM_016529.6(ATP8A2):c.2749A>G (p.Asn917Asp)	ATP8A2	N917D	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800921	13	26402325	13	25828187	800921	788876	rs1593410369	NC_000013.11:25828186:A:G	A	G	CLINICAL
NM_020751.3(COG6):c.1167-24A>G	COG6		Normal	Shaheen syndrome|not provided|COG6-related disorder|Intellectual disability|Hypohidrosis|Congenital disorder of glycosylation type 2L	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183333	13	40273614	13	39699477	183333	181437	rs730882236	NC_000013.11:39699476:A:G	A	G	CLINICAL
NM_014252.4(SLC25A15):c.110T>G (p.Met37Arg)	SLC25A15	M37R	Normal	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000005997	13	41373247	13	40799111	5997	21036	rs121908533	NC_000013.11:40799110:T:G	T	G	CLINICAL
NM_012158.3(FBXL3):c.1072T>C (p.Cys358Arg)	FBXL3	C358R	Normal	Mental retardation, short stature, facial anomalies, and joint dislocations	Pathogenic(Last reviewed: Apr 15, 2019)	no assertion criteria provided	VCV000625421	13	77581495	13	77007360	625421	613735	rs1566225872	NC_000013.11:77007359:A:G	A	G	CLINICAL
NM_014363.6(SACS):c.1707G>A (p.Trp569Ter)	SACS	W422*, W569*	Normal	Spastic paraplegia	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000657319	13	23929044	13	23354905	657319	641621	rs1593144544	NC_000013.11:23354904:C:T	C	T	CLINICAL
NM_000059.4(BRCA2):c.100G>T (p.Glu34Ter)	BRCA2	E34*	Normal	not provided|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000051041	13	32893246	13	32319109	51041	65709	rs80358391	NC_000013.11:32319108:G:T	G	T	CLINICAL
NM_000059.4(BRCA2):c.145G>T (p.Glu49Ter)	BRCA2	E49*	Normal	Malignant tumor of breast|Hereditary breast and ovarian cancer syndrome|Wilms tumor 1|Pancreatic cancer 2|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Fanconi anemia, complementation group D1|Glioma susceptibility 3|Familial cancer of breast|Medulloblastoma|Tracheoesophageal fistula|Familial cancer of breast|not provided|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000051129	13	32893291	13	32319154	51129	65797	rs80358435	NC_000013.11:32319153:G:T	G	T	CLINICAL
NM_000059.3(BRCA2):c.1399A>T (p.Lys467Ter)	BRCA2	K467*	Normal	Hereditary breast and ovarian cancer syndrome|Breast neoplasm|not provided|Breast-ovarian cancer, familial 2|Wilms tumor 1|Glioma susceptibility 3|Breast-ovarian cancer, familial 2|Familial cancer of breast|Medulloblastoma|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000051118	13	32907014	13	32332877	51118	65786	rs80358427	NC_000013.11:32332876:A:T	A	T	CLINICAL
NM_000059.4(BRCA2):c.3109C>T (p.Gln1037Ter)	BRCA2	Q1037*	Normal	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Medulloblastoma|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Malignant tumor of prostate|Wilms tumor 1|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Breast-ovarian cancer, familial 2|Malignant tumor of breast|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037819	13	32911601	13	32337464	37819	46375	rs80358557	NC_000013.11:32337463:C:T	C	T	CLINICAL
NM_000059.3(BRCA2):c.4243G>T (p.Glu1415Ter)	BRCA2	E1415*	Normal	Hereditary breast and ovarian cancer syndrome|not provided|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037890	13	32912735	13	32338598	37890	46446	rs397507327	NC_000013.11:32338597:G:T	G	T	CLINICAL
NM_000059.3(BRCA2):c.5791C>T (p.Gln1931Ter)	BRCA2	Q1931*	Normal	Wilms tumor 1|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Medulloblastoma|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000051939	13	32914283	13	32340146	51939	66607	rs80358807	NC_000013.11:32340145:C:T	C	T	CLINICAL
NM_000059.4(BRCA2):c.5857G>T (p.Glu1953Ter)	BRCA2	E1953*	Normal	Malignant tumor of breast|BRCA2-Related Disorders|Hereditary breast and ovarian cancer syndrome|not specified|Wilms tumor 1|Pancreatic cancer 2|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Fanconi anemia, complementation group D1|Glioma susceptibility 3|Familial cancer of breast|Medulloblastoma|Tracheoesophageal fistula|not provided|Breast-ovarian cancer, familial 2|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000051952	13	32914349	13	32340212	51952	66620	rs80358814	NC_000013.11:32340211:G:T	G	T	CLINICAL
NM_000059.4(BRCA2):c.6952C>T (p.Arg2318Ter)	BRCA2	R2318*	Normal	Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Breast neoplasm|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Familial cancer of breast|not provided	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000038076	13	32920978	13	32346841	38076	46632	rs80358920	NC_000013.11:32346840:C:T	C	T	CLINICAL
NM_000059.4(BRCA2):c.7480C>T (p.Arg2494Ter)	BRCA2	R2494*	Normal	not provided|Hereditary breast and ovarian cancer syndrome|Carcinoma of pancreas|Hereditary cancer-predisposing syndrome|Tracheoesophageal fistula|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000038099	13	32930609	13	32356472	38099	46655	rs80358972	NC_000013.11:32356471:C:T	C	T	CLINICAL
NM_000059.4(BRCA2):c.7879A>T (p.Ile2627Phe)	BRCA2	I2627F	Normal	Hereditary breast and ovarian cancer syndrome|not specified|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000052430	13	32936733	13	32362596	52430	67098	rs80359014	NC_000013.11:32362595:A:T	A	T	CLINICAL
NM_000059.4(BRCA2):c.7988A>T (p.Glu2663Val)	BRCA2	E2663V	Normal	Breast and/or ovarian cancer|not specified|Hereditary breast and ovarian cancer syndrome|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000052462	13	32937327	13	32363190	52462	67130	rs80359031	NC_000013.11:32363189:A:T	A	T	CLINICAL
NM_000059.4(BRCA2):c.9382C>T (p.Arg3128Ter)	BRCA2	R3128*	Normal	Breast neoplasm|Breast and/or ovarian cancer|Hereditary breast and ovarian cancer syndrome|not provided|Wilms tumor 1|Malignant tumor of prostate|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Medulloblastoma|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000052826	13	32968951	13	32394814	52826	67494	rs80359212	NC_000013.11:32394813:C:T	C	T	CLINICAL
NM_000209.4(PDX1):c.492G>T (p.Glu164Asp)	PDX1	E164D	Normal	Pancreatic agenesis 1|Type 2 diabetes mellitus	Pathogenic, risk factor(Last reviewed: Jul 5, 2011)	no assertion criteria provided	VCV000008864	13	28498478	13	27924341	8864	23903	rs80356661	NC_000013.11:27924340:G:T	G	T	CLINICAL
NM_003749.3(IRS2):c.3170G>A (p.Gly1057Asp)	IRS2	G1057D	Normal	DIABETES, TYPE II, SUSCEPTIBILITY TO	risk factor(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000008820	13	110435231	13	109782884	8820	23859	rs1805097	NC_000013.11:109782883:C:T	C	T	CLINICAL
NM_052867.4(NALCN):c.3390G>A (p.Pro1130=)	NALCN		Normal	Strabismus|Seizures|Cachexia|Abnormal pattern of respiration|Intellectual disability, severe	Pathogenic(Last reviewed: Dec 31, 2015)	criteria provided, single submitter	VCV000222073	13	101742197	13	101089846	222073	223771	rs869312873	NC_000013.11:101089845:C:T	C	T	CLINICAL
NM_206937.2(LIG4):c.1406G>A (p.Gly469Glu)	LIG4	G469E, G402E, G481E	Normal	Lig4 syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000007674	13	108862211	13	108209863	7674	22713	rs104894420	NC_000013.11:108209862:C:T	C	T	CLINICAL
NM_206937.2(LIG4):c.833G>A (p.Arg278His)	LIG4	R278H, R211H, R290H	Normal	Lig4 syndrome|not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000007675	13	108862784	13	108210436	7675	22714	rs104894421	NC_000013.11:108210435:C:T	C	T	CLINICAL
NM_032436.4(CHAMP1):c.1192C>T (p.Arg398Ter)	CHAMP1	R398*	Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 40|intellectual disability with severe speech impairment	Pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000208415	13	115090509	13	114325034	208415	204638	rs797044962	NC_000013.11:114325033:C:T	C	T	CLINICAL
NM_032436.4(CHAMP1):c.1489C>T (p.Arg497Ter)	CHAMP1	R497*	Normal	Mental retardation, autosomal dominant 40|not provided|CHAMP1-related syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210050	13	115090806	13	114325331	210050	206662	rs782397980	NC_000013.11:114325330:C:T	C	T	CLINICAL
NM_032436.4(CHAMP1):c.1768C>T (p.Gln590Ter)	CHAMP1	Q590*	Normal	Mental retardation, autosomal dominant 40|intellectual disability with severe speech impairment	Pathogenic(Last reviewed: Aug 13, 2015)	criteria provided, single submitter	VCV000208416	13	115091085	13	114325610	208416	204639	rs200070245	NC_000013.11:114325609:C:T	C	T	CLINICAL
NM_014363.6(SACS):c.9305T>A (p.Leu3102Ter)	SACS	L3102*, L2955*	Normal	not provided|Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and mental retardation|Charlevoix-Saguenay spastic ataxia|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280809	13	23908710	13	23334571	280809	264664	rs886041949	NC_000013.11:23334570:A:T	A	T	CLINICAL
NM_016529.6(ATP8A2):c.1741C>T (p.Arg581Ter)	ATP8A2	R541*, R581*	Normal	Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	Likely pathogenic(Last reviewed: Sep 26, 2019)	no assertion criteria provided	VCV000800920	13	26151235	13	25577097	800920	788875	rs1304109530	NC_000013.11:25577096:C:T	C	T	CLINICAL
NM_014252.4(SLC25A15):c.535C>T (p.Arg179Ter)	SLC25A15	R179*	Normal	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005994	13	41381512	13	40807376	5994	21033	rs104894429	NC_000013.11:40807375:C:T	C	T	CLINICAL
NM_001097577.3(ANG):c.155G>A (p.Ser52Asn)	ANG|RNASE4	S52N	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000018080	14	21161878	14	20693719	18080	33119	rs121909542	NC_000014.9:20693718:G:A	G	A	CLINICAL
NM_001097577.3(ANG):c.164G>A (p.Arg55Lys)	RNASE4|ANG	R55K	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018076	14	21161887	14	20693728	18076	33115	rs121909538	NC_000014.9:20693727:G:A	G	A	CLINICAL
NM_001097577.3(ANG):c.409G>A (p.Val137Ile)	ANG|RNASE4	V137I	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000018082	14	21162132	14	20693973	18082	33121	rs121909544	NC_000014.9:20693972:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.869-1G>A	PSEN1		Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599622	14	73673093	14	73206385	599622	590951	rs63750219	NC_000014.9:73206384:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.781G>A (p.Val261Ile)	PSEN1	V257I, V261I	Normal	Early onset Alzheimer disease with behavioral disturbance	Likely pathogenic(Last reviewed: Feb 28, 2019)	no assertion criteria provided	VCV000691947	14	73664750	14	73198042	691947	679696	rs63750964	NC_000014.9:73198041:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.635C>A (p.Ser212Tyr)	PSEN1	S212Y, S208Y	Normal	Pick disease|Alzheimer disease, type 3|Frontotemporal dementia|Acne inversa, familial, 3|not provided	Likely pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586386	14	73659438	14	73192730	586386	577367	rs1555355250	NC_000014.9:73192729:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.626G>A (p.Gly209Glu)	PSEN1	G205E, G209E	Normal	Acne inversa, familial, 3|Pick disease|Alzheimer disease, type 3|Frontotemporal dementia	Likely pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000663536	14	73659429	14	73192721	663536	642670	rs63750053	NC_000014.9:73192720:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.691G>A (p.Ala231Thr)	PSEN1	A231T, A227T	Normal	Cardiomyopathy, dilated, 1u|Pick disease|Acne inversa, familial, 3|Frontotemporal dementia|Alzheimer disease, type 3|not provided	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000098065	14	73659494	14	73192786	98065	103957	rs63749836	NC_000014.9:73192785:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.796G>A (p.Gly266Ser)	PSEN1	G266S, G262S	Normal	Alzheimer disease, familial, 3, with spastic paraparesis and apraxia	Pathogenic(Last reviewed: Apr 8, 2002)	no assertion criteria provided	VCV000018144	14	73664765	14	73198057	18144	33183	rs121917807	NC_000014.9:73198056:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.347C>A (p.Thr116Asn)	PSEN1	T112N, T116N	Normal	Acne inversa, familial, 3|Pick disease|Alzheimer disease, type 3|Frontotemporal dementia	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000659639	14	73640282	14	73173574	659639	642667	rs63750730	NC_000014.9:73173573:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.806G>A (p.Arg269His)	PSEN1	R269H, R265H	Normal	Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|Pick disease|Alzheimer disease, type 4|not provided	Pathogenic(Last reviewed: Dec 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000038297	14	73664775	14	73198067	38297	46864	rs63750900	NC_000014.9:73198066:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.424G>A (p.Val142Ile)	PSEN1	V142I, V138I	Normal	Alzheimer disease	Pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599627	14	73640359	14	73173651	599627	590948	rs1566630910	NC_000014.9:73173650:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.617G>A (p.Gly206Asp)	PSEN1	G202D, G206D	Normal	Alzheimer disease, type 3	Pathogenic(Last reviewed: Jun 1, 2018)	no assertion criteria provided	VCV000807473	14	73659420	14	73192712	807473	798677	rs63750082	NC_000014.9:73192711:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.1307C>A (p.Pro436Gln)	PSEN1	P436Q, P432Q	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000018150	14	73685900	14	73219192	18150	33189	rs121917808	NC_000014.9:73219191:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.438G>A (p.Met146Ile)	PSEN1	M146I, M142I	Normal	Alzheimer disease, type 3	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000018137	14	73640373	14	73173665	18137	33176	rs63750391	NC_000014.9:73173664:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.1229G>A (p.Cys410Tyr)	PSEN1	C410Y, C406Y	Normal	Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000018127	14	73683933	14	73217225	18127	33166	rs661	NC_000014.9:73217224:G:A	G	A	CLINICAL
NM_000021.4(PSEN1):c.520C>A (p.Leu174Met)	PSEN1	L174M, L170M	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000018147	14	73653600	14	73186892	18147	33186	rs63751144	NC_000014.9:73186891:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.1292C>A (p.Ala431Glu)	PSEN1	A431E, A427E	Normal	Alzheimer disease, type 3|Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018155	14	73685885	14	73219177	18155	33194	rs63750083	NC_000014.9:73219176:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.737C>A (p.Ala246Glu)	PSEN1	A246E, A242E	Normal	Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	VCV000018125	14	73659540	14	73192832	18125	33164	rs63750526	NC_000014.9:73192831:C:A	C	A	CLINICAL
NM_001170629.2(CHD8):c.6730C>T (p.Arg2244Ter)	CHD8	R2244*, R1965*	Normal	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000807384	14	21860707	14	21392548	807384	798671	rs1555313027	NC_000014.9:21392547:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.6103C>T (p.Arg2035Ter)	CHD8	R1756*, R2035*	Normal	not provided|Autism, susceptibility to, 18	Pathogenic(Last reviewed: Oct 15, 2015)	criteria provided, single submitter	VCV000429840	14	21861851	14	21393692	429840	421974	rs1131691627	NC_000014.9:21393691:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.4378C>T (p.Arg1460Ter)	CHD8	R1181*, R1460*	Normal	Autism spectrum disorder|Autism, susceptibility to, 18	Pathogenic(Last reviewed: Nov 17, 2017)	no assertion criteria provided	VCV000488481	14	21868764	14	21400605	488481	481349	rs1454466097	NC_000014.9:21400604:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.4009C>T (p.Arg1337Ter)	CHD8	R1337*, R1058*	Normal	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000039630	14	21870169	14	21402010	39630	48229	rs397514552	NC_000014.9:21402009:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.3724C>T (p.Arg1242Ter)	CHD8	R963*, R1242*	Normal	not provided|Autism, susceptibility to, 18	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437423	14	21870653	14	21402494	437423	430983	rs1555314788	NC_000014.9:21402493:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.3712C>T (p.Gln1238Ter)	CHD8	Q1238*, Q959*	Normal	Autism, susceptibility to, 18	risk factor(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039629	14	21871178	14	21403019	39629	48228	rs397514551	NC_000014.9:21403018:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.3308G>T (p.Gly1103Val)	CHD8	G1103V, G824V	Normal	CHD8-Related Disorders|not provided|Autism, susceptibility to, 18|Autism spectrum disorder	Likely pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000422245	14	21871822	14	21403663	422245	409073	rs1064795655	NC_000014.9:21403662:C:A	C	A	CLINICAL
NM_001170629.2(CHD8):c.2854C>T (p.Arg952Ter)	CHD8	R673*, R952*	Normal	Autism spectrum disorder|not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000429724	14	21875068	14	21406909	429724	421975	rs1131691548	NC_000014.9:21406908:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.2434C>T (p.Arg812Trp)	CHD8	R533W, R812W	Normal	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: Feb 17, 2015)	no assertion criteria provided	VCV000374259	14	21876915	14	21408756	374259	361212	rs1057518651	NC_000014.9:21408755:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.2317C>T (p.Arg773Ter)	CHD8	R494*, R773*	Normal	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	VCV000216902	14	21878057	14	21409898	216902	213629	rs776631057	NC_000014.9:21409897:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.1744C>T (p.Arg582Ter)	CHD8	R303*, R582*	Normal	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: May 13, 2014)	criteria provided, single submitter	VCV000216903	14	21884039	14	21415880	216903	213630	rs863224857	NC_000014.9:21415879:G:A	G	A	CLINICAL
NM_001170629.2(CHD8):c.634C>T (p.Arg212Ter)	CHD8	R212*	Normal	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000811149	14	21899169	14	21431010	811149	799764	rs556977377	NC_000014.9:21431009:G:A	G	A	CLINICAL
NM_003136.4(SRP54):c.677G>A (p.Gly226Glu)	SRP54	G226E, G177E	Normal	Neutropenia, severe congenital, 8, autosomal dominant|Inborn genetic diseases|Shwachman-Diamond syndrome 1	Likely pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000430850	14	35482592	14	35013386	430850	424395	rs1555354750	NC_000014.9:35013385:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.6490G>A (p.Val2164Met)	DYNC1H1	V2164M	Normal	not provided	Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000560252	14	102477161	14	102010824	560252	551313	rs1567010427	NC_000014.9:102010823:G:A	G	A	CLINICAL
NM_002719.4(PPP2R5C):c.364G>A (p.Glu122Lys)	PPP2R5C	E153K, E47K, E122K, E177K, E182K	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000666303	14	102348567	14	101882230	666303	653885	rs1595460164	NC_000014.9:101882229:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.926G>A (p.Arg309His)	DYNC1H1	R309H	Normal	Lissencephaly|not provided|Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Feb 9, 2016)	criteria provided, single submitter	VCV000209107	14	102446852	14	101980515	209107	205703	rs797045177	NC_000014.9:101980514:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.1802T>A (p.Ile601Asn)	DYNC1H1	I601N	Normal	Global developmental delay|Motor delay|Polymicrogyria|Muscular hypotonia	Likely pathogenic(Last reviewed: Jul 5, 2016)	no assertion criteria provided	VCV000373929	14	102452364	14	101986027	373929	360955	rs1057518776	NC_000014.9:101986026:T:A	T	A	CLINICAL
NM_001376.5(DYNC1H1):c.4042G>A (p.Glu1348Lys)	DYNC1H1	E1348K	Normal	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000496684	14	102466704	14	102000367	496684	488159	rs1047509819	NC_000014.9:102000366:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.4552G>A (p.Glu1518Lys)	DYNC1H1	E1518K	Normal	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030031	14	102468883	14	102002546	30031	38986	rs387906740	NC_000014.9:102002545:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.4700G>A (p.Arg1567Gln)	DYNC1H1	R1567Q	Normal	not provided|Inborn genetic diseases|Intellectual disability	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208709	14	102469031	14	102002694	208709	205280	rs797044901	NC_000014.9:102002693:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.4868G>A (p.Arg1623Gln)	DYNC1H1	R1623Q	Normal	not provided|Mental retardation, autosomal dominant 13|Lissencephaly	Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000424046	14	102469287	14	102002950	424046	409059	rs1064796765	NC_000014.9:102002949:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.5885G>A (p.Arg1962His)	DYNC1H1	R1962H	Normal	not provided|Inborn genetic diseases|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373213	14	102474582	14	102008245	373213	360026	rs1057518287	NC_000014.9:102008244:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.10031G>A (p.Arg3344Gln)	DYNC1H1	R3344Q	Normal	Intellectual disability|Lissencephaly|Mental retardation, autosomal dominant 13|Charcot-Marie-Tooth disease, axonal, type 2O	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV000055855	14	102498756	14	102032419	55855	70509	rs397509412	NC_000014.9:102032418:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.10151G>A (p.Arg3384Gln)	DYNC1H1	R3384Q	Normal	not provided|Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000055854	14	102499473	14	102033136	55854	70508	rs397509411	NC_000014.9:102033135:G:A	G	A	CLINICAL
NM_001376.5(DYNC1H1):c.10973G>A (p.Gly3658Glu)	DYNC1H1	G3658E	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000813289	14	102504861	14	102038524	813289	801536	rs1595629181	NC_000014.9:102038523:G:A	G	A	CLINICAL
NM_001100913.3(PACS2):c.625G>A (p.Glu209Lys)	PACS2	E209K, E142K	Normal	not provided|Inborn genetic diseases|Intellectual disability|See cases|Developmental and epileptic encephalopathy, 66	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000495141	14	105834449	14	105368112	495141	486695	rs1555408401	NC_000014.9:105368111:G:A	G	A	CLINICAL
NM_005249.5(FOXG1):c.624C>A (p.Tyr208Ter)	FOXG1	Y208*	Normal	Abnormality of the optic nerve|Muscular hypotonia of the trunk|Stereotypy|Strabismus|Global developmental delay|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000453289	14	29237109	14	28767903	453289	446889	rs267606826	NC_000014.9:28767902:C:A	C	A	CLINICAL
NM_014672.4(PRORP):c.1334G>A (p.Arg445Gln)	PRORP	R445Q, R350Q, R429Q, R73Q	Normal	Global developmental delay|Feeding difficulties|Diffuse white matter abnormalities|Persistent lactic acidosis|Microcephaly|Hypertonia	Likely pathogenic(Last reviewed: Oct 1, 2018)	no assertion criteria provided	VCV000638209	14	35735991	14	35266785	638209	626015	rs777185638	NC_000014.9:35266784:G:A	G	A	CLINICAL
NM_002408.4(MGAT2):c.1017T>A (p.Cys339Ter)	MGAT2	C339*	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006992	14	50089003	14	49622285	6992	22031	rs104894449	NC_000014.9:49622284:T:A	T	A	CLINICAL
NM_015346.4(ZFYVE26):c.5422C>T (p.Gln1808Ter)	ZFYVE26	Q1808*	Normal	Hereditary spastic paraplegia 15	Pathogenic	criteria provided, single submitter	VCV000030933	14	68238826	14	67772109	30933	39890	rs387907057	NC_000014.9:67772108:G:A	G	A	CLINICAL
NM_001363688.1(NPC2):c.358C>T (p.Pro120Ser)	NPC2	P120S	Normal	Niemann-Pick disease, type C2|Niemann-Pick disease type C1	Pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV000008486	14	74951123	14	74484420	8486	23525	rs104894458	NC_000014.9:74484419:G:A	G	A	CLINICAL
NM_194279.4(ISCA2):c.229G>A (p.Gly77Ser)	ISCA2	G77S	Normal	not provided|Multiple mitochondrial dysfunctions syndrome|Multiple mitochondrial dysfunctions syndrome 4|Optic atrophy|Global developmental delay|High CSF lactic acid|Neurodegeration|Failure to thrive|Muscular hypotonia of the trunk|Death in infancy|Spastic tetraplegia	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183353	14	74961032	14	74494329	183353	181441	rs730882246	NC_000014.9:74494328:G:A	G	A	CLINICAL
NM_024496.4(IRF2BPL):c.379C>T (p.Gln127Ter)	IRF2BPL	Q127*	Normal	Developmental regression|Seizures|Intellectual disability|Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	Likely pathogenic(Last reviewed: Jun 8, 2019)	criteria provided, single submitter	VCV000559609	14	77493757	14	77027414	559609	550330	rs1292724234	NC_000014.9:77027413:G:A	G	A	CLINICAL
NM_013382.5(POMT2):c.1417C>T (p.Arg473Ter)	POMT2	R473*	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095535	14	77751891	14	77285548	95535	101434	rs368817785	NC_000014.9:77285547:G:A	G	A	CLINICAL
NM_013382.5(POMT2):c.1261C>T	POMT2	R421W	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162597	14	77753158	14	77286815	162597	172251	rs727502855	NC_000014.9:77286814:G:A	G	A	CLINICAL
NM_013382.5(POMT2):c.958C>T (p.Gln320Ter)	POMT2	Q320*	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|not provided	Pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000289683	14	77765080	14	77298737	289683	273920	rs775932206	NC_000014.9:77298736:G:A	G	A	CLINICAL
NM_001080414.4(CCDC88C):c.934C>T (p.Arg312Ter)	CCDC88C	R312*	Normal	Congenital hydrocephalus 1	Pathogenic(Last reviewed: Jul 10, 2018)	no assertion criteria provided	VCV000039861	14	91804465	14	91338121	39861	48460	rs369384363	NC_000014.9:91338120:G:A	G	A	CLINICAL
NM_006329.3(FBLN5):c.1171G>T (p.Glu391Ter)	FBLN5	E391*	Normal	Autosomal recessive cutis laxa type IA	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000021451	14	92343845	14	91877501	21451	34303	rs80338767	NC_000014.9:91877500:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.1307C>A (p.Pro436Gln)	PSEN1	P436Q, P432Q	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000018150	14	73685900	14	73219192	18150	33189	rs121917808	NC_000014.9:73219191:C:A	C	A	CLINICAL
NM_000021.4(PSEN1):c.505T>C (p.Ser169Pro)	PSEN1	S169P, S165P	Normal	not provided	Likely pathogenic(Last reviewed: Apr 14, 2017)	criteria provided, single submitter	VCV000098040	14	73653585	14	73186877	98040	103932	rs63750418	NC_000014.9:73186876:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.665A>C (p.Gln222Pro)	PSEN1	Q222P, Q218P	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599623	14	73659468	14	73192760	599623	590950	rs63750009	NC_000014.9:73192759:A:C	A	C	CLINICAL
NM_000021.4(PSEN1):c.338T>C (p.Leu113Pro)	PSEN1	L113P, L109P	Normal	not provided|Frontotemporal dementia|Alzheimer disease, type 3|Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia	Likely pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018145	14	73637755	14	73171047	18145	33184	rs63751399	NC_000014.9:73171046:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.254T>C (p.Leu85Pro)	PSEN1	L85P, L81P	Normal	not provided|Alzheimer disease, familial, 3, with spastic paraparesis and apraxia	Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000018153	14	73637671	14	73170963	18153	33192	rs63750599	NC_000014.9:73170962:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.1276G>C (p.Ala426Pro)	PSEN1	A426P, A422P	Normal	Cardiomyopathy, dilated, 1u|Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000018136	14	73685869	14	73219161	18136	33175	rs63751223	NC_000014.9:73219160:G:C	G	C	CLINICAL
NM_000021.4(PSEN1):c.649G>C (p.Gly217Arg)	PSEN1	G217R, G213R	Normal	Pick disease|Frontotemporal dementia|Acne inversa, familial, 3|Alzheimer disease, type 3|Alzheimer disease, familial, 3, with unusual plaques	Likely pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000018159	14	73659452	14	73192744	18159	33198	rs267606983	NC_000014.9:73192743:G:C	G	C	CLINICAL
NM_000021.4(PSEN1):c.833G>C (p.Arg278Thr)	PSEN1	R278T, R274T	Normal	Alzheimer disease, familial, with spastic paraparesis and unusual plaques	Pathogenic(Last reviewed: Apr 14, 1997)	no assertion criteria provided	VCV000018139	14	73664802	14	73198094	18139	33178	rs63749891	NC_000014.9:73198093:G:C	G	C	CLINICAL
NM_000021.4(PSEN1):c.1175T>C (p.Leu392Pro)	PSEN1	L392P, L388P	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000021026	14	73683879	14	73217171	21026	33878	rs63750218	NC_000014.9:73217170:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.767A>C (p.Tyr256Ser)	PSEN1	Y256S, Y252S	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000021029	14	73659570	14	73192862	21029	33881	rs63751320	NC_000014.9:73192861:A:C	A	C	CLINICAL
NM_000021.4(PSEN1):c.749T>C (p.Leu250Ser)	PSEN1	L250S, L246S	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000018138	14	73659552	14	73192844	18138	33177	rs63751163	NC_000014.9:73192843:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.416T>C (p.Met139Thr)	PSEN1	M139T, M135T	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV000098023	14	73640351	14	73173643	98023	103915	rs63751106	NC_000014.9:73173642:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.497T>C (p.Leu166Pro)	PSEN1	L166P, L162P	Normal	Alzheimer disease, type 3	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000018146	14	73653577	14	73186869	18146	33185	rs63750265	NC_000014.9:73186868:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.428T>C (p.Ile143Thr)	PSEN1	I143T, I139T	Normal	Pick disease|Acne inversa, familial, 3|Frontotemporal dementia|Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Nov 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000098026	14	73640363	14	73173655	98026	103918	rs63750004	NC_000014.9:73173654:T:C	T	C	CLINICAL
NM_000021.4(PSEN1):c.275G>C (p.Cys92Ser)	PSEN1	C92S, C88S	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Oct 14, 2000)	no assertion criteria provided	VCV000018142	14	73637692	14	73170984	18142	33181	rs63751141	NC_000014.9:73170983:G:C	G	C	CLINICAL
NM_000021.4(PSEN1):c.436A>C (p.Met146Leu)	PSEN1	M146L, M142L	Normal	Alzheimer disease, type 3|Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000018123	14	73640371	14	73173663	18123	33162	rs63750306	NC_000014.9:73173662:A:C	A	C	CLINICAL
NM_000021.4(PSEN1):c.839A>C (p.Glu280Ala)	PSEN1	E280A, E276A	Normal	Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|Alzheimer disease, type 3	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000018131	14	73664808	14	73198100	18131	33170	rs63750231	NC_000014.9:73198099:A:C	A	C	CLINICAL
NM_000021.4(PSEN1):c.617G>C (p.Gly206Ala)	PSEN1	G206A, G202A	Normal	not provided|Acne inversa, familial, 3|Alzheimer disease, type 3|Pick disease|Frontotemporal dementia|Alzheimer disease, type 3	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018143	14	73659420	14	73192712	18143	33182	rs63750082	NC_000014.9:73192711:G:C	G	C	CLINICAL
NM_001170629.2(CHD8):c.3519-2A>G	CHD8		Normal	Autism spectrum disorder|not provided|Autism, susceptibility to, 18	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, single submitter	VCV000039628	14	21871373	14	21403214	39628	48227	rs1594344233	NC_000014.9:21403213:T:C	T	C	CLINICAL
NM_001170629.2(CHD8):c.185C>G (p.Ser62Ter)	CHD8	S62*	Normal	Autism, susceptibility to, 18	risk factor(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039626	14	21899618	14	21431459	39626	48225	rs1331026006	NC_000014.9:21431458:G:C	G	C	CLINICAL
NM_003403.5(YY1):c.1097T>C (p.Leu366Pro)	YY1	L366P	Normal	Gabriele de Vries syndrome	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000430618	14	100743789	14	100277452	430618	423701	rs1131692163	NC_000014.9:100277451:T:C	T	C	CLINICAL
NM_001376.5(DYNC1H1):c.1706G>C (p.Arg569Pro)	DYNC1H1	R569P	Normal	Mental retardation, autosomal dominant 13|Lissencephaly	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2015)	no assertion criteria provided	VCV000209108	14	102452268	14	101985931	209108	205704	rs797045178	NC_000014.9:101985930:G:C	G	C	CLINICAL
NM_001376.5(DYNC1H1):c.6122T>C (p.Met2041Thr)	DYNC1H1	M2041T	Normal	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000434987	14	102476324	14	102009987	434987	429525	rs1555409836	NC_000014.9:102009986:T:C	T	C	CLINICAL
NM_001376.5(DYNC1H1):c.10280A>C (p.Gln3427Pro)	DYNC1H1	Q3427P	Normal	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Nov 16, 2017)	no assertion criteria provided	VCV000488494	14	102499688	14	102033351	488494	481362	rs1555411394	NC_000014.9:102033350:A:C	A	C	CLINICAL
NM_001376.5(DYNC1H1):c.11183G>C (p.Arg3728Pro)	DYNC1H1	R3728P	Normal	Mental retardation, autosomal dominant 13|Lissencephaly	Likely pathogenic(Last reviewed: Nov 18, 2014)	criteria provided, single submitter	VCV000210861	14	102505162	14	102038825	210861	208078	rs797045529	NC_000014.9:102038824:G:C	G	C	CLINICAL
NM_001376.5(DYNC1H1):c.11465A>C (p.His3822Pro)	DYNC1H1	H3822P	Normal	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Mar 1, 2012)	no assertion criteria provided	VCV000030030	14	102505753	14	102039416	30030	38985	rs387906739	NC_000014.9:102039415:A:C	A	C	CLINICAL
NM_032630.3(CINP):c.637T>G (p.Ter213Gly)	CINP		Normal	Microcephaly|Seizures|Intellectual disability	Likely pathogenic	criteria provided, single submitter	VCV000402142	14	102814896	14	102348559	402142	389158	rs1060499740	NC_000014.9:102348558:A:C	A	C	CLINICAL
NM_025152.3(NUBPL):c.311T>C (p.Leu104Pro)	NUBPL	L104P, L8P	Normal	Mitochondrial complex I deficiency|not provided|Mitochondrial complex 1 deficiency, nuclear type 21|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000209179	14	32068514	14	31599308	209179	205774	rs201430951	NC_000014.9:31599307:T:C	T	C	CLINICAL
NM_002408.4(MGAT2):c.711G>C (p.Lys237Asn)	MGAT2	K237N	Normal	Global developmental delay|Abnormal glycosylation (CDG IIa)|Abnormal facial shape|Congenital disorder of glycosylation, type IIa	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000030270	14	50088697	14	49621979	30270	39226	rs730882218	NC_000014.9:49621978:G:C	G	C	CLINICAL
NM_002408.4(MGAT2):c.799G>C (p.Asp267His)	MGAT2	D267H	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617661	14	50088785	14	49622067	617661	609066	rs1566505013	NC_000014.9:49622066:G:C	G	C	CLINICAL
NM_013382.5(POMT2):c.1997A>G (p.Tyr666Cys)	POMT2		Normal	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Muscular dystrophy|not provided|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003221	14	77745107	14	77278764	3221	18260	rs200198778	NC_000014.9:77278763:T:C	T	C	CLINICAL
NM_013382.5(POMT2):c.924-2A>G	POMT2		Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|not provided	Pathogenic(Last reviewed: Jul 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000289765	14	77765116	14	77298773	289765	274002	rs886044256	NC_000014.9:77298772:T:C	T	C	CLINICAL
NM_001097577.3(ANG):c.121A>G (p.Lys41Glu)	RNASE4|ANG	K41E	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018075	14	21161844	14	20693685	18075	33114	rs121909537	NC_000014.9:20693684:A:G	A	G	CLINICAL
NM_001097577.3(ANG):c.189C>G (p.Cys63Trp)	ANG|RNASE4	C63W	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018077	14	21161912	14	20693753	18077	33116	rs121909539	NC_000014.9:20693752:C:G	C	G	CLINICAL
NM_000021.4(PSEN1):c.257T>G (p.Phe86Cys)	PSEN1	F82C, F86C	Normal	Alzheimer disease, type 3	Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000692235	14	73637674	14	73170966	692235	680052	rs1594998354	NC_000014.9:73170965:T:G	T	G	CLINICAL
NM_000021.4(PSEN1):c.1270C>G (p.Leu424Val)	PSEN1	L424V, L420V	Normal	Alzheimer disease, type 3|not provided	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000638260	14	73685863	14	73219155	638260	626017	rs1555358260	NC_000014.9:73219154:C:G	C	G	CLINICAL
NM_000021.4(PSEN1):c.415A>G (p.Met139Val)	PSEN1	M139V, M135V	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000018128	14	73640350	14	73173642	18128	33167	rs63751037	NC_000014.9:73173641:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.839A>G (p.Glu280Gly)	PSEN1	E280G, E276G	Normal	not provided|Alzheimer disease, type 3|Alzheimer disease, familial, with spastic paraparesis and unusual plaques	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV000018132	14	73664808	14	73198100	18132	33171	rs63750231	NC_000014.9:73198099:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.811C>G (p.Leu271Val)	PSEN1	L271V, L267V	Normal	Alzheimer disease, type 3|Spastic paraparesis|Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, familial, 3, with unusual plaques	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000018148	14	73664780	14	73198072	18148	33187	rs63750886	NC_000014.9:73198071:C:G	C	G	CLINICAL
NM_000021.4(PSEN1):c.856C>G (p.Leu286Val)	PSEN1	L286V, L282V	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000018126	14	73664825	14	73198117	18126	33165	rs63751235	NC_000014.9:73198116:C:G	C	G	CLINICAL
NM_000021.4(PSEN1):c.1141C>G (p.Leu381Val)	PSEN1	L381V, L377V	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	VCV000098101	14	73683845	14	73217137	98101	103993	rs63750687	NC_000014.9:73217136:C:G	C	G	CLINICAL
NM_000021.4(PSEN1):c.436A>G (p.Met146Val)	PSEN1	M146V, M142V	Normal	Alzheimer disease, type 3	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000018129	14	73640371	14	73173663	18129	33168	rs63750306	NC_000014.9:73173662:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.488A>G (p.His163Arg)	PSEN1	H163R, H159R	Normal	not provided|Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|Alzheimer disease, type 3	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, single submitter	VCV000018124	14	73653568	14	73186860	18124	33163	rs63750590	NC_000014.9:73186859:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.404A>G (p.Asn135Ser)	PSEN1	N135S, N131S	Normal	Pick disease|Acne inversa, familial, 3|Frontotemporal dementia|Alzheimer disease, type 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000098022	14	73640339	14	73173631	98022	103914	rs63751278	NC_000014.9:73173630:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.697A>G (p.Met233Val)	PSEN1	M233V, M229V	Normal	not provided|Acne inversa, familial, 3|Alzheimer disease, type 3|Pick disease|Frontotemporal dementia|Alzheimer disease, type 3	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021028	14	73659500	14	73192792	21028	33880	rs63751287	NC_000014.9:73192791:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.344A>G (p.Tyr115Cys)	PSEN1	Y115C, Y111C	Normal	not provided|Alzheimer disease, type 3|Pick disease|Alzheimer disease, type 3|Acne inversa, familial, 3|Frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000098015	14	73640279	14	73173571	98015	103907	rs63750450	NC_000014.9:73173570:A:G	A	G	CLINICAL
NM_003403.5(YY1):c.1096C>G (p.Leu366Val)	YY1	L366V	Normal	Gabriele de Vries syndrome	Pathogenic(Last reviewed: Aug 17, 2018)	no assertion criteria provided	VCV000430619	14	100743788	14	100277451	430619	423702	rs1131692044	NC_000014.9:100277450:C:G	C	G	CLINICAL
NM_001519.4(BRF1):c.654G>C (p.Trp218Cys)	BRF1	W103C, W191C, W218C, W14C	Normal	Intellectual disability, moderate|Postnatal growth retardation|Congenital microcephaly|Heart, malformation of|Sensorineural hearing loss|Abnormality of the inner ear	Pathogenic(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV000867234	14	105707642	14	105241305	867234	857333	rs1343140353	NC_000014.9:105241304:C:G	C	G	CLINICAL
NM_005249.5(FOXG1):c.761A>G (p.Tyr254Cys)	FOXG1	Y254C	Normal	not provided	Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	VCV000427115	14	29237246	14	28768040	427115	415396	rs1085307966	NC_000014.9:28768039:A:G	A	G	CLINICAL
NM_002408.4(MGAT2):c.785A>G (p.His262Arg)	MGAT2	H262R	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000006990	14	50088771	14	49622053	6990	22029	rs104894447	NC_000014.9:49622052:A:G	A	G	CLINICAL
NM_002408.4(MGAT2):c.952A>G (p.Asn318Asp)	MGAT2	N318D	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Nov 1, 2000)	no assertion criteria provided	VCV000006991	14	50088938	14	49622220	6991	22030	rs104894448	NC_000014.9:49622219:A:G	A	G	CLINICAL
NM_000161.3(GCH1):c.662T>C (p.Met221Thr)	GCH1	M221T	Normal	Intellectual disability|Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000009281	14	55310826	14	54844108	9281	24320	rs104894434	NC_000014.9:54844107:A:G	A	G	CLINICAL
NM_000021.4(PSEN1):c.314T>G (p.Phe105Cys)	PSEN1	F105C, F101C	Normal	Mental deterioration|Dementia	Pathogenic(Last reviewed: Feb 6, 2015)	criteria provided, single submitter	VCV000374134	14	73637731	14	73171023	374134	360961	rs1057518919	NC_000014.9:73171022:T:G	T	G	CLINICAL
NM_013382.5(POMT2):c.924-2A>C	POMT2		Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000449378	14	77765116	14	77298773	449378	445254	rs886044256	NC_000014.9:77298772:T:G	T	G	CLINICAL
NM_013382.5(POMT2):c.248+5G>C	POMT2		Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000003234	14	77786772	14	77320429	3234	18273	rs587777816	NC_000014.9:77320428:C:G	C	G	CLINICAL
NM_013382.5(POMT2):c.248+1G>C	POMT2		Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000579369	14	77786776	14	77320433	579369	568318	rs961440747	NC_000014.9:77320432:C:G	C	G	CLINICAL
NM_001097577.3(ANG):c.107A>T (p.Gln36Leu)	ANG|RNASE4	Q36L	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018073	14	21161830	14	20693671	18073	33112	rs121909535	NC_000014.9:20693670:A:T	A	T	CLINICAL
NM_001097577.3(ANG):c.191A>T (p.Lys64Ile)	ANG|RNASE4	K64I	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018078	14	21161914	14	20693755	18078	33117	rs121909540	NC_000014.9:20693754:A:T	A	T	CLINICAL
NM_001097577.3(ANG):c.407C>T (p.Pro136Leu)	ANG|RNASE4	P136L	Normal	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000018081	14	21162130	14	20693971	18081	33120	rs121909543	NC_000014.9:20693970:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.1177G>T (p.Val393Phe)	PSEN1	V393F, V389F	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599628	14	73683881	14	73217173	599628	590952	rs1566656702	NC_000014.9:73217172:G:T	G	T	CLINICAL
NM_000021.4(PSEN1):c.1297C>T (p.Pro433Ser)	PSEN1	P433S, P429S	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599625	14	73685890	14	73219182	599625	590953	rs1566657804	NC_000014.9:73219181:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.356C>T (p.Thr119Ile)	PSEN1	T119I, T115I	Normal	Frontotemporal dementia|Alzheimer disease, type 3	Likely pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000625849	14	73640291	14	73173583	625849	614153	rs1566630791	NC_000014.9:73173582:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.800C>T (p.Pro267Leu)	PSEN1	P267L, P263L	Normal	not provided|Alzheimer disease, type 3	Likely pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV000098081	14	73664769	14	73198061	98081	103973	rs63750779	NC_000014.9:73198060:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.1141C>T (p.Leu381Phe)	PSEN1	L381F, L377F	Normal	Alzheimer disease, type 3|Alzheimer disease familial 3, with spastic paraparesis	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000120170	14	73683845	14	73217137	120170	125778	rs63750687	NC_000014.9:73217136:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.799C>T (p.Pro267Ser)	PSEN1	P267S, P263S	Normal	not provided|Alzheimer disease, type 3	Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000018133	14	73664768	14	73198060	18133	33172	rs63751229	NC_000014.9:73198059:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.869-2A>T	PSEN1		Normal	Pick disease|Frontotemporal dementia|Acne inversa, familial, 3|Alzheimer disease, type 3	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000579680	14	73673092	14	73206384	579680	568253	rs1566650594	NC_000014.9:73206383:A:T	A	T	CLINICAL
NM_000021.4(PSEN1):c.360A>T (p.Glu120Asp)	PSEN1	E120D, E116D	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000018135	14	73640295	14	73173587	18135	33174	rs63751272	NC_000014.9:73173586:A:T	A	T	CLINICAL
NM_000021.4(PSEN1):c.236C>T (p.Ala79Val)	PSEN1	A79V, A75V	Normal	not provided|Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|Alzheimer disease, type 3	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000018157	14	73637653	14	73170945	18157	33196	rs63749824	NC_000014.9:73170944:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.509C>T (p.Ser170Phe)	PSEN1	S170F, S166F	Normal	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000018158	14	73653589	14	73186881	18158	33197	rs63750577	NC_000014.9:73186880:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.265G>T (p.Val89Leu)	PSEN1	V89L, V85L	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000021027	14	73637682	14	73170974	21027	33879	rs63750815	NC_000014.9:73170973:G:T	G	T	CLINICAL
NM_000021.4(PSEN1):c.548G>T (p.Gly183Val)	PSEN1	G183V, G179V	Normal	not provided|Alzheimer disease, type 3|Pick disease	Pathogenic(Last reviewed: Feb 14, 2018)	no assertion criteria provided	VCV000018149	14	73653628	14	73186920	18149	33188	rs63751068	NC_000014.9:73186919:G:T	G	T	CLINICAL
NM_000021.4(PSEN1):c.833G>T (p.Arg278Ile)	PSEN1	R278I, R274I	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Nov 9, 2004)	no assertion criteria provided	VCV000018152	14	73664802	14	73198094	18152	33191	rs63749891	NC_000014.9:73198093:G:T	G	T	CLINICAL
NM_000021.4(PSEN1):c.487C>T (p.His163Tyr)	PSEN1	H163Y, H159Y	Normal	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Oct 1, 1995)	no assertion criteria provided	VCV000018130	14	73653567	14	73186859	18130	33169	rs63749885	NC_000014.9:73186858:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.626G>T (p.Gly209Val)	PSEN1	G209V, G205V	Normal	not provided|Pick disease|Acne inversa, familial, 3|Frontotemporal dementia|Alzheimer disease, type 3	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000098053	14	73659429	14	73192721	98053	103945	rs63750053	NC_000014.9:73192720:G:T	G	T	CLINICAL
NM_000021.4(PSEN1):c.791C>T (p.Pro264Leu)	PSEN1	P264L, P260L	Normal	Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|not provided|Mental deterioration|Dementia	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000098080	14	73664760	14	73198052	98080	103972	rs63750301	NC_000014.9:73198051:C:T	C	T	CLINICAL
NM_001170629.2(CHD8):c.6518C>A (p.Ser2173Ter)	CHD8	S1894*, S2173*	Normal	Autism, susceptibility to, 18	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000374261	14	21860919	14	21392760	374261	361211	rs781575717	NC_000014.9:21392759:G:T	G	T	CLINICAL
NM_001170629.2(CHD8):c.6295G>A (p.Glu2099Lys)	CHD8	E1820K, E2099K	Normal	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, single submitter	VCV000560286	14	21861659	14	21393500	560286	551314	rs1555313219	NC_000014.9:21393499:C:T	C	T	CLINICAL
NM_139318.5(KCNH5):c.980G>A (p.Arg327His)	KCNH5	R327H	Normal	Early infantile epileptic encephalopathy with suppression bursts|not provided	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000100784	14	63417240	14	62950522	100784	106649	rs587777164	NC_000014.9:62950521:C:T	C	T	CLINICAL
NM_003403.5(YY1):c.535A>T (p.Lys179Ter)	YY1	K179*	Normal	Gabriele de Vries syndrome	Pathogenic(Last reviewed: Jul 7, 2017)	no assertion criteria provided	VCV000430621	14	100706116	14	100239779	430621	423704	rs1131692046	NC_000014.9:100239778:A:T	A	T	CLINICAL
NM_003403.5(YY1):c.1030C>T (p.Gln344Ter)	YY1	Q344*	Normal	Gabriele de Vries syndrome	Pathogenic(Last reviewed: Jul 7, 2017)	no assertion criteria provided	VCV000430620	14	100742953	14	100276616	430620	423703	rs1131692045	NC_000014.9:100276615:C:T	C	T	CLINICAL
NM_003403.5(YY1):c.1138G>T (p.Asp380Tyr)	YY1	D380Y	Normal	Gabriele de Vries syndrome	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000430617	14	100743830	14	100277493	430617	423700	rs1131692043	NC_000014.9:100277492:G:T	G	T	CLINICAL
NM_001376.5(DYNC1H1):c.4234C>T (p.His1412Tyr)	DYNC1H1	H1412Y	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000813291	14	102467530	14	102001193	813291	801538	rs1595609005	NC_000014.9:102001192:C:T	C	T	CLINICAL
NM_001376.5(DYNC1H1):c.5884C>T (p.Arg1962Cys)	DYNC1H1	R1962C	Normal	not provided|DYNC1H1-related neurodevelopmental disorders	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000245597	14	102474581	14	102008244	245597	244873	rs879253881	NC_000014.9:102008243:C:T	C	T	CLINICAL
NM_000257.4(MYH7):c.1106G>A (p.Arg369Gln)	MYH7	R369Q	Normal	Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction|Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|not provided|Myosin storage myopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000042822	14	23899016	14	23429807	42822	51992	rs397516089	NC_000014.9:23429806:C:T	C	T	CLINICAL
NM_003403.5(YY1):c.1138G>T (p.Asp380Tyr)	YY1	D380Y	Normal	Gabriele de Vries syndrome	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000430617	14	100743830	14	100277493	430617	423700	rs1131692043	NC_000014.9:100277492:G:T	G	T	CLINICAL
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	R598C	Normal	not provided|Hereditary motor and sensory neuropathy|Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Inborn genetic diseases|Charcot-Marie-Tooth disease, axonal, type 2O|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Mental retardation, autosomal dominant 13	Pathogenic/Likely pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000139652	14	102452354	14	101986017	139652	143271	rs587780564	NC_000014.9:101986016:C:T	C	T	CLINICAL
NM_001376.5(DYNC1H1):c.3603G>T (p.Arg1201Ser)	DYNC1H1	R1201S	Normal	Mental retardation, autosomal dominant 13|Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Pathogenic(Last reviewed: Nov 24, 2014)	no assertion criteria provided	VCV000180211	14	102463410	14	101997073	180211	178391	rs727505393	NC_000014.9:101997072:G:T	G	T	CLINICAL
NM_001376.5(DYNC1H1):c.4234C>T (p.His1412Tyr)	DYNC1H1	H1412Y	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000813291	14	102467530	14	102001193	813291	801538	rs1595609005	NC_000014.9:102001192:C:T	C	T	CLINICAL
NM_001376.5(DYNC1H1):c.4700G>T (p.Arg1567Leu)	DYNC1H1	R1567L	Normal	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	VCV000216921	14	102469031	14	102002694	216921	213627	rs797044901	NC_000014.9:102002693:G:T	G	T	CLINICAL
NM_001376.5(DYNC1H1):c.6994C>T (p.Arg2332Cys)	DYNC1H1	R2332C	Normal	Global developmental delay|Microcephaly|Seizures|Delayed gross motor development|Delayed speech and language development|Charcot-Marie-Tooth disease, axonal, type 2O|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374190	14	102478787	14	102012450	374190	360957	rs1057518961	NC_000014.9:102012449:C:T	C	T	CLINICAL
NM_001376.5(DYNC1H1):c.9959C>T (p.Ala3320Val)	DYNC1H1	A3320V	Normal	Mental retardation, autosomal dominant 13|DYNC1H1-related disorders	Likely pathogenic(Last reviewed: Jun 28, 2016)	criteria provided, single submitter	VCV000434992	14	102498684	14	102032347	434992	429533	rs1555411305	NC_000014.9:102032346:C:T	C	T	CLINICAL
NM_001376.5(DYNC1H1):c.10008G>T (p.Lys3336Asn)	DYNC1H1	K3336N	Normal	Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000055853	14	102498733	14	102032396	55853	70507	rs397509410	NC_000014.9:102032395:G:T	G	T	CLINICAL
NM_001376.5(DYNC1H1):c.10172C>T (p.Pro3391Leu)	DYNC1H1	P3391L	Normal	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000438584	14	102499494	14	102033157	438584	432219	rs1555411378	NC_000014.9:102033156:C:T	C	T	CLINICAL
NM_001376.5(DYNC1H1):c.10573C>T (p.Arg3525Cys)	DYNC1H1	R3525C	Normal	not provided|Mental retardation, autosomal dominant 13	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000224130	14	102500472	14	102034135	224130	225860	rs869312693	NC_000014.9:102034134:C:T	C	T	CLINICAL
NM_005249.5(FOXG1):c.545C>T (p.Pro182Leu)	FOXG1	P182L	Normal	Severe intellectual deficiency	Likely pathogenic	no assertion criteria provided	VCV000205484	14	29237030	14	28767824	205484	202822	rs796052461	NC_000014.9:28767823:C:T	C	T	CLINICAL
NM_005249.5(FOXG1):c.755G>T (p.Gly252Val)	FOXG1	G252V	Normal	not provided|Rett syndrome, congenital variant|Intellectual disability	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158598	14	29237240	14	28768034	158598	169057	rs587783640	NC_000014.9:28768033:G:T	G	T	CLINICAL
NM_001128126.3(AP4S1):c.124C>T (p.Arg42Ter)	AP4S1	R42*	Normal	Spastic paraplegia 52, autosomal recessive|not provided	Pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030658	14	31535526	14	31066320	30658	39615	rs387906970	NC_000014.9:31066319:C:T	C	T	CLINICAL
NM_002408.4(MGAT2):c.91C>T (p.Gln31Ter)	MGAT2	Q31*	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617658	14	50088077	14	49621359	617658	609062	rs1310787426	NC_000014.9:49621358:C:T	C	T	CLINICAL
NM_002408.3(MGAT2):c.869C>T (p.Ser290Phe)	MGAT2	S290F	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000006989	14	50088855	14	49622137	6989	22028	rs104894446	NC_000014.9:49622136:C:T	C	T	CLINICAL
NM_002408.4(MGAT2):c.1120C>T (p.His374Tyr)	MGAT2	H374Y	Normal	Congenital disorder of glycosylation, type IIa	Pathogenic	no assertion criteria provided	VCV000617656	14	50089106	14	49622388	617656	609060	rs776531113	NC_000014.9:49622387:C:T	C	T	CLINICAL
NM_001127713.1(ATL1):c.1246C>T (p.Arg416Cys)	ATL1	R416C	Normal	Hereditary spastic paraplegia 3A	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000030582	14	51094875	14	50628157	30582	39539	rs387906941	NC_000014.9:50628156:C:T	C	T	CLINICAL
NM_000021.4(PSEN1):c.791C>T (p.Pro264Leu)	PSEN1	P264L, P260L	Normal	Pick disease|Acne inversa, familial, 3|Alzheimer disease, type 3|Frontotemporal dementia|not provided|Mental deterioration|Dementia	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000098080	14	73664760	14	73198052	98080	103972	rs63750301	NC_000014.9:73198051:C:T	C	T	CLINICAL
NM_013382.5(POMT2):c.2177G>A (p.Gly726Glu)	POMT2	G726E	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003222	14	77743795	14	77277452	3222	18261	rs267606969	NC_000014.9:77277451:C:T	C	T	CLINICAL
NM_013382.5(POMT2):c.1941G>A (p.Trp647Ter)	POMT2	W647*	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: Sep 18, 2007)	no assertion criteria provided	VCV000003223	14	77745163	14	77278820	3223	18262	rs267606963	NC_000014.9:77278819:C:T	C	T	CLINICAL
NM_013382.5(POMT2):c.1057G>A (p.Gly353Ser)	POMT2	G353S	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2021)	no assertion criteria provided	VCV000003231	14	77762566	14	77296223	3231	18270	rs267606970	NC_000014.9:77296222:C:T	C	T	CLINICAL
NM_013382.5(POMT2):c.1006+1G>A	POMT2		Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003219	14	77765031	14	77298688	3219	18258	rs533916138	NC_000014.9:77298687:C:T	C	T	CLINICAL
NM_013382.5(POMT2):c.737G>A (p.Gly246Asp)	POMT2	G246D	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000003228	14	77767512	14	77301169	3228	18267	rs267606966	NC_000014.9:77301168:C:T	C	T	CLINICAL
NM_013382.5(POMT2):c.648C>A (p.Cys216Ter)	POMT2	C216*	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2|Limb-girdle muscular dystrophy-dystroglycanopathy, type C2|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A2	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000538730	14	77769186	14	77302843	538730	528775	rs147871747	NC_000014.9:77302842:G:T	G	T	CLINICAL
NM_000369.5(TSHR):c.1430C>T (p.Thr477Ile)	TSHR	T477I	Normal	Hypothyroidism, congenital, nongoitrous, 1	Pathogenic(Last reviewed: Mar 1, 2000)	no assertion criteria provided	VCV000006455	14	81609832	14	81143488	6455	21494	rs121908881	NC_000014.9:81143487:C:T	C	T	CLINICAL
NM_000153.4(GALC):c.850G>A (p.Gly284Ser)	GALC	G284S, G258S, G261S	Normal	Status epilepticus|EMG: axonal abnormality|Developmental regression|Amblyopia|Strabismus|EEG abnormality|Hemiparesis|Intrauterine growth retardation|Nystagmus|Progressive visual loss|Loss of ability to walk|Neonatal hypoglycemia|Dysmyelinating leukodystrophy|Global developmental delay|Leukodystrophy|Breech presentation|Small for gestational age|EMG abnormality|Seizures|Galactosylceramide beta-galactosidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374024	14	88434737	14	87968393	374024	360963	rs377274761	NC_000014.9:87968392:C:T	C	T	CLINICAL
NM_000153.4(GALC):c.196G>A (p.Ala66Thr)	GALC	A66T, A40T	Normal	EMG abnormality|Dysmyelinating leukodystrophy|Hemiparesis|Progressive visual loss|Loss of ability to walk|Leukodystrophy|EMG: axonal abnormality|Intrauterine growth retardation|Nystagmus|Global developmental delay|EEG abnormality|Breech presentation|Seizures|Neonatal hypoglycemia|Developmental regression|Status epilepticus|Amblyopia|Strabismus|Small for gestational age|Galactosylceramide beta-galactosidase deficiency	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374023	14	88454867	14	87988523	374023	360964	rs1057518843	NC_000014.9:87988522:C:T	C	T	CLINICAL
NM_024824.5(ZC3H14):c.460C>T (p.Arg154Ter)	ZC3H14	R154*, R120*	Normal	Mental retardation, autosomal recessive 56	Pathogenic(Last reviewed: Sep 20, 2016)	no assertion criteria provided	VCV000254278	14	89038950	14	88572606	254278	248811	rs886037950	NC_000014.9:88572605:C:T	C	T	CLINICAL
NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)	SERPINA1	E366K	Normal	FRAXE|Chronic obstructive pulmonary disease|Alpha-1-antitrypsin deficiency|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|Inborn genetic diseases|not provided|PI Z(AUGSBURG)|PI Z(TUN)|PI Z	Pathogenic, risk factor(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017967	14	94844947	14	94378610	17967	33006	rs28929474	NC_000014.9:94378609:C:T	C	T	CLINICAL
NM_000257.4(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	A797T	Normal	Primary familial dilated cardiomyopathy|Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|not provided|Familial hypertrophic cardiomyopathy 1|Severe combined immunodeficiency disease|Immunodeficiency|Abnormality of T cell physiology|Lymphopenia|Abnormality of cellular immune system|Combined T and B cell immunodeficiency|Cardiovascular phenotype|Myopathy, myosin storage, autosomal recessive|Dilated cardiomyopathy 1S|Familial hypertrophic cardiomyopathy 1|Congenital myopathy with fiber type disproportion|MYH7-related late-onset scapuloperoneal muscular dystrophy|Myopathy, distal, 1|Myosin storage myopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042901	14	23894525	14	23425316	42901	52071	rs3218716	NC_000014.9:23425315:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.1621C>T (p.Gln541Ter)	SPG11	Q541*	Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235891	15	44925817	15	44633619	235891	237526	rs765061840	NC_000015.10:44633618:G:A	G	A	CLINICAL
NM_001018005.2(TPM1):c.574G>A (p.Glu192Lys)	TPM1	E192K, E156K, E234K	Normal	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction 9	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000031882	15	63353922	15	63061723	31882	40542	rs199476315	NC_000015.10:63061722:G:A	G	A	CLINICAL
NM_019066.5(MAGEL2):c.3124C>T (p.Gln1042Ter)	MAGEL2	Q1042*	Normal	not provided|Schaaf-Yang syndrome	Pathogenic(Last reviewed: May 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000089003	15	23889766	15	23644619	89003	94557	rs398122418	NC_000015.10:23644618:G:A	G	A	CLINICAL
NM_000138.5(FBN1):c.4786C>T (p.Arg1596Ter)	FBN1	R1596*	Normal	Familial thoracic aortic aneurysm and aortic dissection|not provided|Marfan syndrome|Weill-Marchesani syndrome 2|Geleophysic dysplasia 2|Stiff skin syndrome|MASS syndrome|Marfan lipodystrophy syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|Acromicric dysplasia|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036082	15	48758017	15	48465820	36082	44746	rs113871094	NC_000015.10:48465819:G:A	G	A	CLINICAL
NM_016194.4(GNB5):c.368C>T (p.Ser123Leu)	GNB5	S81L, S123L, S29L	Normal	not provided|Intellectual developmental disorder with cardiac arrhythmia|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia|Attention deficit hyperactivity disorder|Global developmental delay|Delayed speech and language development|Intellectual developmental disorder with cardiac arrhythmia|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254029	15	52446144	15	52153947	254029	248477	rs761399728	NC_000015.10:52153946:G:A	G	A	CLINICAL
NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	D67N	Normal	Cardiofaciocutaneous syndrome 3|Autism spectrum disorder|Non-small cell lung cancer|not provided|Rasopathy|Melanoma|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|MAP2K1-related RASopathy	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000040781	15	66727483	15	66435145	40781	49251	rs727504317	NC_000015.10:66435144:G:A	G	A	CLINICAL
NM_001271.4(CHD2):c.1053G>A (p.Trp351Ter)	CHD2	W351*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000541367	15	93487645	15	92944415	541367	529224	rs1555439714	NC_000015.10:92944414:G:A	G	A	CLINICAL
NM_001271.4(CHD2):c.1719G>A (p.Thr573=)	CHD2		Normal	Developmental and epileptic encephalopathy 94|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374747	15	93496803	15	92953573	374747	361633	rs1057519228	NC_000015.10:92953572:G:A	G	A	CLINICAL
NM_001271.4(CHD2):c.1809+1G>A	CHD2		Normal	Developmental and epileptic encephalopathy 94|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379377	15	93498743	15	92955513	379377	374913	rs1057520592	NC_000015.10:92955512:G:A	G	A	CLINICAL
NM_001271.4(CHD2):c.4971G>A (p.Trp1657Ter)	CHD2	W1657*	Normal	Inborn genetic diseases|not provided|Developmental and epileptic encephalopathy 94	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092095	15	93563306	15	93020076	92095	97526	rs398122998	NC_000015.10:93020075:G:A	G	A	CLINICAL
NM_033028.5(BBS4):c.626G>A (p.Gly209Glu)	BBS4	G209E, G37E	Normal	Bardet-Biedl syndrome	Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000662070	15	73020319	15	72727978	662070	643521	rs372822977	NC_000015.10:72727977:G:A	G	A	CLINICAL
NM_033028.5(BBS4):c.424G>A (p.Gly142Arg)	BBS4	G142R	Normal	Bardet-Biedl syndrome	Likely pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000812226	15	73015153	15	72722812	812226	800594	rs1595935759	NC_000015.10:72722811:G:A	G	A	CLINICAL
NM_033028.5(BBS4):c.513T>A (p.Tyr171Ter)	BBS4	Y171*	Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000412296	15	73016922	15	72724581	412296	400329	rs367882912	NC_000015.10:72724580:T:A	T	A	CLINICAL
NM_033028.5(BBS4):c.960T>A (p.Tyr320Ter)	BBS4	Y320*, Y297*, Y148*	Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000531832	15	73023991	15	72731650	531832	529619	rs770891152	NC_000015.10:72731649:T:A	T	A	CLINICAL
NM_002666.5(PLIN1):c.1210-1G>T	PLIN1		Normal	Familial partial lipodystrophy 4	Pathogenic(Last reviewed: Feb 24, 2011)	no assertion criteria provided	VCV000029827	15	90209174	15	89665943	29827	38782	rs1567075176	NC_000015.10:89665942:C:A	C	A	CLINICAL
NM_033028.5(BBS4):c.638T>A (p.Leu213Ter)	BBS4	L213*, L41*	Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000412298	15	73020331	15	72727990	412298	400330	rs1060503692	NC_000015.10:72727989:T:A	T	A	CLINICAL
NM_000138.4(FBN1):c.871G>T (p.Glu291Ter)	FBN1	E291*	Normal	Marfan syndrome	Pathogenic(Last reviewed: May 30, 2016)	criteria provided, single submitter	VCV000453293	15	48818444	15	48526247	453293	446890	rs1232880706	NC_000015.10:48526246:C:A	C	A	CLINICAL
NM_033028.5(BBS4):c.1106+2T>A	BBS4		Normal	not provided|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280217	15	73027525	15	72735184	280217	264628	rs886041464	NC_000015.10:72735183:T:A	T	A	CLINICAL
NM_000138.5(FBN1):c.6658C>T (p.Arg2220Ter)	FBN1	R2220*	Normal	Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|not specified|not provided|Inborn genetic diseases|Isolated thoracic aortic aneurysm|Marfan syndrome|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042407	15	48725144	15	48432947	42407	51577	rs113001196	NC_000015.10:48432946:G:A	G	A	CLINICAL
NM_014918.5(CHSY1):c.205C>T (p.Gln69Ter)	CHSY1	Q69*	Normal	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030712	15	101791457	15	101251252	30712	39669	rs387906984	NC_000015.10:101251251:G:A	G	A	CLINICAL
NM_019066.5(MAGEL2):c.1912C>T (p.Gln638Ter)	MAGEL2	Q638*	Normal	Inborn genetic diseases|Prader-Willi syndrome|Schaaf-Yang syndrome|Schaaf-Yang syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208684	15	23890978	15	23645831	208684	205286	rs797044883	NC_000015.10:23645830:G:A	G	A	CLINICAL
NM_130839.5(UBE3A):c.826C>T (p.Arg276Ter)	UBE3A|SNHG14	R276*, R217*, R279*, R256*	Normal	Angelman syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803059	15	25616495	15	25371348	803059	791436	rs997044541	NC_000015.10:25371347:G:A	G	A	CLINICAL
NM_004667.6(HERC2):c.4126C>T (p.Arg1376Ter)	HERC2	R1376*	Normal	Mental retardation, autosomal recessive 38	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803061	15	28479308	15	28234162	803061	791438	rs575492335	NC_000015.10:28234161:G:A	G	A	CLINICAL
NM_004667.5(HERC2):c.1781C>T (p.Pro594Leu)	HERC2	P594L	Normal	Mental retardation, autosomal recessive 38	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000088738	15	28510853	15	28265707	88738	94315	rs397518474	NC_000015.10:28265706:G:A	G	A	CLINICAL
NM_004667.6(HERC2):c.1442C>T (p.Thr481Met)	HERC2	T481M	Normal	Mental retardation, autosomal recessive 38	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803062	15	28514398	15	28269252	803062	791439	rs200457382	NC_000015.10:28269251:G:A	G	A	CLINICAL
NM_005313.5(PDIA3):c.170G>A (p.Cys57Tyr)	PDIA3	C57Y	Normal	Intellectual disability	Likely pathogenic	no assertion criteria provided	VCV000492933	15	44046024	15	43753826	492933	485864	rs1555455456	NC_000015.10:43753825:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6925C>T (p.Gln2309Ter)	SPG11	Q2196*, Q2309*	Normal	Spastic paraplegia 11, autosomal recessive	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800512	15	44858126	15	44565928	800512	789129	rs1595817021	NC_000015.10:44565927:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6856C>T (p.Arg2286Ter)	SPG11	R2286*, R2173*	Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000041353	15	44858195	15	44565997	41353	49777	rs312262785	NC_000015.10:44565996:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6724C>T (p.Gln2242Ter)	SPG11	Q2242*, Q2129*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000652217	15	44859652	15	44567454	652217	643199	rs866400911	NC_000015.10:44567453:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6598A>T (p.Lys2200Ter)	SPG11	K2200*, K2087*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000572602	15	44859778	15	44567580	572602	573246	rs141263564	NC_000015.10:44567579:T:A	T	A	CLINICAL
NM_025137.4(SPG11):c.6586-1G>T	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Likely pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000406523	15	44859791	15	44567593	406523	400583	rs1060501174	NC_000015.10:44567592:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.6418C>T (p.Gln2140Ter)	SPG11	Q2140*, Q2027*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000568554	15	44862782	15	44570584	568554	573256	rs1567129475	NC_000015.10:44570583:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6409C>T (p.Arg2137Ter)	SPG11	R2137*, R2024*	Normal	not provided|Spastic paraplegia 11, autosomal recessive	Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620391	15	44862791	15	44570593	620391	611795	rs769898852	NC_000015.10:44570592:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6343+1G>T	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000534874	15	44864880	15	44572682	534874	529325	rs1555447432	NC_000015.10:44572681:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.6151G>T (p.Glu2051Ter)	SPG11	E2051*	Normal	Spastic paraplegia 11, autosomal recessive	Likely pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000545442	15	44865799	15	44573601	545442	535706	rs771057519	NC_000015.10:44573600:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.6100C>T (p.Arg2034Ter)	SPG11	R2034*	Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Jun 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001109	15	44865850	15	44573652	1109	16148	rs118203963	NC_000015.10:44573651:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.6091C>T (p.Arg2031Ter)	SPG11	R2031*	Normal	not provided|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041340	15	44865859	15	44573661	41340	49764	rs147713329	NC_000015.10:44573660:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.5977C>T (p.Gln1993Ter)	SPG11	Q1993*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041334	15	44867129	15	44574931	41334	49758	rs312262774	NC_000015.10:44574930:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.5974C>T (p.Arg1992Ter)	SPG11	R1992*	Normal	Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5|not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000041333	15	44867132	15	44574934	41333	49757	rs200793464	NC_000015.10:44574933:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.5867-1G>T	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 25, 2016)	criteria provided, single submitter	VCV000406505	15	44867240	15	44575042	406505	400263	rs1060501168	NC_000015.10:44575041:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.5623C>T (p.Gln1875Ter)	SPG11	Q1875*	Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001116	15	44876255	15	44584057	1116	16155	rs141848292	NC_000015.10:44584056:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.5470C>T (p.Arg1824Ter)	SPG11	R1824*	Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041324	15	44876408	15	44584210	41324	49748	rs312262767	NC_000015.10:44584209:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.5158C>T (p.Gln1720Ter)	SPG11	Q1720*	Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000406517	15	44876720	15	44584522	406517	400601	rs1060501173	NC_000015.10:44584521:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.4888G>T (p.Glu1630Ter)	SPG11	E1630*	Normal	Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561117	15	44881468	15	44589270	561117	552182	rs368276916	NC_000015.10:44589269:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.4846C>T (p.Gln1616Ter)	SPG11	Q1616*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041319	15	44881510	15	44589312	41319	49743	rs312262762	NC_000015.10:44589311:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.4591C>T (p.Gln1531Ter)	SPG11	Q1531*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000466532	15	44887501	15	44595303	466532	465093	rs1362530862	NC_000015.10:44595302:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.3785G>T (p.Gly1262Val)	SPG11	G1262V	Normal	Spastic paraplegia 11, autosomal recessive|Generalized hyperreflexia|Spastic paraparesis|Gait disturbance|Difficulty walking	Likely pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000374071	15	44890936	15	44598738	374071	360971	rs1057518874	NC_000015.10:44598737:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.3291+1G>T	SPG11		Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000041304	15	44903037	15	44610839	41304	49728	rs312262753	NC_000015.10:44610838:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.3121C>T (p.Arg1041Ter)	SPG11	R1041*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 22, 2019)	criteria provided, single submitter	VCV000639667	15	44905652	15	44613454	639667	643245	rs771813705	NC_000015.10:44613453:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.2857G>T (p.Glu953Ter)	SPG11	E953*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000534853	15	44907742	15	44615544	534853	529235	rs372906057	NC_000015.10:44615543:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.2834+1G>T	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041299	15	44912387	15	44620189	41299	49723	rs312262749	NC_000015.10:44620188:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.2737C>T (p.Gln913Ter)	SPG11	Q913*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Apr 17, 2017)	criteria provided, single submitter	VCV000466515	15	44912485	15	44620287	466515	464801	rs1555455246	NC_000015.10:44620286:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.2444G>T (p.Arg815Met)	SPG11	R815M	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041291	15	44914418	15	44622220	41291	49715	rs312262742	NC_000015.10:44622219:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.2146C>T (p.Gln716Ter)	SPG11	Q716*	Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041285	15	44918627	15	44626429	41285	49709	rs312262737	NC_000015.10:44626428:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.1951C>T (p.Arg651Ter)	SPG11	R651*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041284	15	44920983	15	44628785	41284	49708	rs199588440	NC_000015.10:44628784:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.1621C>T (p.Gln541Ter)	SPG11	Q541*	Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235891	15	44925817	15	44633619	235891	237526	rs765061840	NC_000015.10:44633618:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.1492C>T (p.Gln498Ter)	SPG11	Q498*	Normal	not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000041399	15	44941174	15	44648976	41399	49823	rs312262728	NC_000015.10:44648975:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.1282A>T (p.Lys428Ter)	SPG11	K428*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041270	15	44943863	15	44651665	41270	49694	rs312262724	NC_000015.10:44651664:T:A	T	A	CLINICAL
NM_025137.4(SPG11):c.925G>T (p.Gly309Ter)	SPG11	G309*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000665852	15	44944409	15	44652211	665852	643269	rs760659950	NC_000015.10:44652210:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.796C>T (p.Gln266Ter)	SPG11	Q266*	Normal	not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432638	15	44949366	15	44657168	432638	426099	rs1234882277	NC_000015.10:44657167:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.592C>T (p.Gln198Ter)	SPG11	Q198*	Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000218143	15	44951352	15	44659154	218143	214791	rs863225440	NC_000015.10:44659153:G:A	G	A	CLINICAL
NM_025137.4(SPG11):c.349G>T (p.Glu117Ter)	SPG11	E117*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000041306	15	44952723	15	44660525	41306	49730	rs312262711	NC_000015.10:44660524:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.334G>T (p.Glu112Ter)	SPG11	E112*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803076	15	44952738	15	44660540	803076	791453	rs1595940058	NC_000015.10:44660539:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.268G>T (p.Glu90Ter)	SPG11	E90*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041295	15	44952804	15	44660606	41295	49719	rs312262710	NC_000015.10:44660605:C:A	C	A	CLINICAL
NM_025137.4(SPG11):c.118C>T (p.Gln40Ter)	SPG11	Q40*	Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Nov 10, 2015)	no assertion criteria provided	VCV000001111	15	44955728	15	44663530	1111	16150	rs267607084	NC_000015.10:44663529:G:A	G	A	CLINICAL
NM_016194.4(GNB5):c.368C>T (p.Ser123Leu)	GNB5	S81L, S123L, S29L	Normal	not provided|Intellectual developmental disorder with cardiac arrhythmia|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia|Attention deficit hyperactivity disorder|Global developmental delay|Delayed speech and language development|Intellectual developmental disorder with cardiac arrhythmia|Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254029	15	52446144	15	52153947	254029	248477	rs761399728	NC_000015.10:52153946:G:A	G	A	CLINICAL
NM_000259.3(MYO5A):c.2332C>T (p.Arg778Ter)	MYO5A	R778*	Normal	Griscelli syndrome type 1	Pathogenic(Last reviewed: Aug 1, 2002)	no assertion criteria provided	VCV000014069	15	52668632	15	52376435	14069	29108	rs764371254	NC_000015.10:52376434:G:A	G	A	CLINICAL
NM_139242.4(MTFMT):c.626C>T (p.Ser209Leu)	MTFMT	S209L	Normal	Combined oxidative phosphorylation deficiency 15|Mitochondrial complex 1 deficiency, nuclear type 27|Leigh syndrome|Decreased activity of mitochondrial complex I|Abnormal facial shape|Inability to walk by childhood/adolescence|Poor speech|Short stature|Cytochrome C oxidase-negative muscle fibers|not provided	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039827	15	65313871	15	65021533	39827	48426	rs201431517	NC_000015.10:65021532:G:A	G	A	CLINICAL
NM_022369.4(STRA6):c.1931C>T (p.Thr644Met)	STRA6	T644M, T681M, T683M, T659M, T635M	Normal	Matthew-Wood syndrome	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001136	15	74472494	15	74180153	1136	16175	rs118203960	NC_000015.10:74180152:G:A	G	A	CLINICAL
NM_022369.4(STRA6):c.878C>T (p.Pro293Leu)	STRA6	P293L, P330L, P332L, P308L, P284L	Normal	Matthew-Wood syndrome	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001133	15	74483230	15	74190889	1133	16172	rs118203958	NC_000015.10:74190888:G:A	G	A	CLINICAL
NM_022369.4(STRA6):c.269C>T (p.Pro90Leu)	STRA6	P90L, P105L, P127L, P129L	Normal	Matthew-Wood syndrome	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001137	15	74488486	15	74196145	1137	16176	rs118203961	NC_000015.10:74196144:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.2T>A (p.Met1Lys)	FAH	M1K	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000371005	15	80445398	15	80153056	371005	358325	rs1057516934	NC_000015.10:80153055:T:A	T	A	CLINICAL
NM_000137.3(FAH):c.82-1G>A	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000551853	15	80450401	15	80158059	551853	547861	rs1247460110	NC_000015.10:80158058:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.314+1G>A	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000370334	15	80452220	15	80159878	370334	358328	rs1057516408	NC_000015.10:80159877:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.401C>A (p.Ala134Asp)	FAH	A134D	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000011866	15	80454624	15	80162282	11866	26905	rs121965074	NC_000015.10:80162281:C:A	C	A	CLINICAL
NM_000137.3(FAH):c.455G>A (p.Trp152Ter)	FAH	W152*	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000370677	15	80454678	15	80162336	370677	358330	rs1057516679	NC_000015.10:80162335:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.456G>A (p.Trp152Ter)	FAH	W152*	Normal	not provided|Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092445	15	80460394	15	80168052	92445	98354	rs370686447	NC_000015.10:80168051:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.607-1G>A	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	VCV000188755	15	80464490	15	80172148	188755	186944	rs771712041	NC_000015.10:80172147:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.707-1G>A	FAH		Normal	Tyrosinemia type I	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558607	15	80465355	15	80173013	558607	548270	rs149052294	NC_000015.10:80173012:G:A	G	A	CLINICAL
NM_000137.4(FAH):c.726G>A (p.Trp242Ter)	FAH	W242*	Normal	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000813490	15	80465375	15	80173033	813490	801725	rs1567118987	NC_000015.10:80173032:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.786G>A (p.Trp262Ter)	FAH	W262*	Normal	Tyrosinemia type I	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011873	15	80465435	15	80173093	11873	26912	rs80338899	NC_000015.10:80173092:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.960+1G>A	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	VCV000371348	15	80469926	15	80177584	371348	358336	rs1057517201	NC_000015.10:80177583:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.963C>A (p.Tyr321Ter)	FAH	Y321*	Normal	not provided|Tyrosinemia type I	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000291075	15	80472468	15	80180126	291075	275312	rs886044640	NC_000015.10:80180125:C:A	C	A	CLINICAL
NM_000137.3(FAH):c.1009G>A (p.Gly337Ser)	FAH	G337S	Normal	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011869	15	80472514	15	80180172	11869	26908	rs80338900	NC_000015.10:80180171:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.1027G>A (p.Gly343Arg)	FAH	G343R	Normal	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558592	15	80472532	15	80180190	558592	547616	rs970505762	NC_000015.10:80180189:G:A	G	A	CLINICAL
NM_000137.4(FAH):c.1062+5G>A	FAH		Normal	Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011870	15	80472572	15	80180230	11870	26909	rs80338901	NC_000015.10:80180229:G:A	G	A	CLINICAL
NM_000137.4(FAH):c.1180+1G>A	FAH		Normal	Tyrosinemia type I	Pathogenic	criteria provided, single submitter	VCV000813493	15	80473502	15	80181160	813493	801728	rs980415517	NC_000015.10:80181159:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.1181-1G>A	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Dec 28, 2015)	criteria provided, single submitter	VCV000370230	15	80478471	15	80186129	370230	358337	rs1057516333	NC_000015.10:80186128:G:A	G	A	CLINICAL
NM_000137.3(FAH):c.1210G>A (p.Gly404Ser)	FAH	G404S	Normal	Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000459903	15	80478501	15	80186159	459903	465319	rs1297118863	NC_000015.10:80186158:G:A	G	A	CLINICAL
NM_032856.5(WDR73):c.1039C>T (p.His347Tyr)	WDR73	H347Y	Normal	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Jun 29, 2015)	no assertion criteria provided	VCV000208467	15	85186799	15	84643568	208467	204988	rs754099015	NC_000015.10:84643567:G:A	G	A	CLINICAL
NM_032856.5(WDR73):c.940C>T (p.Gln314Ter)	WDR73	Q314*	Normal	Galloway-Mowat syndrome 1|not provided	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV000208469	15	85186898	15	84643667	208469	204990	rs797044994	NC_000015.10:84643666:G:A	G	A	CLINICAL
NM_032856.5(WDR73):c.703C>T (p.Gln235Ter)	WDR73	Q235*	Normal	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Jun 1, 2015)	no assertion criteria provided	VCV000208465	15	85188882	15	84645651	208465	204986	rs797044992	NC_000015.10:84645650:G:A	G	A	CLINICAL
NM_001126131.2(POLG):c.3218C>T (p.Pro1073Leu)	POLG	P1073L	Normal	Mitochondrial DNA depletion syndrome 4B, MNGIE type|Progressive sclerosing poliodystrophy|not provided	Pathogenic(Last reviewed: Apr 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013516	15	89862217	15	89318986	13516	28555	rs267606959	NC_000015.10:89318985:G:A	G	A	CLINICAL
NM_198525.3(KIF7):c.3331C>T (p.Arg1111Ter)	KIF7	R1111*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217670	15	90172792	15	89629561	217670	214348	rs778139192	NC_000015.10:89629560:G:A	G	A	CLINICAL
NM_198525.3(KIF7):c.3001C>T (p.Gln1001Ter)	KIF7	Q1001*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000030897	15	90174836	15	89631605	30897	39854	rs387907045	NC_000015.10:89631604:G:A	G	A	CLINICAL
NM_198525.3(KIF7):c.2944G>T (p.Glu982Ter)	KIF7	E982*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: Feb 23, 2015)	criteria provided, multiple submitters, no conflicts	VCV000208593	15	90174893	15	89631662	208593	205178	rs797045093	NC_000015.10:89631661:C:A	C	A	CLINICAL
NM_198525.3(KIF7):c.2917C>T (p.Arg973Ter)	KIF7	R973*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217671	15	90174920	15	89631689	217671	214349	rs202229910	NC_000015.10:89631688:G:A	G	A	CLINICAL
NM_198525.3(KIF7):c.2164G>T (p.Glu722Ter)	KIF7	E722*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000427891	15	90188271	15	89645040	427891	418969	rs1555424505	NC_000015.10:89645039:C:A	C	A	CLINICAL
NM_198525.3(KIF7):c.460C>T (p.Arg154Ter)	KIF7	R154*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000030896	15	90193041	15	89649810	30896	39853	rs387907044	NC_000015.10:89649809:G:A	G	A	CLINICAL
NM_198525.3(KIF7):c.157C>T (p.Arg53Ter)	KIF7	R53*	Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000463142	15	90196005	15	89652774	463142	465405	rs569323391	NC_000015.10:89652773:G:A	G	A	CLINICAL
NM_198525.3(KIF7):c.67C>T (p.Arg23Ter)	KIF7	R23*	Normal	Acrocallosal syndrome|Macrocephaly with multiple epiphyseal dysplasia and distinctive facies	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587434	15	90196095	15	89652864	587434	578521	rs1235928535	NC_000015.10:89652863:G:A	G	A	CLINICAL
NM_020821.3(VPS13C):c.9568G>T (p.Glu3190Ter)	VPS13C	E3190*, E3147*	Normal	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222069	15	62174851	15	61882652	222069	223765	rs869312810	NC_000015.10:61882651:C:A	C	A	CLINICAL
NM_000138.5(FBN1):c.3392A>G (p.Asn1131Ser)	FBN1	N1131S	Normal	Marfan syndrome	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000042332	15	48779580	15	48487383	42332	51502	rs397515790	NC_000015.10:48487382:T:C	T	C	CLINICAL
NM_001110.4(ADAM10):c.541A>G (p.Arg181Gly)	ADAM10	R181G	Normal	Alzheimer disease 18	risk factor(Last reviewed: Oct 16, 2013)	no assertion criteria provided	VCV000092164	15	58957340	15	58665141	92164	97567	rs145518263	NC_000015.10:58665140:T:C	T	C	CLINICAL
NM_001271.4(CHD2):c.692+1G>C	CHD2		Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000474397	15	93482949	15	92939719	474397	465502	rs1555439036	NC_000015.10:92939718:G:C	G	C	CLINICAL
NM_001271.4(CHD2):c.1810-2A>C	CHD2		Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000092096	15	93499687	15	92956457	92096	97527	rs398122999	NC_000015.10:92956456:A:C	A	C	CLINICAL
NM_001271.4(CHD2):c.2432T>C (p.Leu811Pro)	CHD2	L811P	Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV000646181	15	93515574	15	92972344	646181	643736	rs1596419511	NC_000015.10:92972343:T:C	T	C	CLINICAL
NM_000693.4(ALDH1A3):c.1514T>C (p.Ile505Thr)	ALDH1A3|ALDH1A3-AS1	I505T, I398T	Normal	Autistic disorder of childhood onset	Likely pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000212709	15	101454953	15	100914748	212709	209324	rs797046134	NC_000015.10:100914747:T:C	T	C	CLINICAL
NM_207037.2(TCF12):c.1035+3G>C	TCF12		Normal	Craniosynostosis 3	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000055916	15	57526308	15	57234110	55916	70558	rs886037640	NC_000015.10:57234109:G:C	G	C	CLINICAL
NM_033028.5(BBS4):c.220+1G>C	BBS4		Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 10, 2016)	criteria provided, single submitter	VCV000021729	15	73004649	15	72712308	21729	34581	rs113994190	NC_000015.10:72712307:G:C	G	C	CLINICAL
NM_033028.5(BBS4):c.884G>C (p.Arg295Pro)	BBS4	R295P, R123P, R272P	Normal	Bardet-Biedl syndrome|Bardet-Biedl syndrome 4	Pathogenic(Last reviewed: Jun 23, 2019)	no assertion criteria provided	VCV000009145	15	73023915	15	72731574	9145	24184	rs121434632	NC_000015.10:72731573:G:C	G	C	CLINICAL
NM_033028.5(BBS4):c.406-2A>C	BBS4		Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Oct 13, 2009)	no assertion criteria provided	VCV000021730	15	73015133	15	72722792	21730	34582	rs113994191	NC_000015.10:72722791:A:C	A	C	CLINICAL
NM_000057.4(BLM):c.3164G>C (p.Cys1055Ser)	BLM	C1055S, C680S	Normal	Bloom syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042078	15	91337541	15	90794311	42078	51244	rs367543029	NC_000015.10:90794310:G:C	G	C	CLINICAL
NM_001040616.3(LINS1):c.1178T>G (p.Leu393Ter)	LINS1	L393*, L144*, L378*	Normal	Mental retardation, autosomal recessive 27|not provided	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280510	15	101113900	15	100573695	280510	264545	rs149644940	NC_000015.10:100573694:A:C	A	C	CLINICAL
NM_014918.5(CHSY1):c.1616C>G (p.Pro539Arg)	CHSY1	P539R	Normal	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030714	15	101718386	15	101178181	30714	39671	rs387906985	NC_000015.10:101178180:G:C	G	C	CLINICAL
NM_014918.5(CHSY1):c.321-3C>G	CHSY1		Normal	Temtamy preaxial brachydactyly syndrome	Pathogenic(Last reviewed: Dec 10, 2010)	no assertion criteria provided	VCV000030713	15	101775785	15	101235580	30713	39670	rs1567106459	NC_000015.10:101235579:G:C	G	C	CLINICAL
NM_170675.5(MEIS2):c.611C>G (p.Ser204Ter)	MEIS2	S204*, S191*, S116*	Normal	Cleft palate, cardiac defects, and mental retardation	Pathogenic(Last reviewed: Aug 26, 2019)	no assertion criteria provided	VCV000427215	15	37385810	15	37093609	427215	415884	rs749346955	NC_000015.10:37093608:G:C	G	C	CLINICAL
NM_025137.4(SPG11):c.6477+4A>G	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041345	15	44862719	15	44570521	41345	49769	rs312262780	NC_000015.10:44570520:T:C	T	C	CLINICAL
NM_025137.4(SPG11):c.5970C>G (p.Tyr1990Ter)	SPG11	Y1990*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041332	15	44867136	15	44574938	41332	49756	rs312262773	NC_000015.10:44574937:G:C	G	C	CLINICAL
NM_025137.4(SPG11):c.5870C>G (p.Ser1957Ter)	SPG11	S1957*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041330	15	44867236	15	44575038	41330	49754	rs312262772	NC_000015.10:44575037:G:C	G	C	CLINICAL
NM_025137.4(SPG11):c.4435-2A>G	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000664569	15	44887659	15	44595461	664569	652740	rs1555450825	NC_000015.10:44595460:T:C	T	C	CLINICAL
NM_025137.4(SPG11):c.2833A>G (p.Arg945Gly)	SPG11	R945G	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000041298	15	44912389	15	44620191	41298	49722	rs312262748	NC_000015.10:44620190:T:C	T	C	CLINICAL
NM_025137.4(SPG11):c.2608A>G (p.Ile870Val)	SPG11	I870V	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041293	15	44913969	15	44621771	41293	49717	rs312262745	NC_000015.10:44621770:T:C	T	C	CLINICAL
NM_025137.4(SPG11):c.2198T>G (p.Leu733Ter)	SPG11	L733*	Normal	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041287	15	44918575	15	44626377	41287	49711	rs312262739	NC_000015.10:44626376:A:C	A	C	CLINICAL
NM_025137.4(SPG11):c.1679C>G (p.Ser560Ter)	SPG11	S560*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041279	15	44925759	15	44633561	41279	49703	rs312262732	NC_000015.10:44633560:G:C	G	C	CLINICAL
NM_025137.4(SPG11):c.1457-2A>G	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041272	15	44941211	15	44649013	41272	49696	rs312262726	NC_000015.10:44649012:T:C	T	C	CLINICAL
NM_025137.4(SPG11):c.1235C>G (p.Ser412Ter)	SPG11	S412*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041269	15	44943910	15	44651712	41269	49693	rs312262723	NC_000015.10:44651711:G:C	G	C	CLINICAL
NM_000259.3(MYO5A):c.4200C>G (p.Ser1400Arg)	MYO5A	S1400R, S1373R	Normal	Dystonia|Global developmental delay|Cerebellar cortical atrophy|Seizures|Nystagmus	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242881	15	52632432	15	52340235	242881	243993	rs1114167290	NC_000015.10:52340234:G:C	G	C	CLINICAL
NM_032808.7(LINGO1):c.863A>G (p.Tyr288Cys)	LINGO1	Y288C, Y282C	Normal	Intellectual disability, autosomal recessive 64	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000560184	15	77907386	15	77615044	560184	551235	rs750612085	NC_000015.10:77615043:T:C	T	C	CLINICAL
NM_000137.3(FAH):c.81+2T>C	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000370962	15	80445479	15	80153137	370962	358327	rs772895065	NC_000015.10:80153136:T:C	T	C	CLINICAL
NM_000137.4(FAH):c.880A>C (p.Thr294Pro)	FAH	T294P	Normal	Tyrosinemia type I	Likely pathogenic	criteria provided, single submitter	VCV000813491	15	80467400	15	80175058	813491	801726	rs370634385	NC_000015.10:80175057:A:C	A	C	CLINICAL
NM_000137.3(FAH):c.961-2A>C	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000557017	15	80472464	15	80180122	557017	548275	rs1555442289	NC_000015.10:80180121:A:C	A	C	CLINICAL
NM_000137.3(FAH):c.1258T>C (p.Ter420Arg)	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Nov 4, 2016)	criteria provided, single submitter	VCV000371623	15	80478549	15	80186207	371623	358338	rs1057516631	NC_000015.10:80186206:T:C	T	C	CLINICAL
NM_032856.5(WDR73):c.129T>G (p.Tyr43Ter)	WDR73	Y43*	Normal	Galloway-Mowat syndrome 1	Pathogenic(Last reviewed: Dec 4, 2014)	no assertion criteria provided	VCV000162610	15	85196014	15	84652783	162610	172286	rs727502863	NC_000015.10:84652782:A:C	A	C	CLINICAL
NM_198525.3(KIF7):c.3281C>G (p.Ser1094Ter)	KIF7	S1094*	Normal	Acrocallosal syndrome|not provided	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000451951	15	90173555	15	89630324	451951	445466	rs1555423165	NC_000015.10:89630323:G:C	G	C	CLINICAL
NM_198525.3(KIF7):c.2593-3C>G	KIF7		Normal	Acrocallosal syndrome	Pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000427889	15	90176500	15	89633269	427889	418968	rs774403667	NC_000015.10:89633268:G:C	G	C	CLINICAL
NM_198525.3(KIF7):c.328+2T>G	KIF7		Normal	Inborn genetic diseases|Acrocallosal syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000520764	15	90195832	15	89652601	520764	512159	rs781752990	NC_000015.10:89652600:A:C	A	C	CLINICAL
NM_020821.3(VPS13C):c.8445+2T>G	VPS13C		Normal	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222067	15	62207830	15	61915631	222067	223766	rs869312809	NC_000015.10:61915630:A:C	A	C	CLINICAL
NM_001110.4(ADAM10):c.510G>C (p.Gln170His)	ADAM10	Q170H	Normal	Alzheimer disease 18	risk factor(Last reviewed: Oct 16, 2013)	no assertion criteria provided	VCV000092163	15	58957371	15	58665172	92163	97566	rs61751103	NC_000015.10:58665171:C:G	C	G	CLINICAL
NM_001271.4(CHD2):c.1883T>G (p.Leu628Ter)	CHD2	L628*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000548002	15	93499762	15	92956532	548002	538447	rs1555440885	NC_000015.10:92956531:T:G	T	G	CLINICAL
NM_001271.4(CHD2):c.2675A>G (p.Gln892Arg)	CHD2	Q892R	Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803139	15	93521561	15	92978331	803139	791516	rs1596427970	NC_000015.10:92978330:A:G	A	G	CLINICAL
NM_001271.4(CHD2):c.2809C>G (p.His937Asp)	CHD2	H937D	Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Aug 31, 2019)	criteria provided, single submitter	VCV000816666	15	93522446	15	92979216	816666	804864	rs1596429174	NC_000015.10:92979215:C:G	C	G	CLINICAL
NM_001271.4(CHD2):c.3454C>G (p.Arg1152Gly)	CHD2	R1152G	Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Jul 24, 2018)	no assertion criteria provided	VCV000807383	15	93534746	15	92991516	807383	798693	rs1596443241	NC_000015.10:92991515:C:G	C	G	CLINICAL
NM_001271.4(CHD2):c.4106C>G (p.Ser1369Ter)	CHD2	S1369*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000578850	15	93543839	15	93000609	578850	569371	rs1567159145	NC_000015.10:93000608:C:G	C	G	CLINICAL
NM_033028.5(BBS4):c.157-2A>G	BBS4		Normal	Bardet-Biedl syndrome 4|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009147	15	73004583	15	72712242	9147	24186	rs113994192	NC_000015.10:72712241:A:G	A	G	CLINICAL
NM_033028.5(BBS4):c.157-3C>G	BBS4		Normal	Bardet-Biedl syndrome|not provided	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000585184	15	73004582	15	72712241	585184	576240	rs1567412639	NC_000015.10:72712240:C:G	C	G	CLINICAL
NM_001211.5(BUB1B):c.2386-11A>G	BUB1B		Normal	Mosaic variegated aneuploidy syndrome 1|Premature chromatid separation trait	Pathogenic, Affects(Last reviewed: Dec 30, 2010)	no assertion criteria provided	VCV000030279	15	40504689	15	40212488	30279	39235	rs751421137	NC_000015.10:40212487:A:G	A	G	CLINICAL
NM_017553.3(INO80):c.1501T>C (p.Ser501Pro)	INO80	S501P	Normal	Seizures|Intellectual disability|Primary microcephaly	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183321	15	41364151	15	41071953	183321	181443	rs730882226	NC_000015.10:41071952:A:G	A	G	CLINICAL
NM_025137.4(SPG11):c.7152-1G>C	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000001115	15	44855500	15	44563302	1115	16154	rs200079802	NC_000015.10:44563301:C:G	C	G	CLINICAL
NM_025137.4(SPG11):c.6899T>C (p.Leu2300Pro)	SPG11	L2300P, L2187P	Normal	Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000235890	15	44858152	15	44565954	235890	237525	rs371334506	NC_000015.10:44565953:A:G	A	G	CLINICAL
NM_025137.4(SPG11):c.6206-1G>C	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041342	15	44865019	15	44572821	41342	49766	rs312262778	NC_000015.10:44572820:C:G	C	G	CLINICAL
NM_025137.4(SPG11):c.2444+1G>C	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000041290	15	44914417	15	44622219	41290	49714	rs312262743	NC_000015.10:44622218:C:G	C	G	CLINICAL
NM_025137.4(SPG11):c.442+1G>C	SPG11		Normal	not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001114	15	44952629	15	44660431	1114	16153	rs312262715	NC_000015.10:44660430:C:G	C	G	CLINICAL
NM_022369.4(STRA6):c.961A>C (p.Thr321Pro)	STRA6	T321P, T312P, T336P, T358P, T360P	Normal	Matthew-Wood syndrome	Pathogenic(Last reviewed: Nov 8, 2019)	no assertion criteria provided	VCV000001138	15	74481585	15	74189244	1138	16177	rs118203962	NC_000015.10:74189243:T:G	T	G	CLINICAL
NM_025083.5(EDC3):c.161T>C (p.Phe54Ser)	EDC3	F54S	Normal	Mental retardation, autosomal recessive 50	Pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000372218	15	74967305	15	74674964	372218	359123	rs1057517676	NC_000015.10:74674963:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.1A>G (p.Met1Val)	FAH	M1V	Normal	Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372766	15	80445397	15	80153055	372766	360304	rs1057517972	NC_000015.10:80153054:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.193-2A>G	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000550979	15	80452096	15	80159754	550979	547593	rs1555440522	NC_000015.10:80159753:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.315-2A>G	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000554167	15	80452750	15	80160408	554167	547598	rs1555440603	NC_000015.10:80160407:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.364+2T>G	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000659717	15	80452803	15	80160461	659717	652760	rs1595890740	NC_000015.10:80160460:T:G	T	G	CLINICAL
NM_000137.3(FAH):c.456-2A>G	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000551054	15	80460392	15	80168050	551054	548268	rs1555441251	NC_000015.10:80168049:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.497T>G (p.Val166Gly)	FAH	V166G	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000558415	15	80460435	15	80168093	558415	547599	rs778387055	NC_000015.10:80168092:T:G	T	G	CLINICAL
NM_000137.3(FAH):c.706+2T>G	FAH		Normal	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000550532	15	80464592	15	80172250	550532	547873	rs1555441597	NC_000015.10:80172249:T:G	T	G	CLINICAL
NM_000137.3(FAH):c.836A>G (p.Gln279Arg)	FAH	Q279R	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000011875	15	80465485	15	80173143	11875	26914	rs121965078	NC_000015.10:80173142:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.1063-2A>G	FAH		Normal	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558219	15	80473382	15	80181040	558219	547619	rs1555442385	NC_000015.10:80181039:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.1141A>G (p.Arg381Gly)	FAH	R381G	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000011872	15	80473462	15	80181120	11872	26911	rs121965077	NC_000015.10:80181119:A:G	A	G	CLINICAL
NM_000137.3(FAH):c.1258T>G (p.Ter420Gly)	FAH		Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: Mar 9, 2016)	criteria provided, single submitter	VCV000370617	15	80478549	15	80186207	370617	358339	rs1057516631	NC_000015.10:80186206:T:G	T	G	CLINICAL
NM_032856.2(WDR73):c.293T>C	WDR73	L98P	Normal	Galloway-Mowat syndrome 1	Likely pathogenic(Last reviewed: Oct 10, 2018)	no assertion criteria provided	VCV000242543	15	85191180	15	84647949	242543	205481	rs863223396	NC_000015.10:84647948:A:G	A	G	CLINICAL
NM_198525.3(KIF7):c.3518-1G>C	KIF7		Normal	not provided|Acrocallosal syndrome	Likely pathogenic(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000568940	15	90172354	15	89629123	568940	569211	rs1567057019	NC_000015.10:89629122:C:G	C	G	CLINICAL
NM_198525.3(KIF7):c.434A>C (p.Tyr145Ser)	KIF7	Y145S	Normal	Spasticity|Ventriculomegaly|Nystagmus|Cerebellar ataxia|Postaxial hand polydactyly|Postaxial foot polydactyly|Strabismus|Acrocallosal syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2014)	criteria provided, multiple submitters, no conflicts	VCV000374124	15	90193067	15	89649836	374124	360982	rs758361736	NC_000015.10:89649835:T:G	T	G	CLINICAL
NM_016013.4(NDUFAF1):c.619A>C (p.Thr207Pro)	NDUFAF1	T207P	Normal	Mitochondrial complex 1 deficiency, nuclear type 11	Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	VCV000030622	15	41687197	15	41394999	30622	39579	rs387906956	NC_000015.10:41394998:T:G	T	G	CLINICAL
NM_020821.3(VPS13C):c.4165G>C (p.Gly1389Arg)	VPS13C	G1389R, G1346R	Normal	Parkinson disease 23, autosomal recessive early-onset|Parkinson disease	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222070	15	62250807	15	61958608	222070	223768	rs369100678	NC_000015.10:61958607:C:G	C	G	CLINICAL
NM_000138.5(FBN1):c.1468+5G>A	FBN1		Normal	Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|Marfan syndrome|Geleophysic dysplasia 2|Stiff skin syndrome|Acromicric dysplasia|Weill-Marchesani syndrome 2|Marfan syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan lipodystrophy syndrome|MASS syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000042284	15	48807579	15	48515382	42284	51454	rs397515757	NC_000015.10:48515381:C:T	C	T	CLINICAL
NM_001126131.2(POLG):c.2542G>A (p.Gly848Ser)	POLG	G848S	Normal	Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|POLG-Related Spectrum Disorders|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Progressive sclerosing poliodystrophy|Progressive sclerosing poliodystrophy|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Mitochondrial DNA depletion syndrome 4B, MNGIE type|POLG- Related Disorder|Seizures|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Progressive sclerosing poliodystrophy|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013502	15	89865023	15	89321792	13502	28541	rs113994098	NC_000015.10:89321791:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.340C>T (p.Arg114Ter)	CHD2	R114*	Normal	Developmental and epileptic encephalopathy 94|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372997	15	93470519	15	92927289	372997	360144	rs1057518128	NC_000015.10:92927288:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.361C>T (p.Arg121Ter)	CHD2	R121*	Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000060712	15	93470540	15	92927310	60712	75274	rs397514740	NC_000015.10:92927309:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.390C>T (p.Ser130=)	CHD2		Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000474387	15	93472268	15	92929038	474387	465618	rs1555437851	NC_000015.10:92929037:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.628G>T (p.Glu210Ter)	CHD2	E210*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560974	15	93482884	15	92939654	560974	552185	rs1567133726	NC_000015.10:92939653:G:T	G	T	CLINICAL
NM_001271.4(CHD2):c.739G>T (p.Glu247Ter)	CHD2	E247*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000579480	15	93485098	15	92941868	579480	567444	rs1567135138	NC_000015.10:92941867:G:T	G	T	CLINICAL
NM_001271.4(CHD2):c.1081G>T (p.Glu361Ter)	CHD2	E361*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000541360	15	93487673	15	92944443	541360	529208	rs1555439719	NC_000015.10:92944442:G:T	G	T	CLINICAL
NM_001271.4(CHD2):c.1396C>T (p.Arg466Ter)	CHD2	R466*	Normal	Developmental and epileptic encephalopathy 94|not provided	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000092097	15	93492200	15	92948970	92097	97528	rs398123000	NC_000015.10:92948969:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.2425C>T (p.Arg809Ter)	CHD2	R809*	Normal	not provided|Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489275	15	93515567	15	92972337	489275	482084	rs146691368	NC_000015.10:92972336:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.2636C>T (p.Ala879Val)	CHD2	A879V	Normal	Developmental and epileptic encephalopathy 94|Inborn genetic diseases	Likely pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521364	15	93521522	15	92978292	521364	512163	rs1555442813	NC_000015.10:92978291:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.3187G>T (p.Glu1063Ter)	CHD2	E1063*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803140	15	93527680	15	92984450	803140	791517	rs1596436494	NC_000015.10:92984449:G:T	G	T	CLINICAL
NM_001271.4(CHD2):c.3214C>T (p.Arg1072Ter)	CHD2	R1072*	Normal	Developmental and epileptic encephalopathy 94|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280930	15	93527707	15	92984477	280930	264750	rs767106034	NC_000015.10:92984476:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.3409C>T (p.Arg1137Ter)	CHD2	R1137*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000541362	15	93528899	15	92985669	541362	529541	rs773860345	NC_000015.10:92985668:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.3782G>T (p.Trp1261Leu)	CHD2	W1261L	Normal	not provided|Complex neurodevelopmental disorder|Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432036	15	93540530	15	92997300	432036	426142	rs1555444603	NC_000015.10:92997299:G:T	G	T	CLINICAL
NM_001271.4(CHD2):c.3937C>T (p.Arg1313Ter)	CHD2	R1313*	Normal	Inborn genetic diseases|Developmental and epileptic encephalopathy 94|not provided	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521625	15	93541780	15	92998550	521625	512165	rs1555444702	NC_000015.10:92998549:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.4003G>T (p.Glu1335Ter)	CHD2	E1335*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic	no assertion criteria provided	VCV000694745	15	93541846	15	92998616	694745	682862	rs1246923304	NC_000015.10:92998615:G:T	G	T	CLINICAL
NM_001271.4(CHD2):c.4174C>T (p.Gln1392Ter)	CHD2	Q1392*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Dec 30, 2018)	criteria provided, single submitter	VCV000645522	15	93545443	15	93002213	645522	643743	rs3210462	NC_000015.10:93002212:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.4613C>T (p.Ser1538Phe)	CHD2	S1538F	Normal	Developmental and epileptic encephalopathy 94	Likely pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000642482	15	93555595	15	93012365	642482	643747	rs1596456893	NC_000015.10:93012364:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.4909C>T (p.Arg1637Ter)	CHD2	R1637*	Normal	Developmental and epileptic encephalopathy 94|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000218398	15	93563244	15	93020014	218398	215122	rs864309547	NC_000015.10:93020013:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.4921C>T (p.Gln1641Ter)	CHD2	Q1641*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000218399	15	93563256	15	93020026	218399	215123	rs864309548	NC_000015.10:93020025:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.5035C>T (p.Arg1679Ter)	CHD2	R1679*	Normal	Developmental and epileptic encephalopathy 94|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208725	15	93563370	15	93020140	208725	205288	rs797044912	NC_000015.10:93020139:C:T	C	T	CLINICAL
NM_001271.4(CHD2):c.5068C>T (p.Arg1690Ter)	CHD2	R1690*	Normal	Developmental and epileptic encephalopathy 94	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000644061	15	93563403	15	93020173	644061	643750	rs761127171	NC_000015.10:93020172:C:T	C	T	CLINICAL
NM_000693.4(ALDH1A3):c.265C>T (p.Arg89Cys)	ALDH1A3	R89C	Normal	Microphthalmia, isolated 8	Pathogenic(Last reviewed: Feb 7, 2013)	no assertion criteria provided	VCV000040203	15	101427837	15	100887632	40203	48690	rs397514652	NC_000015.10:100887631:C:T	C	T	CLINICAL
NM_033028.5(BBS4):c.830G>T (p.Gly277Val)	BBS4	G277V, G105V, G254V	Normal	Bardet-Biedl syndrome	Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000412297	15	73023764	15	72731423	412297	401166	rs749017489	NC_000015.10:72731422:G:T	G	T	CLINICAL
NM_033028.5(BBS4):c.172C>T (p.Gln58Ter)	BBS4	Q58*	Normal	Bardet-Biedl syndrome	Pathogenic	no assertion criteria provided	VCV000266089	15	73004600	15	72712259	266089	260918	rs886039802	NC_000015.10:72712258:C:T	C	T	CLINICAL
NM_033028.5(BBS4):c.76+1G>T	BBS4		Normal	Bardet-Biedl syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000585186	15	72987570	15	72695229	585186	576239	rs1465437164	NC_000015.10:72695228:G:T	G	T	CLINICAL
NM_033028.5(BBS4):c.883C>T (p.Arg295Ter)	BBS4	R295*, R272*, R123*	Normal	Bardet-Biedl syndrome 4|not provided|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000397593	15	73023914	15	72731573	397593	384491	rs775710800	NC_000015.10:72731572:C:T	C	T	CLINICAL
NM_001040616.3(LINS1):c.937G>A (p.Glu313Lys)	LINS1	E313K, E298K, E64K	Normal	Mental retardation, autosomal recessive 27	Likely pathogenic(Last reviewed: Feb 29, 2016)	no assertion criteria provided	VCV000374936	15	101114141	15	100573936	374936	361846	rs1057519019	NC_000015.10:100573935:C:T	C	T	CLINICAL
NM_001040616.3(LINS1):c.717C>A (p.Cys239Ter)	LINS1	C224*, C239*	Normal	Mental retardation, autosomal recessive 27	Likely pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800811	15	101114361	15	100574156	800811	788885	rs1596891223	NC_000015.10:100574155:G:T	G	T	CLINICAL
NM_130839.5(UBE3A):c.2272G>A (p.Gly758Arg)	UBE3A|SNHG14	G738R, G761R, G758R, G341R, G321R, G683R, G699R	Normal	Global developmental delay|Seizures|Expressive language delay|Poor speech|Abnormality of the corpus callosum|EEG abnormality	Pathogenic(Last reviewed: May 7, 2016)	no assertion criteria provided	VCV000373923	15	25599683	15	25354536	373923	360966	rs1057518770	NC_000015.10:25354535:C:T	C	T	CLINICAL
NM_000814.6(GABRB3):c.695G>A (p.Arg232Gln)	GABRB3	R232Q, R147Q, R161Q	Normal	not provided|Intellectual disability|Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000393256	15	26812868	15	26567721	393256	376349	rs797045045	NC_000015.10:26567720:C:T	C	T	CLINICAL
NM_004667.5(HERC2):c.9710T>A (p.Leu3237Ter)	HERC2	L3237*	Normal	Mental retardation, autosomal recessive 38	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522952	15	28420779	15	28175633	522952	513626	rs1555415658	NC_000015.10:28175632:A:T	A	T	CLINICAL
NM_017553.3(INO80):c.3737G>A (p.Arg1246Gln)	INO80	R1246Q	Normal	Seizures|Intellectual disability|Primary microcephaly	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183320	15	41279384	15	40987186	183320	181442	rs199722402	NC_000015.10:40987185:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.7115T>A (p.Leu2372Ter)	SPG11	L2372*, L2259*	Normal	Spastic paraplegia 11, autosomal recessive	Likely pathogenic(Last reviewed: Mar 5, 2015)	criteria provided, single submitter	VCV000216009	15	44856781	15	44564583	216009	213129	rs762984907	NC_000015.10:44564582:A:T	A	T	CLINICAL
NM_025137.4(SPG11):c.7023C>A (p.Tyr2341Ter)	SPG11	Y2341*, Y2228*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041356	15	44856873	15	44564675	41356	49780	rs80338869	NC_000015.10:44564674:G:T	G	T	CLINICAL
NM_025137.4(SPG11):c.4790G>A (p.Trp1597Ter)	SPG11	W1597*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000466534	15	44881566	15	44589368	466534	465091	rs753920931	NC_000015.10:44589367:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.4668T>A (p.Tyr1556Ter)	SPG11	Y1556*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041318	15	44884604	15	44592406	41318	49742	rs312262761	NC_000015.10:44592405:A:T	A	T	CLINICAL
NM_025137.4(SPG11):c.4434+1G>A	SPG11		Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803073	15	44888280	15	44596082	803073	791450	rs1567148391	NC_000015.10:44596081:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.4365G>A (p.Trp1455Ter)	SPG11	W1455*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000569547	15	44888350	15	44596152	569547	569384	rs138103656	NC_000015.10:44596151:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.4046T>A (p.Phe1349Tyr)	SPG11	F1349Y	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041313	15	44889097	15	44596899	41313	49737	rs312262758	NC_000015.10:44596898:A:T	A	T	CLINICAL
NM_025137.4(SPG11):c.2990T>A (p.Leu997Ter)	SPG11	L997*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 26, 2016)	criteria provided, single submitter	VCV000406526	15	44907609	15	44615411	406526	400273	rs1060501176	NC_000015.10:44615410:A:T	A	T	CLINICAL
NM_025137.4(SPG11):c.2877C>A (p.Cys959Ter)	SPG11	C959*	Normal	not provided|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	VCV000188250	15	44907722	15	44615524	188250	186203	rs786204176	NC_000015.10:44615523:G:T	G	T	CLINICAL
NM_025137.4(SPG11):c.2697G>A (p.Trp899Ter)	SPG11	W899*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041296	15	44912525	15	44620327	41296	49720	rs312262746	NC_000015.10:44620326:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.2316+1G>A	SPG11		Normal	Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000041288	15	44914925	15	44622727	41288	49712	rs312262740	NC_000015.10:44622726:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.2048G>A (p.Trp683Ter)	SPG11	W683*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803074	15	44920886	15	44628688	803074	791451	rs1595898030	NC_000015.10:44628687:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.1085G>A (p.Trp362Ter)	SPG11	W362*	Normal	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive|not provided	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488833	15	44944060	15	44651862	488833	482070	rs140385286	NC_000015.10:44651861:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.869+1G>A	SPG11		Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000041367	15	44949292	15	44657094	41367	49791	rs312262721	NC_000015.10:44657093:C:T	C	T	CLINICAL
NM_025137.4(SPG11):c.782C>A (p.Ser261Ter)	SPG11	S261*	Normal	Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, single submitter	VCV000466570	15	44949380	15	44657182	466570	464271	rs765477482	NC_000015.10:44657181:G:T	G	T	CLINICAL
NM_025137.4(SPG11):c.267G>A (p.Trp89Ter)	SPG11	W89*	Normal	not provided|Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000041294	15	44952805	15	44660607	41294	49718	rs312262709	NC_000015.10:44660606:C:T	C	T	CLINICAL
NM_000138.4(FBN1):c.3668G>A (p.Cys1223Tyr)	FBN1	C1223Y	Normal	Cardiovascular phenotype|Marfan syndrome	Pathogenic(Last reviewed: Nov 9, 2012)	criteria provided, single submitter	VCV000016444	15	48777615	15	48485418	16444	31483	rs137854469	NC_000015.10:48485417:C:T	C	T	CLINICAL
NM_000138.4(FBN1):c.3662G>A (p.Cys1221Tyr)	FBN1	C1221Y	Normal	Marfan syndrome	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000016464	15	48777621	15	48485424	16464	31503	rs137854483	NC_000015.10:48485423:C:T	C	T	CLINICAL
NM_000520.6(HEXA):c.533G>A (p.Arg178His)	HEXA	R178H, R189H	Normal	not provided|Tay-Sachs disease, B1 variant|Hexa, dn allele|Tay-Sachs disease|Global developmental delay	Pathogenic(Last reviewed: Dec 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003896	15	72645446	15	72353105	3896	18935	rs28941770	NC_000015.10:72353104:C:T	C	T	CLINICAL
NM_020843.4(SCAPER):c.3656G>A (p.Ser1219Asn)	SCAPER	S1219N, S1085N, S1225N, S1091N, S973N	Normal	Intellectual developmental disorder and retinitis pigmentosa; IDDRP|Intellectual disability, moderate|Rod-cone dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2018)	no assertion criteria provided	VCV000427855	15	76673768	15	76381427	427855	418811	rs1305542291	NC_000015.10:76381426:C:T	C	T	CLINICAL
NM_032808.7(LINGO1):c.869G>A (p.Arg290His)	LINGO1	R290H, R284H	Normal	Intellectual disability, autosomal recessive 64	Pathogenic(Last reviewed: Aug 29, 2018)	no assertion criteria provided	VCV000560183	15	77907380	15	77615038	560183	551234	rs757077698	NC_000015.10:77615037:C:T	C	T	CLINICAL
NM_000137.3(FAH):c.47A>T (p.Asn16Ile)	FAH	N16I	Normal	Tyrosinemia type I	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000011865	15	80445443	15	80153101	11865	26904	rs121965073	NC_000015.10:80153100:A:T	A	T	CLINICAL
NM_000137.3(FAH):c.192G>T (p.Gln64His)	FAH	Q64H	Normal	not provided|Tyrosinemia type I	Pathogenic(Last reviewed: Oct 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021054	15	80450512	15	80158170	21054	33906	rs80338894	NC_000015.10:80158169:G:T	G	T	CLINICAL
NM_000137.3(FAH):c.192+1G>T	FAH		Normal	Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189085	15	80450513	15	80158171	189085	186942	rs786204683	NC_000015.10:80158170:G:T	G	T	CLINICAL
NM_000137.3(FAH):c.520C>T (p.Arg174Ter)	FAH	R174*	Normal	Tyrosinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188751	15	80460458	15	80168116	188751	186943	rs781496816	NC_000015.10:80168115:C:T	C	T	CLINICAL
NM_000137.3(FAH):c.554-1G>T	FAH		Normal	Tyrosinemia type I|not provided	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011874	15	80460605	15	80168263	11874	26913	rs80338895	NC_000015.10:80168262:G:T	G	T	CLINICAL
NM_000137.3(FAH):c.698A>T (p.Asp233Val)	FAH	D233V	Normal	Tyrosinemia type I	Pathogenic(Last reviewed: Aug 25, 2011)	no assertion criteria provided	VCV000021057	15	80464582	15	80172240	21057	33909	rs80338897	NC_000015.10:80172239:A:T	A	T	CLINICAL
NM_000137.3(FAH):c.709C>T (p.Arg237Ter)	FAH	R237*	Normal	Tyrosinemia type I	Pathogenic(Last reviewed: May 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437463	15	80465358	15	80173016	437463	431016	rs769550316	NC_000015.10:80173015:C:T	C	T	CLINICAL
NM_000137.4(FAH):c.745C>T (p.Pro249Ser)	FAH	P249S	Normal	Tyrosinemia type I	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803109	15	80465394	15	80173052	803109	791486	rs1595894742	NC_000015.10:80173051:C:T	C	T	CLINICAL
NM_000137.3(FAH):c.782C>T (p.Pro261Leu)	FAH	P261L	Normal	not provided|Tyrosinemia type I	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021058	15	80465431	15	80173089	21058	33910	rs80338898	NC_000015.10:80173088:C:T	C	T	CLINICAL
NM_000137.4(FAH):c.982C>T (p.Gln328Ter)	FAH	Q328*	Normal	Tyrosinemia type I	Pathogenic	criteria provided, single submitter	VCV000813492	15	80472487	15	80180145	813492	801727	rs765134063	NC_000015.10:80180144:C:T	C	T	CLINICAL
NM_000137.3(FAH):c.1025C>T (p.Pro342Leu)	FAH	P342L	Normal	not provided|Tyrosinemia type I	Pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551024	15	80472530	15	80180188	551024	547617	rs779040832	NC_000015.10:80180187:C:T	C	T	CLINICAL
NM_000137.3(FAH):c.1027G>T (p.Gly343Trp)	FAH	G343W	Normal	Tyrosinemia type I|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000576751	15	80472532	15	80180190	576751	567293	rs970505762	NC_000015.10:80180189:G:T	G	T	CLINICAL
NM_000137.3(FAH):c.1069G>T (p.Glu357Ter)	FAH	E357*	Normal	Tyrosinemia type I	Pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011871	15	80473390	15	80181048	11871	26910	rs121965075	NC_000015.10:80181047:G:T	G	T	CLINICAL
NM_000137.3(FAH):c.1090G>T (p.Glu364Ter)	FAH	E364*	Normal	Tyrosinemia type I	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011867	15	80473411	15	80181069	11867	26906	rs121965076	NC_000015.10:80181068:G:T	G	T	CLINICAL
NM_032856.5(WDR73):c.884G>A (p.Gly295Asp)	WDR73	G295D	Normal	Galloway-Mowat syndrome 1	Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000804250	15	85186954	15	84643723	804250	792609	rs1596048227	NC_000015.10:84643722:C:T	C	T	CLINICAL
NM_032856.5(WDR73):c.767G>A (p.Arg256Gln)	WDR73	R256Q	Normal	Galloway-Mowat syndrome 1	Likely pathogenic(Last reviewed: Oct 10, 2018)	no assertion criteria provided	VCV000635182	15	85188818	15	84645587	635182	623016	rs866551482	NC_000015.10:84645586:C:T	C	T	CLINICAL
NM_032856.5(WDR73):c.287G>A (p.Arg96Lys)	WDR73	R96K	Normal	Galloway-Mowat syndrome 1|not provided	Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208470	15	85191768	15	84648537	208470	204991	rs797044995	NC_000015.10:84648536:C:T	C	T	CLINICAL
NM_032856.5(WDR73):c.68T>A (p.Leu23Gln)	WDR73	L23Q	Normal	Galloway-Mowat syndrome 1|not provided	Likely pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000208468	15	85196904	15	84653673	208468	204989	rs797044993	NC_000015.10:84653672:A:T	A	T	CLINICAL
NM_002693.3(POLG):c.1399G>A (p.Ala467Thr)	POLG	A467T	Normal	Toe walking|Progressive sclerosing poliodystrophy|POLG-Related Spectrum Disorders|Mitochondrial diseases|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|POLG-related condition|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Myoclonic epilepsy myopathy sensory ataxia|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive sclerosing poliodystrophy|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Mitochondrial DNA depletion syndrome 4B, MNGIE type|not provided|Seizures|Mitochondrial DNA depletion syndrome 4B, MNGIE type|POLG-related disorders|Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	Pathogenic(Last reviewed: Feb 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013496	15	89870432	15	89327201	13496	28535	rs113994095	NC_000015.10:89327200:C:T	C	T	CLINICAL
NM_002693.2(POLG):c.3406G>A (p.Glu1136Lys)	POLG	E1136K	Normal	not provided	Likely pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000206558	15	89861848	15	89318617	206558	202917	rs56047213	NC_000015.10:89318616:C:T	C	T	CLINICAL
NM_004960.3(FUS):c.616G>A (p.Gly206Ser)	FUS	G206S, G205S, G202S	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000029708	16	31196352	16	31185031	29708	38663	rs387906628	NC_000016.10:31185030:G:A	G	A	CLINICAL
NM_004960.3(FUS):c.1520G>A (p.Gly507Asp)	FUS	G507D, G506D, G503D	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000016226	16	31202410	16	31191089	16226	31265	rs267606831	NC_000016.10:31191088:G:A	G	A	CLINICAL
NM_004960.3(FUS):c.1553G>A (p.Arg518Lys)	FUS	R518K, R514K, R517K	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016223	16	31202731	16	31191410	16223	31262	rs121909669	NC_000016.10:31191409:G:A	G	A	CLINICAL
NM_004960.3(FUS):c.1562G>A (p.Arg521His)	FUS	R521H, R517H, R520H	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016225	16	31202740	16	31191419	16225	31264	rs121909671	NC_000016.10:31191418:G:A	G	A	CLINICAL
NM_000512.5(GALNS):c.268C>T (p.Arg90Trp)	GALNS	R90W, R96W	Normal	Mucopolysaccharidosis, MPS-IV-A|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000520618	16	88908356	16	88841948	520618	512232	rs1028668536	NC_000016.10:88841947:G:A	G	A	CLINICAL
NM_000294.3(PHKG2):c.926G>A (p.Arg309Gln)	PHKG2	R309Q	Normal	Mauriac syndrome|not provided	Pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	VCV000253061	16	30768035	16	30756714	253061	247472	rs572115942	NC_000016.10:30756713:G:A	G	A	CLINICAL
NM_031885.4(BBS2):c.646C>T (p.Arg216Ter)	BBS2	R216*	Normal	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Bardet-biedl syndrome 2/6, digenic|Retinal dystrophy	Pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004583	16	56540103	16	56506191	4583	19622	rs121908180	NC_000016.10:56506190:G:A	G	A	CLINICAL
NM_000303.3(PMM2):c.422G>A (p.Arg141His)	PMM2	R141H	Normal	Cerebellar ataxia|Congenital cerebellar hypoplasia|Inborn genetic diseases|Congenital disorder of glycosylation|Spasticity|Cerebral palsy|Cerebellar ataxia|Cerebral atrophy|Poor speech|Congenital cerebellar hypoplasia|Muscular dystrophy|Cerebellar ataxia|Diabetes mellitus|Congenital cerebellar hypoplasia|not provided|Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007706	16	8905010	16	8811153	7706	22745	rs28936415	NC_000016.10:8811152:G:A	G	A	CLINICAL
NM_031885.4(BBS2):c.2107C>T (p.Arg703Ter)	BBS2	R703*	Normal	Retinitis pigmentosa 74|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496478	16	56518732	16	56484820	496478	487920	rs567573386	NC_000016.10:56484819:G:A	G	A	CLINICAL
NM_001134407.3(GRIN2A):c.292C>T (p.Leu98Phe)	GRIN2A	L98F	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000646422	16	10273977	16	10180120	646422	643761	rs1596586969	NC_000016.10:10180119:G:A	G	A	CLINICAL
NM_002582.4(PARN):c.1045C>T (p.Arg349Trp)	PARN	R349W, R303W, R288W	Normal	Dyskeratosis congenita, autosomal recessive 6	Pathogenic(Last reviewed: Nov 1, 2015)	no assertion criteria provided	VCV000219120	16	14678240	16	14584383	219120	216922	rs754368658	NC_000016.10:14584382:G:A	G	A	CLINICAL
NM_000548.5(TSC2):c.2714G>A (p.Arg905Gln)	TSC2	R905Q, R705Q, R868Q, R856Q, R916Q	Normal	Tuberous sclerosis 2|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012403	16	2126143	16	2076142	12403	27442	rs45517259	NC_000016.10:2076141:G:A	G	A	CLINICAL
NM_000548.5(TSC2):c.4662+1G>A	TSC2		Normal	Tuberous sclerosis syndrome|Lymphangiomyomatosis|Infantile spasms|Intellectual disability, severe	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000050031	16	2135324	16	2085323	50031	59193	rs45514095	NC_000016.10:2085322:G:A	G	A	CLINICAL
NM_001083614.2(EARS2):c.322C>T (p.Arg108Trp)	EARS2	R108W	Normal	not provided|Seizures|Motor delay|Abnormality of the pinna|High palate|Global developmental delay|Abnormal facial shape|Generalized tonic-clonic seizures|Limb tremor|Prominent forehead|Combined oxidative phosphorylation deficiency 12|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039787	16	23555998	16	23544677	39787	48386	rs376103091	NC_000016.10:23544676:G:A	G	A	CLINICAL
NM_001199107.2(TBC1D24):c.321T>A (p.Asn107Lys)	TBC1D24	N107K	Normal	Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|not provided	Likely pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391688	16	2546470	16	2496469	391688	377432	rs1057524192	NC_000016.10:2496468:T:A	T	A	CLINICAL
NM_001199107.2(TBC1D24):c.468C>A (p.Cys156Ter)	TBC1D24	C156*	Normal	Early infantile epileptic encephalopathy 16	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000056847	16	2546617	16	2496616	56847	71465	rs397514714	NC_000016.10:2496615:C:A	C	A	CLINICAL
NM_001199107.2(TBC1D24):c.483C>A (p.Cys161Ter)	TBC1D24	C161*	Normal	Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000489172	16	2546632	16	2496631	489172	482095	rs745800110	NC_000016.10:2496630:C:A	C	A	CLINICAL
NM_001199107.2(TBC1D24):c.1206+5G>A	TBC1D24		Normal	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091399	16	2549426	16	2499425	91399	96875	rs398122968	NC_000016.10:2499424:G:A	G	A	CLINICAL
NM_024339.5(THOC6):c.135C>A (p.Tyr45Ter)	THOC6	Y45*, Y21*	Normal	Beaulieu-Boycott-Innes syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2020)	no assertion criteria provided	VCV000561207	16	3075804	16	3025803	561207	552314	rs772533643	NC_000016.10:3025802:C:A	C	A	CLINICAL
NM_024339.5(THOC6):c.136G>A (p.Gly46Arg)	THOC6	G46R, G22R	Normal	Beaulieu-Boycott-Innes syndrome	Pathogenic(Last reviewed: Aug 5, 2020)	no assertion criteria provided	VCV000064681	16	3075805	16	3025804	64681	75616	rs587777030	NC_000016.10:3025803:G:A	G	A	CLINICAL
NM_024339.5(THOC6):c.298T>A (p.Trp100Arg)	THOC6	W100R, W76R	Normal	Inborn genetic diseases|Beaulieu-Boycott-Innes syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000521347	16	3076141	16	3026140	521347	512192	rs138632121	NC_000016.10:3026139:T:A	T	A	CLINICAL
NM_024339.5(THOC6):c.299G>A (p.Trp100Ter)	THOC6	W100*, W76*	Normal	Beaulieu-Boycott-Innes syndrome	Likely pathogenic	no assertion criteria provided	VCV000633694	16	3076142	16	3026141	633694	622127	rs1567415595	NC_000016.10:3026140:G:A	G	A	CLINICAL
NM_024339.5(THOC6):c.824G>A (p.Gly275Asp)	THOC6	G275D, G251D	Normal	Beaulieu-Boycott-Innes syndrome|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521349	16	3077380	16	3027379	521349	512195	rs200426926	NC_000016.10:3027378:G:A	G	A	CLINICAL
NM_024339.5(THOC6):c.837C>A (p.Cys279Ter)	THOC6	C255*, C279*	Normal	Beaulieu-Boycott-Innes syndrome	Likely pathogenic(Last reviewed: Feb 5, 2020)	no assertion criteria provided	VCV000828106	16	3077393	16	3027392	828106	816486	rs146682486	NC_000016.10:3027391:C:A	C	A	CLINICAL
NM_003041.4(SLC5A2):c.1320G>A (p.Trp440Ter)	SLC5A2	W440*	Normal	Familial renal glucosuria	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000012904	16	31500240	16	31488919	12904	27943	rs121918621	NC_000016.10:31488918:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.6436C>T (p.Gln2146Ter)	CREBBP	Q2108*, Q2146*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic	criteria provided, single submitter	VCV000694717	16	3778612	16	3728611	694717	682825	rs1596783639	NC_000016.10:3728610:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.6244C>T (p.Gln2082Ter)	CREBBP	Q2082*, Q2044*	Normal	not provided|Global developmental delay|Scoliosis	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000373943	16	3778804	16	3728803	373943	360998	rs1057518789	NC_000016.10:3728802:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.6088C>T (p.Gln2030Ter)	CREBBP	Q2030*, Q1992*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158394	16	3778960	16	3728959	158394	169210	rs587783510	NC_000016.10:3728958:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.5905C>T (p.Gln1969Ter)	CREBBP	Q1969*, Q1931*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545607	16	3779143	16	3729142	545607	536101	rs1567262537	NC_000016.10:3729141:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.5821C>T (p.Gln1941Ter)	CREBBP	Q1941*, Q1903*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000158388	16	3779227	16	3729226	158388	169215	rs587783505	NC_000016.10:3729225:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.5237G>T (p.Gly1746Val)	CREBBP	G1746V, G1708V	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000224160	16	3779811	16	3729810	224160	225888	rs869312714	NC_000016.10:3729809:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.5014A>T (p.Arg1672Ter)	CREBBP	R1672*, R1634*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527962	16	3781351	16	3731350	527962	529980	rs1555471874	NC_000016.10:3731349:T:A	T	A	CLINICAL
NM_004380.3(CREBBP):c.4663G>T (p.Glu1555Ter)	CREBBP	E1555*, E1517*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000527961	16	3786102	16	3736101	527961	529982	rs1555472931	NC_000016.10:3736100:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.4660A>T (p.Lys1554Ter)	CREBBP	K1554*, K1516*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545605	16	3786105	16	3736104	545605	536103	rs1567269316	NC_000016.10:3736103:T:A	T	A	CLINICAL
NM_004380.3(CREBBP):c.4613C>T (p.Pro1538Leu)	CREBBP	P1500L, P1538L	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694825	16	3786152	16	3736151	694825	682875	rs1596804126	NC_000016.10:3736150:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.4303G>T (p.Asp1435Tyr)	CREBBP	D1435Y, D1397Y	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694788	16	3788651	16	3738650	694788	682880	rs1596810419	NC_000016.10:3738649:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.4281G>T (p.Arg1427Ser)	CREBBP	R1427S, R1389S	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Apr 28, 2015)	criteria provided, single submitter	VCV000210780	16	3788673	16	3738672	210780	208265	rs797045494	NC_000016.10:3738671:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.4243C>T (p.Gln1415Ter)	CREBBP	Q1377*, Q1415*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694783	16	3789616	16	3739615	694783	682885	rs1596812202	NC_000016.10:3739614:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.4175G>T (p.Arg1392Leu)	CREBBP	R1354L, R1392L	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694782	16	3789684	16	3739683	694782	682886	rs1596812290	NC_000016.10:3739682:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.4174C>T (p.Arg1392Ter)	CREBBP	R1392*, R1354*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694781	16	3789685	16	3739684	694781	682887	rs1596812306	NC_000016.10:3739683:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.4145C>T (p.Ser1382Phe)	CREBBP	S1344F, S1382F	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694780	16	3789714	16	3739713	694780	682888	rs149877180	NC_000016.10:3739712:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.4134-1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: May 13, 2016)	criteria provided, single submitter	VCV000268132	16	3789726	16	3739725	268132	263759	rs886041048	NC_000016.10:3739724:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.4078C>T (p.Arg1360Ter)	CREBBP	R1360*, R1322*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158368	16	3790455	16	3740454	158368	169235	rs587783490	NC_000016.10:3740453:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.4045C>T (p.Gln1349Ter)	CREBBP	Q1349*, Q1311*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158367	16	3790488	16	3740487	158367	169236	rs587783489	NC_000016.10:3740486:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.3982+3A>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803203	16	3794892	16	3744891	803203	791616	rs1596823180	NC_000016.10:3744890:T:A	T	A	CLINICAL
NM_004380.3(CREBBP):c.3914+3G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158363	16	3795275	16	3745274	158363	169240	rs587783485	NC_000016.10:3745273:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3914+1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 13, 2016)	criteria provided, single submitter	VCV000434830	16	3795277	16	3745276	434830	429809	rs1555475352	NC_000016.10:3745275:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3837-2A>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 15, 2003)	no assertion criteria provided	VCV000009434	16	3795357	16	3745356	9434	24473	rs1567277287	NC_000016.10:3745355:T:A	T	A	CLINICAL
NM_004380.3(CREBBP):c.3779+1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694820	16	3801726	16	3751725	694820	682940	rs587783483	NC_000016.10:3751724:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3625C>T (p.Gln1209Ter)	CREBBP	Q1171*, Q1209*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694814	16	3807362	16	3757361	694814	682896	rs1596852578	NC_000016.10:3757360:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.3613G>T (p.Glu1205Ter)	CREBBP	E1205*, E1167*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158358	16	3807374	16	3757373	158358	169244	rs587783482	NC_000016.10:3757372:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3436C>T (p.Gln1146Ter)	CREBBP	Q1146*, Q1108*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	VCV000210775	16	3807983	16	3757982	210775	208269	rs797045489	NC_000016.10:3757981:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.3369+1G>T	CREBBP		Normal	not provided|Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158356	16	3808854	16	3758853	158356	169246	rs587783480	NC_000016.10:3758852:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3310C>T (p.Gln1104Ter)	CREBBP	Q1104*, Q1066*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158355	16	3808914	16	3758913	158355	169247	rs587783479	NC_000016.10:3758912:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.3097A>T (p.Lys1033Ter)	CREBBP	K995*, K1033*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694772	16	3817874	16	3767873	694772	682903	rs1596878921	NC_000016.10:3767872:T:A	T	A	CLINICAL
NM_004380.3(CREBBP):c.3061-1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548491	16	3817911	16	3767910	548491	539065	rs1555481030	NC_000016.10:3767909:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3060+1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694771	16	3819174	16	3769173	694771	682944	rs1596882004	NC_000016.10:3769172:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.3058G>T (p.Glu1020Ter)	CREBBP	E1020*, E982*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694770	16	3819177	16	3769176	694770	682904	rs1596882010	NC_000016.10:3769175:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.2911A>T (p.Arg971Ter)	CREBBP	R933*, R971*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694768	16	3819324	16	3769323	694768	682906	rs1374436403	NC_000016.10:3769322:T:A	T	A	CLINICAL
NM_004380.3(CREBBP):c.2791C>T (p.Gln931Ter)	CREBBP	Q931*, Q893*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158351	16	3820660	16	3770659	158351	169248	rs587783475	NC_000016.10:3770658:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.2773C>T (p.Gln925Ter)	CREBBP	Q887*, Q925*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694763	16	3820678	16	3770677	694763	682911	rs1596886132	NC_000016.10:3770676:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.2159-1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694806	16	3824695	16	3774694	694806	682945	rs1596897799	NC_000016.10:3774693:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.1941+1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000545600	16	3828700	16	3778699	545600	536106	rs1555483834	NC_000016.10:3778698:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.1801C>T (p.Arg601Trp)	CREBBP	R563W, R601W	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000694802	16	3830755	16	3780754	694802	682917	rs1354934373	NC_000016.10:3780753:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1549C>T (p.Gln517Ter)	CREBBP	Q479*, Q517*	Normal	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000694799	16	3832709	16	3782708	694799	682919	rs1596920501	NC_000016.10:3782707:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1483C>T (p.Gln495Ter)	CREBBP	Q495*, Q457*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694798	16	3832775	16	3782774	694798	682920	rs1596920745	NC_000016.10:3782773:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1447C>T (p.Arg483Ter)	CREBBP	R483*, R445*	Normal	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000458197	16	3832811	16	3782810	458197	466468	rs1555484797	NC_000016.10:3782809:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1270C>T (p.Arg424Ter)	CREBBP	R424*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000158338	16	3842042	16	3792041	158338	169260	rs587783464	NC_000016.10:3792040:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1237C>T (p.Arg413Ter)	CREBBP	R413*	Normal	not provided|Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000434831	16	3842075	16	3792074	434831	429810	rs1302427305	NC_000016.10:3792073:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1156C>T (p.Arg386Ter)	CREBBP	R386*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158335	16	3843447	16	3793446	158335	169263	rs587783461	NC_000016.10:3793445:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1108C>T (p.Arg370Ter)	CREBBP	R370*	Normal	Rubinstein-Taybi syndrome 1|Corpus callosum, agenesis of	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000694759	16	3843495	16	3793494	694759	682924	rs1384496494	NC_000016.10:3793493:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1069C>T (p.Gln357Ter)	CREBBP	Q357*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000009429	16	3843534	16	3793533	9429	24468	rs121434625	NC_000016.10:3793532:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.1063C>T (p.Gln355Ter)	CREBBP	Q355*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158334	16	3843540	16	3793539	158334	169264	rs587783460	NC_000016.10:3793538:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.997G>T (p.Gly333Ter)	CREBBP	G333*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694757	16	3843606	16	3793605	694757	682926	rs1596948165	NC_000016.10:3793604:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.613C>T (p.Gln205Ter)	CREBBP	Q205*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694753	16	3900483	16	3850482	694753	682930	rs1597053504	NC_000016.10:3850481:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.598C>T (p.Gln200Ter)	CREBBP	Q200*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158393	16	3900498	16	3850497	158393	169266	rs587783509	NC_000016.10:3850496:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.508C>T (p.Gln170Ter)	CREBBP	Q170*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000458201	16	3900588	16	3850587	458201	465745	rs1555496560	NC_000016.10:3850586:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.406C>T (p.Gln136Ter)	CREBBP	Q136*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jul 27, 1995)	no assertion criteria provided	VCV000009428	16	3900690	16	3850689	9428	24467	rs121434624	NC_000016.10:3850688:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.376G>T (p.Gly126Ter)	CREBBP	G126*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694750	16	3900720	16	3850719	694750	682933	rs1597054242	NC_000016.10:3850718:C:A	C	A	CLINICAL
NM_004380.3(CREBBP):c.316C>T (p.Gln106Ter)	CREBBP	Q106*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	VCV000158354	16	3900780	16	3850779	158354	169267	rs587783478	NC_000016.10:3850778:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.286C>T (p.Gln96Ter)	CREBBP	Q96*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158352	16	3900810	16	3850809	158352	169269	rs587783476	NC_000016.10:3850808:G:A	G	A	CLINICAL
NM_004380.3(CREBBP):c.86-1G>T	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000210790	16	3901011	16	3851010	210790	208279	rs11644721	NC_000016.10:3851009:C:A	C	A	CLINICAL
NM_015272.5(RPGRIP1L):c.2413C>T (p.Arg805Ter)	RPGRIP1L	R805*	Normal	COACH syndrome 3|Joubert syndrome 7|Meckel-Gruber syndrome|Joubert syndrome|not provided	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001079	16	53679807	16	53645895	1079	16118	rs145665129	NC_000016.10:53645894:G:A	G	A	CLINICAL
NM_015272.5(RPGRIP1L):c.2050C>T (p.Gln684Ter)	RPGRIP1L	Q684*	Normal	Joubert syndrome|Meckel syndrome, type 5|Joubert syndrome 7|Joubert syndrome with hepatic defect|Meckel-Gruber syndrome|Joubert syndrome|Joubert syndrome 7	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001076	16	53686549	16	53652637	1076	16115	rs121918204	NC_000016.10:53652636:G:A	G	A	CLINICAL
NM_015272.5(RPGRIP1L):c.757C>T (p.Gln253Ter)	RPGRIP1L	Q253*	Normal	Joubert syndrome 7|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV000001070	16	53720364	16	53686452	1070	16109	rs121918199	NC_000016.10:53686451:G:A	G	A	CLINICAL
NM_005853.6(IRX5):c.498C>A (p.Asn166Lys)	IRX5	N166K	Normal	Hamamy syndrome	Pathogenic(Last reviewed: May 13, 2012)	no assertion criteria provided	VCV000031910	16	54966658	16	54932746	31910	40566	rs786200931	NC_000016.10:54932745:C:A	C	A	CLINICAL
NM_006565.4(CTCF):c.848G>A (p.Arg283His)	CTCF	R283H	Normal	Mental retardation, autosomal dominant 21	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000562205	16	67645920	16	67612017	562205	553394	rs1567609067	NC_000016.10:67612016:G:A	G	A	CLINICAL
NM_019023.5(PRMT7):c.1713C>A (p.Cys571Ter)	PRMT7	C571*, C521*, C572*, C492*, C502*	Normal	Insulin resistance|Short stature|Renal hypoplasia (disease)|Brachydactyly|Obesity|Acanthosis nigricans|Hyperlipidemia|Short metacarpal|Lumbar hyperlordosis|Skeletal dysplasia|Hepatic steatosis|Abnormality of the dentition|Self-injurious behavior|Abnormal facial shape|Intellectual disability, severe	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523434	16	68389688	16	68355785	523434	514065	rs1251713297	NC_000016.10:68355784:C:A	C	A	CLINICAL
NM_138383.3(MTSS2):c.1790C>T (p.Thr597Met)	MTSS2	T597M	Normal	Global developmental delay|Iron deposition in globus pallidus|Intellectual disability|Microcephaly|Muscular hypotonia	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183351	16	70698034	16	70664131	183351	181447	rs531163149	NC_000016.10:70664130:G:A	G	A	CLINICAL
NM_016373.4(WWOX):c.107+1G>A	WWOX		Normal	Epileptic encephalopathy, early infantile, 1|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689796	16	78133783	16	78099886	689796	677452	rs1300924648	NC_000016.10:78099885:G:A	G	A	CLINICAL
NM_016373.4(WWOX):c.139C>A (p.Pro47Thr)	WWOX	P47T	Normal	Spinocerebellar ataxia, autosomal recessive 12	Pathogenic(Last reviewed: Feb 1, 2014)	no assertion criteria provided	VCV000100649	16	78142351	16	78108454	100649	106521	rs587777128	NC_000016.10:78108453:C:A	C	A	CLINICAL
NM_016373.4(WWOX):c.606-1G>A	WWOX		Normal	not provided|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|Epileptic encephalopathy, early infantile, 28|Brain atrophy|Global developmental delay|Abnormal facial shape	Pathogenic(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000183303	16	78458766	16	78424869	183303	181448	rs730882215	NC_000016.10:78424868:G:A	G	A	CLINICAL
NM_005360.5(MAF):c.176C>T (p.Pro59Leu)	MAF	P59L	Normal	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162516	16	79633624	16	79599727	162516	172187	rs727502770	NC_000016.10:79599726:G:A	G	A	CLINICAL
NM_005360.5(MAF):c.173C>T (p.Thr58Ile)	MAF	T58I	Normal	not provided|Ayme-gripp syndrome	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000162514	16	79633627	16	79599730	162514	172189	rs727502769	NC_000016.10:79599729:G:A	G	A	CLINICAL
NM_005360.5(MAF):c.161C>T (p.Ser54Leu)	MAF	S54L	Normal	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162512	16	79633639	16	79599742	162512	172191	rs727502766	NC_000016.10:79599741:G:A	G	A	CLINICAL
NM_022041.3(GAN):c.505G>A (p.Glu169Lys)	GAN	E169K	Normal	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000005038	16	81388232	16	81354627	5038	20077	rs119485095	NC_000016.10:81354626:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.7180C>T (p.Gln2394Ter)	ANKRD11|TRAPPC2L	Q2394*	Normal	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis|KBG syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000217881	16	89345770	16	89279362	217881	214544	rs863225296	NC_000016.10:89279361:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.6847C>T (p.Gln2283Ter)	ANKRD11	Q2283*	Normal	KBG syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000441154	16	89346103	16	89279695	441154	434772	rs1221781038	NC_000016.10:89279694:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.6742C>T (p.Gln2248Ter)	ANKRD11	Q2248*	Normal	KBG syndrome	Pathogenic(Last reviewed: Dec 5, 2017)	criteria provided, single submitter	VCV000691266	16	89346208	16	89279800	691266	678946	rs1597435896	NC_000016.10:89279799:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.6670G>T (p.Glu2224Ter)	ANKRD11	E2224*	Normal	KBG syndrome	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000434197	16	89346280	16	89279872	434197	429885	rs1381957912	NC_000016.10:89279871:C:A	C	A	CLINICAL
NM_013275.6(ANKRD11):c.6472G>T (p.Glu2158Ter)	ANKRD11	E2158*	Normal	KBG syndrome	Pathogenic(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224159	16	89346478	16	89280070	224159	225887	rs869312713	NC_000016.10:89280069:C:A	C	A	CLINICAL
NM_013275.6(ANKRD11):c.5317G>T (p.Glu1773Ter)	ANKRD11	E1773*	Normal	Epicanthus|Esotropia|Wide nasal bridge|Hypertelorism|Hypermetropia|Cryptorchidism|Retrognathia|Astigmatism|Intellectual disability|Global developmental delay	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242882	16	89347633	16	89281225	242882	243994	rs1114167291	NC_000016.10:89281224:C:A	C	A	CLINICAL
NM_013275.6(ANKRD11):c.4288A>T (p.Lys1430Ter)	ANKRD11	K1430*	Normal	KBG syndrome	Likely pathogenic(Last reviewed: May 18, 2017)	no assertion criteria provided	VCV000488445	16	89348662	16	89282254	488445	481321	rs1555527929	NC_000016.10:89282253:T:A	T	A	CLINICAL
NM_013275.6(ANKRD11):c.4087C>T (p.Arg1363Ter)	ANKRD11	R1363*	Normal	Global developmental delay|KBG syndrome|not provided	Pathogenic(Last reviewed: Jan 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000488985	16	89348863	16	89282455	488985	482111	rs1364690005	NC_000016.10:89282454:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.3706C>T (p.Gln1236Ter)	ANKRD11	Q1236*	Normal	KBG syndrome	Likely pathogenic(Last reviewed: Apr 6, 2018)	no assertion criteria provided	VCV000545701	16	89349244	16	89282836	545701	536193	rs1555528356	NC_000016.10:89282835:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.3562C>T (p.Arg1188Ter)	ANKRD11	R1188*	Normal	not provided|KBG syndrome	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000280480	16	89349388	16	89282980	280480	264823	rs761848111	NC_000016.10:89282979:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.2716C>T (p.Arg906Ter)	ANKRD11	R906*	Normal	KBG syndrome	Pathogenic(Last reviewed: Aug 16, 2019)	no assertion criteria provided	VCV000807371	16	89350234	16	89283826	807371	798707	rs929007085	NC_000016.10:89283825:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.2704G>T (p.Glu902Ter)	ANKRD11	E902*	Normal	not provided|KBG syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000807372	16	89350246	16	89283838	807372	798708	rs1597459649	NC_000016.10:89283837:C:A	C	A	CLINICAL
NM_013275.6(ANKRD11):c.2692C>T (p.Arg898Ter)	ANKRD11	R898*	Normal	Global developmental delay|not provided|KBG syndrome	Pathogenic(Last reviewed: Jan 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000620276	16	89350258	16	89283850	620276	611834	rs780011005	NC_000016.10:89283849:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.2647G>T (p.Glu883Ter)	ANKRD11	E883*	Normal	KBG syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431133	16	89350303	16	89283895	431133	424664	rs1135401804	NC_000016.10:89283894:C:A	C	A	CLINICAL
NM_013275.6(ANKRD11):c.2197C>T (p.Arg733Ter)	ANKRD11	R733*	Normal	not provided|Inborn genetic diseases|KBG syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280620	16	89350753	16	89284345	280620	264834	rs886041791	NC_000016.10:89284344:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.1948C>T (p.Gln650Ter)	ANKRD11	Q650*	Normal	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560939	16	89351002	16	89284594	560939	552194	rs1567579525	NC_000016.10:89284593:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.1801C>T (p.Arg601Ter)	ANKRD11	R601*	Normal	not provided|KBG syndrome	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000280209	16	89351149	16	89284741	280209	264988	rs772229371	NC_000016.10:89284740:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.1621C>T (p.Gln541Ter)	ANKRD11	Q541*	Normal	KBG syndrome	Pathogenic	criteria provided, single submitter	VCV000694688	16	89351329	16	89284921	694688	682829	rs1156815415	NC_000016.10:89284920:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.1372C>T (p.Arg458Ter)	ANKRD11	R458*	Normal	not provided|KBG syndrome	Pathogenic(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000694682	16	89351578	16	89285170	694682	682830	rs900492387	NC_000016.10:89285169:G:A	G	A	CLINICAL
NM_013275.6(ANKRD11):c.160C>T (p.Arg54Ter)	ANKRD11	R54*	Normal	KBG syndrome|not provided	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546032	16	89371680	16	89305272	546032	536480	rs749607205	NC_000016.10:89305271:G:A	G	A	CLINICAL
NM_006086.4(TUBB3):c.613G>A (p.Glu205Lys)	TUBB3	E205K, E133K	Normal	not provided|Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000030274	16	90001472	16	89935064	30274	39230	rs878853257	NC_000016.10:89935063:G:A	G	A	CLINICAL
NM_001134407.3(GRIN2A):c.2041C>T (p.Arg681Ter)	GRIN2A	R681*	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic(Last reviewed: Dec 23, 2015)	criteria provided, single submitter	VCV000088734	16	9916248	16	9822391	88734	94311	rs397518472	NC_000016.10:9822390:G:A	G	A	CLINICAL
NM_001134407.3(GRIN2A):c.1592C>T (p.Thr531Met)	GRIN2A	T531M	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000088730	16	9934563	16	9840706	88730	94307	rs397518468	NC_000016.10:9840705:G:A	G	A	CLINICAL
NM_001134407.3(GRIN2A):c.1553G>T (p.Arg518Leu)	GRIN2A	R518L	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000567708	16	9934602	16	9840745	567708	574238	rs397518470	NC_000016.10:9840744:C:A	C	A	CLINICAL
NM_001134407.3(GRIN2A):c.1510C>T (p.Arg504Trp)	GRIN2A	R504W	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV000650867	16	9934645	16	9840788	650867	645260	rs1360906241	NC_000016.10:9840787:G:A	G	A	CLINICAL
NM_001134407.3(GRIN2A):c.652C>T (p.Gln218Ter)	GRIN2A	Q218*	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 1, 2010)	no assertion criteria provided	VCV000029732	16	10032171	16	9938314	29732	38687	rs387906637	NC_000016.10:9938313:G:A	G	A	CLINICAL
NM_001134407.3(GRIN2A):c.487C>T (p.Gln163Ter)	GRIN2A	Q163*	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000391457	16	10032336	16	9938479	391457	378038	rs1057524089	NC_000016.10:9938478:G:A	G	A	CLINICAL
NM_004970.2(IGFALS):c.827A>G (p.Asn276Ser)	IGFALS	N276S, N314S	Normal	Acid-labile subunit deficiency	Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000318251	16	1841592	16	1791591	318251	340812	rs551618643	NC_000016.10:1791590:T:C	T	C	CLINICAL
NM_000548.5(TSC2):c.4508A>C (p.Gln1503Pro)	TSC2	Q1503P, Q1400P, Q1436P, Q1437P, Q1388P, Q1459P, Q1460P, Q1480P, Q1259P, Q1447P	Normal	Tuberous sclerosis 2|not provided|History of neurodevelopmental disorder|Tuberous sclerosis syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012401	16	2134966	16	2084965	12401	27440	rs45516293	NC_000016.10:2084964:A:C	A	C	CLINICAL
NM_022773.4(LMF1):c.1317C>G (p.Tyr439Ter)	LMF1	Y439*, Y222*, Y306*, Y330*	Normal	Lipase deficiency, combined	Pathogenic(Last reviewed: May 27, 2020)	no assertion criteria provided	VCV000000792	16	919982	16	869982	792	15831	rs121909397	NC_000016.10:869981:G:C	G	C	CLINICAL
NM_031885.4(BBS2):c.224T>G (p.Val75Gly)	BBS2	V75G	Normal	Bardet-Biedl syndrome 2|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004569	16	56548486	16	56514574	4569	19608	rs121908174	NC_000016.10:56514573:A:C	A	C	CLINICAL
NM_001199107.2(TBC1D24):c.313T>C (p.Cys105Arg)	TBC1D24	C105R	Normal	DOORS syndrome	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000183153	16	2546462	16	2496461	183153	181289	rs797044547	NC_000016.10:2496460:T:C	T	C	CLINICAL
NM_001199107.2(TBC1D24):c.439G>C (p.Asp147His)	TBC1D24	D147H	Normal	Myoclonic epilepsy, familial infantile	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000000048	16	2546588	16	2496587	48	15087	rs267607103	NC_000016.10:2496586:G:C	G	C	CLINICAL
NM_001199107.2(TBC1D24):c.751T>C (p.Phe251Leu)	TBC1D24	F251L	Normal	Myoclonic epilepsy, familial infantile	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000000050	16	2546900	16	2496899	50	15089	rs267607104	NC_000016.10:2496898:T:C	T	C	CLINICAL
NM_001199107.2(TBC1D24):c.878G>C (p.Arg293Pro)	TBC1D24	R293P	Normal	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000100678	16	2547027	16	2497026	100678	106550	rs199700840	NC_000016.10:2497025:G:C	G	C	CLINICAL
NM_001199107.2(TBC1D24):c.919A>C (p.Asn307His)	TBC1D24	N307H	Normal	Deafness, autosomal dominant 65	Likely pathogenic	no assertion criteria provided	VCV000425556	16	2547068	16	2497067	425556	413897	rs1555501320	NC_000016.10:2497066:A:C	A	C	CLINICAL
NM_001199107.2(TBC1D24):c.983+2T>C	TBC1D24		Normal	Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000658011	16	2547730	16	2497729	658011	653252	rs1596969717	NC_000016.10:2497728:T:C	T	C	CLINICAL
NM_024339.5(THOC6):c.611A>C (p.Gln204Pro)	THOC6	Q204P, Q180P	Normal	Beaulieu-Boycott-Innes syndrome	Pathogenic(Last reviewed: Oct 22, 2020)	no assertion criteria provided	VCV000561206	16	3076892	16	3026891	561206	552313	rs1567416845	NC_000016.10:3026890:A:C	A	C	CLINICAL
NM_004380.3(CREBBP):c.6275C>G (p.Ser2092Ter)	CREBBP	S2092*, S2054*	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Jun 13, 2017)	no assertion criteria provided	VCV000437830	16	3778773	16	3728772	437830	431385	rs1555471077	NC_000016.10:3728771:G:C	G	C	CLINICAL
NM_004380.3(CREBBP):c.5614A>G (p.Met1872Val)	CREBBP	M1872V, M1834V	Normal	Rubinstein-Taybi syndrome 1|Intellectual disability|Menke-Hennekam syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000209145	16	3779434	16	3729433	209145	205780	rs797045037	NC_000016.10:3729432:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.4508A>G (p.Tyr1503Cys)	CREBBP	Y1503C, Y1465C	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158377	16	3786703	16	3736702	158377	169226	rs587783497	NC_000016.10:3736701:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.4460A>G (p.His1487Arg)	CREBBP	H1487R, H1449R	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694823	16	3786751	16	3736750	694823	682877	rs1596805792	NC_000016.10:3736749:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.4445A>G (p.Tyr1482Cys)	CREBBP	Y1482C, Y1444C	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158376	16	3786766	16	3736765	158376	169227	rs587783496	NC_000016.10:3736764:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.4444T>G (p.Tyr1482Asp)	CREBBP	Y1482D, Y1444D	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000158375	16	3786767	16	3736766	158375	169228	rs587783495	NC_000016.10:3736765:A:C	A	C	CLINICAL
NM_004380.3(CREBBP):c.4439A>G (p.Asp1480Gly)	CREBBP	D1480G, D1442G	Normal	not provided|Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000279963	16	3786772	16	3736771	279963	264634	rs886041286	NC_000016.10:3736770:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.4376A>G (p.Glu1459Gly)	CREBBP	E1459G, E1421G	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158373	16	3788578	16	3738577	158373	169230	rs587783494	NC_000016.10:3738576:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.4281-11C>G	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158372	16	3788684	16	3738683	158372	169231	rs587783493	NC_000016.10:3738682:G:C	G	C	CLINICAL
NM_004380.3(CREBBP):c.4277C>G (p.Thr1426Arg)	CREBBP	T1388R, T1426R	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000694784	16	3789582	16	3739581	694784	682884	rs145988918	NC_000016.10:3739580:G:C	G	C	CLINICAL
NM_004380.3(CREBBP):c.3983-2A>G	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	VCV000158364	16	3790552	16	3740551	158364	169239	rs587783486	NC_000016.10:3740550:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.3690T>G (p.Tyr1230Ter)	CREBBP	Y1192*, Y1230*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694817	16	3807297	16	3757296	694817	682893	rs748451307	NC_000016.10:3757295:A:C	A	C	CLINICAL
NM_004380.3(CREBBP):c.3610-2A>G	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694813	16	3807379	16	3757378	694813	682943	rs1596852674	NC_000016.10:3757377:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.3535A>G (p.Ser1179Gly)	CREBBP	S1141G, S1179G	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694811	16	3807884	16	3757883	694811	682897	rs1596854023	NC_000016.10:3757882:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.3524A>G (p.Tyr1175Cys)	CREBBP	Y1175C, Y1137C	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000009432	16	3807895	16	3757894	9432	24471	rs28937315	NC_000016.10:3757893:T:C	T	C	CLINICAL
NM_004380.3(CREBBP):c.1646C>G (p.Ser549Ter)	CREBBP	S511*, S549*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694801	16	3831235	16	3781234	694801	682918	rs1596917200	NC_000016.10:3781233:G:C	G	C	CLINICAL
NM_004380.3(CREBBP):c.37A>G (p.Lys13Glu)	CREBBP	K13E	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158360	16	3929881	16	3879880	158360	169272	rs587783484	NC_000016.10:3879879:T:C	T	C	CLINICAL
NM_005853.6(IRX5):c.448G>C (p.Ala150Pro)	IRX5	A150P	Normal	Hamamy syndrome	Pathogenic(Last reviewed: May 13, 2012)	no assertion criteria provided	VCV000031911	16	54966608	16	54932696	31911	40567	rs387907198	NC_000016.10:54932695:G:C	G	C	CLINICAL
NM_016373.4(WWOX):c.409+1G>C	WWOX		Normal	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	VCV000410092	16	78149052	16	78115155	410092	401330	rs1060502727	NC_000016.10:78115154:G:C	G	C	CLINICAL
NM_016373.4(WWOX):c.1114G>C (p.Gly372Arg)	MAF|WWOX	G372R, G259R	Normal	Spinocerebellar ataxia, autosomal recessive 12|not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000100648	16	79245562	16	79211665	100648	106520	rs587777127	NC_000016.10:79211664:G:C	G	C	CLINICAL
NM_005360.5(MAF):c.206C>G (p.Pro69Arg)	MAF	P69R	Normal	Ayme-gripp syndrome|not provided	Likely pathogenic(Last reviewed: Sep 22, 2016)	criteria provided, single submitter	VCV000162518	16	79633594	16	79599697	162518	172185	rs727502768	NC_000016.10:79599696:G:C	G	C	CLINICAL
NM_005360.5(MAF):c.185C>G (p.Thr62Arg)	MAF	T62R	Normal	Ayme-gripp syndrome	Pathogenic	no assertion criteria provided	VCV000162517	16	79633615	16	79599718	162517	172186	rs727502771	NC_000016.10:79599717:G:C	G	C	CLINICAL
NM_005360.5(MAF):c.172A>G (p.Thr58Ala)	MAF	T58A	Normal	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162513	16	79633628	16	79599731	162513	172190	rs727502767	NC_000016.10:79599730:T:C	T	C	CLINICAL
NM_000303.3(PMM2):c.255+2T>C	PMM2		Normal	not provided|Intellectual disability|Congenital disorder of glycosylation, type Ia	Pathogenic(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000321216	16	8898702	16	8804845	321216	326612	rs139716296	NC_000016.10:8804844:T:C	T	C	CLINICAL
NM_013275.6(ANKRD11):c.7814T>G (p.Leu2605Arg)	ANKRD11	L2605R	Normal	not provided|Intellectual disability	Likely pathogenic(Last reviewed: Jul 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429654	16	89335064	16	89268656	429654	422126	rs1131691512	NC_000016.10:89268655:A:C	A	C	CLINICAL
NM_013275.6(ANKRD11):c.6212C>G (p.Ser2071Ter)	ANKRD11	S2071*	Normal	KBG syndrome	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000375613	16	89346738	16	89280330	375613	362427	rs763407068	NC_000016.10:89280329:G:C	G	C	CLINICAL
NM_013275.6(ANKRD11):c.4206C>G (p.Tyr1402Ter)	ANKRD11	Y1402*	Normal	KBG syndrome|Intellectual disability	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000579848	16	89348744	16	89282336	579848	568459	rs749632782	NC_000016.10:89282335:G:C	G	C	CLINICAL
NM_013275.6(ANKRD11):c.2327T>G (p.Leu776Ter)	ANKRD11	L776*	Normal	KBG syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666326	16	89350623	16	89284215	666326	653892	rs1597461100	NC_000016.10:89284214:A:C	A	C	CLINICAL
NM_013275.6(ANKRD11):c.1977C>G (p.Tyr659Ter)	ANKRD11	Y659*	Normal	not provided|KBG syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000489328	16	89350973	16	89284565	489328	482112	rs749201074	NC_000016.10:89284564:G:C	G	C	CLINICAL
NM_013275.6(ANKRD11):c.1679C>G (p.Ser560Ter)	ANKRD11	S560*	Normal	KBG syndrome	Pathogenic(Last reviewed: Mar 7, 2018)	no assertion criteria provided	VCV000559634	16	89351271	16	89284863	559634	550370	rs1555529551	NC_000016.10:89284862:G:C	G	C	CLINICAL
NM_001134407.3(GRIN2A):c.4375A>G (p.Ser1459Gly)	GRIN2A	S1459G	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 9, 2014)	criteria provided, single submitter	VCV000224108	16	9857026	16	9763169	224108	225838	rs869312681	NC_000016.10:9763168:T:C	T	C	CLINICAL
NM_001134407.3(GRIN2A):c.2829C>G (p.Tyr943Ter)	GRIN2A	Y943*	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088729	16	9858572	16	9764715	88729	94306	rs397518467	NC_000016.10:9764714:G:C	G	C	CLINICAL
NM_001134407.3(GRIN2A):c.1954T>G (p.Phe652Val)	GRIN2A	F652V	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088733	16	9923333	16	9829476	88733	94310	rs397518471	NC_000016.10:9829475:A:C	A	C	CLINICAL
NM_001134407.3(GRIN2A):c.1945C>G (p.Leu649Val)	GRIN2A	L649V	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Oct 18, 2018)	no assertion criteria provided	VCV000039662	16	9923342	16	9829485	39662	48261	rs397514557	NC_000016.10:9829484:G:C	G	C	CLINICAL
NM_001134407.3(GRIN2A):c.1936A>G (p.Thr646Ala)	GRIN2A	T646A	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 13, 2017)	no assertion criteria provided	VCV000488524	16	9923351	16	9829494	488524	481392	rs1555492758	NC_000016.10:9829493:T:C	T	C	CLINICAL
NM_001134407.3(GRIN2A):c.1841A>G (p.Asn614Ser)	GRIN2A	N614S	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224990	16	9923446	16	9829589	224990	226960	rs869312916	NC_000016.10:9829588:T:C	T	C	CLINICAL
NM_001134407.3(GRIN2A):c.1734C>G (p.Tyr578Ter)	GRIN2A	Y578*	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000411285	16	9928005	16	9834148	411285	401471	rs1060503228	NC_000016.10:9834147:G:C	G	C	CLINICAL
NM_001134407.3(GRIN2A):c.1655C>G (p.Pro552Arg)	GRIN2A	P552R	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039663	16	9928084	16	9834227	39663	48262	rs397518450	NC_000016.10:9834226:G:C	G	C	CLINICAL
NM_001134407.3(GRIN2A):c.1328A>G (p.Asn443Ser)	GRIN2A	N443S	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803218	16	9943613	16	9849756	803218	791671	rs1596494610	NC_000016.10:9849755:T:C	T	C	CLINICAL
NM_001134407.3(GRIN2A):c.1123-2A>G	GRIN2A		Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088731	16	9943820	16	9849963	88731	94308	rs397518469	NC_000016.10:9849962:T:C	T	C	CLINICAL
NM_004960.3(FUS):c.1561C>G (p.Arg521Gly)	FUS	R521G, R520G, R517G	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: May 26, 2019)	criteria provided, single submitter	VCV000016222	16	31202739	16	31191418	16222	31261	rs121909668	NC_000016.10:31191417:C:G	C	G	CLINICAL
NM_000243.3(MEFV):c.2177T>C (p.Val726Ala)	MEFV	V726A	Normal	not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|Inborn genetic diseases|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|Acute febrile neutrophilic dermatosis	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002540	16	3293310	16	3243310	2540	17579	rs28940579	NC_000016.10:3243309:A:G	A	G	CLINICAL
NM_001370466.1(NOD2):c.1065C>G (p.Asp355Glu)	NOD2	D382E, D355E	Normal	Blau syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000004699	16	50744968	16	50711057	4699	19738	rs104895476	NC_000016.10:50711056:C:G	C	G	CLINICAL
NM_031885.4(BBS2):c.1895G>C (p.Arg632Pro)	BBS2	R632P	Normal	Retinal dystrophy|Retinitis pigmentosa|not provided|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|BBS2-Related Disorders|Retinitis pigmentosa 74	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004578	16	56530894	16	56496982	4578	19617	rs138043021	NC_000016.10:56496981:C:G	C	G	CLINICAL
NM_031885.4(BBS2):c.311A>C (p.Asp104Ala)	BBS2	D104A	Normal	Retinitis pigmentosa|Bardet-Biedl syndrome|Bardet-biedl syndrome 1/2, digenic|Retinitis pigmentosa 74|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2|Retinitis pigmentosa 74	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004577	16	56548399	16	56514487	4577	19616	rs121908179	NC_000016.10:56514486:T:G	T	G	CLINICAL
NM_001134407.3(GRIN2A):c.2T>C (p.Met1Thr)	GRIN2A	M1T	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000088728	16	10274267	16	10180410	88728	94305	rs397518466	NC_000016.10:10180409:A:G	A	G	CLINICAL
NM_001199107.2(TBC1D24):c.58C>G (p.Gln20Glu)	TBC1D24	Q20E	Normal	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000091397	16	2546207	16	2496206	91397	96873	rs201257588	NC_000016.10:2496205:C:G	C	G	CLINICAL
NM_001199107.2(TBC1D24):c.1131C>G (p.Tyr377Ter)	TBC1D24	Y377*, Y371*	Normal	Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1|Caused by mutation in the TBC1 domain family, member 24	Pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000569501	16	2548386	16	2498385	569501	570225	rs1567413218	NC_000016.10:2498384:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.5050T>C (p.Ser1684Pro)	CREBBP	S1684P, S1646P	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158385	16	3781315	16	3731314	158385	169218	rs587783503	NC_000016.10:3731313:A:G	A	G	CLINICAL
NM_004380.3(CREBBP):c.4297T>C (p.Tyr1433His)	CREBBP	Y1395H, Y1433H	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694787	16	3788657	16	3738656	694787	682881	rs1596810435	NC_000016.10:3738655:A:G	A	G	CLINICAL
NM_004380.3(CREBBP):c.4283G>C (p.Arg1428Pro)	CREBBP	R1428P, R1390P	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694785	16	3788671	16	3738670	694785	682883	rs778448390	NC_000016.10:3738669:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.4226T>C (p.Phe1409Ser)	CREBBP	F1409S, F1371S	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158370	16	3789633	16	3739632	158370	169233	rs587783492	NC_000016.10:3739631:A:G	A	G	CLINICAL
NM_004380.3(CREBBP):c.4133G>C (p.Arg1378Pro)	CREBBP	R1378P, R1340P	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000009430	16	3790400	16	3740399	9430	24469	rs121434626	NC_000016.10:3740398:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.4040G>C (p.Arg1347Pro)	CREBBP	R1309P, R1347P	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694778	16	3790493	16	3740492	694778	682890	rs1596813665	NC_000016.10:3740491:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.4022G>C (p.Arg1341Pro)	CREBBP	R1341P, R1303P	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158366	16	3790511	16	3740510	158366	169237	rs587783488	NC_000016.10:3740509:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.3836+1G>C	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000568079	16	3799627	16	3749626	568079	570193	rs200782888	NC_000016.10:3749625:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.3610-1G>C	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694812	16	3807378	16	3757377	694812	682942	rs1596852670	NC_000016.10:3757376:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.3490G>C (p.Ala1164Pro)	CREBBP	A1164P, A1126P	Normal	Kabuki-like syndrome|Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 24, 2014)	criteria provided, single submitter	VCV000210778	16	3807929	16	3757928	210778	208267	rs797045492	NC_000016.10:3757927:C:G	C	G	CLINICAL
NM_004380.3(CREBBP):c.1941+2T>C	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694805	16	3828699	16	3778698	694805	682946	rs1596909656	NC_000016.10:3778697:A:G	A	G	CLINICAL
NM_004380.3(CREBBP):c.86-2A>C	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158402	16	3901012	16	3851011	158402	169271	rs587783515	NC_000016.10:3851010:T:G	T	G	CLINICAL
NM_133443.4(GPT2):c.459C>G (p.Ser153Arg)	GPT2	S153R, S53R	Normal	Mental retardation, autosomal recessive 49	Pathogenic(Last reviewed: Mar 3, 2015)	no assertion criteria provided	VCV000187856	16	46940770	16	46906858	187856	185748	rs786203999	NC_000016.10:46906857:C:G	C	G	CLINICAL
NM_015272.5(RPGRIP1L):c.2083G>C (p.Ala695Pro)	RPGRIP1L	A695P	Normal	Joubert syndrome 7	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000001071	16	53686516	16	53652604	1071	16110	rs121918200	NC_000016.10:53652603:C:G	C	G	CLINICAL
NM_015272.5(RPGRIP1L):c.1843A>C (p.Thr615Pro)	RPGRIP1L	T615P	Normal	not provided|Joubert syndrome 7|Joubert syndrome|Joubert syndrome|Meckel-Gruber syndrome	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001069	16	53686756	16	53652844	1069	16108	rs121918198	NC_000016.10:53652843:T:G	T	G	CLINICAL
NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	CTCF	H127Q, H455Q	Normal	Mental retardation, autosomal dominant 21	Likely pathogenic(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000812003	16	67660465	16	67626562	812003	799962	rs1597725291	NC_000016.10:67626561:C:G	C	G	CLINICAL
NM_020457.3(THAP11):c.240C>G (p.Phe80Leu)	THAP11|CENPT	F80L	Normal	Mental retardation 3, X-linked	Likely pathogenic(Last reviewed: Dec 7, 2016)	criteria provided, single submitter	VCV000393304	16	67876697	16	67842794	393304	380161	rs188675529	NC_000016.10:67842793:C:G	C	G	CLINICAL
NM_016373.4(WWOX):c.255C>G (p.Tyr85Ter)	WWOX	Y85*	Normal	not provided|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000419259	16	78148897	16	78115000	419259	409741	rs990150249	NC_000016.10:78114999:C:G	C	G	CLINICAL
NM_016373.4(WWOX):c.749C>G (p.Ser250Ter)	WWOX	S250*, S137*	Normal	not provided|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000284393	16	78458910	16	78425013	284393	268630	rs368928190	NC_000016.10:78425012:C:G	C	G	CLINICAL
NM_016373.4(WWOX):c.779C>G (p.Ser260Ter)	WWOX	S260*, S147*	Normal	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000241104	16	78458940	16	78425043	241104	242511	rs878855021	NC_000016.10:78425042:C:G	C	G	CLINICAL
NM_013275.6(ANKRD11):c.7570-1G>C	ANKRD11		Normal	KBG syndrome	Pathogenic(Last reviewed: Aug 12, 2011)	no assertion criteria provided	VCV000030890	16	89341366	16	89274958	30890	39847	rs863223319	NC_000016.10:89274957:C:G	C	G	CLINICAL
NM_013275.6(ANKRD11):c.2006A>C (p.Asp669Ala)	ANKRD11	D669A	Normal	KBG syndrome	Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689739	16	89350944	16	89284536	689739	677454	rs1597462279	NC_000016.10:89284535:T:G	T	G	CLINICAL
NM_013275.6(ANKRD11):c.893-1G>C	ANKRD11		Normal	KBG syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560944	16	89352058	16	89285650	560944	552196	rs1567583835	NC_000016.10:89285649:C:G	C	G	CLINICAL
NM_006086.4(TUBB3):c.967A>G (p.Met323Val)	TUBB3	M323V, M251V	Normal	Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Nov 15, 2010)	no assertion criteria provided	VCV000030272	16	90001826	16	89935418	30272	39228	rs878853256	NC_000016.10:89935417:A:G	A	G	CLINICAL
NM_001134407.3(GRIN2A):c.2450T>C (p.Met817Thr)	GRIN2A	M817T	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803217	16	9862853	16	9768996	803217	791670	rs1064796608	NC_000016.10:9768995:A:G	A	G	CLINICAL
NM_001134407.3(GRIN2A):c.1673G>C (p.Trp558Ser)	GRIN2A	W558S	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000532714	16	9928066	16	9834209	532714	530612	rs1555493585	NC_000016.10:9834208:C:G	C	G	CLINICAL
NM_014712.3(SETD1A):c.518-2A>G	SETD1A		Normal	Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224650	16	30974752	16	30963431	224650	226431	rs869312829	NC_000016.10:30963430:A:G	A	G	CLINICAL
NM_014712.3(SETD1A):c.1938C>G (p.Tyr646Ter)	SETD1A	Y646*	Normal	Schizophrenia|not provided	Pathogenic(Last reviewed: May 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224654	16	30977140	16	30965819	224654	226433	rs770913157	NC_000016.10:30965818:C:G	C	G	CLINICAL
NM_004960.3(FUS):c.646C>T (p.Arg216Cys)	FUS	R216C, R212C, R215C	Normal	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000016227	16	31196382	16	31185061	16227	31266	rs267606832	NC_000016.10:31185060:C:T	C	T	CLINICAL
NM_004960.3(FUS):c.1483C>T (p.Arg495Ter)	FUS	R495*, R494*, R491*	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000029707	16	31202373	16	31191052	29707	38662	rs387906627	NC_000016.10:31191051:C:T	C	T	CLINICAL
NM_004960.4(FUS):c.1540A>T (p.Arg514Trp)	FUS	R514W, R510W, R513W	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803253	16	31202430	16	31191109	803253	791586	rs1555509609	NC_000016.10:31191108:A:T	A	T	CLINICAL
NM_004960.3(FUS):c.1561C>T (p.Arg521Cys)	FUS	R521C, R517C, R520C	Normal	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000016224	16	31202739	16	31191418	16224	31263	rs121909668	NC_000016.10:31191417:C:T	C	T	CLINICAL
NM_004960.3(FUS):c.1574C>T (p.Pro525Leu)	FUS	P525L, P521L, P524L	Normal	not provided|Juvenile amyotrophic lateral sclerosis|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280110	16	31202752	16	31191431	280110	264787	rs886041390	NC_000016.10:31191430:C:T	C	T	CLINICAL
NM_000548.5(TSC2):c.1258G>T (p.Glu420Ter)	TSC2	E420*, E371*, E220*, E383*, E431*	Normal	Tuberous sclerosis 2|not provided	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207712	16	2112498	16	2062497	207712	203108	rs796053484	NC_000016.10:2062496:G:T	G	T	CLINICAL
NM_013275.6(ANKRD11):c.3138T>A (p.Cys1046Ter)	ANKRD11	C1046*	Normal	Autism spectrum disorder	Pathogenic(Last reviewed: Jan 11, 2017)	criteria provided, single submitter	VCV000589485	16	89349812	16	89283404	589485	580222	rs1567574466	NC_000016.10:89283403:A:T	A	T	CLINICAL
NM_152649.4(MLKL):c.947G>A (p.Gly316Asp)	MLKL	G316D	Normal	Maturity onset diabetes mellitus in young	Pathogenic(Last reviewed: Dec 16, 2020)	criteria provided, single submitter	VCV001177643	16	74716558	16	74682660	1177643	1167130	rs375490660	NC_000016.10:74682659:C:T	C	T	CLINICAL
NM_017668.3(NDE1):c.83+1G>T	NDE1		Normal	Lissencephaly 4	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000435939	16	15758719	16	15664862	435939	429772	rs1456594953	NC_000016.10:15664861:G:T	G	T	CLINICAL
NM_017668.3(NDE1):c.109C>T (p.Arg37Ter)	NDE1	R37*	Normal	Lissencephaly 4|not provided	Pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620567	16	15761168	16	15667311	620567	611812	rs757604577	NC_000016.10:15667310:C:T	C	T	CLINICAL
NM_017668.3(NDE1):c.658C>T (p.Arg220Ter)	NDE1	R220*	Normal	Lissencephaly 4	Pathogenic(Last reviewed: Aug 13, 2013)	criteria provided, single submitter	VCV000159015	16	15785135	16	15691278	159015	169188	rs576928842	NC_000016.10:15691277:C:T	C	T	CLINICAL
NM_003366.4(UQCRC2):c.547C>T (p.Arg183Trp)	UQCRC2|PDZD9	R183W	Normal	Mitochondrial complex III deficiency, nuclear type 5	Pathogenic(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000041880	16	21976761	16	21965440	41880	50318	rs374661051	NC_000016.10:21965439:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.116C>T (p.Ala39Val)	TBC1D24	A39V	Normal	Caused by mutation in the TBC1 domain family, member 24|Deafness, autosomal dominant 65|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV000474302	16	2546265	16	2496264	474302	466552	rs773916549	NC_000016.10:2496263:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.118C>T (p.Arg40Cys)	TBC1D24	R40C	Normal	not provided|DOORS syndrome	Pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000091396	16	2546267	16	2496266	91396	96872	rs398122966	NC_000016.10:2496265:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.119G>T (p.Arg40Leu)	TBC1D24	R40L	Normal	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000183152	16	2546268	16	2496267	183152	181288	rs760474458	NC_000016.10:2496266:G:T	G	T	CLINICAL
NM_001199107.2(TBC1D24):c.121C>T (p.Gln41Ter)	TBC1D24	Q41*	Normal	not provided|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391687	16	2546270	16	2496269	391687	377427	rs1057524191	NC_000016.10:2496268:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.194G>T (p.Arg65Leu)	TBC1D24	R65L	Normal	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Feb 16, 2016)	no assertion criteria provided	VCV000236046	16	2546343	16	2496342	236046	237618	rs878853232	NC_000016.10:2496341:G:T	G	T	CLINICAL
NM_001199107.2(TBC1D24):c.208G>T (p.Asp70Tyr)	TBC1D24	D70Y	Normal	Deafness, autosomal recessive 86	Pathogenic(Last reviewed: Dec 22, 2014)	no assertion criteria provided	VCV000100677	16	2546357	16	2496356	100677	106549	rs587777147	NC_000016.10:2496355:G:T	G	T	CLINICAL
NM_001199107.2(TBC1D24):c.346A>T (p.Lys116Ter)	TBC1D24	K116*	Normal	Deafness, autosomal recessive 86|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000587507	16	2546495	16	2496494	587507	578528	rs1567411469	NC_000016.10:2496493:A:T	A	T	CLINICAL
NM_001199107.2(TBC1D24):c.533C>T (p.Ser178Leu)	TBC1D24	S178L	Normal	Deafness, autosomal recessive 86|not provided|Deafness, autosomal dominant 65	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000133246	16	2546682	16	2496681	133246	136991	rs483352866	NC_000016.10:2496680:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys)	TBC1D24	R242C	Normal	DOORS syndrome|Epileptic encephalopathy, early infantile, 1|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|not provided|Early infantile epileptic encephalopathy 16	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000091395	16	2546873	16	2496872	91395	96871	rs398122965	NC_000016.10:2496871:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.866C>T (p.Ala289Val)	TBC1D24	A289V	Normal	Myoclonic epilepsy, familial infantile	Likely pathogenic(Last reviewed: Dec 10, 2015)	criteria provided, single submitter	VCV000436948	16	2547015	16	2497014	436948	429781	rs748759187	NC_000016.10:2497013:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.901C>T (p.Gln301Ter)	TBC1D24	Q301*	Normal	Movement disorder|Specific learning disability|Seizures|Global developmental delay|Cerebellar atrophy	Likely pathogenic	no assertion criteria provided	VCV000812998	16	2547050	16	2497049	812998	801159	rs1596969013	NC_000016.10:2497048:C:T	C	T	CLINICAL
NM_001199107.2(TBC1D24):c.999G>T (p.Leu333Phe)	TBC1D24	L333F, L327F	Normal	DOORS syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000183155	16	2548254	16	2498253	183155	181291	rs797044548	NC_000016.10:2498252:G:T	G	T	CLINICAL
NM_001199107.2(TBC1D24):c.1079G>T (p.Arg360Leu)	TBC1D24	R360L, R354L	Normal	Intellectual disability|Periodic paralysis|Neurodevelopmental delay|Progressive myoclonus epilepsy with ataxia	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000183157	16	2548334	16	2498333	183157	181292	rs765965968	NC_000016.10:2498332:G:T	G	T	CLINICAL
NM_001199107.2(TBC1D24):c.1499C>T (p.Ala500Val)	TBC1D24	A500V, A494V	Normal	Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome|not provided|Deafness, autosomal dominant 65|Caused by mutation in the TBC1 domain family, member 24|Epileptic encephalopathy, early infantile, 1	Likely pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419296	16	2550465	16	2500464	419296	409583	rs564477999	NC_000016.10:2500463:C:T	C	T	CLINICAL
NM_024339.5(THOC6):c.139C>T (p.Gln47Ter)	THOC6	Q47*, Q23*	Normal	Beaulieu-Boycott-Innes syndrome|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000633695	16	3075808	16	3025807	633695	622126	rs578012528	NC_000016.10:3025806:C:T	C	T	CLINICAL
NM_024339.5(THOC6):c.259C>T (p.Arg87Ter)	THOC6	R87*, R63*	Normal	Inborn genetic diseases|Beaulieu-Boycott-Innes syndrome	Pathogenic(Last reviewed: Jan 9, 2015)	criteria provided, single submitter	VCV000520614	16	3076102	16	3026101	520614	512191	rs763344375	NC_000016.10:3026100:C:T	C	T	CLINICAL
NM_006662.3(SRCAP):c.7300G>T (p.Glu2434Ter)	SRCAP	E2434*	Normal	Intellectual disability, moderate	Likely pathogenic	no assertion criteria provided	VCV000812778	16	30748661	16	30737340	812778	801160	rs1596667777	NC_000016.10:30737339:G:T	G	T	CLINICAL
NM_004380.3(CREBBP):c.6324C>A (p.Tyr2108Ter)	CREBBP	Y2108*, Y2070*	Normal	Rubinstein-Taybi syndrome 1|Inborn genetic diseases	Likely pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431483	16	3778724	16	3728723	431483	424990	rs199821421	NC_000016.10:3728722:G:T	G	T	CLINICAL
NM_004380.3(CREBBP):c.5412C>A (p.His1804Gln)	CREBBP	H1804Q, H1766Q	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 17, 2014)	criteria provided, single submitter	VCV000210782	16	3779636	16	3729635	210782	208263	rs797045496	NC_000016.10:3729634:G:T	G	T	CLINICAL
NM_004380.3(CREBBP):c.5027G>A (p.Trp1676Ter)	CREBBP	W1676*, W1638*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Dec 23, 2014)	criteria provided, single submitter	VCV000210781	16	3781338	16	3731337	210781	208264	rs797045495	NC_000016.10:3731336:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.4991G>A (p.Arg1664His)	CREBBP	R1626H, R1664H	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694829	16	3781374	16	3731373	694829	682873	rs1596791996	NC_000016.10:3731372:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.4890+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694828	16	3781776	16	3731775	694828	682936	rs1596793242	NC_000016.10:3731774:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.4417G>A (p.Ala1473Thr)	CREBBP	A1435T, A1473T	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694790	16	3786794	16	3736793	694790	682879	rs1596805927	NC_000016.10:3736792:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.4398T>A (p.Tyr1466Ter)	CREBBP	Y1466*, Y1428*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158374	16	3786813	16	3736812	158374	169229	rs147688139	NC_000016.10:3736811:A:T	A	T	CLINICAL
NM_004380.3(CREBBP):c.4290C>A (p.Tyr1430Ter)	CREBBP	Y1430*, Y1392*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694786	16	3788664	16	3738663	694786	682882	rs1596810465	NC_000016.10:3738662:G:T	G	T	CLINICAL
NM_004380.3(CREBBP):c.4133+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	VCV000158369	16	3790399	16	3740398	158369	169234	rs587783491	NC_000016.10:3740397:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3982+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Aug 17, 2015)	criteria provided, multiple submitters, no conflicts	VCV000095046	16	3794894	16	3744893	95046	100946	rs398124145	NC_000016.10:3744892:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3914+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694777	16	3795277	16	3745276	694777	682939	rs1555475352	NC_000016.10:3745275:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3836+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome	Pathogenic(Last reviewed: Jul 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158361	16	3799627	16	3749626	158361	169242	rs200782888	NC_000016.10:3749625:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3832G>A (p.Glu1278Lys)	CREBBP	E1278K, E1240K	Normal	Rubinstein-Taybi syndrome 1|not provided|Inborn genetic diseases|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009433	16	3799632	16	3749631	9433	24472	rs267606752	NC_000016.10:3749630:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3779+1G>A	CREBBP		Normal	not provided|Rubinstein-Taybi syndrome 1|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158359	16	3801726	16	3751725	158359	169243	rs587783483	NC_000016.10:3751724:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3719G>A (p.Cys1240Tyr)	CREBBP	C1202Y, C1240Y	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000694819	16	3801787	16	3751786	694819	682892	rs1596839714	NC_000016.10:3751785:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.3698G>A (p.Arg1233Lys)	CREBBP	R1233K, R1195K	Normal	Rubinstein-Taybi syndrome 1|Glaucoma|Thumb deformity (disease)	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374025	16	3807289	16	3757288	374025	360999	rs1057518844	NC_000016.10:3757287:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.2535C>A (p.Cys845Ter)	CREBBP	C845*, C807*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158346	16	3820916	16	3770915	158346	169253	rs587783471	NC_000016.10:3770914:G:T	G	T	CLINICAL
NM_004380.3(CREBBP):c.1941+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000527959	16	3828700	16	3778699	527959	530307	rs1555483834	NC_000016.10:3778698:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.1824-1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694803	16	3828819	16	3778818	694803	682947	rs1596910004	NC_000016.10:3778817:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.1573+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694800	16	3832684	16	3782683	694800	682948	rs1596920360	NC_000016.10:3782682:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.1257G>A (p.Trp419Ter)	CREBBP	W419*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158337	16	3842055	16	3792054	158337	169261	rs587783463	NC_000016.10:3792053:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.1216+2T>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 5, 2019)	no assertion criteria provided	VCV000694796	16	3843385	16	3793384	694796	682949	rs1596947522	NC_000016.10:3793383:A:T	A	T	CLINICAL
NM_004380.3(CREBBP):c.953C>A (p.Ser318Ter)	CREBBP	S318*	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158403	16	3860626	16	3810625	158403	169265	rs587783516	NC_000016.10:3810624:G:T	G	T	CLINICAL
NM_004380.3(CREBBP):c.85+1G>A	CREBBP		Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000689621	16	3929832	16	3879831	689621	677299	rs1597099388	NC_000016.10:3879830:C:T	C	T	CLINICAL
NM_004380.3(CREBBP):c.2T>A (p.Met1Lys)	CREBBP	M1K	Normal	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Nov 13, 2014)	criteria provided, single submitter	VCV000210773	16	3929916	16	3879915	210773	208281	rs797045487	NC_000016.10:3879914:A:T	A	T	CLINICAL
NM_133443.4(GPT2):c.70C>T (p.Gln24Ter)	GPT2	Q24*	Normal	Inborn genetic diseases|Mental retardation, autosomal recessive 49	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, single submitter	VCV000522105	16	46918697	16	46884785	522105	512212	rs1437184398	NC_000016.10:46884784:C:T	C	T	CLINICAL
NM_133443.4(GPT2):c.1210C>T (p.Arg404Ter)	GPT2	R404*, R304*	Normal	Mental retardation, autosomal recessive 49	Pathogenic(Last reviewed: Nov 5, 2020)	no assertion criteria provided	VCV000254655	16	46956326	16	46922414	254655	249203	rs115352435	NC_000016.10:46922413:C:T	C	T	CLINICAL
NM_133368.3(RSPRY1):c.121G>T (p.Gly41Cys)	RSPRY1	G41C	Normal	Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type	Pathogenic(Last reviewed: Oct 1, 2015)	no assertion criteria provided	VCV000218886	16	57238691	16	57204779	218886	215643	rs864309652	NC_000016.10:57204778:G:T	G	T	CLINICAL
NM_004204.4(PIGQ):c.619C>T (p.Arg207Ter)	PIGQ	R207*	Normal	Developmental and epileptic encephalopathy, 77|Global developmental delay|Optic atrophy|Intractable seizure	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	no assertion criteria provided	VCV000183339	16	624693	16	574693	183339	181445	rs730882240	NC_000016.10:574692:C:T	C	T	CLINICAL
NM_006565.4(CTCF):c.1699C>T (p.Arg567Trp)	CTCF	R567W, R239W	Normal	Mental retardation, autosomal dominant 21|not provided	Pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000088638	16	67662453	16	67628550	88638	94227	rs879255516	NC_000016.10:67628549:C:T	C	T	CLINICAL
NM_006565.4(CTCF):c.1990C>T (p.Gln664Ter)	CTCF	Q664*, Q336*	Normal	Mental retardation, autosomal dominant 21	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803262	16	67670745	16	67636842	803262	791631	rs200677445	NC_000016.10:67636841:C:T	C	T	CLINICAL
NM_019023.5(PRMT7):c.322G>T (p.Glu108Ter)	PRMT7	E108*, E58*, E29*	Normal	Short stature, brachydactyly, intellectual developmental disability, and seizures|Insulin resistance|Short stature|Renal hypoplasia (disease)|Brachydactyly|Obesity|Acanthosis nigricans|Hyperlipidemia|Short metacarpal|Lumbar hyperlordosis|Skeletal dysplasia|Hepatic steatosis|Abnormality of the dentition|Self-injurious behavior|Abnormal facial shape|Intellectual disability, severe|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000523435	16	68363008	16	68329105	523435	514064	rs1014959895	NC_000016.10:68329104:G:T	G	T	CLINICAL
NM_016373.4(WWOX):c.108-2A>T	WWOX		Normal	Spinocerebellar ataxia, autosomal recessive 12|Malignant tumor of esophagus|Epileptic encephalopathy, early infantile, 28	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804478	16	78142318	16	78108421	804478	792801	rs1597207802	NC_000016.10:78108420:A:T	A	T	CLINICAL
NM_016373.4(WWOX):c.160C>T (p.Arg54Ter)	WWOX	R54*	Normal	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|Epileptic encephalopathy, early infantile, 28	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000120325	16	78142372	16	78108475	120325	125920	rs587777248	NC_000016.10:78108474:C:T	C	T	CLINICAL
NM_016373.4(WWOX):c.214C>T (p.Gln72Ter)	WWOX	Q72*	Normal	not provided|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449920	16	78143716	16	78109819	449920	445615	rs201008667	NC_000016.10:78109818:C:T	C	T	CLINICAL
NM_016373.4(WWOX):c.511G>T (p.Glu171Ter)	WWOX	E171*, E58*	Normal	Spinocerebellar ataxia, autosomal recessive 12	Likely pathogenic(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225517	16	78198181	16	78164284	225517	227381	rs751181600	NC_000016.10:78164283:G:T	G	T	CLINICAL
NM_016373.4(WWOX):c.583G>T (p.Glu195Ter)	WWOX	E195*, E82*	Normal	Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000568364	16	78420823	16	78386926	568364	570546	rs1567542020	NC_000016.10:78386925:G:T	G	T	CLINICAL
NM_016373.4(WWOX):c.790C>T (p.Arg264Ter)	WWOX	R264*, R151*	Normal	not provided|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 28|Malignant tumor of esophagus|Spinocerebellar ataxia, autosomal recessive 12|Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000241105	16	78458951	16	78425054	241105	242512	rs756762196	NC_000016.10:78425053:C:T	C	T	CLINICAL
NM_005360.5(MAF):c.176C>A (p.Pro59His)	MAF	P59H	Normal	Ayme-gripp syndrome	Pathogenic(Last reviewed: May 7, 2015)	no assertion criteria provided	VCV000162515	16	79633624	16	79599727	162515	172188	rs727502770	NC_000016.10:79599726:G:T	G	T	CLINICAL
NM_022041.3(GAN):c.1429C>T (p.Arg477Ter)	GAN	R477*	Normal	Giant axonal neuropathy 1	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000005037	16	81399010	16	81365405	5037	20076	rs119485094	NC_000016.10:81365404:C:T	C	T	CLINICAL
NM_000303.3(PMM2):c.710C>T (p.Thr237Met)	PMM2	T237M	Normal	Congenital disorder of glycosylation, type Ia|Intellectual disability|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021145	16	8941651	16	8847794	21145	33997	rs80338708	NC_000016.10:8847793:C:T	C	T	CLINICAL
NM_013275.6(ANKRD11):c.7751C>A (p.Ala2584Asp)	ANKRD11	A2584D	Normal	KBG syndrome	Likely pathogenic	no assertion criteria provided	VCV000375576	16	89337280	16	89270872	375576	362386	rs1555521799	NC_000016.10:89270871:G:T	G	T	CLINICAL
NM_013275.6(ANKRD11):c.7569+1G>A	ANKRD11		Normal	Inborn genetic diseases|not provided|KBG syndrome	Pathogenic(Last reviewed: May 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000208695	16	89341500	16	89275092	208695	205298	rs797044890	NC_000016.10:89275091:C:T	C	T	CLINICAL
NM_013275.6(ANKRD11):c.3122C>A (p.Ser1041Ter)	ANKRD11	S1041*	Normal	KBG syndrome	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374273	16	89349828	16	89283420	374273	361224	rs1057518663	NC_000016.10:89283419:G:T	G	T	CLINICAL
NM_013275.6(ANKRD11):c.3084C>A (p.Tyr1028Ter)	ANKRD11	Y1028*	Normal	not provided|KBG syndrome|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jun 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000418939	16	89349866	16	89283458	418939	409797	rs1064793539	NC_000016.10:89283457:G:T	G	T	CLINICAL
NM_013275.6(ANKRD11):c.867C>A (p.Tyr289Ter)	ANKRD11	Y289*	Normal	not provided|KBG syndrome	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000560943	16	89352472	16	89286064	560943	552197	rs761636251	NC_000016.10:89286063:G:T	G	T	CLINICAL
NM_006086.4(TUBB3):c.905C>T (p.Ala302Val)	TUBB3	A302V, A230V	Normal	Cortical dysplasia, complex, with other brain malformations 1	Pathogenic(Last reviewed: Nov 15, 2010)	no assertion criteria provided	VCV000030275	16	90001764	16	89935356	30275	39231	rs878853258	NC_000016.10:89935355:C:T	C	T	CLINICAL
NM_001134407.3(GRIN2A):c.2453C>A (p.Ala818Glu)	GRIN2A	A818E	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000495226	16	9862850	16	9768993	495226	486724	rs751455326	NC_000016.10:9768992:G:T	G	T	CLINICAL
NM_001134407.3(GRIN2A):c.2084G>A (p.Arg695Gln)	GRIN2A	R695Q	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000205689	16	9916205	16	9822348	205689	203359	rs796052563	NC_000016.10:9822347:C:T	C	T	CLINICAL
NM_001134407.3(GRIN2A):c.1901G>A (p.Trp634Ter)	GRIN2A	W634*	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000532718	16	9923386	16	9829529	532718	530803	rs1555492769	NC_000016.10:9829528:C:T	C	T	CLINICAL
NM_001134407.3(GRIN2A):c.1845C>A (p.Asn615Lys)	GRIN2A	N615K	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation	Pathogenic(Last reviewed: Mar 16, 2016)	no assertion criteria provided	VCV000029733	16	9923442	16	9829585	29733	38688	rs397518447	NC_000016.10:9829584:G:T	G	T	CLINICAL
NM_001134407.3(GRIN2A):c.1662C>A (p.Ser554Arg)	GRIN2A	S554R	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000691255	16	9928077	16	9834220	691255	678947	rs1596476657	NC_000016.10:9834219:G:T	G	T	CLINICAL
NM_001134407.3(GRIN2A):c.1553G>A (p.Arg518His)	GRIN2A	R518H	Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000088732	16	9934602	16	9840745	88732	94309	rs397518470	NC_000016.10:9840744:C:T	C	T	CLINICAL
NM_001134407.3(GRIN2A):c.1007+1G>A	GRIN2A		Normal	Epilepsy, focal, with speech disorder and with or without mental retardation|Rolandic epilepsy|not provided	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000088727	16	10031815	16	9937958	88727	94304	rs397518465	NC_000016.10:9937957:C:T	C	T	CLINICAL
NM_018206.6(VPS35):c.1858G>A (p.Asp620Asn)	VPS35	D620N	Normal	Parkinson disease 17	Pathogenic(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000030196	16	46696364	16	46662452	30196	39152	rs188286943	NC_000016.10:46662451:C:T	C	T	CLINICAL
NM_014712.3(SETD1A):c.2209C>T (p.Gln737Ter)	SETD1A	Q737*	Normal	Schizophrenia	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000224652	16	30977411	16	30966090	224652	226435	rs869312831	NC_000016.10:30966089:C:T	C	T	CLINICAL
NM_018206.6(VPS35):c.1858G>A (p.Asp620Asn)	VPS35	D620N	Normal	Parkinson disease 17	Pathogenic(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000030196	16	46696364	16	46662452	30196	39152	rs188286943	NC_000016.10:46662451:C:T	C	T	CLINICAL
NM_005022.4(PFN1):c.353G>T (p.Gly118Val)	PFN1	G118V	Normal	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037036	17	4849265	17	4945970	37036	45722	rs387907266	NC_000017.11:4945969:C:A	C	A	CLINICAL
NM_173477.5(USH1G):c.1373A>T (p.Asp458Val)	USH1G	D458V, D355V	Normal	not provided|Rare genetic deafness	Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000048127	17	72915558	17	74919463	48127	57291	rs397517925	NC_000017.11:74919462:T:A	T	A	CLINICAL
NM_002087.3(GRN):c.264+1G>A	GRN		Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599611	17	42426920	17	44349552	599611	590955	rs1567885728	NC_000017.11:44349551:G:A	G	A	CLINICAL
NM_000430.4(PAFAH1B1):c.484G>A (p.Gly162Ser)	PAFAH1B1	G162S	Normal	Lissencephaly due to LIS1 mutation	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000008079	17	2573541	17	2670247	8079	23118	rs121434487	NC_000017.11:2670246:G:A	G	A	CLINICAL
NM_144997.7(FLCN):c.1429C>T (p.Arg477Ter)	FLCN	R477*, R495*	Normal	not provided|Hereditary cancer-predisposing syndrome|Multiple fibrofolliculomas|Pneumothorax, primary spontaneous|Renal cell carcinoma, nonpapillary|Multiple fibrofolliculomas|Potocki-Lupski syndrome|Carcinoma of colon|not specified	Pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000253251	17	17118502	17	17215188	253251	247653	rs879255678	NC_000017.11:17215187:G:A	G	A	CLINICAL
NM_144997.7(FLCN):c.779+1G>T	FLCN		Normal	not specified|Multiple fibrofolliculomas|Pneumothorax, primary spontaneous|Renal cell carcinoma, nonpapillary|Multiple fibrofolliculomas|Potocki-Lupski syndrome|Carcinoma of colon|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231274	17	17125814	17	17222500	231274	235483	rs758175953	NC_000017.11:17222499:C:A	C	A	CLINICAL
NM_007144.3(PCGF2):c.194C>T (p.Pro65Leu)	PCGF2	P65L	Normal	Abnormality of the outer ear|Intellectual disability|Turnpenny-fry syndrome|Global developmental delay	Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000619193	17	36895854	17	38739601	619193	610591	rs1567941252	NC_000017.11:38739600:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.245G>A (p.Gly82Asp)	NAGLU	G82D	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803391	17	40688535	17	42536517	803391	791745	rs1599253815	NC_000017.11:42536516:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.309G>A (p.Trp103Ter)	NAGLU	W103*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Jun 7, 2017)	no assertion criteria provided	VCV000590818	17	40688599	17	42536581	590818	581774	rs1567890328	NC_000017.11:42536580:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.384-1G>A	NAGLU		Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552772	17	40689415	17	42537397	552772	548856	rs764134891	NC_000017.11:42537396:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.503G>A (p.Trp168Ter)	NAGLU	W168*	Normal	Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000092695	17	40689535	17	42537517	92695	98602	rs398123281	NC_000017.11:42537516:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1211G>A (p.Trp404Ter)	NAGLU	W404*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551331	17	40695235	17	42543217	551331	548454	rs904672363	NC_000017.11:42543216:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1277G>A (p.Gly426Asp)	NAGLU	G426D	Normal	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000643204	17	40695301	17	42543283	643204	645903	rs771151036	NC_000017.11:42543282:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1421G>A (p.Trp474Ter)	NAGLU	W474*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	VCV000555099	17	40695445	17	42543427	555099	548163	rs1555622351	NC_000017.11:42543426:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1694G>A (p.Arg565Gln)	NAGLU	R565Q	Normal	Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Sanfilippo syndrome|not provided	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030795	17	40695718	17	42543700	30795	39752	rs104894598	NC_000017.11:42543699:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1863G>A (p.Trp621Ter)	NAGLU	W621*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000551779	17	40695887	17	42543869	551779	548165	rs1555622488	NC_000017.11:42543868:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1946G>A (p.Trp649Ter)	NAGLU	W649*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000660650	17	40695970	17	42543952	660650	645904	rs527236038	NC_000017.11:42543951:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.1949G>A (p.Gly650Glu)	NAGLU	G650E	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Apr 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143188	17	40695973	17	42543955	143188	152906	rs527236037	NC_000017.11:42543954:G:A	G	A	CLINICAL
NM_000263.4(NAGLU):c.2021G>A (p.Arg674His)	NAGLU	R674H	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001560	17	40696045	17	42544027	1560	16599	rs104894590	NC_000017.11:42544026:G:A	G	A	CLINICAL
NM_001193466.2(KANSL1):c.868C>T (p.Arg290Ter)	KANSL1	R290*	Normal	not provided|Koolen-de Vries syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000421289	17	44248642	17	46171276	421289	410051	rs149830411	NC_000017.11:46171275:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.1375C>T (p.Gln459Ter)	SGSH	Q459*	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic	criteria provided, single submitter	VCV000619124	17	78184385	17	80210586	619124	610522	rs1567914459	NC_000017.11:80210585:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.1297C>T (p.Arg433Trp)	SGSH	R433W	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551014	17	78184463	17	80210664	551014	548846	rs777267343	NC_000017.11:80210663:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.1225C>T (p.Gln409Ter)	SGSH	Q409*	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000555736	17	78184535	17	80210736	555736	548472	rs1323958195	NC_000017.11:80210735:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.1138C>T (p.Gln380Ter)	SGSH	Q380*	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000550040	17	78184622	17	80210823	550040	548462	rs1424242431	NC_000017.11:80210822:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.1129C>T (p.Arg377Cys)	SGSH	R377C	Normal	Inborn genetic diseases|not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000559103	17	78184631	17	80210832	559103	549765	rs772311757	NC_000017.11:80210831:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.911G>T (p.Arg304Leu)	SGSH	R304L	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000555619	17	78185908	17	80212109	555619	548855	rs745884647	NC_000017.11:80212108:C:A	C	A	CLINICAL
NM_000199.5(SGSH):c.877C>T (p.Pro293Ser)	SGSH	P293S	Normal	Inborn genetic diseases|Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265258	17	78185942	17	80212143	265258	260197	rs143947056	NC_000017.11:80212142:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.812C>T (p.Thr271Met)	SGSH	T271M	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522769	17	78186007	17	80212208	522769	513371	rs746776254	NC_000017.11:80212207:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.697C>T (p.Arg233Ter)	SGSH	R233*	Normal	Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370732	17	78187651	17	80213852	370732	358524	rs374621913	NC_000017.11:80213851:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.664-1G>T	SGSH		Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000554868	17	78187685	17	80213886	554868	548864	rs1555621425	NC_000017.11:80213885:C:A	C	A	CLINICAL
NM_000199.5(SGSH):c.544C>T (p.Arg182Cys)	SGSH	R182C	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523015	17	78188090	17	80214291	523015	513649	rs529855742	NC_000017.11:80214290:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.490C>T (p.Gln164Ter)	SGSH	Q164*	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000654350	17	78188430	17	80214631	654350	646966	rs1598749661	NC_000017.11:80214630:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.383C>T (p.Pro128Leu)	SGSH	P128L	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Apr 1, 2003)	no assertion criteria provided	VCV000005110	17	78188537	17	80214738	5110	20149	rs104894642	NC_000017.11:80214737:G:A	G	A	CLINICAL
NM_000199.5(SGSH):c.220C>T (p.Arg74Cys)	SGSH	R74C	Normal	Mucopolysaccharidosis|not provided|Abnormality of carbohydrate metabolism/homeostasis|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005108	17	78190860	17	80217061	5108	20147	rs104894636	NC_000017.11:80217060:G:A	G	A	CLINICAL
NM_000250.2(MPO):c.1705C>T (p.Arg569Trp)	MPO|LOC106694316	R569W	Normal	not provided|Myeloperoxidase deficiency	Pathogenic(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003626	17	56350196	17	58272835	3626	18665	rs119468010	NC_000017.11:58272834:G:A	G	A	CLINICAL
NM_001042492.3(NF1):c.3827G>A (p.Arg1276Gln)	NF1	R1276Q	Normal	Neurofibromatosis, type 1|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, type 1|Juvenile myelomonocytic leukemia|Neurofibromatosis-Noonan syndrome|Neurofibromatosis, familial spinal|Café-au-lait macules with pulmonary stenosis|Hereditary cancer-predisposing syndrome|not provided|Neurofibromatosis, type 1	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000068341	17	29562747	17	31235729	68341	79232	rs137854556	NC_000017.11:31235728:G:A	G	A	CLINICAL
NM_004278.4(PIGL):c.427-1G>A	PIGL		Normal	CHIME syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030547	17	16216860	17	16313546	30547	39504	rs770084126	NC_000017.11:16313545:G:A	G	A	CLINICAL
NM_000382.3(ALDH3A2):c.733G>A (p.Asp245Asn)	ALDH3A2	D245N, D52N	Normal	not provided|Sjögren-Larsson syndrome	Pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265459	17	19561110	17	19657797	265459	260161	rs72547568	NC_000017.11:19657796:G:A	G	A	CLINICAL
NM_007144.3(PCGF2):c.194C>T (p.Pro65Leu)	PCGF2	P65L	Normal	Abnormality of the outer ear|Intellectual disability|Turnpenny-fry syndrome|Global developmental delay	Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000619193	17	36895854	17	38739601	619193	610591	rs1567941252	NC_000017.11:38739600:G:A	G	A	CLINICAL
NM_033419.5(PGAP3):c.861G>T (p.Trp287Cys)	PGAP3	W287C, W236C, W266C	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224641	17	37829342	17	39673089	224641	226422	rs869312813	NC_000017.11:39673088:C:A	C	A	CLINICAL
NM_033419.5(PGAP3):c.850C>T (p.His284Tyr)	PGAP3	H284Y, H263Y, H233Y	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000800935	17	37829353	17	39673100	800935	788909	rs759541820	NC_000017.11:39673099:G:A	G	A	CLINICAL
NM_004247.4(EFTUD2):c.2770C>T (p.Gln924Ter)	EFTUD2	Q924*, Q914*, Q889*	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030401	17	42929131	17	44851763	30401	39358	rs387906878	NC_000017.11:44851762:G:A	G	A	CLINICAL
NM_004247.4(EFTUD2):c.2335C>T (p.Leu779Phe)	EFTUD2	L744F, L769F, L779F	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000690304	17	42931649	17	44854281	690304	677984	rs1597789186	NC_000017.11:44854280:G:A	G	A	CLINICAL
NM_004247.4(EFTUD2):c.2047A>T (p.Asn683Tyr)	EFTUD2	N683Y, N648Y, N673Y	Normal	Seizures|Global developmental delay	Likely pathogenic(Last reviewed: Oct 29, 2014)	criteria provided, single submitter	VCV000374152	17	42932371	17	44855003	374152	361016	rs1057518932	NC_000017.11:44855002:T:A	T	A	CLINICAL
NM_004247.4(EFTUD2):c.1732C>T (p.Arg578Ter)	EFTUD2	R578*, R568*, R543*	Normal	not provided|Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000379625	17	42937401	17	44860033	379625	375142	rs1057520673	NC_000017.11:44860032:G:A	G	A	CLINICAL
NM_004247.4(EFTUD2):c.1060C>T (p.Arg354Ter)	EFTUD2	R354*, R319*, R344*	Normal	not provided|Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Jan 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620475	17	42945264	17	44867896	620475	611859	rs996949678	NC_000017.11:44867895:G:A	G	A	CLINICAL
NM_004247.4(EFTUD2):c.784C>T (p.Arg262Trp)	EFTUD2	R262W, R227W, R252W	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Nov 7, 2014)	criteria provided, single submitter	VCV000030400	17	42953387	17	44876019	30400	39357	rs387906877	NC_000017.11:44876018:G:A	G	A	CLINICAL
NM_001193466.2(KANSL1):c.1816C>T (p.Arg606Ter)	KANSL1	R606*	Normal	not provided|Koolen-de Vries syndrome|Global developmental delay	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031693	17	44143935	17	46066569	31693	40353	rs281865469	NC_000017.11:46066568:G:A	G	A	CLINICAL
NM_001193466.2(KANSL1):c.1042C>T (p.Arg348Ter)	KANSL1	R348*	Normal	Intellectual disability|Koolen-de Vries syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000521688	17	44248468	17	46171102	521688	512297	rs1427624649	NC_000017.11:46171101:G:A	G	A	CLINICAL
NM_005121.3(MED13):c.977C>T (p.Thr326Ile)	MED13	T326I	Normal	Intellectual developmental disorder 61	Pathogenic(Last reviewed: Dec 14, 2020)	no assertion criteria provided	VCV000810681	17	60108837	17	62031476	810681	798967	rs1603405457	NC_000017.11:62031475:G:A	G	A	CLINICAL
NM_001284333.2(TLK2):c.777C>A (p.Tyr259Ter)	TLK2	Y110*, Y227*, Y259*	Normal	not provided|Intellectual disability, autosomal dominant 57	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000617921	17	60637433	17	62560072	617921	609320	rs1567920106	NC_000017.11:62560071:C:A	C	A	CLINICAL
NM_006852.6(TLK2):c.968+1G>A	TLK2		Normal	Intellectual disability, autosomal dominant 57|TLK2-related neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000828197	17	60642499	17	62565138	828197	816534	rs1598620094	NC_000017.11:62565137:G:A	G	A	CLINICAL
NM_006852.4(TLK2):c.989C>A (p.Ser330Ter)	TLK2	S330*, S181*, S298*	Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000548935	17	60650596	17	62573235	548935	539422	rs1555644480	NC_000017.11:62573234:C:A	C	A	CLINICAL
NM_006852.4(TLK2):c.1819G>A (p.Asp607Asn)	TLK2	D458N, D575N, D607N, D629N	Normal	Intellectual disability, autosomal dominant 57	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617906	17	60679501	17	62602140	617906	609330	rs1568006217	NC_000017.11:62602139:G:A	G	A	CLINICAL
NM_182641.4(BPTF):c.5392G>A (p.Ala1798Thr)	BPTF	A1924T, A1798T	Normal	Expressive language delay|Postnatal microcephaly|Global developmental delay	Likely pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000431070	17	65914918	17	67918802	431070	424593	rs1425998598	NC_000017.11:67918801:G:A	G	A	CLINICAL
NM_001321075.3(DLG4):c.1102C>T (p.Arg368Ter)	DLG4	R411*, R408*, R308*, R365*, R341*, R368*	Normal	Intellectual developmental disorder 62	Pathogenic(Last reviewed: Dec 11, 2020)	no assertion criteria provided	VCV000813880	17	7099876	17	7196557	813880	802109	rs1597452702	NC_000017.11:7196556:G:A	G	A	CLINICAL
NM_001321075.3(DLG4):c.925C>T (p.Arg309Ter)	DLG4	R352*, R349*, R282*, R309*, R249*, R306*	Normal	Intellectual developmental disorder 62|not provided	Likely pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000813881	17	7100234	17	7196915	813881	802110	rs1182894684	NC_000017.11:7196914:G:A	G	A	CLINICAL
NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	TP53	R248W, R116W, R209W, R89W	Normal	Carcinoma of esophagus|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Glioblastoma|Choroid plexus carcinoma|Breast neoplasm|Neoplasm of brain|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Chronic lymphocytic leukemia|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Squamous cell lung carcinoma|Multiple myeloma|Myelodysplastic syndrome|Malignant melanoma of skin|Neoplasm of ovary|Pancreatic adenocarcinoma|Medulloblastoma|Gallbladder cancer|Acute myeloid leukemia|Short stature|Pectus excavatum|Webbed neck|Cognitive impairment|Abnormality of the tongue|Pancytopenia|Hepatocellular carcinoma|Brainstem glioma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Uterine Carcinosarcoma|Acute myeloid leukemia|Small cell lung carcinoma|not provided|Neoplasm|Lip and oral cavity carcinoma|Neoplasm of the large intestine	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000012347	17	7577539	17	7674221	12347	27386	rs121912651	NC_000017.11:7674220:G:A	G	A	CLINICAL
NM_001005273.2(CHD3):c.2761G>A (p.Glu921Lys)	CHD3	E921K, E980K	Normal	Snijders blok-campeau syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549731	17	7803686	17	7900368	549731	540498	rs1567855704	NC_000017.11:7900367:G:A	G	A	CLINICAL
NM_001005273.2(CHD3):c.2882G>A (p.Gly961Glu)	CHD3	G961E, G1020E	Normal	Snijders blok-campeau syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549732	17	7803953	17	7900635	549732	540499	rs1567856045	NC_000017.11:7900634:G:A	G	A	CLINICAL
NM_001005273.2(CHD3):c.2954G>A (p.Arg985Gln)	CHD3	R985Q, R1044Q	Normal	Intellectual disability|Snijders blok-campeau syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549733	17	7804025	17	7900707	549733	540500	rs1567856331	NC_000017.11:7900706:G:A	G	A	CLINICAL
NM_005852.4(CHD3):c.3477C>A (p.Asn1159Lys)	CHD3	N1159K, N1218K	Normal	not provided|Intellectual disability|Marfanoid habitus and intellectual disability|Snijders blok-campeau syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000549739	17	7806361	17	7903043	549739	540506	rs754919272	NC_000017.11:7903042:C:A	C	A	CLINICAL
NM_001005271.3(CHD3):c.3692G>A (p.Arg1231Gln)	CHD3	R1172Q, R1231Q	Normal	Intellectual disability|Snijders blok-campeau syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549743	17	7806609	17	7903291	549743	540510	rs1567861501	NC_000017.11:7903290:G:A	G	A	CLINICAL
NM_001005271.3(CHD3):c.4202G>A (p.Arg1401Gln)	CHD3	R1342Q, R1401Q	Normal	Inborn genetic diseases|Intellectual disability|Snijders blok-campeau syndrome	Likely pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000549746	17	7807890	17	7904572	549746	540513	rs1567863732	NC_000017.11:7904571:G:A	G	A	CLINICAL
NM_006907.4(PYCR1):c.616G>T (p.Gly206Trp)	PYCR1	G206W, G233W	Normal	Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013191	17	79892546	17	81934670	13191	28230	rs121918375	NC_000017.11:81934669:C:A	C	A	CLINICAL
NM_001040025.2(ARL16):c.32G>T (p.Arg11Leu)	ARL16|LOC112533681	R11L	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208393	17	79650824	17	81683794	208393	204625	rs863223352	NC_000017.11:81683793:C:A	C	A	CLINICAL
NM_005022.4(PFN1):c.350A>G (p.Glu117Gly)	PFN1	E117G	Normal	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037037	17	4849268	17	4945973	37037	45723	rs140547520	NC_000017.11:4945972:T:C	T	C	CLINICAL
NM_005022.4(PFN1):c.211T>G (p.Cys71Gly)	PFN1	C71G	Normal	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037034	17	4850037	17	4946742	37034	45720	rs387907264	NC_000017.11:4946741:A:C	A	C	CLINICAL
NM_000263.4(NAGLU):c.2T>C (p.Met1Thr)	NAGLU	M1T	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000553224	17	40688292	17	42536274	553224	548134	rs1013345784	NC_000017.11:42536273:T:C	T	C	CLINICAL
NM_000263.4(NAGLU):c.142T>C (p.Phe48Leu)	NAGLU	F48L	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Nov 15, 2000)	no assertion criteria provided	VCV000001569	17	40688432	17	42536414	1569	16608	rs118204024	NC_000017.11:42536413:T:C	T	C	CLINICAL
NM_000263.4(NAGLU):c.1004A>C (p.Tyr335Ser)	NAGLU	Y335S	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803393	17	40693207	17	42541189	803393	791747	rs768918822	NC_000017.11:42541188:A:C	A	C	CLINICAL
NM_000263.4(NAGLU):c.1694G>C (p.Arg565Pro)	NAGLU	R565P	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001568	17	40695718	17	42543700	1568	16607	rs104894598	NC_000017.11:42543699:G:C	G	C	CLINICAL
NM_000199.5(SGSH):c.1166A>G (p.Asn389Ser)	SGSH	N389S	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550252	17	78184594	17	80210795	550252	549212	rs1555620214	NC_000017.11:80210794:T:C	T	C	CLINICAL
NM_000199.5(SGSH):c.1139A>G (p.Gln380Arg)	SGSH	Q380R	Normal	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279891	17	78184621	17	80210822	279891	264874	rs144143780	NC_000017.11:80210821:T:C	T	C	CLINICAL
NM_000199.5(SGSH):c.197C>G (p.Ser66Trp)	SGSH	S66W	Normal	Sanfilippo syndrome|Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005111	17	78190883	17	80217084	5111	20150	rs104894637	NC_000017.11:80217083:G:C	G	C	CLINICAL
NM_000199.5(SGSH):c.89-2A>G	SGSH		Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634541	17	78190993	17	80217194	634541	622512	rs1369704445	NC_000017.11:80217193:T:C	T	C	CLINICAL
NM_000199.5(SGSH):c.1A>G (p.Met1Val)	SGSH|SLC26A11	M1V	Normal	Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552260	17	78194112	17	80220313	552260	549226	rs1250300189	NC_000017.11:80220312:T:C	T	C	CLINICAL
NM_000382.3(ALDH3A2):c.798G>C (p.Lys266Asn)	ALDH3A2	K266N, K73N	Normal	Sjögren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001643	17	19561175	17	19657862	1643	16682	rs72547569	NC_000017.11:19657861:G:C	G	C	CLINICAL
NM_001383.4(DPH1):c.701T>C (p.Leu234Pro)	DPH1	L234P, L223P, L94P	Normal	Developmental delay with short stature, dysmorphic features, and sparse hair|Dandy-Walker syndrome|Global developmental delay|Cerebellar vermis hypoplasia|Hydrocephalus	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2020)	no assertion criteria provided	VCV000183359	17	1943054	17	2039760	183359	181451	rs730882250	NC_000017.11:2039759:T:C	T	C	CLINICAL
NM_000430.4(PAFAH1B1):c.722G>C (p.Arg241Pro)	PAFAH1B1	R241P	Normal	Subcortical band heterotopia	Pathogenic(Last reviewed: Oct 28, 2003)	no assertion criteria provided	VCV000008080	17	2577404	17	2674110	8080	23119	rs121434488	NC_000017.11:2674109:G:C	G	C	CLINICAL
NM_001346754.2(PIGW):c.211A>C (p.Thr71Pro)	PIGW	T71P	Normal	Hyperphosphatasia with mental retardation syndrome 5	Pathogenic(Last reviewed: Mar 1, 2014)	no assertion criteria provided	VCV000156156	17	34893161	17	36537312	156156	165955	rs587777733	NC_000017.11:36537311:A:C	A	C	CLINICAL
NM_033419.5(PGAP3):c.914A>G (p.Asp305Gly)	PGAP3	D305G, D191G, D254G, D284G, D170G	Normal	Hyperphosphatasia with mental retardation syndrome 4|not provided	Likely pathogenic(Last reviewed: May 17, 2017)	criteria provided, single submitter	VCV000125439	17	37829105	17	39672852	125439	130977	rs587777252	NC_000017.11:39672851:T:C	T	C	CLINICAL
NM_033419.5(PGAP3):c.851A>G (p.His284Arg)	PGAP3	H284R, H233R, H263R	Normal	Congenital diaphragmatic hernia|Profound global developmental delay|Infantile axial hypotonia|Seizures|Low-set ears|Agenesis of maxillary lateral incisor|Global developmental delay|Severe global developmental delay|Low posterior hairline|Cleft palate|not provided|Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Apr 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000599004	17	37829352	17	39673099	599004	590083	rs776720232	NC_000017.11:39673098:T:C	T	C	CLINICAL
NM_033419.5(PGAP3):c.845A>G (p.Asp282Gly)	PGAP3	D282G, D261G, D231G	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000224644	17	37829358	17	39673105	224644	226423	rs869312814	NC_000017.11:39673104:T:C	T	C	CLINICAL
NM_033419.5(PGAP3):c.314C>G (p.Pro105Arg)	PGAP3	P105R	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000125440	17	37840968	17	39684715	125440	130978	rs371549948	NC_000017.11:39684714:G:C	G	C	CLINICAL
NM_004247.4(EFTUD2):c.2496C>G (p.Tyr832Ter)	EFTUD2	Y832*, Y797*, Y822*	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: May 4, 2012)	no assertion criteria provided	VCV000031642	17	42930729	17	44853361	31642	40319	rs879253727	NC_000017.11:44853360:G:C	G	C	CLINICAL
NM_004247.4(EFTUD2):c.2045+2T>G	EFTUD2		Normal	Mandibulofacial dysostosis-microcephaly syndrome	Likely pathogenic(Last reviewed: Apr 29, 2014)	criteria provided, single submitter	VCV000216924	17	42934441	17	44857073	216924	213646	rs863224868	NC_000017.11:44857072:A:C	A	C	CLINICAL
NM_004247.4(EFTUD2):c.1910T>G (p.Leu637Arg)	EFTUD2	L637R, L602R, L627R	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030404	17	42936500	17	44859132	30404	39361	rs387906879	NC_000017.11:44859131:A:C	A	C	CLINICAL
NM_004247.4(EFTUD2):c.1414-2A>G	EFTUD2		Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic	criteria provided, single submitter	VCV000694683	17	42940276	17	44862908	694683	682841	rs1597797917	NC_000017.11:44862907:T:C	T	C	CLINICAL
NM_004247.4(EFTUD2):c.623A>G (p.His208Arg)	EFTUD2	H208R, H198R, H173R	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Dec 1, 2012)	no assertion criteria provided	VCV000040047	17	42957003	17	44879635	40047	48561	rs397515431	NC_000017.11:44879634:T:C	T	C	CLINICAL
NM_002055.5(GFAP):c.1125C>G (p.Asn375Lys)	GFAP	N375K	Normal	Alexander Disease	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000590968	17	42988606	17	44911238	590968	581912	rs1567773470	NC_000017.11:44911237:G:C	G	C	CLINICAL
NM_005910.5(MAPT):c.915+11T>C	MAPT		Normal	not provided|Frontotemporal dementia	Pathogenic(Last reviewed: Jul 1, 2001)	no assertion criteria provided	VCV000098219	17	44087779	17	46010413	98219	104111	rs63751394	NC_000017.11:46010412:T:C	T	C	CLINICAL
NM_004859.4(CLTC):c.3140T>C (p.Leu1047Pro)	CLTC	L1047P, L1051P	Normal	Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488419	17	57758730	17	59681369	488419	481275	rs1555607159	NC_000017.11:59681368:T:C	T	C	CLINICAL
NM_006852.6(TLK2):c.968+1G>C	TLK2		Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Sep 27, 2018)	no assertion criteria provided	VCV000807711	17	60642499	17	62565138	807711	798720	rs1598620094	NC_000017.11:62565137:G:C	G	C	CLINICAL
NM_177550.4(SLC13A5):c.231+2T>G	SLC13A5		Normal	Global developmental delay|Seizures|Chronic kidney disease	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183313	17	6610345	17	6707026	183313	181455	rs730882222	NC_000017.11:6707025:A:C	A	C	CLINICAL
NM_212472.2(PRKAR1A):c.980T>C (p.Ile327Thr)	PRKAR1A|FAM20A	I327T	Normal	Acrodysostosis 1 with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000029910	17	66526424	17	68530283	29910	38865	rs387906695	NC_000017.11:68530282:T:C	T	C	CLINICAL
NM_212472.2(PRKAR1A):c.1004G>C (p.Arg335Pro)	PRKAR1A|FAM20A	R335P	Normal	Acrodysostosis 1 with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000029909	17	66526448	17	68530307	29909	38864	rs387906694	NC_000017.11:68530306:G:C	G	C	CLINICAL
NM_212472.2(PRKAR1A):c.1117T>C (p.Tyr373His)	PRKAR1A|FAM20A	Y373H	Normal	Acrodysostosis 1 with or without hormone resistance	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000029908	17	66526561	17	68530420	29908	38863	rs387906693	NC_000017.11:68530419:T:C	T	C	CLINICAL
NM_001005273.2(CHD3):c.3362G>C (p.Arg1121Pro)	CHD3	R1121P, R1180P	Normal	Snijders blok-campeau syndrome|Intellectual disability	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549736	17	7806037	17	7902719	549736	540503	rs1567860112	NC_000017.11:7902718:G:C	G	C	CLINICAL
NM_001005273.2(CHD3):c.3472T>C (p.Trp1158Arg)	CHD3	W1158R, W1217R	Normal	Intellectual disability|Snijders blok-campeau syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549738	17	7806356	17	7903038	549738	540505	rs1567860891	NC_000017.11:7903037:T:C	T	C	CLINICAL
NM_001005273.2(CHD3):c.3707T>C (p.Leu1236Pro)	CHD3	L1236P, L1295P	Normal	Snijders blok-campeau syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549745	17	7806801	17	7903483	549745	540512	rs1567861894	NC_000017.11:7903482:T:C	T	C	CLINICAL
NM_006907.4(PYCR1):c.355C>G (p.Arg119Gly)	PYCR1	R119G, R146G	Normal	Autosomal recessive cutis laxa type 2B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013196	17	79892987	17	81935111	13196	28235	rs121918376	NC_000017.11:81935110:G:C	G	C	CLINICAL
NM_005022.4(PFN1):c.341T>C (p.Met114Thr)	PFN1	M114T	Normal	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037035	17	4849277	17	4945982	37035	45721	rs387907265	NC_000017.11:4945981:A:G	A	G	CLINICAL
NM_000263.4(NAGLU):c.230T>G (p.Val77Gly)	NAGLU	V77G	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000638092	17	40688520	17	42536502	638092	625884	rs1599253805	NC_000017.11:42536501:T:G	T	G	CLINICAL
NM_000263.4(NAGLU):c.419A>G (p.Tyr140Cys)	NAGLU	Y140C	Normal	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Thick eyebrow|Mucopolysacchariduria|Hepatosplenomegaly|Coarse facial features|Abnormal facial shape|Intellectual disability, severe|Abnormality of metabolism/homeostasis|Hypertrichosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371634	17	40689451	17	42537433	371634	358436	rs753520553	NC_000017.11:42537432:A:G	A	G	CLINICAL
NM_000263.4(NAGLU):c.942C>G (p.Phe314Leu)	NAGLU	F314L	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jan 1, 2002)	no assertion criteria provided	VCV000001570	17	40693145	17	42541127	1570	16609	rs118204025	NC_000017.11:42541126:C:G	C	G	CLINICAL
NM_000263.4(NAGLU):c.1241A>G (p.His414Arg)	NAGLU	H414R	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552833	17	40695265	17	42543247	552833	548470	rs768814260	NC_000017.11:42543246:A:G	A	G	CLINICAL
NM_000263.4(NAGLU):c.1313T>G (p.Met438Arg)	NAGLU	M438R	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623313	17	40695337	17	42543319	623313	612319	rs1567893399	NC_000017.11:42543318:T:G	T	G	CLINICAL
NM_000263.4(NAGLU):c.1674C>G (p.Tyr558Ter)	NAGLU	Y558*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000558459	17	40695698	17	42543680	558459	548926	rs762031686	NC_000017.11:42543679:C:G	C	G	CLINICAL
NM_000263.4(NAGLU):c.1834A>G (p.Ser612Gly)	NAGLU	S612G	Normal	Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522823	17	40695858	17	42543840	522823	513465	rs148881970	NC_000017.11:42543839:A:G	A	G	CLINICAL
NM_000263.4(NAGLU):c.1932C>G (p.Tyr644Ter)	NAGLU	Y644*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000557035	17	40695956	17	42543938	557035	548488	rs1555622533	NC_000017.11:42543937:C:G	C	G	CLINICAL
NM_000263.4(NAGLU):c.1973A>G (p.Tyr658Cys)	NAGLU	Y658C	Normal	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV000572445	17	40695997	17	42543979	572445	574462	rs1230894568	NC_000017.11:42543978:A:G	A	G	CLINICAL
NM_003620.3(PPM1D):c.1451T>G (p.Leu484Ter)	PPM1D	L484*	Normal	not provided	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000488841	17	58740546	17	60663185	488841	482149	rs766524048	NC_000017.11:60663184:T:G	T	G	CLINICAL
NM_000199.5(SGSH):c.892T>C (p.Ser298Pro)	SGSH	S298P	Normal	Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-A|Sanfilippo syndrome|Retinal dystrophy|Global developmental delay|Severe visual impairment|Diarrhea|Nystagmus|Developmental regression|Gastrointestinal dysmotility	Pathogenic(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030459	17	78185927	17	80212128	30459	39416	rs138504221	NC_000017.11:80212127:A:G	A	G	CLINICAL
NM_000199.5(SGSH):c.673T>C (p.Phe225Leu)	SGSH	F225L	Normal	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000383967	17	78187675	17	80213876	383967	375756	rs1057521801	NC_000017.11:80213875:A:G	A	G	CLINICAL
NM_000199.5(SGSH):c.617G>C (p.Arg206Pro)	SGSH	R206P	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005118	17	78188017	17	80214218	5118	20157	rs104894643	NC_000017.11:80214217:C:G	C	G	CLINICAL
NM_000199.5(SGSH):c.578T>C (p.Phe193Ser)	SGSH	F193S	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523016	17	78188056	17	80214257	523016	513648	rs1555621662	NC_000017.11:80214256:A:G	A	G	CLINICAL
NM_000199.5(SGSH):c.235A>C (p.Thr79Pro)	SGSH	T79P	Normal	not provided|Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000372782	17	78190845	17	80217046	372782	360293	rs779703983	NC_000017.11:80217045:T:G	T	G	CLINICAL
NM_000199.5(SGSH):c.2T>C (p.Met1Thr)	SGSH|SLC26A11	M1T	Normal	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488839	17	78194111	17	80220312	488839	482159	rs1488660868	NC_000017.11:80220311:A:G	A	G	CLINICAL
NM_000199.5(SGSH):c.1A>C (p.Met1Leu)	SGSH|SLC26A11	M1L	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000694732	17	78194112	17	80220313	694732	682851	rs1250300189	NC_000017.11:80220312:T:G	T	G	CLINICAL
NM_000250.2(MPO):c.2031-2A>C	MPO		Normal	not provided|Myeloperoxidase deficiency	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003632	17	56348226	17	58270865	3632	18671	rs35897051	NC_000017.11:58270864:T:G	T	G	CLINICAL
NM_001146312.2(MYOCD):c.1252A>G (p.Ile418Val)	MYOCD	I418V	Normal	Seizures|Intellectual disability	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183354	17	12655857	17	12752540	183354	181449	rs137939966	NC_000017.11:12752539:A:G	A	G	CLINICAL
NM_030665.4(RAI1):c.4685A>G (p.Gln1562Arg)	RAI1	Q1562R	Normal	Smith-Magenis syndrome	Pathogenic(Last reviewed: Jun 8, 2012)	no assertion criteria provided	VCV000002950	17	17700947	17	17797633	2950	17989	rs104894634	NC_000017.11:17797632:A:G	A	G	CLINICAL
NM_000382.3(ALDH3A2):c.1157A>G (p.Asn386Ser)	ALDH3A2	N386S, N193S	Normal	Sjögren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001644	17	19568310	17	19664997	1644	16683	rs72547575	NC_000017.11:19664996:A:G	A	G	CLINICAL
NM_000267.3(NF1):c.3104T>G (p.Met1035Arg)	NF1	M1035R	Normal	Neurofibromatosis, type 1	Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000000347	17	29557391	17	31230373	347	15386	rs137854553	NC_000017.11:31230372:T:G	T	G	CLINICAL
NM_001346754.2(PIGW):c.460A>G (p.Arg154Gly)	PIGW	R154G	Normal	not provided|Hyperphosphatasia with mental retardation syndrome 5	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000495299	17	34893410	17	36537561	495299	486796	rs1256773607	NC_000017.11:36537560:A:G	A	G	CLINICAL
NM_033419.5(PGAP3):c.842T>C (p.Leu281Pro)	PGAP3	L281P, L230P, L260P	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224648	17	37829361	17	39673108	224648	226424	rs869312817	NC_000017.11:39673107:A:G	A	G	CLINICAL
NM_033419.5(PGAP3):c.511T>C (p.Cys171Arg)	PGAP3	C171R, C120R, C150R	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000224647	17	37830292	17	39674039	224647	226426	rs869312816	NC_000017.11:39674038:A:G	A	G	CLINICAL
NM_000263.4(NAGLU):c.419A>G (p.Tyr140Cys)	NAGLU	Y140C	Normal	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Thick eyebrow|Mucopolysacchariduria|Hepatosplenomegaly|Coarse facial features|Abnormal facial shape|Intellectual disability, severe|Abnormality of metabolism/homeostasis|Hypertrichosis	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000371634	17	40689451	17	42537433	371634	358436	rs753520553	NC_000017.11:42537432:A:G	A	G	CLINICAL
NM_000263.4(NAGLU):c.1834A>G (p.Ser612Gly)	NAGLU	S612G	Normal	Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|not provided|Mucopolysaccharidosis	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000522823	17	40695858	17	42543840	522823	513465	rs148881970	NC_000017.11:42543839:A:G	A	G	CLINICAL
NM_004247.4(EFTUD2):c.1149+1G>C	EFTUD2		Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Oct 28, 2014)	criteria provided, single submitter	VCV000210914	17	42945174	17	44867806	210914	208400	rs797045550	NC_000017.11:44867805:C:G	C	G	CLINICAL
NM_002055.5(GFAP):c.259G>C (p.Val87Leu)	GFAP	V87L	Normal	not provided|Alexander Disease	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000066477	17	42992596	17	44915228	66477	77374	rs267607518	NC_000017.11:44915227:C:G	C	G	CLINICAL
NM_000023.4(SGCA):c.410A>G (p.Glu137Gly)	SGCA	E137G	Normal	Autosomal recessive limb-girdle muscular dystrophy type 2D	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000009438	17	48245759	17	50168398	9438	24477	rs397514451	NC_000017.11:50168397:A:G	A	G	CLINICAL
NM_153229.3(TMEM92):c.95+3A>G	TMEM92		Normal	Global developmental delay|Cerebellar atrophy|Bilateral squint|Hydrocephalus	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183355	17	48355104	17	50277743	183355	181452	rs730882247	NC_000017.11:50277742:A:G	A	G	CLINICAL
NM_016077.4(PTRH2):c.254A>C (p.Gln85Pro)	PTRH2	Q85P, Q86P	Normal	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset|Global developmental delay|Cerebellar ataxia|Hearing impairment	Pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000183332	17	57775086	17	59697725	183332	181454	rs730882234	NC_000017.11:59697724:T:G	T	G	CLINICAL
NM_006852.4(TLK2):c.1412A>G (p.His471Arg)	TLK2	H322R, H439R, H471R, H493R	Normal	Intellectual disability, autosomal dominant 57	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617910	17	60663539	17	62586178	617910	609326	rs1567974030	NC_000017.11:62586177:A:G	A	G	CLINICAL
NM_006852.4(TLK2):c.1460+2T>G	TLK2		Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548936	17	60663589	17	62586228	548936	539423	rs1555651572	NC_000017.11:62586227:T:G	T	G	CLINICAL
NM_006852.4(TLK2):c.1487A>G (p.His496Arg)	TLK2	H347R, H464R, H496R, H518R	Normal	Intellectual disability, autosomal dominant 57	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617930	17	60673972	17	62596611	617930	609327	rs1567995650	NC_000017.11:62596610:A:G	A	G	CLINICAL
NM_006852.4(TLK2):c.1973C>G (p.Pro658Arg)	TLK2	P509R, P626R, P658R, P680R	Normal	Intellectual disability, autosomal dominant 57	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617915	17	60685403	17	62608042	617915	609331	rs1568018905	NC_000017.11:62608041:C:G	C	G	CLINICAL
NM_182641.4(BPTF):c.8609T>G (p.Met2870Arg)	BPTF	M2853R, M2870R	Normal	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies|Postnatal microcephaly|Expressive language delay|Global developmental delay	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000431071	17	65971957	17	67975841	431071	424594	rs782736894	NC_000017.11:67975840:T:G	T	G	CLINICAL
NM_212472.2(PRKAR1A):c.620A>G (p.Tyr207Cys)	PRKAR1A	Y207C	Normal	Acrodysostosis 1 with or without hormone resistance	Likely pathogenic(Last reviewed: Feb 5, 2019)	no assertion criteria provided	VCV000638687	17	66521965	17	68525824	638687	626463	rs1600486197	NC_000017.11:68525823:A:G	A	G	CLINICAL
NM_001365.4(DLG4):c.1672+2T>C	DLG4		Normal	Marfanoid habitus and intellectual disability|Intellectual developmental disorder 62	Likely pathogenic	criteria provided, single submitter	VCV000689720	17	7097161	17	7193842	689720	677399	rs1597444614	NC_000017.11:7193841:A:G	A	G	CLINICAL
NM_015721.3(GEMIN4):c.2452T>C (p.Trp818Arg)	GEMIN4	W818R	Normal	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities|Global developmental delay|Microcephaly|Severe dystonia|Congenital cataract	Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV000183310	17	648831	17	745591	183310	181456	rs730882219	NC_000017.11:745590:A:G	A	G	CLINICAL
NM_001005271.3(CHD3):c.2834A>G (p.His945Arg)	CHD3	H886R, H945R	Normal	Neurodevelopmental abnormality|Snijders blok-campeau syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549729	17	7803326	17	7900008	549729	540496	rs1567855081	NC_000017.11:7900007:A:G	A	G	CLINICAL
NM_001005273.2(CHD3):c.3482A>G (p.His1161Arg)	CHD3	H1161R, H1220R	Normal	Intellectual disability|Snijders blok-campeau syndrome	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549740	17	7806366	17	7903048	549740	540507	rs1567860919	NC_000017.11:7903047:A:G	A	G	CLINICAL
NM_001005273.2(CHD3):c.3512A>G (p.His1171Arg)	CHD3	H1171R, H1230R	Normal	Intellectual disability|Snijders blok-campeau syndrome	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549742	17	7806606	17	7903288	549742	540509	rs1567861489	NC_000017.11:7903287:A:G	A	G	CLINICAL
NM_001005273.2(CHD3):c.4073-2A>G	CHD3		Normal	Intellectual disability	Likely pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000549747	17	7808416	17	7905098	549747	540514	rs1567864750	NC_000017.11:7905097:A:G	A	G	CLINICAL
NM_000199.5(SGSH):c.892T>C (p.Ser298Pro)	SGSH	S298P	Normal	Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-A|Sanfilippo syndrome|Retinal dystrophy|Global developmental delay|Severe visual impairment|Diarrhea|Nystagmus|Developmental regression|Gastrointestinal dysmotility	Pathogenic(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000030459	17	78185927	17	80212128	30459	39416	rs138504221	NC_000017.11:80212127:A:G	A	G	CLINICAL
NM_000199.5(SGSH):c.617G>C (p.Arg206Pro)	SGSH	R206P	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005118	17	78188017	17	80214218	5118	20157	rs104894643	NC_000017.11:80214217:C:G	C	G	CLINICAL
NM_016841.5(MAPT):c.649-3919T>G	MAPT	N279K, N221K, N250K, N596K, N614K	Normal	Frontotemporal dementia|not provided|Progressive supranuclear ophthalmoplegia|Pick disease|Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014253	17	44087690	17	46010324	14253	29292	rs63750756	NC_000017.11:46010323:T:G	T	G	CLINICAL
NM_007294.4(BRCA1):c.5346G>A (p.Trp1782Ter)	BRCA1	W1782*, W678*, W1803*, W1735*	Normal	Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037658	17	41201198	17	43049181	37658	46214	rs80357284	NC_000017.11:43049180:C:T	C	T	CLINICAL
NM_005910.5(MAPT):c.1084C>T (p.His362Tyr)	MAPT	H362Y, H679Y, H331Y, H697Y, H302Y, H304Y, H273Y, H333Y	Normal	Alzheimer disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000599620	17	44096070	17	46018704	599620	590965	rs1568339995	NC_000017.11:46018703:C:T	C	T	CLINICAL
NM_005910.5(MAPT):c.1216C>T (p.Arg406Trp)	MAPT	R406W, R723W, R375W, R317W, R346W, R741W, R348W, R377W	Normal	not provided|Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|Pick disease|Parkinson disease, late-onset|Frontotemporal dementia|Parkinson-dementia syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014247	17	44101427	17	46024061	14247	29286	rs63750424	NC_000017.11:46024060:C:T	C	T	CLINICAL
NM_002087.4(GRN):c.1477C>T (p.Arg493Ter)	GRN	R493*	Normal	Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|Ceroid lipofuscinosis, neuronal, 11|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|not provided	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016014	17	42429772	17	44352404	16014	31053	rs63751294	NC_000017.11:44352403:C:T	C	T	CLINICAL
NM_005910.5(MAPT):c.915+16C>T	MAPT		Normal	not provided|Memory impairment|Mental deterioration|Frontotemporal dementia|Dementia|Frontotemporal dementia	Pathogenic(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000098222	17	44087784	17	46010418	98222	104114	rs63751011	NC_000017.11:46010417:C:T	C	T	CLINICAL
NM_000180.4(GUCY2D):c.1633C>T (p.Gln545Ter)	GUCY2D	Q545*	Normal	Night blindness, congenital stationary, type1i|Leber congenital amaurosis 1	Pathogenic(Last reviewed: Sep 3, 2019)	no assertion criteria provided	VCV000689384	17	7911315	17	8007997	689384	676976	rs1290420698	NC_000017.11:8007996:C:T	C	T	CLINICAL
NM_001369369.1(FOXN1):c.146C>T (p.Ser49Leu)	FOXN1	S49L	Normal	Autistic disorder of childhood onset	Likely pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000212710	17	26851543	17	28524525	212710	209326	rs797046135	NC_000017.11:28524524:C:T	C	T	CLINICAL
NM_000458.4(HNF1B):c.896G>A (p.Trp299Ter)	HNF1B	W273*, W299*	Normal	Renal cysts and diabetes syndrome	Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000692161	17	36091735	17	37731744	692161	679902	rs1598840996	NC_000017.11:37731743:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.4G>T (p.Glu2Ter)	NAGLU	E2*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000551575	17	40688294	17	42536276	551575	548845	rs1555621397	NC_000017.11:42536275:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.343C>T (p.Pro115Ser)	NAGLU	P115S	Normal	Intellectual disability|Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000553505	17	40688633	17	42536615	553505	548854	rs758785463	NC_000017.11:42536614:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.358G>T (p.Glu120Ter)	NAGLU	E120*	Normal	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552642	17	40688648	17	42536630	552642	548425	rs1445294968	NC_000017.11:42536629:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.367G>T (p.Glu123Ter)	NAGLU	E123*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000204586	17	40688657	17	42536639	204586	200976	rs796052123	NC_000017.11:42536638:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.383+1G>T	NAGLU		Normal	not provided|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000167321	17	40688674	17	42536656	167321	177853	rs727504028	NC_000017.11:42536655:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.694C>T (p.Gln232Ter)	NAGLU	Q232*	Normal	Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000288040	17	40690703	17	42538685	288040	272277	rs886043792	NC_000017.11:42538684:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.700C>T (p.Arg234Cys)	NAGLU	R234C	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001572	17	40690709	17	42538691	1572	16611	rs104894601	NC_000017.11:42538690:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.889C>T (p.Arg297Ter)	NAGLU	R297*	Normal	Mucopolysaccharidosis|not provided|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001562	17	40693092	17	42541074	1562	16601	rs104894592	NC_000017.11:42541073:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.911G>T (p.Gly304Val)	NAGLU	G304V	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803392	17	40693114	17	42541096	803392	791746	rs1599258487	NC_000017.11:42541095:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.1006G>T (p.Glu336Ter)	NAGLU	E336*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000370575	17	40693209	17	42541191	370575	358437	rs376090795	NC_000017.11:42541190:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.1093C>T (p.Gln365Ter)	NAGLU	Q365*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557513	17	40695117	17	42543099	557513	548453	rs1555622242	NC_000017.11:42543098:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1390C>T (p.Arg464Ter)	NAGLU	R464*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Jan 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552920	17	40695414	17	42543396	552920	548904	rs138387856	NC_000017.11:42543395:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1444C>T (p.Arg482Trp)	NAGLU	R482W	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000001571	17	40695468	17	42543450	1571	16610	rs104894596	NC_000017.11:42543449:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1558C>T (p.Arg520Trp)	NAGLU	R520W	Normal	not provided|Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000553515	17	40695582	17	42543564	553515	548925	rs992677795	NC_000017.11:42543563:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1562C>T (p.Pro521Leu)	NAGLU	P521L	Normal	Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V	Pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001566	17	40695586	17	42543568	1566	16605	rs104894595	NC_000017.11:42543567:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1597C>T (p.Arg533Ter)	NAGLU	R533*	Normal	Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|Charcot-Marie-Tooth disease, axonal type 2V|Sanfilippo syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000495784	17	40695621	17	42543603	495784	487839	rs1244655820	NC_000017.11:42543602:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1693C>T (p.Arg565Trp)	NAGLU	R565W	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001567	17	40695717	17	42543699	1567	16606	rs104894597	NC_000017.11:42543698:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1705C>T (p.Gln569Ter)	NAGLU	Q569*	Normal	Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557506	17	40695729	17	42543711	557506	548161	rs1555622441	NC_000017.11:42543710:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1708G>T (p.Glu570Ter)	NAGLU	E570*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000552424	17	40695732	17	42543714	552424	548170	rs1555622443	NC_000017.11:42543713:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.1811C>T (p.Pro604Leu)	NAGLU	P604L	Normal	Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554402	17	40695835	17	42543817	554402	548177	rs751203469	NC_000017.11:42543816:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1876C>T (p.Arg626Ter)	NAGLU	R626*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B|not provided	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001561	17	40695900	17	42543882	1561	16600	rs104894591	NC_000017.11:42543881:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1915G>T (p.Glu639Ter)	NAGLU	E639*	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522822	17	40695939	17	42543921	522822	513466	rs555145190	NC_000017.11:42543920:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.1927C>T (p.Arg643Cys)	NAGLU	R643C	Normal	Mucopolysaccharidosis|Mucopolysaccharidosis, MPS-III-B|not provided|Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV000001565	17	40695951	17	42543933	1565	16604	rs104894594	NC_000017.11:42543932:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1946G>T (p.Trp649Leu)	NAGLU	W649L	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV000143187	17	40695970	17	42543952	143187	152905	rs527236038	NC_000017.11:42543951:G:T	G	T	CLINICAL
NM_000263.4(NAGLU):c.2020C>T (p.Arg674Cys)	NAGLU	R674C	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553061	17	40696044	17	42544026	553061	548939	rs763299645	NC_000017.11:42544025:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.2062C>T (p.Gln688Ter)	NAGLU	Q688*	Normal	Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000556657	17	40696086	17	42544068	556657	548496	rs1195831432	NC_000017.11:42544067:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.2116C>T (p.Gln706Ter)	NAGLU	Q706*	Normal	Charcot-Marie-Tooth disease, axonal type 2V|Mucopolysaccharidosis, MPS-III-B|Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553260	17	40696140	17	42544122	553260	548497	rs752527478	NC_000017.11:42544121:C:T	C	T	CLINICAL
NM_004859.4(CLTC):c.4420G>T (p.Glu1474Ter)	CLTC	E1474*, E1478*	Normal	Inborn genetic diseases	Pathogenic(Last reviewed: Jan 16, 2017)	criteria provided, single submitter	VCV000521468	17	57761332	17	59683971	521468	512306	rs1555607504	NC_000017.11:59683970:G:T	G	T	CLINICAL
NM_003620.3(PPM1D):c.1654C>T (p.Arg552Ter)	PPM1D	R552*	Normal	Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold|not provided	Likely pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620148	17	58740749	17	60663388	620148	611863	rs779070661	NC_000017.11:60663387:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.1339G>A (p.Glu447Lys)	SGSH	E447K	Normal	not provided|Mucopolysaccharidosis, MPS-III-A|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005114	17	78184421	17	80210622	5114	20153	rs104894639	NC_000017.11:80210621:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.1308G>A (p.Trp436Ter)	SGSH	W436*	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000550048	17	78184452	17	80210653	550048	548467	rs1555620141	NC_000017.11:80210652:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.1298G>A (p.Arg433Gln)	SGSH	R433Q	Normal	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000005109	17	78184462	17	80210663	5109	20148	rs104894641	NC_000017.11:80210662:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.1167C>A (p.Asn389Lys)	SGSH	N389K	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550465	17	78184593	17	80210794	550465	548847	rs764057581	NC_000017.11:80210793:G:T	G	T	CLINICAL
NM_000199.5(SGSH):c.1105G>A (p.Glu369Lys)	SGSH	E369K	Normal	Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000005117	17	78184655	17	80210856	5117	20156	rs104894640	NC_000017.11:80210855:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.734G>A (p.Arg245His)	SGSH|CARD14	R245H	Normal	Inborn genetic diseases|not provided|Mucopolysaccharidosis|Sanfilippo syndrome|Mucopolysaccharidosis, MPS-III-A	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000005107	17	78187614	17	80213815	5107	20146	rs104894635	NC_000017.11:80213814:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.703G>A (p.Asp235Asn)	SGSH	D235N	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553004	17	78187645	17	80213846	553004	548861	rs753472891	NC_000017.11:80213845:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.629G>A (p.Trp210Ter)	SGSH	W210*	Normal	not provided|Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280083	17	78188005	17	80214206	280083	265041	rs886041370	NC_000017.11:80214205:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.582T>A (p.Cys194Ter)	SGSH	C194*	Normal	Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000557068	17	78188052	17	80214253	557068	548485	rs1555621659	NC_000017.11:80214252:A:T	A	T	CLINICAL
NM_000199.5(SGSH):c.571G>A (p.Gly191Arg)	SGSH	G191R	Normal	Mucopolysaccharidosis, MPS-III-A|not provided	Likely pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000372781	17	78188063	17	80214264	372781	360474	rs753666460	NC_000017.11:80214263:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.449G>A (p.Arg150Gln)	SGSH	R150Q	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005113	17	78188471	17	80214672	5113	20152	rs104894638	NC_000017.11:80214671:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.364G>A (p.Gly122Arg)	SGSH	G122R	Normal	Mucopolysaccharidosis, MPS-III-A|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518269	17	78188556	17	80214757	518269	508894	rs761607612	NC_000017.11:80214756:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.356-1G>A	SGSH		Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000553818	17	78188565	17	80214766	553818	548471	rs1555621984	NC_000017.11:80214765:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.268G>A (p.Gly90Arg)	SGSH	G90R	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000550542	17	78188919	17	80215120	550542	549219	rs774010006	NC_000017.11:80215119:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.221G>A (p.Arg74His)	SGSH	R74H	Normal	Mucopolysaccharidosis, MPS-III-A	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550504	17	78190859	17	80217060	550504	548867	rs778336949	NC_000017.11:80217059:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.130G>A (p.Ala44Thr)	SGSH	A44T	Normal	Mucopolysaccharidosis, MPS-III-A|not provided	Likely pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000381685	17	78190950	17	80217151	381685	376651	rs1057521146	NC_000017.11:80217150:C:T	C	T	CLINICAL
NM_000199.5(SGSH):c.118T>A (p.Tyr40Asn)	SGSH	Y40N	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000638087	17	78190962	17	80217163	638087	625890	rs1598758001	NC_000017.11:80217162:A:T	A	T	CLINICAL
NM_000199.5(SGSH):c.54C>A (p.Cys18Ter)	SGSH	C18*	Normal	Mucopolysaccharidosis, MPS-III-A	Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000557899	17	78194059	17	80220260	557899	548873	rs1555624080	NC_000017.11:80220259:G:T	G	T	CLINICAL
NM_000458.4(HNF1B):c.896G>A (p.Trp299Ter)	HNF1B	W273*, W299*	Normal	Renal cysts and diabetes syndrome	Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000692161	17	36091735	17	37731744	692161	679902	rs1598840996	NC_000017.11:37731743:C:T	C	T	CLINICAL
NM_004278.4(PIGL):c.652C>T (p.Gln218Ter)	PIGL	Q218*	Normal	CHIME syndrome	Pathogenic(Last reviewed: Apr 6, 2012)	no assertion criteria provided	VCV000030546	17	16221214	17	16317900	30546	39503	rs139004722	NC_000017.11:16317899:C:T	C	T	CLINICAL
NM_001163809.1(WDR81):c.2567C>T (p.Pro856Leu)	WDR81	P856L	Normal	Intellectual disability|Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2020)	no assertion criteria provided	VCV000031611	17	1630820	17	1727526	31611	40295	rs587776906	NC_000017.11:1727525:C:T	C	T	CLINICAL
NM_001163809.1(WDR81):c.3997C>T (p.Arg1333Ter)	WDR81	R1333*, R130*, R106*, R282*	Normal	Inborn genetic diseases|Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000224836	17	1634392	17	1731098	224836	226676	rs138358708	NC_000017.11:1731097:C:T	C	T	CLINICAL
NM_000382.3(ALDH3A2):c.529C>T (p.Arg177Ter)	ALDH3A2	R177*	Normal	Sjögren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265027	17	19559736	17	19656423	265027	260160	rs72547561	NC_000017.11:19656422:C:T	C	T	CLINICAL
NM_000382.3(ALDH3A2):c.551C>T (p.Thr184Met)	ALDH3A2	T184M	Normal	Sjögren-Larsson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000188768	17	19559758	17	19656445	188768	186957	rs72547562	NC_000017.11:19656444:C:T	C	T	CLINICAL
NM_000382.3(ALDH3A2):c.943C>T (p.Pro315Ser)	ALDH3A2	P315S, P122S	Normal	not provided|Sjögren-Larsson syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001640	17	19566648	17	19663335	1640	16679	rs72547571	NC_000017.11:19663334:C:T	C	T	CLINICAL
NM_000382.3(ALDH3A2):c.1309A>T (p.Lys437Ter)	ALDH3A2	K437*, K244*	Normal	Sjögren-Larsson syndrome|not provided	Pathogenic(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000619024	17	19575135	17	19671822	619024	610422	rs1567607328	NC_000017.11:19671821:A:T	A	T	CLINICAL
NM_080669.6(SLC46A1):c.337C>A (p.Arg113Ser)	SLC46A1	R113S	Normal	Congenital defect of folate absorption|not provided	Pathogenic(Last reviewed: Dec 8, 2011)	no assertion criteria provided	VCV000000852	17	26732378	17	28405360	852	15891	rs80338770	NC_000017.11:28405359:G:T	G	T	CLINICAL
NM_000267.3(NF1):c.5425C>T (p.Arg1809Cys)	NF1	R1809C, R1830C	Normal	Neurofibromatosis-Noonan syndrome|Café-au-lait macules with pulmonary stenosis|Neurofibromatosis, familial spinal|Neurofibromatosis, type 1|not specified|Neurofibromatosis, type 1|Intellectual disability|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208853	17	29654736	17	31327718	208853	205416	rs797045139	NC_000017.11:31327717:C:T	C	T	CLINICAL
NM_033419.5(PGAP3):c.558-10G>A	PGAP3		Normal	not provided|Hyperphosphatasia with mental retardation syndrome 4	Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000224645	17	37829913	17	39673660	224645	226425	rs200598755	NC_000017.11:39673659:C:T	C	T	CLINICAL
NM_033419.5(PGAP3):c.507C>A (p.Tyr169Ter)	PGAP3	Y118*, Y148*, Y169*	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2020)	no assertion criteria provided	VCV000522596	17	37830296	17	39674043	522596	513209	rs1567871748	NC_000017.11:39674042:G:T	G	T	CLINICAL
NM_033419.5(PGAP3):c.432+1G>A	PGAP3		Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522978	17	37840849	17	39684596	522978	513643	rs1555610241	NC_000017.11:39684595:C:T	C	T	CLINICAL
NM_033419.5(PGAP3):c.275G>A (p.Gly92Asp)	PGAP3	G92D	Normal	Hyperphosphatasia with mental retardation syndrome 4	Pathogenic(Last reviewed: Feb 6, 2014)	no assertion criteria provided	VCV000125437	17	37842179	17	39685926	125437	130975	rs587777251	NC_000017.11:39685925:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.343C>T (p.Pro115Ser)	NAGLU	P115S	Normal	Intellectual disability|Mucopolysaccharidosis, MPS-III-B	Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000553505	17	40688633	17	42536615	553505	548854	rs758785463	NC_000017.11:42536614:C:T	C	T	CLINICAL
NM_000263.4(NAGLU):c.1915G>T (p.Glu639Ter)	NAGLU	E639*	Normal	Mucopolysaccharidosis, MPS-III-B	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000522822	17	40695939	17	42543921	522822	513466	rs555145190	NC_000017.11:42543920:G:T	G	T	CLINICAL
NM_004247.4(EFTUD2):c.2493C>A (p.Tyr831Ter)	EFTUD2	Y831*, Y821*, Y796*	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Feb 10, 2012)	no assertion criteria provided	VCV000030403	17	42930732	17	44853364	30403	39360	rs879253726	NC_000017.11:44853363:G:T	G	T	CLINICAL
NM_004247.4(EFTUD2):c.2198G>A (p.Trp733Ter)	EFTUD2	W733*, W698*, W723*	Normal	Mandibulofacial dysostosis-microcephaly syndrome	Pathogenic(Last reviewed: Jan 21, 2016)	criteria provided, single submitter	VCV000435033	17	42931985	17	44854617	435033	429977	rs1555564341	NC_000017.11:44854616:C:T	C	T	CLINICAL
NM_004247.4(EFTUD2):c.1058+1G>A	EFTUD2		Normal	Mandibulofacial dysostosis-microcephaly syndrome|not provided	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000426481	17	42945654	17	44868286	426481	415565	rs1085307647	NC_000017.11:44868285:C:T	C	T	CLINICAL
NM_005910.5(MAPT):c.915+16C>T	MAPT		Normal	not provided|Memory impairment|Mental deterioration|Frontotemporal dementia|Dementia|Frontotemporal dementia	Pathogenic(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000098222	17	44087784	17	46010418	98222	104114	rs63751011	NC_000017.11:46010417:C:T	C	T	CLINICAL
NM_004859.4(CLTC):c.187C>T (p.Arg63Ter)	CLTC	R63*	Normal	not provided|Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000816974	17	57721781	17	59644420	816974	805961	rs1598211790	NC_000017.11:59644419:C:T	C	T	CLINICAL
NM_004859.4(CLTC):c.2669C>T (p.Pro890Leu)	CLTC	P890L, P894L	Normal	not provided|Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488418	17	57754422	17	59677061	488418	481274	rs1555606635	NC_000017.11:59677060:C:T	C	T	CLINICAL
NM_004859.4(CLTC):c.4663C>T (p.Gln1555Ter)	CLTC	Q1555*, Q1559*	Normal	Inborn genetic diseases|Intellectual disability, autosomal dominant 56	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000488420	17	57763005	17	59685644	488420	481276	rs1555607682	NC_000017.11:59685643:C:T	C	T	CLINICAL
NM_005121.3(MED13):c.1745T>A (p.Leu582Ter)	MED13	L582*	Normal	Intellectual developmental disorder 61|not provided	Pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000620176	17	60088133	17	62010772	620176	611868	rs780070113	NC_000017.11:62010771:A:T	A	T	CLINICAL
NM_001330418.2(TLK2):c.-461C>T	TLK2	Q13*	Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617935	17	60558523	17	62481162	617935	609317	rs1567758622	NC_000017.11:62481161:C:T	C	T	CLINICAL
NM_001330418.2(TLK2):c.-171C>T	TLK2	R61*	Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617928	17	60599592	17	62522231	617928	609318	rs1567844041	NC_000017.11:62522230:C:T	C	T	CLINICAL
NM_001330418.2(TLK2):c.-150G>T	TLK2	E68*	Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617923	17	60599613	17	62522252	617923	609319	rs1567844114	NC_000017.11:62522251:G:T	G	T	CLINICAL
NM_006852.6(TLK2):c.367C>T (p.Arg123Ter)	TLK2	R91*, R123*, R137*	Normal	Intellectual disability, autosomal dominant 57|not provided	Pathogenic(Last reviewed: May 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000816982	17	60613534	17	62536173	816982	805975	rs758726258	NC_000017.11:62536172:C:T	C	T	CLINICAL
NM_006852.4(TLK2):c.784C>T (p.Arg262Ter)	TLK2	R113*, R230*, R262*	Normal	Intellectual disability, autosomal dominant 57|not provided	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617919	17	60637440	17	62560079	617919	609321	rs1567920209	NC_000017.11:62560078:C:T	C	T	CLINICAL
NM_006852.4(TLK2):c.907C>T (p.Arg303Ter)	TLK2	R154*, R271*, R303*	Normal	not provided|Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000617933	17	60642437	17	62565076	617933	609322	rs138247472	NC_000017.11:62565075:C:T	C	T	CLINICAL
NM_006852.4(TLK2):c.1636C>T (p.Arg546Trp)	TLK2	R397W, R514W, R546W, R568W	Normal	Intellectual disability, autosomal dominant 57	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617931	17	60678097	17	62600736	617931	609328	rs1283838287	NC_000017.11:62600735:C:T	C	T	CLINICAL
NM_006852.4(TLK2):c.1651C>T (p.Gln551Ter)	TLK2	Q402*, Q519*, Q551*, Q573*	Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000617937	17	60678112	17	62600751	617937	609329	rs1568003569	NC_000017.11:62600750:C:T	C	T	CLINICAL
NM_006852.4(TLK2):c.1720+1G>T	TLK2		Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Jul 12, 2018)	no assertion criteria provided	VCV000548933	17	60678182	17	62600821	548933	539420	rs1555660806	NC_000017.11:62600820:G:T	G	T	CLINICAL
NM_006852.4(TLK2):c.2107C>T (p.Arg703Ter)	TLK2	R554*, R703*, R725*, R671*	Normal	Intellectual disability, autosomal dominant 57	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689792	17	60689780	17	62612419	689792	677456	rs1598940393	NC_000017.11:62612418:C:T	C	T	CLINICAL
NM_182641.4(BPTF):c.8701A>T (p.Lys2901Ter)	BPTF	K2884*, K2901*	Normal	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies|Postnatal microcephaly|Expressive language delay|Global developmental delay	Pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	VCV000431066	17	65972049	17	67975933	431066	424595	rs1555693714	NC_000017.11:67975932:A:T	A	T	CLINICAL
NM_212472.2(PRKAR1A):c.1003C>T (p.Arg335Cys)	PRKAR1A|FAM20A	R335C	Normal	not provided|Acrodysostosis 1 with or without hormone resistance|Familial atrial myxoma|Acrodysostosis 1 with or without hormone resistance|Pigmented nodular adrenocortical disease, primary, 1|Carney complex, type 1	Likely pathogenic(Last reviewed: Jun 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000433148	17	66526447	17	68530306	433148	426726	rs1555815121	NC_000017.11:68530305:C:T	C	T	CLINICAL
NM_212472.2(PRKAR1A):c.1102C>T (p.Arg368Ter)	PRKAR1A|FAM20A	R368*	Normal	Acrodysostosis 1 with or without hormone resistance|not provided	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029907	17	66526546	17	68530405	29907	38862	rs387906692	NC_000017.11:68530404:C:T	C	T	CLINICAL
NM_207346.3(TSEN54):c.919G>T (p.Ala307Ser)	TSEN54	A307S	Normal	Global developmental delay|Amblyopia|Hypertonia|Global developmental delay|Microcephaly|Pontocerebellar hypoplasia type 2A|Pontocerebellar hypoplasia type 4|Inborn genetic diseases|Pontocerebellar hypoplasia type 4|Pontocerebellar hypoplasia type 2A|not provided|Olivopontocerebellar hypoplasia|Pontoneocerebellar hypoplasia|Intellectual disability|Congenital cerebellar hypoplasia|Pontocerebellar hypoplasia type 5	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002120	17	73518081	17	75522000	2120	17159	rs113994152	NC_000017.11:75521999:G:T	G	T	CLINICAL
NM_001080510.4(METTL23):c.397C>T (p.Gln133Ter)	METTL23	Q133*, Q129*, Q66*	Normal	Mental retardation, autosomal recessive 44	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000144025	17	74729449	17	76733367	144025	153756	rs587777646	NC_000017.11:76733366:C:T	C	T	CLINICAL
NM_001005273.2(CHD3):c.1369G>T (p.Glu457Ter)	CHD3	E457*, E516*	Normal	Intellectual disability	Likely pathogenic(Last reviewed: May 3, 2018)	no assertion criteria provided	VCV000549728	17	7798334	17	7895016	549728	540495	rs1567844992	NC_000017.11:7895015:G:T	G	T	CLINICAL
NM_001005273.2(CHD3):c.2745G>T (p.Leu915Phe)	CHD3	L915F, L974F	Normal	Intellectual disability|Snijders blok-campeau syndrome	Pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549730	17	7803670	17	7900352	549730	540497	rs1567855669	NC_000017.11:7900351:G:T	G	T	CLINICAL
NM_001005271.3(CHD3):c.3130C>T (p.Arg1044Trp)	CHD3	R1044W, R985W	Normal	Intellectual disability|Snijders blok-campeau syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520977	17	7804024	17	7900706	520977	512330	rs1555611722	NC_000017.11:7900705:C:T	C	T	CLINICAL
NM_001005273.2(CHD3):c.3407C>T (p.Thr1136Ile)	CHD3	T1136I, T1195I	Normal	Intellectual disability|Snijders blok-campeau syndrome	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549737	17	7806291	17	7902973	549737	540504	rs1567860640	NC_000017.11:7902972:C:T	C	T	CLINICAL
NM_001005271.3(CHD3):c.3682C>T (p.Arg1228Trp)	CHD3	R1169W, R1228W	Normal	Intellectual disability|Snijders blok-campeau syndrome|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000549741	17	7806599	17	7903281	549741	540508	rs1567861468	NC_000017.11:7903280:C:T	C	T	CLINICAL
NM_001005273.2(CHD3):c.5642G>T (p.Arg1881Leu)	CHD3	R1881L, R1847L, R1940L	Normal	Intellectual disability|Snijders blok-campeau syndrome	Likely pathogenic(Last reviewed: Feb 19, 2019)	criteria provided, single submitter	VCV000549748	17	7813797	17	7910479	549748	540515	rs1567877108	NC_000017.11:7910478:G:T	G	T	CLINICAL
NM_012140.5(SLC25A10):c.304A>T (p.Lys102Ter)	SLC25A10	K102*	Normal	Mitochondrial complex I deficiency|Mitochondrial DNA depletion syndrome 19	Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000446175	17	79682598	17	81715568	446175	439523	rs1555703272	NC_000017.11:81715567:A:T	A	T	CLINICAL
NM_006907.4(PYCR1):c.797G>A (p.Arg266Gln)	PYCR1	R266Q, R235Q, R293Q	Normal	not provided|Autosomal recessive cutis laxa type 2B|Cutis laxa|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013190	17	79892202	17	81934326	13190	28229	rs121918374	NC_000017.11:81934325:C:T	C	T	CLINICAL
NM_006907.4(PYCR1):c.752G>A (p.Arg251His)	PYCR1	R251H, R220H, R278H	Normal	Autosomal recessive cutis laxa type 3B	Pathogenic(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000013198	17	79892247	17	81934371	13198	28237	rs121918378	NC_000017.11:81934370:C:T	C	T	CLINICAL
NM_006907.4(PYCR1):c.356G>A (p.Arg119His)	PYCR1	R119H, R146H	Normal	Autosomal recessive cutis laxa type 2B|not provided|Autosomal recessive cutis laxa type 3B|Wiedemann-Rautenstrauch-like progeroid syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013197	17	79892986	17	81935110	13197	28236	rs121918377	NC_000017.11:81935109:C:T	C	T	CLINICAL
NM_005052.3(RAC3):c.86C>T (p.Pro29Leu)	RAC3	P29L	Normal	Abnormality of brain morphology|Intellectual disability|Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies	Pathogenic, association(Last reviewed: Sep 12, 2019)	no assertion criteria provided	VCV000585004	17	79990313	17	82032437	585004	576060	rs1568018697	NC_000017.11:82032436:C:T	C	T	CLINICAL
NM_005052.3(RAC3):c.182A>T (p.Gln61Leu)	RAC3	Q61L	Normal	Abnormality of brain morphology|Intellectual disability|Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies	Pathogenic, association(Last reviewed: Aug 3, 2021)	no assertion criteria provided	VCV000585005	17	79990661	17	82032785	585005	576061	rs1568018920	NC_000017.11:82032784:A:T	A	T	CLINICAL
NM_005910.5(MAPT):c.902C>T (p.Pro301Leu)	MAPT	P301L, P243L, P272L, P618L, P636L	Normal	Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|not provided|Pick disease|Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Progressive supranuclear ophthalmoplegia	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014245	17	44087755	17	46010389	14245	29284	rs63751273	NC_000017.11:46010388:C:T	C	T	CLINICAL
NM_005910.5(MAPT):c.1216C>T (p.Arg406Trp)	MAPT	R406W, R723W, R375W, R317W, R346W, R741W, R348W, R377W	Normal	not provided|Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|Pick disease|Parkinson disease, late-onset|Frontotemporal dementia|Parkinson-dementia syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014247	17	44101427	17	46024061	14247	29286	rs63750424	NC_000017.11:46024060:C:T	C	T	CLINICAL
NM_000458.4(HNF1B):c.896G>A (p.Trp299Ter)	HNF1B	W273*, W299*	Normal	Renal cysts and diabetes syndrome	Likely pathogenic(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000692161	17	36091735	17	37731744	692161	679902	rs1598840996	NC_000017.11:37731743:C:T	C	T	CLINICAL
NM_198993.5(STAC2):c.257G>A (p.Arg86Lys)	STAC2	R86K	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208390	17	37374260	17	39218007	208390	204624	rs863223351	NC_000017.11:39218006:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1876C>T (p.Arg626Ter)	TCF4	R626*, R462*, R551*, R584*, R597*, R601*, R603*, R625*, R632*, R728*, R466*, R619*, R621*, R622*, R410*, R496*, R580*, R602*, R461*, R492*, R555*, R598*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430016	18	52896081	18	55228850	430016	422225	rs1131691735	NC_000018.10:55228849:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1849G>T (p.Val617Phe)	TCF4	V617F, V453F, V546F, V613F, V623F, V571F, V588F, V589F, V592F, V593F, V401F, V452F, V487F, V610F, V616F, V719F, V457F, V483F, V542F, V575F, V594F, V612F	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000560273	18	52896108	18	55228877	560273	551328	rs1568303086	NC_000018.10:55228876:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1841C>T (p.Ala614Val)	TCF4	A614V, A398V, A449V, A450V, A454V, A480V, A539V, A543V, A585V, A590V, A607V, A609V, A620V, A716V, A484V, A572V, A591V, A613V, A568V, A586V, A589V, A610V	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000581714	18	52896116	18	55228885	581714	571970	rs1568303352	NC_000018.10:55228884:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1760C>T (p.Ala587Val)	TCF4	A587V, A371V, A457V, A512V, A541V, A564V, A583V, A586V, A593V, A422V, A423V, A427V, A516V, A562V, A453V, A545V, A558V, A580V, A582V, A559V, A563V, A689V	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000436964	18	52896197	18	55228966	436964	430067	rs1555710523	NC_000018.10:55228965:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1738C>T (p.Arg580Trp)	TCF4	R576W, R580W, R682W, R364W, R505W, R534W, R552W, R557W, R420W, R446W, R509W, R555W, R573W, R575W, R579W, R415W, R416W, R450W, R538W, R551W, R556W, R586W	Normal	Inborn genetic diseases|Pitt-Hopkins syndrome|Severe intellectual deficiency|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007370	18	52896219	18	55228988	7370	22409	rs121909120	NC_000018.10:55228987:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1726C>T (p.Arg576Ter)	TCF4	R576*, R678*, R360*, R411*, R416*, R446*, R530*, R534*, R547*, R548*, R551*, R553*, R571*, R552*, R575*, R582*, R412*, R442*, R501*, R505*, R569*, R572*	Normal	Pitt-Hopkins syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488988	18	52896231	18	55229000	488988	482178	rs1555710726	NC_000018.10:55228999:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1570C>T (p.Gln524Ter)	TCF4	Q524*, Q363*, Q482*, Q523*, Q364*, Q453*, Q499*, Q500*, Q501*, Q521*, Q626*, Q308*, Q394*, Q530*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207534	18	52899819	18	55232588	207534	203505	rs796053418	NC_000018.10:55232587:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1552G>T (p.Glu518Ter)	TCF4	E518*, E388*, E495*, E517*, E357*, E493*, E524*, E620*, E358*, E447*, E494*, E515*, E302*, E476*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000577819	18	52899837	18	55232606	577819	574765	rs1555718063	NC_000018.10:55232605:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1498G>T (p.Gly500Ter)	TCF4	G500*, G506*, G284*, G370*, G458*, G475*, G497*, G602*, G339*, G340*, G429*, G476*, G477*, G499*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160078	18	52899891	18	55232660	160078	169441	rs587784459	NC_000018.10:55232659:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1486G>T (p.Gly496Cys)	TCF4	G280C, G335C, G336C, G366C, G425C, G454C, G471C, G472C, G473C, G493C, G495C, G496C, G502C, G598C	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: May 11, 2021)	reviewed by expert panel	VCV000690393	18	52901779	18	55234548	690393	678075	rs1599570613	NC_000018.10:55234547:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1438C>T (p.Gln480Ter)	TCF4	Q480*, Q409*, Q457*, Q479*, Q264*, Q455*, Q477*, Q319*, Q350*, Q456*, Q582*, Q320*, Q438*, Q486*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000180214	18	52901827	18	55234596	180214	178394	rs727505396	NC_000018.10:55234595:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1411C>T (p.Gln471Ter)	TCF4	Q471*, Q400*, Q446*, Q470*, Q310*, Q311*, Q429*, Q448*, Q477*, Q341*, Q468*, Q255*, Q447*, Q573*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000212377	18	52901854	18	55234623	212377	208457	rs797046033	NC_000018.10:55234622:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1153C>T (p.Arg385Ter)	TCF4	R385*, R225*, R314*, R362*, R382*, R384*, R343*, R360*, R169*, R361*, R487*, R224*, R255*, R391*	Normal	not provided|Pitt-Hopkins syndrome|Pitt-Hopkins syndrome|Corneal dystrophy, Fuchs endothelial, 3	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007372	18	52921925	18	55254694	7372	22411	rs121909122	NC_000018.10:55254693:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1069+1G>T	TCF4	G333V	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	VCV000209195	18	52927179	18	55259948	209195	205790	rs797045072	NC_000018.10:55259947:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.968C>T (p.Ala323Val)	TCF4	A323V, A107V, A163V, A252V, A298V, A425V, A193V, A281V, A299V, A322V, A321V, A329V	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 19, 2014)	no assertion criteria provided	VCV000208487	18	52928719	18	55261488	208487	205021	rs797045003	NC_000018.10:55261487:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.748C>T (p.Gln250Ter)	TCF4	Q250*, Q226*, Q34*, Q120*, Q208*, Q249*, Q256*, Q179*, Q352*, Q90*, Q225*, Q248*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000167728	18	52942891	18	55275660	167728	177295	rs727504175	NC_000018.10:55275659:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.655+1G>T	TCF4		Normal	Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167729	18	52946781	18	55279550	167729	178096	rs587784465	NC_000018.10:55279549:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.520C>T (p.Arg174Ter)	TCF4	R174*, R103*, R172*, R173*, R150*, R149*, R132*, R276*, R44*	Normal	Intellectual disability|not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235853	18	53017619	18	55350388	235853	237503	rs878853149	NC_000018.10:55350387:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.469C>T (p.Arg157Ter)	TCF4	R157*, R115*, R132*, R259*, R27*, R133*, R156*, R86*, R155*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160085	18	53018135	18	55350904	160085	169452	rs587784464	NC_000018.10:55350903:G:A	G	A	CLINICAL
NM_013435.3(RAX):c.439C>T (p.Gln147Ter)	RAX	Q147*	Normal	Microphthalmia, isolated 3	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000007635	18	56939697	18	59272465	7635	22674	rs104894663	NC_000018.10:59272464:G:A	G	A	CLINICAL
NM_030632.3(ASXL3):c.3464C>A (p.Ser1155Ter)	ASXL3	S1155*	Normal	not provided|Bainbridge-Ropers syndrome|Decreased activity of mitochondrial complex I|Generalized hypotonia|Gastrostomy tube feeding in infancy|Absent speech|Global developmental delay	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000426517	18	31323276	18	33743312	426517	415601	rs377619533	NC_000018.10:33743311:C:A	C	A	CLINICAL
NM_015559.3(SETBP1):c.821G>A (p.Trp274Ter)	SETBP1	W274*	Normal	Mental retardation, autosomal dominant 29|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000489124	18	42530126	18	44950161	489124	482171	rs1555705966	NC_000018.10:44950160:G:A	G	A	CLINICAL
NM_000271.5(NPC1):c.1421C>T (p.Pro474Leu)	NPC1	P474L	Normal	Niemann-Pick disease type C1|Cerebellar ataxia|Headache|Cataplexy|Postural instability|Speech apraxia|Cognitive impairment	Pathogenic(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374049	18	21134854	18	23554890	374049	361031	rs372445155	NC_000018.10:23554889:G:A	G	A	CLINICAL
NM_001792.5(CDH2):c.1789G>T (p.Asp597Tyr)	CDH2	D566Y, D597Y	Normal	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome|Corpus callosum, agenesis of|Axon pathfinding, cardiac, ocular and genital defects	Pathogenic(Last reviewed: Jun 26, 2020)	no assertion criteria provided	VCV000805760	18	25565678	18	27985714	805760	794098	rs1599011050	NC_000018.10:27985713:C:A	C	A	CLINICAL
NM_000371.4(TTR):c.148G>A (p.Val50Met)	TTR	V50M	Normal	none provided|Charcot-Marie-Tooth disease|Amyloidogenic transthyretin amyloidosis|Amyloidogenic transthyretin amyloidosis|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome|not provided|Cardiomyopathy	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013417	18	29172937	18	31592974	13417	28456	rs28933979	NC_000018.10:31592973:G:A	G	A	CLINICAL
NM_030632.3(ASXL3):c.1986C>A (p.Tyr662Ter)	ASXL3	Y662*	Normal	intellectual deficiency|Language retardation	Likely pathogenic	no assertion criteria provided	VCV000374244	18	31319354	18	33739390	374244	361147	rs1057519005	NC_000018.10:33739389:C:A	C	A	CLINICAL
NM_030632.3(ASXL3):c.3464C>A (p.Ser1155Ter)	ASXL3	S1155*	Normal	not provided|Bainbridge-Ropers syndrome|Decreased activity of mitochondrial complex I|Generalized hypotonia|Gastrostomy tube feeding in infancy|Absent speech|Global developmental delay	Pathogenic(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000426517	18	31323276	18	33743312	426517	415601	rs377619533	NC_000018.10:33743311:C:A	C	A	CLINICAL
NM_015559.3(SETBP1):c.821G>A (p.Trp274Ter)	SETBP1	W274*	Normal	Mental retardation, autosomal dominant 29|not provided	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000489124	18	42530126	18	44950161	489124	482171	rs1555705966	NC_000018.10:44950160:G:A	G	A	CLINICAL
NM_015559.3(SETBP1):c.1596G>A (p.Trp532Ter)	SETBP1	W532*	Normal	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157556	18	42530901	18	44950936	157556	167419	rs672601342	NC_000018.10:44950935:G:A	G	A	CLINICAL
NM_015559.3(SETBP1):c.2602G>A (p.Asp868Asn)	SETBP1	D868N	Normal	not provided|Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29|Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000001032	18	42531907	18	44951942	1032	16071	rs267607042	NC_000018.10:44951941:G:A	G	A	CLINICAL
NM_004046.6(ATP5F1A):c.985C>T (p.Arg329Cys)	ATP5F1A	R329C, R279C, R307C	Normal	Mitochondrial complex v (atp synthase) deficiency, nuclear type 4	Pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	VCV000050353	18	43667165	18	46087199	50353	59478	rs587776960	NC_000018.10:46087198:G:A	G	A	CLINICAL
NM_005359.6(SMAD4):c.1082G>A (p.Arg361His)	SMAD4	R361H	Normal	Lung adenocarcinoma|Carcinoma of esophagus|Neoplasm of the large intestine|Breast neoplasm|Squamous cell carcinoma of the head and neck|Juvenile polyposis syndrome|Neoplasm of uterine cervix|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|JP and JP/HHT|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of pancreas|Generalized juvenile polyposis/juvenile polyposis coli|Myhre syndrome	Pathogenic(Last reviewed: Aug 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024832	18	48591919	18	51065549	24832	36173	rs377767347	NC_000018.10:51065548:G:A	G	A	CLINICAL
NM_005215.4(DCC):c.2260G>A (p.Val754Met)	DCC	V754M	Normal	Corpus callosum, agenesis of	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375286	18	50866178	18	53339808	375286	362055	rs775565634	NC_000018.10:53339807:G:A	G	A	CLINICAL
NM_005215.4(DCC):c.2414G>A (p.Gly805Glu)	DCC	G805E	Normal	Corpus callosum, agenesis of|Mirror movements 1	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000375283	18	50912467	18	53386097	375283	362057	rs1057519055	NC_000018.10:53386096:G:A	G	A	CLINICAL
NM_005215.4(DCC):c.2677G>A (p.Ala893Thr)	DCC	A893T	Normal	Corpus callosum, agenesis of	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375287	18	50918246	18	53391876	375287	362058	rs1057519057	NC_000018.10:53391875:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1876C>T (p.Arg626Ter)	TCF4	R626*, R462*, R551*, R584*, R597*, R601*, R603*, R625*, R632*, R728*, R466*, R619*, R621*, R622*, R410*, R496*, R580*, R602*, R461*, R492*, R555*, R598*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430016	18	52896081	18	55228850	430016	422225	rs1131691735	NC_000018.10:55228849:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1849G>T (p.Val617Phe)	TCF4	V617F, V453F, V546F, V613F, V623F, V571F, V588F, V589F, V592F, V593F, V401F, V452F, V487F, V610F, V616F, V719F, V457F, V483F, V542F, V575F, V594F, V612F	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000560273	18	52896108	18	55228877	560273	551328	rs1568303086	NC_000018.10:55228876:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1841C>T (p.Ala614Val)	TCF4	A614V, A398V, A449V, A450V, A454V, A480V, A539V, A543V, A585V, A590V, A607V, A609V, A620V, A716V, A484V, A572V, A591V, A613V, A568V, A586V, A589V, A610V	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000581714	18	52896116	18	55228885	581714	571970	rs1568303352	NC_000018.10:55228884:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1760C>T (p.Ala587Val)	TCF4	A587V, A371V, A457V, A512V, A541V, A564V, A583V, A586V, A593V, A422V, A423V, A427V, A516V, A562V, A453V, A545V, A558V, A580V, A582V, A559V, A563V, A689V	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 17, 2016)	criteria provided, single submitter	VCV000436964	18	52896197	18	55228966	436964	430067	rs1555710523	NC_000018.10:55228965:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1738C>T (p.Arg580Trp)	TCF4	R576W, R580W, R682W, R364W, R505W, R534W, R552W, R557W, R420W, R446W, R509W, R555W, R573W, R575W, R579W, R415W, R416W, R450W, R538W, R551W, R556W, R586W	Normal	Inborn genetic diseases|Pitt-Hopkins syndrome|Severe intellectual deficiency|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007370	18	52896219	18	55228988	7370	22409	rs121909120	NC_000018.10:55228987:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1726C>T (p.Arg576Ter)	TCF4	R576*, R678*, R360*, R411*, R416*, R446*, R530*, R534*, R547*, R548*, R551*, R553*, R571*, R552*, R575*, R582*, R412*, R442*, R501*, R505*, R569*, R572*	Normal	Pitt-Hopkins syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000488988	18	52896231	18	55229000	488988	482178	rs1555710726	NC_000018.10:55228999:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1570C>T (p.Gln524Ter)	TCF4	Q524*, Q363*, Q482*, Q523*, Q364*, Q453*, Q499*, Q500*, Q501*, Q521*, Q626*, Q308*, Q394*, Q530*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207534	18	52899819	18	55232588	207534	203505	rs796053418	NC_000018.10:55232587:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1552G>T (p.Glu518Ter)	TCF4	E518*, E388*, E495*, E517*, E357*, E493*, E524*, E620*, E358*, E447*, E494*, E515*, E302*, E476*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	VCV000577819	18	52899837	18	55232606	577819	574765	rs1555718063	NC_000018.10:55232605:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1498G>T (p.Gly500Ter)	TCF4	G500*, G506*, G284*, G370*, G458*, G475*, G497*, G602*, G339*, G340*, G429*, G476*, G477*, G499*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160078	18	52899891	18	55232660	160078	169441	rs587784459	NC_000018.10:55232659:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1486G>T (p.Gly496Cys)	TCF4	G280C, G335C, G336C, G366C, G425C, G454C, G471C, G472C, G473C, G493C, G495C, G496C, G502C, G598C	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: May 11, 2021)	reviewed by expert panel	VCV000690393	18	52901779	18	55234548	690393	678075	rs1599570613	NC_000018.10:55234547:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.1438C>T (p.Gln480Ter)	TCF4	Q480*, Q409*, Q457*, Q479*, Q264*, Q455*, Q477*, Q319*, Q350*, Q456*, Q582*, Q320*, Q438*, Q486*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000180214	18	52901827	18	55234596	180214	178394	rs727505396	NC_000018.10:55234595:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1411C>T (p.Gln471Ter)	TCF4	Q471*, Q400*, Q446*, Q470*, Q310*, Q311*, Q429*, Q448*, Q477*, Q341*, Q468*, Q255*, Q447*, Q573*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000212377	18	52901854	18	55234623	212377	208457	rs797046033	NC_000018.10:55234622:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1153C>T (p.Arg385Ter)	TCF4	R385*, R225*, R314*, R362*, R382*, R384*, R343*, R360*, R169*, R361*, R487*, R224*, R255*, R391*	Normal	not provided|Pitt-Hopkins syndrome|Pitt-Hopkins syndrome|Corneal dystrophy, Fuchs endothelial, 3	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007372	18	52921925	18	55254694	7372	22411	rs121909122	NC_000018.10:55254693:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.1069+1G>T	TCF4	G333V	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 10, 2014)	criteria provided, single submitter	VCV000209195	18	52927179	18	55259948	209195	205790	rs797045072	NC_000018.10:55259947:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.968C>T (p.Ala323Val)	TCF4	A323V, A107V, A163V, A252V, A298V, A425V, A193V, A281V, A299V, A322V, A321V, A329V	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 19, 2014)	no assertion criteria provided	VCV000208487	18	52928719	18	55261488	208487	205021	rs797045003	NC_000018.10:55261487:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.748C>T (p.Gln250Ter)	TCF4	Q250*, Q226*, Q34*, Q120*, Q208*, Q249*, Q256*, Q179*, Q352*, Q90*, Q225*, Q248*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000167728	18	52942891	18	55275660	167728	177295	rs727504175	NC_000018.10:55275659:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.655+1G>T	TCF4		Normal	Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000167729	18	52946781	18	55279550	167729	178096	rs587784465	NC_000018.10:55279549:C:A	C	A	CLINICAL
NM_001083962.2(TCF4):c.520C>T (p.Arg174Ter)	TCF4	R174*, R103*, R172*, R173*, R150*, R149*, R132*, R276*, R44*	Normal	Intellectual disability|not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000235853	18	53017619	18	55350388	235853	237503	rs878853149	NC_000018.10:55350387:G:A	G	A	CLINICAL
NM_001083962.2(TCF4):c.469C>T (p.Arg157Ter)	TCF4	R157*, R115*, R132*, R259*, R27*, R133*, R156*, R86*, R155*	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160085	18	53018135	18	55350904	160085	169452	rs587784464	NC_000018.10:55350903:G:A	G	A	CLINICAL
NM_173630.4(RTTN):c.2796A>T (p.Leu932Phe)	RTTN	L932F, L20F	Normal	MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH SEIZURES|not provided	Pathogenic(Last reviewed: Sep 7, 2012)	no assertion criteria provided	VCV000068847	18	67802509	18	70135273	68847	79738	rs318240757	NC_000018.10:70135272:T:A	T	A	CLINICAL
NM_001083962.2(TCF4):c.1486+2T>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic	no assertion criteria provided	VCV000626271	18	52901777	18	55234546	626271	614614	rs1555721921	NC_000018.10:55234545:A:C	A	C	CLINICAL
NM_001083962.2(TCF4):c.1469C>G (p.Pro490Arg)	TCF4	P490R, P330R, P360R, P466R, P487R, P448R, P465R, P274R, P419R, P467R, P329R, P592R, P489R, P496R	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000468947	18	52901796	18	55234565	468947	469003	rs1555722023	NC_000018.10:55234564:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.1328C>G (p.Ser443Ter)	TCF4	S282*, S313*, S545*, S418*, S443*, S283*, S372*, S401*, S420*, S440*, S449*, S227*, S419*, S442*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000661273	18	52921750	18	55254519	661273	647325	rs1600285757	NC_000018.10:55254518:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.1146+3A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000565600	18	52924543	18	55257312	565600	572668	rs1568490874	NC_000018.10:55257311:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.991-2A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	VCV000160093	18	52927260	18	55260029	160093	169444	rs587784470	NC_000018.10:55260028:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.923-2A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000656789	18	52928766	18	55261535	656789	652892	rs1600578193	NC_000018.10:55261534:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.790-2A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803496	18	52937196	18	55269965	803496	791870	rs1600866162	NC_000018.10:55269964:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.759C>G (p.Ser253Arg)	TCF4	S253R, S37R, S123R, S182R, S229R, S251R, S252R, S93R, S211R, S355R, S228R, S259R	Normal	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000432062	18	52942880	18	55275649	432062	426274	rs1555796785	NC_000018.10:55275648:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.550-2A>G	TCF4	Q189R	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 21, 2012)	criteria provided, single submitter	VCV000217015	18	52946889	18	55279658	217015	213650	rs863224934	NC_000018.10:55279657:T:C	T	C	CLINICAL
NM_001792.5(CDH2):c.1880A>G (p.Asp627Gly)	CDH2	D596G, D627G	Normal	Syndromic neurodevelopmental disorder|Corpus callosum, agenesis of|Axon pathfinding, cardiac, ocular and genital defects	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000805763	18	25565587	18	27985623	805763	794095	rs1599010918	NC_000018.10:27985622:T:C	T	C	CLINICAL
NM_001792.5(CDH2):c.1839C>G (p.Cys613Trp)	CDH2	C582W, C613W	Normal	Corpus callosum, agenesis of|Axon pathfinding, cardiac, ocular and genital defects	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000805762	18	25565628	18	27985664	805762	794096	rs754880999	NC_000018.10:27985663:G:C	G	C	CLINICAL
NM_018255.4(ELP2):c.1663A>C (p.Thr555Pro)	ELP2	T555P, T620P, T594P, T485P, T505P, T550P, T406P, T511P, T529P	Normal	Mental retardation, autosomal recessive 58	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000374911	18	33739953	18	36159990	374911	361816	rs772450541	NC_000018.10:36159989:A:C	A	C	CLINICAL
NM_005359.6(SMAD4):c.1308+2T>C	SMAD4		Normal	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Myhre syndrome|Generalized juvenile polyposis/juvenile polyposis coli	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548563	18	48593559	18	51067189	548563	539082	rs1555686624	NC_000018.10:51067188:T:C	T	C	CLINICAL
NM_005359.6(SMAD4):c.1499T>C (p.Ile500Thr)	SMAD4	I500T	Normal	not provided|Myhre syndrome	Pathogenic(Last reviewed: May 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030149	18	48604677	18	51078307	30149	39105	rs281875321	NC_000018.10:51078306:T:C	T	C	CLINICAL
NM_005215.4(DCC):c.1790G>C (p.Arg597Pro)	DCC	R597P	Normal	Corpus callosum, agenesis of	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375284	18	50734116	18	53207746	375284	362053	rs1057519056	NC_000018.10:53207745:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.1486+2T>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic	no assertion criteria provided	VCV000626271	18	52901777	18	55234546	626271	614614	rs1555721921	NC_000018.10:55234545:A:C	A	C	CLINICAL
NM_001083962.2(TCF4):c.1469C>G (p.Pro490Arg)	TCF4	P490R, P330R, P360R, P466R, P487R, P448R, P465R, P274R, P419R, P467R, P329R, P592R, P489R, P496R	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000468947	18	52901796	18	55234565	468947	469003	rs1555722023	NC_000018.10:55234564:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.1328C>G (p.Ser443Ter)	TCF4	S282*, S313*, S545*, S418*, S443*, S283*, S372*, S401*, S420*, S440*, S449*, S227*, S419*, S442*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000661273	18	52921750	18	55254519	661273	647325	rs1600285757	NC_000018.10:55254518:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.1146+3A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000565600	18	52924543	18	55257312	565600	572668	rs1568490874	NC_000018.10:55257311:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.991-2A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 1, 2013)	criteria provided, single submitter	VCV000160093	18	52927260	18	55260029	160093	169444	rs587784470	NC_000018.10:55260028:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.923-2A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000656789	18	52928766	18	55261535	656789	652892	rs1600578193	NC_000018.10:55261534:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.790-2A>G	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803496	18	52937196	18	55269965	803496	791870	rs1600866162	NC_000018.10:55269964:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.759C>G (p.Ser253Arg)	TCF4	S253R, S37R, S123R, S182R, S229R, S251R, S252R, S93R, S211R, S355R, S228R, S259R	Normal	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000432062	18	52942880	18	55275649	432062	426274	rs1555796785	NC_000018.10:55275648:G:C	G	C	CLINICAL
NM_001083962.2(TCF4):c.550-2A>G	TCF4	Q189R	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 21, 2012)	criteria provided, single submitter	VCV000217015	18	52946889	18	55279658	217015	213650	rs863224934	NC_000018.10:55279657:T:C	T	C	CLINICAL
NM_001083962.2(TCF4):c.1871A>C (p.Gln624Pro)	TCF4	Q624P, Q408P, Q549P, Q553P, Q623P, Q630P, Q490P, Q494P, Q578P, Q582P, Q617P, Q620P, Q460P, Q464P, Q595P, Q596P, Q601P, Q459P, Q599P, Q600P, Q619P, Q726P	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000212378	18	52896086	18	55228855	212378	208456	rs797046034	NC_000018.10:55228854:T:G	T	G	CLINICAL
NM_001083962.2(TCF4):c.1840G>C (p.Ala614Pro)	TCF4	A614P, A480P, A543P, A568P, A590P, A613P, A716P, A454P, A539P, A620P, A484P, A572P, A585P, A589P, A607P, A609P, A398P, A449P, A450P, A586P, A591P, A610P	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160081	18	52896117	18	55228886	160081	169438	rs587784462	NC_000018.10:55228885:C:G	C	G	CLINICAL
NM_001083962.2(TCF4):c.1826T>C (p.Leu609Pro)	TCF4	L609P, L393P, L479P, L534P, L584P, L538P, L563P, L567P, L585P, L602P, L608P, L444P, L445P, L449P, L475P, L580P, L581P, L586P, L604P, L615P, L605P, L711P	Normal	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000393171	18	52896131	18	55228900	393171	379059	rs1057524821	NC_000018.10:55228899:A:G	A	G	CLINICAL
NM_001083962.2(TCF4):c.1733G>C (p.Arg578Pro)	TCF4	R574P, R578P, R413P, R448P, R507P, R536P, R549P, R550P, R553P, R418P, R555P, R362P, R532P, R554P, R571P, R414P, R444P, R503P, R573P, R577P, R584P, R680P	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000007374	18	52896224	18	55228993	7374	22413	rs121909123	NC_000018.10:55228992:C:G	C	G	CLINICAL
NM_001083962.2(TCF4):c.1710G>C (p.Arg570Ser)	TCF4	R436S, R542S, R546S, R563S, R565S, R354S, R405S, R495S, R499S, R541S, R545S, R547S, R566S, R410S, R524S, R569S, R570S, R406S, R440S, R528S, R576S, R672S	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666313	18	52896247	18	55229016	666313	653895	rs1599377405	NC_000018.10:55229015:C:G	C	G	CLINICAL
NM_001083962.2(TCF4):c.656-1G>C	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160087	18	52942984	18	55275753	160087	169449	rs587784466	NC_000018.10:55275752:C:G	C	G	CLINICAL
NM_000271.5(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	G992R	Normal	not provided|Niemann-Pick disease, type C|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002969	18	21118573	18	23538609	2969	18008	rs80358254	NC_000018.10:23538608:C:G	C	G	CLINICAL
NM_001650.7(AQP4):c.332G>C (p.Ser111Thr)	AQP4	S111T, S89T	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Nov 1, 2017)	no assertion criteria provided	VCV000446492	18	24442261	18	26862297	446492	440008	rs1555661648	NC_000018.10:26862296:C:G	C	G	CLINICAL
NM_001792.5(CDH2):c.1802A>C (p.Asn601Thr)	CDH2	N570T, N601T	Normal	Corpus callosum, agenesis of|Axon pathfinding, cardiac, ocular and genital defects	Pathogenic(Last reviewed: Sep 4, 2019)	no assertion criteria provided	VCV000805761	18	25565665	18	27985701	805761	794097	rs201775968	NC_000018.10:27985700:T:G	T	G	CLINICAL
NM_003244.3(TGIF1):c.16+1651C>G	TGIF1	Y59*	Normal	Holoprosencephaly 4	Pathogenic(Last reviewed: Feb 1, 2003)	no assertion criteria provided	VCV000006983	18	3452154	18	3452156	6983	22022	rs121909070	NC_000018.10:3452155:C:G	C	G	CLINICAL
NM_003244.3(TGIF1):c.188C>G (p.Pro63Arg)	TGIF1	P63R, P192R, P66R, P77R, P43R	Normal	Holoprosencephaly 4	Pathogenic(Last reviewed: Jun 1, 2000)	no assertion criteria provided	VCV000006980	18	3456523	18	3456525	6980	22019	rs121909067	NC_000018.10:3456524:C:G	C	G	CLINICAL
NM_018255.4(ELP2):c.617A>G (p.His206Arg)	ELP2	H271R, H206R, H57R, H245R, H180R	Normal	Inborn genetic diseases|ELP2-Related Disorders|Mental retardation, autosomal recessive 58|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000225008	18	33722272	18	36142309	225008	226967	rs773432002	NC_000018.10:36142308:A:G	A	G	CLINICAL
NM_015559.3(SETBP1):c.3032C>G (p.Ser1011Ter)	SETBP1	S1011*	Normal	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 1, 2014)	no assertion criteria provided	VCV000157557	18	42532337	18	44952372	157557	167420	rs606231270	NC_000018.10:44952371:C:G	C	G	CLINICAL
NM_005359.6(SMAD4):c.1498A>G (p.Ile500Val)	SMAD4	I500V	Normal	Intellectual disability|Myhre syndrome|not provided|Generalized juvenile polyposis/juvenile polyposis coli|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of pancreas|Generalized juvenile polyposis/juvenile polyposis coli|Myhre syndrome|Inborn genetic diseases|Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Generalized juvenile polyposis/juvenile polyposis coli|Myhre syndrome|Neurodevelopmental delay	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000030150	18	48604676	18	51078306	30150	39106	rs281875322	NC_000018.10:51078305:A:G	A	G	CLINICAL
NM_005359.6(SMAD4):c.1500A>G (p.Ile500Met)	SMAD4	I500M	Normal	Myhre syndrome|not provided	Pathogenic(Last reviewed: Jan 31, 2017)	no assertion criteria provided	VCV000030151	18	48604678	18	51078308	30151	39107	rs281875320	NC_000018.10:51078307:A:G	A	G	CLINICAL
NM_005215.4(DCC):c.2378T>G (p.Val793Gly)	DCC	V793G	Normal	Corpus callosum, agenesis of|Mirror movements 1	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	VCV000375282	18	50912431	18	53386061	375282	362056	rs1057519054	NC_000018.10:53386060:T:G	T	G	CLINICAL
NM_001083962.2(TCF4):c.1871A>C (p.Gln624Pro)	TCF4	Q624P, Q408P, Q549P, Q553P, Q623P, Q630P, Q490P, Q494P, Q578P, Q582P, Q617P, Q620P, Q460P, Q464P, Q595P, Q596P, Q601P, Q459P, Q599P, Q600P, Q619P, Q726P	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Jul 20, 2015)	criteria provided, single submitter	VCV000212378	18	52896086	18	55228855	212378	208456	rs797046034	NC_000018.10:55228854:T:G	T	G	CLINICAL
NM_001083962.2(TCF4):c.1840G>C (p.Ala614Pro)	TCF4	A614P, A480P, A543P, A568P, A590P, A613P, A716P, A454P, A539P, A620P, A484P, A572P, A585P, A589P, A607P, A609P, A398P, A449P, A450P, A586P, A591P, A610P	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160081	18	52896117	18	55228886	160081	169438	rs587784462	NC_000018.10:55228885:C:G	C	G	CLINICAL
NM_001083962.2(TCF4):c.1826T>C (p.Leu609Pro)	TCF4	L609P, L393P, L479P, L534P, L584P, L538P, L563P, L567P, L585P, L602P, L608P, L444P, L445P, L449P, L475P, L580P, L581P, L586P, L604P, L615P, L605P, L711P	Normal	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000393171	18	52896131	18	55228900	393171	379059	rs1057524821	NC_000018.10:55228899:A:G	A	G	CLINICAL
NM_001083962.2(TCF4):c.1733G>C (p.Arg578Pro)	TCF4	R574P, R578P, R413P, R448P, R507P, R536P, R549P, R550P, R553P, R418P, R555P, R362P, R532P, R554P, R571P, R414P, R444P, R503P, R573P, R577P, R584P, R680P	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000007374	18	52896224	18	55228993	7374	22413	rs121909123	NC_000018.10:55228992:C:G	C	G	CLINICAL
NM_001083962.2(TCF4):c.1710G>C (p.Arg570Ser)	TCF4	R436S, R542S, R546S, R563S, R565S, R354S, R405S, R495S, R499S, R541S, R545S, R547S, R566S, R410S, R524S, R569S, R570S, R406S, R440S, R528S, R576S, R672S	Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666313	18	52896247	18	55229016	666313	653895	rs1599377405	NC_000018.10:55229015:C:G	C	G	CLINICAL
NM_001083962.2(TCF4):c.656-1G>C	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160087	18	52942984	18	55275753	160087	169449	rs587784466	NC_000018.10:55275752:C:G	C	G	CLINICAL
NM_000271.5(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	G992R	Normal	not provided|Niemann-Pick disease, type C|Niemann-Pick disease type C1	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002969	18	21118573	18	23538609	2969	18008	rs80358254	NC_000018.10:23538608:C:G	C	G	CLINICAL
NM_030632.3(ASXL3):c.1783C>T (p.Gln595Ter)	ASXL3	Q595*	Normal	not provided	Pathogenic(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000620192	18	31319151	18	33739187	620192	611885	rs1568360291	NC_000018.10:33739186:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	R576Q, R580Q, R446Q, R552Q, R364Q, R415Q, R450Q, R538Q, R586Q, R416Q, R420Q, R509Q, R534Q, R551Q, R556Q, R575Q, R682Q, R505Q, R555Q, R557Q, R573Q, R579Q	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007371	18	52896218	18	55228987	7371	22410	rs121909121	NC_000018.10:55228986:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1733G>A (p.Arg578His)	TCF4	R578H, R680H, R413H, R448H, R503H, R536H, R574H, R554H, R555H, R571H, R573H, R418H, R532H, R549H, R550H, R553H, R362H, R414H, R444H, R507H, R577H, R584H	Normal	Microcephaly|Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000093542	18	52896224	18	55228993	93542	99447	rs121909123	NC_000018.10:55228992:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1727G>A (p.Arg576Gln)	TCF4	R576Q, R553Q, R360Q, R411Q, R501Q, R505Q, R530Q, R548Q, R582Q, R678Q, R416Q, R534Q, R547Q, R551Q, R552Q, R571Q, R575Q, R412Q, R442Q, R446Q, R569Q, R572Q	Normal	Pitt-Hopkins syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000381549	18	52896230	18	55228999	381549	375991	rs1057521070	NC_000018.10:55228998:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1146+1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160076	18	52924545	18	55257314	160076	169443	rs587784458	NC_000018.10:55257313:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1086G>A (p.Trp362Ter)	TCF4	W362*, W146*, W232*, W320*, W337*, W361*, W464*, W201*, W202*, W291*, W338*, W359*, W339*, W368*	Normal	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000093540	18	52924606	18	55257375	93540	99445	rs398123560	NC_000018.10:55257374:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1067C>A (p.Ser356Ter)	TCF4	S332*, S355*, S362*, S196*, S331*, S356*, S285*, S314*, S354*, S458*, S140*, S226*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000695020	18	52927182	18	55259951	695020	683147	rs1600504872	NC_000018.10:55259950:G:T	G	T	CLINICAL
NM_001083962.2(TCF4):c.990G>A (p.Ser330=)	TCF4		Normal	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160092	18	52928697	18	55261466	160092	169445	rs587784469	NC_000018.10:55261465:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.795T>A (p.Tyr265Ter)	TCF4	Y105*, Y135*, Y194*, Y240*, Y241*, Y264*, Y367*, Y263*, Y223*, Y265*, Y271*, Y49*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000807513	18	52937189	18	55269958	807513	798737	rs1600865932	NC_000018.10:55269957:A:T	A	T	CLINICAL
NM_001083962.2(TCF4):c.655+1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160086	18	52946781	18	55279550	160086	169451	rs587784465	NC_000018.10:55279549:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.550-1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000647281	18	52946888	18	55279657	647281	653096	rs1601260508	NC_000018.10:55279656:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.500-1G>A	TCF4		Normal	Pitt-Hopkins syndrome|Epicanthus|Global developmental delay|Stereotypy|Anteverted nares|Drooling|Feeding difficulties in infancy|Short nose	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374054	18	53017640	18	55350409	374054	361037	rs1057518864	NC_000018.10:55350408:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.145+1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Likely pathogenic	criteria provided, single submitter	VCV000375416	18	53252510	18	55585279	375416	362183	rs1555782724	NC_000018.10:55585278:C:T	C	T	CLINICAL
NM_001792.5(CDH2):c.1789G>A (p.Asp597Asn)	CDH2	D566N, D597N	Normal	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome|Syndromic neurodevelopmental disorder|Corpus callosum, agenesis of|Axon pathfinding, cardiac, ocular and genital defects	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2020)	no assertion criteria provided	VCV000805759	18	25565678	18	27985714	805759	794099	rs1599011050	NC_000018.10:27985713:C:T	C	T	CLINICAL
NM_001792.5(CDH2):c.1057G>A (p.Asp353Asn)	CDH2	D322N, D353N	Normal	Corpus callosum, agenesis of|Syndromic neurodevelopmental disorder|Corpus callosum, agenesis of|Axon pathfinding, cardiac, ocular and genital defects	Likely pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000805758	18	25573565	18	27993601	805758	794100	rs1599017933	NC_000018.10:27993600:C:T	C	T	CLINICAL
NM_030632.3(ASXL3):c.4330C>T (p.Arg1444Ter)	ASXL3	R1444*	Normal	Intellectual disability|Bainbridge-Ropers syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000520661	18	31324142	18	33744178	520661	512351	rs1555744282	NC_000018.10:33744177:C:T	C	T	CLINICAL
NM_018255.4(ELP2):c.1385G>T (p.Arg462Leu)	ELP2	R462L, R527L, R392L, R418L, R313L, R412L, R436L, R501L, R457L	Normal	Mental retardation, autosomal recessive 58	Pathogenic(Last reviewed: Sep 21, 2011)	no assertion criteria provided	VCV000374912	18	33736538	18	36156575	374912	361817	rs371310428	NC_000018.10:36156574:G:T	G	T	CLINICAL
NM_015559.3(SETBP1):c.265C>T (p.Gln89Ter)	SETBP1	Q89*	Normal	not provided|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000620362	18	42281576	18	44701611	620362	611888	rs1568097623	NC_000018.10:44701610:C:T	C	T	CLINICAL
NM_015559.3(SETBP1):c.1630C>T (p.Arg544Ter)	SETBP1	R544*	Normal	not provided|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000620563	18	42530935	18	44950970	620563	611890	rs1568234874	NC_000018.10:44950969:C:T	C	T	CLINICAL
NM_015559.3(SETBP1):c.1765C>T (p.Arg589Ter)	SETBP1	R589*	Normal	Mental retardation, autosomal dominant 29|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000620410	18	42531070	18	44951105	620410	611891	rs1568235086	NC_000018.10:44951104:C:T	C	T	CLINICAL
NM_015559.3(SETBP1):c.1873C>T (p.Arg625Ter)	SETBP1	R625*	Normal	not provided|Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157559	18	42531178	18	44951213	157559	167422	rs606231272	NC_000018.10:44951212:C:T	C	T	CLINICAL
NM_015559.3(SETBP1):c.1876C>T (p.Arg626Ter)	SETBP1	R626*	Normal	not provided|Mental retardation, autosomal dominant 29|Schinzel-Giedion syndrome|Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000157560	18	42531181	18	44951216	157560	167423	rs606231273	NC_000018.10:44951215:C:T	C	T	CLINICAL
NM_015559.3(SETBP1):c.2425C>T (p.Gln809Ter)	SETBP1	Q809*	Normal	Mental retardation, autosomal dominant 29	Pathogenic(Last reviewed: Jun 7, 2019)	no assertion criteria provided	VCV000807682	18	42531730	18	44951765	807682	798736	rs1599368323	NC_000018.10:44951764:C:T	C	T	CLINICAL
NM_005359.6(SMAD4):c.1486C>T (p.Arg496Cys)	SMAD4	R496C	Normal	Generalized juvenile polyposis/juvenile polyposis coli|Moyamoya angiopathy|Inborn genetic diseases|Hereditary cancer-predisposing syndrome|not provided|Myhre syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000088673	18	48604664	18	51078294	88673	94253	rs397518413	NC_000018.10:51078293:C:T	C	T	CLINICAL
NM_005215.4(DCC):c.823C>T (p.Arg275Ter)	DCC	R275*	Normal	Corpus callosum, agenesis of|Mirror movements 1	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000187796	18	50450202	18	52923832	187796	185692	rs754914260	NC_000018.10:52923831:C:T	C	T	CLINICAL
NM_005215.4(DCC):c.2227A>T (p.Met743Leu)	DCC	M743L	Normal	Corpus callosum, agenesis of	Pathogenic(Last reviewed: Jan 1, 2016)	no assertion criteria provided	VCV000375285	18	50866145	18	53339775	375285	362054	rs199651452	NC_000018.10:53339774:A:T	A	T	CLINICAL
NM_001083962.2(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	R576Q, R580Q, R446Q, R552Q, R364Q, R415Q, R450Q, R538Q, R586Q, R416Q, R420Q, R509Q, R534Q, R551Q, R556Q, R575Q, R682Q, R505Q, R555Q, R557Q, R573Q, R579Q	Normal	not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007371	18	52896218	18	55228987	7371	22410	rs121909121	NC_000018.10:55228986:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1733G>A (p.Arg578His)	TCF4	R578H, R680H, R413H, R448H, R503H, R536H, R574H, R554H, R555H, R571H, R573H, R418H, R532H, R549H, R550H, R553H, R362H, R414H, R444H, R507H, R577H, R584H	Normal	Microcephaly|Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000093542	18	52896224	18	55228993	93542	99447	rs121909123	NC_000018.10:55228992:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1727G>A (p.Arg576Gln)	TCF4	R576Q, R553Q, R360Q, R411Q, R501Q, R505Q, R530Q, R548Q, R582Q, R678Q, R416Q, R534Q, R547Q, R551Q, R552Q, R571Q, R575Q, R412Q, R442Q, R446Q, R569Q, R572Q	Normal	Pitt-Hopkins syndrome|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000381549	18	52896230	18	55228999	381549	375991	rs1057521070	NC_000018.10:55228998:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1146+1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160076	18	52924545	18	55257314	160076	169443	rs587784458	NC_000018.10:55257313:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1086G>A (p.Trp362Ter)	TCF4	W362*, W146*, W232*, W320*, W337*, W361*, W464*, W201*, W202*, W291*, W338*, W359*, W339*, W368*	Normal	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000093540	18	52924606	18	55257375	93540	99445	rs398123560	NC_000018.10:55257374:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.1067C>A (p.Ser356Ter)	TCF4	S332*, S355*, S362*, S196*, S331*, S356*, S285*, S314*, S354*, S458*, S140*, S226*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000695020	18	52927182	18	55259951	695020	683147	rs1600504872	NC_000018.10:55259950:G:T	G	T	CLINICAL
NM_001083962.2(TCF4):c.990G>A (p.Ser330=)	TCF4		Normal	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160092	18	52928697	18	55261466	160092	169445	rs587784469	NC_000018.10:55261465:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.795T>A (p.Tyr265Ter)	TCF4	Y105*, Y135*, Y194*, Y240*, Y241*, Y264*, Y367*, Y263*, Y223*, Y265*, Y271*, Y49*	Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000807513	18	52937189	18	55269958	807513	798737	rs1600865932	NC_000018.10:55269957:A:T	A	T	CLINICAL
NM_001083962.2(TCF4):c.655+1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160086	18	52946781	18	55279550	160086	169451	rs587784465	NC_000018.10:55279549:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.550-1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000647281	18	52946888	18	55279657	647281	653096	rs1601260508	NC_000018.10:55279656:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.500-1G>A	TCF4		Normal	Pitt-Hopkins syndrome|Epicanthus|Global developmental delay|Stereotypy|Anteverted nares|Drooling|Feeding difficulties in infancy|Short nose	Pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000374054	18	53017640	18	55350409	374054	361037	rs1057518864	NC_000018.10:55350408:C:T	C	T	CLINICAL
NM_001083962.2(TCF4):c.145+1G>A	TCF4		Normal	Pitt-Hopkins syndrome	Likely pathogenic	criteria provided, single submitter	VCV000375416	18	53252510	18	55585279	375416	362183	rs1555782724	NC_000018.10:55585278:C:T	C	T	CLINICAL
NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)	MC4R	Y35*	Normal	not provided|Obesity|Schizophrenia	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014318	18	58039478	18	60372245	14318	29357	rs13447324	NC_000018.10:60372244:G:T	G	T	CLINICAL
NM_001127222.2(CACNA1A):c.3829C>T (p.Arg1277Ter)	CACNA1A	R1281*, R1278*, R1277*	Normal	Episodic ataxia type 2	Pathogenic(Last reviewed: Nov 25, 2014)	no assertion criteria provided	VCV000008506	19	13387936	19	13277122	8506	23545	rs121909323	NC_000019.10:13277121:G:A	G	A	CLINICAL
NM_000540.2(RYR1):c.7836-1G>A	RYR1		Normal	Central core myopathy|Malignant hyperthermia, susceptibility to, 1	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000560259	19	38993519	19	38502879	560259	551331	rs1568507354	NC_000019.10:38502878:G:A	G	A	CLINICAL
NM_014516.4(CNOT3):c.1866G>A (p.Trp622Ter)	CNOT3	W622*	Normal	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694671	19	54656325	19	54152588	694671	682790	rs1600501018	NC_000019.10:54152587:G:A	G	A	CLINICAL
NM_000660.7(TGFB1):c.328C>T (p.Arg110Cys)	TGFB1	R110C	Normal	Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome|Encephalopathy|Inflammatory bowel disease, immunodeficiency, and encephalopathy	Likely pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, single submitter	VCV000488345	19	41858622	19	41352717	488345	481174	rs1555755242	NC_000019.10:41352716:G:A	G	A	CLINICAL
NM_000363.5(TNNI3):c.379G>T (p.Asp127Tyr)	TNNI3	D127Y	Normal	Familial restrictive cardiomyopathy 1	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000265828	19	55665568	19	55154200	265828	260545	rs1114167340	NC_000019.10:55154199:C:A	C	A	CLINICAL
NM_004714.3(DYRK1B):c.304C>T (p.Arg102Cys)	DYRK1B	R102C	Normal	Abdominal obesity-metabolic syndrome 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000132792	19	40321083	19	39830443	132792	136541	rs367643250	NC_000019.10:39830442:G:A	G	A	CLINICAL
NM_021175.4(HAMP):c.216C>A (p.Cys72Ter)	HAMP	C72*	Normal	Hereditary hemochromatosis|Hemochromatosis type 1	Pathogenic(Last reviewed: Sep 12, 2014)	criteria provided, single submitter	VCV000188077	19	35775906	19	35285003	188077	186284	rs763369315	NC_000019.10:35285002:C:A	C	A	CLINICAL
NM_003072.5(SMARCA4):c.1675G>A (p.Glu559Lys)	SMARCA4	E559K	Normal	Mental retardation, autosomal dominant 16	Pathogenic(Last reviewed: May 29, 2019)	no assertion criteria provided	VCV000807689	19	11106970	19	10996294	807689	798740	rs1600082188	NC_000019.10:10996293:G:A	G	A	CLINICAL
NM_001128849.2(SMARCA4):c.2647G>A (p.Gly883Ser)	SMARCA4	G883S	Normal	Mental retardation, autosomal dominant 16	Likely pathogenic(Last reviewed: Mar 21, 2019)	no assertion criteria provided	VCV000625157	19	11132431	19	11021755	625157	613500	rs1568486679	NC_000019.10:11021754:G:A	G	A	CLINICAL
NM_003072.4(SMARCA4):c.2851G>A (p.Gly951Arg)	SMARCA4	G951R	Normal	Mental retardation, autosomal dominant 16	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000403671	19	11132635	19	11021959	403671	390651	rs1060499936	NC_000019.10:11021958:G:A	G	A	CLINICAL
NM_000159.4(GCDH):c.675G>A (p.Trp225Ter)	GCDH	W225*	Normal	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000191375	19	13007058	19	12896244	191375	189178	rs786205862	NC_000019.10:12896243:G:A	G	A	CLINICAL
NM_002501.4(NFIX):c.440G>A (p.Gly147Glu)	NFIX	G147E, G155E, G139E, G146E, G100E	Normal	Global developmental delay|Laryngomalacia|Long toe|Long fingers|Proximal placement of thumb|Megalocornea|Strabismus|Short nose|Distal ulnar hypoplasia|Pointed chin|High, narrow palate|Proptosis|Blue sclerae|Midface retrusion|Hypoplasia of the corpus callosum	Likely pathogenic	criteria provided, single submitter	VCV000627622	19	13136247	19	13025433	627622	615872	rs1568269273	NC_000019.10:13025432:G:A	G	A	CLINICAL
NM_017722.4(TRMT1):c.1506+1G>T	TRMT1		Normal	Intellectual developmental disorder, autosomal recessive 68	Pathogenic(Last reviewed: Jan 31, 2019)	no assertion criteria provided	VCV000617603	19	13218564	19	13107750	617603	609000	rs1568361011	NC_000019.10:13107749:C:A	C	A	CLINICAL
NM_001127222.2(CACNA1A):c.5419G>T (p.Ala1807Ser)	CACNA1A	A1808S, A1807S, A1810S, A1813S	Normal	Global developmental delay|Generalized hypotonia|Strabismus	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523409	19	13341005	19	13230191	523409	514091	rs1555736565	NC_000019.10:13230190:C:A	C	A	CLINICAL
NM_000453.3(SLC5A5):c.816C>A (p.Cys272Ter)	SLC5A5	C272*	Normal	Thyroid dyshormonogenesis 1	Pathogenic(Last reviewed: Nov 17, 1997)	no assertion criteria provided	VCV000007665	19	17988649	19	17877840	7665	22704	rs121909175	NC_000019.10:17877839:C:A	C	A	CLINICAL
NM_005027.4(PIK3R2):c.1117G>A (p.Gly373Arg)	PIK3R2	G373R	Normal	not provided|Intellectual disability|Megalencephaly-capillary malformation-polymicrogyria syndrome|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039808	19	18273784	19	18162974	39808	48407	rs587776934	NC_000019.10:18162973:G:A	G	A	CLINICAL
NM_138422.4(ADAT3):c.430G>A (p.Val144Met)	ADAT3|SCAMP4	V144M, V128M	Normal	not provided|Mental retardation, autosomal recessive 36	Pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000183301	19	1912476	19	1912477	183301	181459	rs730882213	NC_000019.10:1912476:G:A	G	A	CLINICAL
NM_015965.7(NDUFA13):c.170G>A (p.Arg57His)	NDUFA13	R57H	Normal	Mitochondrial complex I deficiency|Mitochondrial complex 1 deficiency, nuclear type 28	Pathogenic(Last reviewed: Jan 29, 2021)	no assertion criteria provided	VCV000132643	19	19637066	19	19526257	132643	136391	rs752513525	NC_000019.10:19526256:G:A	G	A	CLINICAL
NM_031448.5(C19orf12):c.161G>T (p.Gly54Val)	C19orf12	G54V, G65V	Normal	Neurodegeneration with brain iron accumulation 4|not provided|Intellectual disability|Global developmental delay	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000402183	19	30193884	19	29702977	402183	389176	rs752450983	NC_000019.10:29702976:C:A	C	A	CLINICAL
NM_024301.5(FKRP):c.663C>A (p.Ser221Arg)	FKRP	S221R	Normal	Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5	Pathogenic(Last reviewed: Mar 25, 2003)	no assertion criteria provided	VCV000004225	19	47259370	19	46756113	4225	19264	rs28937902	NC_000019.10:46756112:C:A	C	A	CLINICAL
NM_024301.5(FKRP):c.826C>A (p.Leu276Ile)	FKRP	L276I	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Myopathy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Muscular dystrophy-dystroglycanopathy|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Muscle weakness|Headache|Scapular winging|Difficulty standing|Difficulty climbing stairs|Difficulty walking|Paresthesia|Gait imbalance|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004221	19	47259533	19	46756276	4221	19260	rs28937900	NC_000019.10:46756275:C:A	C	A	CLINICAL
NM_024301.5(FKRP):c.919T>A (p.Tyr307Asn)	FKRP	Y307N	Normal	Walker-Warburg congenital muscular dystrophy|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|FKRP-Related Disorder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004233	19	47259626	19	46756369	4233	19272	rs104894692	NC_000019.10:46756368:T:A	T	A	CLINICAL
NM_024301.5(FKRP):c.953G>A (p.Cys318Tyr)	FKRP	C318Y	Normal	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5	Pathogenic(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000004234	19	47259660	19	46756403	4234	19273	rs104894684	NC_000019.10:46756402:G:A	G	A	CLINICAL
NM_024301.5(FKRP):c.1364C>A (p.Ala455Asp)	FKRP	A455D	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004226	19	47260071	19	46756814	4226	19265	rs28937903	NC_000019.10:46756813:C:A	C	A	CLINICAL
NM_004977.2(KCNC3):c.1283C>T (p.Thr428Ile)	KCNC3	T428I	Normal	Spinocerebellar ataxia type 13	Pathogenic(Last reviewed: Jul 20, 2016)	no assertion criteria provided	VCV000245604	19	50826927	19	50323670	245604	245205	rs879253883	NC_000019.10:50323669:G:A	G	A	CLINICAL
NM_014225.6(PPP2R1A):c.548G>A (p.Arg183Gln)	PPP2R1A	R183Q, R4Q	Normal	Uterine Carcinosarcoma|Adenocarcinoma of stomach|Neoplasm of the large intestine|Ovarian Serous Cystadenocarcinoma|Mental retardation, autosomal dominant 36|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Breast neoplasm|not provided|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck	Likely pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376506	19	52715983	19	52212730	376506	363385	rs1057519947	NC_000019.10:52212729:G:A	G	A	CLINICAL
NM_014225.6(PPP2R1A):c.773G>A (p.Arg258His)	PPP2R1A	R258H, R79H	Normal	Mental retardation, autosomal dominant 36|not provided|Brachydactyly|Autistic behavior|Stereotypy|Abnormal facial shape|Profound global developmental delay|Microcephaly|Impaired use of nonverbal behaviors|Synophrys|Generalized hypotonia	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000217458	19	52716329	19	52213076	217458	214099	rs863225094	NC_000019.10:52213075:G:A	G	A	CLINICAL
NM_000208.4(INSR):c.2286G>T (p.Arg762Ser)	INSR	R750S, R762S	Normal	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jun 1, 1988)	no assertion criteria provided	VCV000014684	19	7143083	19	7143072	14684	29723	rs121913138	NC_000019.10:7143071:C:A	C	A	CLINICAL
NM_001166114.2(PNPLA6):c.3266G>A (p.Arg1089Gln)	PNPLA6	R1099Q, R1051Q, R1024Q, R1089Q	Normal	not provided|Trichomegaly-retina pigmentary degeneration-dwarfism syndrome|Ataxia-hypogonadism-choroidal dystrophy syndrome	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, single submitter	VCV000183693	19	7621596	19	7556710	183693	181592	rs786201037	NC_000019.10:7556709:G:A	G	A	CLINICAL
NM_001166114.2(PNPLA6):c.3298G>A (p.Val1100Met)	PNPLA6	V1110M, V1062M, V1035M, V1100M	Normal	Trichomegaly-retina pigmentary degeneration-dwarfism syndrome|Ataxia-hypogonadism-choroidal dystrophy syndrome	Likely pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000101041	19	7622071	19	7557185	101041	106806	rs587777182	NC_000019.10:7557184:G:A	G	A	CLINICAL
NM_000146.4(FTL):c.286G>A (p.Ala96Thr)	FTL	A96T	Normal	Neuroferritinopathy	Pathogenic(Last reviewed: Aug 23, 2005)	no assertion criteria provided	VCV000016486	19	49469574	19	48966317	16486	31525	rs104894685	NC_000019.10:48966316:G:A	G	A	CLINICAL
NM_000527.5(LDLR):c.761A>C (p.Gln254Pro)	LDLR	Q254P, Q213P, Q127P	Normal	Familial hypercholesterolemia|Familial hypercholesterolemia 1|Homozygous familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000251437	19	11217307	19	11106631	251437	245773	rs879254667	NC_000019.10:11106630:A:C	A	C	CLINICAL
NM_003072.4(SMARCA4):c.3032T>C (p.Met1011Thr)	SMARCA4	M1011T	Normal	not provided|Mental retardation, autosomal dominant 16	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000030346	19	11135065	19	11024389	30346	39302	rs281875229	NC_000019.10:11024388:T:C	T	C	CLINICAL
NM_000159.4(GCDH):c.431A>C (p.Gln144Pro)	GCDH	Q144P	Normal	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000235858	19	13004393	19	12893579	235858	237514	rs878853154	NC_000019.10:12893578:A:C	A	C	CLINICAL
NM_000159.4(GCDH):c.701G>C (p.Arg234Pro)	GCDH	R234P	Normal	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000625293	19	13007084	19	12896270	625293	613625	rs1203022386	NC_000019.10:12896269:G:C	G	C	CLINICAL
NM_001083961.2(WDR62):c.671G>C (p.Trp224Ser)	WDR62	W224S	Normal	Primary autosomal recessive microcephaly 2	Pathogenic(Last reviewed: Sep 9, 2010)	no assertion criteria provided	VCV000000042	19	36558317	19	36067415	42	15081	rs267607176	NC_000019.10:36067414:G:C	G	C	CLINICAL
NM_133444.3(ZNF526):c.479A>C (p.Lys160Thr)	ZNF526	K160T	Normal	not provided|Noonan-like facies|Intellectual disability|Pulmonic stenosis (disease)	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183288	19	42729034	19	42224882	183288	181461	rs730882205	NC_000019.10:42224881:A:C	A	C	CLINICAL
NM_019108.4(SMG9):c.701+4A>G	SMG9		Normal	Heart and brain malformation syndrome|Abnormal facial shape|Global developmental delay|Brainstem dysplasia|Abnormality of cardiovascular system morphology	Likely pathogenic(Last reviewed: Oct 13, 2014)	criteria provided, single submitter	VCV000224498	19	44248920	19	43744768	224498	226235	rs869312742	NC_000019.10:43744767:T:C	T	C	CLINICAL
NM_024301.5(FKRP):c.679G>C (p.Ala227Pro)	FKRP	A227P	Normal	Fukuyama congenital muscular dystrophy	Pathogenic	no assertion criteria provided	VCV000430845	19	47259386	19	46756129	430845	424236	rs775681117	NC_000019.10:46756128:G:C	G	C	CLINICAL
NM_014681.6(DHX34):c.2327G>C (p.Arg776Pro)	DHX34	R776P	Normal	Seizures|Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691942	19	47879200	19	47375943	691942	679689	rs764483792	NC_000019.10:47375942:G:C	G	C	CLINICAL
NM_020533.3(MCOLN1):c.777+1G>C	MCOLN1		Normal	Periventricular leukomalacia|Corneal opacity|Delayed speech and language development|Atrophy/Degeneration affecting the brainstem|Intellectual disability|Delayed myelination|Growth delay	Likely pathogenic(Last reviewed: Jun 8, 2016)	no assertion criteria provided	VCV000373935	19	7592847	19	7527961	373935	361059	rs1057518781	NC_000019.10:7527960:G:C	G	C	CLINICAL
NM_001277126.1(NLRP12):c.858C>G (p.Pro286=)	NLRP12		Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208384	19	54314055	19	53810801	208384	204626	rs145171629	NC_000019.10:53810800:G:C	G	C	CLINICAL
NM_004714.3(DYRK1B):c.269A>C (p.His90Pro)	DYRK1B	H90P	Normal	Abdominal obesity-metabolic syndrome 3	Pathogenic(Last reviewed: May 15, 2014)	no assertion criteria provided	VCV000132793	19	40321118	19	39830478	132793	136542	rs587777380	NC_000019.10:39830477:T:G	T	G	CLINICAL
NM_003072.4(SMARCA4):c.3469C>G (p.Arg1157Gly)	SMARCA4	R1157G	Normal	Mental retardation, autosomal dominant 16|not provided	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000030347	19	11141492	19	11030816	30347	39303	rs281875230	NC_000019.10:11030815:C:G	C	G	CLINICAL
NM_001128849.2(SMARCA4):c.3734C>G (p.Ala1245Gly)	SMARCA4	A1245G	Normal	Mental retardation, autosomal dominant 16	Likely pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000212251	19	11144153	19	11033477	212251	208527	rs797045984	NC_000019.10:11033476:C:G	C	G	CLINICAL
NM_000159.4(GCDH):c.296A>G (p.Glu99Gly)	GCDH	E99G	Normal	Glutaric aciduria, type 1	Pathogenic(Last reviewed: May 18, 2016)	no assertion criteria provided	VCV000625292	19	13002954	19	12892140	625292	613624	rs1294124984	NC_000019.10:12892139:A:G	A	G	CLINICAL
NM_000159.4(GCDH):c.456C>G (p.Ile152Met)	GCDH	I152M	Normal	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Dec 22, 2015)	no assertion criteria provided	VCV000235857	19	13004418	19	12893604	235857	237515	rs878853153	NC_000019.10:12893603:C:G	C	G	CLINICAL
NM_000159.4(GCDH):c.1114A>G (p.Arg372Gly)	GCDH	R372G	Normal	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Aug 16, 2016)	no assertion criteria provided	VCV000625294	19	13008548	19	12897734	625294	613626	rs771924230	NC_000019.10:12897733:A:G	A	G	CLINICAL
NM_001127222.2(CACNA1A):c.5015G>C (p.Arg1672Pro)	CACNA1A	R1672P, R1673P, R1675P, R1678P	Normal	Cerebellar ataxia|Intellectual disability|Cerebellar atrophy|Cerebellar ataxia	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2015)	no assertion criteria provided	VCV000375366	19	13346480	19	13235666	375366	362161	rs1057519429	NC_000019.10:13235665:C:G	C	G	CLINICAL
NM_000156.6(GAMT):c.148A>C (p.Met50Leu)	GAMT	M50L	Normal	Deficiency of guanidinoacetate methyltransferase	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000008305	19	1401328	19	1401329	8305	23344	rs104894694	NC_000019.10:1401328:T:G	T	G	CLINICAL
NM_000435.3(NOTCH3):c.634T>C (p.Cys212Arg)	NOTCH3	C212R	Normal	Cognitive impairment|Ischemic stroke, susceptibility to|Migraine with aura|Migraine|Depressivity|Abnormality of the cerebral white matter|Behavioral abnormality	Pathogenic	no assertion criteria provided	VCV000812745	19	15302816	19	15192005	812745	801189	rs1555729455	NC_000019.10:15192004:A:G	A	G	CLINICAL
NM_024301.5(FKRP):c.1A>G (p.Met1Val)	FKRP	M1V	Normal	not provided|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5	Pathogenic(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	VCV000120180	19	47258708	19	46755451	120180	125788	rs587777223	NC_000019.10:46755450:A:G	A	G	CLINICAL
NM_024301.5(FKRP):c.545A>G (p.Tyr182Cys)	FKRP	Y182C	Normal	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|not provided|Walker-Warburg congenital muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000282247	19	47259252	19	46755995	282247	266484	rs543163491	NC_000019.10:46755994:A:G	A	G	CLINICAL
NM_024301.5(FKRP):c.1387A>G (p.Asn463Asp)	FKRP	N463D	Normal	Muscular dystrophy|not provided|MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Walker-Warburg congenital muscular dystrophy	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004235	19	47260094	19	46756837	4235	19274	rs121908110	NC_000019.10:46756836:A:G	A	G	CLINICAL
NM_014681.6(DHX34):c.1322A>G (p.Asn441Ser)	DHX34	N441S	Normal	Microcephaly|Short stature|Unilateral renal agenesis|Neurodevelopmental delay|Intellectual disability|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691940	19	47863274	19	47360017	691940	679688	rs549149043	NC_000019.10:47360016:A:G	A	G	CLINICAL
NM_024298.5(MBOAT7):c.854+1G>C	MBOAT7		Normal	Mental retardation, autosomal recessive 57	Pathogenic(Last reviewed: Jan 27, 2017)	no assertion criteria provided	VCV000268114	19	54684489	19	54180772	268114	263640	rs886041060	NC_000019.10:54180771:C:G	C	G	CLINICAL
NM_020533.3(MCOLN1):c.378C>G (p.Tyr126Ter)	MCOLN1	Y126*	Normal	Periventricular leukomalacia|Corneal opacity|Delayed speech and language development|Atrophy/Degeneration affecting the brainstem|Intellectual disability|Delayed myelination|Growth delay	Likely pathogenic(Last reviewed: Jun 8, 2016)	no assertion criteria provided	VCV000373936	19	7591465	19	7526579	373936	361058	rs1057518782	NC_000019.10:7526578:C:G	C	G	CLINICAL
NM_017721.5(CC2D1A):c.748+1G>T	CC2D1A		Normal	Mental Retardation, Psychosocial|not provided|Mental retardation, autosomal recessive 3	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228325	19	14024452	19	13913639	228325	230984	rs876657679	NC_000019.10:13913638:G:T	G	T	CLINICAL
NM_020719.3(PRR12):c.1918G>T (p.Glu640Ter)	PRR12	E640*	Normal	Autistic disorder of childhood onset|Motor delay|Iris coloboma|Abnormality of vision|Delayed speech and language development	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000446254	19	50099510	19	49596253	446254	439633	rs1555740650	NC_000019.10:49596252:G:T	G	T	CLINICAL
NM_014516.4(CNOT3):c.2080C>T (p.Gln694Ter)	CNOT3	Q694*	Normal	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694673	19	54657494	19	54153757	694673	682792	rs1600514073	NC_000019.10:54153756:C:T	C	T	CLINICAL
NM_001626.6(AKT2):c.821G>A (p.Arg274His)	AKT2	R274H, R212H	Normal	Type 2 diabetes mellitus	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000013982	19	40743886	19	40237979	13982	29021	rs121434593	NC_000019.10:40237978:C:T	C	T	CLINICAL
NM_000208.4(INSR):c.479G>A (p.Trp160Ter)	INSR	W160*	Normal	Insulin-resistant diabetes mellitus AND acanthosis nigricans	Pathogenic(Last reviewed: Jul 1, 1990)	no assertion criteria provided	VCV000014694	19	7267529	19	7267518	14694	29733	rs121913146	NC_000019.10:7267517:C:T	C	T	CLINICAL
NM_032737.4(LMNB2):c.1279G>A (p.Ala427Thr)	LMNB2	A427T	Normal	not provided|Acquired partial lipodystrophy	risk factor(Last reviewed: Aug 1, 2006)	no assertion criteria provided	VCV000014475	19	2434027	19	2434029	14475	29514	rs57521499	NC_000019.10:2434028:C:T	C	T	CLINICAL
NM_003072.4(SMARCA4):c.2576C>T (p.Thr859Met)	SMARCA4	T859M	Normal	Mental retardation, autosomal dominant 16|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	VCV000030343	19	11130337	19	11019661	30343	39299	rs281875226	NC_000019.10:11019660:C:T	C	T	CLINICAL
NM_003072.4(SMARCA4):c.2653C>T (p.Arg885Cys)	SMARCA4	R885C	Normal	Inborn genetic diseases|Mental retardation, autosomal dominant 16|not provided	Pathogenic(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000030344	19	11132437	19	11021761	30344	39300	rs281875227	NC_000019.10:11021760:C:T	C	T	CLINICAL
NM_003072.4(SMARCA4):c.2761C>T (p.Leu921Phe)	SMARCA4	L921F	Normal	Mental retardation, autosomal dominant 16|not provided	Pathogenic(Last reviewed: Mar 18, 2012)	no assertion criteria provided	VCV000030345	19	11132545	19	11021869	30345	39301	rs281875228	NC_000019.10:11021868:C:T	C	T	CLINICAL
NM_001128849.2(SMARCA4):c.3127C>T (p.Arg1043Trp)	SMARCA4	R1043W	Normal	Mental retardation, autosomal dominant 16	Likely pathogenic(Last reviewed: May 31, 2016)	criteria provided, single submitter	VCV000436813	19	11136143	19	11025467	436813	430124	rs770014321	NC_000019.10:11025466:C:T	C	T	CLINICAL
NM_003072.4(SMARCA4):c.3922C>T (p.Arg1308Trp)	SMARCA4	R1308W, R1275W	Normal	Mental retardation, autosomal dominant 16	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000126361	19	11144847	19	11034171	126361	131893	rs587779750	NC_000019.10:11034170:C:T	C	T	CLINICAL
NM_000121.4(EPOR):c.1317G>A (p.Trp439Ter)	EPOR	W439*	Normal	Primary familial polycythemia due to EPO receptor mutation	Pathogenic, Affects(Last reviewed: Jun 28, 2016)	no assertion criteria provided	VCV000016595	19	11488870	19	11378194	16595	31634	rs121918116	NC_000019.10:11378193:C:T	C	T	CLINICAL
NM_000121.4(EPOR):c.1316G>A (p.Trp439Ter)	EPOR	W439*	Normal	Acute megakaryoblastic leukemia without down syndrome|Primary familial polycythemia due to EPO receptor mutation	Likely pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000268131	19	11488871	19	11378195	268131	263757	rs121917830	NC_000019.10:11378194:C:T	C	T	CLINICAL
NM_001611.5(ACP5):c.325G>A (p.Gly109Arg)	ACP5|ZNF627	G109R	Normal	Spondyloenchondrodysplasia with immune dysregulation|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000029833	19	11687595	19	11576780	29833	38788	rs781050795	NC_000019.10:11576779:C:T	C	T	CLINICAL
NM_000159.4(GCDH):c.856C>T (p.Pro286Ser)	GCDH	P286S	Normal	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Mar 13, 2015)	criteria provided, single submitter	VCV000191374	19	13007727	19	12896913	191374	189179	rs786205861	NC_000019.10:12896912:C:T	C	T	CLINICAL
NM_000159.4(GCDH):c.1031C>T (p.Thr344Ile)	GCDH	T344I	Normal	Glutaric aciduria, type 1	Likely pathogenic(Last reviewed: Nov 30, 2015)	no assertion criteria provided	VCV000221907	19	13008191	19	12897377	221907	223594	rs869025299	NC_000019.10:12897376:C:T	C	T	CLINICAL
NM_000159.4(GCDH):c.1240G>T (p.Glu414Ter)	GCDH	E414*	Normal	Glutaric aciduria, type 1	Pathogenic(Last reviewed: Jun 23, 2015)	no assertion criteria provided	VCV000625295	19	13008674	19	12897860	625295	613628	rs147611168	NC_000019.10:12897859:G:T	G	T	CLINICAL
NM_017721.5(CC2D1A):c.748+1G>T	CC2D1A		Normal	Mental Retardation, Psychosocial|not provided|Mental retardation, autosomal recessive 3	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000228325	19	14024452	19	13913639	228325	230984	rs876657679	NC_000019.10:13913638:G:T	G	T	CLINICAL
NM_138501.6(TECR):c.545C>T (p.Pro182Leu)	TECR	P182L, P197L	Normal	Mental retardation, autosomal recessive 14	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000030810	19	14675653	19	14564841	30810	39767	rs199469705	NC_000019.10:14564840:C:T	C	T	CLINICAL
NM_000435.3(NOTCH3):c.2126G>A (p.Cys709Tyr)	NOTCH3	C709Y	Normal	Progressive psychomotor deterioration	Likely pathogenic	no assertion criteria provided	VCV000812742	19	15296316	19	15185505	812742	801186	rs1599387121	NC_000019.10:15185504:C:T	C	T	CLINICAL
NM_032620.4(GTPBP3):c.865G>T (p.Glu289Ter)	GTPBP3	E311*, E289*, E321*	Normal	Intellectual disability|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000642459	19	17450299	19	17339490	642459	647795	rs1599560256	NC_000019.10:17339489:G:T	G	T	CLINICAL
NM_001031726.3(C19orf12):c.205G>A (p.Gly69Arg)	C19orf12	G69R, G58R	Normal	Tremor|Peripheral visual field loss|Dystonia|Adult-onset night blindness|Mental deterioration|Spastic paraplegia 43, autosomal recessive|Neurodegeneration with brain iron accumulation 4	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000031157	19	30193873	19	29702966	31157	40114	rs515726205	NC_000019.10:29702965:C:T	C	T	CLINICAL
NM_014727.3(KMT2B):c.424C>T (p.Arg142Ter)	KMT2B	R142*	Normal	Global developmental delay|Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Nov 1, 2019)	no assertion criteria provided	VCV000807435	19	36210431	19	35719529	807435	798746	rs748888652	NC_000019.10:35719528:C:T	C	T	CLINICAL
NM_152296.5(ATP1A3):c.2443G>A (p.Glu815Lys)	ATP1A3	E815K, E826K, E828K	Normal	Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2|Dystonia 12|not specified|Dystonia 12|not provided|Alternating hemiplegia of childhood 2|Inborn genetic diseases|Global developmental delay|Oculogyric crisis|Hemiplegia	Pathogenic(Last reviewed: May 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000037108	19	42474436	19	41970284	37108	45778	rs387907281	NC_000019.10:41970283:C:T	C	T	CLINICAL
NM_152296.5(ATP1A3):c.2330T>A (p.Ile777Asn)	ATP1A3	I777N, I790N, I788N	Normal	Alternating hemiplegia of childhood	Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000667000	19	42474628	19	41970476	667000	654885	rs1599706522	NC_000019.10:41970475:A:T	A	T	CLINICAL
NM_015125.4(CIC):c.1057C>T (p.Arg353Ter)	CIC	R353*, R1262*	Normal	Intellectual disability, autosomal dominant 45|not provided	Pathogenic(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	VCV000431168	19	42793165	19	42289013	431168	424691	rs1135401823	NC_000019.10:42289012:C:T	C	T	CLINICAL
NM_015125.4(CIC):c.1474C>T (p.Arg492Trp)	CIC	R492W, R1401W	Normal	Intellectual disability, autosomal dominant 45	Pathogenic(Last reviewed: Dec 1, 2010)	no assertion criteria provided	VCV000437890	19	42794394	19	42290242	437890	431511	rs373584239	NC_000019.10:42290241:C:T	C	T	CLINICAL
NM_015125.4(CIC):c.1867G>T (p.Gly623Ter)	CIC	G1532*, G623*	Normal	Intellectual disability, autosomal dominant 45	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803567	19	42794787	19	42290635	803567	791938	rs747706524	NC_000019.10:42290634:G:T	G	T	CLINICAL
NM_015125.4(CIC):c.2974C>T (p.Gln992Ter)	CIC	Q992*, Q1901*	Normal	Intellectual disability, autosomal dominant 45|Marfanoid habitus and intellectual disability	Likely pathogenic	criteria provided, single submitter	VCV000431171	19	42796325	19	42292173	431171	424694	rs1135401825	NC_000019.10:42292172:C:T	C	T	CLINICAL
NM_024301.5(FKRP):c.1213G>T (p.Val405Leu)	FKRP	V405L	Normal	Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000004227	19	47259920	19	46756663	4227	19266	rs28937904	NC_000019.10:46756662:G:T	G	T	CLINICAL
NM_024301.5(FKRP):c.1343C>T (p.Pro448Leu)	FKRP	P448L	Normal	Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5|Limb-girdle muscular dystrophy-dystroglycanopathy, type C5|Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1|Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5|MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004220	19	47260050	19	46756793	4220	19259	rs104894681	NC_000019.10:46756792:C:T	C	T	CLINICAL
NM_014681.6(DHX34):c.466C>T (p.Gln156Ter)	DHX34	Q156*	Normal	Pulmonary emphysema|Neurodevelopmental delay|Intellectual disability|Polycystic kidney disease|Postaxial polydactyly|Reduced renal corticomedullary differentiation|Neurodevelopmental disorders	Likely pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000691941	19	47856753	19	47353496	691941	679687	rs1599751192	NC_000019.10:47353495:C:T	C	T	CLINICAL
NM_007059.4(KPTN):c.776C>A (p.Ser259Ter)	KPTN	S259*, S203*	Normal	Mental retardation, autosomal recessive 41|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100679	19	47983131	19	47479874	100679	106551	rs374298314	NC_000019.10:47479873:G:T	G	T	CLINICAL
NM_004977.2(KCNC3):c.1344C>A (p.Phe448Leu)	KCNC3	F448L	Normal	Spinocerebellar ataxia type 13	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000013474	19	50826866	19	50323609	13474	28513	rs104894700	NC_000019.10:50323608:G:T	G	T	CLINICAL
NM_004977.3(KCNC3):c.1268G>A	KCNC3	R423H	Normal	Inborn genetic diseases|not provided|Spinocerebellar ataxia type 13	Pathogenic(Last reviewed: Dec 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000208671	19	50826942	19	50323685	208671	205316	rs797044872	NC_000019.10:50323684:C:T	C	T	CLINICAL
NM_004977.2(KCNC3):c.1259G>A (p.Arg420His)	KCNC3	R420H	Normal	Spinocerebellar ataxia type 13|not provided	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013473	19	50826951	19	50323694	13473	28512	rs104894699	NC_000019.10:50323693:C:T	C	T	CLINICAL
NM_014225.6(PPP2R1A):c.536C>T (p.Pro179Leu)	PPP2R1A	P179L	Normal	not provided|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Mental retardation, autosomal dominant 36|PPP2R1A-related neurodevelopmental disorders|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190313	19	52715971	19	52212718	190313	188142	rs786205228	NC_000019.10:52212717:C:T	C	T	CLINICAL
NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp)	PPP2R1A	R182W, R3W	Normal	Mental retardation, autosomal dominant 36|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000190312	19	52715979	19	52212726	190312	188141	rs786205227	NC_000019.10:52212725:C:T	C	T	CLINICAL
NM_014225.6(PPP2R1A):c.547C>T (p.Arg183Trp)	PPP2R1A	R183W, R4W	Normal	Ovarian Serous Cystadenocarcinoma|Uterine Carcinosarcoma|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Mental retardation, autosomal dominant 36|Adenocarcinoma of stomach|Breast neoplasm|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck	Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000376505	19	52715982	19	52212729	376505	363384	rs1057519946	NC_000019.10:52212728:C:T	C	T	CLINICAL
NM_005934.4(MLLT1):c.1418G>A (p.Arg473Gln)	MLLT1	R473Q	Normal	Muscular hypotonia|Short nose|Infantile spasms|Abnormal cortical gyration|Cerebral atrophy|Hypertelorism|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242890	19	6213798	19	6213787	242890	243996	rs749203329	NC_000019.10:6213786:C:T	C	T	CLINICAL
NM_006087.4(TUBB4A):c.1164G>A (p.Met388Ile)	TUBB4A	M439I, M388I, M316I, M433I	Normal	Leukodystrophy, hypomyelinating, 6|not provided|Global developmental delay|Abnormal basal ganglia MRI signal intensity|Microcephaly|Cerebral hypomyelination|Aplasia/Hypoplasia of the cerebellum|Tetraplegia/tetraparesis	Pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, single submitter	VCV000267792	19	6495346	19	6495335	267792	263150	rs797045074	NC_000019.10:6495334:C:T	C	T	CLINICAL
NM_006087.4(TUBB4A):c.5G>A (p.Arg2Gln)	TUBB4A	R2Q, R53Q, R47Q	Normal	not provided|Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000139452	19	6502219	19	6502208	139452	143144	rs587777467	NC_000019.10:6502207:C:T	C	T	CLINICAL
NM_000363.5(TNNI3):c.607G>A (p.Gly203Ser)	TNNI3	G203S	Normal	Familial hypertrophic cardiomyopathy 7	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000012432	19	55663228	19	55151860	12432	27471	rs267607127	NC_000019.10:55151859:C:T	C	T	CLINICAL
NM_033409.4(SLC52A3):c.989G>T (p.Gly330Val)	SLC52A3	G330V	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210023	20	744226	20	763582	210023	206615	rs797045196	NC_000020.11:763581:C:A	C	A	CLINICAL
NM_033409.4(SLC52A3):c.955C>T (p.Pro319Ser)	SLC52A3	P319S	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210022	20	744260	20	763616	210022	206616	rs797045195	NC_000020.11:763615:G:A	G	A	CLINICAL
NM_033409.4(SLC52A3):c.211G>T (p.Glu71Ter)	SLC52A3	E71*	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000140	20	746208	20	765564	140	15179	rs267606683	NC_000020.11:765563:C:A	C	A	CLINICAL
NM_001282531.3(ADNP):c.2188C>T (p.Arg730Ter)	ADNP	R730*	Normal	Corpus callosum, agenesis of|Global developmental delay|Aggressive behavior|Growth hormone deficiency|Seizures|Stereotypy|Hypothyroidism|Abnormality of the dentition|Helsmoortel-Van der Aa Syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279598	20	49509063	20	50892526	279598	263863	rs886041116	NC_000020.11:50892525:G:A	G	A	CLINICAL
NM_001282531.3(ADNP):c.673C>T (p.Arg225Ter)	ADNP	R225*	Normal	Global developmental delay|Autism, severe|intellectual deficiency	Likely pathogenic	criteria provided, single submitter	VCV000374229	20	49510578	20	50894041	374229	361149	rs1057518991	NC_000020.11:50894040:G:A	G	A	CLINICAL
NM_001282531.3(ADNP):c.517C>T (p.Arg173Ter)	ADNP	R173*	Normal	not provided|Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Mar 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431117	20	49510734	20	50894197	431117	424673	rs1135401791	NC_000020.11:50894196:G:A	G	A	CLINICAL
NM_006363.6(SEC23B):c.2237C>A (p.Thr746Asn)	SEC23B	T728N, T746N	Normal	Congenital dyserythropoietic anemia, type II	Likely pathogenic	no assertion criteria provided	VCV000812899	20	18541317	20	18560673	812899	801196	rs1600288964	NC_000020.11:18560672:C:A	C	A	CLINICAL
NM_175914.4(HNF4A):c.640T>A (p.Ser214Thr)	HNF4A	S211T, S214T, S236T, S229T	Normal	Maturity-onset diabetes of the young, type 1	Likely pathogenic	no assertion criteria provided	VCV000397578	20	43047122	20	44418482	397578	384504	rs1060499693	NC_000020.11:44418481:T:A	T	A	CLINICAL
NM_175914.4(HNF4A):c.427-1G>A	HNF4A		Normal	Maturity-onset diabetes of the young, type 1	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000587398	20	43043146	20	44414506	587398	578356	rs1568731279	NC_000020.11:44414505:G:A	G	A	CLINICAL
NM_000490.5(AVP):c.56C>T (p.Ala19Val)	AVP	A19V	Normal	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Feb 1, 1998)	no assertion criteria provided	VCV000012212	20	3065265	20	3084619	12212	27251	rs387906512	NC_000020.11:3084618:G:A	G	A	CLINICAL
NM_000490.5(AVP):c.337G>T (p.Glu113Ter)	AVP	E113*	Normal	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Mar 1, 1998)	no assertion criteria provided	VCV000012215	20	3063434	20	3082788	12215	27254	rs121964889	NC_000020.11:3082787:C:A	C	A	CLINICAL
NM_000490.5(AVP):c.287G>T (p.Gly96Val)	AVP	G96V	Normal	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: May 1, 1996)	no assertion criteria provided	VCV000012211	20	3063658	20	3083012	12211	27250	rs121964886	NC_000020.11:3083011:C:A	C	A	CLINICAL
NM_000490.5(AVP):c.260C>T (p.Ser87Phe)	AVP	S87F	Normal	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000012216	20	3063685	20	3083039	12216	27255	rs121964890	NC_000020.11:3083038:G:A	G	A	CLINICAL
NM_175914.4(HNF4A):c.582+1G>A	HNF4A		Normal	Maturity-onset diabetes of the young, type 1	Pathogenic(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000617652	20	43043303	20	44414663	617652	609057	rs1392795567	NC_000020.11:44414662:G:A	G	A	CLINICAL
NM_017714.3(TASP1):c.701C>T (p.Thr234Met)	TASP1	T234M, T103M, T132M	Normal	Suleiman-El-Hattab syndrome|Global developmental delay|Abnormal facial shape|Happy demeanor	Pathogenic(Last reviewed: Jul 28, 2020)	no assertion criteria provided	VCV000633774	20	13514763	20	13534116	633774	622207	rs904200599	NC_000020.11:13534115:G:A	G	A	CLINICAL
NM_017714.3(TASP1):c.199C>T (p.Arg67Ter)	TASP1	R67*	Normal	Global developmental delay|Suleiman-El-Hattab syndrome	Pathogenic(Last reviewed: Jul 28, 2020)	no assertion criteria provided	VCV000633609	20	13605846	20	13625199	633609	622041	rs1200336864	NC_000020.11:13625198:G:A	G	A	CLINICAL
NM_020536.4(KAT14):c.1399G>A (p.Glu467Lys)	KAT14	E467K	Normal	Global developmental delay|Seizures	Likely pathogenic	criteria provided, single submitter	VCV000402155	20	18143317	20	18162673	402155	389178	rs771882905	NC_000020.11:18162672:G:A	G	A	CLINICAL
NM_001271874.2(AAR2):c.520G>A (p.Val174Met)	AAR2	V174M	Normal	Cerebellar malformation|Patent foramen ovale|Microcephaly|Macule|Hypoplasia of the corpus callosum|Anteriorly placed anus|Ventricular septal defect|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242897	20	34828310	20	36240388	242897	243997	rs746800707	NC_000020.11:36240387:G:A	G	A	CLINICAL
NM_033550.4(TP53RK):c.727C>T (p.Arg243Cys)	TP53RK	R243C	Normal	Global developmental delay|Seizures	Likely pathogenic	no assertion criteria provided	VCV000812787	20	45315427	20	46686788	812787	801199	rs553547069	NC_000020.11:46686787:G:A	G	A	CLINICAL
NM_033550.4(TP53RK):c.128C>T (p.Ala43Val)	TP53RK	A43V	Normal	Global developmental delay|Seizures	Likely pathogenic	no assertion criteria provided	VCV000812788	20	45317926	20	46689287	812788	801200	rs886913294	NC_000020.11:46689286:G:A	G	A	CLINICAL
NM_004975.4(KCNB1):c.1747C>T (p.Arg583Ter)	KCNB1	R583*	Normal	Epileptic encephalopathy, early infantile, 26|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000633637	20	47990350	20	49373813	633637	622051	rs781663444	NC_000020.11:49373812:G:A	G	A	CLINICAL
NM_004975.4(KCNB1):c.1489G>T (p.Glu497Ter)	KCNB1	E497*	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633636	20	47990608	20	49374071	633636	622052	rs1569016820	NC_000020.11:49374070:C:A	C	A	CLINICAL
NM_004975.4(KCNB1):c.1115C>T (p.Thr372Ile)	KCNB1	T372I	Normal	Intellectual disability	Pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633626	20	47990982	20	49374445	633626	622061	rs1569017160	NC_000020.11:49374444:G:A	G	A	CLINICAL
NM_004975.4(KCNB1):c.643C>T (p.Gln215Ter)	KCNB1	Q215*	Normal	not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000817559	20	47991454	20	49374917	817559	806078	rs1601071971	NC_000020.11:49374916:G:A	G	A	CLINICAL
NM_001282531.3(ADNP):c.2188C>T (p.Arg730Ter)	ADNP	R730*	Normal	Corpus callosum, agenesis of|Global developmental delay|Aggressive behavior|Growth hormone deficiency|Seizures|Stereotypy|Hypothyroidism|Abnormality of the dentition|Helsmoortel-Van der Aa Syndrome|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000279598	20	49509063	20	50892526	279598	263863	rs886041116	NC_000020.11:50892525:G:A	G	A	CLINICAL
NM_001282531.3(ADNP):c.673C>T (p.Arg225Ter)	ADNP	R225*	Normal	Global developmental delay|Autism, severe|intellectual deficiency	Likely pathogenic	criteria provided, single submitter	VCV000374229	20	49510578	20	50894041	374229	361149	rs1057518991	NC_000020.11:50894040:G:A	G	A	CLINICAL
NM_000744.7(CHRNA4):c.851C>T (p.Ser284Leu)	CHRNA4	S284L, S108L	Normal	Autosomal dominant nocturnal frontal lobe epilepsy|Epilepsy, nocturnal frontal lobe, type 1|Seizures|not provided	Pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000017500	20	61981912	20	63350560	17500	32539	rs28931591	NC_000020.11:63350559:G:A	G	A	CLINICAL
NM_172107.4(KCNQ2):c.1678C>T (p.Arg560Trp)	KCNQ2	R560W, R529W, R532W, R542W	Normal	Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 7|not provided|Absent speech|Global developmental delay|Limb dystonia|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000205915	20	62044888	20	63413535	205915	203726	rs773171451	NC_000020.11:63413534:G:A	G	A	CLINICAL
NM_172107.4(KCNQ2):c.1662G>T (p.Lys554Asn)	KCNQ2	K526N, K523N, K536N, K554N	Normal	Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|Benign familial neonatal seizures 2	Pathogenic(Last reviewed: Mar 31, 2016)	no assertion criteria provided	VCV000007388	20	62044904	20	63413551	7388	22427	rs267607198	NC_000020.11:63413550:C:A	C	A	CLINICAL
NM_172107.4(KCNQ2):c.1004C>T (p.Pro335Leu)	KCNQ2	P335L	Normal	Early infantile epileptic encephalopathy with suppression bursts|not provided|Epicanthus|Autistic behavior|Intellectual disability, moderate|Seizures|Abnormal facial shape	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205892	20	62069997	20	63438644	205892	203766	rs796052641	NC_000020.11:63438643:G:A	G	A	CLINICAL
NM_172107.4(KCNQ2):c.794C>T (p.Ala265Val)	KCNQ2	A265V	Normal	not provided|Seizures|Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 7|Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|KCNQ2-Related Disorders|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000120176	20	62073781	20	63442428	120176	125784	rs587777219	NC_000020.11:63442427:G:A	G	A	CLINICAL
NM_172107.4(KCNQ2):c.628C>T (p.Arg210Cys)	KCNQ2	R210C	Normal	Early infantile epileptic encephalopathy 7|Early infantile epileptic encephalopathy with suppression bursts|Intellectual disability	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000205873	20	62076074	20	63444721	205873	203788	rs796052626	NC_000020.11:63444720:G:A	G	A	CLINICAL
NM_001200.4(BMP2):c.987C>A (p.Cys329Ter)	BMP2	C329*	Normal	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000492937	20	6759532	20	6778885	492937	485876	rs1555786156	NC_000020.11:6778884:C:A	C	A	CLINICAL
NM_006047.6(RBM12):c.2377G>T (p.Gly793Ter)	CPNE1|RBM12	G793*	Normal	Schizophrenia 19	Pathogenic(Last reviewed: Aug 17, 2017)	no assertion criteria provided	VCV000433195	20	34240868	20	35652946	433195	426758	rs781720548	NC_000020.11:35652945:C:A	C	A	CLINICAL
NM_033409.4(SLC52A3):c.671T>G (p.Phe224Cys)	SLC52A3	F224C	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210033	20	744544	20	763900	210033	206619	rs797045197	NC_000020.11:763899:A:C	A	C	CLINICAL
NM_033409.4(SLC52A3):c.639C>G (p.Tyr213Ter)	SLC52A3	Y213*	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000210018	20	744576	20	763932	210018	206621	rs778363575	NC_000020.11:763931:G:C	G	C	CLINICAL
NM_000311.5(PRNP):c.593T>C (p.Phe198Ser)	PRNP	F198S	Normal	Gerstmann-Straussler-Scheinker syndrome|Huntington disease-like 1|not provided	Pathogenic(Last reviewed: Jun 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013401	20	4680459	20	4699813	13401	28440	rs74315405	NC_000020.11:4699812:T:C	T	C	CLINICAL
NM_001282531.3(ADNP):c.2157C>G (p.Tyr719Ter)	ADNP	Y719*	Normal	not provided|Inborn genetic diseases|Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000139635	20	49509094	20	50892557	139635	143258	rs587777526	NC_000020.11:50892556:G:C	G	C	CLINICAL
NM_175914.4(HNF4A):c.740T>C (p.Leu247Pro)	HNF4A	L244P, L247P, L269P, L262P	Normal	Maturity-onset diabetes of the young, type 1	Likely pathogenic(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000435438	20	43048430	20	44419790	435438	430314	rs1555816654	NC_000020.11:44419789:T:C	T	C	CLINICAL
NM_000457.4(HNF4A):c.619G>C (p.Ala207Pro)	HNF4A	A185P, A207P, A182P, A200P	Normal	Maturity-onset diabetes of the young, type 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036354	20	43043273	20	44414633	36354	45018	rs193922474	NC_000020.11:44414632:G:C	G	C	CLINICAL
NM_000457.4(HNF4A):c.1253G>C (p.Cys418Ser)	HNF4A	C396S, C418S, C393S, C411S	Normal	Maturity-onset diabetes of the young, type 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036344	20	43057098	20	44428458	36344	45008	rs193922470	NC_000020.11:44428457:G:C	G	C	CLINICAL
NM_018848.3(MKKS):c.110A>G (p.Tyr37Cys)	MKKS	Y37C	Normal	Bardet-biedl syndrome 2/6, digenic|Nephronophthisis|McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|Retinal dystrophy|Inborn genetic diseases|Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome|Bardet-Biedl syndrome|McKusick-Kaufman syndrome|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005309	20	10394053	20	10413405	5309	20348	rs74315396	NC_000020.11:10413404:T:C	T	C	CLINICAL
NM_018848.3(MKKS):c.169A>G (p.Thr57Ala)	MKKS	T57A	Normal	McKusick-Kaufman syndrome|Bardet-Biedl syndrome 6|McKusick-Kaufman syndrome|Bardet-Biedl syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005316	20	10393994	20	10413346	5316	20355	rs74315399	NC_000020.11:10413345:T:C	T	C	CLINICAL
NM_024120.5(NDUFAF5):c.477A>C (p.Leu159Phe)	NDUFAF5	L159F	Normal	Mitochondrial complex 1 deficiency, nuclear type 16	Pathogenic(Last reviewed: Aug 1, 2010)	no assertion criteria provided	VCV000000571	20	13775585	20	13794939	571	15610	rs267606689	NC_000020.11:13794938:A:C	A	C	CLINICAL
NM_006886.4(ATP5F1E):c.35A>G (p.Tyr12Cys)	ATP5F1E|SLMO2-ATP5E	Y12C	Normal	Nuclearly-encoded mitochondrial complex V (ATP synthase) deficiency 3	Pathogenic(Last reviewed: Sep 1, 2010)	no assertion criteria provided	VCV000030551	20	57605482	20	59030427	30551	39508	rs387906929	NC_000020.11:59030426:T:C	T	C	CLINICAL
NM_172107.4(KCNQ2):c.1067T>G (p.Leu356Arg)	KCNQ2	L356R	Normal	Intellectual disability|Early infantile epileptic encephalopathy 7	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000373925	20	62065213	20	63433860	373925	361066	rs1057518772	NC_000020.11:63433859:A:C	A	C	CLINICAL
NM_033409.4(SLC52A3):c.1198-2A>C	SLC52A3		Normal	Brown-Vialetto-Van Laere syndrome 1|Progressive bulbar palsy of childhood	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210025	20	741884	20	761240	210025	206613	rs754753126	NC_000020.11:761239:T:G	T	G	CLINICAL
NM_033409.4(SLC52A3):c.670T>C (p.Phe224Leu)	SLC52A3	F224L	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000142	20	744545	20	763901	142	15181	rs267606685	NC_000020.11:763900:A:G	A	G	CLINICAL
NM_033409.4(SLC52A3):c.224T>C (p.Ile75Thr)	SLC52A3	I75T	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210016	20	746195	20	765551	210016	206625	rs797045193	NC_000020.11:765550:A:G	A	G	CLINICAL
NM_033409.4(SLC52A3):c.49T>C (p.Trp17Arg)	SLC52A3	W17R	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210011	20	746370	20	765726	210011	206630	rs797045190	NC_000020.11:765725:A:G	A	G	CLINICAL
NM_001282531.3(ADNP):c.201G>C (p.Gln67His)	ADNP	Q67H	Normal	Helsmoortel-Van der Aa Syndrome|Inborn genetic diseases	Likely pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000521542	20	49518554	20	50902017	521542	512464	rs1555812161	NC_000020.11:50902016:C:G	C	G	CLINICAL
NM_001282531.3(ADNP):c.-5-1G>C	ADNP		Normal	Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803615	20	49520539	20	50904002	803615	791990	rs1064796656	NC_000020.11:50904001:C:G	C	G	CLINICAL
NM_000457.4(HNF4A):c.1163C>G (p.Pro388Arg)	HNF4A	P366R, P388R, P363R, P381R	Normal	Maturity-onset diabetes of the young, type 1	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036342	20	43057008	20	44428368	36342	45006	rs193922469	NC_000020.11:44428367:C:G	C	G	CLINICAL
NM_175914.4(HNF4A):c.1052T>G (p.Met351Arg)	HNF4A	M351R, M366R, M373R, M348R	Normal	Maturity-onset diabetes of the young, type 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000009216	20	43052883	20	44424243	9216	24255	rs137853338	NC_000020.11:44424242:T:G	T	G	CLINICAL
NM_030590.4(MATN4):c.515G>C (p.Gly172Ala)	MATN4	G172A	Normal	Global developmental delay|Diabetes insipidus|Lumbosacral myelomeningocele|Microcephaly|Proptosis|Seizures|Holoprosencephaly sequence	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183295	20	43932996	20	45304356	183295	181463	rs730882210	NC_000020.11:45304355:C:G	C	G	CLINICAL
NM_000308.3(CTSA):c.1372T>G (p.Phe458Val)	CTSA	F458V, F440V, F441V	Normal	Galactosialidosis, late infantile	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000000375	20	44526707	20	45898068	375	15414	rs137854540	NC_000020.11:45898067:T:G	T	G	CLINICAL
NM_000308.3(CTSA):c.1411A>G (p.Lys471Glu)	CTSA	K453E, K454E, K471E	Normal	Galactosialidosis, late infantile	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000000388	20	44526746	20	45898107	388	15427	rs137854549	NC_000020.11:45898106:A:G	A	G	CLINICAL
NM_004975.4(KCNB1):c.1226T>C (p.Ile409Thr)	KCNB1	I409T	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633634	20	47990871	20	49374334	633634	622054	rs1569017025	NC_000020.11:49374333:A:G	A	G	CLINICAL
NM_016592.4(GNAS):c.*1069T>G	GNAS	L388R, L389R, L373R, L374R, L1031R, L329R	Normal	Pseudohypoparathyroidism type 1C	Pathogenic(Last reviewed: Jun 1, 2011)	no assertion criteria provided	VCV000029746	20	57485862	20	58910807	29746	38701	rs397514457	NC_000020.11:58910806:T:G	T	G	CLINICAL
NM_001958.4(EEF1A2):c.754G>C (p.Asp252His)	EEF1A2	D252H	Normal	Epileptic encephalopathy, early infantile, 33|Mental retardation, autosomal dominant 38	Pathogenic(Last reviewed: Apr 1, 2015)	no assertion criteria provided	VCV000192251	20	62124508	20	63493155	192251	190048	rs786205865	NC_000020.11:63493154:C:G	C	G	CLINICAL
NM_033409.4(SLC52A3):c.1316G>A (p.Gly439Asp)	SLC52A3	G439D	Normal	Brown-Vialetto-Van Laere syndrome 1	Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000488380	20	741764	20	761120	488380	481243	rs1555783467	NC_000020.11:761119:C:T	C	T	CLINICAL
NM_033409.4(SLC52A3):c.1296C>A (p.Cys432Ter)	SLC52A3	C432*	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210027	20	741784	20	761140	210027	206611	rs758570021	NC_000020.11:761139:G:T	G	T	CLINICAL
NM_033409.4(SLC52A3):c.1293G>A (p.Trp431Ter)	SLC52A3	W431*	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210036	20	741787	20	761143	210036	206635	rs1060499531	NC_000020.11:761142:C:T	C	T	CLINICAL
NM_033409.4(SLC52A3):c.1255G>A (p.Val419Met)	SLC52A3	V419M	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210035	20	741825	20	761181	210035	206612	rs797045198	NC_000020.11:761180:C:T	C	T	CLINICAL
NM_033409.4(SLC52A3):c.659C>A (p.Pro220His)	SLC52A3	P220H	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210019	20	744556	20	763912	210019	206620	rs797045194	NC_000020.11:763911:G:T	G	T	CLINICAL
NM_033409.4(SLC52A3):c.374C>A (p.Thr125Asn)	SLC52A3	T125N	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210030	20	746045	20	765401	210030	206624	rs767263985	NC_000020.11:765400:G:T	G	T	CLINICAL
NM_033409.4(SLC52A3):c.211G>A (p.Glu71Lys)	SLC52A3	E71K	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210015	20	746208	20	765564	210015	206626	rs267606683	NC_000020.11:765563:C:T	C	T	CLINICAL
NM_033409.4(SLC52A3):c.173T>A (p.Val58Asp)	SLC52A3	V58D	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210014	20	746246	20	765602	210014	206627	rs797045192	NC_000020.11:765601:A:T	A	T	CLINICAL
NM_033409.4(SLC52A3):c.160G>A (p.Gly54Arg)	SLC52A3	G54R	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210013	20	746259	20	765615	210013	206628	rs797045191	NC_000020.11:765614:C:T	C	T	CLINICAL
NM_033409.4(SLC52A3):c.82C>A (p.Pro28Thr)	SLC52A3	P28T	Normal	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000145	20	746337	20	765693	145	15184	rs267606688	NC_000020.11:765692:G:T	G	T	CLINICAL
NM_004738.5(VAPB):c.137C>T (p.Thr46Ile)	VAPB	T46I	Normal	not provided|Amyotrophic lateral sclerosis type 8	Pathogenic(Last reviewed: Dec 17, 2010)	no assertion criteria provided	VCV000030510	20	56993345	20	58418289	30510	39467	rs281875284	NC_000020.11:58418288:C:T	C	T	CLINICAL
NM_004738.5(VAPB):c.166C>T (p.Pro56Ser)	VAPB	P56S	Normal	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8|not provided|Amyotrophic lateral sclerosis type 8|Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis, typical	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004806	20	56993374	20	58418318	4806	19845	rs74315431	NC_000020.11:58418317:C:T	C	T	CLINICAL
NM_000311.5(PRNP):c.478C>T (p.Gln160Ter)	PRNP	Q160*	Normal	CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000021148	20	4680344	20	4699698	21148	34000	rs80356711	NC_000020.11:4699697:C:T	C	T	CLINICAL
NM_000311.5(PRNP):c.350C>T (p.Ala117Val)	PRNP	A117V	Normal	Inborn genetic diseases|Gerstmann-Straussler-Scheinker syndrome	Pathogenic(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000013396	20	4680216	20	4699570	13396	28435	rs74315402	NC_000020.11:4699569:C:T	C	T	CLINICAL
NM_015338.5(ASXL1):c.3700C>T (p.Gln1234Ter)	ASXL1	Q1234*, Q1173*	Normal	Bohring-Opitz syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560957	20	31024215	20	32436412	560957	552222	rs1569337452	NC_000020.11:32436411:C:T	C	T	CLINICAL
NM_001282531.3(ADNP):c.2157C>A (p.Tyr719Ter)	ADNP	Y719*	Normal	Helsmoortel-Van der Aa Syndrome|not provided	Pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000280623	20	49509094	20	50892557	280623	265101	rs587777526	NC_000020.11:50892556:G:T	G	T	CLINICAL
NM_001282531.3(ADNP):c.1211C>A (p.Ser404Ter)	ADNP	S404*	Normal	Helsmoortel-Van der Aa Syndrome	Pathogenic(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000139633	20	49510040	20	50893503	139633	143256	rs587777524	NC_000020.11:50893502:G:T	G	T	CLINICAL
NM_175914.4(HNF4A):c.187C>T (p.Arg63Trp)	HNF4A	R60W, R63W, R85W, R78W	Normal	Maturity-onset diabetes of the young, type 1|Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young|Type 2 diabetes mellitus|Maturity-onset diabetes of the young, type 1|Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young|Hyperinsulinemia|not provided|Hyperinsulinism due to HNF4A deficiency|Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156152	20	43034835	20	44406195	156152	165951	rs587777732	NC_000020.11:44406194:C:T	C	T	CLINICAL
NM_175914.4(HNF4A):c.265C>T (p.Gln89Ter)	HNF4A	Q111*, Q86*, Q89*, Q104*	Normal	Maturity-onset diabetes of the young, type 1	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000617653	20	43036061	20	44407421	617653	609056	rs1568724014	NC_000020.11:44407420:C:T	C	T	CLINICAL
NM_000490.5(AVP):c.262G>A (p.Gly88Ser)	AVP	G88S	Normal	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Feb 1, 1991)	no assertion criteria provided	VCV000012204	20	3063683	20	3083037	12204	27243	rs121964882	NC_000020.11:3083036:C:T	C	T	CLINICAL
NM_006363.6(SEC23B):c.40C>T (p.Arg14Trp)	SEC23B	R14W	Normal	not provided|none provided|Congenital dyserythropoietic anemia, type II|Cowden syndrome 7|Congenital dyserythropoietic anemia, type II	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001223	20	18491519	20	18510875	1223	16262	rs121918222	NC_000020.11:18510874:C:T	C	T	CLINICAL
NM_175914.4(HNF4A):c.421C>T (p.Arg141Ter)	HNF4A	R141*, R156*, R163*, R138*	Normal	Maturity-onset diabetes of the young, type 1|not provided	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000009211	20	43042435	20	44413795	9211	24250	rs137853335	NC_000020.11:44413794:C:T	C	T	CLINICAL
NM_000490.5(AVP):c.55G>A (p.Ala19Thr)	AVP	A19T	Normal	Neurohypophyseal diabetes insipidus	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000012206	20	3065266	20	3084620	12206	27245	rs387906511	NC_000020.11:3084619:C:T	C	T	CLINICAL
NM_175914.4(HNF4A):c.763C>T (p.Gln255Ter)	HNF4A	Q255*, Q270*, Q277*, Q252*	Normal	Maturity-onset diabetes of the young, type 1	Pathogenic(Last reviewed: Sep 27, 2001)	no assertion criteria provided	VCV000009210	20	43048453	20	44419813	9210	24249	rs137853334	NC_000020.11:44419812:C:T	C	T	CLINICAL
NM_006363.6(SEC23B):c.970C>T (p.Arg324Ter)	SEC23B	R324*, R306*	Normal	Congenital dyserythropoietic anemia, type II	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000001226	20	18507152	20	18526508	1226	16265	rs121918225	NC_000020.11:18526507:C:T	C	T	CLINICAL
NM_130811.3(SNAP25):c.142G>T (p.Val48Phe)	SNAP25	V48F	Normal	not provided|Epilepsy with generalized tonic-clonic seizures|Unilateral Hypotonia|Focal epilepsy|Mental Retardation, Psychosocial	Likely pathogenic(Last reviewed: Jun 5, 2014)	criteria provided, single submitter	VCV000208672	20	10265399	20	10284751	208672	205317	rs797044873	NC_000020.11:10284750:G:T	G	T	CLINICAL
NM_018848.3(MKKS):c.155G>A (p.Gly52Asp)	MKKS	G52D	Normal	Bardet-Biedl syndrome 6	Pathogenic(Last reviewed: Feb 12, 2018)	no assertion criteria provided	VCV000005311	20	10394008	20	10413360	5311	20350	rs28937875	NC_000020.11:10413359:C:T	C	T	CLINICAL
NM_024120.5(NDUFAF5):c.749G>T (p.Gly250Val)	NDUFAF5	G250V, G222V, G93V, G63V	Normal	Mitochondrial complex I deficiency|not provided|Mitochondrial complex 1 deficiency, nuclear type 16	Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372253	20	13789519	20	13808873	372253	359158	rs757043077	NC_000020.11:13808872:G:T	G	T	CLINICAL
NM_015338.5(ASXL1):c.1210C>T (p.Arg404Ter)	ASXL1	R404*, R343*	Normal	Developmental delay|dystrophia|Bohring-Opitz syndrome|not provided|Abnormality of the corpus callosum|Delayed gross motor development|Intellectual disability, severe|Global developmental delay|Prominent metopic ridge|Hypertrichosis|Small for gestational age|Feeding difficulties|Delayed speech and language development|Glabellar hemangioma|Myelodysplastic syndrome	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000030986	20	31021211	20	32433408	30986	39943	rs373145711	NC_000020.11:32433407:C:T	C	T	CLINICAL
NM_000178.4(GSS):c.491G>A (p.Arg164Gln)	GSS	R164Q	Normal	not provided|Gluthathione synthetase deficiency	Pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008525	20	33530291	20	34942488	8525	23564	rs121909307	NC_000020.11:34942487:C:T	C	T	CLINICAL
NM_012156.2(EPB41L1):c.2560C>T (p.Pro854Ser)	EPB41L1	P854S, P752S, P853S, P674S	Normal	Mental retardation, autosomal dominant 11	Pathogenic(Last reviewed: Mar 11, 2011)	no assertion criteria provided	VCV000030281	20	34810239	20	36222317	30281	39237	rs1569376434	NC_000020.11:36222316:C:T	C	T	CLINICAL
NM_015937.6(PIGT):c.1079G>T (p.Gly360Val)	PIGT	G360V, G304V, G258V	Normal	not provided|Global developmental delay|Seizures|Inborn genetic diseases|Multiple congenital anomalies-hypotonia-seizures syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000451026	20	44050068	20	45421428	451026	446250	rs1277383877	NC_000020.11:45421427:G:T	G	T	CLINICAL
NM_004975.4(KCNB1):c.1115C>A (p.Thr372Asn)	KCNB1	T372N	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000633627	20	47990982	20	49374445	633627	622062	rs1569017160	NC_000020.11:49374444:G:T	G	T	CLINICAL
NM_004975.4(KCNB1):c.935G>A (p.Arg312His)	KCNB1	R312H	Normal	Delayed speech and language development|Seizures|Difficulty walking|Generalized hypotonia|Intellectual disability|Epileptic encephalopathy|Early infantile epileptic encephalopathy with suppression bursts|not provided|Epileptic encephalopathy|Intellectual disability|developmental encephalopathy with epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000523478	20	47991162	20	49374625	523478	514105	rs1555889127	NC_000020.11:49374624:C:T	C	T	CLINICAL
NM_000516.6(GNAS):c.85C>T (p.Gln29Ter)	GNAS	Q29*	Normal	Pseudohypoparathyroidism type 1B|not provided|McCune-Albright syndrome|Pseudohypoparathyroidism type 1B|Pituitary adenoma 3, multiple types|Progressive osseous heteroplasia|Pseudopseudohypoparathyroidism|Pseudohypoparathyroidism|Pseudohypoparathyroidism type 1C|Cushing syndrome|Cognitive impairment|Brachydactyly|Short stature|Round face|Subcutaneous nodule|Obesity|Tetany|Hypocalcemia	Pathogenic(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374113	20	57466866	20	58891811	374113	361065	rs1057518907	NC_000020.11:58891810:C:T	C	T	CLINICAL
NM_172107.4(KCNQ2):c.602G>A (p.Arg201His)	KCNQ2	R201H	Normal	Early infantile epileptic encephalopathy with suppression bursts|Early infantile epileptic encephalopathy 7|Severe intellectual deficiency|not provided	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000369753	20	62076100	20	63444747	369753	354023	rs1057516085	NC_000020.11:63444746:C:T	C	T	CLINICAL
NM_172107.4(KCNQ2):c.431G>A (p.Arg144Gln)	KCNQ2	R144Q	Normal	not provided|Early infantile epileptic encephalopathy 7|Early infantile epileptic encephalopathy with suppression bursts|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000205864	20	62076674	20	63445321	205864	203798	rs796052618	NC_000020.11:63445320:C:T	C	T	CLINICAL
NM_001958.4(EEF1A2):c.370G>A (p.Glu124Lys)	EEF1A2	E124K	Normal	not provided|Epileptic encephalopathy, early infantile, 33|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280924	20	62126409	20	63495056	280924	264765	rs886042041	NC_000020.11:63495055:C:T	C	T	CLINICAL
NM_001958.4(EEF1A2):c.271G>A (p.Asp91Asn)	EEF1A2	D91N	Normal	Mental retardation, autosomal dominant 38|Epileptic encephalopathy, early infantile, 33|not provided|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279803	20	62127262	20	63495909	279803	264912	rs886041197	NC_000020.11:63495908:C:T	C	T	CLINICAL
NM_001958.4(EEF1A2):c.208G>A (p.Gly70Ser)	EEF1A2	G70S	Normal	Inborn genetic diseases|EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy|Epileptic encephalopathy, early infantile, 33|not provided|Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100782	20	62127325	20	63495972	100782	106647	rs587777162	NC_000020.11:63495971:C:T	C	T	CLINICAL
NM_000961.4(PTGIS):c.824G>A (p.Arg275Gln)	PTGIS	R275Q	Normal	Childhood-Onset Schizophrenia	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000208402	20	48140626	20	49524089	208402	204627	rs61734270	NC_000020.11:49524088:C:T	C	T	CLINICAL
NM_032957.4(RTEL1):c.3028C>T	RTEL1|RTEL1-TNFRSF6B	R1010*, R986*, R763*	Normal	Dyskeratosis congenita|Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3|Dyskeratosis congenita, autosomal recessive, 5|Dyskeratosis congenita, autosomal recessive, 5|Dyskeratosis congenita, autosomal dominant, 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000065417	20	62324600	20	63693247	65417	76347	rs373740199	NC_000020.11:63693246:C:T	C	T	CLINICAL
NM_000454.4(SOD1):c.13G>A (p.Ala5Thr)	SOD1	A5T	Normal	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014765	21	33032095	21	31659782	14765	29804	rs121912444	NC_000021.9:31659781:G:A	G	A	CLINICAL
NM_000454.4(SOD1):c.49G>A (p.Gly17Ser)	SOD1	G17S	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014776	21	33032131	21	31659818	14776	29815	rs121912453	NC_000021.9:31659817:G:A	G	A	CLINICAL
NM_000454.4(SOD1):c.64G>A (p.Glu22Lys)	SOD1	E22K	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000014773	21	33032146	21	31659833	14773	29812	rs121912450	NC_000021.9:31659832:G:A	G	A	CLINICAL
NM_000454.4(SOD1):c.217G>A (p.Gly73Ser)	SOD1	G73S	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 9, 1997)	no assertion criteria provided	VCV000014779	21	33038809	21	31666496	14779	29818	rs121912455	NC_000021.9:31666495:G:A	G	A	CLINICAL
NM_000454.4(SOD1):c.301G>A (p.Glu101Lys)	SOD1	E101K	Normal	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000574319	21	33039632	21	31667319	574319	573721	rs76731700	NC_000021.9:31667318:G:A	G	A	CLINICAL
NM_000454.4(SOD1):c.380T>A (p.Leu127Ter)	SOD1	L127*	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000014777	21	33040806	21	31668493	14777	29816	rs121912454	NC_000021.9:31668492:T:A	T	A	CLINICAL
NM_000454.4(SOD1):c.404G>A (p.Ser135Asn)	SOD1	S135N	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014774	21	33040830	21	31668517	14774	29813	rs121912451	NC_000021.9:31668516:G:A	G	A	CLINICAL
NM_000484.4(APP):c.2141C>T (p.Thr714Ile)	APP	T714I, T677I, T690I, T604I, T639I, T658I, T621I, T695I, T696I, T583I	Normal	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: Jan 25, 2005)	no assertion criteria provided	VCV000018100	21	27264104	21	25891792	18100	33139	rs63750973	NC_000021.9:25891791:G:A	G	A	CLINICAL
NM_000484.4(APP):c.2018C>T (p.Ala673Val)	APP	A673V, A654V, A542V, A598V, A580V, A617V, A655V, A563V, A636V, A649V	Normal	Alzheimer disease	Pathogenic(Last reviewed: Mar 13, 2009)	no assertion criteria provided	VCV000018106	21	27269931	21	25897619	18106	33145	rs193922916	NC_000021.9:25897618:G:A	G	A	CLINICAL
NM_000484.4(APP):c.2149G>T (p.Val717Phe)	APP	V717F, V624F, V661F, V693F, V586F, V607F, V642F, V680F, V698F, V699F	Normal	Alzheimer disease, type 1|Alzheimer disease	Pathogenic(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000018089	21	27264096	21	25891784	18089	33128	rs63750264	NC_000021.9:25891783:C:A	C	A	CLINICAL
NM_203446.3(SYNJ1):c.3208C>T (p.Arg1070Ter)	SYNJ1	R1065*, R1070*, R1109*	Normal	Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV000978699	21	34018742	21	32646432	978699	966776	rs1373545506	NC_000021.9:32646431:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.484G>A (p.Gly162Arg)	DYRK1A	G162R, G171R, G133R	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000655610	21	38853123	21	37480821	655610	648994	rs1555980467	NC_000021.9:37480820:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.945T>A (p.Ser315Arg)	DYRK1A	S324R, S315R, S286R	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic	criteria provided, single submitter	VCV000627624	21	38865339	21	37493037	627624	615979	rs1569380375	NC_000021.9:37493036:T:A	T	A	CLINICAL
NM_001347721.2(DYRK1A):c.1071+1G>A	DYRK1A		Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039623	21	38865466	21	37493164	39623	48222	rs587776930	NC_000021.9:37493163:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.1373G>A (p.Arg458Gln)	DYRK1A	R467Q, R458Q, R429Q	Normal	Intellectual disability|Complex neurodevelopmental disorder|not provided|Mental retardation, autosomal dominant 7	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000209150	21	38877746	21	37505443	209150	205795	rs797045041	NC_000021.9:37505442:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.1008G>A (p.Trp336Ter)	DYRK1A	W345*, W336*, W307*	Normal	Inborn genetic diseases|Complex neurodevelopmental disorder	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000522162	21	38865402	21	37493100	522162	512490	rs1555985642	NC_000021.9:37493099:G:A	G	A	CLINICAL
NM_138927.4(SON):c.6920G>A (p.Gly2307Glu)	SON	G2307E, G335E	Normal	ZTTK syndrome	Pathogenic	criteria provided, single submitter	VCV000827763	21	34945648	21	33573342	827763	815961	rs1601299278	NC_000021.9:33573341:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.476G>A (p.Gly159Asp)	DYRK1A	G168D, G159D, G130D	Normal	Intellectual disability|not provided	Likely pathogenic(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	VCV000423407	21	38853115	21	37480813	423407	410858	rs1064796406	NC_000021.9:37480812:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.484G>A (p.Gly162Arg)	DYRK1A	G162R, G171R, G133R	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000655610	21	38853123	21	37480821	655610	648994	rs1555980467	NC_000021.9:37480820:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.945T>A (p.Ser315Arg)	DYRK1A	S324R, S315R, S286R	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic	criteria provided, single submitter	VCV000627624	21	38865339	21	37493037	627624	615979	rs1569380375	NC_000021.9:37493036:T:A	T	A	CLINICAL
NM_001347721.2(DYRK1A):c.1071+1G>A	DYRK1A		Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Dec 21, 2012)	no assertion criteria provided	VCV000039623	21	38865466	21	37493164	39623	48222	rs587776930	NC_000021.9:37493163:G:A	G	A	CLINICAL
NM_001347721.2(DYRK1A):c.1373G>A (p.Arg458Gln)	DYRK1A	R467Q, R458Q, R429Q	Normal	Intellectual disability|Complex neurodevelopmental disorder|not provided|Mental retardation, autosomal dominant 7	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000209150	21	38877746	21	37505443	209150	205795	rs797045041	NC_000021.9:37505442:G:A	G	A	CLINICAL
NM_000100.3(CSTB):c.202C>T (p.Arg68Ter)	CSTB	R68*	Normal	Intellectual disability, severe|Motor delay|Aplasia/Hypoplasia of the corpus callosum|Severe global developmental delay|Dystonia|Global brain atrophy|Progressive microcephaly|Dyskinesia|Progressive myoclonic epilepsy|Rolandic epilepsy|Unverricht-Lundborg syndrome	Pathogenic(Last reviewed: Apr 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008396	21	45194178	21	43774297	8396	23435	rs74315442	NC_000021.9:43774296:G:A	G	A	CLINICAL
NM_206965.2(FTCD):c.763C>T (p.Arg255Ter)	FTCD	R255*	Normal	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000632385	21	47570313	21	46150399	632385	620679	rs140217223	NC_000021.9:46150398:G:A	G	A	CLINICAL
NM_206965.2(FTCD):c.403C>T (p.Arg135Cys)	FTCD|FTCD-AS1	R135C	Normal	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000004017	21	47571859	21	46151945	4017	19056	rs28941768	NC_000021.9:46151944:G:A	G	A	CLINICAL
NM_002340.6(LSS):c.625A>T (p.Asn209Tyr)	LSS	N209Y, N129Y, N198Y	Normal	Alopecia-intellectual disability syndrome 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000599323	21	47639412	21	46219498	599323	590598	rs754230211	NC_000021.9:46219497:T:A	T	A	CLINICAL
NM_000454.4(SOD1):c.37G>C (p.Gly13Arg)	SOD1	G13R	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014780	21	33032119	21	31659806	14780	29819	rs121912456	NC_000021.9:31659805:G:C	G	C	CLINICAL
NM_000454.4(SOD1):c.281G>C (p.Gly94Ala)	SOD1	G94A	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jul 25, 1997)	no assertion criteria provided	VCV000014760	21	33039612	21	31667299	14760	29799	rs121912438	NC_000021.9:31667298:G:C	G	C	CLINICAL
NM_000454.4(SOD1):c.338T>C (p.Ile113Thr)	SOD1	I113T	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000014762	21	33039669	21	31667356	14762	29801	rs74315452	NC_000021.9:31667355:T:C	T	C	CLINICAL
NM_000454.4(SOD1):c.341T>C (p.Ile114Thr)	SOD1	I114T	Normal	not provided|Amyotrophic lateral sclerosis type 1|Motor neuron disease	Pathogenic(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000197145	21	33039672	21	31667359	197145	194306	rs121912441	NC_000021.9:31667358:T:C	T	C	CLINICAL
NM_000454.4(SOD1):c.435G>C (p.Leu145Phe)	SOD1	L145F	Normal	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586637	21	33040861	21	31668548	586637	577887	rs1482760341	NC_000021.9:31668547:G:C	G	C	CLINICAL
NM_000454.4(SOD1):c.455T>C (p.Ile152Thr)	SOD1	I152T	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000014772	21	33040881	21	31668568	14772	29811	rs121912449	NC_000021.9:31668567:T:C	T	C	CLINICAL
NM_000484.4(APP):c.2075C>G (p.Ala692Gly)	APP	A692G, A655G, A561G, A582G, A617G, A636G, A599G, A668G, A673G, A674G	Normal	not provided|ABetaA21G amyloidosis|Alzheimer disease, type 1|Alzheimer disease	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000018091	21	27264170	21	25891858	18091	33130	rs63750671	NC_000021.9:25891857:G:C	G	C	CLINICAL
NM_000484.4(APP):c.2078A>G (p.Glu693Gly)	APP	E693G, E562G, E669G, E618G, E583G, E637G, E656G, E600G, E674G, E675G	Normal	ABeta amyloidosis, Arctic type|not provided|Alzheimer disease, type 1|Alzheimer disease	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000018098	21	27264167	21	25891855	18098	33137	rs63751039	NC_000021.9:25891854:T:C	T	C	CLINICAL
NM_000484.4(APP):c.2146A>G (p.Ile716Val)	APP	I716V, I585V, I641V, I698V, I697V, I606V, I623V, I660V, I679V, I692V	Normal	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV000018096	21	27264099	21	25891787	18096	33135	rs63750399	NC_000021.9:25891786:T:C	T	C	CLINICAL
NM_000484.4(APP):c.2140A>G (p.Thr714Ala)	APP	T714A, T604A, T639A, T658A, T583A, T696A, T677A, T690A, T621A, T695A	Normal	not provided|Alzheimer disease, type 1	Pathogenic(Last reviewed: May 28, 2002)	no assertion criteria provided	VCV000018102	21	27264105	21	25891793	18102	33141	rs63750643	NC_000021.9:25891792:T:C	T	C	CLINICAL
NM_000484.4(APP):c.2150T>G (p.Val717Gly)	APP	V717G, V607G, V699G, V586G, V624G, V642G, V661G, V680G, V693G, V698G	Normal	Alzheimer disease, type 1|not provided	Pathogenic(Last reviewed: Oct 31, 1991)	no assertion criteria provided	VCV000018090	21	27264095	21	25891783	18090	33129	rs63749964	NC_000021.9:25891782:A:C	A	C	CLINICAL
NM_001347721.2(DYRK1A):c.637+2T>C	DYRK1A		Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000571196	21	38858918	21	37486616	571196	575165	rs1569371303	NC_000021.9:37486615:T:C	T	C	CLINICAL
NM_001347721.2(DYRK1A):c.896T>C (p.Phe299Ser)	DYRK1A	F308S, F270S, F299S	Normal	not provided|Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000594952	21	38862735	21	37490433	594952	586014	rs1569376809	NC_000021.9:37490432:T:C	T	C	CLINICAL
NM_001347721.2(DYRK1A):c.637+2T>C	DYRK1A		Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 10, 2018)	criteria provided, single submitter	VCV000571196	21	38858918	21	37486616	571196	575165	rs1569371303	NC_000021.9:37486615:T:C	T	C	CLINICAL
NM_001347721.2(DYRK1A):c.896T>C (p.Phe299Ser)	DYRK1A	F308S, F270S, F299S	Normal	not provided|Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000594952	21	38862735	21	37490433	594952	586014	rs1569376809	NC_000021.9:37490432:T:C	T	C	CLINICAL
NM_001347721.2(DYRK1A):c.1009T>C (p.Ser337Pro)	DYRK1A	S346P, S308P, S337P	Normal	Deeply set eye|Absent or delayed speech development|Seizures|Feeding difficulties|Microcephaly|Intellectual disability	Likely pathogenic(Last reviewed: Sep 9, 2014)	no assertion criteria provided	VCV000162155	21	38865403	21	37493101	162155	171871	rs724159951	NC_000021.9:37493100:T:C	T	C	CLINICAL
NM_206965.2(FTCD):c.378C>G (p.Tyr126Ter)	FTCD|FTCD-AS1	Y126*	Normal	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Pathogenic(Last reviewed: Jan 20, 2017)	criteria provided, single submitter	VCV000459967	21	47571884	21	46151970	459967	470829	rs374724805	NC_000021.9:46151969:G:C	G	C	CLINICAL
NM_003895.3(SYNJ1):c.1318-2A>G	SYNJ1		Normal	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000570738	21	34053960	21	32681650	570738	573062	rs1569086116	NC_000021.9:32681649:T:C	T	C	CLINICAL
NM_000454.4(SOD1):c.137T>G (p.Phe46Cys)	SOD1	F46C	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014781	21	33036167	21	31663854	14781	29820	rs121912457	NC_000021.9:31663853:T:G	T	G	CLINICAL
NM_000454.4(SOD1):c.140A>G (p.His47Arg)	SOD1	H47R	Normal	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Jan 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014764	21	33036170	21	31663857	14764	29803	rs121912443	NC_000021.9:31663856:A:G	A	G	CLINICAL
NM_000454.4(SOD1):c.242A>G (p.His81Arg)	SOD1	H81R	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000014782	21	33039573	21	31667260	14782	29821	rs121912458	NC_000021.9:31667259:A:G	A	G	CLINICAL
NM_000454.4(SOD1):c.253T>G (p.Leu85Val)	SOD1	L85V	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1995)	no assertion criteria provided	VCV000014775	21	33039584	21	31667271	14775	29814	rs121912452	NC_000021.9:31667270:T:G	T	G	CLINICAL
NM_000454.4(SOD1):c.260A>G (p.Asn87Ser)	SOD1	N87S	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468253	21	33039591	21	31667278	468253	471562	rs11556620	NC_000021.9:31667277:A:G	A	G	CLINICAL
NM_000454.4(SOD1):c.319C>G (p.Leu107Val)	SOD1	L107V	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000014757	21	33039650	21	31667337	14757	29796	rs121912440	NC_000021.9:31667336:C:G	C	G	CLINICAL
NM_000454.5(SOD1):c.346C>G (p.Arg116Gly)	SOD1	R116G	Normal	not provided	Pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000805495	21	33039677	21	31667364	805495	793852	rs1301635320	NC_000021.9:31667363:C:G	C	G	CLINICAL
NM_000454.4(SOD1):c.358-11A>G	SOD1		Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000014778	21	33040773	21	31668460	14778	29817	rs369600566	NC_000021.9:31668459:A:G	A	G	CLINICAL
NM_000454.4(SOD1):c.358-10T>G	SOD1		Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000014770	21	33040774	21	31668461	14770	29809	rs1197141604	NC_000021.9:31668460:T:G	T	G	CLINICAL
NM_000484.4(APP):c.2149G>C (p.Val717Leu)	APP	V717L, V680L, V607L, V642L, V661L, V586L, V624L, V693L, V698L, V699L	Normal	Alzheimer disease, type 1|not provided	Pathogenic(Last reviewed: Jul 27, 2020)	criteria provided, single submitter	VCV000018105	21	27264096	21	25891784	18105	33144	rs63750264	NC_000021.9:25891783:C:G	C	G	CLINICAL
NM_000484.4(APP):c.2077G>C (p.Glu693Gln)	APP	E693Q, E618Q, E637Q, E656Q, E562Q, E583Q, E669Q, E600Q, E674Q, E675Q	Normal	ABeta amyloidosis, Dutch type|Alzheimer disease	Pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV000018087	21	27264168	21	25891856	18087	33126	rs63750579	NC_000021.9:25891855:C:G	C	G	CLINICAL
NM_005441.3(CHAF1B):c.496A>G (p.Ile166Val)	CHAF1B	I166V	Normal	Global developmental delay|Intellectual disability|Attention deficit hyperactivity disorder	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183350	21	37769727	21	36397429	183350	181465	rs140630794	NC_000021.9:36397428:A:G	A	G	CLINICAL
NM_001347721.2(DYRK1A):c.285C>G (p.Tyr95Ter)	DYRK1A	Y104*, Y95*, Y66*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204004	21	38850587	21	37478285	204004	200400	rs797044519	NC_000021.9:37478284:C:G	C	G	CLINICAL
NM_001347721.2(DYRK1A):c.895T>G (p.Phe299Val)	DYRK1A	F308V, F299V, F270V	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000210898	21	38862734	21	37490432	210898	208717	rs797045540	NC_000021.9:37490431:T:G	T	G	CLINICAL
NM_001347721.2(DYRK1A):c.953A>G (p.Tyr318Cys)	DYRK1A	Y327C, Y289C, Y318C	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000438288	21	38865347	21	37493045	438288	431925	rs1555985554	NC_000021.9:37493044:A:G	A	G	CLINICAL
NM_001347721.2(DYRK1A):c.1213-2A>G	DYRK1A		Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000666564	21	38877584	21	37505281	666564	654150	rs1601315812	NC_000021.9:37505280:A:G	A	G	CLINICAL
NM_005441.3(CHAF1B):c.496A>G (p.Ile166Val)	CHAF1B	I166V	Normal	Global developmental delay|Intellectual disability|Attention deficit hyperactivity disorder	Likely pathogenic(Last reviewed: Dec 1, 2014)	no assertion criteria provided	VCV000183350	21	37769727	21	36397429	183350	181465	rs140630794	NC_000021.9:36397428:A:G	A	G	CLINICAL
NM_001347721.2(DYRK1A):c.285C>G (p.Tyr95Ter)	DYRK1A	Y104*, Y95*, Y66*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204004	21	38850587	21	37478285	204004	200400	rs797044519	NC_000021.9:37478284:C:G	C	G	CLINICAL
NM_001347721.2(DYRK1A):c.638-2A>G	DYRK1A		Normal	Intellectual disability|not provided	Pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000373544	21	38862475	21	37490173	373544	360443	rs1057518474	NC_000021.9:37490172:A:G	A	G	CLINICAL
NM_001347721.2(DYRK1A):c.895T>G (p.Phe299Val)	DYRK1A	F308V, F299V, F270V	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000210898	21	38862734	21	37490432	210898	208717	rs797045540	NC_000021.9:37490431:T:G	T	G	CLINICAL
NM_001347721.2(DYRK1A):c.953A>G (p.Tyr318Cys)	DYRK1A	Y327C, Y289C, Y318C	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Feb 16, 2016)	criteria provided, single submitter	VCV000438288	21	38865347	21	37493045	438288	431925	rs1555985554	NC_000021.9:37493044:A:G	A	G	CLINICAL
NM_001347721.2(DYRK1A):c.1213-2A>G	DYRK1A		Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000666564	21	38877584	21	37505281	666564	654150	rs1601315812	NC_000021.9:37505280:A:G	A	G	CLINICAL
NM_000071.3(CBS):c.833T>C (p.Ile278Thr)	CBS	I278T, I173T	Normal	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|none provided|Homocystinuria|Classic homocystinuria|not provided|Intellectual disability|Cardiovascular phenotype	Pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000120	21	44483184	21	43063074	120	15159	rs5742905	NC_000021.9:43063073:A:G	A	G	CLINICAL
NM_206965.2(FTCD):c.896G>C (p.Arg299Pro)	FTCD	R299P	Normal	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY	Pathogenic(Last reviewed: Jul 1, 2003)	no assertion criteria provided	VCV000004018	21	47570043	21	46150129	4018	19057	rs119469015	NC_000021.9:46150128:C:G	C	G	CLINICAL
NM_003895.3(SYNJ1):c.1376G>C (p.Arg459Pro)	SYNJ1	R459P, R420P	Normal	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Mar 8, 2017)	no assertion criteria provided	VCV000393356	21	34053900	21	32681590	393356	380176	rs1060499619	NC_000021.9:32681589:C:G	C	G	CLINICAL
NM_000454.4(SOD1):c.14C>T (p.Ala5Val)	SOD1	A5V	Normal	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Feb 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014763	21	33032096	21	31659783	14763	29802	rs121912442	NC_000021.9:31659782:C:T	C	T	CLINICAL
NM_000454.4(SOD1):c.20G>T (p.Cys7Phe)	SOD1	C7F	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000014771	21	33032102	21	31659789	14771	29810	rs121912448	NC_000021.9:31659788:G:T	G	T	CLINICAL
NM_000454.4(SOD1):c.280G>T (p.Gly94Cys)	SOD1	G94C	Normal	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000014759	21	33039611	21	31667298	14759	29798	rs121912437	NC_000021.9:31667297:G:T	G	T	CLINICAL
NM_000454.4(SOD1):c.290A>T (p.Asp97Val)	SOD1	D97V	Normal	Amyotrophic lateral sclerosis type 1	Likely pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000692200	21	33039621	21	31667308	692200	679942	rs1555836803	NC_000021.9:31667307:A:T	A	T	CLINICAL
NM_000454.5(SOD1):c.317C>T (p.Ser106Leu)	SOD1	S106L	Normal	Amyotrophic lateral sclerosis	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000695024	21	33039648	21	31667335	695024	683149	rs1378590183	NC_000021.9:31667334:C:T	C	T	CLINICAL
NM_000484.4(APP):c.2143G>A (p.Val715Met)	APP	V715M, V622M, V640M, V678M, V584M, V691M, V697M, V605M, V659M, V696M	Normal	Alzheimer disease, type 1|not provided	Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000018097	21	27264102	21	25891790	18097	33136	rs63750734	NC_000021.9:25891789:C:T	C	T	CLINICAL
NM_000484.4(APP):c.2080G>A (p.Asp694Asn)	APP	D563N, D584N, D601N, D619N, D638N, D657N, D670N, D675N, D676N, D694N	Normal	not provided|ABeta amyloidosis, Iowa type|Alzheimer disease	Pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	VCV000018101	21	27264165	21	25891853	18101	33140	rs63749810	NC_000021.9:25891852:C:T	C	T	CLINICAL
NM_000484.4(APP):c.2149G>A (p.Val717Ile)	APP	V717I, V607I, V624I, V661I, V642I, V680I, V693I, V698I, V699I, V586I	Normal	Alzheimer disease, type 1|not provided|Alzheimer disease	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018088	21	27264096	21	25891784	18088	33127	rs63750264	NC_000021.9:25891783:C:T	C	T	CLINICAL
NM_138927.3(SON):c.3334C>T (p.Arg1112Ter)	SON	R1112*	Normal	not provided|ZTTK syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423520	21	34924871	21	33552565	423520	410844	rs1064796472	NC_000021.9:33552564:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.322C>T (p.Arg108Ter)	DYRK1A	R117*, R108*, R79*	Normal	Mental retardation, autosomal dominant 7|not provided|Complex neurodevelopmental disorder|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373087	21	38852961	21	37480659	373087	360481	rs1057518204	NC_000021.9:37480658:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.334C>T (p.Gln112Ter)	DYRK1A	Q121*, Q112*, Q83*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000620014	21	38852973	21	37480671	620014	611436	rs1555980234	NC_000021.9:37480670:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.536A>T (p.Lys179Ile)	DYRK1A	K188I, K179I, K150I	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204009	21	38858815	21	37486513	204009	200403	rs797044524	NC_000021.9:37486512:A:T	A	T	CLINICAL
NM_001347721.2(DYRK1A):c.586C>T (p.Arg196Ter)	DYRK1A	R205*, R196*, R167*	Normal	Deeply set eye|Absent or delayed speech development|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Intellectual disability|not provided|Microcephaly|Generalized seizures|Global developmental delay|Microphthalmia|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162153	21	38858865	21	37486563	162153	171866	rs724159949	NC_000021.9:37486562:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.664C>T (p.Arg222Ter)	DYRK1A	R231*, R193*, R222*	Normal	Complex neurodevelopmental disorder|Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423502	21	38862503	21	37490201	423502	410863	rs780441716	NC_000021.9:37490200:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.736C>T (p.Arg246Ter)	DYRK1A	R255*, R217*, R246*	Normal	Deeply set eye|Absent or delayed speech development|Seizures|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Intellectual disability|not provided	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162152	21	38862575	21	37490273	162152	171868	rs724159948	NC_000021.9:37490272:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.833A>T (p.Asp278Val)	DYRK1A	D287V, D249V, D278V	Normal	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437414	21	38862672	21	37490370	437414	430970	rs1555984343	NC_000021.9:37490369:A:T	A	T	CLINICAL
NM_001347721.2(DYRK1A):c.856C>T (p.Leu286Phe)	DYRK1A	L295F, L257F, L286F	Normal	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204011	21	38862695	21	37490393	204011	200405	rs797044526	NC_000021.9:37490392:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.905C>T (p.Ser302Phe)	DYRK1A	S311F, S302F, S273F	Normal	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000381574	21	38862744	21	37490442	381574	377246	rs1039571136	NC_000021.9:37490441:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.910C>T (p.Gln304Ter)	DYRK1A	Q313*, Q275*, Q304*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000559653	21	38862749	21	37490447	559653	550373	rs1555984433	NC_000021.9:37490446:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1010C>T (p.Ser337Phe)	DYRK1A	S346F, S308F, S337F	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000505359	21	38865404	21	37493102	505359	497342	rs1555985649	NC_000021.9:37493101:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1069G>T (p.Glu357Ter)	DYRK1A	E328*, E357*, E366*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000664970	21	38865463	21	37493161	664970	648995	rs1555985742	NC_000021.9:37493160:G:T	G	T	CLINICAL
NM_001347721.2(DYRK1A):c.1282C>T (p.Arg428Ter)	DYRK1A	R437*, R428*, R399*	Normal	Deeply set eye|Absent or delayed speech development|Seizures|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Complex neurodevelopmental disorder|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162158	21	38877655	21	37505352	162158	171873	rs724159953	NC_000021.9:37505351:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1372C>T (p.Arg458Ter)	DYRK1A	R467*, R458*, R429*	Normal	not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000204005	21	38877745	21	37505442	204005	200407	rs797044520	NC_000021.9:37505441:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1378C>T (p.Gln460Ter)	DYRK1A	Q469*, Q460*, Q431*	Normal	not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000620200	21	38877751	21	37505448	620200	611918	rs1555990955	NC_000021.9:37505447:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1612C>T (p.Gln538Ter)	DYRK1A	Q547*, Q538*, Q509*	Normal	not provided|Mental retardation, autosomal dominant 7	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000224154	21	38878494	21	37506191	224154	225882	rs869312708	NC_000021.9:37506190:C:T	C	T	CLINICAL
NM_000383.4(AIRE):c.682G>T (p.Gly228Trp)	AIRE	G228W	Normal	Autoimmune polyglandular syndrome type 1, autosomal dominant	Pathogenic(Last reviewed: Feb 28, 2017)	no assertion criteria provided	VCV000003313	21	45709569	21	44289686	3313	18352	rs121434257	NC_000021.9:44289685:G:T	G	T	CLINICAL
NM_001347721.2(DYRK1A):c.1282C>T (p.Arg428Ter)	DYRK1A	R437*, R428*, R399*	Normal	Deeply set eye|Absent or delayed speech development|Seizures|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Complex neurodevelopmental disorder|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162158	21	38877655	21	37505352	162158	171873	rs724159953	NC_000021.9:37505351:C:T	C	T	CLINICAL
NM_138927.3(SON):c.286C>T (p.Gln96Ter)	SON	Q96*	Normal	ZTTK syndrome|Failure to thrive|Global developmental delay	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000252926	21	34921823	21	33549517	252926	247328	rs886039777	NC_000021.9:33549516:C:T	C	T	CLINICAL
NM_138927.3(SON):c.3334C>T (p.Arg1112Ter)	SON	R1112*	Normal	not provided|ZTTK syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423520	21	34924871	21	33552565	423520	410844	rs1064796472	NC_000021.9:33552564:C:T	C	T	CLINICAL
NM_138927.3(SON):c.3556C>T (p.Gln1186Ter)	SON	Q1186*	Normal	ZTTK syndrome	Pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000548026	21	34925093	21	33552787	548026	538493	rs1275312464	NC_000021.9:33552786:C:T	C	T	CLINICAL
NM_032195.2(SON):c.6022C>T (p.Arg2008Ter)	SON	R2008*	Normal	not provided|ZTTK syndrome	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000453018	21	34927559	21	33555253	453018	446312	rs1555899560	NC_000021.9:33555252:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.322C>T (p.Arg108Ter)	DYRK1A	R117*, R108*, R79*	Normal	Mental retardation, autosomal dominant 7|not provided|Complex neurodevelopmental disorder|Inborn genetic diseases	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373087	21	38852961	21	37480659	373087	360481	rs1057518204	NC_000021.9:37480658:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.334C>T (p.Gln112Ter)	DYRK1A	Q121*, Q112*, Q83*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000620014	21	38852973	21	37480671	620014	611436	rs1555980234	NC_000021.9:37480670:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.536A>T (p.Lys179Ile)	DYRK1A	K188I, K179I, K150I	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	VCV000204009	21	38858815	21	37486513	204009	200403	rs797044524	NC_000021.9:37486512:A:T	A	T	CLINICAL
NM_001347721.2(DYRK1A):c.586C>T (p.Arg196Ter)	DYRK1A	R205*, R196*, R167*	Normal	Deeply set eye|Absent or delayed speech development|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Intellectual disability|not provided|Microcephaly|Generalized seizures|Global developmental delay|Microphthalmia|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162153	21	38858865	21	37486563	162153	171866	rs724159949	NC_000021.9:37486562:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.664C>T (p.Arg222Ter)	DYRK1A	R231*, R193*, R222*	Normal	Complex neurodevelopmental disorder|Inborn genetic diseases|not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423502	21	38862503	21	37490201	423502	410863	rs780441716	NC_000021.9:37490200:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.736C>T (p.Arg246Ter)	DYRK1A	R255*, R217*, R246*	Normal	Deeply set eye|Absent or delayed speech development|Seizures|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Intellectual disability|not provided	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162152	21	38862575	21	37490273	162152	171868	rs724159948	NC_000021.9:37490272:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.760C>T (p.Arg254Ter)	DYRK1A	R263*, R225*, R254*	Normal	not provided|Global developmental delay	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000279970	21	38862599	21	37490297	279970	264914	rs886041291	NC_000021.9:37490296:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.833A>T (p.Asp278Val)	DYRK1A	D287V, D249V, D278V	Normal	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437414	21	38862672	21	37490370	437414	430970	rs1555984343	NC_000021.9:37490369:A:T	A	T	CLINICAL
NM_001347721.2(DYRK1A):c.856C>T (p.Leu286Phe)	DYRK1A	L295F, L257F, L286F	Normal	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000204011	21	38862695	21	37490393	204011	200405	rs797044526	NC_000021.9:37490392:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.905C>T (p.Ser302Phe)	DYRK1A	S311F, S302F, S273F	Normal	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000381574	21	38862744	21	37490442	381574	377246	rs1039571136	NC_000021.9:37490441:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.910C>T (p.Gln304Ter)	DYRK1A	Q313*, Q275*, Q304*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000559653	21	38862749	21	37490447	559653	550373	rs1555984433	NC_000021.9:37490446:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1010C>T (p.Ser337Phe)	DYRK1A	S346F, S308F, S337F	Normal	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	VCV000505359	21	38865404	21	37493102	505359	497342	rs1555985649	NC_000021.9:37493101:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1069G>T (p.Glu357Ter)	DYRK1A	E328*, E357*, E366*	Normal	Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000664970	21	38865463	21	37493161	664970	648995	rs1555985742	NC_000021.9:37493160:G:T	G	T	CLINICAL
NM_001347721.2(DYRK1A):c.1282C>T (p.Arg428Ter)	DYRK1A	R437*, R428*, R399*	Normal	Deeply set eye|Absent or delayed speech development|Seizures|Feeding difficulties|Microcephaly|Intellectual disability|Mental retardation, autosomal dominant 7|Complex neurodevelopmental disorder|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000162158	21	38877655	21	37505352	162158	171873	rs724159953	NC_000021.9:37505351:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1372C>T (p.Arg458Ter)	DYRK1A	R467*, R458*, R429*	Normal	not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000204005	21	38877745	21	37505442	204005	200407	rs797044520	NC_000021.9:37505441:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1378C>T (p.Gln460Ter)	DYRK1A	Q469*, Q460*, Q431*	Normal	not provided|Mental retardation, autosomal dominant 7	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000620200	21	38877751	21	37505448	620200	611918	rs1555990955	NC_000021.9:37505447:C:T	C	T	CLINICAL
NM_001347721.2(DYRK1A):c.1612C>T (p.Gln538Ter)	DYRK1A	Q547*, Q538*, Q509*	Normal	not provided|Mental retardation, autosomal dominant 7	Pathogenic/Likely pathogenic(Last reviewed: Feb 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000224154	21	38878494	21	37506191	224154	225882	rs869312708	NC_000021.9:37506190:C:T	C	T	CLINICAL
NM_206965.2(FTCD):c.1607T>A (p.Leu536Ter)	FTCD	L536*	Normal	GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY|not provided	Pathogenic(Last reviewed: Apr 30, 2018)	criteria provided, single submitter	VCV000194395	21	47556920	21	46137006	194395	191558	rs149266909	NC_000021.9:46137005:A:T	A	T	CLINICAL
NM_002340.6(LSS):c.423G>A (p.Trp141Ter)	LSS	W141*, W61*	Normal	Alopecia-intellectual disability syndrome 4	Pathogenic(Last reviewed: Apr 7, 2020)	no assertion criteria provided	VCV000599322	21	47642549	21	46222635	599322	590597	rs1569036540	NC_000021.9:46222634:C:T	C	T	CLINICAL
NM_203446.2(SYNJ1):c.773G>A (p.Arg258Gln)	SYNJ1	R258Q, R219Q	Normal	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000088844	21	34067416	21	32695106	88844	94413	rs398122403	NC_000021.9:32695105:C:T	C	T	CLINICAL
NM_203446.2(SYNJ1):c.512G>A (p.Trp171Ter)	SYNJ1	W171*, W132*	Normal	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000549503	21	34072232	21	32699922	549503	539985	rs1555907463	NC_000021.9:32699921:C:T	C	T	CLINICAL
NM_003895.3(SYNJ1):c.24G>A (p.Trp8Ter)	SYNJ1	W8*	Normal	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000575322	21	34100328	21	32728017	575322	571505	rs1569147057	NC_000021.9:32728016:C:T	C	T	CLINICAL
NM_213720.3(CHCHD10):c.197G>T (p.Gly66Val)	CHCHD10	G66V	Normal	Spinal muscular atrophy, jokela type	Pathogenic(Last reviewed: Apr 14, 2015)	no assertion criteria provided	VCV000180221	22	24109625	22	23767438	180221	178408	rs730880031	NC_000022.11:23767437:C:A	C	A	CLINICAL
NM_213720.3(CHCHD10):c.176C>T (p.Ser59Leu)	CHCHD10	S59L	Normal	not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000140745	22	24109646	22	23767459	140745	150458	rs587777574	NC_000022.11:23767458:G:A	G	A	CLINICAL
NM_213720.3(CHCHD10):c.44G>T (p.Arg15Leu)	CHCHD10	R15L	Normal	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not provided|Myopathy, isolated mitochondrial, autosomal dominant|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV000180220	22	24109778	22	23767591	180220	178407	rs730880030	NC_000022.11:23767590:C:A	C	A	CLINICAL
NM_001242897.2(DEPDC5):c.193+1G>A	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264714	22	32156689	22	31760703	264714	259331	rs886039245	NC_000022.11:31760702:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.279+1G>A	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264715	22	32161047	22	31765061	264715	259333	rs886039246	NC_000022.11:31765060:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.434G>A (p.Trp145Ter)	DEPDC5	W145*, W117*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000407346	22	32174105	22	31778119	407346	404370	rs1060501488	NC_000022.11:31778118:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.435G>A (p.Trp145Ter)	DEPDC5	W145*, W117*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264716	22	32174106	22	31778120	264716	259334	rs886039247	NC_000022.11:31778119:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.484-1G>A	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264718	22	32179892	22	31783906	264718	259336	rs886039249	NC_000022.11:31783905:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.624+1G>A	DEPDC5		Normal	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000264721	22	32180862	22	31784876	264721	259339	rs886039252	NC_000022.11:31784875:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.1224C>A (p.Tyr408Ter)	DEPDC5	Y380*, Y408*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000646869	22	32202114	22	31806128	646869	649416	rs1602010382	NC_000022.11:31806127:C:A	C	A	CLINICAL
NM_001242897.2(DEPDC5):c.2091T>A (p.Tyr697Ter)	DEPDC5	Y697*, Y775*, Y766*, Y747*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000571591	22	32233112	22	31837126	571591	574112	rs374158137	NC_000022.11:31837125:T:A	T	A	CLINICAL
NM_001242897.2(DEPDC5):c.3263+1G>A	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000534788	22	32269319	22	31873333	534788	534302	rs1261611694	NC_000022.11:31873332:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.3396+5G>A	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264740	22	32270396	22	31874410	264740	259371	rs886039267	NC_000022.11:31874409:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.3807G>A (p.Trp1269Ter)	DEPDC5	W1369*, W1269*, W1338*, W1341*, W1347*, W1360*, W1291*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 19, 2015)	no assertion criteria provided	VCV000050822	22	32289641	22	31893655	50822	59812	rs587776975	NC_000022.11:31893654:G:A	G	A	CLINICAL
NM_001242897.2(DEPDC5):c.4097G>A (p.Trp1366Ter)	DEPDC5	W1366*, W1466*, W1457*, W1388*, W1438*, W1435*, W1444*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264746	22	32297749	22	31901763	264746	259378	rs886039273	NC_000022.11:31901762:G:A	G	A	CLINICAL
NM_005650.3(TCF20):c.5725C>T (p.His1909Tyr)	TCF20	H1909Y	Normal	Neurodevelopmental abnormality|Attention deficit hyperactivity disorder|Muscular hypotonia|Autistic behavior|Neurodevelopmental delay	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000590780	22	42575639	22	42179633	590780	581716	rs1569110700	NC_000022.11:42179632:G:A	G	A	CLINICAL
NM_005650.3(TCF20):c.2224C>T (p.Arg742Ter)	TCF20	R742*	Normal	Developmental delay with variable intellectual impairment and behavioral abnormalities|Neurodevelopmental abnormality|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521787	22	42609088	22	42213082	521787	512539	rs1555926209	NC_000022.11:42213081:G:A	G	A	CLINICAL
NM_005650.3(TCF20):c.2155C>T (p.Arg719Ter)	TCF20	R719*	Normal	Neurodevelopmental abnormality|not provided	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000599642	22	42609157	22	42213151	599642	590978	rs1569150452	NC_000022.11:42213150:G:A	G	A	CLINICAL
NM_005650.3(TCF20):c.1960C>T (p.Gln654Ter)	TCF20	Q654*	Normal	Neurodevelopmental abnormality|not provided|Developmental delay with variable intellectual impairment and behavioral abnormalities	Pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000599641	22	42609352	22	42213346	599641	590977	rs1569150885	NC_000022.11:42213345:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.973C>T (p.Gln325Ter)	MLC1	Q325*	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000370408	22	50502549	22	50064120	370408	358664	rs1057516465	NC_000022.11:50064119:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.617G>T (p.Gly206Val)	MLC1	G206V	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242875	22	50512742	22	50074313	242875	243999	rs1114167286	NC_000022.11:50074312:C:A	C	A	CLINICAL
NM_015166.3(MLC1):c.321+1G>T	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000558348	22	50518772	22	50080343	558348	549166	rs765879182	NC_000022.11:50080342:C:A	C	A	CLINICAL
NM_015166.3(MLC1):c.278C>T (p.Ser93Leu)	MLC1	S93L	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004714	22	50518816	22	50080387	4714	19753	rs80358245	NC_000022.11:50080386:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.274C>T (p.Pro92Ser)	MLC1	P92S	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004719	22	50518820	22	50080391	4719	19758	rs121908345	NC_000022.11:50080390:G:A	G	A	CLINICAL
NM_015166.4(MLC1):c.249G>T (p.Leu83Phe)	MLC1	L4F, L83F	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV001162193	22	50521531	22	50083102	1162193	1151089	rs1289520784	NC_000022.11:50083101:C:A	C	A	CLINICAL
NM_015166.3(MLC1):c.206C>T (p.Ser69Leu)	MLC1	S69L	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031622	22	50521574	22	50083145	31622	40300	rs281875309	NC_000022.11:50083144:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.67C>T (p.Gln23Ter)	MLC1	Q23*	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000371381	22	50523265	22	50084836	371381	358672	rs1057517228	NC_000022.11:50084835:G:A	G	A	CLINICAL
NM_002972.4(SBF1):c.1180G>T (p.Glu394Ter)	SBF1	E394*, E395*	Normal	Autism spectrum disorder	Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000562151	22	50903667	22	50465238	562151	553325	rs1569513495	NC_000022.11:50465237:C:A	C	A	CLINICAL
NM_033517.1(SHANK3):c.2265+1G>A	SHANK3		Normal	not provided|22q13.3 deletion syndrome|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000546923	22	51153476	22	50715048	546923	537412	rs1396379503	NC_000022.11:50715047:G:A	G	A	CLINICAL
NM_001177701.3(IFT27):c.352+1G>T	IFT27|CACNG2-DT		Normal	Bardet-Biedl syndrome 19|not provided|Bardet-Biedl syndrome	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000585274	22	37159962	22	36763918	585274	576322	rs780659194	NC_000022.11:36763917:C:A	C	A	CLINICAL
NM_080647.1(TBX1):c.443T>A (p.Phe148Tyr)	TBX1	F148Y	Normal	Conotruncal anomaly face syndrome/velocardiofacial syndrome	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000007563	22	19750796	22	19763273	7563	22602	rs28939675	NC_000022.11:19763272:T:A	T	A	CLINICAL
NM_152906.7(TANGO2):c.460G>A (p.Gly154Arg)	TANGO2	G154R, G120R, G56R, G92R, G133R, G195R	Normal	Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome|Acute rhabdomyolysis|Seizures|Episodic flaccid weakness|Intellectual disability|Cardiac arrhythmia	Pathogenic(Last reviewed: Apr 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000208823	22	20049061	22	20061538	208823	205385	rs752298579	NC_000022.11:20061537:G:A	G	A	CLINICAL
NM_152906.7(TANGO2):c.605+1G>A	TANGO2		Normal	Acute rhabdomyolysis|Seizures|Cardiac arrhythmia|Episodic flaccid weakness|Intellectual disability|Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome|Neurodegeneration	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208824	22	20049207	22	20061684	208824	205386	rs372949028	NC_000022.11:20061683:G:A	G	A	CLINICAL
NM_003073.5(SMARCB1):c.602G>A (p.Arg201Gln)	SMARCB1	R201Q, R210Q, R192Q, R219Q	Normal	Mental retardation, autosomal dominant 15	Likely pathogenic(Last reviewed: Nov 1, 2016)	no assertion criteria provided	VCV000438304	22	24145583	22	23803396	438304	431926	rs1555877287	NC_000022.11:23803395:G:A	G	A	CLINICAL
NM_003073.5(SMARCB1):c.1121G>A (p.Arg374Gln)	SMARCB1	R374Q, R365Q, R392Q, R383Q	Normal	not provided|SMARCB1-related BAFopathy|Inborn genetic diseases|Mental retardation, autosomal dominant 15	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000372511	22	24176330	22	23834143	372511	360483	rs1057517825	NC_000022.11:23834142:G:A	G	A	CLINICAL
NM_001303256.3(MORC2):c.260C>T (p.Ser87Leu)	MORC2	S25L, S87L	Normal	Global developmental delay|Charcot-Marie-Tooth disease, axonal, type 2z|Charcot-Marie-Tooth disease|not provided	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000218308	22	31345795	22	30949809	218308	215004	rs864309504	NC_000022.11:30949808:G:A	G	A	CLINICAL
NM_000026.4(ADSL):c.1277G>A (p.Arg426His)	ADSL	R426H, R362H	Normal	not provided|Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000002462	22	40760969	22	40364965	2462	17501	rs119450941	NC_000022.11:40364964:G:A	G	A	CLINICAL
NM_001429.4(EP300):c.3573T>A (p.Tyr1191Ter)	EP300	Y1191*, Y1165*	Normal	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome 2	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000208498	22	41554487	22	41158483	208498	205026	rs565779970	NC_000022.11:41158482:T:A	T	A	CLINICAL
NM_001429.4(EP300):c.3749G>A (p.Cys1250Tyr)	EP300	C1224Y, C1250Y	Normal	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803701	22	41560077	22	41164073	803701	792076	rs1601629319	NC_000022.11:41164072:G:A	G	A	CLINICAL
NM_005650.3(TCF20):c.4774C>T (p.Gln1592Ter)	TCF20	Q1592*	Normal	Hypotelorism|Generalized hypotonia|Intellectual disability	Pathogenic(Last reviewed: Nov 6, 2018)	no assertion criteria provided	VCV000599400	22	42606538	22	42210532	599400	590736	rs1601592351	NC_000022.11:42210531:G:A	G	A	CLINICAL
NM_000398.7(CYB5R3):c.655C>T (p.Arg219Ter)	CYB5R3	R219*, R196*, R252*	Normal	Methemoglobinemia type 2	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000240	22	43019873	22	42623867	240	15279	rs121965010	NC_000022.11:42623866:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.973C>T (p.Gln325Ter)	MLC1	Q325*	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Feb 2, 2016)	criteria provided, single submitter	VCV000370408	22	50502549	22	50064120	370408	358664	rs1057516465	NC_000022.11:50064119:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.617G>T (p.Gly206Val)	MLC1	G206V	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242875	22	50512742	22	50074313	242875	243999	rs1114167286	NC_000022.11:50074312:C:A	C	A	CLINICAL
NM_015166.3(MLC1):c.321+1G>T	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000558348	22	50518772	22	50080343	558348	549166	rs765879182	NC_000022.11:50080342:C:A	C	A	CLINICAL
NM_015166.3(MLC1):c.278C>T (p.Ser93Leu)	MLC1	S93L	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004714	22	50518816	22	50080387	4714	19753	rs80358245	NC_000022.11:50080386:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.274C>T (p.Pro92Ser)	MLC1	P92S	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004719	22	50518820	22	50080391	4719	19758	rs121908345	NC_000022.11:50080390:G:A	G	A	CLINICAL
NM_015166.4(MLC1):c.249G>T (p.Leu83Phe)	MLC1	L4F, L83F	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV001162193	22	50521531	22	50083102	1162193	1151089	rs1289520784	NC_000022.11:50083101:C:A	C	A	CLINICAL
NM_015166.3(MLC1):c.206C>T (p.Ser69Leu)	MLC1	S69L	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000031622	22	50521574	22	50083145	31622	40300	rs281875309	NC_000022.11:50083144:G:A	G	A	CLINICAL
NM_015166.3(MLC1):c.67C>T (p.Gln23Ter)	MLC1	Q23*	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, single submitter	VCV000371381	22	50523265	22	50084836	371381	358672	rs1057517228	NC_000022.11:50084835:G:A	G	A	CLINICAL
NM_020461.4(TUBGCP6):c.2356C>T (p.Arg786Ter)	TUBGCP6	R786*	Normal	Microcephaly and chorioretinopathy with or without mental retardation	Pathogenic(Last reviewed: May 29, 2015)	criteria provided, single submitter	VCV000212509	22	50660936	22	50222507	212509	208809	rs772174079	NC_000022.11:50222506:G:A	G	A	CLINICAL
NM_020461.4(TUBGCP6):c.895C>T (p.Arg299Ter)	TUBGCP6	R299*	Normal	Microcephaly and chorioretinopathy with or without mental retardation	Pathogenic(Last reviewed: Dec 12, 2014)	criteria provided, single submitter	VCV000212517	22	50678643	22	50240214	212517	208816	rs192919234	NC_000022.11:50240213:G:A	G	A	CLINICAL
NM_005198.4(CHKB):c.1129C>T (p.Arg377Trp)	CHKB|CHKB-CPT1B	R377W	Normal	Megaconial type congenital muscular dystrophy	Pathogenic(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	VCV000689474	22	51017669	22	50579240	689474	677067	rs766848672	NC_000022.11:50579239:G:A	G	A	CLINICAL
NM_000487.6(ARSA):c.1283C>T (p.Pro428Leu)	ARSA	P428L, P342L	Normal	Metachromatic leukodystrophy|not provided|Intellectual disability|Metachromatic leukodystrophy, adult type|Arylsulfatase a, allele a|Metachromatic leukodystrophy, juvenile type	Pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003052	22	51063820	22	50625392	3052	18091	rs28940893	NC_000022.11:50625391:G:A	G	A	CLINICAL
NM_001372044.1(SHANK3):c.1797C>A (p.Cys599Ter)	SHANK3	C599*	Normal	Intellectual disability|Abnormality of the cerebral white matter|Hyperammonemia|Neurodegeneration	Likely pathogenic	no assertion criteria provided	VCV000812791	22	51137191	22	50698763	812791	801217	rs377573165	NC_000022.11:50698762:C:A	C	A	CLINICAL
NM_003560.4(PLA2G6):c.2239C>T (p.Arg747Trp)	PLA2G6	R747W, R521W, R515W, R569W, R693W	Normal	not provided|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Parkinson disease 14|Parkinson disease 14	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006204	22	38508548	22	38112541	6204	21243	rs121908687	NC_000022.11:38112540:G:A	G	A	CLINICAL
NM_003560.4(PLA2G6):c.1354C>T (p.Gln452Ter)	PLA2G6	Q452*, Q220*, Q226*, Q274*, Q398*	Normal	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030367	22	38522451	22	38126444	30367	39324	rs387906864	NC_000022.11:38126443:G:A	G	A	CLINICAL
NM_003560.4(PLA2G6):c.991G>T (p.Asp331Tyr)	PLA2G6	D331Y, D105Y, D153Y	Normal	not provided|Parkinson disease 14	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000030371	22	38528924	22	38132917	30371	39328	rs199935023	NC_000022.11:38132916:C:A	C	A	CLINICAL
NM_023004.6(RTN4R):c.355C>T (p.Arg119Trp)	RTN4R	R119W	Normal	Schizophrenia, susceptibility to	risk factor(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000004882	22	20230301	22	20242778	4882	19921	rs74315508	NC_000022.11:20242777:G:A	G	A	CLINICAL
NM_006767.4(LZTR1):c.597G>C (p.Leu199Phe)	LZTR1	L199F	Normal	not provided	Likely pathogenic(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000546579	22	21343917	22	20989628	546579	537070	rs1555927827	NC_000022.11:20989627:G:C	G	C	CLINICAL
NM_001242897.2(DEPDC5):c.59-1G>C	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264712	22	32154531	22	31758545	264712	259328	rs886039243	NC_000022.11:31758544:G:C	G	C	CLINICAL
NM_001242897.2(DEPDC5):c.1325-1G>C	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000466449	22	32206506	22	31810520	466449	471535	rs1555882867	NC_000022.11:31810519:G:C	G	C	CLINICAL
NM_001242897.2(DEPDC5):c.3263+1G>C	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000566892	22	32269319	22	31873333	566892	571965	rs1261611694	NC_000022.11:31873332:G:C	G	C	CLINICAL
NM_015166.3(MLC1):c.903C>G (p.Tyr301Ter)	MLC1	Y301*	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000552088	22	50502619	22	50064190	552088	549439	rs764754702	NC_000022.11:50064189:G:C	G	C	CLINICAL
NM_015166.3(MLC1):c.895-2A>G	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004716	22	50502629	22	50064200	4716	19755	rs1183818307	NC_000022.11:50064199:T:C	T	C	CLINICAL
NM_015166.3(MLC1):c.422A>G (p.Asn141Ser)	MLC1	N141S	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004718	22	50518348	22	50079919	4718	19757	rs121908344	NC_000022.11:50079918:T:C	T	C	CLINICAL
NM_000026.4(ADSL):c.340T>C (p.Tyr114His)	ADSL	Y114H, Y50H	Normal	Inability to walk|Generalized myoclonic seizures|Severe global developmental delay|Progressive neurologic deterioration|Difficulty standing|Adenylosuccinate lyase deficiency|not provided	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000204807	22	40746022	22	40350018	204807	203840	rs374259530	NC_000022.11:40350017:T:C	T	C	CLINICAL
NM_001429.4(EP300):c.4763T>C (p.Met1588Thr)	EP300	M1588T, M1562T	Normal	Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation|Rubinstein-Taybi syndrome 2|Rubinstein-Taybi syndrome 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000383803	22	41569772	22	41173768	383803	379858	rs1057521737	NC_000022.11:41173767:T:C	T	C	CLINICAL
NM_005650.3(TCF20):c.2594C>G (p.Ser865Ter)	TCF20	S865*	Normal	Myoclonus|Autistic disorder of childhood onset|Intellectual disability, mild	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, single submitter	VCV000590778	22	42608718	22	42212712	590778	581714	rs1569149539	NC_000022.11:42212711:G:C	G	C	CLINICAL
NM_015166.3(MLC1):c.903C>G (p.Tyr301Ter)	MLC1	Y301*	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000552088	22	50502619	22	50064190	552088	549439	rs764754702	NC_000022.11:50064189:G:C	G	C	CLINICAL
NM_015166.3(MLC1):c.895-2A>G	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004716	22	50502629	22	50064200	4716	19755	rs1183818307	NC_000022.11:50064199:T:C	T	C	CLINICAL
NM_015166.3(MLC1):c.422A>G (p.Asn141Ser)	MLC1	N141S	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004718	22	50518348	22	50079919	4718	19757	rs121908344	NC_000022.11:50079918:T:C	T	C	CLINICAL
NM_001242897.2(DEPDC5):c.21C>G (p.Tyr7Ter)	DEPDC5	Y7*	Normal	Epilepsy, familial focal, with variable foci 1|not provided|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Dec 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050819	22	32150928	22	31754942	50819	59809	rs768241563	NC_000022.11:31754941:C:G	C	G	CLINICAL
NM_001242897.2(DEPDC5):c.918C>G (p.Tyr306Ter)	DEPDC5	Y306*, Y278*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264726	22	32194614	22	31798628	264726	259347	rs886039256	NC_000022.11:31798627:C:G	C	G	CLINICAL
NM_001242897.2(DEPDC5):c.1081+2T>G	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000641534	22	32198826	22	31802840	641534	653326	rs1601970824	NC_000022.11:31802839:T:G	T	G	CLINICAL
NM_001242897.2(DEPDC5):c.2121-2A>G	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000183029	22	32234669	22	31838683	183029	181177	rs797044545	NC_000022.11:31838682:A:G	A	G	CLINICAL
NM_015166.3(MLC1):c.1132T>C (p.Ter378Arg)	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000552370	22	50500014	22	50061585	552370	549153	rs1555962581	NC_000022.11:50061584:A:G	A	G	CLINICAL
NM_015166.3(MLC1):c.895-1G>C	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000371564	22	50502628	22	50064199	371564	358665	rs755271052	NC_000022.11:50064198:C:G	C	G	CLINICAL
NM_015166.3(MLC1):c.634G>C (p.Gly212Arg)	MLC1	G212R	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000553381	22	50512725	22	50074296	553381	549161	rs281875317	NC_000022.11:50074295:C:G	C	G	CLINICAL
NM_001372044.1(SHANK3):c.494+2T>G	SHANK3		Normal	22q13.3 deletion syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803709	22	51113681	22	50675253	803709	792084	rs1603445997	NC_000022.11:50675252:T:G	T	G	CLINICAL
NM_033517.1(SHANK3):c.421C>G (p.Pro141Ala)	SHANK3	P141A	Normal	22q13.3 deletion syndrome	Pathogenic(Last reviewed: Mar 1, 2013)	no assertion criteria provided	VCV000050949	22	51117094	22	50678666	50949	65612	rs397514705	NC_000022.11:50678665:C:G	C	G	CLINICAL
NM_001362873.1(PPARA):c.484C>G (p.Leu162Val)	PPARA	L162V	Normal	Hyperapobetalipoproteinemia, susceptibility to	risk factor(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000013701	22	46614274	22	46218377	13701	28740	rs1800206	NC_000022.11:46218376:C:G	C	G	CLINICAL
NM_003073.5(SMARCB1):c.1070C>G (p.Thr357Arg)	SMARCB1	T357R, T348R, T366R, T375R	Normal	Mental retardation, autosomal dominant 15	Likely pathogenic(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000559897	22	24175842	22	23833655	559897	550644	rs1555881567	NC_000022.11:23833654:C:G	C	G	CLINICAL
NM_003073.5(SMARCB1):c.1087A>G (p.Lys363Glu)	SMARCB1	K363E, K354E, K372E, K381E	Normal	Mental retardation, autosomal dominant 15|not provided	Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000212263	22	24175859	22	23833672	212263	208780	rs797045989	NC_000022.11:23833671:A:G	A	G	CLINICAL
NM_004737.6(LARGE1):c.1483T>C (p.Trp495Arg)	LARGE1	W495R	Normal	Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A6	Pathogenic(Last reviewed: May 26, 2009)	no assertion criteria provided	VCV000006219	22	33700462	22	33304476	6219	21258	rs267607209	NC_000022.11:33304475:A:G	A	G	CLINICAL
NM_006941.3(SOX10):c.698-2A>C	POLR2F|SOX10		Normal	Waardenburg syndrome type 2E, with neurologic involvement	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000007409	22	38370207	22	37974200	7409	22448	rs397515370	NC_000022.11:37974199:T:G	T	G	CLINICAL
NM_003560.4(PLA2G6):c.1634A>C (p.Lys545Thr)	PLA2G6	K545T, K491T, K313T, K319T, K367T	Normal	Global developmental delay|Developmental regression|Congenital cerebellar hypoplasia|Cerebellar ataxia|Microcephaly|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14	Pathogenic	criteria provided, single submitter	VCV000006196	22	38516874	22	38120867	6196	21235	rs121908681	NC_000022.11:38120866:T:G	T	G	CLINICAL
NM_001429.4(EP300):c.3262-2A>G	EP300		Normal	CHARGE association|Rubinstein-Taybi syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	no assertion criteria provided	VCV000488375	22	41553171	22	41157167	488375	481223	rs1555910114	NC_000022.11:41157166:A:G	A	G	CLINICAL
NM_001429.3(EP300):c.3857A>G	EP300	N1286S, N1260S	Normal	Intellectual disability|Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation|Rubinstein-Taybi syndrome 2|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000378053	22	41562653	22	41166649	378053	380144	rs1555910821	NC_000022.11:41166648:A:G	A	G	CLINICAL
NM_000398.7(CYB5R3):c.464-2A>C	CYB5R3		Normal	Deficiency of cytochrome-b5 reductase|Methemoglobinemia type 2|not provided	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000245	22	43023696	22	42627690	245	15284	rs794728013	NC_000022.11:42627689:T:G	T	G	CLINICAL
NM_000398.7(CYB5R3):c.446T>C (p.Leu149Pro)	CYB5R3	L149P, L126P, L182P	Normal	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000236	22	43024175	22	42628169	236	15275	rs121965008	NC_000022.11:42628168:A:G	A	G	CLINICAL
NM_000398.7(CYB5R3):c.218T>C (p.Leu73Pro)	CYB5R3	L73P, L106P, L50P	Normal	Methemoglobinemia, type I	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000000246	22	43027392	22	42631386	246	15285	rs121965013	NC_000022.11:42631385:A:G	A	G	CLINICAL
NM_015166.3(MLC1):c.1132T>C (p.Ter378Arg)	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000552370	22	50500014	22	50061585	552370	549153	rs1555962581	NC_000022.11:50061584:A:G	A	G	CLINICAL
NM_015166.3(MLC1):c.895-1G>C	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000371564	22	50502628	22	50064199	371564	358665	rs755271052	NC_000022.11:50064198:C:G	C	G	CLINICAL
NM_015166.3(MLC1):c.634G>C (p.Gly212Arg)	MLC1	G212R	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, single submitter	VCV000553381	22	50512725	22	50074296	553381	549161	rs281875317	NC_000022.11:50074295:C:G	C	G	CLINICAL
NM_012179.4(FBXO7):c.1132C>G (p.Arg378Gly)	FBXO7	R378G, R264G, R299G	Normal	Parkinson disease 15	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000004808	22	32889256	22	32493269	4808	19847	rs71799110	NC_000022.11:32493268:C:G	C	G	CLINICAL
NM_003560.4(PLA2G6):c.1634A>C (p.Lys545Thr)	PLA2G6	K545T, K491T, K313T, K319T, K367T	Normal	Global developmental delay|Developmental regression|Congenital cerebellar hypoplasia|Cerebellar ataxia|Microcephaly|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14	Pathogenic	criteria provided, single submitter	VCV000006196	22	38516874	22	38120867	6196	21235	rs121908681	NC_000022.11:38120866:T:G	T	G	CLINICAL
NM_007098.4(CLTCL1):c.988G>A (p.Glu330Lys)	CLTCL1	E330K	Normal	not provided	Likely pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000372327	22	19222211	22	19234688	372327	360611	rs199652160	NC_000022.11:19234687:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.418C>T (p.Gln140Ter)	DEPDC5	Q140*, Q112*	Normal	Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000190476	22	32174089	22	31778103	190476	188295	rs786205703	NC_000022.11:31778102:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.526C>T (p.Gln176Ter)	DEPDC5	Q176*, Q148*	Normal	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV000264720	22	32179935	22	31783949	264720	259338	rs886039251	NC_000022.11:31783948:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.715C>T (p.Arg239Ter)	DEPDC5	R239*, R211*	Normal	not provided|Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jun 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050824	22	32188751	22	31792765	50824	59814	rs587776976	NC_000022.11:31792764:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.727C>T (p.Arg243Ter)	DEPDC5	R243*, R215*	Normal	Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264723	22	32188763	22	31792777	264723	259341	rs772872014	NC_000022.11:31792776:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.730C>T (p.Gln244Ter)	DEPDC5	Q244*, Q216*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264722	22	32188766	22	31792780	264722	259342	rs886039253	NC_000022.11:31792779:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.856C>T (p.Arg286Ter)	DEPDC5	R286*, R258*	Normal	Familial focal epilepsy with variable foci|not provided|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264725	22	32193674	22	31797688	264725	259346	rs886039255	NC_000022.11:31797687:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.865C>T (p.Gln289Ter)	DEPDC5	Q289*, Q261*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000534791	22	32193683	22	31797697	534791	534739	rs759952667	NC_000022.11:31797696:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.871+1G>T	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000466497	22	32193690	22	31797704	466497	470225	rs1556607762	NC_000022.11:31797703:G:T	G	T	CLINICAL
NM_001242897.2(DEPDC5):c.982C>T (p.Arg328Ter)	DEPDC5	R328*, R300*	Normal	Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV000050825	22	32198725	22	31802739	50825	59815	rs587776977	NC_000022.11:31802738:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1114C>T (p.Gln372Ter)	DEPDC5	Q372*, Q344*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264729	22	32200180	22	31804194	264729	259350	rs886039259	NC_000022.11:31804193:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1264C>T (p.Arg422Ter)	DEPDC5	R422*, R394*	Normal	Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci|not provided	Pathogenic(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000264730	22	32202154	22	31806168	264730	259352	rs757511744	NC_000022.11:31806167:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1393C>T (p.Gln465Ter)	DEPDC5	Q465*, Q437*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264731	22	32206575	22	31810589	264731	259355	rs886039260	NC_000022.11:31810588:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1446-1G>T	DEPDC5		Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000534786	22	32210977	22	31814991	534786	534743	rs1555885023	NC_000022.11:31814990:G:T	G	T	CLINICAL
NM_001242897.2(DEPDC5):c.1459C>T (p.Arg487Ter)	DEPDC5	R487*, R459*	Normal	not provided|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Feb 25, 2019)	criteria provided, single submitter	VCV000139434	22	32210991	22	31815005	139434	143126	rs587777459	NC_000022.11:31815004:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1555C>T (p.Gln519Ter)	DEPDC5	Q519*, Q491*	Normal	not provided|Seizures|Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264732	22	32211087	22	31815101	264732	259357	rs886039261	NC_000022.11:31815100:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1663C>T (p.Arg555Ter)	DEPDC5	R555*, R527*	Normal	not provided|Epilepsy, familial focal, with variable foci 1|Familial focal epilepsy with variable foci|Seizures	Pathogenic(Last reviewed: Aug 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000050820	22	32211195	22	31815209	50820	59810	rs587776973	NC_000022.11:31815208:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1759C>T (p.Arg587Ter)	DEPDC5	R587*, R559*	Normal	not provided|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, single submitter	VCV000264734	22	32215100	22	31819114	264734	259360	rs886039263	NC_000022.11:31819113:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.1870+2315C>T	DEPDC5	R637*, R609*	Normal	Epilepsy, familial focal, with variable foci 1|not provided|Familial focal epilepsy with variable foci	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000264735	22	32217526	22	31821540	264735	259361	rs780960812	NC_000022.11:31821539:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.2278C>T (p.Arg760Ter)	DEPDC5	R760*, R838*, R810*, R829*	Normal	Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000590901	22	32234828	22	31838842	590901	581846	rs1569067939	NC_000022.11:31838841:C:T	C	T	CLINICAL
NM_001242896.3(DEPDC5):c.2516G>T (p.Gly839Val)	DEPDC5	G811V, G761V, G830V, G839V	Normal	Epilepsy, familial focal, with variable foci 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803680	22	32239081	22	31843095	803680	792055	rs1602349641	NC_000022.11:31843094:G:T	G	T	CLINICAL
NM_001242897.2(DEPDC5):c.2293C>T (p.Arg765Ter)	DEPDC5	R843*, R765*, R834*, R815*	Normal	Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV000180644	22	32239092	22	31843106	180644	178806	rs541024038	NC_000022.11:31843105:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.2386C>T (p.Arg796Ter)	DEPDC5	R796*, R874*, R846*, R865*	Normal	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000264737	22	32239185	22	31843199	264737	259363	rs578185749	NC_000022.11:31843198:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.2812C>T (p.Gln938Ter)	DEPDC5	Q1016*, Q938*, Q988*, Q1007*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264738	22	32242844	22	31846858	264738	259364	rs886039265	NC_000022.11:31846857:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.3025C>T (p.Arg1009Ter)	DEPDC5	R1087*, R1009*, R1059*, R1078*	Normal	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1|not provided	Pathogenic(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139433	22	32253534	22	31857548	139433	143125	rs587777458	NC_000022.11:31857547:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.3502C>T (p.Arg1168Ter)	DEPDC5	R1168*, R1268*, R1237*, R1240*, R1259*, R1190*, R1246*	Normal	Familial focal epilepsy with variable foci|Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000264741	22	32272248	22	31876262	264741	259372	rs886039268	NC_000022.11:31876261:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.3568C>T (p.Gln1190Ter)	DEPDC5	Q1290*, Q1190*, Q1212*, Q1259*, Q1268*, Q1281*, Q1262*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000575135	22	32275573	22	31879587	575135	575265	rs1569186093	NC_000022.11:31879586:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.3694C>T (p.Arg1232Ter)	DEPDC5	R1232*, R1332*, R1254*, R1323*, R1301*, R1304*, R1310*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000264742	22	32275699	22	31879713	264742	259374	rs886039269	NC_000022.11:31879712:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.4267C>T (p.Gln1423Ter)	DEPDC5	Q1423*, Q1523*, Q1492*, Q1495*, Q1445*, Q1501*, Q1514*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000183030	22	32302238	22	31906252	183030	181178	rs797044546	NC_000022.11:31906251:C:T	C	T	CLINICAL
NM_001242897.2(DEPDC5):c.4306C>T (p.Gln1436Ter)	DEPDC5	Q1436*, Q1536*, Q1458*, Q1505*, Q1514*, Q1527*, Q1508*	Normal	Epilepsy, familial focal, with variable foci 1	Pathogenic(Last reviewed: Apr 13, 2016)	no assertion criteria provided	VCV000264747	22	32302277	22	31906291	264747	259379	rs886039274	NC_000022.11:31906290:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.1059+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000558425	22	50502462	22	50064033	558425	549081	rs1555963392	NC_000022.11:50064032:C:T	C	T	CLINICAL
NM_015166.4(MLC1):c.959C>A	MLC1	T320K	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068797	22	50502563	22	50064134	68797	79689	rs281875313	NC_000022.11:50064133:G:T	G	T	CLINICAL
NM_015166.3(MLC1):c.824C>A (p.Ala275Asp)	MLC1	A275D	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000554164	22	50506932	22	50068503	554164	549440	rs764669598	NC_000022.11:50068502:G:T	G	T	CLINICAL
NM_015166.3(MLC1):c.714+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000188980	22	50512644	22	50074215	188980	187067	rs761620701	NC_000022.11:50074214:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.634G>A (p.Gly212Arg)	MLC1	G212R	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Likely pathogenic(Last reviewed: Sep 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068794	22	50512725	22	50074296	68794	79686	rs281875317	NC_000022.11:50074295:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.525+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000371509	22	50515829	22	50077400	371509	358667	rs769135961	NC_000022.11:50077399:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.423C>A (p.Asn141Lys)	MLC1	N141K	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004717	22	50518347	22	50079918	4717	19756	rs121908343	NC_000022.11:50079917:G:T	G	T	CLINICAL
NM_015166.3(MLC1):c.321+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000550431	22	50518772	22	50080343	550431	549443	rs765879182	NC_000022.11:50080342:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.178-10T>A	MLC1		Normal	Macrocephalus|Cerebellar ataxia|CNS demyelination|Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021522	22	50521612	22	50083183	21522	34374	rs80358243	NC_000022.11:50083182:A:T	A	T	CLINICAL
NM_015166.3(MLC1):c.176G>A (p.Gly59Glu)	MLC1	G59E	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004721	22	50523156	22	50084727	4721	19760	rs80358242	NC_000022.11:50084726:C:T	C	T	CLINICAL
NM_033517.1(SHANK3):c.1030G>T (p.Val344Leu)	SHANK3	V344L	Normal	22q13.3 deletion syndrome	Likely pathogenic	no assertion criteria provided	VCV000375622	22	51123079	22	50684651	375622	362436	rs1057519406	NC_000022.11:50684650:G:T	G	T	CLINICAL
NM_001372044.1(SHANK3):c.4978G>T (p.Glu1660Ter)	SHANK3	E1660*	Normal	22q13.3 deletion syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800506	22	51169297	22	50730869	800506	789134	rs1603447380	NC_000022.11:50730868:G:T	G	T	CLINICAL
NM_007098.4(CLTCL1):c.988G>A (p.Glu330Lys)	CLTCL1	E330K	Normal	not provided	Likely pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000372327	22	19222211	22	19234688	372327	360611	rs199652160	NC_000022.11:19234687:C:T	C	T	CLINICAL
NM_004737.6(LARGE1):c.1525G>A (p.Glu509Lys)	LARGE1	E509K	Normal	Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6	Pathogenic(Last reviewed: Nov 1, 2008)	no assertion criteria provided	VCV000006216	22	33700420	22	33304434	6216	21255	rs121908675	NC_000022.11:33304433:C:T	C	T	CLINICAL
NM_001429.4(EP300):c.4933C>T (p.Arg1645Ter)	EP300	R1645*, R1619*	Normal	Rubinstein-Taybi syndrome 2|Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and mental retardation|Rubinstein-Taybi syndrome 2	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183678	22	41572404	22	41176400	183678	181577	rs139310551	NC_000022.11:41176399:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.1059+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000558425	22	50502462	22	50064033	558425	549081	rs1555963392	NC_000022.11:50064032:C:T	C	T	CLINICAL
NM_015166.4(MLC1):c.959C>A	MLC1	T320K	Normal	not provided|Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068797	22	50502563	22	50064134	68797	79689	rs281875313	NC_000022.11:50064133:G:T	G	T	CLINICAL
NM_015166.3(MLC1):c.824C>A (p.Ala275Asp)	MLC1	A275D	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000554164	22	50506932	22	50068503	554164	549440	rs764669598	NC_000022.11:50068502:G:T	G	T	CLINICAL
NM_015166.3(MLC1):c.714+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000188980	22	50512644	22	50074215	188980	187067	rs761620701	NC_000022.11:50074214:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.634G>A (p.Gly212Arg)	MLC1	G212R	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Likely pathogenic(Last reviewed: Sep 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000068794	22	50512725	22	50074296	68794	79686	rs281875317	NC_000022.11:50074295:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.525+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Oct 7, 2016)	criteria provided, single submitter	VCV000371509	22	50515829	22	50077400	371509	358667	rs769135961	NC_000022.11:50077399:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.423C>A (p.Asn141Lys)	MLC1	N141K	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Pathogenic(Last reviewed: Mar 1, 2002)	no assertion criteria provided	VCV000004717	22	50518347	22	50079918	4717	19756	rs121908343	NC_000022.11:50079917:G:T	G	T	CLINICAL
NM_015166.3(MLC1):c.321+1G>A	MLC1		Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000550431	22	50518772	22	50080343	550431	549443	rs765879182	NC_000022.11:50080342:C:T	C	T	CLINICAL
NM_015166.3(MLC1):c.178-10T>A	MLC1		Normal	Macrocephalus|Cerebellar ataxia|CNS demyelination|Megalencephalic leukoencephalopathy with subcortical cysts 1	Likely pathogenic(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000021522	22	50521612	22	50083183	21522	34374	rs80358243	NC_000022.11:50083182:A:T	A	T	CLINICAL
NM_015166.3(MLC1):c.176G>A (p.Gly59Glu)	MLC1	G59E	Normal	Megalencephalic leukoencephalopathy with subcortical cysts 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004721	22	50523156	22	50084727	4721	19760	rs80358242	NC_000022.11:50084726:C:T	C	T	CLINICAL
NM_000487.6(ARSA):c.465+1G>A	ARSA		Normal	Intellectual disability|Inborn genetic diseases|not provided|Metachromatic leukodystrophy|Metachromatic leukodystrophy, adult type|Metachromatic leukodystrophy, juvenile type	Pathogenic(Last reviewed: Mar 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003051	22	51065593	22	50627165	3051	18090	rs80338815	NC_000022.11:50627164:C:T	C	T	CLINICAL
NM_033517.1(SHANK3):c.271C>T (p.Arg91Ter)	SHANK3	R91*	Normal	Seizures|Global developmental delay|History of neurodevelopmental disorder|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000587762	22	51115053	22	50676625	587762	580794	rs1569097392	NC_000022.11:50676624:C:T	C	T	CLINICAL
NM_033517.1(SHANK3):c.3349C>T (p.Arg1117Ter)	SHANK3	R1117*	Normal	Schizophrenia 15|Intellectual disability	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV000030560	22	51159610	22	50721182	30560	39517	rs387906932	NC_000022.11:50721181:C:T	C	T	CLINICAL
NM_003073.5(SMARCB1):c.34C>T (p.Gln12Ter)	SMARCB1	Q12*	Normal	Schwannomatosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000008026	22	24129390	22	23787203	8026	23065	rs74315513	NC_000022.11:23787202:C:T	C	T	CLINICAL
NM_012179.4(FBXO7):c.65C>T (p.Thr22Met)	FBXO7	T22M	Normal	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004811	22	32871054	22	32475067	4811	19850	rs121918305	NC_000022.11:32475066:C:T	C	T	CLINICAL
NM_012179.4(FBXO7):c.1144+1G>T	FBXO7		Normal	Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	no assertion criteria provided	VCV000004810	22	32889269	22	32493282	4810	19849	rs730880272	NC_000022.11:32493281:G:T	G	T	CLINICAL
NM_012179.4(FBXO7):c.1492C>T (p.Arg498Ter)	FBXO7	R498*, R419*, R384*	Normal	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004809	22	32894440	22	32498453	4809	19848	rs121918304	NC_000022.11:32498452:C:T	C	T	CLINICAL
NM_003560.4(PLA2G6):c.2222G>A (p.Arg741Gln)	PLA2G6	R741Q, R515Q, R687Q, R509Q, R563Q	Normal	Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|Infantile neuroaxonal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006203	22	38508565	22	38112558	6203	21242	rs121908686	NC_000022.11:38112557:C:T	C	T	CLINICAL
NM_003560.4(PLA2G6):c.1427+1G>A	PLA2G6		Normal	Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Parkinson disease 14	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437465	22	38522377	22	38126370	437465	431023	rs750939090	NC_000022.11:38126369:C:T	C	T	CLINICAL
NM_003560.4(PLA2G6):c.1077G>A (p.Ser359=)	PLA2G6		Normal	Infantile neuroaxonal dystrophy|not provided	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279875	22	38528838	22	38132831	279875	264928	rs368497893	NC_000022.11:38132830:C:T	C	T	CLINICAL
NM_003560.4(PLA2G6):c.216C>A (p.Phe72Leu)	PLA2G6	F72L	Normal	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030368	22	38541654	22	38145647	30368	39325	rs774631197	NC_000022.11:38145646:G:T	G	T	CLINICAL
NM_023004.6(RTN4R):c.587G>A (p.Arg196His)	RTN4R	R196H	Normal	Schizophrenia, susceptibility to	risk factor(Last reviewed: Dec 1, 2004)	no assertion criteria provided	VCV000004883	22	20230069	22	20242546	4883	19922	rs74315509	NC_000022.11:20242545:C:T	C	T	CLINICAL
NM_033517.1(SHANK3):c.1606C>T (p.Arg536Trp)	SHANK3	R536W	Normal	Schizophrenia 15	Pathogenic(Last reviewed: Apr 27, 2010)	no assertion criteria provided	VCV000030561	22	51137225	22	50698797	30561	39518	rs387906933	NC_000022.11:50698796:C:T	C	T	CLINICAL
NM_033517.1(SHANK3):c.3349C>T (p.Arg1117Ter)	SHANK3	R1117*	Normal	Schizophrenia 15|Intellectual disability	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV000030560	22	51159610	22	50721182	30560	39517	rs387906932	NC_000022.11:50721181:C:T	C	T	CLINICAL
m.12258C>A	MT-TS2		Normal	Cerebellar ataxia, cataract, and diabetes mellitus|Retinitis pigmentosa-deafness syndrome	Pathogenic(Last reviewed: Apr 1, 1999)	no assertion criteria provided	VCV000009560	MT	12258	MT	12258	9560	24599	rs118203888	NC_012920.1:12257:C:A	C	A	CLINICAL
m.14459G>A	MT-ND6	A72V	Normal	Leber hereditary optic neuropathy|Leigh syndrome|Leber optic atrophy and dystonia|Leigh syndrome due to mitochondrial complex I deficiency	Pathogenic(Last reviewed: Feb 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009689	MT	14459	MT	14459	9689	24728	rs199476105	NC_012920.1:14458:G:A	G	A	CLINICAL
m.3376G>A	MT-ND1	E24K	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065921	MT	3376	MT	3376	65921	76829	rs397515612	NC_012920.1:3375:G:A	G	A	CLINICAL
m.3700G>A	MT-ND1	A132T	Normal	Leber hereditary optic neuropathy|Abnormal electroretinogram|Optic neuropathy|Visual loss	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065519	MT	3700	MT	3700	65519	76427	rs397515508	NC_012920.1:3699:G:A	G	A	CLINICAL
m.3733G>A	MT-ND1	E143K	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009736	MT	3733	MT	3733	9736	24775	rs199476125	NC_012920.1:3732:G:A	G	A	CLINICAL
m.13730G>A	MT-ND5	G465E	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009697	MT	13730	MT	13730	9697	24736	rs387906425	NC_012920.1:13729:G:A	G	A	CLINICAL
m.14482C>A	MT-ND6	M64I	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009693	MT	14482	MT	14482	9693	24732	rs199476108	NC_012920.1:14481:C:A	C	A	CLINICAL
m.3697G>A	MT-ND1	G131S	Normal	Leber optic atrophy and dystonia|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009733	MT	3697	MT	3697	9733	24772	rs199476122	NC_012920.1:3696:G:A	G	A	CLINICAL
m.3946G>A	MT-ND1	E214K	Normal	Leber hereditary optic neuropathy|Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009734	MT	3946	MT	3946	9734	24773	rs199476123	NC_012920.1:3945:G:A	G	A	CLINICAL
m.11777C>A	MT-ND4	R340S	Normal	Leigh syndrome|Leber hereditary optic neuropathy|Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009711	MT	11777	MT	11777	9711	24750	rs28384199	NC_012920.1:11776:C:A	C	A	CLINICAL
m.13042G>A	MT-ND5	A236T	Normal	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Leber hereditary optic neuropathy|Leigh syndrome due to mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009703	MT	13042	MT	13042	9703	24742	rs267606898	NC_012920.1:13041:G:A	G	A	CLINICAL
m.10197G>A	MT-ND3	A47T	Normal	Leber optic atrophy and dystonia|Mitochondrial complex 1 deficiency, mitochondrial type 1|not provided|Leigh syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009715	MT	10197	MT	10197	9715	24754	rs267606891	NC_012920.1:10196:G:A	G	A	CLINICAL
m.11777C>A	MT-ND4	R340S	Normal	Leigh syndrome|Leber hereditary optic neuropathy|Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009711	MT	11777	MT	11777	9711	24750	rs28384199	NC_012920.1:11776:C:A	C	A	CLINICAL
m.13513G>A	MT-ND5	D393N	Normal	not provided|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leigh syndrome due to mitochondrial complex I deficiency|Mitochondrial diseases|Leigh syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009702	MT	13513	MT	13513	9702	24741	rs267606897	NC_012920.1:13512:G:A	G	A	CLINICAL
m.14459G>A	MT-ND6	A72V	Normal	Leber hereditary optic neuropathy|Leigh syndrome|Leber optic atrophy and dystonia|Leigh syndrome due to mitochondrial complex I deficiency	Pathogenic(Last reviewed: Feb 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009689	MT	14459	MT	14459	9689	24728	rs199476105	NC_012920.1:14458:G:A	G	A	CLINICAL
m.1606G>A	MT-TV		Normal	Ataxia, progressive seizures, mental deterioration, and hearing loss|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009548	MT	1606	MT	1606	9548	24587	rs199476143	NC_012920.1:1605:G:A	G	A	CLINICAL
NC_012920.1:m.3460G>A	MT-ND1	A52T	Normal	not provided|Leber hereditary optic neuropathy|MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 3|Leigh syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009722	MT	3460	MT	3460	9722	24761	rs199476118	NC_012920.1:3459:G:A	G	A	CLINICAL
m.3697G>A	MT-ND1	G131S	Normal	Leber optic atrophy and dystonia|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009733	MT	3697	MT	3697	9733	24772	rs199476122	NC_012920.1:3696:G:A	G	A	CLINICAL
m.4284G>A	MT-TI		Normal	Multisystem disorder|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009604	MT	4284	MT	4284	9604	24643	rs121434468	NC_012920.1:4283:G:A	G	A	CLINICAL
m.4810G>A	MT-ND2	W114*	Normal	Mitochondrial complex I deficiency	Pathogenic(Last reviewed: Mar 22, 2005)	no assertion criteria provided	VCV000009720	MT	4810	MT	4810	9720	24759	rs267606888	NC_012920.1:4809:G:A	G	A	CLINICAL
m.8313G>A	MT-TK		Normal	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	Pathogenic(Last reviewed: Oct 1, 1997)	no assertion criteria provided	VCV000009583	MT	8313	MT	8313	9583	24622	rs118192101	NC_012920.1:8312:G:A	G	A	CLINICAL
m.13042G>A	MT-ND5	A236T	Normal	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Leber hereditary optic neuropathy|Leigh syndrome due to mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009703	MT	13042	MT	13042	9703	24742	rs267606898	NC_012920.1:13041:G:A	G	A	CLINICAL
NC_012920.1:m.8969G>A	MT-ATP6	S148N	Normal	Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Myopathy, lactic acidosis, and sideroblastic anemia 3	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000191364	MT	8969	MT	8969	191364	189167	rs794726857	NC_012920.1:8968:G:A	G	A	CLINICAL
NC_012920.1:m.8851T>C	MT-ATP6	W109R	Normal	not provided|Leber hereditary optic neuropathy|Leigh syndrome|Striatonigral degeneration, infantile, mitochondrial	Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009645	MT	8851	MT	8851	9645	24684	rs199476136	NC_012920.1:8850:T:C	T	C	CLINICAL
m.4409T>C	MT-TM		Normal	Mitochondrial myopathy	Pathogenic(Last reviewed: Dec 5, 2008)	no assertion criteria provided	VCV000009578	MT	4409	MT	4409	9578	24617	rs118203884	NC_012920.1:4408:T:C	T	C	CLINICAL
NC_012920.1:m.9176T>C	MT-ATP6	L217P	Normal	Leber hereditary optic neuropathy|Leigh syndrome|Striatonigral degeneration, infantile, mitochondrial|not provided|Mitochondrial complex v (atp synthase) deficiency, mitochondrial type 1	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009644	MT	9176	MT	9176	9644	24683	rs199476135	NC_012920.1:9175:T:C	T	C	CLINICAL
m.14709T>C	MT-TE		Normal	Myopathy, mitochondrial, with diabetes mellitus|Diabetes-deafness syndrome maternally transmitted|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial myopathy|Mitochondrial diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009617	MT	14709	MT	14709	9617	24656	rs121434453	NC_012920.1:14708:T:C	T	C	CLINICAL
m.10191T>C	MT-ND3	S45P	Normal	Leigh syndrome|Mitochondrial complex I deficiency|Mitochondrial complex 1 deficiency, mitochondrial type 1	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009712	MT	10191	MT	10191	9712	24751	rs267606890	NC_012920.1:10190:T:C	T	C	CLINICAL
m.14709T>C	MT-TE		Normal	Myopathy, mitochondrial, with diabetes mellitus|Diabetes-deafness syndrome maternally transmitted|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial myopathy|Mitochondrial diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009617	MT	14709	MT	14709	9617	24656	rs121434453	NC_012920.1:14708:T:C	T	C	CLINICAL
m.5728T>C	MT-TN		Normal	MITOCHONDRIAL COMPLEX I DEFICIENCY, MITOCHONDRIAL TYPE 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009622	MT	5728	MT	5728	9622	24661	rs199476132	NC_012920.1:5727:T:C	T	C	CLINICAL
m.7512T>C	MT-TS1		Normal	Mitochondrial cytochrome c oxidase deficiency|MERRF/MELAS overlap syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009562	MT	7512	MT	7512	9562	24601	rs199474817	NC_012920.1:7511:T:C	T	C	CLINICAL
NC_012920.1:m.8993T>C	MT-ATP6	L156P	Normal	not provided|Mitochondrial complex v (atp synthase) deficiency, mitochondrial type 1|NARP syndrome|Ataxia and polyneuropathy, adult-onset|Mitochondrial diseases|Leigh syndrome	Pathogenic(Last reviewed: Feb 17, 2021)	reviewed by expert panel	VCV000009642	MT	8993	MT	8993	9642	24681	rs199476133	NC_012920.1:8992:T:C	T	C	CLINICAL
NC_012920.1:m.3243A>G	MT-TL1		Normal	not provided|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Short stature|Sensorineural hearing loss|Stroke|Glucose intolerance|3-Methylglutaconic aciduria type 1|Mitochondrial diseases|Leigh syndrome|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G	A	G	CLINICAL
m.14482C>G	MT-ND6	M64I	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065513	MT	14482	MT	14482	65513	76421	rs199476108	NC_012920.1:14481:C:G	C	G	CLINICAL
m.14495A>G	MT-ND6	L60S	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009691	MT	14495	MT	14495	9691	24730	rs199476106	NC_012920.1:14494:A:G	A	G	CLINICAL
NC_012920.1:m.3243A>G	MT-TL1		Normal	not provided|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Short stature|Sensorineural hearing loss|Stroke|Glucose intolerance|3-Methylglutaconic aciduria type 1|Mitochondrial diseases|Leigh syndrome|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G	A	G	CLINICAL
NC_012920.1:m.14692A>G	MT-TE		Normal	Diabetes-deafness syndrome maternally transmitted	Pathogenic(Last reviewed: Oct 25, 2016)	no assertion criteria provided	VCV000267298	MT	14692	MT	14692	267298	262350	rs879192165	NC_012920.1:14691:A:G	A	G	CLINICAL
m.15579A>G	MT-CYB	Y278C	Normal	Mitochondrial myopathy, infantile, transient|Multisystem disorder	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009683	MT	15579	MT	15579	9683	24722	rs207460002	NC_012920.1:15578:A:G	A	G	CLINICAL
NC_012920.1:m.3243A>G	MT-TL1		Normal	not provided|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Short stature|Sensorineural hearing loss|Stroke|Glucose intolerance|3-Methylglutaconic aciduria type 1|Mitochondrial diseases|Leigh syndrome|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G	A	G	CLINICAL
m.3252A>G	MT-TL1		Normal	Mitochondrial encephalomyopathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009594	MT	3252	MT	3252	9594	24633	rs199474661	NC_012920.1:3251:A:G	A	G	CLINICAL
m.8344A>G	MT-TK		Normal	MERRF syndrome|Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial diseases|not provided|Leigh syndrome	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009579	MT	8344	MT	8344	9579	24618	rs118192098	NC_012920.1:8343:A:G	A	G	CLINICAL
NC_012920.1:m.8993T>G	MT-ATP6	L156R	Normal	Cerebellar ataxia|Leber hereditary optic neuropathy|NARP syndrome|Wide intermamillary distance|Scrotal hypoplasia|Premature birth|Bilateral cleft lip and palate|Camptodactyly of finger|Hypertelorism|Low-set ears|Postaxial hand polydactyly|Leigh syndrome|Rod-cone dystrophy|Mitochondrial diseases|not provided|Mitochondrial complex v (atp synthase) deficiency, mitochondrial type 1	Pathogenic(Last reviewed: Mar 22, 2021)	reviewed by expert panel	VCV000009641	MT	8993	MT	8993	9641	24680	rs199476133	NC_012920.1:8992:T:G	T	G	CLINICAL
NC_012920.1:m.3243A>G	MT-TL1		Normal	not provided|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Short stature|Sensorineural hearing loss|Stroke|Glucose intolerance|3-Methylglutaconic aciduria type 1|Mitochondrial diseases|Leigh syndrome|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G	A	G	CLINICAL
m.8344A>G	MT-TK		Normal	MERRF syndrome|Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|Mitochondrial diseases|not provided|Leigh syndrome	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009579	MT	8344	MT	8344	9579	24618	rs118192098	NC_012920.1:8343:A:G	A	G	CLINICAL
m.12848C>T	MT-ND5	A171V	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009704	MT	12848	MT	12848	9704	24743	rs267606899	NC_012920.1:12847:C:T	C	T	CLINICAL
m.14568C>T	MT-ND6	G36S	Normal	Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000065515	MT	14568	MT	14568	65515	76423	rs397515506	NC_012920.1:14567:C:T	C	T	CLINICAL
m.14596A>T	MT-ND6	I26M	Normal	Leber optic atrophy and dystonia|Leber hereditary optic neuropathy	Pathogenic(Last reviewed: Mar 3, 2021)	no assertion criteria provided	VCV000009690	MT	14596	MT	14596	9690	24729	rs387906424	NC_012920.1:14595:A:T	A	T	CLINICAL
NM_013444.3(UBQLN2):c.1490C>A (p.Pro497His)	UBQLN2	P497H	Normal	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029950	X	56591796	X	56565363	29950	38905	rs387906709	NC_000023.11:56565362:C:A	C	A	CLINICAL
NM_013444.3(UBQLN2):c.1516C>A (p.Pro506Thr)	UBQLN2	P506T	Normal	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029952	X	56591822	X	56565389	29952	38907	rs387906711	NC_000023.11:56565388:C:A	C	A	CLINICAL
NM_181332.3(NLGN4X):c.301C>T (p.Arg101Ter)	NLGN4X	R101*	Normal	Autism, susceptibility to, X-linked 2|not provided	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374392	X	6069207	X	6151166	374392	361250	rs756651509	NC_000023.11:6151165:G:A	G	A	CLINICAL
NM_000351.6(STS):c.287G>A (p.Trp96Ter)	STS	W96*, W91*, W103*	Normal	X-linked ichthyosis with steryl-sulfatase deficiency	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000625856	X	7175519	X	7257478	625856	614160	rs1463414987	NC_000023.11:7257477:G:A	G	A	CLINICAL
NM_173495.3(PTCHD1):c.893G>A (p.Trp298Ter)	PTCHD1	W298*	Normal	Autism, susceptibility to, X-linked 4	Likely pathogenic(Last reviewed: Apr 20, 2016)	criteria provided, single submitter	VCV000436440	X	23398249	X	23380132	436440	430767	rs1555912102	NC_000023.11:23380131:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.873C>A (p.Tyr291Ter)	DDX3X	Y291*, Y105*, Y275*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208548	X	41203500	X	41344247	208548	205065	rs869320681	NC_000023.11:41344246:C:A	C	A	CLINICAL
NM_001193417.3(DDX3X):c.856G>A (p.Gly286Ser)	DDX3X	G286S, G302S, G116S	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000225893	X	41203531	X	41344278	225893	227710	rs875989802	NC_000023.11:41344277:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.977G>A (p.Arg326His)	DDX3X	R326H, R310H, R140H	Normal	not provided|Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208547	X	41203604	X	41344351	208547	205064	rs797045025	NC_000023.11:41344350:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.1052G>A (p.Arg351Gln)	DDX3X	R351Q, R165Q, R335Q	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000374335	X	41204459	X	41345206	374335	361243	rs1057518707	NC_000023.11:41345205:G:A	G	A	CLINICAL
NM_001193416.3(DDX3X):c.1463G>A (p.Arg488His)	DDX3X	R488H, R472H, R302H	Normal	not provided|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207817	X	41205629	X	41346376	207817	204058	rs796052235	NC_000023.11:41346375:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.1486G>A (p.Val496Met)	DDX3X	V496M, V310M, V480M	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000548024	X	41205652	X	41346399	548024	538512	rs1555954154	NC_000023.11:41346398:G:A	G	A	CLINICAL
NM_006950.3(SYN1):c.1663C>T (p.Gln555Ter)	SYN1	Q555*	Normal	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	Pathogenic(Last reviewed: Jun 1, 2013)	no assertion criteria provided	VCV000041888	X	47433720	X	47574321	41888	50325	rs397514679	NC_000023.11:47574320:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.827+1G>T	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803997	X	48933022	X	49075363	803997	792467	rs1557083958	NC_000023.11:49075362:C:A	C	A	CLINICAL
NM_001029896.2(WDR45):c.697C>T (p.Arg233Ter)	WDR45	R234*, R233*	Normal	Neurodegeneration with brain iron accumulation 5|not provided|Inborn genetic diseases|Global developmental delay|Absent speech|Hypoplasia of the corpus callosum|Seizures|Delayed gross motor development|Delayed speech and language development	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041912	X	48933232	X	49075573	41912	51081	rs387907329	NC_000023.11:49075572:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.634C>T (p.Gln212Ter)	WDR45	Q213*, Q212*	Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000041915	X	48933295	X	49075636	41915	51084	rs387907332	NC_000023.11:49075635:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.516+1G>T	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jul 16, 2015)	criteria provided, single submitter	VCV000212593	X	48933524	X	49075865	212593	209076	rs797046102	NC_000023.11:49075864:C:A	C	A	CLINICAL
NM_001029896.2(WDR45):c.397C>T (p.Arg133Ter)	WDR45	R134*, R133*	Normal	not provided|Cerebral-cerebellar-coloboma syndrome, X-linked|Neurodegeneration with brain iron accumulation 5	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000212592	X	48934128	X	49076469	212592	209077	rs797046101	NC_000023.11:49076468:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.52C>T (p.Gln18Ter)	WDR45	Q18*	Normal	not provided|Neurodegeneration with brain iron accumulation 5	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620358	X	48935703	X	49078044	620358	611949	rs1569523562	NC_000023.11:49078043:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.19C>T (p.Arg7Ter)	WDR45	R7*	Normal	Inborn genetic diseases|Neurodegeneration with brain iron accumulation 5|Global developmental delay|not provided	Pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280098	X	48935736	X	49078077	280098	265026	rs886041382	NC_000023.11:49078076:G:A	G	A	CLINICAL
NM_018094.5(GSPT2):c.1021G>A (p.Val341Ile)	GSPT2	V341I	Normal	Autistic disorder of childhood onset|Seizures|Delayed speech and language development	Pathogenic	no assertion criteria provided	VCV000375379	X	51487743	X	51744647	375379	362170	rs1057519440	NC_000023.11:51744646:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2854C>T (p.Gln952Ter)	IQSEC2	Q952*, Q747*	Normal	Autistic disorder of childhood onset|Severe intellectual deficiency	Likely pathogenic	no assertion criteria provided	VCV000374231	X	53272549	X	53243367	374231	361154	rs1057518993	NC_000023.11:53243366:G:A	G	A	CLINICAL
NM_018486.3(HDAC8):c.490C>T (p.Arg164Ter)	HDAC8	R164*, R73*	Normal	not provided|Cornelia de Lange syndrome 5	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039710	X	71715066	X	72495216	39710	48309	rs397515415	NC_000023.11:72495215:G:A	G	A	CLINICAL
NM_153252.5(BRWD3):c.568C>T (p.Arg190Ter)	BRWD3	R190*	Normal	Mental retardation, X-linked 93	Pathogenic(Last reviewed: Feb 17, 2015)	no assertion criteria provided	VCV000374258	X	80001091	X	80745592	374258	361256	rs1057518650	NC_000023.11:80745591:G:A	G	A	CLINICAL
NM_016032.4(ZDHHC9):c.442C>T (p.Arg148Trp)	ZDHHC9	R148W	Normal	not provided|Mental retardation, X-linked, syndromic, Raymond type|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000010711	X	128957700	X	129823724	10711	25750	rs137852214	NC_000023.11:129823723:G:A	G	A	CLINICAL
NM_004484.3(GPC3):c.1471G>T (p.Glu491Ter)	GPC3	E491*, E437*, E514*, E475*	Normal	Wilms tumor 1	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000565351	X	132730570	X	133596542	565351	572199	rs1569392947	NC_000023.11:133596541:C:A	C	A	CLINICAL
NM_001164617.2(GPC3):c.1228C>T (p.Arg410Ter)	GPC3	R387*, R410*, R371*, R333*	Normal	Wilms tumor 1|not provided|Simpson-Golabi-Behmel syndrome type 1	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011694	X	132833930	X	133699902	11694	26733	rs122453121	NC_000023.11:133699901:G:A	G	A	CLINICAL
NM_004484.3(GPC3):c.595C>T (p.Arg199Ter)	GPC3	R199*, R145*, R183*	Normal	not provided|Wilms tumor 1|Simpson-Golabi-Behmel syndrome type 1	Pathogenic(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011689	X	132887946	X	133753919	11689	26728	rs104894855	NC_000023.11:133753918:G:A	G	A	CLINICAL
NM_004484.3(GPC3):c.361C>T (p.His121Tyr)	GPC3	H105Y, H121Y, H67Y	Normal	Wilms tumor 1	Pathogenic(Last reviewed: Jun 17, 2002)	no assertion criteria provided	VCV000011690	X	132888180	X	133754153	11690	26729	rs122453119	NC_000023.11:133754152:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.508-1G>A	SLC9A6		Normal	not provided|Christianson syndrome	Pathogenic(Last reviewed: Mar 2, 2021)	reviewed by expert panel	VCV000167702	X	135080640	X	135998481	167702	178080	rs797044508	NC_000023.11:135998480:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.803+1G>A	SLC9A6		Normal	not provided|Christianson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432837	X	135084373	X	136002214	432837	426407	rs1556617455	NC_000023.11:136002213:G:A	G	A	CLINICAL
NM_001042537.1(SLC9A6):c.1148G>A (p.Gly383Asp)	SLC9A6	G383D, G299D, G331D, G351D	Normal	Christianson syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000813744	X	135095508	X	136013349	813744	802043	rs782108464	NC_000023.11:136013348:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.1367-1G>A	SLC9A6		Normal	Christianson syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000625179	X	135106488	X	136024329	625179	613522	rs1603215383	NC_000023.11:136024328:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.1376G>A (p.Gly459Asp)	SLC9A6	G459D, G491D, G439D, G407D	Normal	Christianson syndrome	Likely pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000577815	X	135106498	X	136024339	577815	573553	rs1569525357	NC_000023.11:136024338:G:A	G	A	CLINICAL
NM_002024.6(FMR1):c.80C>A (p.Ser27Ter)	FMR1	S27*	Normal	Fragile X syndrome	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000029987	X	147003479	X	147921961	29987	38942	rs1569545382	NC_000023.11:147921960:C:A	C	A	CLINICAL
NM_002024.6(FMR1):c.911T>A (p.Ile304Asn)	FMR1	I304N	Normal	Fragile X syndrome	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000009969	X	147018053	X	147936534	9969	25008	rs121434622	NC_000023.11:147936533:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.1399G>T (p.Glu467Ter)	MECP2	E455*, E467*, E362*	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000011834	X	153295916	X	154030465	11834	26873	rs104894864	NC_000023.11:154030464:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.1393C>T (p.Arg465Ter)	MECP2	R453*, R465*, R360*	Normal	Intellectual disability|not provided|Rett syndrome	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143467	X	153295922	X	154030471	143467	153199	rs61753979	NC_000023.11:154030470:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1252C>T (p.Gln418Ter)	MECP2	Q406*, Q418*, Q313*	Normal	not provided|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143441	X	153296063	X	154030612	143441	153173	rs61753965	NC_000023.11:154030611:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1225G>T (p.Glu409Ter)	MECP2	E397*, E409*, E304*	Normal	Rett syndrome	Pathogenic(Last reviewed: Aug 24, 2010)	no assertion criteria provided	VCV000143425	X	153296090	X	154030639	143425	153157	rs56268439	NC_000023.11:154030638:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.1216G>T (p.Glu406Ter)	MECP2	E406*, E394*, E301*	Normal	Mental retardation, X-linked, syndromic 13|Rett syndrome	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	VCV000011817	X	153296099	X	154030648	11817	26856	rs63094662	NC_000023.11:154030647:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.1123A>T (p.Lys375Ter)	MECP2	K363*, K375*, K270*	Normal	Rett syndrome	Pathogenic(Last reviewed: Feb 3, 2006)	no assertion criteria provided	VCV000143326	X	153296192	X	154030741	143326	153058	rs61752375	NC_000023.11:154030740:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.1001C>T (p.Pro334Leu)	MECP2	P322L, P334L, P229L	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000143754	X	153296314	X	154030863	143754	153486	rs61751450	NC_000023.11:154030862:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1000C>T (p.Pro334Ser)	MECP2	P322S, P334S, P229S	Normal	Mental retardation, X-linked, syndromic 13|not provided|Rett syndrome	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000011843	X	153296315	X	154030864	11843	26882	rs61751449	NC_000023.11:154030863:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.961C>T (p.Arg321Trp)	MECP2	R309W, R321W, R216W	Normal	Rett syndrome|not provided|Autism, susceptibility to, X-linked 3|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143749	X	153296354	X	154030903	143749	153481	rs61751444	NC_000023.11:154030902:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.953G>T (p.Arg318Leu)	MECP2	R306L, R318L, R213L	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: May 13, 2021)	criteria provided, single submitter	VCV000143747	X	153296362	X	154030911	143747	153479	rs61751443	NC_000023.11:154030910:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.952C>T (p.Arg318Cys)	MECP2	R306C, R318C, R213C	Normal	Rett syndrome|none provided|Severe neonatal-onset encephalopathy with microcephaly|not provided|Intellectual disability|Angelman syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011824	X	153296363	X	154030912	11824	26863	rs28935468	NC_000023.11:154030911:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.941C>T (p.Pro314Leu)	MECP2	P302L, P314L, P209L	Normal	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143738	X	153296374	X	154030923	143738	153470	rs61749723	NC_000023.11:154030922:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.940C>T (p.Pro314Ser)	MECP2	P302S, P314S, P209S	Normal	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|none provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143735	X	153296375	X	154030924	143735	153467	rs61751373	NC_000023.11:154030923:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.925C>T (p.Gln309Ter)	MECP2	Q297*, Q309*, Q204*	Normal	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000143727	X	153296390	X	154030939	143727	153459	rs61751367	NC_000023.11:154030938:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.916C>T (p.Arg306Ter)	MECP2	R294*, R306*, R201*	Normal	Inborn genetic diseases|not provided|Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|See cases	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011819	X	153296399	X	154030948	11819	26858	rs61751362	NC_000023.11:154030947:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.901A>T (p.Lys301Ter)	MECP2	K289*, K301*, K196*	Normal	Rett syndrome	Pathogenic(Last reviewed: Feb 3, 2006)	no assertion criteria provided	VCV000143718	X	153296414	X	154030963	143718	153450	rs61750259	NC_000023.11:154030962:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.844C>T (p.Arg282Ter)	MECP2	R270*, R282*, R177*	Normal	Rett syndrome|Encephalopathy, neonatal severeMental retardation, X-linked, syndromic 13Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|not provided|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011815	X	153296471	X	154031020	11815	26854	rs61750240	NC_000023.11:154031019:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.835A>T (p.Lys279Ter)	MECP2	K267*, K279*, K174*	Normal	Rett syndrome	Pathogenic(Last reviewed: Nov 15, 2007)	no assertion criteria provided	VCV000143699	X	153296480	X	154031029	143699	153431	rs61750238	NC_000023.11:154031028:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.820C>T (p.Gln274Ter)	MECP2	Q262*, Q274*, Q169*	Normal	Rett syndrome	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	VCV000143696	X	153296495	X	154031044	143696	153428	rs267608525	NC_000023.11:154031043:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.802A>T (p.Lys268Ter)	MECP2	K256*, K268*, K163*	Normal	Rett syndrome	Pathogenic(Last reviewed: Dec 5, 2013)	no assertion criteria provided	VCV000189719	X	153296513	X	154031062	189719	187547	rs786205027	NC_000023.11:154031061:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.799C>T (p.Arg267Ter)	MECP2	R255*, R267*, R162*	Normal	Mental retardation, X-linked, syndromic 13|Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|none provided|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011829	X	153296516	X	154031065	11829	26868	rs61749721	NC_000023.11:154031064:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.766C>T (p.Gln256Ter)	MECP2	Q244*, Q256*, Q151*	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Nov 15, 2013)	criteria provided, multiple submitters, no conflicts	VCV000095200	X	153296549	X	154031098	95200	101100	rs61749747	NC_000023.11:154031097:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.710C>T (p.Pro237Leu)	MECP2	P225L, P237L, P132L	Normal	Mental retardation, X-linked, syndromic 13|Rett syndrome	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	VCV000011841	X	153296605	X	154031154	11841	26880	rs61749715	NC_000023.11:154031153:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.658C>T (p.Gln220Ter)	MECP2	Q208*, Q220*, Q115*	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000143641	X	153296657	X	154031206	143641	153373	rs61749729	NC_000023.11:154031205:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.649G>T (p.Glu217Ter)	MECP2	E205*, E217*, E112*	Normal	Rett syndrome	Pathogenic(Last reviewed: Sep 5, 2002)	no assertion criteria provided	VCV000143636	X	153296666	X	154031215	143636	153368	rs61749726	NC_000023.11:154031214:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.634A>T (p.Lys212Ter)	MECP2	K200*, K212*, K107*	Normal	Rett syndrome	Pathogenic(Last reviewed: Jun 17, 2004)	no assertion criteria provided	VCV000143631	X	153296681	X	154031230	143631	153363	rs61749718	NC_000023.11:154031229:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.628A>T (p.Arg210Ter)	MECP2	R198*, R210*, R105*	Normal	Rett syndrome	Pathogenic(Last reviewed: Jan 21, 2008)	no assertion criteria provided	VCV000143629	X	153296687	X	154031236	143629	153361	rs61749717	NC_000023.11:154031235:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.610A>T (p.Lys204Ter)	MECP2	K192*, K204*, K99*	Normal	Rett syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000036493	X	153296705	X	154031254	36493	45155	rs193922679	NC_000023.11:154031253:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.574A>T (p.Lys192Ter)	MECP2	K180*, K192*, K87*	Normal	Rett syndrome	Pathogenic(Last reviewed: Jan 21, 2008)	no assertion criteria provided	VCV000143615	X	153296741	X	154031290	143615	153347	rs267608495	NC_000023.11:154031289:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.544C>T (p.Gln182Ter)	MECP2	Q170*, Q182*, Q77*	Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000143604	X	153296771	X	154031320	143604	153336	rs61748425	NC_000023.11:154031319:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.541G>T (p.Glu181Ter)	MECP2	E169*, E181*, E76*	Normal	Rett syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804126	X	153296774	X	154031323	804126	792165	rs1603309480	NC_000023.11:154031322:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.538C>T (p.Arg180Ter)	MECP2	R168*, R180*, R75*	Normal	not provided|not specified|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder|Developmental regression|Global developmental delay|Intellectual disability	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011828	X	153296777	X	154031326	11828	26867	rs61748421	NC_000023.11:154031325:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)	MECP2	T158M, T170M, T65M	Normal	Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Angelman syndrome|Rett syndrome|not specified|History of neurodevelopmental disorder|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011811	X	153296806	X	154031355	11811	26850	rs28934906	NC_000023.11:154031354:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.502G>T (p.Asp168Tyr)	MECP2	D168Y, D156Y, D63Y	Normal	Rett syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804127	X	153296813	X	154031362	804127	792166	rs1603309620	NC_000023.11:154031361:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.487G>T (p.Asp163Tyr)	MECP2	D151Y, D163Y, D58Y	Normal	Rett syndrome|not provided	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000444834	X	153296828	X	154031377	444834	438474	rs1557137042	NC_000023.11:154031376:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.466A>T (p.Lys156Ter)	MECP2	K144*, K156*, K51*	Normal	Rett syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000143572	X	153296849	X	154031398	143572	153304	rs61748399	NC_000023.11:154031397:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.455C>T (p.Ala152Val)	MECP2	A140V, A152V, A47V	Normal	Autism, susceptibility to, X-linked 3|Rett syndrome|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Behavioral abnormality|Severe neonatal-onset encephalopathy with microcephaly|not provided|Intellectual disability|Stenosis of the external auditory canal|Micrognathia|Hearing impairment|Microcephaly|Downslanted palpebral fissures|Intellectual disability|Motor delay|Postnatal growth retardation|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011823	X	153296860	X	154031409	11823	26862	rs28934908	NC_000023.11:154031408:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.437C>T (p.Ser146Phe)	MECP2	S134F, S146F, S41F	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	VCV000143563	X	153296878	X	154031427	143563	153295	rs61748390	NC_000023.11:154031426:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.418C>T (p.Gln140Ter)	MECP2	Q128*, Q140*, Q35*	Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000143553	X	153296897	X	154031446	143553	153285	rs267608469	NC_000023.11:154031445:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.416C>T (p.Pro139Leu)	MECP2	P127L, P139L, P34L	Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000143552	X	153296899	X	154031448	143552	153284	rs267608387	NC_000023.11:154031447:G:A	G	A	CLINICAL
NM_004992.3(MECP2):c.378-2A>T	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Feb 18, 2008)	no assertion criteria provided	VCV000156067	X	153296903	X	154031452	156067	165863	rs267608464	NC_000023.11:154031451:T:A	T	A	CLINICAL
NM_004992.3(MECP2):c.377+1G>T	MECP2		Normal	not provided|Bruxism|Stereotypy|Delayed speech and language development|Delayed gross motor development|Rett syndrome	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000156053	X	153297657	X	154032206	156053	165849	rs267608463	NC_000023.11:154032205:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.408G>T (p.Leu136Phe)	MECP2	L124F, L136F, L31F	Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000143550	X	153297663	X	154032212	143550	153282	rs61755763	NC_000023.11:154032211:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.352C>T (p.Arg118Trp)	MECP2	R106W, R118W, R13W	Normal	not provided|Autism, susceptibility to, X-linked 3|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder|not specified	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011814	X	153297719	X	154032268	11814	26853	rs28934907	NC_000023.11:154032267:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.338C>T (p.Pro113Leu)	MECP2	P101L, P113L, P8L	Normal	Rett syndrome	Pathogenic(Last reviewed: Feb 3, 2006)	no assertion criteria provided	VCV000143527	X	153297733	X	154032282	143527	153259	rs61754453	NC_000023.11:154032281:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.337C>T (p.Pro113Ser)	MECP2	P101S, P113S, P8S	Normal	Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143524	X	153297734	X	154032283	143524	153256	rs61754452	NC_000023.11:154032282:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.310G>T (p.Gly104Ter)	MECP2	G104*, G92*	Normal	Rett syndrome	Pathogenic(Last reviewed: Dec 3, 2010)	no assertion criteria provided	VCV000143512	X	153297761	X	154032310	143512	153244	rs267608445	NC_000023.11:154032309:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.230C>T (p.Ser77Leu)	MECP2	S77L, S65L	Normal	Rett syndrome	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000816914	X	153297841	X	154032390	816914	805126	rs61754437	NC_000023.11:154032389:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.100A>T (p.Lys34Ter)	MECP2	K22*, K34*	Normal	Rett syndrome	Pathogenic(Last reviewed: Sep 5, 2002)	no assertion criteria provided	VCV000143647	X	153297971	X	154032520	143647	153379	rs62641234	NC_000023.11:154032519:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.91C>T (p.Gln31Ter)	MECP2	Q19*, Q31*	Normal	History of neurodevelopmental disorder|Rett syndrome	Pathogenic(Last reviewed: Jul 21, 2016)	criteria provided, single submitter	VCV000143620	X	153297980	X	154032529	143620	153352	rs61754425	NC_000023.11:154032528:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.64G>T (p.Glu22Ter)	MECP2	E10*, E22*	Normal	Rett syndrome	Pathogenic(Last reviewed: Jan 21, 2008)	no assertion criteria provided	VCV000143519	X	153298007	X	154032556	143519	153251	rs61754421	NC_000023.11:154032555:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.62+5395A>T	MECP2	M1L	Normal	Rett syndrome	Pathogenic	criteria provided, single submitter	VCV000192289	X	153357667	X	154092209	192289	190087	rs786205892	NC_000023.11:154092208:T:A	T	A	CLINICAL
NM_001110792.2(MECP2):c.48C>T (p.Gly16=)	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000189773	X	153363075	X	154097618	189773	187565	rs786205045	NC_000023.11:154097617:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.5C>T (p.Ala2Val)	MECP2	A2V	Normal	Rett syndrome	Likely pathogenic	criteria provided, single submitter	VCV000011845	X	153363118	X	154097661	11845	26884	rs179363901	NC_000023.11:154097660:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1A>T (p.Met1Leu)	MECP2	M1L	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, multiple submitters, no conflicts	VCV000156661	X	153363122	X	154097665	156661	166515	rs587783132	NC_000023.11:154097664:T:A	T	A	CLINICAL
NM_001303626.1(RPL10):c.*167C>A	RPL10	L206M, L170M	Normal	Autism, susceptibility to, X-linked 5	risk factor(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000029990	X	153629166	X	154400825	29990	38945	rs387906727	NC_000023.11:154400824:C:A	C	A	CLINICAL
NM_018196.4(TMLHE):c.1107G>T (p.Glu369Asp)	TMLHE|TMLHE-AS1	E369D	Normal	Autism, susceptibility to, X-linked 6	risk factor(Last reviewed: Oct 23, 2012)	no assertion criteria provided	VCV000225230	X	154722045	X	155492384	225230	227144	rs782001959	NC_000023.11:155492383:C:A	C	A	CLINICAL
NM_014009.4(FOXP3):c.398C>T (p.Pro133Leu)	FOXP3	P133L, P98L	Normal	Diabetes mellitus type 1	Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000268095	X	49113940	X	49257483	268095	263530	rs782511378	NC_000023.11:49257482:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.816G>A (p.Met272Ile)	AVPR2	M272I	Normal	Nephrogenic diabetes insipidus, X-linked	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804120	X	153171776	X	153906322	804120	792159	rs1603282342	NC_000023.11:153906321:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.137T>A (p.Ile46Lys)	AVPR2	I46K	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000010852	X	153171097	X	153905643	10852	25891	rs104894759	NC_000023.11:153905642:T:A	T	A	CLINICAL
NM_000054.6(AVPR2):c.253G>A (p.Asp85Asn)	AVPR2	D85N	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000010845	X	153171213	X	153905759	10845	25884	rs104894754	NC_000023.11:153905758:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.602G>A (p.Gly201Asp)	AVPR2	G201D	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Jun 1, 1997)	no assertion criteria provided	VCV000010846	X	153171562	X	153906108	10846	25885	rs104894755	NC_000023.11:153906107:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.410G>A (p.Arg137His)	AVPR2	R137H	Normal	Nephrogenic syndrome of inappropriate antidiuresis|Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 5, 2005)	no assertion criteria provided	VCV000010849	X	153171370	X	153905916	10849	25888	rs104894756	NC_000023.11:153905915:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.878G>A (p.Trp293Ter)	AVPR2	W293*	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 2016)	criteria provided, single submitter	VCV000424624	X	153171838	X	153906384	424624	411518	rs1064797077	NC_000023.11:153906383:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.213G>A (p.Trp71Ter)	AVPR2	W71*	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Sep 1, 1993)	no assertion criteria provided	VCV000010842	X	153171173	X	153905719	10842	25881	rs104894751	NC_000023.11:153905718:G:A	G	A	CLINICAL
NM_000054.6(AVPR2):c.395C>A (p.Ala132Asp)	AVPR2	A132D	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Sep 17, 1992)	no assertion criteria provided	VCV000010836	X	153171355	X	153905901	10836	25875	rs104894747	NC_000023.11:153905900:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.961C>T (p.Arg321Trp)	MECP2	R309W, R321W, R216W	Normal	Rett syndrome|not provided|Autism, susceptibility to, X-linked 3|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143749	X	153296354	X	154030903	143749	153481	rs61751444	NC_000023.11:154030902:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)	MECP2	T158M, T170M, T65M	Normal	Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Angelman syndrome|Rett syndrome|not specified|History of neurodevelopmental disorder|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011811	X	153296806	X	154031355	11811	26850	rs28934906	NC_000023.11:154031354:G:A	G	A	CLINICAL
NM_019597.5(HNRNPH2):c.617G>A (p.Arg206Gln)	HNRNPH2|RPL36A-HNRNPH2	R206Q	Normal	not provided|Mental retardation, X-linked, syndromic, Bain type	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225761	X	100667593	X	101412605	225761	227576	rs886039764	NC_000023.11:101412604:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.1555C>T (p.Arg519Ter)	PCDH19	R519*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000533844	X	99662041	X	100407043	533844	534418	rs1555985105	NC_000023.11:100407042:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.1342G>T (p.Asp448Tyr)	PCDH19	D448Y	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000576123	X	99662254	X	100407256	576123	572133	rs1569314809	NC_000023.11:100407255:C:A	C	A	CLINICAL
NM_001184880.2(PCDH19):c.1183C>T (p.Arg395Ter)	PCDH19	R395*	Normal	Early infantile epileptic encephalopathy 9|not provided	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533856	X	99662413	X	100407415	533856	534561	rs769967221	NC_000023.11:100407414:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.1114C>T (p.Arg372Trp)	PCDH19	R372W	Normal	not provided|Early infantile epileptic encephalopathy 9	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000206327	X	99662482	X	100407484	206327	203921	rs796052812	NC_000023.11:100407483:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.959A>T (p.Asp320Val)	PCDH19	D320V	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804057	X	99662637	X	100407639	804057	792094	rs1602636925	NC_000023.11:100407638:T:A	T	A	CLINICAL
NM_001184880.2(PCDH19):c.937G>T (p.Glu313Ter)	PCDH19	E313*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804058	X	99662659	X	100407661	804058	792095	rs1602636952	NC_000023.11:100407660:C:A	C	A	CLINICAL
NM_001184880.2(PCDH19):c.859G>T (p.Glu287Ter)	PCDH19	E287*	Normal	Early infantile epileptic encephalopathy 9|not provided	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447921	X	99662737	X	100407739	447921	442360	rs1555985427	NC_000023.11:100407738:C:A	C	A	CLINICAL
NM_001184880.2(PCDH19):c.814C>T (p.Gln272Ter)	PCDH19	Q272*	Normal	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000193191	X	99662782	X	100407784	193191	190356	rs794726897	NC_000023.11:100407783:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.707C>T (p.Pro236Leu)	PCDH19	P236L	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000626145	X	99662889	X	100407891	626145	614495	rs1060502176	NC_000023.11:100407890:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.695A>T (p.Asn232Ile)	PCDH19	N232I	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	VCV000159561	X	99662901	X	100407903	159561	169845	rs587784299	NC_000023.11:100407902:T:A	T	A	CLINICAL
NM_001184880.2(PCDH19):c.565G>T (p.Glu189Ter)	PCDH19	E189*	Normal	not provided|Early infantile epileptic encephalopathy 9	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000816990	X	99663031	X	100408033	816990	806145	rs1602637696	NC_000023.11:100408032:C:A	C	A	CLINICAL
NM_001184880.2(PCDH19):c.535A>T (p.Lys179Ter)	PCDH19	K179*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000649112	X	99663061	X	100408063	649112	649583	rs1602637774	NC_000023.11:100408062:T:A	T	A	CLINICAL
NM_001184880.2(PCDH19):c.490C>T (p.Gln164Ter)	PCDH19	Q164*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	VCV000211839	X	99663106	X	100408108	211839	208822	rs797045873	NC_000023.11:100408107:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.253C>T (p.Gln85Ter)	PCDH19	Q85*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011017	X	99663343	X	100408345	11017	26056	rs132630324	NC_000023.11:100408344:G:A	G	A	CLINICAL
NM_001184880.2(PCDH19):c.142G>T (p.Glu48Ter)	PCDH19	E48*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Dec 7, 2020)	no assertion criteria provided	VCV000011020	X	99663454	X	100408456	11020	26059	rs132630326	NC_000023.11:100408455:C:A	C	A	CLINICAL
NM_004085.4(TIMM8A):c.238C>T (p.Arg80Ter)	TIMM8A	R80*	Normal	Deafness dystonia syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011324	X	100601543	X	101346555	11324	26363	rs1054894	NC_000023.11:101346554:G:A	G	A	CLINICAL
NM_004085.4(TIMM8A):c.112C>T (p.Gln38Ter)	TIMM8A	Q38*	Normal	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 6, 2003)	no assertion criteria provided	VCV000021393	X	100603541	X	101348553	21393	34245	rs80356559	NC_000023.11:101348552:G:A	G	A	CLINICAL
NM_004085.4(TIMM8A):c.70G>T (p.Glu24Ter)	TIMM8A	E24*	Normal	Deafness dystonia syndrome	Pathogenic(Last reviewed: Apr 20, 2016)	no assertion criteria provided	VCV000011320	X	100603583	X	101348595	11320	26359	rs111033631	NC_000023.11:101348594:C:A	C	A	CLINICAL
NM_019597.5(HNRNPH2):c.617G>A (p.Arg206Gln)	HNRNPH2|RPL36A-HNRNPH2	R206Q	Normal	not provided|Mental retardation, X-linked, syndromic, Bain type	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225761	X	100667593	X	101412605	225761	227576	rs886039764	NC_000023.11:101412604:G:A	G	A	CLINICAL
NM_001830.4(CLCN4):c.232G>A (p.Gly78Ser)	CLCN4	G78S	Normal	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253114	X	10155642	X	10187602	253114	247526	rs1569226551	NC_000023.11:10187601:G:A	G	A	CLINICAL
NM_001830.4(CLCN4):c.1399G>A (p.Gly467Ser)	CLCN4	G467S, G373S	Normal	Mental retardation 49, X-linked	Likely pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000807385	X	10180516	X	10212476	807385	798777	rs1602159841	NC_000023.11:10212475:G:A	G	A	CLINICAL
NM_001830.4(CLCN4):c.1606G>A (p.Val536Met)	CLCN4	V536M, V442M	Normal	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253116	X	10181750	X	10213710	253116	247528	rs1569231897	NC_000023.11:10213709:G:A	G	A	CLINICAL
NM_001830.4(CLCN4):c.1630G>A (p.Gly544Arg)	CLCN4	G544R, G450R	Normal	not provided|Mental retardation 49, X-linked	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100781	X	10181774	X	10213734	100781	106646	rs587777161	NC_000023.11:10213733:G:A	G	A	CLINICAL
NM_000533.5(PLP1):c.3G>A (p.Met1Ile)	PLP1|RAB9B	M1I	Normal	Pelizaeus-Merzbacher disease, mild	Pathogenic(Last reviewed: Mar 1, 1996)	no assertion criteria provided	VCV000011087	X	103031926	X	103776998	11087	26126	rs132630290	NC_000023.11:103776997:G:A	G	A	CLINICAL
NM_000533.5(PLP1):c.434G>A (p.Trp145Ter)	PLP1|RAB9B	W145*, W90*	Normal	Hereditary spastic paraplegia 2|Pelizaeus-Merzbacher disease, atypical	Pathogenic(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000011090	X	103041636	X	103786707	11090	26129	rs132630292	NC_000023.11:103786706:G:A	G	A	CLINICAL
NM_001204402.1(PRPS1):c.-82-4197C>A	PRPS1	L129I	Normal	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009931	X	106884210	X	107640980	9931	24970	rs137852543	NC_000023.11:107640979:C:A	C	A	CLINICAL
NM_012216.4(MID2):c.1040G>A (p.Arg347Gln)	MID2|LOC101928335	R347Q	Normal	Mental retardation, X-linked 101	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	VCV000143857	X	107148823	X	107905593	143857	153582	rs587777605	NC_000023.11:107905592:G:A	G	A	CLINICAL
NM_012216.4(MID2):c.1558G>A (p.Gly520Ser)	MID2|LOC101928335	G520S, G490S	Normal	Mental retardation, X-linked 101	Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000800883	X	107167695	X	107924465	800883	788947	rs750972972	NC_000023.11:107924464:G:A	G	A	CLINICAL
NM_001318510.2(ACSL4):c.1001C>T (p.Pro334Leu)	ACSL4	P375L, P334L	Normal	Mental retardation 63, X-linked	Pathogenic(Last reviewed: Jan 1, 2003)	no assertion criteria provided	VCV000011566	X	108917632	X	109674403	11566	26605	rs122458139	NC_000023.11:109674402:G:A	G	A	CLINICAL
NM_015365.3(AMMECR1):c.502C>T (p.Arg168Ter)	AMMECR1	R45*, R168*	Normal	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	Pathogenic(Last reviewed: Jan 25, 2018)	no assertion criteria provided	VCV000375305	X	109507799	X	110264571	375305	362081	rs1057519338	NC_000023.11:110264570:G:A	G	A	CLINICAL
NM_002578.5(PAK3):c.1094C>A (p.Ala365Glu)	PAK3	A365E, A386E, A401E, A380E	Normal	Mental retardation 30, X-linked	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000011570	X	110437630	X	111194402	11570	26609	rs121434613	NC_000023.11:111194401:C:A	C	A	CLINICAL
NM_002578.5(PAK3):c.1112G>A (p.Cys371Tyr)	PAK3	C371Y, C386Y, C392Y, C407Y	Normal	Mental retardation 30, X-linked	Likely pathogenic(Last reviewed: Aug 27, 2019)	no assertion criteria provided	VCV000689610	X	110439071	X	111195843	689610	677288	rs1603377813	NC_000023.11:111195842:G:A	G	A	CLINICAL
NM_002578.5(PAK3):c.1270G>A (p.Gly424Arg)	PAK3	G424R, G445R, G460R, G439R	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000626256	X	110439731	X	111196503	626256	614550	rs1569459580	NC_000023.11:111196502:G:A	G	A	CLINICAL
NM_002578.5(PAK3):c.1282T>A (p.Trp428Arg)	PAK3	W428R, W443R, W449R, W464R	Normal	Mental retardation 30, X-linked	Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000633605	X	110439743	X	111196515	633605	622037	rs1603378331	NC_000023.11:111196514:T:A	T	A	CLINICAL
NM_001099922.3(ALG13):c.50T>A (p.Ile17Asn)	ALG13	I17N	Normal	Congenital disorder of glycosylation|Global developmental delay|Cortical visual impairment|Microcephaly|Infantile spasms|Osteopenia	Likely pathogenic	criteria provided, single submitter	VCV000598969	X	110924496	X	111681268	598969	590093	rs1569508922	NC_000023.11:111681267:T:A	T	A	CLINICAL
NM_078629.4(MSL3):c.1466+1G>A	MSL3		Normal	Basilicata-Akhtar syndrome	Likely pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000807631	X	11790825	X	11772706	807631	798801	rs1601774648	NC_000023.11:11772705:G:A	G	A	CLINICAL
NM_003336.4(UBE2A):c.32G>A (p.Arg11Gln)	UBE2A	R11Q	Normal	Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000029993	X	118708706	X	119574743	29993	38948	rs387906728	NC_000023.11:119574742:G:A	G	A	CLINICAL
NM_003336.4(UBE2A):c.67G>A (p.Gly23Arg)	UBE2A	G23R	Normal	Syndromic mental retardation, Nascimento type, X-linked|not provided	Pathogenic(Last reviewed: Feb 18, 2016)	criteria provided, single submitter	VCV000437188	X	118708886	X	119574923	437188	430634	rs1556235551	NC_000023.11:119574922:G:A	G	A	CLINICAL
NM_080632.2(UPF3B):c.1288C>T (p.Arg430Ter)	UPF3B	R430*, R417*	Normal	not provided|Mental retardation, syndromic 14, X-linked	Likely pathogenic(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000011400	X	118971734	X	119837771	11400	26439	rs122468181	NC_000023.11:119837770:G:A	G	A	CLINICAL
NM_013995.2(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Q174*	Normal	Danon disease	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000009981	X	119582861	X	120449006	9981	25020	rs104894857	NC_000023.11:120449005:G:A	G	A	CLINICAL
NM_003588.3(CUL4B):c.1906+1G>T	CUL4B		Normal	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000208796	X	119672514	X	120538659	208796	205357	rs797044862	NC_000023.11:120538658:C:A	C	A	CLINICAL
NM_003588.3(CUL4B):c.1714C>T (p.Arg572Cys)	CUL4B	R572C, R554C, R376C, R559C	Normal	Syndromic X-linked mental retardation, Cabezas type|not provided	Pathogenic(Last reviewed: Jan 8, 2021)	no assertion criteria provided	VCV000011338	X	119673204	X	120539349	11338	26377	rs121434615	NC_000023.11:120539348:G:A	G	A	CLINICAL
NM_001079872.2(CUL4B):c.1396C>T (p.Arg466Ter)	CUL4B	R288*, R484*, R466*, R471*	Normal	Syndromic X-linked mental retardation, Cabezas type	Likely pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666344	X	119675504	X	120541649	666344	653901	rs905353542	NC_000023.11:120541648:G:A	G	A	CLINICAL
NM_003588.3(CUL4B):c.1162C>T (p.Arg388Ter)	CUL4B	R388*, R192*, R370*, R375*	Normal	Syndromic X-linked mental retardation, Cabezas type|Intellectual disability|Global developmental delay|Abnormal facial shape|Seizures|Short stature	Pathogenic(Last reviewed: Nov 29, 2014)	criteria provided, single submitter	VCV000011339	X	119678034	X	120544179	11339	26378	rs121434616	NC_000023.11:120544178:G:A	G	A	CLINICAL
NM_003588.3(CUL4B):c.149C>T (p.Pro50Leu)	CUL4B	P50L, P32L, P37L	Normal	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000208797	X	119694399	X	120560544	208797	205358	rs869320682	NC_000023.11:120560543:G:A	G	A	CLINICAL
NM_007325.5(GRIA3):c.1891C>A (p.Arg631Ser)	GRIA3	R631S	Normal	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010357	X	122561805	X	123427954	10357	25396	rs137852351	NC_000023.11:123427953:C:A	C	A	CLINICAL
NM_007325.5(GRIA3):c.2497G>A (p.Gly833Arg)	GRIA3	G833R	Normal	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010356	X	122616707	X	123482856	10356	25395	rs137852350	NC_000023.11:123482855:G:A	G	A	CLINICAL
NM_001081550.2(THOC2):c.3559C>T (p.His1187Tyr)	THOC2	H1187Y	Normal	Mental retardation, X-linked 12	Likely pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488432	X	122757079	X	123623228	488432	481300	rs1556014935	NC_000023.11:123623227:G:A	G	A	CLINICAL
NM_001081550.2(THOC2):c.2087C>T (p.Thr696Ile)	THOC2	T696I	Normal	Mental retardation, X-linked 12|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488430	X	122767853	X	123634002	488430	481305	rs1556024875	NC_000023.11:123634001:G:A	G	A	CLINICAL
NM_001081550.2(THOC2):c.937C>T (p.Leu313Phe)	THOC2	L313F	Normal	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208524	X	122802090	X	123668239	208524	205042	rs797045019	NC_000023.11:123668238:G:A	G	A	CLINICAL
NM_016032.4(ZDHHC9):c.448C>T (p.Pro150Ser)	ZDHHC9	P150S	Normal	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010712	X	128957694	X	129823718	10712	25751	rs137852215	NC_000023.11:129823717:G:A	G	A	CLINICAL
NM_016032.4(ZDHHC9):c.442C>T (p.Arg148Trp)	ZDHHC9	R148W	Normal	not provided|Mental retardation, X-linked, syndromic, Raymond type|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000010711	X	128957700	X	129823724	10711	25750	rs137852214	NC_000023.11:129823723:G:A	G	A	CLINICAL
NM_016032.4(ZDHHC9):c.286C>T (p.Arg96Trp)	ZDHHC9	R96W	Normal	not provided|Mental retardation, X-linked, syndromic, Raymond type	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2020)	no assertion criteria provided	VCV000429192	X	128962999	X	129829023	429192	421144	rs1131690786	NC_000023.11:129829022:G:A	G	A	CLINICAL
NM_004208.4(AIFM1):c.1646C>T (p.Ala549Val)	AIFM1|RAB33A	A549V, A545V, A210V	Normal	Leukodystrophy|Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000373913	X	129264069	X	130130094	373913	361079	rs761953453	NC_000023.11:130130093:G:A	G	A	CLINICAL
NM_004208.4(AIFM1):c.1478A>T (p.Glu493Val)	AIFM1|RAB33A	E493V, E154V, E489V	Normal	Cowchock syndrome	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039601	X	129265745	X	130131770	39601	48200	rs281864468	NC_000023.11:130131769:T:A	T	A	CLINICAL
NM_004208.4(AIFM1):c.422C>T (p.Thr141Ile)	AIFM1|RAB33A	T141I, T137I	Normal	Cowchock syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000732674	X	129281779	X	130147804	732674	745482	rs1603227409	NC_000023.11:130147803:G:A	G	A	CLINICAL
NM_001015877.2(PHF6):c.65C>A (p.Ser22Ter)	PHF6	S22*	Normal	Borjeson-Forssman-Lehmann syndrome	Likely pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, single submitter	VCV000623207	X	133511712	X	134377682	623207	612169	rs1569334260	NC_000023.11:134377681:C:A	C	A	CLINICAL
NM_001015877.2(PHF6):c.134G>A (p.Cys45Tyr)	PHF6	C45Y	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011066	X	133511781	X	134377751	11066	26105	rs132630299	NC_000023.11:134377750:G:A	G	A	CLINICAL
NM_001015877.2(PHF6):c.255C>A (p.Cys85Ter)	PHF6	C85*	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242879	X	133527545	X	134393515	242879	244000	rs1114167289	NC_000023.11:134393514:C:A	C	A	CLINICAL
NM_001015877.2(PHF6):c.418G>A (p.Ala140Thr)	PHF6	A140T	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 15, 2015)	criteria provided, single submitter	VCV000218375	X	133527982	X	134393952	218375	215102	rs864309532	NC_000023.11:134393951:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.508-1G>A	SLC9A6		Normal	not provided|Christianson syndrome	Pathogenic(Last reviewed: Mar 2, 2021)	reviewed by expert panel	VCV000167702	X	135080640	X	135998481	167702	178080	rs797044508	NC_000023.11:135998480:G:A	G	A	CLINICAL
NM_001042537.1(SLC9A6):c.793+1G>A	SLC9A6		Normal	Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625212	X	135081128	X	135998969	625212	613551	rs1603198937	NC_000023.11:135998968:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.803+1G>A	SLC9A6		Normal	not provided|Christianson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432837	X	135084373	X	136002214	432837	426407	rs1556617455	NC_000023.11:136002213:G:A	G	A	CLINICAL
NM_001042537.1(SLC9A6):c.1148G>A (p.Gly383Asp)	SLC9A6	G383D, G299D, G331D, G351D	Normal	Christianson syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000813744	X	135095508	X	136013349	813744	802043	rs782108464	NC_000023.11:136013348:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.1367-1G>A	SLC9A6		Normal	Christianson syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000625179	X	135106488	X	136024329	625179	613522	rs1603215383	NC_000023.11:136024328:G:A	G	A	CLINICAL
NM_006359.3(SLC9A6):c.1376G>A (p.Gly459Asp)	SLC9A6	G459D, G491D, G439D, G407D	Normal	Christianson syndrome	Likely pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000577815	X	135106498	X	136024339	577815	573553	rs1569525357	NC_000023.11:136024338:G:A	G	A	CLINICAL
NM_002024.6(FMR1):c.80C>A (p.Ser27Ter)	FMR1	S27*	Normal	Fragile X syndrome	Pathogenic(Last reviewed: Apr 1, 2011)	no assertion criteria provided	VCV000029987	X	147003479	X	147921961	29987	38942	rs1569545382	NC_000023.11:147921960:C:A	C	A	CLINICAL
NM_002024.6(FMR1):c.911T>A (p.Ile304Asn)	FMR1	I304N	Normal	Fragile X syndrome	Pathogenic(Last reviewed: Oct 15, 2008)	no assertion criteria provided	VCV000009969	X	147018053	X	147936534	9969	25008	rs121434622	NC_000023.11:147936533:T:A	T	A	CLINICAL
NM_002024.5(FMR1):c.990+1G>A	FMR1		Normal	Intellectual disability	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000268183	X	147018133	X	147936614	268183	263803	rs886041089	NC_000023.11:147936613:G:A	G	A	CLINICAL
NM_000202.8(IDS):c.1006+1G>T	IDS|LOC106050102		Normal	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000221978	X	148571844	X	149490313	221978	223661	rs869025308	NC_000023.11:149490312:C:A	C	A	CLINICAL
NM_000202.8(IDS):c.1003C>T (p.His335Tyr)	IDS|LOC106050102	H335Y, H245Y	Normal	Mucopolysaccharidosis, MPS-II	Likely pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000221971	X	148571848	X	149490317	221971	223662	rs869025302	NC_000023.11:149490316:G:A	G	A	CLINICAL
NM_005629.4(SLC6A8):c.259G>A (p.Gly87Arg)	SLC6A8	G87R	Normal	Creatine transporter deficiency|not provided	Likely pathogenic(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV000011700	X	152954288	X	153688833	11700	26739	rs122453115	NC_000023.11:153688832:G:A	G	A	CLINICAL
NM_005629.4(SLC6A8):c.1396G>A (p.Gly466Arg)	SLC6A8	G466R, G351R, G456R	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804101	X	152959802	X	153694347	804101	792140	rs1603217473	NC_000023.11:153694346:G:A	G	A	CLINICAL
NM_005629.4(SLC6A8):c.1428C>A (p.Tyr476Ter)	SLC6A8	Y361*, Y466*, Y476*	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000663194	X	152959834	X	153694379	663194	649769	rs1239466041	NC_000023.11:153694378:C:A	C	A	CLINICAL
NM_005629.4(SLC6A8):c.1455G>A (p.Trp485Ter)	SLC6A8	W485*, W370*, W475*	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000579906	X	152959861	X	153694406	579906	572253	rs1569539443	NC_000023.11:153694405:G:A	G	A	CLINICAL
NM_005629.4(SLC6A8):c.1703C>A (p.Ser568Tyr)	SLC6A8	S453Y, S558Y, S568Y	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000666596	X	152960280	X	153694825	666596	654143	rs1603217815	NC_000023.11:153694824:C:A	C	A	CLINICAL
NM_000033.4(ABCD1):c.854G>A (p.Arg285His)	ABCD1	R285H	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625214	X	152991575	X	153726120	625214	613544	rs782635828	NC_000023.11:153726119:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.3581C>T (p.Ser1194Leu)	L1CAM	S1194L, S1185L, S1190L	Normal	not provided|Hydrops fetalis|Severe hydrocephalus|X-linked hydrocephalus syndrome|MASA syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009993	X	153128311	X	153862856	9993	25032	rs137852522	NC_000023.11:153862855:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.2974C>T (p.Gln992Ter)	L1CAM	Q992*, Q987*	Normal	not provided|Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction	Pathogenic(Last reviewed: Jan 5, 2017)	criteria provided, single submitter	VCV000010000	X	153130348	X	153864893	10000	25039	rs879253717	NC_000023.11:153864892:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.2380C>T (p.Gln794Ter)	L1CAM	Q794*, Q789*	Normal	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000226120	X	153132155	X	153866700	226120	227923	rs875989884	NC_000023.11:153866699:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.2278C>T (p.Arg760Ter)	L1CAM	R760*, R755*	Normal	Hydrocephalus due to aqueductal stenosis|X-linked hydrocephalus syndrome|Corpus callosum, partial agenesis of, X-linked|not provided	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000211339	X	153132257	X	153866802	211339	208929	rs797045673	NC_000023.11:153866801:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.1453C>T (p.Arg485Ter)	L1CAM	R485*, R480*	Normal	not provided|X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265223	X	153134109	X	153868654	265223	260289	rs886039407	NC_000023.11:153868653:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.1417C>T (p.Arg473Cys)	L1CAM	R473C, R468C	Normal	Spastic paraplegia|L1 syndrome|not provided	Pathogenic(Last reviewed: Jul 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000265224	X	153134145	X	153868690	265224	260290	rs886039408	NC_000023.11:153868689:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.1408C>T (p.Gln470Ter)	L1CAM	Q470*, Q465*	Normal	X-linked hydrocephalus syndrome|not provided	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418278	X	153134154	X	153868699	418278	411165	rs1064793163	NC_000023.11:153868698:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.924C>T (p.Gly308=)	L1CAM		Normal	X-linked hydrocephalus syndrome|not provided	Likely pathogenic(Last reviewed: Feb 10, 2015)	criteria provided, single submitter	VCV000198728	X	153135578	X	153870123	198728	195889	rs797044787	NC_000023.11:153870122:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.719C>T (p.Pro240Leu)	L1CAM	P240L, P235L	Normal	not provided|Congenital cerebellar hypoplasia|X-linked hydrocephalus syndrome|Corpus callosum, partial agenesis of, X-linked	Pathogenic(Last reviewed: Jan 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000010001	X	153135930	X	153870475	10001	25040	rs137852526	NC_000023.11:153870474:G:A	G	A	CLINICAL
NM_001278116.2(L1CAM):c.523+12C>T	L1CAM		Normal	not provided|L1 syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265222	X	153136500	X	153871045	265222	260292	rs886039406	NC_000023.11:153871044:G:A	G	A	CLINICAL
NM_005334.3(HCFC1):c.344C>T (p.Ala115Val)	HCFC1	A115V	Normal	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Jun 30, 2018)	criteria provided, single submitter	VCV000066984	X	153229734	X	153964283	66984	77869	rs397515485	NC_000023.11:153964282:G:A	G	A	CLINICAL
NM_005334.3(HCFC1):c.218C>T (p.Ala73Val)	HCFC1	A73V	Normal	not provided|Mental retardation 3, X-linked|Intellectual disability|Cobalamin C disease	Pathogenic(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066985	X	153230153	X	153964702	66985	77870	rs397515486	NC_000023.11:153964701:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1393C>T (p.Arg465Ter)	MECP2	R453*, R465*, R360*	Normal	Intellectual disability|not provided|Rett syndrome	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143467	X	153295922	X	154030471	143467	153199	rs61753979	NC_000023.11:154030470:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1252C>T (p.Gln418Ter)	MECP2	Q406*, Q418*, Q313*	Normal	not provided|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143441	X	153296063	X	154030612	143441	153173	rs61753965	NC_000023.11:154030611:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.1216G>T (p.Glu406Ter)	MECP2	E406*, E394*, E301*	Normal	Mental retardation, X-linked, syndromic 13|Rett syndrome	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	VCV000011817	X	153296099	X	154030648	11817	26856	rs63094662	NC_000023.11:154030647:C:A	C	A	CLINICAL
NM_001110792.2(MECP2):c.1000C>T (p.Pro334Ser)	MECP2	P322S, P334S, P229S	Normal	Mental retardation, X-linked, syndromic 13|not provided|Rett syndrome	Pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, single submitter	VCV000011843	X	153296315	X	154030864	11843	26882	rs61751449	NC_000023.11:154030863:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.961C>T (p.Arg321Trp)	MECP2	R309W, R321W, R216W	Normal	Rett syndrome|not provided|Autism, susceptibility to, X-linked 3|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143749	X	153296354	X	154030903	143749	153481	rs61751444	NC_000023.11:154030902:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.952C>T (p.Arg318Cys)	MECP2	R306C, R318C, R213C	Normal	Rett syndrome|none provided|Severe neonatal-onset encephalopathy with microcephaly|not provided|Intellectual disability|Angelman syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011824	X	153296363	X	154030912	11824	26863	rs28935468	NC_000023.11:154030911:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.916C>T (p.Arg306Ter)	MECP2	R294*, R306*, R201*	Normal	Inborn genetic diseases|not provided|Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|See cases	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011819	X	153296399	X	154030948	11819	26858	rs61751362	NC_000023.11:154030947:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.844C>T (p.Arg282Ter)	MECP2	R270*, R282*, R177*	Normal	Rett syndrome|Encephalopathy, neonatal severeMental retardation, X-linked, syndromic 13Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|not provided|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011815	X	153296471	X	154031020	11815	26854	rs61750240	NC_000023.11:154031019:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.799C>T (p.Arg267Ter)	MECP2	R255*, R267*, R162*	Normal	Mental retardation, X-linked, syndromic 13|Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|none provided|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011829	X	153296516	X	154031065	11829	26868	rs61749721	NC_000023.11:154031064:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.710C>T (p.Pro237Leu)	MECP2	P225L, P237L, P132L	Normal	Mental retardation, X-linked, syndromic 13|Rett syndrome	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	VCV000011841	X	153296605	X	154031154	11841	26880	rs61749715	NC_000023.11:154031153:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.538C>T (p.Arg180Ter)	MECP2	R168*, R180*, R75*	Normal	not provided|not specified|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder|Developmental regression|Global developmental delay|Intellectual disability	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011828	X	153296777	X	154031326	11828	26867	rs61748421	NC_000023.11:154031325:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)	MECP2	T158M, T170M, T65M	Normal	Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Angelman syndrome|Rett syndrome|not specified|History of neurodevelopmental disorder|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011811	X	153296806	X	154031355	11811	26850	rs28934906	NC_000023.11:154031354:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.455C>T (p.Ala152Val)	MECP2	A140V, A152V, A47V	Normal	Autism, susceptibility to, X-linked 3|Rett syndrome|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Behavioral abnormality|Severe neonatal-onset encephalopathy with microcephaly|not provided|Intellectual disability|Stenosis of the external auditory canal|Micrognathia|Hearing impairment|Microcephaly|Downslanted palpebral fissures|Intellectual disability|Motor delay|Postnatal growth retardation|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011823	X	153296860	X	154031409	11823	26862	rs28934908	NC_000023.11:154031408:G:A	G	A	CLINICAL
NM_001256577.2(RPL10):c.330-87G>A	RPL10	G161S, G125S	Normal	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000430613	X	153628956	X	154400615	430613	423404	rs1131692041	NC_000023.11:154400614:G:A	G	A	CLINICAL
NM_171998.4(RAB39B):c.559G>T (p.Glu187Ter)	RAB39B	E187*	Normal	Mental retardation, X-linked 72	Pathogenic(Last reviewed: May 10, 2016)	criteria provided, single submitter	VCV000436462	X	154490171	X	155260886	436462	430743	rs1557314191	NC_000023.11:155260885:C:A	C	A	CLINICAL
NM_018196.4(TMLHE):c.277C>T (p.Arg93Cys)	TMLHE	R93C	Normal	Congenital cerebellar hypoplasia|Corpus callosum, agenesis of|Cerebellar vermis hypoplasia	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632605	X	154754198	X	155524537	632605	621035	rs782785654	NC_000023.11:155524536:G:A	G	A	CLINICAL
NM_001272071.2(AP1S2):c.426+1G>T	AP1S2		Normal	Pettigrew syndrome	Pathogenic(Last reviewed: Sep 26, 2013)	criteria provided, single submitter	VCV000140457	X	15863501	X	15845378	140457	150141	rs587777542	NC_000023.11:15845377:C:A	C	A	CLINICAL
NM_001272071.2(AP1S2):c.226G>T (p.Glu76Ter)	AP1S2	Q66*, E76*	Normal	Pettigrew syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000010781	X	15864088	X	15845965	10781	25820	rs137852213	NC_000023.11:15845964:C:A	C	A	CLINICAL
NM_001272071.2(AP1S2):c.154C>T (p.Arg52Ter)	AP1S2	R52*	Normal	not provided|Pettigrew syndrome	Pathogenic(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000010778	X	15870494	X	15852371	10778	25817	rs104894735	NC_000023.11:15852370:G:A	G	A	CLINICAL
NM_001272071.2(AP1S2):c.106C>T (p.Gln36Ter)	AP1S2	Q36*	Normal	Pettigrew syndrome	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000010777	X	15870542	X	15852419	10777	25816	rs104894739	NC_000023.11:15852418:G:A	G	A	CLINICAL
NM_001037343.1(CDKL5):c.2810G>A (p.Cys937Tyr)	RS1|CDKL5	C937Y	Normal	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000620063	X	18668542	X	18650422	620063	611443	rs1569231336	NC_000023.11:18650421:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.2185C>T (p.Arg729Trp)	RPS6KA3	R729W	Normal	Coffin-Lowry syndrome|Mental retardation, X-linked 19	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000547768	X	20173554	X	20155436	547768	538304	rs1555924331	NC_000023.11:20155435:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.2065C>T (p.Gln689Ter)	RPS6KA3	Q689*	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jan 1, 1999)	no assertion criteria provided	VCV000011657	X	20174262	X	20156144	11657	26696	rs122454128	NC_000023.11:20156143:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.1996C>T (p.Gln666Ter)	RPS6KA3	Q666*	Normal	Mental retardation, X-linked 19|Coffin-Lowry syndrome|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000652883	X	20174331	X	20156213	652883	649929	rs1603417440	NC_000023.11:20156212:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.1894C>T (p.Arg632Ter)	RPS6KA3	R632*	Normal	not provided|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000426465	X	20179827	X	20161709	426465	415762	rs1085307639	NC_000023.11:20161708:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.1522C>T (p.Gln508Ter)	RPS6KA3	Q508*	Normal	Thick vermilion border|Global developmental delay|Macrocephalus|Motor delay|Dolichocephaly|Delayed speech and language development|Muscular hypotonia	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523475	X	20185787	X	20167669	523475	514129	rs1555928716	NC_000023.11:20167668:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.1147C>T (p.Arg383Trp)	RPS6KA3	R383W	Normal	Mental retardation, X-linked 19	Pathogenic(Last reviewed: May 1, 1999)	no assertion criteria provided	VCV000011659	X	20193362	X	20175244	11659	26698	rs122454129	NC_000023.11:20175243:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.727C>T (p.Arg243Ter)	RPS6KA3	R243*	Normal	Mental retardation, X-linked 19|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000651889	X	20205993	X	20187875	651889	649930	rs1603425345	NC_000023.11:20187874:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.629C>T (p.Thr210Ile)	RPS6KA3	T210I	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000559935	X	20206617	X	20188499	559935	550654	rs1325953089	NC_000023.11:20188498:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.343A>T (p.Thr115Ser)	RPS6KA3	T115S	Normal	Mental retardation, X-linked 19	Pathogenic(Last reviewed: Dec 1, 2006)	no assertion criteria provided	VCV000029932	X	20213246	X	20195128	29932	38887	rs387906703	NC_000023.11:20195127:T:A	T	A	CLINICAL
NM_004586.3(RPS6KA3):c.340C>T (p.Arg114Trp)	RPS6KA3	R114W	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000011655	X	20213249	X	20195131	11655	26694	rs122454127	NC_000023.11:20195130:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.334C>T (p.Arg112Ter)	RPS6KA3	R112*	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547762	X	20213255	X	20195137	547762	538310	rs1555943479	NC_000023.11:20195136:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.328C>T (p.Arg110Ter)	RPS6KA3	R110*	Normal	Intellectual disability|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000547761	X	20213261	X	20195143	547761	538311	rs1555943484	NC_000023.11:20195142:G:A	G	A	CLINICAL
NM_004586.3(RPS6KA3):c.244G>T (p.Val82Phe)	RPS6KA3	V82F	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 1998)	no assertion criteria provided	VCV000011653	X	20222221	X	20204103	11653	26692	rs122454126	NC_000023.11:20204102:C:A	C	A	CLINICAL
NM_004586.3(RPS6KA3):c.224G>T (p.Gly75Val)	RPS6KA3	G75V	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 12, 1996)	no assertion criteria provided	VCV000011651	X	20227425	X	20209307	11651	26690	rs122454124	NC_000023.11:20209306:C:A	C	A	CLINICAL
NM_014927.5(CNKSR2):c.1734G>A (p.Trp578Ter)	CNKSR2	W578*, W499*, W529*, W548*	Normal	Intellectual disability, X-linked, syndromic, Houge type	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634608	X	21609216	X	21591098	634608	622491	rs1569261319	NC_000023.11:21591097:G:A	G	A	CLINICAL
NM_004595.5(SMS):c.166G>A (p.Gly56Ser)	SMS	G56S	Normal	Inborn genetic diseases|Syndromic X-linked intellectual disability Snyder type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 30, 2015)	criteria provided, multiple submitters, no conflicts	VCV000011624	X	21985430	X	21967312	11624	26663	rs121434610	NC_000023.11:21967311:G:A	G	A	CLINICAL
NM_004595.5(SMS):c.174T>A (p.Phe58Leu)	SMS	F58L	Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jan 30, 2020)	no assertion criteria provided	VCV000065676	X	21990018	X	21971900	65676	76584	rs397515549	NC_000023.11:21971899:T:A	T	A	CLINICAL
NM_004595.5(SMS):c.200G>A (p.Gly67Glu)	SMS	G67E	Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Sep 1, 2013)	no assertion criteria provided	VCV000065677	X	21990044	X	21971926	65677	76585	rs397515550	NC_000023.11:21971925:G:A	G	A	CLINICAL
NM_004595.5(SMS):c.329+5G>A	SMS		Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000011623	X	21990694	X	21972576	11623	26662	rs397515381	NC_000023.11:21972575:G:A	G	A	CLINICAL
NM_001330360.2(POLA1):c.346G>A (p.Gly116Arg)	POLA1	G110R, G116R	Normal	Van Esch-O'Driscoll syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627636	X	24722586	X	24704469	627636	615988	rs1569271892	NC_000023.11:24704468:G:A	G	A	CLINICAL
NM_001330360.2(POLA1):c.525+1G>A	POLA1		Normal	Van Esch-O'Driscoll syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627634	X	24733321	X	24715204	627634	615991	rs1569277899	NC_000023.11:24715203:G:A	G	A	CLINICAL
NM_001330360.2(POLA1):c.1207G>A (p.Asp403Asn)	POLA1	D397N, D403N	Normal	Van Esch-O'Driscoll syndrome	Likely pathogenic(Last reviewed: Jan 16, 2020)	no assertion criteria provided	VCV000807658	X	24742458	X	24724341	807658	798812	rs774419889	NC_000023.11:24724340:G:A	G	A	CLINICAL
NM_139058.3(ARX):c.1058C>T (p.Pro353Leu)	ARX	P353L	Normal	Epileptic encephalopathy, early infantile, 1	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000011188	X	25031054	X	25012937	11188	26227	rs104894743	NC_000023.11:25012936:G:A	G	A	CLINICAL
NM_139058.3(ARX):c.232G>T (p.Glu78Ter)	ARX	E78*	Normal	Lissencephaly 2, X-linked	Pathogenic(Last reviewed: Feb 1, 2004)	no assertion criteria provided	VCV000011205	X	25031880	X	25013763	11205	26244	rs267606666	NC_000023.11:25013762:C:A	C	A	CLINICAL
NM_014271.4(IL1RAPL1):c.1377C>A (p.Tyr459Ter)	IL1RAPL1	Y459*	Normal	Intellectual disability, X-linked 21	Pathogenic(Last reviewed: Sep 1, 1999)	no assertion criteria provided	VCV000011480	X	29973223	X	29955106	11480	26519	rs122461160	NC_000023.11:29955105:C:A	C	A	CLINICAL
NM_014271.4(IL1RAPL1):c.1460G>A (p.Trp487Ter)	IL1RAPL1	W487*	Normal	Intellectual disability, X-linked 21	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000011481	X	29973306	X	29955189	11481	26520	rs122461161	NC_000023.11:29955188:G:A	G	A	CLINICAL
NM_001123385.2(BCOR):c.254C>T (p.Pro85Leu)	BCOR	P85L	Normal	Oculofaciocardiodental syndrome|not provided	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000010911	X	39934345	X	40075092	10911	25950	rs121434618	NC_000023.11:40075091:G:A	G	A	CLINICAL
NM_005765.3(ATP6AP2):c.168+6T>A	ATP6AP2		Normal	Mental retardation, X-linked, syndromic, Hedera type	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000375269	X	40448374	X	40589122	375269	362040	rs1057519331	NC_000023.11:40589121:T:A	T	A	CLINICAL
NM_001039591.3(USP9X):c.6278T>A (p.Leu2093His)	USP9X	L2093H	Normal	Mental retardation, X-linked 99	Pathogenic(Last reviewed: Mar 6, 2014)	no assertion criteria provided	VCV000127090	X	41077693	X	41218440	127090	132600	rs587777317	NC_000023.11:41218439:T:A	T	A	CLINICAL
NM_001356.4(DDX3X):c.873C>A (p.Tyr291Ter)	DDX3X	Y291*, Y105*, Y275*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208548	X	41203500	X	41344247	208548	205065	rs869320681	NC_000023.11:41344246:C:A	C	A	CLINICAL
NM_001193417.3(DDX3X):c.856G>A (p.Gly286Ser)	DDX3X	G286S, G302S, G116S	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000225893	X	41203531	X	41344278	225893	227710	rs875989802	NC_000023.11:41344277:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.977G>A (p.Arg326His)	DDX3X	R326H, R310H, R140H	Normal	not provided|Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208547	X	41203604	X	41344351	208547	205064	rs797045025	NC_000023.11:41344350:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.1052G>A (p.Arg351Gln)	DDX3X	R351Q, R165Q, R335Q	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000374335	X	41204459	X	41345206	374335	361243	rs1057518707	NC_000023.11:41345205:G:A	G	A	CLINICAL
NM_001193416.3(DDX3X):c.1463G>A (p.Arg488His)	DDX3X	R488H, R472H, R302H	Normal	not provided|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000207817	X	41205629	X	41346376	207817	204058	rs796052235	NC_000023.11:41346375:G:A	G	A	CLINICAL
NM_001356.4(DDX3X):c.1486G>A (p.Val496Met)	DDX3X	V496M, V310M, V480M	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000548024	X	41205652	X	41346399	548024	538512	rs1555954154	NC_000023.11:41346398:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.2604+1G>T	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000433537	X	41383203	X	41523950	433537	427111	rs1555972599	NC_000023.11:41523949:C:A	C	A	CLINICAL
NM_001367721.1(CASK):c.2485C>T (p.Gln829Ter)	CASK	Q824*, Q800*, Q829*, Q801*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158074	X	41390295	X	41531042	158074	167921	rs587783364	NC_000023.11:41531041:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.2392C>T (p.Gln798Ter)	CASK	Q793*, Q798*, Q769*, Q770*	Normal	Deficiency of butyrylcholine esterase|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jul 23, 2015)	criteria provided, single submitter	VCV000210585	X	41390388	X	41531135	210585	209042	rs749742837	NC_000023.11:41531134:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.2074C>T (p.Gln692Ter)	CASK	Q692*, Q663*, Q669*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158070	X	41402025	X	41542772	158070	167917	rs587783361	NC_000023.11:41542771:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.2041C>T (p.Arg681Ter)	CASK	R681*, R658*, R652*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000158069	X	41402058	X	41542805	158069	167916	rs587783360	NC_000023.11:41542804:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.1915C>T (p.Arg639Ter)	CASK	R639*, R610*, R616*	Normal	not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jul 7, 2016)	criteria provided, single submitter	VCV000011530	X	41413096	X	41553843	11530	26569	rs137852815	NC_000023.11:41553842:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.1864G>T (p.Glu622Ter)	CASK	E622*, E593*, E599*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000434587	X	41413147	X	41553894	434587	430788	rs1555980033	NC_000023.11:41553893:C:A	C	A	CLINICAL
NM_001367721.1(CASK):c.1837C>T (p.Arg613Ter)	CASK	R613*, R584*, R590*	Normal	not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000418109	X	41414858	X	41555605	418109	411363	rs779508996	NC_000023.11:41555604:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.1639C>T (p.Gln547Ter)	CASK	Q547*, Q541*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000029941	X	41420841	X	41561588	29941	38896	rs387906705	NC_000023.11:41561587:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.1609C>T (p.Arg537Ter)	CASK	R537*, R531*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503609	X	41420871	X	41561618	503609	495820	rs1555981717	NC_000023.11:41561617:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.1465C>T (p.Arg489Trp)	CASK	R489W, R483W	Normal	Smith-Magenis Syndrome-like|Mental retardation and microcephaly with pontine and cerebellar hypoplasia|CASK-Related Disorder	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254208	X	41437631	X	41578378	254208	248723	rs1114167352	NC_000023.11:41578377:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.880C>T (p.Gln294Ter)	CASK	Q294*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158087	X	41495866	X	41636613	158087	167938	rs587783371	NC_000023.11:41636612:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.430-2A>T	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158077	X	41530785	X	41671532	158077	167924	rs587783366	NC_000023.11:41671531:T:A	T	A	CLINICAL
NM_001367721.1(CASK):c.316C>T (p.Arg106Ter)	CASK	R106*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029939	X	41604817	X	41745564	29939	38894	rs387906704	NC_000023.11:41745563:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.109C>T (p.Gln37Ter)	CASK	Q37*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000446288	X	41712431	X	41853178	446288	439694	rs1556254569	NC_000023.11:41853177:G:A	G	A	CLINICAL
NM_001367721.1(CASK):c.83G>T (p.Arg28Leu)	CASK	R28L	Normal	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|FG syndrome 4	Pathogenic(Last reviewed: Feb 1, 2009)	no assertion criteria provided	VCV000011532	X	41712457	X	41853204	11532	26571	rs137852816	NC_000023.11:41853203:C:A	C	A	CLINICAL
NM_001367721.1(CASK):c.79C>T (p.Arg27Ter)	CASK	R27*	Normal	Congenital cerebellar hypoplasia|not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000195200	X	41712461	X	41853208	195200	192361	rs794727270	NC_000023.11:41853207:G:A	G	A	CLINICAL
NM_000266.4(NDP):c.302C>T (p.Ser101Phe)	NDP|NDP-AS1	S101F	Normal	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000010699	X	43809145	X	43949899	10699	25738	rs104894883	NC_000023.11:43949898:G:A	G	A	CLINICAL
NM_001257291.2(SLC9A7):c.1543C>T (p.Leu515Phe)	SLC9A7	L514F, L515F	Normal	Intellectual developmental disorder, X-linked 108|not provided|SLC9A7-related neurodevelopmental disorder	Likely pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548948	X	46502744	X	46643309	548948	539431	rs1569507511	NC_000023.11:46643308:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.697C>T (p.Arg233Ter)	WDR45	R234*, R233*	Normal	Neurodegeneration with brain iron accumulation 5|not provided|Inborn genetic diseases|Global developmental delay|Absent speech|Hypoplasia of the corpus callosum|Seizures|Delayed gross motor development|Delayed speech and language development	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041912	X	48933232	X	49075573	41912	51081	rs387907329	NC_000023.11:49075572:G:A	G	A	CLINICAL
NM_001029896.2(WDR45):c.19C>T (p.Arg7Ter)	WDR45	R7*	Normal	Inborn genetic diseases|Neurodegeneration with brain iron accumulation 5|Global developmental delay|not provided	Pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280098	X	48935736	X	49078077	280098	265026	rs886041382	NC_000023.11:49078076:G:A	G	A	CLINICAL
NM_020717.3(SHROOM4):c.3266C>T (p.Ser1089Leu)	SHROOM4	S1089L	Normal	Stocco dos Santos syndrome	Pathogenic(Last reviewed: Jan 1, 2006)	no assertion criteria provided	VCV000010795	X	50350876	X	50607876	10795	25834	rs121434620	NC_000023.11:50607875:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.3118C>T (p.Gln1040Ter)	KDM5C	Q1040*, Q1039*, Q973*	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Sep 11, 2014)	criteria provided, single submitter	VCV000211249	X	53225100	X	53195918	211249	209093	rs782246658	NC_000023.11:53195917:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.2482C>T (p.Arg828Ter)	KDM5C	R828*, R761*, R827*	Normal	not provided|Inborn genetic diseases|Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000431128	X	53227706	X	53198524	431128	424677	rs1135401800	NC_000023.11:53198523:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.2296C>T (p.Arg766Trp)	KDM5C	R766W, R699W, R765W	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000009777	X	53228018	X	53198836	9777	24816	rs199422238	NC_000023.11:53198835:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.2191C>T (p.Leu731Phe)	KDM5C	L731F, L730F, L664F	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000009772	X	53228211	X	53199029	9772	24811	rs199422234	NC_000023.11:53199028:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.2080C>T (p.Arg694Ter)	KDM5C	R694*, R693*, R627*	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000009775	X	53228322	X	53199140	9775	24814	rs199422236	NC_000023.11:53199139:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.1866G>T (p.Trp622Cys)	KDM5C	W555C, W622C, W621C	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000666339	X	53231036	X	53201854	666339	653905	rs1602183619	NC_000023.11:53201853:C:A	C	A	CLINICAL
NM_004187.5(KDM5C):c.1795C>T (p.Arg599Cys)	KDM5C	R599C, R598C, R532C	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000559937	X	53231107	X	53201925	559937	550656	rs1556842184	NC_000023.11:53201924:G:A	G	A	CLINICAL
NM_004187.4(KDM5C):c.1747G>T (p.Val583Phe)	KDM5C	V516F, V582F, V583F	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000691272	X	53231155	X	53201973	691272	678951	rs1602183890	NC_000023.11:53201972:C:A	C	A	CLINICAL
NM_004187.5(KDM5C):c.1613C>T (p.Pro538Leu)	KDM5C	P538L, P537L, P471L	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Oct 31, 2014)	criteria provided, single submitter	VCV000129374	X	53239729	X	53210547	129374	134820	rs587780372	NC_000023.11:53210546:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.1439C>T (p.Pro480Leu)	KDM5C	P480L, P413L, P479L	Normal	Spastic paraplegia|Mental retardation, syndromic, Claes-Jensen type, X-linked|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374324	X	53240002	X	53210820	374324	361245	rs1057518697	NC_000023.11:53210819:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.709C>T (p.Gln237Ter)	KDM5C	Q237*, Q236*, Q170*	Normal	Intellectual disability	Likely pathogenic	no assertion criteria provided	VCV000813008	X	53245328	X	53216146	813008	801229	rs1602226289	NC_000023.11:53216145:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.595C>T (p.Gln199Ter)	KDM5C	Q199*, Q132*, Q198*	Normal	not provided|Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000520414	X	53246387	X	53217205	520414	511020	rs1556852362	NC_000023.11:53217204:G:A	G	A	CLINICAL
NM_004187.5(KDM5C):c.156G>T (p.Trp52Cys)	KDM5C	W52C	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic	no assertion criteria provided	VCV000254174	X	53250093	X	53220911	254174	248653	rs886037836	NC_000023.11:53220910:C:A	C	A	CLINICAL
NM_001111125.3(IQSEC2):c.3817C>T (p.Gln1273Ter)	IQSEC2	Q1273*	Normal	Mental retardation, X-linked 1	Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000599452	X	53264051	X	53234869	599452	590810	rs1569291699	NC_000023.11:53234868:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.3097C>T (p.Gln1033Ter)	IQSEC2	Q1033*, Q828*	Normal	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235847	X	53268395	X	53239213	235847	237510	rs878853144	NC_000023.11:53239212:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2983C>T (p.Arg995Trp)	IQSEC2	R995W, R790W	Normal	Mental retardation, X-linked 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000383534	X	53270998	X	53241816	383534	380077	rs1057521657	NC_000023.11:53241815:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2911C>T (p.Arg971Ter)	IQSEC2	R971*, R766*	Normal	Mental retardation, X-linked 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000430286	X	53271070	X	53241888	430286	422494	rs1131691887	NC_000023.11:53241887:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2854C>T (p.Gln952Ter)	IQSEC2	Q952*, Q747*	Normal	Autistic disorder of childhood onset|Severe intellectual deficiency	Likely pathogenic	no assertion criteria provided	VCV000374231	X	53272549	X	53243367	374231	361154	rs1057518993	NC_000023.11:53243366:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2776C>T (p.Arg926Ter)	IQSEC2	R926*, R721*	Normal	not provided|Mental retardation, X-linked 1	Pathogenic(Last reviewed: Dec 21, 2016)	criteria provided, multiple submitters, no conflicts	VCV000380487	X	53272627	X	53243445	380487	379449	rs1057520858	NC_000023.11:53243444:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2563C>T (p.Arg855Ter)	IQSEC2	R855*, R650*	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000126417	X	53277315	X	53248133	126417	131949	rs587777261	NC_000023.11:53248132:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2507C>T (p.Ala836Val)	IQSEC2	A836V, A631V	Normal	Mental retardation, X-linked 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377978	X	53277371	X	53248189	377978	378457	rs782099475	NC_000023.11:53248188:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2366C>T (p.Ala789Val)	IQSEC2	A789V, A584V	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000225865	X	53277996	X	53248814	225865	227679	rs875989799	NC_000023.11:53248813:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.2272C>T (p.Arg758Ter)	IQSEC2	R758*, R553*	Normal	not provided|Mental retardation, X-linked 1	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280180	X	53279486	X	53250304	280180	265167	rs886041433	NC_000023.11:53250303:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.1591C>T (p.Arg531Ter)	IQSEC2	R531*, R326*	Normal	not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000637967	X	53280167	X	53250985	637967	625829	rs1602284689	NC_000023.11:53250984:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.1579C>T (p.Gln527Ter)	IQSEC2	Q527*, Q322*	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000574377	X	53280179	X	53250997	574377	573922	rs1569302816	NC_000023.11:53250996:G:A	G	A	CLINICAL
NM_001111125.3(IQSEC2):c.1186G>T (p.Glu396Ter)	IQSEC2	E396*, E191*	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000639042	X	53283927	X	53254745	639042	650119	rs1602291658	NC_000023.11:53254744:C:A	C	A	CLINICAL
NM_001111125.3(IQSEC2):c.1075C>T (p.Arg359Cys)	IQSEC2	R359C, R154C	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000010865	X	53284038	X	53254856	10865	25904	rs267607188	NC_000023.11:53254855:G:A	G	A	CLINICAL
NM_001281463.1(SMC1A):c.55C>T (p.Leu19Phe)	SMC1A	L41F, L19F	Normal	Wiedemann-Steiner syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180200	X	53442107	X	53415158	180200	178386	rs727503776	NC_000023.11:53415157:G:A	G	A	CLINICAL
NM_001037811.2(HSD17B10):c.388C>T (p.Arg130Cys)	HSD17B10	R130C	Normal	not provided|HSD10 disease	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011442	X	53459034	X	53432086	11442	26481	rs28935475	NC_000023.11:53432085:G:A	G	A	CLINICAL
NM_031407.7(HUWE1):c.12559C>T (p.Arg4187Cys)	HUWE1	R4187C	Normal	not provided|Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000010678	X	53562435	X	53535474	10678	25717	rs121918527	NC_000023.11:53535473:G:A	G	A	CLINICAL
NM_031407.7(HUWE1):c.12205A>T (p.Ile4069Phe)	HUWE1	I4069F	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375719	X	53563561	X	53536600	375719	362605	rs1556913268	NC_000023.11:53536599:T:A	T	A	CLINICAL
NM_031407.7(HUWE1):c.9208C>T (p.Arg3070Cys)	HUWE1	R3070C	Normal	Intellectual disability|Syndromic X-linked intellectual disability Turner type|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280723	X	53578039	X	53551078	280723	265043	rs886041876	NC_000023.11:53551077:G:A	G	A	CLINICAL
NM_031407.7(HUWE1):c.4013C>T (p.Ala1338Val)	HUWE1	A1338V	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: May 28, 2013)	criteria provided, single submitter	VCV000216942	X	53618042	X	53591082	216942	213670	rs863224879	NC_000023.11:53591081:G:A	G	A	CLINICAL
NM_031407.7(HUWE1):c.344C>T (p.Ser115Phe)	HUWE1	S115F	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375710	X	53674318	X	53647375	375710	362614	rs1557036757	NC_000023.11:53647374:G:A	G	A	CLINICAL
NM_015107.3(PHF8):c.631C>T (p.Arg211Ter)	PHF8	R211*, R247*	Normal	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Oct 1, 2005)	no assertion criteria provided	VCV000010798	X	54040962	X	54014529	10798	25837	rs121918522	NC_000023.11:54014528:G:A	G	A	CLINICAL
NM_015107.3(PHF8):c.529A>T (p.Lys177Ter)	PHF8	K177*, K213*	Normal	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Jul 1, 2007)	no assertion criteria provided	VCV000010799	X	54043095	X	54016662	10799	25838	rs121918523	NC_000023.11:54016661:T:A	T	A	CLINICAL
NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	ZC4H2	R213W, R190W	Normal	not provided|Wieacker-Wolff, X-linked recessive	Pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000050983	X	64137701	X	64917821	50983	65654	rs879255236	NC_000023.11:64917820:G:A	G	A	CLINICAL
NM_018684.4(ZC4H2):c.631C>T (p.Arg211Trp)	ZC4H2	R211W, R188W	Normal	not provided|Wieacker-Wolff, X-linked recessive	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000451159	X	64137707	X	64917827	451159	446729	rs1555933616	NC_000023.11:64917826:G:A	G	A	CLINICAL
NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	ZC4H2	P201S, P178S	Normal	Wieacker-Wolff, X-linked recessive|Neurodevelopmental disorder	Likely pathogenic(Last reviewed: Jun 24, 2020)	criteria provided, single submitter	VCV000050982	X	64137737	X	64917857	50982	65653	rs398122939	NC_000023.11:64917856:G:A	G	A	CLINICAL
NM_018684.4(ZC4H2):c.592C>T (p.Arg198Trp)	ZC4H2	R198W, R175W	Normal	not provided|Wieacker-Wolff, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000432364	X	64137746	X	64917866	432364	426484	rs137962226	NC_000023.11:64917865:G:A	G	A	CLINICAL
NM_018684.4(ZC4H2):c.427C>T (p.Gln143Ter)	ZC4H2	Q143*, Q120*	Normal	not provided|Wieacker-Wolff, X-linked recessive	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548020	X	64139056	X	64919176	548020	538517	rs1260869746	NC_000023.11:64919175:G:A	G	A	CLINICAL
NM_018684.4(ZC4H2):c.412C>T (p.Gln138Ter)	ZC4H2	Q115*, Q138*	Normal	not provided|Wieacker-Wolff, X-linked recessive	Pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000689619	X	64139071	X	64919191	689619	677298	rs1602379828	NC_000023.11:64919190:G:A	G	A	CLINICAL
NM_018684.4(ZC4H2):c.199C>T (p.Arg67Ter)	ZC4H2	R67*, R44*	Normal	not provided|Wieacker-Wolff, X-linked recessive|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000429826	X	64141723	X	64921843	429826	422499	rs1131691616	NC_000023.11:64921842:G:A	G	A	CLINICAL
NM_002547.3(OPHN1):c.496C>T (p.Gln166Ter)	OPHN1	Q166*	Normal	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159477	X	67433805	X	68213963	159477	170172	rs587784234	NC_000023.11:68213962:G:A	G	A	CLINICAL
NM_002547.3(OPHN1):c.184C>T (p.Gln62Ter)	OPHN1	Q62*	Normal	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: Jun 1, 2003)	no assertion criteria provided	VCV000011579	X	67518909	X	68299067	11579	26618	rs137854493	NC_000023.11:68299066:G:A	G	A	CLINICAL
NM_012310.5(KIF4A):c.1525G>A (p.Asp509Asn)	KIF4A	D509N	Normal	Mental retardation, X-linked 100	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804023	X	69573508	X	70353658	804023	792493	rs1344933833	NC_000023.11:70353657:G:A	G	A	CLINICAL
NM_021120.4(DLG3):c.1721G>A (p.Arg574Gln)	DLG3	R574Q, R237Q, R91Q	Normal	X-Linked mental retardation 90	Likely pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000224095	X	69712394	X	70492544	224095	225825	rs149595793	NC_000023.11:70492543:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.887G>A (p.Arg296Gln)	MED12	R296Q	Normal	Inborn genetic diseases|FG syndrome 1	Likely pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000522111	X	70341452	X	71121602	522111	512733	rs1556334519	NC_000023.11:71121601:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.1547G>A (p.Arg516His)	MED12	R516H	Normal	not provided|FG syndrome 1	Likely pathogenic(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000452540	X	70343006	X	71123156	452540	446745	rs1556334969	NC_000023.11:71123155:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.1862G>A (p.Arg621Gln)	MED12	R621Q	Normal	FG syndrome 1	Likely pathogenic(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	VCV000225253	X	70344126	X	71124276	225253	227160	rs1057519381	NC_000023.11:71124275:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.2444G>A (p.Arg815Gln)	MED12	R815Q	Normal	FG syndrome 1	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV000252962	X	70345907	X	71126057	252962	247364	rs762905361	NC_000023.11:71126056:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.2873G>A (p.Gly958Glu)	MED12	G958E	Normal	FG syndrome 1	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV000065683	X	70347209	X	71127359	65683	76591	rs397515554	NC_000023.11:71127358:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.3443G>A (p.Arg1148His)	MED12	R1148H	Normal	Ohdo syndrome, X-linked|not provided|FG syndrome 1	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000050279	X	70348536	X	71128686	50279	59420	rs387907360	NC_000023.11:71128685:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.4342G>A (p.Gly1448Arg)	MED12	G1448R	Normal	Seizures|Expressive language delay|Microcephaly|Ventriculomegaly|Abnormal facial shape|Global developmental delay|Absent speech	Likely pathogenic(Last reviewed: Sep 16, 2014)	criteria provided, single submitter	VCV000374138	X	70352315	X	71132465	374138	361104	rs1057518921	NC_000023.11:71132464:G:A	G	A	CLINICAL
NM_005120.3(MED12):c.5185C>A (p.His1729Asn)	MED12	H1729N	Normal	FG syndrome 1|Ohdo syndrome, X-linked	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV000050281	X	70356290	X	71136440	50281	59422	rs387907362	NC_000023.11:71136439:C:A	C	A	CLINICAL
NM_007363.5(NONO):c.1131G>A (p.Ala377=)	NONO		Normal	not provided|Inborn genetic diseases|Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000222081	X	70517788	X	71297938	222081	223780	rs869025343	NC_000023.11:71297937:G:A	G	A	CLINICAL
NM_004606.5(TAF1):c.1979G>A (p.Gly660Asp)	TAF1	G680D, G639D, G660D	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000694243	X	70603843	X	71383993	694243	682091	rs1602489684	NC_000023.11:71383992:G:A	G	A	CLINICAL
NM_004606.5(TAF1):c.3973G>A (p.Val1325Ile)	TAF1	V1345I, V1325I, V1304I	Normal	Mental retardation, X-linked, syndromic 33|not provided	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	VCV000430463	X	70621564	X	71401714	430463	422515	rs1131691982	NC_000023.11:71401713:G:A	G	A	CLINICAL
NM_018486.3(HDAC8):c.496C>T (p.Arg166Ter)	HDAC8	R166*, R75*	Normal	not provided|Inborn genetic diseases|Abnormal facial shape|Global developmental delay|Microcephaly|Intrauterine growth retardation|Sparse scalp hair|Delayed speech and language development|Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280793	X	71715060	X	72495210	280793	265061	rs886041936	NC_000023.11:72495209:G:A	G	A	CLINICAL
NM_006517.5(SLC16A2):c.434G>A (p.Trp145Ter)	SLC16A2	W145*	Normal	not provided|Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000496891	X	73740828	X	74520993	496891	488315	rs1555989364	NC_000023.11:74520992:G:A	G	A	CLINICAL
NM_006517.5(SLC16A2):c.439G>A (p.Gly147Arg)	SLC16A2	G147R	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000666343	X	73740833	X	74520998	666343	653909	rs1602140936	NC_000023.11:74520997:G:A	G	A	CLINICAL
NM_006517.5(SLC16A2):c.449C>A (p.Ala150Glu)	SLC16A2	A150E	Normal	Allan-Herndon-Dudley syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159907	X	73740843	X	74521008	159907	170181	rs104894936	NC_000023.11:74521007:C:A	C	A	CLINICAL
NM_006517.5(SLC16A2):c.979G>A (p.Gly327Arg)	SLC16A2	G327R	Normal	Spastic paraplegia|Decreased activity of the pyruvate dehydrogenase complex|Allan-Herndon-Dudley syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000159901	X	73744597	X	74524762	159901	170183	rs587784383	NC_000023.11:74524761:G:A	G	A	CLINICAL
NM_006517.5(SLC16A2):c.1121C>A (p.Ser374Ter)	SLC16A2	S374*	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000011640	X	73745679	X	74525844	11640	26679	rs104894940	NC_000023.11:74525843:C:A	C	A	CLINICAL
NM_016120.4(RLIM):c.1831C>T (p.Arg611Cys)	RLIM	R611C	Normal	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000585245	X	73811319	X	74591484	585245	576294	rs1569309449	NC_000023.11:74591483:G:A	G	A	CLINICAL
NM_016120.4(RLIM):c.1795C>T (p.Arg599Cys)	RLIM	R599C	Normal	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000253089	X	73811355	X	74591520	253089	247500	rs1569309459	NC_000023.11:74591519:G:A	G	A	CLINICAL
NM_016120.4(RLIM):c.1159C>T (p.Arg387Cys)	RLIM	R387C	Normal	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000253088	X	73811991	X	74592156	253088	247499	rs1569309776	NC_000023.11:74592155:G:A	G	A	CLINICAL
NM_016120.4(RLIM):c.1093C>T (p.Arg365Cys)	RLIM	R365C	Normal	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000585244	X	73812057	X	74592222	585244	576293	rs1569309816	NC_000023.11:74592221:G:A	G	A	CLINICAL
NM_001008537.3(NEXMIF):c.1882C>T (p.Arg628Ter)	NEXMIF	R628*	Normal	Mental retardation, X-linked 98|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190220	X	73962510	X	74742675	190220	188055	rs786205208	NC_000023.11:74742674:G:A	G	A	CLINICAL
NM_001008537.3(NEXMIF):c.1441C>T (p.Arg481Ter)	NEXMIF	R481*	Normal	not provided|Inborn genetic diseases|Mental retardation, X-linked 98	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280509	X	73962951	X	74743116	280509	265066	rs886041701	NC_000023.11:74743115:G:A	G	A	CLINICAL
NM_001008537.3(NEXMIF):c.1042C>T (p.Arg348Ter)	NEXMIF	R348*	Normal	not provided|Mental retardation, X-linked 98	Pathogenic(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000280835	X	73963350	X	74743515	280835	265174	rs886041971	NC_000023.11:74743514:G:A	G	A	CLINICAL
NM_001008537.3(NEXMIF):c.964C>T (p.Arg322Ter)	NEXMIF	R322*	Normal	not provided|Mental retardation, X-linked 98	Pathogenic(Last reviewed: Apr 15, 2019)	criteria provided, single submitter	VCV000438478	X	73963428	X	74743593	438478	432100	rs1556016731	NC_000023.11:74743592:G:A	G	A	CLINICAL
NM_001008537.3(NEXMIF):c.937C>T (p.Arg313Ter)	NEXMIF	R313*	Normal	Mental retardation, X-linked 98|not provided	Pathogenic(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242327	X	73963455	X	74743620	242327	243875	rs878854425	NC_000023.11:74743619:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.7192C>T (p.Gln2398Ter)	ATRX	Q2398*, Q2360*	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000560706	X	76776274	X	77520796	560706	551801	rs1569515457	NC_000023.11:77520795:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.7162G>T (p.Glu2388Ter)	ATRX	E2350*, E2388*	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011729	X	76776304	X	77520826	11729	26768	rs122445100	NC_000023.11:77520825:C:A	C	A	CLINICAL
NM_000489.5(ATRX):c.7156C>T (p.Arg2386Ter)	ATRX	R2348*, R2386*	Normal	not provided|Alpha thalassemia-X-linked intellectual disability syndrome|Intellectual disability, severe|Microcephaly|Osteosarcoma|Ambiguous genitalia|Cryptorchidism	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011728	X	76776310	X	77520832	11728	26767	rs122445099	NC_000023.11:77520831:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.6254G>T (p.Arg2085Leu)	ATRX	R2085L, R2047L	Normal	X-linked intellectual disability-hypotonic face syndrome	Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000635054	X	76829787	X	77574322	635054	622930	rs1057517948	NC_000023.11:77574321:C:A	C	A	CLINICAL
NM_000489.5(ATRX):c.6104A>T (p.Asp2035Val)	ATRX	D1997V, D2035V	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011725	X	76849172	X	77593702	11725	26764	rs122445096	NC_000023.11:77593701:T:A	T	A	CLINICAL
NM_000489.5(ATRX):c.5131C>T (p.Pro1711Ser)	ATRX	P1673S, P1711S	Normal	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Jan 1, 1996)	no assertion criteria provided	VCV000011732	X	76888698	X	77633210	11732	26771	rs122445102	NC_000023.11:77633209:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.4950G>T (p.Lys1650Asn)	ATRX	K1612N, K1650N	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011723	X	76889060	X	77633572	11723	26762	rs122445095	NC_000023.11:77633571:C:A	C	A	CLINICAL
NM_000489.5(ATRX):c.4865C>T (p.Ala1622Val)	ATRX	A1622V, A1584V	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431119	X	76889145	X	77633657	431119	424679	rs1135401793	NC_000023.11:77633656:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.4862C>T (p.Thr1621Met)	ATRX	T1621M, T1583M	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Jul 1, 2002)	no assertion criteria provided	VCV000011739	X	76889148	X	77633660	11739	26778	rs122445106	NC_000023.11:77633659:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.1676C>T (p.Ser559Leu)	ATRX	S559L, S521L	Normal	Global developmental delay|Microcephaly	Likely pathogenic	criteria provided, single submitter	VCV000402182	X	76939072	X	77683580	402182	389193	rs1060499760	NC_000023.11:77683579:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.736C>T (p.Arg246Cys)	ATRX	R246C, R208C	Normal	not provided|Alpha thalassemia-X-linked intellectual disability syndrome|Renier-Gabreels-Jasper syndrome|Acquired hemoglobin H disease|X-linked intellectual disability-hypotonic face syndrome|Alpha thalassemia-X-linked intellectual disability syndrome|Inborn genetic diseases|X-linked intellectual disability-hypotonic face syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011735	X	76940012	X	77684520	11735	26774	rs122445105	NC_000023.11:77684519:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.569C>T (p.Pro190Leu)	ATRX	P190L, P152L	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374337	X	76944336	X	77688843	374337	361255	rs1057518708	NC_000023.11:77688842:G:A	G	A	CLINICAL
NM_000489.5(ATRX):c.109C>T (p.Arg37Ter)	ATRX	R37*	Normal	Alpha thalassemia-X-linked intellectual disability syndrome|Mental retardation-hypotonic facies syndrome, X-linked|Intellectual disability|X-linked intellectual disability-hypotonic face syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011742	X	76972632	X	77717155	11742	26781	rs122445108	NC_000023.11:77717154:G:A	G	A	CLINICAL
NM_000291.4(PGK1):c.140T>A (p.Ile47Asn)	PGK1	I46N, I47N	Normal	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000009952	X	77369264	X	78113767	9952	24991	rs137852536	NC_000023.11:78113766:T:A	T	A	CLINICAL
NM_000291.4(PGK1):c.756+5G>A	PGK1		Normal	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Mar 28, 2006)	no assertion criteria provided	VCV000009955	X	77378451	X	78122954	9955	24994	rs431905503	NC_000023.11:78122953:G:A	G	A	CLINICAL
NM_153252.5(BRWD3):c.3325+1G>T	BRWD3		Normal	Mental retardation, X-linked 93	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010802	X	79947587	X	80692088	10802	25841	rs730882185	NC_000023.11:80692087:C:A	C	A	CLINICAL
NM_153252.5(BRWD3):c.568C>T (p.Arg190Ter)	BRWD3	R190*	Normal	Mental retardation, X-linked 93	Pathogenic(Last reviewed: Feb 17, 2015)	no assertion criteria provided	VCV000374258	X	80001091	X	80745592	374258	361256	rs1057518650	NC_000023.11:80745591:G:A	G	A	CLINICAL
NM_013995.2(LAMP2):c.1075C>T (p.Gln359Ter)	LAMP2	Q359*	Normal	not provided	Likely pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000372712	X	119575603	X	120441748	372712	360562	rs1057517940	NC_000023.11:120441747:G:A	G	A	CLINICAL
NM_013995.2(LAMP2):c.718C>T (p.Gln240Ter)	LAMP2	Q240*	Normal	not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000488987	X	119581719	X	120447864	488987	482232	rs1556101420	NC_000023.11:120447863:G:A	G	A	CLINICAL
NM_013995.2(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Q174*	Normal	Danon disease	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000009981	X	119582861	X	120449006	9981	25020	rs104894857	NC_000023.11:120449005:G:A	G	A	CLINICAL
NM_000202.8(IDS):c.238C>T (p.Gln80Ter)	IDS	Q80*	Normal	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633269	X	148585689	X	149504159	633269	621680	rs1569560527	NC_000023.11:149504158:G:A	G	A	CLINICAL
NM_001110792.2(MECP2):c.455C>T (p.Ala152Val)	MECP2	A140V, A152V, A47V	Normal	Autism, susceptibility to, X-linked 3|Rett syndrome|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Behavioral abnormality|Severe neonatal-onset encephalopathy with microcephaly|not provided|Intellectual disability|Stenosis of the external auditory canal|Micrognathia|Hearing impairment|Microcephaly|Downslanted palpebral fissures|Intellectual disability|Motor delay|Postnatal growth retardation|Neurodevelopmental disorder	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011823	X	153296860	X	154031409	11823	26862	rs28934908	NC_000023.11:154031408:G:A	G	A	CLINICAL
NM_001323289.2(CDKL5):c.215T>C (p.Ile72Thr)	CDKL5	I72T	Normal	not provided|Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|CDKL5 disorder	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011503	X	18593543	X	18575423	11503	26542	rs62641235	NC_000023.11:18575422:T:C	T	C	CLINICAL
NM_001193416.3(DDX3X):c.887G>C (p.Arg296Pro)	DDX3X	R280P, R296P, R110P	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000666341	X	41203514	X	41344261	666341	653904	rs1602132216	NC_000023.11:41344260:G:C	G	C	CLINICAL
NM_001193416.3(DDX3X):c.1171-1G>C	DDX3X		Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000638013	X	41204656	X	41345403	638013	625834	rs1602134459	NC_000023.11:41345402:G:C	G	C	CLINICAL
NM_001356.4(DDX3X):c.1439G>C (p.Arg480Thr)	DDX3X	R480T, R294T, R464T	Normal	Congenital cerebellar hypoplasia|Cerebellar vermis hypoplasia|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632603	X	41205605	X	41346352	632603	621036	rs1569240005	NC_000023.11:41346351:G:C	G	C	CLINICAL
NM_001356.4(DDX3X):c.1520T>C (p.Ile507Thr)	DDX3X	I507T, I321T, I491T	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208546	X	41205780	X	41346527	208546	205063	rs797045024	NC_000023.11:41346526:T:C	T	C	CLINICAL
NM_001029896.2(WDR45):c.1030A>G (p.Asn344Asp)	WDR45	N345D, N344D	Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Feb 13, 2015)	criteria provided, single submitter	VCV000212591	X	48932515	X	49074856	212591	209072	rs797046100	NC_000023.11:49074855:T:C	T	C	CLINICAL
NM_001029896.2(WDR45):c.870C>G (p.Tyr290Ter)	WDR45	Y291*, Y290*	Normal	Neurodegeneration with brain iron accumulation 5|not provided	Pathogenic(Last reviewed: Mar 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000545700	X	48932898	X	49075239	545700	536192	rs782557596	NC_000023.11:49075238:G:C	G	C	CLINICAL
NM_001029896.2(WDR45):c.517-2A>G	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000659190	X	48933414	X	49075755	659190	653717	rs1602538148	NC_000023.11:49075754:T:C	T	C	CLINICAL
NM_001029896.2(WDR45):c.437-3T>G	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000639197	X	48933607	X	49075948	639197	653464	rs1602538385	NC_000023.11:49075947:A:C	A	C	CLINICAL
NM_001029896.2(WDR45):c.235+2T>G	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803999	X	48935300	X	49077641	803999	792469	rs1602540211	NC_000023.11:49077640:A:C	A	C	CLINICAL
NM_001029896.2(WDR45):c.131-2A>G	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000540346	X	48935408	X	49077749	540346	534835	rs1557084491	NC_000023.11:49077748:T:C	T	C	CLINICAL
NM_001029896.2(WDR45):c.56-2A>G	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000649495	X	48935572	X	49077913	649495	653535	rs1602540595	NC_000023.11:49077912:T:C	T	C	CLINICAL
NM_016120.4(RLIM):c.1067A>G (p.Tyr356Cys)	RLIM	Y356C	Normal	Non-syndromic X-linked intellectual disability|Mental retardation, X-linked 61|Global developmental delay	Pathogenic	criteria provided, single submitter	VCV000156224	X	73812083	X	74592248	156224	166020	rs786205133	NC_000023.11:74592247:T:C	T	C	CLINICAL
NM_023010.3(UPF3B):c.478T>G (p.Tyr160Asp)	UPF3B	Y160D	Normal	Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000011401	X	118977256	X	119843293	11401	26440	rs122468182	NC_000023.11:119843292:A:C	A	C	CLINICAL
NM_001110792.2(MECP2):c.1154C>G (p.Ser385Ter)	MECP2	S373*, S385*, S280*	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143334	X	153296161	X	154030710	143334	153066	rs267608569	NC_000023.11:154030709:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.1074C>G (p.Ser358Arg)	MECP2	S346R, S358R, S253R	Normal	Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000143310	X	153296241	X	154030790	143310	153042	rs61752365	NC_000023.11:154030789:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.941C>G (p.Pro314Arg)	MECP2	P302R, P314R, P209R	Normal	Rett syndrome	Pathogenic(Last reviewed: Sep 27, 2012)	no assertion criteria provided	VCV000143737	X	153296374	X	154030923	143737	153469	rs61749723	NC_000023.11:154030922:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.710C>G (p.Pro237Arg)	MECP2	P225R, P237R, P132R	Normal	Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Absent speech|Seizures|Developmental regression|Severe global developmental delay|Irregular respiration	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143653	X	153296605	X	154031154	143653	153385	rs61749715	NC_000023.11:154031153:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.647C>G (p.Ser216Ter)	MECP2	S204*, S216*, S111*	Normal	Inborn genetic diseases|not provided|Rett syndrome	Pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095199	X	153296668	X	154031217	95199	101099	rs61749724	NC_000023.11:154031216:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.520A>G (p.Arg174Gly)	MECP2	R162G, R174G, R69G	Normal	Rett syndrome	Pathogenic(Last reviewed: Dec 10, 2014)	no assertion criteria provided	VCV000180209	X	153296795	X	154031344	180209	178396	rs727505391	NC_000023.11:154031343:T:C	T	C	CLINICAL
NM_001110792.2(MECP2):c.508A>G (p.Thr170Ala)	MECP2	T158A, T170A, T65A	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Jul 7, 2017)	criteria provided, single submitter	VCV000143590	X	153296807	X	154031356	143590	153322	rs61748411	NC_000023.11:154031355:T:C	T	C	CLINICAL
NM_001110792.2(MECP2):c.507C>G (p.Phe169Leu)	MECP2	F157L, F169L, F64L	Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV000143589	X	153296808	X	154031357	143589	153321	rs267608484	NC_000023.11:154031356:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.504C>G (p.Asp168Glu)	MECP2	D156E, D168E, D63E	Normal	not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095196	X	153296811	X	154031360	95196	101096	rs61748408	NC_000023.11:154031359:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.503A>G (p.Asp168Gly)	MECP2	D156G, D168G, D63G	Normal	Rett syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000143583	X	153296812	X	154031361	143583	153315	rs61748407	NC_000023.11:154031360:T:C	T	C	CLINICAL
NM_001110792.2(MECP2):c.490C>G (p.Pro164Ala)	MECP2	P152A, P164A, P59A	Normal	Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Rett syndrome, zappella variant	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011844	X	153296825	X	154031374	11844	26883	rs179363900	NC_000023.11:154031373:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.488A>G (p.Asp163Gly)	MECP2	D151G, D163G, D58G	Normal	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000143578	X	153296827	X	154031376	143578	153310	rs61748403	NC_000023.11:154031375:T:C	T	C	CLINICAL
NM_001110792.2(MECP2):c.459C>G (p.Tyr153Ter)	MECP2	Y141*, Y153*, Y48*	Normal	Severe neonatal-onset encephalopathy with microcephaly|Atypical Rett syndrome|Rett syndrome|Inborn genetic diseases|not provided|Angelman syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011833	X	153296856	X	154031405	11833	26872	rs61748396	NC_000023.11:154031404:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.439A>G (p.Lys147Glu)	MECP2	K135E, K147E, K42E	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143564	X	153296876	X	154031425	143564	153296	rs61748391	NC_000023.11:154031424:T:C	T	C	CLINICAL
NM_001110792.2(MECP2):c.437C>G (p.Ser146Cys)	MECP2	S134C, S146C, S41C	Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143562	X	153296878	X	154031427	143562	153294	rs61748390	NC_000023.11:154031426:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.414-2A>G	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000156066	X	153296903	X	154031452	156066	165862	rs267608464	NC_000023.11:154031451:T:C	T	C	CLINICAL
NM_004992.3(MECP2):c.378-3C>G	MECP2		Normal	Rett syndrome|not provided|not specified|Severe neonatal-onset encephalopathy with microcephaly	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156068	X	153296904	X	154031453	156068	165864	rs267608465	NC_000023.11:154031452:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.338C>G (p.Pro113Arg)	MECP2	P101R, P113R, P8R	Normal	Rett syndrome|Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143526	X	153297733	X	154032282	143526	153258	rs61754453	NC_000023.11:154032281:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.334C>G (p.Leu112Val)	MECP2	L100V, L112V, L7V	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011835	X	153297737	X	154032286	11835	26874	rs28935168	NC_000023.11:154032285:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.239C>G (p.Ser80Ter)	MECP2	S68*, S80*	Normal	Rett syndrome	Pathogenic(Last reviewed: Jul 10, 2015)	criteria provided, single submitter	VCV000143500	X	153297832	X	154032381	143500	153232	rs267608438	NC_000023.11:154032380:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.230C>G (p.Ser77Ter)	MECP2	S65*, S77*	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143498	X	153297841	X	154032390	143498	153230	rs61754437	NC_000023.11:154032389:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.182C>G (p.Ser61Ter)	MECP2	S49*, S61*	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143492	X	153297889	X	154032438	143492	153224	rs61754432	NC_000023.11:154032437:G:C	G	C	CLINICAL
NM_004992.3(MECP2):c.27-2A>G	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Dec 3, 2007)	no assertion criteria provided	VCV000156046	X	153298010	X	154032559	156046	165842	rs267608412	NC_000023.11:154032558:T:C	T	C	CLINICAL
NM_004992.3(MECP2):c.27-6C>G	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Sep 11, 2015)	criteria provided, single submitter	VCV000156048	X	153298014	X	154032563	156048	165844	rs267608411	NC_000023.11:154032562:G:C	G	C	CLINICAL
NM_004992.3(MECP2):c.-99+2T>G	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000503729	X	153363059	X	154097602	503729	495805	rs1557150841	NC_000023.11:154097601:A:C	A	C	CLINICAL
NM_018196.4(TMLHE):c.359-2A>G	TMLHE		Normal	not provided	Pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	VCV000372796	X	154743928	X	155514267	372796	360564	rs782792356	NC_000023.11:155514266:T:C	T	C	CLINICAL
NM_001184880.2(PCDH19):c.2676-6A>G	PCDH19		Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000648238	X	99597079	X	100342081	648238	653428	rs1602595136	NC_000023.11:100342080:T:C	T	C	CLINICAL
NM_001184880.2(PCDH19):c.2012C>G (p.Ser671Ter)	PCDH19	S671*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011018	X	99661584	X	100406586	11018	26057	rs132630325	NC_000023.11:100406585:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1925T>G (p.Val642Gly)	PCDH19	V642G	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804053	X	99661671	X	100406673	804053	792090	rs1602635282	NC_000023.11:100406672:A:C	A	C	CLINICAL
NM_001184880.2(PCDH19):c.1815C>G (p.Tyr605Ter)	PCDH19	Y605*	Normal	Early infantile epileptic encephalopathy 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000445698	X	99661781	X	100406783	445698	438970	rs1057521256	NC_000023.11:100406782:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1755C>G (p.Tyr585Ter)	PCDH19	Y585*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000658664	X	99661841	X	100406843	658664	649574	rs749662385	NC_000023.11:100406842:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1681C>G (p.Pro561Ala)	PCDH19	P561A	Normal	not provided|Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000624433	X	99661915	X	100406917	624433	613210	rs1569314471	NC_000023.11:100406916:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1671C>G (p.Asn557Lys)	PCDH19	N557K	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000011022	X	99661925	X	100406927	11022	26061	rs267606933	NC_000023.11:100406926:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1442A>G (p.Asp481Gly)	PCDH19	D481G	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804055	X	99662154	X	100407156	804055	792092	rs1602636096	NC_000023.11:100407155:T:C	T	C	CLINICAL
NM_001184880.2(PCDH19):c.1133C>G (p.Ser378Ter)	PCDH19	S378*	Normal	not provided|Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447916	X	99662463	X	100407465	447916	442357	rs1555985301	NC_000023.11:100407464:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1098C>G (p.Tyr366Ter)	PCDH19	Y366*	Normal	Early infantile epileptic encephalopathy 9|not provided	Pathogenic(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447915	X	99662498	X	100407500	447915	442358	rs1239794408	NC_000023.11:100407499:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.1019A>G (p.Asn340Ser)	PCDH19	N340S	Normal	Early infantile epileptic encephalopathy 9|not provided|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206364	X	99662577	X	100407579	206364	203925	rs796052839	NC_000023.11:100407578:T:C	T	C	CLINICAL
NM_001184880.2(PCDH19):c.918C>G (p.Tyr306Ter)	PCDH19	Y306*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 15, 2018)	criteria provided, single submitter	VCV000566069	X	99662678	X	100407680	566069	575311	rs1569315231	NC_000023.11:100407679:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.707C>G (p.Pro236Arg)	PCDH19	P236R	Normal	Early infantile epileptic encephalopathy 9|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000408904	X	99662889	X	100407891	408904	404042	rs1060502176	NC_000023.11:100407890:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.695A>G (p.Asn232Ser)	PCDH19	N232S	Normal	not provided|Early infantile epileptic encephalopathy 9|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206321	X	99662901	X	100407903	206321	203932	rs587784299	NC_000023.11:100407902:T:C	T	C	CLINICAL
NM_001184880.2(PCDH19):c.462C>G (p.Tyr154Ter)	PCDH19	Y154*	Normal	not provided|Early infantile epileptic encephalopathy 9	Pathogenic/Likely pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000619130	X	99663134	X	100408136	619130	610524	rs1569315876	NC_000023.11:100408135:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.437C>G (p.Thr146Arg)	PCDH19	T146R	Normal	Early infantile epileptic encephalopathy 9|not provided	Likely pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000206313	X	99663159	X	100408161	206313	203943	rs796052799	NC_000023.11:100408160:G:C	G	C	CLINICAL
NM_001184880.2(PCDH19):c.374A>G (p.Asn125Ser)	PCDH19	N125S	Normal	not provided|Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093676	X	99663222	X	100408224	93676	99579	rs398123603	NC_000023.11:100408223:T:C	T	C	CLINICAL
NM_004085.4(TIMM8A):c.198C>G (p.Cys66Trp)	TIMM8A	C66W	Normal	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 6, 2003)	no assertion criteria provided	VCV000011321	X	100601583	X	101346595	11321	26360	rs80356560	NC_000023.11:101346594:G:C	G	C	CLINICAL
NM_001830.4(CLCN4):c.2191G>C (p.Gly731Arg)	CLCN4	G731R, G637R	Normal	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253113	X	10188916	X	10220876	253113	247525	rs1569233549	NC_000023.11:10220875:G:C	G	C	CLINICAL
NM_000533.5(PLP1):c.560T>C (p.Ile187Thr)	PLP1|RAB9B	I152T, I187T, I132T	Normal	Hereditary spastic paraplegia 2	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000011085	X	103042833	X	103787904	11085	26124	rs132630288	NC_000023.11:103787903:T:C	T	C	CLINICAL
NM_002764.3(PRPS1):c.398A>C (p.Gln133Pro)	PRPS1	Q133P	Normal	Arts syndrome	Pathogenic(Last reviewed: Nov 18, 2010)	no assertion criteria provided	VCV000009937	X	106884223	X	107640993	9937	24976	rs80338675	NC_000023.11:107640992:A:C	A	C	CLINICAL
NM_001204402.1(PRPS1):c.-82-2793G>C	PRPS1	V142L	Normal	Arts syndrome	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000029989	X	106885614	X	107642384	29989	38944	rs398122855	NC_000023.11:107642383:G:C	G	C	CLINICAL
NM_001204402.1(PRPS1):c.-66G>C	PRPS1	D183H	Normal	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000009929	X	106888423	X	107645193	9929	24968	rs137852541	NC_000023.11:107645192:G:C	G	C	CLINICAL
NM_002764.3(PRPS1):c.830A>C (p.Gln277Pro)	PRPS1	Q277P, Q73P	Normal	Deafness, X-linked 1|Arts syndrome	Pathogenic(Last reviewed: Mar 1, 2016)	no assertion criteria provided	VCV000223100	X	106890961	X	107647731	223100	224827	rs869025593	NC_000023.11:107647730:A:C	A	C	CLINICAL
NM_001318510.2(ACSL4):c.1712T>G (p.Val571Gly)	ACSL4	V571G, V612G	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625210	X	108902726	X	109659497	625210	613541	rs1603401125	NC_000023.11:109659496:A:C	A	C	CLINICAL
NM_001318510.2(ACSL4):c.1003-2A>G	ACSL4		Normal	Mental retardation 63, X-linked	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011565	X	108912404	X	109669175	11565	26604	rs1569423317	NC_000023.11:109669174:T:C	T	C	CLINICAL
NM_002578.5(PAK3):c.976G>C (p.Val326Leu)	PAK3	V341L, V362L, V326L, V347L	Normal	Microcephaly|Intellectual disability	Pathogenic(Last reviewed: Mar 24, 2019)	criteria provided, single submitter	VCV000684413	X	110435830	X	111192602	684413	672009	rs1603373827	NC_000023.11:111192601:G:C	G	C	CLINICAL
NM_002578.5(PAK3):c.1337G>C (p.Trp446Ser)	PAK3	W446S, W467S, W461S, W482S	Normal	Mental retardation 30, X-linked	Pathogenic(Last reviewed: Oct 15, 2007)	no assertion criteria provided	VCV000011571	X	110439798	X	111196570	11571	26610	rs121434614	NC_000023.11:111196569:G:C	G	C	CLINICAL
NM_078629.4(MSL3):c.923T>C (p.Leu308Pro)	MSL3	L142P, L308P, L296P, L159P	Normal	Basilicata-Akhtar syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000487567	X	11783600	X	11765481	487567	480613	rs1555906707	NC_000023.11:11765480:T:C	T	C	CLINICAL
NM_023010.3(UPF3B):c.478T>G (p.Tyr160Asp)	UPF3B	Y160D	Normal	Mental retardation, syndromic 14, X-linked	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000011401	X	118977256	X	119843293	11401	26440	rs122468182	NC_000023.11:119843292:A:C	A	C	CLINICAL
NM_003588.3(CUL4B):c.901-2A>G	CUL4B		Normal	Syndromic X-linked mental retardation, Cabezas type	Pathogenic(Last reviewed: Aug 21, 2021)	no assertion criteria provided	VCV000011340	X	119679374	X	120545519	11340	26379	rs786200913	NC_000023.11:120545518:T:C	T	C	CLINICAL
NM_007325.5(GRIA3):c.1888G>C (p.Gly630Arg)	GRIA3	G630R	Normal	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000127195	X	122561802	X	123427951	127195	132679	rs587777361	NC_000023.11:123427950:G:C	G	C	CLINICAL
NM_007325.5(GRIA3):c.1964T>C (p.Phe655Ser)	GRIA3	F655S	Normal	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431114	X	122561878	X	123428027	431114	424674	rs1135401788	NC_000023.11:123428026:T:C	T	C	CLINICAL
NM_007325.5(GRIA3):c.2117T>C (p.Met706Thr)	GRIA3	M706T	Normal	Mental retardation, X-linked, syndromic, wu type	Pathogenic(Last reviewed: Nov 13, 2007)	no assertion criteria provided	VCV000010358	X	122598756	X	123464905	10358	25397	rs137852352	NC_000023.11:123464904:T:C	T	C	CLINICAL
NM_001081550.2(THOC2):c.4450-2A>G	THOC2		Normal	Mental retardation, X-linked 12	Likely pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488434	X	122747561	X	123613710	488434	481298	rs1556005930	NC_000023.11:123613709:T:C	T	C	CLINICAL
NM_001368397.1(FRMPD4):c.1657T>C (p.Cys553Arg)	FRMPD4	C553R, C545R, C513R, C555R, C590R, C550R	Normal	Mental retardation, X-linked 104	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000254683	X	12734235	X	12716116	254683	249259	rs886038209	NC_000023.11:12716115:T:C	T	C	CLINICAL
NM_004208.4(AIFM1):c.710A>G (p.Asp237Gly)	AIFM1|RAB33A	D237G, D233G	Normal	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694665	X	129274579	X	130140604	694665	682784	rs1202786652	NC_000023.11:130140603:T:C	T	C	CLINICAL
NM_004208.4(AIFM1):c.697-44T>G	AIFM1|RAB33A		Normal	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	Pathogenic(Last reviewed: Dec 2, 2019)	no assertion criteria provided	VCV000694668	X	129274636	X	130140661	694668	682787	rs1603225182	NC_000023.11:130140660:A:C	A	C	CLINICAL
NM_001015877.2(PHF6):c.2T>C (p.Met1Thr)	PHF6	M1T	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Feb 23, 2019)	criteria provided, single submitter	VCV000011068	X	133511649	X	134377619	11068	26107	rs132630300	NC_000023.11:134377618:T:C	T	C	CLINICAL
NM_003611.3(OFD1):c.1303A>C (p.Ser435Arg)	OFD1	S435R, S395R, S295R	Normal	Orofaciodigital syndrome I	Pathogenic(Last reviewed: Feb 28, 2013)	no assertion criteria provided	VCV000011537	X	13774778	X	13756659	11537	26576	rs122460150	NC_000023.11:13756658:A:C	A	C	CLINICAL
NM_005629.4(SLC6A8):c.1141G>C (p.Gly381Arg)	SLC6A8	G381R, G266R, G371R	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: May 1, 2002)	no assertion criteria provided	VCV000011697	X	152959041	X	153693586	11697	26736	rs122453114	NC_000023.11:153693585:G:C	G	C	CLINICAL
NM_005629.4(SLC6A8):c.1142-2A>C	SLC6A8		Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000691273	X	152959358	X	153693903	691273	678963	rs1603217176	NC_000023.11:153693902:A:C	A	C	CLINICAL
NM_001278116.2(L1CAM):c.1615T>G (p.Cys539Gly)	L1CAM	C539G, C534G	Normal	X-linked hydrocephalus syndrome	Likely pathogenic(Last reviewed: Apr 1, 2016)	no assertion criteria provided	VCV000279601	X	153133845	X	153868390	279601	263869	rs886041102	NC_000023.11:153868389:A:C	A	C	CLINICAL
NM_001278116.2(L1CAM):c.536T>G (p.Ile179Ser)	L1CAM	I179S, I174S	Normal	MASA syndrome	Pathogenic(Last reviewed: Jul 1, 1995)	no assertion criteria provided	VCV000009994	X	153136403	X	153870948	9994	25033	rs137852523	NC_000023.11:153870947:A:C	A	C	CLINICAL
NM_003491.4(NAA10):c.*43A>G	NAA10		Normal	Lenz microphthalmia syndrome|Microphthalmia-ankyloblepharon-intellectual disability syndrome	Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000617463	X	153195397	X	153929944	617463	608812	rs1603289772	NC_000023.11:153929943:T:C	T	C	CLINICAL
NM_003491.4(NAA10):c.*40A>G	NAA10		Normal	Lenz microphthalmia syndrome|Microphthalmia-ankyloblepharon-intellectual disability syndrome	Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000617458	X	153195400	X	153929947	617458	608807	rs1342269961	NC_000023.11:153929946:T:C	T	C	CLINICAL
NM_003491.4(NAA10):c.*39A>G	NAA10		Normal	Lenz microphthalmia syndrome|Microphthalmia-ankyloblepharon-intellectual disability syndrome	Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000617462	X	153195401	X	153929948	617462	608811	rs1603289774	NC_000023.11:153929947:T:C	T	C	CLINICAL
NM_005334.3(HCFC1):c.5048C>G (p.Pro1683Arg)	HCFC1	P1683R	Normal	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	VCV000224121	X	153217504	X	153952053	224121	225851	rs869312686	NC_000023.11:153952052:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.710C>G (p.Pro237Arg)	MECP2	P225R, P237R, P132R	Normal	Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Absent speech|Seizures|Developmental regression|Severe global developmental delay|Irregular respiration	Pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143653	X	153296605	X	154031154	143653	153385	rs61749715	NC_000023.11:154031153:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.490C>G (p.Pro164Ala)	MECP2	P152A, P164A, P59A	Normal	Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Rett syndrome, zappella variant	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011844	X	153296825	X	154031374	11844	26883	rs179363900	NC_000023.11:154031373:G:C	G	C	CLINICAL
NM_001110792.2(MECP2):c.446A>G (p.Glu149Gly)	MECP2	E137G, E149G, E44G	Normal	Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|not provided	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000011825	X	153296869	X	154031418	11825	26864	rs61748392	NC_000023.11:154031417:T:C	T	C	CLINICAL
NM_001493.3(GDI1):c.275T>C (p.Leu92Pro)	GDI1	L92P	Normal	X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Jul 12, 1996)	no assertion criteria provided	VCV000011626	X	153667373	X	154439027	11626	26665	rs121434607	NC_000023.11:154439026:T:C	T	C	CLINICAL
NM_001493.3(GDI1):c.1268G>C (p.Arg423Pro)	GDI1	R423P	Normal	X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Aug 1, 1998)	no assertion criteria provided	VCV000011628	X	153670943	X	154442596	11628	26667	rs121434609	NC_000023.11:154442595:G:C	G	C	CLINICAL
NM_001289.6(CLIC2):c.303C>G (p.His101Gln)	CLIC2	H101Q	Normal	Mental retardation, X-linked, syndromic 32	Pathogenic(Last reviewed: Oct 15, 2012)	no assertion criteria provided	VCV000039823	X	154509348	X	155280059	39823	48422	rs398122917	NC_000023.11:155280058:G:C	G	C	CLINICAL
NM_001323289.2(CDKL5):c.215T>C (p.Ile72Thr)	CDKL5	I72T	Normal	not provided|Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|CDKL5 disorder	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011503	X	18593543	X	18575423	11503	26542	rs62641235	NC_000023.11:18575422:T:C	T	C	CLINICAL
NM_004586.3(RPS6KA3):c.932T>G (p.Leu311Ter)	RPS6KA3	L311*	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000637053	X	20195116	X	20176998	637053	624874	rs1603422403	NC_000023.11:20176997:A:C	A	C	CLINICAL
NM_004586.3(RPS6KA3):c.679T>G (p.Ser227Ala)	RPS6KA3	S227A	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 12, 1996)	no assertion criteria provided	VCV000011652	X	20206041	X	20187923	11652	26691	rs122454125	NC_000023.11:20187922:A:C	A	C	CLINICAL
NM_004586.3(RPS6KA3):c.646A>G (p.Lys216Glu)	RPS6KA3	K216E	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000522803	X	20206074	X	20187956	522803	513482	rs1555939456	NC_000023.11:20187955:T:C	T	C	CLINICAL
NM_004586.3(RPS6KA3):c.486+3A>G	RPS6KA3		Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Jun 1, 2002)	no assertion criteria provided	VCV000011661	X	20212304	X	20194186	11661	26700	rs1603426293	NC_000023.11:20194185:T:C	T	C	CLINICAL
NM_015884.4(MBTPS2):c.1424T>C (p.Phe475Ser)	MBTPS2	F475S	Normal	IFAP syndrome with or without BRESHECK syndrome	Pathogenic(Last reviewed: Apr 1, 2009)	no assertion criteria provided	VCV000011405	X	21900637	X	21882519	11405	26444	rs122468179	NC_000023.11:21882518:T:C	T	C	CLINICAL
NM_001415.4(EIF2S3):c.665T>C (p.Ile222Thr)	EIF2S3	I222T	Normal	MEHMO syndrome	Pathogenic(Last reviewed: Jan 18, 2018)	no assertion criteria provided	VCV000267205	X	24082345	X	24064228	267205	262084	rs886040855	NC_000023.11:24064227:T:C	T	C	CLINICAL
NM_139058.3(ARX):c.81C>G (p.Tyr27Ter)	ARX	Y27*	Normal	Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000029964	X	25033774	X	25015657	29964	38919	rs398122854	NC_000023.11:25015656:G:C	G	C	CLINICAL
NM_000109.4(DMD):c.9201-285A>G	DMD		Normal	not provided|Becker muscular dystrophy|Duchenne muscular dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011286	X	31279418	X	31261301	11286	26325	rs587776747	NC_000023.11:31261300:T:C	T	C	CLINICAL
NM_001193416.3(DDX3X):c.887G>C (p.Arg296Pro)	DDX3X	R280P, R296P, R110P	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, single submitter	VCV000666341	X	41203514	X	41344261	666341	653904	rs1602132216	NC_000023.11:41344260:G:C	G	C	CLINICAL
NM_001193416.3(DDX3X):c.1171-1G>C	DDX3X		Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000638013	X	41204656	X	41345403	638013	625834	rs1602134459	NC_000023.11:41345402:G:C	G	C	CLINICAL
NM_001356.4(DDX3X):c.1439G>C (p.Arg480Thr)	DDX3X	R480T, R294T, R464T	Normal	Congenital cerebellar hypoplasia|Cerebellar vermis hypoplasia|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632603	X	41205605	X	41346352	632603	621036	rs1569240005	NC_000023.11:41346351:G:C	G	C	CLINICAL
NM_001356.4(DDX3X):c.1520T>C (p.Ile507Thr)	DDX3X	I507T, I321T, I491T	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208546	X	41205780	X	41346527	208546	205063	rs797045024	NC_000023.11:41346526:T:C	T	C	CLINICAL
NM_001367721.1(CASK):c.2318-2A>G	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	VCV000216899	X	41390464	X	41531211	216899	213668	rs863224854	NC_000023.11:41531210:T:C	T	C	CLINICAL
NM_001367721.1(CASK):c.2183A>G (p.Tyr728Cys)	CASK	Y728C, Y723C, Y700C, Y699C	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|FG syndrome 4	Likely pathogenic(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000029937	X	41394199	X	41534946	29937	38892	rs398122844	NC_000023.11:41534945:T:C	T	C	CLINICAL
NM_001367721.1(CASK):c.2129A>G (p.Asp710Gly)	CASK	D710G, D681G, D687G	Normal	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Mental retardation and microcephaly with pontine and cerebellar hypoplasia|FG syndrome 4|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|FG syndrome 4	Likely pathogenic(Last reviewed: Mar 8, 2017)	criteria provided, single submitter	VCV000011534	X	41401970	X	41542717	11534	26573	rs137852818	NC_000023.11:41542716:T:C	T	C	CLINICAL
NM_001367721.1(CASK):c.1315-7A>G	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000446287	X	41437788	X	41578535	446287	439693	rs1555986221	NC_000023.11:41578534:T:C	T	C	CLINICAL
NM_001367721.1(CASK):c.846C>G (p.Tyr282Ter)	CASK	Y282*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia|FG syndrome 4|Anemia, nonspherocytic hemolytic, due to G6PD deficiency	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000434588	X	41495900	X	41636647	434588	430790	rs886128077	NC_000023.11:41636646:G:C	G	C	CLINICAL
NM_001367721.1(CASK):c.533-2A>G	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|Congenital cerebellar hypoplasia	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632601	X	41524707	X	41665454	632601	621041	rs1569380062	NC_000023.11:41665453:T:C	T	C	CLINICAL
NM_001367721.1(CASK):c.359A>G (p.His120Arg)	CASK	H120R	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000813732	X	41598707	X	41739454	813732	802050	rs1602550687	NC_000023.11:41739453:T:C	T	C	CLINICAL
NM_003688.3(CASK):c.305A>G (p.Glu102Gly)	CASK	E102G	Normal	Mental retardation, CASK-related, X-linked	Likely pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000575647	X	41604828	X	41745575	575647	573870	rs1569429756	NC_000023.11:41745574:T:C	T	C	CLINICAL
NM_000266.4(NDP):c.38T>G (p.Leu13Arg)	NDP|NDP-AS1	L13R	Normal	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000010689	X	43817854	X	43958608	10689	25728	rs104894879	NC_000023.11:43958607:A:C	A	C	CLINICAL
NM_000266.4(NDP):c.1A>G (p.Met1Val)	NDP|NDP-AS1	M1V	Normal	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000010687	X	43817891	X	43958645	10687	25726	rs28933685	NC_000023.11:43958644:T:C	T	C	CLINICAL
NM_203475.3(PORCN):c.565T>C (p.Trp189Arg)	PORCN	W189R, W118R	Normal	Focal dermal hypoplasia	Likely pathogenic	no assertion criteria provided	VCV000374245	X	48370986	X	48512598	374245	361152	rs1057519006	NC_000023.11:48512597:T:C	T	C	CLINICAL
NM_001145073.3(USP27X):c.1141T>C (p.Tyr381His)	USP27X	Y381H	Normal	Mental retardation, X-linked 105	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000254685	X	49646051	X	49881448	254685	249261	rs886038211	NC_000023.11:49881447:T:C	T	C	CLINICAL
NM_004187.5(KDM5C):c.1353C>G (p.Ser451Arg)	KDM5C	S451R, S384R, S450R	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: May 1, 2006)	no assertion criteria provided	VCV000009776	X	53240727	X	53211545	9776	24815	rs199422237	NC_000023.11:53211544:G:C	G	C	CLINICAL
NM_004187.5(KDM5C):c.255C>G (p.Tyr85Ter)	KDM5C	Y85*	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813905	X	53247554	X	53218372	813905	802237	rs1602231587	NC_000023.11:53218371:G:C	G	C	CLINICAL
NM_001111125.3(IQSEC2):c.2460-2A>G	IQSEC2		Normal	Mental retardation, X-linked 1	Likely pathogenic(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000651293	X	53277420	X	53248238	651293	653790	rs1602279457	NC_000023.11:53248237:T:C	T	C	CLINICAL
NM_001281463.1(SMC1A):c.2908-2A>G	SMC1A		Normal	Wiedemann-Steiner syndrome|Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000180198	X	53410176	X	53383255	180198	178384	rs727503774	NC_000023.11:53383254:T:C	T	C	CLINICAL
NM_001037811.2(HSD17B10):c.713A>G (p.Asn238Ser)	HSD17B10	N247S, N238S	Normal	HSD10 disease	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000011444	X	53458398	X	53431450	11444	26483	rs122461163	NC_000023.11:53431449:T:C	T	C	CLINICAL
NM_001037811.2(HSD17B10):c.607A>G (p.Lys203Glu)	HSD17B10	K212E, K203E	Normal	not provided|HSD10 disease	Pathogenic(Last reviewed: Sep 15, 2016)	criteria provided, single submitter	VCV000280839	X	53458504	X	53431556	280839	265040	rs886041974	NC_000023.11:53431555:T:C	T	C	CLINICAL
NM_001037811.2(HSD17B10):c.364C>G (p.Leu122Val)	HSD17B10	L122V	Normal	HSD10 disease	Pathogenic(Last reviewed: May 1, 2003)	no assertion criteria provided	VCV000011443	X	53459058	X	53432110	11443	26482	rs28935476	NC_000023.11:53432109:G:C	G	C	CLINICAL
NM_001037811.2(HSD17B10):c.257A>G (p.Asp86Gly)	HSD17B10	D86G	Normal	HSD10 disease	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000144033	X	53459295	X	53432347	144033	153772	rs587777651	NC_000023.11:53432346:T:C	T	C	CLINICAL
NM_031407.7(HUWE1):c.12469C>G (p.Leu4157Val)	HUWE1	L4157V	Normal	not provided|Intellectual disability|Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000375722	X	53563170	X	53536209	375722	362602	rs1556912828	NC_000023.11:53536208:G:C	G	C	CLINICAL
NM_031407.7(HUWE1):c.12317A>G (p.Tyr4106Cys)	HUWE1	Y4106C	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375721	X	53563449	X	53536488	375721	362603	rs1556913180	NC_000023.11:53536487:T:C	T	C	CLINICAL
NM_031407.7(HUWE1):c.12225C>G (p.Asn4075Lys)	HUWE1	N4075K	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375720	X	53563541	X	53536580	375720	362604	rs1556913258	NC_000023.11:53536579:G:C	G	C	CLINICAL
NM_031407.7(HUWE1):c.6267T>G (p.Ile2089Met)	HUWE1	I2089M	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375716	X	53600755	X	53573795	375716	362608	rs1556955128	NC_000023.11:53573794:A:C	A	C	CLINICAL
NM_031407.7(HUWE1):c.3982A>G (p.Met1328Val)	HUWE1	M1328V	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375714	X	53618073	X	53591113	375714	362610	rs1556978515	NC_000023.11:53591112:T:C	T	C	CLINICAL
NM_031407.7(HUWE1):c.2007T>G (p.His669Gln)	HUWE1	H669Q	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375713	X	53642747	X	53615786	375713	362611	rs1557006873	NC_000023.11:53615785:A:C	A	C	CLINICAL
NM_031407.7(HUWE1):c.145-2A>G	HUWE1		Normal	Syndromic X-linked intellectual disability Turner type|Trigonocephaly-short stature-developmental delay syndrome	Likely pathogenic	criteria provided, single submitter	VCV000617512	X	53674519	X	53647576	617512	608875	rs1569509136	NC_000023.11:53647575:T:C	T	C	CLINICAL
NM_015107.3(PHF8):c.2444-2A>G	PHF8		Normal	Syndromic X-linked intellectual disability Siderius type	Likely pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000666346	X	53989374	X	53962941	666346	653919	rs1603305030	NC_000023.11:53962940:T:C	T	C	CLINICAL
NM_021120.4(DLG3):c.357+1G>C	DLG3		Normal	X-Linked mental retardation 90	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000127193	X	69665409	X	70445559	127193	132677	rs587777359	NC_000023.11:70445558:G:C	G	C	CLINICAL
NM_021120.4(DLG3):c.985+1G>C	DLG3		Normal	X-Linked mental retardation 90	Pathogenic(Last reviewed: Apr 11, 2014)	no assertion criteria provided	VCV000127194	X	69670634	X	70450784	127194	132678	rs587777360	NC_000023.11:70450783:G:C	G	C	CLINICAL
NM_005120.3(MED12):c.224G>C (p.Ser75Thr)	MED12	S75T	Normal	FG syndrome 1	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804025	X	70339555	X	71119705	804025	792495	rs867655376	NC_000023.11:71119704:G:C	G	C	CLINICAL
NM_005120.3(MED12):c.3493T>C (p.Ser1165Pro)	MED12	S1165P	Normal	Ohdo syndrome, X-linked|FG syndrome 1	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV000050280	X	70348981	X	71129131	50280	59421	rs387907361	NC_000023.11:71129130:T:C	T	C	CLINICAL
NM_005120.3(MED12):c.4669T>C (p.Trp1557Arg)	MED12	W1557R	Normal	FG syndrome 1|not provided	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000196905	X	70354258	X	71134408	196905	194066	rs794727576	NC_000023.11:71134407:T:C	T	C	CLINICAL
NM_005120.3(MED12):c.6476A>C (p.Gln2159Pro)	MED12	Q2159P	Normal	Ohdo syndrome, X-linked|FG syndrome 1|not provided	Likely pathogenic(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000427070	X	70361800	X	71141950	427070	415813	rs1085307941	NC_000023.11:71141949:A:C	A	C	CLINICAL
NM_004606.5(TAF1):c.2359T>C (p.Cys787Arg)	TAF1	C766R, C787R	Normal	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219115	X	70607243	X	71387393	219115	216917	rs864321628	NC_000023.11:71387392:T:C	T	C	CLINICAL
NM_004606.5(TAF1):c.2866G>C (p.Asp956His)	TAF1	D935H, D956H	Normal	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: Dec 3, 2015)	no assertion criteria provided	VCV000219118	X	70612503	X	71392653	219118	216920	rs864321631	NC_000023.11:71392652:G:C	G	C	CLINICAL
NM_004606.5(TAF1):c.3950T>C (p.Ile1317Thr)	TAF1	I1296T, I1317T	Normal	Mental retardation, X-linked, syndromic 33	Pathogenic(Last reviewed: May 12, 2021)	criteria provided, single submitter	VCV000219114	X	70621541	X	71401691	219114	216916	rs864321627	NC_000023.11:71401690:T:C	T	C	CLINICAL
NM_181672.3(OGT):c.762G>C (p.Leu254Phe)	OGT	L244F, L254F	Normal	Intellectual disability, X-linked 106	Pathogenic	no assertion criteria provided	VCV000804282	X	70775073	X	71555223	804282	792638	rs1131692155	NC_000023.11:71555222:G:C	G	C	CLINICAL
NM_181672.3(OGT):c.851G>C (p.Arg284Pro)	OGT	R284P, R274P	Normal	Intellectual disability, X-linked 106	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000428571	X	70775162	X	71555312	428571	420005	rs1114167891	NC_000023.11:71555311:G:C	G	C	CLINICAL
NM_018486.3(HDAC8):c.584T>G (p.Val195Gly)	HDAC8	V195G, V104G	Normal	4-5 finger syndactyly|Clinodactyly of the 5th finger|Abnormality of the face|Atrial septal defect|Intellectual disability|Polycystic kidney disease	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523523	X	71710823	X	72490973	523523	514145	rs1556009247	NC_000023.11:72490972:A:C	A	C	CLINICAL
NM_018486.3(HDAC8):c.466A>G (p.Asn156Asp)	HDAC8	N156D, N65D	Normal	not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	VCV000691250	X	71715090	X	72495240	691250	678954	rs1603083434	NC_000023.11:72495239:T:C	T	C	CLINICAL
NM_006517.5(SLC16A2):c.1190T>C (p.Leu397Pro)	SLC16A2	L397P	Normal	Allan-Herndon-Dudley syndrome|Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000011636	X	73749067	X	74529232	11636	26675	rs122455132	NC_000023.11:74529231:T:C	T	C	CLINICAL
NM_006517.5(SLC16A2):c.1253T>C (p.Leu418Pro)	SLC16A2	L418P	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Apr 11, 2013)	no assertion criteria provided	VCV000042110	X	73749130	X	74529295	42110	51276	rs367543059	NC_000023.11:74529294:T:C	T	C	CLINICAL
NM_006517.5(SLC16A2):c.1313T>C (p.Leu438Pro)	SLC16A2	L438P	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000011632	X	73749190	X	74529355	11632	26671	rs104894931	NC_000023.11:74529354:T:C	T	C	CLINICAL
NM_006517.5(SLC16A2):c.1481T>C (p.Leu494Pro)	SLC16A2	L494P	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000011638	X	73751249	X	74531414	11638	26677	rs104894938	NC_000023.11:74531413:T:C	T	C	CLINICAL
NM_016120.4(RLIM):c.1760C>G (p.Pro587Arg)	RLIM	P587R	Normal	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000253087	X	73811390	X	74591555	253087	247498	rs1569309474	NC_000023.11:74591554:G:C	G	C	CLINICAL
NM_016120.4(RLIM):c.1067A>G (p.Tyr356Cys)	RLIM	Y356C	Normal	Non-syndromic X-linked intellectual disability|Mental retardation, X-linked 61|Global developmental delay	Pathogenic	criteria provided, single submitter	VCV000156224	X	73812083	X	74592248	156224	166020	rs786205133	NC_000023.11:74592247:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.7201-2A>G	ATRX		Normal	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Mar 6, 2000)	no assertion criteria provided	VCV000011737	X	76764109	X	77508631	11737	26776	rs1569513021	NC_000023.11:77508630:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.6811A>G (p.Arg2271Gly)	ATRX	R2271G, R2233G	Normal	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Nov 15, 2005)	no assertion criteria provided	VCV000011746	X	76778768	X	77523290	11746	26785	rs122445112	NC_000023.11:77523289:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.6488A>G (p.Tyr2163Cys)	ATRX	Y2125C, Y2163C	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011727	X	76814156	X	77558685	11727	26766	rs122445098	NC_000023.11:77558684:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.6104A>G (p.Asp2035Gly)	ATRX	D2035G, D1997G	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804033	X	76849172	X	77593702	804033	792503	rs122445096	NC_000023.11:77593701:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.5048A>G (p.Tyr1683Cys)	ATRX	Y1645C, Y1683C	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Likely pathogenic(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV000692089	X	76888781	X	77633293	692089	679816	rs1602979414	NC_000023.11:77633292:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.4826A>G (p.His1609Arg)	ATRX	H1571R, H1609R	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011721	X	76889184	X	77633696	11721	26760	rs122445093	NC_000023.11:77633695:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.4558-3T>G	ATRX		Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic	criteria provided, single submitter	VCV000694709	X	76891550	X	77636059	694709	682845	rs1602996115	NC_000023.11:77636058:A:C	A	C	CLINICAL
NM_000489.5(ATRX):c.751A>G (p.Lys251Glu)	ATRX	K251E, K213E	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Jul 15, 1997)	no assertion criteria provided	VCV000011733	X	76939997	X	77684505	11733	26772	rs1569539477	NC_000023.11:77684504:T:C	T	C	CLINICAL
NM_000489.5(ATRX):c.729C>G (p.Cys243Trp)	ATRX	C243W, C205W	Normal	Alpha thalassemia-X-linked intellectual disability syndrome|not provided	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000391590	X	76940019	X	77684527	391590	379543	rs1057524153	NC_000023.11:77684526:G:C	G	C	CLINICAL
NM_000489.5(ATRX):c.568C>G (p.Pro190Ala)	ATRX	P152A, P190A	Normal	Alpha thalassemia-X-linked intellectual disability syndrome|X-linked intellectual disability-hypotonic face syndrome|Alpha thalassemia-X-linked intellectual disability syndrome	Likely pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	VCV000011734	X	76944337	X	77688844	11734	26773	rs122445103	NC_000023.11:77688843:G:C	G	C	CLINICAL
NM_000489.5(ATRX):c.536A>G (p.Asn179Ser)	ATRX	N179S, N141S	Normal	X-linked intellectual disability-hypotonic face syndrome|not provided|Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093141	X	76944369	X	77688876	93141	99048	rs398123425	NC_000023.11:77688875:T:C	T	C	CLINICAL
NM_000291.4(PGK1):c.263T>C (p.Leu88Pro)	PGK1	L88P	Normal	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: Mar 15, 1991)	no assertion criteria provided	VCV000009946	X	77369387	X	78113890	9946	24985	rs137852531	NC_000023.11:78113889:T:C	T	C	CLINICAL
NM_000291.4(PGK1):c.946T>C (p.Cys316Arg)	PGK1	C315R, C316R	Normal	Phosphoglycerate kinase 1 deficiency	Pathogenic(Last reviewed: May 15, 1992)	no assertion criteria provided	VCV000009948	X	77380380	X	78124883	9948	24987	rs137852533	NC_000023.11:78124882:T:C	T	C	CLINICAL
NM_153252.5(BRWD3):c.4786A>G (p.Lys1596Glu)	BRWD3	K1596E	Normal	Mental retardation, X-linked 93	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010804	X	79932731	X	80677232	10804	25843	rs137853272	NC_000023.11:80677231:T:C	T	C	CLINICAL
NM_153252.5(BRWD3):c.4255T>G (p.Leu1419Val)	BRWD3	L1419V	Normal	Mental retardation, X-linked 93	Likely pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	VCV000216895	X	79938106	X	80682607	216895	213673	rs863224851	NC_000023.11:80682606:A:C	A	C	CLINICAL
NM_001330574.2(ZNF711):c.731T>C (p.Ile244Thr)	ZNF711	I244T	Normal	ZNF711-Related X-linked Mental Retardation|Intellectual disability	Likely pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000417762	X	84519389	X	85264383	417762	404663	rs1060505033	NC_000023.11:85264382:T:C	T	C	CLINICAL
NM_004586.3(RPS6KA3):c.646A>G (p.Lys216Glu)	RPS6KA3	K216E	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000522803	X	20206074	X	20187956	522803	513482	rs1555939456	NC_000023.11:20187955:T:C	T	C	CLINICAL
NM_000444.6(PHEX):c.1739A>G (p.His580Arg)	PHEX|PTCHD1-AS	H580R	Normal	Familial X-linked hypophosphatemic vitamin D refractory rickets|not provided	Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000383966	X	22237191	X	22219074	383966	379204	rs1057521800	NC_000023.11:22219073:A:G	A	G	CLINICAL
NM_031442.4(TMEM47):c.35G>C (p.Arg12Pro)	TMEM47	R12P	Normal	Muscular hypotonia|Cerebellar atrophy|Hypoplasia of the corpus callosum|Attention deficit hyperactivity disorder|Dandy-Walker syndrome|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242889	X	34675112	X	34656995	242889	244002	rs1114167296	NC_000023.11:34656994:C:G	C	G	CLINICAL
NM_001356.5(DDX3X):c.113A>G	DDX3X	Y38C	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000545446	X	41198298	X	41339045	545446	535712	rs1555951993	NC_000023.11:41339044:A:G	A	G	CLINICAL
NM_001356.5(DDX3X):c.173C>G (p.Ser58Ter)	DDX3X	S58*, S42*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803981	X	41200758	X	41341505	803981	792451	rs1602126980	NC_000023.11:41341504:C:G	C	G	CLINICAL
NM_001356.5(DDX3X):c.1148C>G (p.Ala383Gly)	DDX3X	A197G, A383G, A367G	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jun 19, 2018)	no assertion criteria provided	VCV000807402	X	41204555	X	41345302	807402	798813	rs1602134248	NC_000023.11:41345301:C:G	C	G	CLINICAL
NM_001356.5(DDX3X):c.1316-2A>G	DDX3X		Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000807403	X	41205480	X	41346227	807403	798814	rs1602135698	NC_000023.11:41346226:A:G	A	G	CLINICAL
NM_001356.4(DDX3X):c.1429C>G (p.Gln477Glu)	DDX3X	Q477E, Q461E, Q291E	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	VCV000559627	X	41205595	X	41346342	559627	550377	rs1555954105	NC_000023.11:41346341:C:G	C	G	CLINICAL
NM_001356.4(DDX3X):c.1600C>G (p.Arg534Gly)	DDX3X	R348G, R518G, R534G	Normal	Mental retardation, X-linked 102	Pathogenic	criteria provided, single submitter	VCV000694687	X	41205860	X	41346607	694687	682836	rs1555954284	NC_000023.11:41346606:C:G	C	G	CLINICAL
NM_001029896.2(WDR45):c.827+1G>C	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000573902	X	48933022	X	49075363	573902	572515	rs1557083958	NC_000023.11:49075362:C:G	C	G	CLINICAL
NM_001029896.2(WDR45):c.516G>C (p.Val172=)	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000041913	X	48933525	X	49075866	41913	51082	rs387907330	NC_000023.11:49075865:C:G	C	G	CLINICAL
NM_001029896.2(WDR45):c.437-2A>C	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000473122	X	48933606	X	49075947	473122	471614	rs886041693	NC_000023.11:49075946:T:G	T	G	CLINICAL
NM_001029896.2(WDR45):c.342-2A>C	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689799	X	48934185	X	49076526	689799	677472	rs1602539140	NC_000023.11:49076525:T:G	T	G	CLINICAL
NM_001029896.2(WDR45):c.341+4A>C	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000635758	X	48934300	X	49076641	635758	623593	rs1602539322	NC_000023.11:49076640:T:G	T	G	CLINICAL
NM_001029896.2(WDR45):c.185T>C (p.Leu62Pro)	WDR45	L62P	Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000813807	X	48935352	X	49077693	813807	802052	rs1602540295	NC_000023.11:49077692:A:G	A	G	CLINICAL
NM_001029896.2(WDR45):c.170T>C (p.Leu57Pro)	WDR45	L57P	Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804000	X	48935367	X	49077708	804000	792470	rs1602540331	NC_000023.11:49077707:A:G	A	G	CLINICAL
NM_001042537.1(SLC9A6):c.2078T>G (p.Leu693Ter)	SLC9A6	L693*, L641*, L609*, L661*	Normal	Christianson syndrome	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000159932	X	135126855	X	136044696	159932	169942	rs587784399	NC_000023.11:136044695:T:G	T	G	CLINICAL
NM_001110792.2(MECP2):c.500T>C (p.Phe167Ser)	MECP2	F155S, F167S, F62S	Normal	Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000011810	X	153296815	X	154031364	11810	26849	rs28934905	NC_000023.11:154031363:A:G	A	G	CLINICAL
NM_004992.3(MECP2):c.378-2A>C	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Mar 31, 2003)	no assertion criteria provided	VCV000156065	X	153296903	X	154031452	156065	165861	rs267608464	NC_000023.11:154031451:T:G	T	G	CLINICAL
NM_018196.4(TMLHE):c.730G>C (p.Asp244His)	TMLHE	D244H	Normal	Autism, susceptibility to, X-linked 6	risk factor(Last reviewed: Oct 23, 2012)	no assertion criteria provided	VCV000225229	X	154741362	X	155511701	225229	227143	rs869320708	NC_000023.11:155511700:C:G	C	G	CLINICAL
NM_000054.6(AVPR2):c.313T>G (p.Phe105Val)	AVPR2	F105V	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000010851	X	153171273	X	153905819	10851	25890	rs104894758	NC_000023.11:153905818:T:G	T	G	CLINICAL
NM_000054.6(AVPR2):c.614A>G (p.Tyr205Cys)	AVPR2	Y205C	Normal	Nephrogenic diabetes insipidus, X-linked|Nephrogenic diabetes insipidus	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000010838	X	153171574	X	153906120	10838	25877	rs104894749	NC_000023.11:153906119:A:G	A	G	CLINICAL
NM_000054.6(AVPR2):c.839A>G (p.Tyr280Cys)	AVPR2	Y280C	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Aug 30, 1994)	no assertion criteria provided	VCV000010843	X	153171799	X	153906345	10843	25882	rs104894752	NC_000023.11:153906344:A:G	A	G	CLINICAL
NM_001184880.2(PCDH19):c.1469A>C (p.Tyr490Ser)	PCDH19	Y490S	Normal	not provided|Early infantile epileptic encephalopathy 9|Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	VCV000451251	X	99662127	X	100407129	451251	446441	rs1555985142	NC_000023.11:100407128:T:G	T	G	CLINICAL
NM_001184880.2(PCDH19):c.745G>C (p.Glu249Gln)	PCDH19	E249Q	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV000664153	X	99662851	X	100407853	664153	649579	rs1602637340	NC_000023.11:100407852:C:G	C	G	CLINICAL
NM_001184880.2(PCDH19):c.268G>C (p.Asp90His)	PCDH19	D90H	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Jun 30, 2018)	criteria provided, single submitter	VCV000465301	X	99663328	X	100408330	465301	471210	rs1555985780	NC_000023.11:100408329:C:G	C	G	CLINICAL
NM_004085.4(TIMM8A):c.133-23A>C	TIMM8A		Normal	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011325	X	100601671	X	101346683	11325	26364	rs869320666	NC_000023.11:101346682:T:G	T	G	CLINICAL
NM_004085.4(TIMM8A):c.127T>C (p.Cys43Arg)	TIMM8A	C43R	Normal	Deafness dystonia syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804062	X	100603526	X	101348538	804062	792099	rs1602996815	NC_000023.11:101348537:A:G	A	G	CLINICAL
NM_001830.4(CLCN4):c.661C>G (p.Leu221Val)	CLCN4	L221V, L127V	Normal	Mental retardation 49, X-linked	Pathogenic(Last reviewed: Nov 7, 2018)	no assertion criteria provided	VCV000253115	X	10174503	X	10206463	253115	247527	rs1569230006	NC_000023.11:10206462:C:G	C	G	CLINICAL
NM_000533.5(PLP1):c.658T>G (p.Cys220Gly)	PLP1|RAB9B	C220G, C165G, C185G	Normal	Intellectual disability|Pelizaeus-Merzbacher disease	Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000545437	X	103043401	X	103788472	545437	535711	rs1556270312	NC_000023.11:103788471:T:G	T	G	CLINICAL
NM_002764.3(PRPS1):c.341A>G (p.Asn114Ser)	PRPS1	N114S	Normal	Arts syndrome|Phosphoribosylpyrophosphate synthetase superactivity|Inborn genetic diseases	Likely pathogenic(Last reviewed: Apr 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009928	X	106884166	X	107640936	9928	24967	rs137852540	NC_000023.11:107640935:A:G	A	G	CLINICAL
NM_001204402.1(PRPS1):c.-34C>G	PRPS1	H193Q	Normal	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009933	X	106888455	X	107645225	9933	24972	rs137852545	NC_000023.11:107645224:C:G	C	G	CLINICAL
NM_001099922.3(ALG13):c.320A>G (p.Asn107Ser)	ALG13	N107S, N3S, N109S, N29S	Normal	Intellectual disability|Rare genetic intellectual disability|not provided|Seizures|Epileptic encephalopathy, early infantile, 36	Pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000066086	X	110928268	X	111685040	66086	76988	rs398122394	NC_000023.11:111685039:A:G	A	G	CLINICAL
NM_024528.4(NKAP):c.1010T>C (p.Ile337Thr)	NKAP	I337T	Normal	Intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827656	X	119064042	X	119930079	827656	815860	rs1603379772	NC_000023.11:119930078:A:G	A	G	CLINICAL
NM_013995.2(LAMP2):c.961T>C (p.Trp321Arg)	LAMP2	W321R	Normal	Danon disease	Pathogenic(Last reviewed: Jun 1, 2005)	no assertion criteria provided	VCV000009983	X	119575717	X	120441862	9983	25022	rs104894859	NC_000023.11:120441861:A:G	A	G	CLINICAL
NM_001081550.2(THOC2):c.3503+4A>C	THOC2		Normal	Mental retardation, X-linked 12	Likely pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488433	X	122757634	X	123623783	488433	481301	rs1556015437	NC_000023.11:123623782:T:G	T	G	CLINICAL
NM_001081550.2(THOC2):c.3034T>C (p.Ser1012Pro)	THOC2	S1012P	Normal	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208525	X	122759786	X	123625935	208525	205043	rs797045020	NC_000023.11:123625934:A:G	A	G	CLINICAL
NM_001081550.2(THOC2):c.2399T>C (p.Ile800Thr)	THOC2	I800T	Normal	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208526	X	122765621	X	123631770	208526	205044	rs797045021	NC_000023.11:123631769:A:G	A	G	CLINICAL
NM_001081550.2(THOC2):c.1313T>C (p.Leu438Pro)	THOC2	L438P	Normal	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208523	X	122799566	X	123665715	208523	205041	rs797045018	NC_000023.11:123665714:A:G	A	G	CLINICAL
NM_001081550.2(THOC2):c.149A>C (p.Tyr50Ser)	THOC2	Y50S	Normal	Mental retardation, X-linked 12	Likely pathogenic(Last reviewed: Aug 8, 2019)	no assertion criteria provided	VCV000807709	X	122840781	X	123706931	807709	798803	rs1603326578	NC_000023.11:123706930:T:G	T	G	CLINICAL
NM_016032.4(ZDHHC9):c.167+5G>C	ZDHHC9		Normal	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010710	X	128975750	X	129841774	10710	25749	rs606231183	NC_000023.11:129841773:C:G	C	G	CLINICAL
NM_004208.4(AIFM1):c.1019T>C (p.Met340Thr)	AIFM1|RAB33A	M340T, M1T, M336T	Normal	Pes planus|Distal muscle weakness|Foot dorsiflexor weakness|Sensorineural hearing loss|not provided|Cowchock syndrome|Combined oxidative phosphorylation deficiency|Charcot-Marie-Tooth Neuropathy X	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374094	X	129271109	X	130137134	374094	361080	rs1057518895	NC_000023.11:130137133:A:G	A	G	CLINICAL
NM_004208.4(AIFM1):c.705G>C (p.Gln235His)	AIFM1|RAB33A	Q235H, Q231H	Normal	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	Pathogenic(Last reviewed: Nov 27, 2019)	no assertion criteria provided	VCV000694667	X	129274584	X	130140609	694667	682786	rs377527583	NC_000023.11:130140608:C:G	C	G	CLINICAL
NM_001077188.2(HS6ST2):c.916G>C (p.Gly306Arg)	HS6ST2	G306R	Normal	Paganini-Miozzo syndrome	Pathogenic(Last reviewed: Jun 18, 2019)	no assertion criteria provided	VCV000633697	X	132090867	X	132956839	633697	622129	rs866919041	NC_000023.11:132956838:C:G	C	G	CLINICAL
NM_001015877.2(PHF6):c.139-8A>G	PHF6		Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000011071	X	133512027	X	134377997	11071	26110	rs771399346	NC_000023.11:134377996:A:G	A	G	CLINICAL
NM_001015877.2(PHF6):c.686A>G (p.His229Arg)	PHF6	H229R, H230R	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011067	X	133547953	X	134413923	11067	26106	rs104894918	NC_000023.11:134413922:A:G	A	G	CLINICAL
NM_001015877.2(PHF6):c.700A>G (p.Lys234Glu)	PHF6	K234E, K235E	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011065	X	133547967	X	134413937	11065	26104	rs104894917	NC_000023.11:134413936:A:G	A	G	CLINICAL
NM_001015877.2(PHF6):c.769A>G (p.Arg257Gly)	PHF6	R257G, R258G	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000011069	X	133549085	X	134415055	11069	26108	rs104894919	NC_000023.11:134415054:A:G	A	G	CLINICAL
NM_001042537.1(SLC9A6):c.2078T>G (p.Leu693Ter)	SLC9A6	L693*, L641*, L609*, L661*	Normal	Christianson syndrome	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000159932	X	135126855	X	136044696	159932	169942	rs587784399	NC_000023.11:136044695:T:G	T	G	CLINICAL
NM_002024.5(FMR1):c.199-2A>G	FMR1		Normal	Autistic behavior|Intellectual disability	Likely pathogenic(Last reviewed: Nov 6, 2015)	criteria provided, single submitter	VCV000374035	X	147009838	X	147928320	374035	361081	rs1057518850	NC_000023.11:147928319:A:G	A	G	CLINICAL
NM_002024.5(FMR1):c.420-8A>G	FMR1		Normal	Intellectual disability	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, single submitter	VCV000268182	X	147011459	X	147929940	268182	263802	rs886041088	NC_000023.11:147929939:A:G	A	G	CLINICAL
NM_000202.8(IDS):c.1025A>C (p.His342Pro)	IDS|LOC106050102	H342P, H252P	Normal	Mucopolysaccharidosis, MPS-II	Likely pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000221972	X	148568611	X	149487080	221972	223660	rs869025303	NC_000023.11:149487079:T:G	T	G	CLINICAL
NM_000202.8(IDS):c.508-1G>C	IDS|LOC106050102		Normal	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Oct 18, 2015)	criteria provided, single submitter	VCV000221977	X	148579839	X	149498308	221977	223664	rs113993947	NC_000023.11:149498307:C:G	C	G	CLINICAL
NM_000202.8(IDS):c.133G>C (p.Asp45His)	IDS	D45H	Normal	Mucopolysaccharidosis, MPS-II	Likely pathogenic(Last reviewed: Feb 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000221970	X	148585794	X	149504264	221970	223666	rs869025301	NC_000023.11:149504263:C:G	C	G	CLINICAL
NM_005629.4(SLC6A8):c.263-2A>G	SLC6A8		Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000011701	X	152955828	X	153690373	11701	26740	rs1569539244	NC_000023.11:153690372:A:G	A	G	CLINICAL
NM_005629.4(SLC6A8):c.1011C>G (p.Cys337Trp)	SLC6A8	C337W, C222W	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Jul 1, 2004)	no assertion criteria provided	VCV000011702	X	152958816	X	153693361	11702	26741	rs122453116	NC_000023.11:153693360:C:G	C	G	CLINICAL
NM_005629.4(SLC6A8):c.1473C>G (p.Cys491Trp)	SLC6A8	C491W, C481W, C376W	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000011704	X	152959879	X	153694424	11704	26743	rs122453118	NC_000023.11:153694423:C:G	C	G	CLINICAL
NM_005629.4(SLC6A8):c.1494C>G (p.Tyr498Ter)	SLC6A8	Y383*, Y488*, Y498*	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000827674	X	152959900	X	153694445	827674	815874	rs143916832	NC_000023.11:153694444:C:G	C	G	CLINICAL
NM_005629.4(SLC6A8):c.1659C>G (p.Tyr553Ter)	SLC6A8	Y553*, Y543*, Y438*	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000580873	X	152960236	X	153694781	580873	575353	rs1569539466	NC_000023.11:153694780:C:G	C	G	CLINICAL
NM_001278116.2(L1CAM):c.3458-1G>C	L1CAM		Normal	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000029986	X	153129005	X	153863550	29986	38941	rs879253724	NC_000023.11:153863549:C:G	C	G	CLINICAL
NM_001278116.2(L1CAM):c.2432-19A>C	L1CAM		Normal	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000009985	X	153131293	X	153865838	9985	25024	rs879253713	NC_000023.11:153865837:T:G	T	G	CLINICAL
NM_000054.6(AVPR2):c.614A>G (p.Tyr205Cys)	AVPR2	Y205C	Normal	Nephrogenic diabetes insipidus, X-linked|Nephrogenic diabetes insipidus	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	VCV000010838	X	153171574	X	153906120	10838	25877	rs104894749	NC_000023.11:153906119:A:G	A	G	CLINICAL
NM_005334.3(HCFC1):c.-970T>C	HCFC1		Normal	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039694	X	153237261	X	153971810	39694	48293	rs398122908	NC_000023.11:153971809:A:G	A	G	CLINICAL
NM_001291867.2(NHS):c.4448C>G (p.Ser1483Cys)	NHS	S1462C, S1306C, S1483C, S1285C	Normal	Nance-Horan syndrome|Syndromic intellectual disability, X-linked	Pathogenic(Last reviewed: Feb 12, 2017)	criteria provided, single submitter	VCV000375706	X	17750076	X	17731956	375706	362596	rs1481421967	NC_000023.11:17731955:C:G	C	G	CLINICAL
NM_004586.3(RPS6KA3):c.1762G>C (p.Glu588Gln)	RPS6KA3	E588Q	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Apr 12, 2016)	no assertion criteria provided	VCV000438301	X	20183019	X	20164901	438301	431932	rs1555927532	NC_000023.11:20164900:C:G	C	G	CLINICAL
NM_004586.3(RPS6KA3):c.803T>C (p.Phe268Ser)	RPS6KA3	F268S	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Dec 1, 2003)	no assertion criteria provided	VCV000011666	X	20204456	X	20186338	11666	26705	rs122454131	NC_000023.11:20186337:A:G	A	G	CLINICAL
NM_004586.3(RPS6KA3):c.774+1G>C	RPS6KA3		Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547764	X	20205945	X	20187827	547764	538308	rs1555939331	NC_000023.11:20187826:C:G	C	G	CLINICAL
NM_004586.3(RPS6KA3):c.632-1G>C	RPS6KA3		Normal	not provided|Coffin-Lowry syndrome	Pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	VCV000095150	X	20206089	X	20187971	95150	101050	rs398124177	NC_000023.11:20187970:C:G	C	G	CLINICAL
NM_004586.3(RPS6KA3):c.326-1G>C	RPS6KA3		Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Nov 1, 1998)	no assertion criteria provided	VCV000011654	X	20213264	X	20195146	11654	26693	rs587776755	NC_000023.11:20195145:C:G	C	G	CLINICAL
NM_004595.5(SMS):c.395T>G (p.Val132Gly)	SMS	V132G, V79G	Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Mar 1, 2009)	no assertion criteria provided	VCV000011625	X	21995244	X	21977126	11625	26664	rs267607076	NC_000023.11:21977125:T:G	T	G	CLINICAL
NM_004595.5(SMS):c.443A>G (p.Gln148Arg)	SMS	Q148R, Q95R	Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jun 27, 2013)	no assertion criteria provided	VCV000065679	X	21995292	X	21977174	65679	76587	rs397515551	NC_000023.11:21977173:A:G	A	G	CLINICAL
NM_004595.5(SMS):c.983A>G (p.Tyr328Cys)	SMS	Y328C, Y275C	Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Sep 15, 2013)	no assertion criteria provided	VCV000088767	X	22010752	X	21992634	88767	94346	rs397515553	NC_000023.11:21992633:A:G	A	G	CLINICAL
NM_001415.4(EIF2S3):c.433A>G (p.Met145Val)	EIF2S3	M145V	Normal	MEHMO syndrome	Likely pathogenic(Last reviewed: Dec 19, 2017)	no assertion criteria provided	VCV000804299	X	24078254	X	24060137	804299	792655	rs1602041478	NC_000023.11:24060136:A:G	A	G	CLINICAL
NM_001415.4(EIF2S3):c.777T>G (p.Ile259Met)	EIF2S3	I259M	Normal	MEHMO syndrome	Pathogenic(Last reviewed: Jan 18, 2018)	no assertion criteria provided	VCV000267206	X	24084119	X	24066002	267206	262085	rs886040856	NC_000023.11:24066001:T:G	T	G	CLINICAL
NM_001330360.2(POLA1):c.254T>G (p.Ile85Ser)	POLA1	I79S, I85S	Normal	Van Esch-O'Driscoll syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627632	X	24721453	X	24703336	627632	615987	rs1569271378	NC_000023.11:24703335:T:G	T	G	CLINICAL
NM_139058.3(ARX):c.98T>C (p.Leu33Pro)	ARX	L33P	Normal	Mental retardation, with or without seizures, ARX-related, X-linked	Pathogenic(Last reviewed: Apr 15, 2002)	no assertion criteria provided	VCV000011198	X	25033757	X	25015640	11198	26237	rs28936077	NC_000023.11:25015639:A:G	A	G	CLINICAL
NM_031442.4(TMEM47):c.35G>C (p.Arg12Pro)	TMEM47	R12P	Normal	Muscular hypotonia|Cerebellar atrophy|Hypoplasia of the corpus callosum|Attention deficit hyperactivity disorder|Dandy-Walker syndrome|Global developmental delay	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000242889	X	34675112	X	34656995	242889	244002	rs1114167296	NC_000023.11:34656994:C:G	C	G	CLINICAL
NM_001039591.3(USP9X):c.1315-4A>G	USP9X		Normal	Mental retardation, X-linked 99|not provided	Likely pathogenic(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000384654	X	41003771	X	41144518	384654	379410	rs1057522024	NC_000023.11:41144517:A:G	A	G	CLINICAL
NM_001039591.3(USP9X):c.3028-2A>G	USP9X		Normal	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000223095	X	41031089	X	41171836	223095	224822	rs869025589	NC_000023.11:41171835:A:G	A	G	CLINICAL
NM_001356.5(DDX3X):c.113A>G	DDX3X	Y38C	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000545446	X	41198298	X	41339045	545446	535712	rs1555951993	NC_000023.11:41339044:A:G	A	G	CLINICAL
NM_001356.5(DDX3X):c.173C>G (p.Ser58Ter)	DDX3X	S58*, S42*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803981	X	41200758	X	41341505	803981	792451	rs1602126980	NC_000023.11:41341504:C:G	C	G	CLINICAL
NM_001356.5(DDX3X):c.1148C>G (p.Ala383Gly)	DDX3X	A197G, A383G, A367G	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jun 19, 2018)	no assertion criteria provided	VCV000807402	X	41204555	X	41345302	807402	798813	rs1602134248	NC_000023.11:41345301:C:G	C	G	CLINICAL
NM_001356.5(DDX3X):c.1316-2A>G	DDX3X		Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Oct 16, 2019)	no assertion criteria provided	VCV000807403	X	41205480	X	41346227	807403	798814	rs1602135698	NC_000023.11:41346226:A:G	A	G	CLINICAL
NM_001356.4(DDX3X):c.1429C>G (p.Gln477Glu)	DDX3X	Q477E, Q461E, Q291E	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Oct 6, 2017)	no assertion criteria provided	VCV000559627	X	41205595	X	41346342	559627	550377	rs1555954105	NC_000023.11:41346341:C:G	C	G	CLINICAL
NM_001356.4(DDX3X):c.1600C>G (p.Arg534Gly)	DDX3X	R348G, R518G, R534G	Normal	Mental retardation, X-linked 102	Pathogenic	criteria provided, single submitter	VCV000694687	X	41205860	X	41346607	694687	682836	rs1555954284	NC_000023.11:41346606:C:G	C	G	CLINICAL
NM_001367721.1(CASK):c.2561T>C (p.Val854Ala)	CASK	V849A, V825A, V854A, V826A	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|FG syndrome 4	Likely pathogenic	criteria provided, single submitter	VCV000619127	X	41383247	X	41523994	619127	610525	rs1569283243	NC_000023.11:41523993:A:G	A	G	CLINICAL
NM_001367721.1(CASK):c.2155+1G>C	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000523666	X	41401943	X	41542690	523666	514314	rs1555977199	NC_000023.11:41542689:C:G	C	G	CLINICAL
NM_003688.3(CASK):c.1592A>C (p.His531Pro)	CASK	H531P, H525P	Normal	Mental retardation, CASK-related, X-linked	Likely pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000470207	X	41420888	X	41561635	470207	470816	rs1555981722	NC_000023.11:41561634:T:G	T	G	CLINICAL
NM_001367721.1(CASK):c.802T>C (p.Tyr268His)	CASK	Y268H	Normal	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|FG syndrome 4	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000011533	X	41519721	X	41660468	11533	26572	rs137852817	NC_000023.11:41660467:A:G	A	G	CLINICAL
NM_001367721.1(CASK):c.626T>C (p.Leu209Pro)	CASK	L209P	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000432816	X	41524612	X	41665359	432816	426464	rs1556014749	NC_000023.11:41665358:A:G	A	G	CLINICAL
NM_012280.4(FTSJ1):c.192-2A>G	FTSJ1		Normal	Mental retardation 9, X-linked	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000010897	X	48337003	X	48478615	10897	25936	rs1602048728	NC_000023.11:48478614:A:G	A	G	CLINICAL
NM_005710.2(PQBP1):c.194A>G (p.Tyr65Cys)	PQBP1	Y65C, Y57C	Normal	Renpenning syndrome 1	Pathogenic(Last reviewed: Jun 18, 2010)	no assertion criteria provided	VCV000010985	X	48759221	X	48901944	10985	26024	rs121917899	NC_000023.11:48901943:A:G	A	G	CLINICAL
NM_003179.2(SYP):c.649G>C (p.Gly217Arg)	SYP	G217R	Normal	Mental retardation, X-linked 96	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009866	X	49048187	X	49191730	9866	24905	rs137852561	NC_000023.11:49191729:C:G	C	G	CLINICAL
NM_004187.5(KDM5C):c.2152G>C (p.Ala718Pro)	KDM5C	A718P, A651P, A717P	Normal	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235844	X	53228250	X	53199068	235844	237508	rs878853141	NC_000023.11:53199067:C:G	C	G	CLINICAL
NM_004187.5(KDM5C):c.1162G>C (p.Ala388Pro)	KDM5C	A388P, A321P, A387P	Normal	Inborn genetic diseases|Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000009774	X	53241049	X	53211867	9774	24813	rs199422235	NC_000023.11:53211866:C:G	C	G	CLINICAL
NM_001111125.3(IQSEC2):c.2582+2T>C	IQSEC2		Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000599451	X	53277294	X	53248112	599451	590811	rs1569300277	NC_000023.11:53248111:A:G	A	G	CLINICAL
NM_001111125.3(IQSEC2):c.2477T>C (p.Met826Thr)	IQSEC2	M826T, M621T	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Nov 10, 2014)	criteria provided, single submitter	VCV000397526	X	53277401	X	53248219	397526	384428	rs1060499660	NC_000023.11:53248218:A:G	A	G	CLINICAL
NM_001111125.3(IQSEC2):c.2402A>C (p.Gln801Pro)	IQSEC2	Q801P, Q596P	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000010863	X	53277960	X	53248778	10863	25902	rs267607187	NC_000023.11:53248777:T:G	T	G	CLINICAL
NM_001037811.2(HSD17B10):c.718G>C (p.Glu240Gln)	HSD17B10	E249Q, E240Q	Normal	HSD10 disease	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	VCV000011446	X	53458393	X	53431445	11446	26485	rs62626305	NC_000023.11:53431444:C:G	C	G	CLINICAL
NM_004493.3(HSD17B10):c.517G>C (p.Gly173Arg)	HSD17B10	G173R	Normal	HSD10 disease	Likely pathogenic(Last reviewed: Jan 24, 2020)	no assertion criteria provided	VCV000813313	X	53458824	X	53431876	813313	801552	rs1602426573	NC_000023.11:53431875:C:G	C	G	CLINICAL
NM_031407.7(HUWE1):c.12928G>C (p.Gly4310Arg)	HUWE1	G4310R	Normal	Syndromic X-linked intellectual disability Turner type	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375725	X	53561062	X	53534101	375725	362599	rs1556909287	NC_000023.11:53534100:C:G	C	G	CLINICAL
NM_031407.7(HUWE1):c.12885G>C (p.Lys4295Asn)	HUWE1	K4295N	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375724	X	53561105	X	53534144	375724	362600	rs1325394060	NC_000023.11:53534143:C:G	C	G	CLINICAL
NM_031407.7(HUWE1):c.12732G>C (p.Glu4244Asp)	HUWE1	E4244D	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375723	X	53561576	X	53534615	375723	362601	rs1556910184	NC_000023.11:53534614:C:G	C	G	CLINICAL
NM_031407.7(HUWE1):c.9581T>C (p.Phe3194Ser)	HUWE1	F3194S	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375717	X	53576374	X	53549413	375717	362607	rs782393002	NC_000023.11:53549412:A:G	A	G	CLINICAL
NM_031407.7(HUWE1):c.567+1G>C	HUWE1		Normal	Syndromic X-linked intellectual disability Turner type	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375711	X	53661187	X	53634235	375711	362613	rs1557024919	NC_000023.11:53634234:C:G	C	G	CLINICAL
NM_015107.3(PHF8):c.1141+5G>C	PHF8		Normal	Intellectual disability	Pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235852	X	54028583	X	54002150	235852	237511	rs878853148	NC_000023.11:54002149:C:G	C	G	CLINICAL
NM_015107.3(PHF8):c.836T>C (p.Phe279Ser)	PHF8	F279S, F315S	Normal	Syndromic X-linked intellectual disability Siderius type	Pathogenic(Last reviewed: Aug 1, 2007)	no assertion criteria provided	VCV000010800	X	54037665	X	54011232	10800	25839	rs121918524	NC_000023.11:54011231:A:G	A	G	CLINICAL
NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)	ZC4H2	V63L, V40L	Normal	Wieacker-Wolff, X-linked recessive	Pathogenic(Last reviewed: May 2, 2013)	no assertion criteria provided	VCV000050980	X	64141735	X	64921855	50980	65651	rs398122938	NC_000023.11:64921854:C:G	C	G	CLINICAL
NM_021120.4(DLG3):c.1373C>G (p.Ser458Ter)	DLG3|DLG3-AS1	S458*, S121*	Normal	X-Linked mental retardation 90	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000029943	X	69674134	X	70454284	29943	38898	rs398122847	NC_000023.11:70454283:C:G	C	G	CLINICAL
NM_005120.3(MED12):c.3020A>G (p.Asn1007Ser)	MED12	N1007S	Normal	FG syndrome 1|X-linked mental retardation with marfanoid habitus syndrome|not provided	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV000011521	X	70347781	X	71127931	11521	26560	rs80338759	NC_000023.11:71127930:A:G	A	G	CLINICAL
NM_005120.3(MED12):c.3067A>G (p.Ile1023Val)	MED12	I1023V	Normal	FG syndrome 1	Pathogenic(Last reviewed: Aug 5, 2021)	no assertion criteria provided	VCV000252963	X	70347828	X	71127978	252963	247365	rs879255526	NC_000023.11:71127977:A:G	A	G	CLINICAL
NM_004606.5(TAF1):c.1520A>G (p.Asp507Gly)	TAF1	D527G, D486G, D507G	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000694242	X	70601752	X	71381902	694242	682089	rs1602481623	NC_000023.11:71381901:A:G	A	G	CLINICAL
NM_004606.5(TAF1):c.4394A>G (p.His1465Arg)	TAF1	H1485R, H1444R, H1465R	Normal	not provided|Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Jan 25, 2017)	criteria provided, single submitter	VCV000419442	X	70641168	X	71421318	419442	411477	rs1064793874	NC_000023.11:71421317:A:G	A	G	CLINICAL
NM_181672.3(OGT):c.463-6T>G	OGT		Normal	Intellectual disability, X-linked 106	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000428572	X	70764411	X	71544561	428572	420006	rs943295842	NC_000023.11:71544560:T:G	T	G	CLINICAL
NM_181672.3(OGT):c.1016A>G (p.Glu339Gly)	OGT	E329G, E339G	Normal	Intellectual disability, X-linked 106	Pathogenic	no assertion criteria provided	VCV000804284	X	70775895	X	71556045	804284	792640	rs1602147880	NC_000023.11:71556044:A:G	A	G	CLINICAL
NM_006517.5(SLC16A2):c.1079T>G (p.Leu360Trp)	SLC16A2	L360W	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000011639	X	73745637	X	74525802	11639	26678	rs104894939	NC_000023.11:74525801:T:G	T	G	CLINICAL
NM_016120.4(RLIM):c.1729T>C (p.Tyr577His)	RLIM	Y577H	Normal	Mental retardation, X-linked 61	Likely pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000598940	X	73811421	X	74591586	598940	590027	rs1569309484	NC_000023.11:74591585:A:G	A	G	CLINICAL
NM_000489.5(ATRX):c.6250T>C (p.Tyr2084His)	ATRX	Y2046H, Y2084H	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011726	X	76829791	X	77574326	11726	26765	rs122445097	NC_000023.11:77574325:A:G	A	G	CLINICAL
NM_000489.5(ATRX):c.6149T>C (p.Ile2050Thr)	ATRX	I2012T, I2050T	Normal	Inborn genetic diseases|Mental retardation-hypotonic facies syndrome, X-linked|History of neurodevelopmental disorder	Likely pathogenic(Last reviewed: Nov 3, 2016)	criteria provided, single submitter	VCV000011744	X	76845372	X	77589902	11744	26783	rs122445110	NC_000023.11:77589901:A:G	A	G	CLINICAL
NM_000489.5(ATRX):c.5405A>C (p.Lys1802Thr)	ATRX	K1764T, K1802T	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804034	X	76874317	X	77618849	804034	792504	rs1602876401	NC_000023.11:77618848:T:G	T	G	CLINICAL
NM_000489.5(ATRX):c.5039T>C (p.Ile1680Thr)	ATRX	I1680T, I1642T	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547182	X	76888790	X	77633302	547182	538323	rs1557106482	NC_000023.11:77633301:A:G	A	G	CLINICAL
NM_000489.5(ATRX):c.4840T>C (p.Cys1614Arg)	ATRX	C1576R, C1614R	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 1995)	no assertion criteria provided	VCV000011722	X	76889170	X	77633682	11722	26761	rs122445094	NC_000023.11:77633681:A:G	A	G	CLINICAL
NM_000489.5(ATRX):c.1226T>C (p.Leu409Ser)	ATRX	L409S, L371S	Normal	Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011743	X	76939522	X	77684030	11743	26782	rs122445109	NC_000023.11:77684029:A:G	A	G	CLINICAL
NM_012084.4(GLUD2):c.1492T>G (p.Ser498Ala)	GLUD2	S445A, S498A	Normal	Parkinson disease, late-onset	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000029936	X	120183030	X	121049176	29936	38891	rs9697983	NC_000023.11:121049175:T:G	T	G	CLINICAL
NM_016032.4(ZDHHC9):c.167+5G>C	ZDHHC9		Normal	Mental retardation, X-linked, syndromic, Raymond type	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010710	X	128975750	X	129841774	10710	25749	rs606231183	NC_000023.11:129841773:C:G	C	G	CLINICAL
NM_013444.4(UBQLN2):c.1319C>T (p.Pro440Leu)	UBQLN2	P440L	Normal	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Likely pathogenic(Last reviewed: Apr 14, 2020)	no assertion criteria provided	VCV000870530	X	56591625	X	56565192	870530	858692	rs763131369	NC_000023.11:56565191:C:T	C	T	CLINICAL
NM_013444.3(UBQLN2):c.1489C>T (p.Pro497Ser)	UBQLN2	P497S	Normal	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029951	X	56591795	X	56565362	29951	38906	rs387906710	NC_000023.11:56565361:C:T	C	T	CLINICAL
NM_013444.3(UBQLN2):c.1490C>T (p.Pro497Leu)	UBQLN2	P497L	Normal	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000157594	X	56591796	X	56565363	157594	167455	rs387906709	NC_000023.11:56565362:C:T	C	T	CLINICAL
NM_001399.5(EDA):c.526+5G>T	EDA		Normal	Hypohidrotic X-linked ectodermal dysplasia	Likely pathogenic(Last reviewed: Jan 26, 2015)	criteria provided, single submitter	VCV000044196	X	69243096	X	70023246	44196	53363	rs397516664	NC_000023.11:70023245:G:T	G	T	CLINICAL
NM_001323289.2(CDKL5):c.199C>T (p.Leu67Phe)	CDKL5	L67F	Normal	Early infantile epileptic encephalopathy 2|Rett syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143791	X	18593527	X	18575407	143791	153523	rs267608437	NC_000023.11:18575406:C:T	C	T	CLINICAL
NM_001323289.2(CDKL5):c.1099C>T (p.Leu367=)	CDKL5		Normal	Early infantile epileptic encephalopathy 4	Pathogenic	criteria provided, single submitter	VCV000813743	X	18622143	X	18604023	813743	802049	rs1602286005	NC_000023.11:18604022:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.121C>T (p.Pro41Ser)	DDX3X	P41S	Normal	not provided|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000419328	X	41198306	X	41339053	419328	411341	rs1064793796	NC_000023.11:41339052:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.136C>T (p.Arg46Ter)	DDX3X	R46*	Normal	not provided|Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620156	X	41198321	X	41339068	620156	611947	rs1569234653	NC_000023.11:41339067:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.362G>T (p.Arg121Leu)	DDX3X	R121L, R105L	Normal	Mental retardation, X-linked 102	Pathogenic	no assertion criteria provided	VCV000375386	X	41201825	X	41342572	375386	362168	rs1057519446	NC_000023.11:41342571:G:T	G	T	CLINICAL
NM_001356.4(DDX3X):c.577G>T (p.Gly193Ter)	DDX3X	G177*, G193*, G7*	Normal	Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000225894	X	41202502	X	41343249	225894	227709	rs875989803	NC_000023.11:41343248:G:T	G	T	CLINICAL
NM_001356.4(DDX3X):c.619C>T (p.Gln207Ter)	DDX3X	Q207*, Q21*, Q191*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000224129	X	41202544	X	41343291	224129	225859	rs869312692	NC_000023.11:41343290:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.745G>T (p.Glu249Ter)	DDX3X	E249*, E233*, E63*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000224100	X	41203055	X	41343802	224100	225830	rs752738546	NC_000023.11:41343801:G:T	G	T	CLINICAL
NM_001356.4(DDX3X):c.820C>T (p.Pro274Ser)	DDX3X	P274S, P258S, P88S	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Mar 28, 2018)	no assertion criteria provided	VCV000559641	X	41203337	X	41344084	559641	550376	rs1267519974	NC_000023.11:41344083:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.874C>T (p.Arg292Ter)	DDX3X	R292*, R276*, R106*	Normal	not provided|History of neurodevelopmental disorder|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000452201	X	41203501	X	41344248	452201	446655	rs1555953488	NC_000023.11:41344247:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.976C>T (p.Arg326Cys)	DDX3X	R326C, R140C, R310C	Normal	Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521573	X	41203603	X	41344350	521573	512673	rs1555953548	NC_000023.11:41344349:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.1084C>T (p.Arg362Cys)	DDX3X	R362C, R346C, R176C	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208549	X	41204491	X	41345238	208549	205066	rs797045026	NC_000023.11:41345237:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.1126C>T (p.Arg376Cys)	DDX3X	R376C, R360C, R190C	Normal	Mental retardation, X-linked 102|Congenital cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV000207813	X	41204533	X	41345280	207813	204050	rs796052231	NC_000023.11:41345279:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.1595C>T (p.Thr532Met)	DDX3X	T532M, T346M, T516M	Normal	Mental retardation, X-linked 102|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421830	X	41205855	X	41346602	421830	411356	rs1064795387	NC_000023.11:41346601:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.1600C>T (p.Arg534Cys)	DDX3X	R534C, R348C, R518C	Normal	Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522795	X	41205860	X	41346607	522795	513483	rs1555954284	NC_000023.11:41346606:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.1703C>T (p.Pro568Leu)	DDX3X	P568L, P382L, P552L	Normal	Inborn genetic diseases|not provided|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375367	X	41206199	X	41346946	375367	362169	rs1057519430	NC_000023.11:41346945:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.1804C>T (p.Arg602Ter)	DDX3X	R603*, R602*, R587*, R416*	Normal	not provided|Mental retardation, X-linked 102|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280514	X	41206602	X	41347349	280514	265017	rs886041705	NC_000023.11:41347348:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.1005T>A (p.Tyr335Ter)	WDR45	Y335*, Y336*	Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000663120	X	48932540	X	49074881	663120	650097	rs781972464	NC_000023.11:49074880:A:T	A	T	CLINICAL
NM_001029896.2(WDR45):c.974-1G>A	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000523624	X	48932572	X	49074913	523624	514280	rs1557083830	NC_000023.11:49074912:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.973+1G>A	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	VCV000224075	X	48932794	X	49075135	224075	225806	rs869312661	NC_000023.11:49075134:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.827+1G>A	WDR45		Normal	Neurodegeneration with brain iron accumulation|Neurodegeneration with brain iron accumulation 5|not provided	Pathogenic(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000265508	X	48933022	X	49075363	265508	260331	rs1557083958	NC_000023.11:49075362:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.695G>A (p.Arg232His)	WDR45	R232H, R233H	Normal	Neurodegeneration with brain iron accumulation 5|See cases	Likely pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000639948	X	48933234	X	49075575	639948	650099	rs781978699	NC_000023.11:49075574:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.611G>A (p.Gly204Asp)	WDR45	G205D, G204D	Normal	Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000242347	X	48933318	X	49075659	242347	243898	rs878855326	NC_000023.11:49075658:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.516+1G>A	WDR45		Normal	not provided|Neurodegeneration with brain iron accumulation 5	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000545080	X	48933524	X	49075865	545080	535360	rs797046102	NC_000023.11:49075864:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.437-1G>A	WDR45		Normal	Neurodegeneration with brain iron accumulation 5	Likely pathogenic(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000666584	X	48933605	X	49075946	666584	654153	rs1602538372	NC_000023.11:49075945:C:T	C	T	CLINICAL
NM_001029896.2(WDR45):c.2T>A (p.Met1Lys)	WDR45	M1K	Normal	not provided|Neurodegeneration with brain iron accumulation 5	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620005	X	48935753	X	49078094	620005	611452	rs1569523565	NC_000023.11:49078093:A:T	A	T	CLINICAL
NM_031407.7(HUWE1):c.3239G>A (p.Arg1080His)	HUWE1	R1080H	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Aug 24, 2015)	no assertion criteria provided	VCV000374333	X	53622288	X	53595328	374333	361247	rs1057518704	NC_000023.11:53595327:C:T	C	T	CLINICAL
NM_181303.2(NLGN3):c.1411C>T (p.Arg471Cys)	NLGN3	R451C, R431C, R471C, R334C	Normal	Autism, susceptibility to, X-linked 1|Asperger syndrome X-linked 1	risk factor(Last reviewed: Jul 15, 2004)	no assertion criteria provided	VCV000011327	X	70387358	X	71167508	11327	26366	rs121917893	NC_000023.11:71167507:C:T	C	T	CLINICAL
NM_181303.2(NLGN3):c.1849C>T (p.Arg617Trp)	NLGN3	R597W, R617W, R480W, R577W	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235850	X	70389249	X	71169399	235850	237512	rs878853147	NC_000023.11:71169398:C:T	C	T	CLINICAL
NM_019597.5(HNRNPH2):c.616C>T (p.Arg206Trp)	HNRNPH2|RPL36A-HNRNPH2	R206W	Normal	Inborn genetic diseases|not provided|Neurodevelopmental disorder|Mental retardation, X-linked, syndromic, Bain type	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225760	X	100667592	X	101412604	225760	227575	rs886039763	NC_000023.11:101412603:C:T	C	T	CLINICAL
NM_004484.3(GPC3):c.1705G>A (p.Ala569Thr)	GPC3	A515T, A553T, A569T, A592T	Normal	Wilms tumor 1	Pathogenic(Last reviewed: Jun 17, 2002)	no assertion criteria provided	VCV000011691	X	132670190	X	133536162	11691	26730	rs122453120	NC_000023.11:133536161:C:T	C	T	CLINICAL
NM_006359.3(SLC9A6):c.976C>T (p.Gln326Ter)	SLC9A6	Q326*, Q358*, Q274*, Q306*	Normal	Christianson syndrome|not provided	Pathogenic(Last reviewed: Feb 10, 2021)	reviewed by expert panel	VCV000095378	X	135095138	X	136012979	95378	101277	rs398124224	NC_000023.11:136012978:C:T	C	T	CLINICAL
NM_006359.3(SLC9A6):c.1402C>T (p.Arg468Ter)	SLC9A6	R468*, R448*, R500*, R416*	Normal	Christianson syndrome|not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000011477	X	135106524	X	136024365	11477	26516	rs122461162	NC_000023.11:136024364:C:T	C	T	CLINICAL
NM_006359.3(SLC9A6):c.1543G>T (p.Glu515Ter)	SLC9A6	E547*, E463*, E495*, E515*	Normal	Christianson syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000092121	X	135112313	X	136030154	92121	97547	rs398123003	NC_000023.11:136030153:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.1115C>A (p.Ser372Ter)	MECP2	S360*, S372*, S267*	Normal	Rett syndrome	Pathogenic(Last reviewed: Dec 16, 2015)	criteria provided, single submitter	VCV000143322	X	153296200	X	154030749	143322	153054	rs61752372	NC_000023.11:154030748:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.953G>A (p.Arg318His)	MECP2	R306H, R318H, R213H	Normal	Rett syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143746	X	153296362	X	154030911	143746	153478	rs61751443	NC_000023.11:154030910:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.941C>A (p.Pro314His)	MECP2	P302H, P314H, P209H	Normal	Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly	Pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000143736	X	153296374	X	154030923	143736	153468	rs61749723	NC_000023.11:154030922:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.722C>A (p.Ser241Ter)	MECP2	S229*, S241*, S136*	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143658	X	153296593	X	154031142	143658	153390	rs61749739	NC_000023.11:154031141:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.709C>A (p.Pro237Thr)	MECP2	P225T, P237T, P132T	Normal	Rett syndrome|not provided	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143652	X	153296606	X	154031155	143652	153384	rs267608513	NC_000023.11:154031154:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.605G>A (p.Arg202His)	MECP2	R190H, R202H, R97H	Normal	Rett syndrome	Likely pathogenic	criteria provided, single submitter	VCV000548706	X	153296710	X	154031259	548706	539190	rs1557136818	NC_000023.11:154031258:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.553C>A (p.Pro185Thr)	MECP2	P173T, P185T, P80T	Normal	Rett syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804125	X	153296762	X	154031311	804125	792164	rs61748427	NC_000023.11:154031310:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.538C>A (p.Arg180=)	MECP2		Normal	Rett syndrome	Pathogenic(Last reviewed: May 18, 2012)	no assertion criteria provided	VCV000189712	X	153296777	X	154031326	189712	187551	rs61748421	NC_000023.11:154031325:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.504C>A (p.Asp168Glu)	MECP2	D156E, D168E, D63E	Normal	Rett syndrome	Likely pathogenic(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	VCV000393489	X	153296811	X	154031360	393489	380325	rs61748408	NC_000023.11:154031359:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.449T>A (p.Leu150Ter)	MECP2	L138*, L150*, L45*	Normal	Rett syndrome	Pathogenic(Last reviewed: Jan 21, 2008)	no assertion criteria provided	VCV000143566	X	153296866	X	154031415	143566	153298	rs267608475	NC_000023.11:154031414:A:T	A	T	CLINICAL
NM_001110792.2(MECP2):c.434G>A (p.Arg145His)	MECP2	R133H, R145H, R40H	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, single submitter	VCV000143559	X	153296881	X	154031430	143559	153291	rs61748389	NC_000023.11:154031429:C:T	C	T	CLINICAL
NM_004992.3(MECP2):c.377+1G>A	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Dec 3, 2010)	no assertion criteria provided	VCV000156052	X	153297657	X	154032206	156052	165848	rs267608463	NC_000023.11:154032205:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.400G>A (p.Val134Met)	MECP2	V122M, V134M, V29M	Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000143546	X	153297671	X	154032220	143546	153278	rs267608455	NC_000023.11:154032219:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.368G>A (p.Arg123Lys)	MECP2	R111K, R123K, R18K	Normal	Rett syndrome	Likely pathogenic(Last reviewed: Jun 30, 2014)	no assertion criteria provided	VCV000374353	X	153297703	X	154032252	374353	361240	rs1057518718	NC_000023.11:154032251:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.353G>A (p.Arg118Gln)	MECP2	R106Q, R118Q, R13Q	Normal	not provided|Rett syndrome	Likely pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000143534	X	153297718	X	154032267	143534	153266	rs61754457	NC_000023.11:154032266:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.347G>A (p.Trp116Ter)	MECP2	W104*, W116*, W11*	Normal	Rett syndrome	Pathogenic(Last reviewed: Feb 3, 2006)	no assertion criteria provided	VCV000143530	X	153297724	X	154032273	143530	153262	rs61754455	NC_000023.11:154032272:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.338C>A (p.Pro113His)	MECP2	P101H, P113H, P8H	Normal	Rett syndrome	Pathogenic(Last reviewed: Feb 3, 2006)	no assertion criteria provided	VCV000143525	X	153297733	X	154032282	143525	153257	rs61754453	NC_000023.11:154032281:G:T	G	T	CLINICAL
NM_001110792.2(MECP2):c.182C>A (p.Ser61Ter)	MECP2	S49*, S61*	Normal	Rett syndrome	Pathogenic(Last reviewed: Feb 3, 2006)	no assertion criteria provided	VCV000143491	X	153297889	X	154032438	143491	153223	rs61754432	NC_000023.11:154032437:G:T	G	T	CLINICAL
NM_004992.3(MECP2):c.26+2T>A	MECP2		Normal	not provided|Rett syndrome	Pathogenic(Last reviewed: Feb 4, 2003)	no assertion criteria provided	VCV000156045	X	153357640	X	154092182	156045	165841	rs267608409	NC_000023.11:154092181:A:T	A	T	CLINICAL
NM_001110792.2(MECP2):c.62+1G>A	MECP2		Normal	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000189776	X	153363060	X	154097603	189776	187559	rs786205048	NC_000023.11:154097602:C:T	C	T	CLINICAL
NM_171998.4(RAB39B):c.215+1G>A	RAB39B		Normal	Mental retardation, X-linked 72	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000010542	X	154493358	X	155264073	10542	25581	rs587776734	NC_000023.11:155264072:C:T	C	T	CLINICAL
NM_171998.4(RAB39B):c.21C>A (p.Tyr7Ter)	RAB39B	Y7*	Normal	Mental retardation, X-linked 72	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000010543	X	154493553	X	155264268	10543	25582	rs267606995	NC_000023.11:155264267:G:T	G	T	CLINICAL
NM_000054.6(AVPR2):c.310C>T (p.Arg104Cys)	AVPR2	R104C	Normal	Nephrogenic diabetes insipidus|Nephrogenic syndrome of inappropriate antidiuresis|Nephrogenic diabetes insipidus, X-linked|Nephrogenic diabetes insipidus, X-linked	Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, single submitter	VCV000010853	X	153171270	X	153905816	10853	25892	rs104894760	NC_000023.11:153905815:C:T	C	T	CLINICAL
NM_000054.6(AVPR2):c.335G>T (p.Cys112Phe)	AVPR2	C112F	Normal	Nephrogenic diabetes insipidus, X-linked	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	VCV000374351	X	153171295	X	153905841	374351	361239	rs1057518723	NC_000023.11:153905840:G:T	G	T	CLINICAL
NM_000054.6(AVPR2):c.388A>T (p.Ile130Phe)	AVPR2	I130F	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Apr 1, 2000)	no assertion criteria provided	VCV000204318	X	153171348	X	153905894	204318	200712	rs796052096	NC_000023.11:153905893:A:T	A	T	CLINICAL
NM_000054.6(AVPR2):c.541C>T (p.Arg181Cys)	AVPR2	R181C	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000010850	X	153171501	X	153906047	10850	25889	rs104894757	NC_000023.11:153906046:C:T	C	T	CLINICAL
NM_000054.6(AVPR2):c.1009C>T (p.Arg337Ter)	AVPR2	R337*	Normal	not provided|Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 16, 2016)	criteria provided, single submitter	VCV000010844	X	153172075	X	153906621	10844	25883	rs104894753	NC_000023.11:153906620:C:T	C	T	CLINICAL
NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)	AVPR2	R113W	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: May 27, 1993)	no assertion criteria provided	VCV000010840	X	153171297	X	153905843	10840	25879	rs28935496	NC_000023.11:153905842:C:T	C	T	CLINICAL
NM_000054.6(AVPR2):c.553G>T (p.Gly185Cys)	AVPR2	G185C	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000010837	X	153171513	X	153906059	10837	25876	rs104894748	NC_000023.11:153906058:G:T	G	T	CLINICAL
NM_000054.6(AVPR2):c.607C>T (p.Arg203Cys)	AVPR2	R203C	Normal	Nephrogenic diabetes insipidus, X-linked	Pathogenic(Last reviewed: Oct 1, 1992)	no assertion criteria provided	VCV000010839	X	153171567	X	153906113	10839	25878	rs104894750	NC_000023.11:153906112:C:T	C	T	CLINICAL
NM_000169.3(GLA):c.640-801G>A	GLA|RPL36A-HNRNPH2		Normal	Fabry disease, cardiac variant|Fabry disease|Cardiomyopathy|not provided|Fabry disease|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000010768	X	100654735	X	101399747	10768	25807	rs199473684	NC_000023.11:101399746:C:T	C	T	CLINICAL
NM_001184880.2(PCDH19):c.2617-1G>A	PCDH19		Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648240	X	99605703	X	100350705	648240	653771	rs1602600561	NC_000023.11:100350704:C:T	C	T	CLINICAL
NM_001184880.2(PCDH19):c.2616+1G>A	PCDH19		Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000657366	X	99657521	X	100402523	657366	653429	rs1602632270	NC_000023.11:100402522:C:T	C	T	CLINICAL
NM_001184880.2(PCDH19):c.1938C>A (p.Asp646Glu)	PCDH19	D646E	Normal	Early infantile epileptic encephalopathy 9	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804052	X	99661658	X	100406660	804052	792089	rs1602635261	NC_000023.11:100406659:G:T	G	T	CLINICAL
NM_001184880.2(PCDH19):c.1548C>A (p.Tyr516Ter)	PCDH19	Y516*	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Oct 21, 2018)	criteria provided, single submitter	VCV000651548	X	99662048	X	100407050	651548	649575	rs587784295	NC_000023.11:100407049:G:T	G	T	CLINICAL
NM_001184880.2(PCDH19):c.1335C>A (p.Asp445Glu)	PCDH19	D445E	Normal	not provided|Early infantile epileptic encephalopathy 9|Non-ketotic hyperglycinemia	Likely pathogenic(Last reviewed: Mar 15, 2013)	criteria provided, single submitter	VCV000206331	X	99662261	X	100407263	206331	203911	rs796052815	NC_000023.11:100407262:G:T	G	T	CLINICAL
NM_001184880.2(PCDH19):c.1322T>A (p.Val441Glu)	PCDH19	V441E	Normal	Early infantile epileptic encephalopathy 9	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000011016	X	99662274	X	100407276	11016	26055	rs132630323	NC_000023.11:100407275:A:T	A	T	CLINICAL
NM_001184880.2(PCDH19):c.498C>A (p.Tyr166Ter)	PCDH19	Y166*	Normal	Early infantile epileptic encephalopathy 9|History of neurodevelopmental disorder	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589938	X	99663098	X	100408100	589938	580592	rs796052837	NC_000023.11:100408099:G:T	G	T	CLINICAL
NM_019597.5(HNRNPH2):c.85C>T (p.Arg29Cys)	HNRNPH2|RPL36A-HNRNPH2	R29C	Normal	Mental retardation, X-linked, syndromic, Bain type	Likely pathogenic(Last reviewed: Dec 12, 2018)	no assertion criteria provided	VCV000807430	X	100667061	X	101412073	807430	798776	rs1555988314	NC_000023.11:101412072:C:T	C	T	CLINICAL
NM_019597.5(HNRNPH2):c.616C>T (p.Arg206Trp)	HNRNPH2|RPL36A-HNRNPH2	R206W	Normal	Inborn genetic diseases|not provided|Neurodevelopmental disorder|Mental retardation, X-linked, syndromic, Bain type	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000225760	X	100667592	X	101412604	225760	227575	rs886039763	NC_000023.11:101412603:C:T	C	T	CLINICAL
NM_019597.5(HNRNPH2):c.626C>T (p.Pro209Leu)	HNRNPH2|RPL36A-HNRNPH2	P209L	Normal	Mental retardation, X-linked, syndromic, Bain type|not provided	Pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000225759	X	100667602	X	101412614	225759	227574	rs1555988417	NC_000023.11:101412613:C:T	C	T	CLINICAL
NM_001830.4(CLCN4):c.2051C>T (p.Pro684Leu)	CLCN4	P590L, P684L	Normal	Mental retardation 49, X-linked	Likely pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000827824	X	10188776	X	10220736	827824	816009	rs1246068842	NC_000023.11:10220735:C:T	C	T	CLINICAL
NM_001830.4(CLCN4):c.2152C>T (p.Arg718Trp)	CLCN4	R718W, R624W	Normal	Mental retardation 49, X-linked|not provided|CLCN4-related disorder	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209116	X	10188877	X	10220837	209116	205713	rs879255584	NC_000023.11:10220836:C:T	C	T	CLINICAL
NM_000533.5(PLP1):c.169G>T (p.Asp57Tyr)	PLP1|RAB9B	D57Y	Normal	Pelizaeus-Merzbacher disease	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000011099	X	103040675	X	103785746	11099	26138	rs132630296	NC_000023.11:103785745:G:T	G	T	CLINICAL
NM_001204402.1(PRPS1):c.-44C>T	PRPS1	A190V	Normal	Phosphoribosylpyrophosphate synthetase superactivity	Pathogenic(Last reviewed: Feb 21, 2017)	no assertion criteria provided	VCV000009932	X	106888445	X	107645215	9932	24971	rs137852544	NC_000023.11:107645214:C:T	C	T	CLINICAL
NM_002764.3(PRPS1):c.640C>T (p.Arg214Trp)	PRPS1	R214W, R10W	Normal	Phosphoribosylpyrophosphate synthetase superactivity|Retinal dystrophy|Hearing loss|Retinal dystrophy|Arts syndrome	Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446163	X	106888516	X	107645286	446163	439510	rs1556300621	NC_000023.11:107645285:C:T	C	T	CLINICAL
NM_001318510.2(ACSL4):c.1585C>A (p.Arg529Ser)	ACSL4	R529S, R570S	Normal	Mental retardation 63, X-linked	Pathogenic(Last reviewed: Apr 1, 2002)	no assertion criteria provided	VCV000011564	X	108904872	X	109661643	11564	26603	rs122458138	NC_000023.11:109661642:G:T	G	T	CLINICAL
NM_015365.3(AMMECR1):c.429T>A (p.Tyr143Ter)	AMMECR1	Y143*, Y20*	Normal	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	Pathogenic	no assertion criteria provided	VCV000446130	X	109560871	X	110317643	446130	439477	rs765498367	NC_000023.11:110317642:A:T	A	T	CLINICAL
NM_002578.5(PAK3):c.199C>T (p.Arg67Cys)	PAK3	R67C	Normal	Mental retardation 30, X-linked	Pathogenic(Last reviewed: Aug 14, 2000)	no assertion criteria provided	VCV000011569	X	110385347	X	111142119	11569	26608	rs121434612	NC_000023.11:111142118:C:T	C	T	CLINICAL
NM_002578.5(PAK3):c.298C>T (p.Arg100Ter)	PAK3	R100*, R115*, R136*, R121*	Normal	Mental retardation 30, X-linked	Likely pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, single submitter	VCV000438299	X	110390986	X	111147758	438299	431930	rs780775497	NC_000023.11:111147757:C:T	C	T	CLINICAL
NM_002578.5(PAK3):c.1255C>T (p.Arg419Ter)	PAK3	R419*, R455*, R440*, R434*	Normal	not provided|Mental retardation 30, X-linked	Pathogenic(Last reviewed: Jan 3, 2018)	no assertion criteria provided	VCV000011568	X	110439716	X	111196488	11568	26607	rs121434611	NC_000023.11:111196487:C:T	C	T	CLINICAL
NM_078629.4(MSL3):c.1036C>T (p.Gln346Ter)	MSL3	Q180*, Q346*, Q197*, Q334*	Normal	Intellectual disability|Basilicata-Akhtar syndrome	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000487566	X	11783713	X	11765594	487566	480614	rs1555906768	NC_000023.11:11765593:C:T	C	T	CLINICAL
NM_078629.4(MSL3):c.1372C>T (p.Arg458Ter)	MSL3	R292*, R458*, R446*, R309*	Normal	Basilicata-Akhtar syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000487568	X	11790365	X	11772246	487568	480616	rs1555907620	NC_000023.11:11772245:C:T	C	T	CLINICAL
NM_078629.4(MSL3):c.1381+1G>T	MSL3		Normal	Basilicata-Akhtar syndrome|Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000487564	X	11790375	X	11772256	487564	480618	rs1555907626	NC_000023.11:11772255:G:T	G	T	CLINICAL
NM_003336.4(UBE2A):c.382C>T (p.Gln128Ter)	UBE2A	Q128*, Q98*, Q95*	Normal	Syndromic mental retardation, Nascimento type, X-linked	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000009922	X	118717141	X	119583178	9922	24961	rs104894952	NC_000023.11:119583177:C:T	C	T	CLINICAL
NM_024528.4(NKAP):c.1082G>A (p.Arg361Gln)	NKAP	R361Q	Normal	Intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827657	X	119059349	X	119925386	827657	815861	rs1603379318	NC_000023.11:119925385:C:T	C	T	CLINICAL
NM_024528.4(NKAP):c.998G>A (p.Arg333Gln)	NKAP	R333Q	Normal	Intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827653	X	119064054	X	119930091	827653	815857	rs1603379779	NC_000023.11:119930090:C:T	C	T	CLINICAL
NM_024528.4(NKAP):c.989G>A (p.Arg330His)	NKAP	R330H	Normal	Intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type	Pathogenic(Last reviewed: Mar 17, 2020)	no assertion criteria provided	VCV000827655	X	119064063	X	119930100	827655	815859	rs1603379780	NC_000023.11:119930099:C:T	C	T	CLINICAL
NM_003588.3(CUL4B):c.2687G>A (p.Arg896Gln)	CUL4B	R896Q, R878Q, R883Q, R700Q	Normal	Pettigrew syndrome	Likely pathogenic(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	VCV000434871	X	119660671	X	120526816	434871	430637	rs1556173896	NC_000023.11:120526815:C:T	C	T	CLINICAL
NM_007325.5(GRIA3):c.2327C>T (p.Thr776Met)	GRIA3	T776M	Normal	Epileptic encephalopathy|Dystonia|Generalized hypotonia|Neurodegeneration|Spasticity|Focal seizures|Infantile spasms|Severe global developmental delay|Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625211	X	122613916	X	123480065	625211	613542	rs780680047	NC_000023.11:123480064:C:T	C	T	CLINICAL
NM_001081550.2(THOC2):c.2138G>A (p.Gly713Asp)	THOC2	G713D	Normal	Mental retardation, X-linked 12	Pathogenic(Last reviewed: Feb 2, 2018)	no assertion criteria provided	VCV000488431	X	122766890	X	123633039	488431	481304	rs1556023928	NC_000023.11:123633038:C:T	C	T	CLINICAL
NM_001368397.1(FRMPD4):c.856C>T (p.Arg286Ter)	FRMPD4	R286*, R278*, R246*, R288*, R323*, R283*	Normal	Mental retardation, X-linked 104	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000599280	X	12712496	X	12694377	599280	590542	rs1569057837	NC_000023.11:12694376:C:T	C	T	CLINICAL
NM_004208.4(AIFM1):c.784G>A (p.Gly262Ser)	AIFM1|RAB33A	G262S, G258S	Normal	Cowchock syndrome	Pathogenic(Last reviewed: Dec 10, 2019)	no assertion criteria provided	VCV000732670	X	129273844	X	130139869	732670	745480	rs1603224817	NC_000023.11:130139868:C:T	C	T	CLINICAL
NM_001015877.2(PHF6):c.22A>T (p.Lys8Ter)	PHF6	K8*	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011070	X	133511669	X	134377639	11070	26109	rs132630301	NC_000023.11:134377638:A:T	A	T	CLINICAL
NM_001015877.2(PHF6):c.296G>T (p.Cys99Phe)	PHF6	C99F	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 1, 2002)	no assertion criteria provided	VCV000011064	X	133527586	X	134393556	11064	26103	rs132630298	NC_000023.11:134393555:G:T	G	T	CLINICAL
NM_001015877.2(PHF6):c.673C>T (p.Arg225Ter)	PHF6	R225*, R226*	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000488410	X	133547940	X	134413910	488410	481264	rs1556018932	NC_000023.11:134413909:C:T	C	T	CLINICAL
NM_001015877.2(PHF6):c.914G>T (p.Cys305Phe)	PHF6	C305F	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	VCV000139557	X	133551278	X	134417248	139557	143192	rs587777489	NC_000023.11:134417247:G:T	G	T	CLINICAL
NM_001015877.2(PHF6):c.1024C>T (p.Arg342Ter)	PHF6	R342*	Normal	Borjeson-Forssman-Lehmann syndrome	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011063	X	133559286	X	134425256	11063	26102	rs132630297	NC_000023.11:134425255:C:T	C	T	CLINICAL
NM_006359.3(SLC9A6):c.976C>T (p.Gln326Ter)	SLC9A6	Q326*, Q358*, Q274*, Q306*	Normal	Christianson syndrome|not provided	Pathogenic(Last reviewed: Feb 10, 2021)	reviewed by expert panel	VCV000095378	X	135095138	X	136012979	95378	101277	rs398124224	NC_000023.11:136012978:C:T	C	T	CLINICAL
NM_006359.3(SLC9A6):c.1402C>T (p.Arg468Ter)	SLC9A6	R468*, R448*, R500*, R416*	Normal	Christianson syndrome|not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000011477	X	135106524	X	136024365	11477	26516	rs122461162	NC_000023.11:136024364:C:T	C	T	CLINICAL
NM_006359.3(SLC9A6):c.1543G>T (p.Glu515Ter)	SLC9A6	E547*, E463*, E495*, E515*	Normal	Christianson syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000092121	X	135112313	X	136030154	92121	97547	rs398123003	NC_000023.11:136030153:G:T	G	T	CLINICAL
NM_005634.2(SOX3):c.449C>A (p.Ser150Tyr)	SOX3	S150Y	Normal	Mental retardation with panhypopituitarism, X-linked	Likely pathogenic(Last reviewed: Oct 2, 2017)	no assertion criteria provided	VCV000444006	X	139586777	X	140504612	444006	437667	rs1556518231	NC_000023.11:140504611:G:T	G	T	CLINICAL
NM_002025.4(AFF2):c.3229C>T (p.Gln1077Ter)	AFF2	Q1077*, Q1042*, Q1067*, Q718*, Q1038*	Normal	Intellectual disability	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000625213	X	148049184	X	148967654	625213	613543	rs1603350606	NC_000023.11:148967653:C:T	C	T	CLINICAL
NM_001001344.2(ATP2B3):c.3594G>T (p.Lys1198Asn)	ATP2B3	K1198N	Normal	Spinocerebellar ataxia, X-linked 1|Microcephaly|Abnormality of the cerebral cortex|Oral-pharyngeal dysphagia|Skeletal muscle atrophy|Muscular hypotonia|Carious teeth|Intellectual disability|Global developmental delay	Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000242886	X	152845687	X	153580229	242886	244001	rs782596945	NC_000023.11:153580228:G:T	G	T	CLINICAL
NM_005629.4(SLC6A8):c.395G>T (p.Gly132Val)	SLC6A8	G132V, G17V	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000011703	X	152956759	X	153691304	11703	26742	rs122453117	NC_000023.11:153691303:G:T	G	T	CLINICAL
NM_005629.4(SLC6A8):c.1208C>T (p.Ala403Val)	SLC6A8	A403V, A393V, A288V	Normal	Abnormal facial shape|Low-set ears|Seizures|Intellectual disability	Likely pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523485	X	152959426	X	153693971	523485	514124	rs1557045296	NC_000023.11:153693970:C:T	C	T	CLINICAL
NM_005629.4(SLC6A8):c.1540C>T (p.Arg514Ter)	SLC6A8	R514*, R399*, R504*	Normal	Creatine transporter deficiency|not provided|Inborn genetic diseases|Intellectual disability	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011696	X	152960032	X	153694577	11696	26735	rs122453113	NC_000023.11:153694576:C:T	C	T	CLINICAL
NM_005629.4(SLC6A8):c.1631C>T (p.Pro544Leu)	SLC6A8	P544L, P429L, P534L	Normal	Creatine transporter deficiency	Likely pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000065692	X	152960208	X	153694753	65692	76600	rs397515558	NC_000023.11:153694752:C:T	C	T	CLINICAL
NM_005629.4(SLC6A8):c.1661C>T (p.Pro554Leu)	SLC6A8	P554L, P544L, P439L	Normal	Creatine transporter deficiency	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000065693	X	152960238	X	153694783	65693	76601	rs397515559	NC_000023.11:153694782:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.3166+1G>A	L1CAM		Normal	L1 syndrome	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635331	X	153130039	X	153864584	635331	623180	rs1603273984	NC_000023.11:153864583:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.1792G>A (p.Asp598Asn)	L1CAM	D598N, D593N	Normal	MASA syndrome	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009989	X	153133489	X	153868034	9989	25028	rs137852519	NC_000023.11:153868033:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.1354G>A (p.Gly452Arg)	L1CAM	G452R, G447R	Normal	L1 syndrome|Spastic paraplegia|Hydrocephalus due to aqueductal stenosis|not provided|X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Jul 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009990	X	153134321	X	153868866	9990	25029	rs137852520	NC_000023.11:153868865:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.1268-1G>A	L1CAM		Normal	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000827844	X	153134408	X	153868953	827844	816043	rs1603275538	NC_000023.11:153868952:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.1267+1G>A	L1CAM		Normal	L1 syndrome|Spastic paraplegia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449047	X	153134974	X	153869519	449047	446548	rs1557092247	NC_000023.11:153869518:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.1108G>A (p.Gly370Arg)	L1CAM	G370R, G365R	Normal	X-linked hydrocephalus syndrome|MASA syndrome|Spastic paraplegia|not provided	Pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009995	X	153135273	X	153869818	9995	25034	rs137852524	NC_000023.11:153869817:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.791G>A (p.Cys264Tyr)	L1CAM	C264Y, C259Y	Normal	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Aug 1, 1993)	no assertion criteria provided	VCV000009986	X	153135858	X	153870403	9986	25025	rs137852518	NC_000023.11:153870402:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.630C>A (p.His210Gln)	L1CAM	H210Q, H205Q	Normal	MASA syndrome	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009988	X	153136309	X	153870854	9988	25027	rs28933683	NC_000023.11:153870853:G:T	G	T	CLINICAL
NM_001278116.2(L1CAM):c.604G>A (p.Asp202Asn)	L1CAM	D202N, D197N	Normal	X-linked hydrocephalus syndrome|Corpus callosum, partial agenesis of, X-linked|MASA syndrome	Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000689728	X	153136335	X	153870880	689728	677467	rs1603276146	NC_000023.11:153870879:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.551G>A (p.Arg184Gln)	L1CAM	R184Q, R179Q	Normal	X-linked hydrocephalus syndrome	Pathogenic(Last reviewed: Jul 1, 1994)	no assertion criteria provided	VCV000009991	X	153136388	X	153870933	9991	25030	rs137852521	NC_000023.11:153870932:C:T	C	T	CLINICAL
NM_001278116.2(L1CAM):c.3G>A (p.Met1Ile)	L1CAM	M1I	Normal	X-linked hydrocephalus syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804113	X	153141289	X	153875834	804113	792152	rs1603277433	NC_000023.11:153875833:C:T	C	T	CLINICAL
NM_003491.4(NAA10):c.248G>A (p.Arg83His)	NAA10	R77H, R83H	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Apr 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000691256	X	153197862	X	153932409	691256	678950	rs1603290366	NC_000023.11:153932408:C:T	C	T	CLINICAL
NM_005334.3(HCFC1):c.674G>A (p.Ser225Asn)	HCFC1	S225N	Normal	not provided|Mental retardation 3, X-linked	Pathogenic(Last reviewed: Oct 5, 2012)	no assertion criteria provided	VCV000039695	X	153228714	X	153963263	39695	48294	rs318240758	NC_000023.11:153963262:C:T	C	T	CLINICAL
NM_005334.3(HCFC1):c.217G>A (p.Ala73Thr)	HCFC1	A73T	Normal	Mental retardation 3, X-linked	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000066986	X	153230154	X	153964703	66986	77871	rs397515487	NC_000023.11:153964702:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.605G>A (p.Arg202His)	MECP2	R190H, R202H, R97H	Normal	Rett syndrome	Likely pathogenic	criteria provided, single submitter	VCV000548706	X	153296710	X	154031259	548706	539190	rs1557136818	NC_000023.11:154031258:C:T	C	T	CLINICAL
NM_006013.4(RPL10):c.191C>T (p.Ala64Val)	RPL10	A64V, A28V	Normal	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000430614	X	153628144	X	154399803	430614	423405	rs1131692042	NC_000023.11:154399802:C:T	C	T	CLINICAL
NM_006013.5(RPL10):c.565C>T (p.Arg189Trp)	RPL10	R153W, R189W	Normal	MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35	Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000818225	X	153629115	X	154400774	818225	806438	rs1019534975	NC_000023.11:154400773:C:T	C	T	CLINICAL
NM_001493.3(GDI1):c.208C>T (p.Arg70Ter)	GDI1	R70*	Normal	X-Linked Mental Retardation 41	Pathogenic(Last reviewed: Jun 1, 1998)	no assertion criteria provided	VCV000011627	X	153667165	X	154438819	11627	26666	rs121434608	NC_000023.11:154438818:C:T	C	T	CLINICAL
NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg)	RAB39B	G192R	Normal	Early-onset parkinsonism-intellectual disability syndrome|Parkinson disease, X-linked dominant	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218362	X	154490156	X	155260871	218362	215090	rs864309527	NC_000023.11:155260870:C:T	C	T	CLINICAL
NM_171998.4(RAB39B):c.503C>A (p.Thr168Lys)	RAB39B	T168K	Normal	Early-onset parkinsonism-intellectual disability syndrome|not provided	Pathogenic	criteria provided, single submitter	VCV000156532	X	154490227	X	155260942	156532	166303	rs587777874	NC_000023.11:155260941:G:T	G	T	CLINICAL
NM_171998.4(RAB39B):c.215+1G>A	RAB39B		Normal	Mental retardation, X-linked 72	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000010542	X	154493358	X	155264073	10542	25581	rs587776734	NC_000023.11:155264072:C:T	C	T	CLINICAL
NM_171998.4(RAB39B):c.21C>A (p.Tyr7Ter)	RAB39B	Y7*	Normal	Mental retardation, X-linked 72	Pathogenic(Last reviewed: Feb 12, 2010)	no assertion criteria provided	VCV000010543	X	154493553	X	155264268	10543	25582	rs267606995	NC_000023.11:155264267:G:T	G	T	CLINICAL
NM_001272071.2(AP1S2):c.288+5G>A	AP1S2		Normal	Pettigrew syndrome	Pathogenic(Last reviewed: Nov 1, 2007)	no assertion criteria provided	VCV000010780	X	15864021	X	15845898	10780	25819	rs587776739	NC_000023.11:15845897:C:T	C	T	CLINICAL
NM_001272071.2(AP1S2):c.1-3C>A	AP1S2		Normal	Pettigrew syndrome	Pathogenic(Last reviewed: Jun 24, 2015)	criteria provided, single submitter	VCV000397541	X	15870650	X	15852527	397541	384444	rs1060499672	NC_000023.11:15852526:G:T	G	T	CLINICAL
NM_001291867.2(NHS):c.1180C>T (p.Arg394Ter)	NHS	R217*, R373*, R196*, R394*	Normal	not provided|Nance-Horan syndrome	Pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011025	X	17742490	X	17724370	11025	26064	rs132630322	NC_000023.11:17724369:C:T	C	T	CLINICAL
NM_001323289.2(CDKL5):c.400C>T (p.Arg134Ter)	CDKL5	R134*	Normal	Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000143820	X	18598085	X	18579965	143820	153552	rs267608472	NC_000023.11:18579964:C:T	C	T	CLINICAL
NM_001323289.2(CDKL5):c.532C>T (p.Arg178Trp)	CDKL5	R178W	Normal	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|not provided|Intellectual disability|Atypical Rett syndrome	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143823	X	18602451	X	18584331	143823	153555	rs267608493	NC_000023.11:18584330:C:T	C	T	CLINICAL
NM_001323289.2(CDKL5):c.622C>T (p.Gln208Ter)	CDKL5	Q208*	Normal	Global developmental delay|Seizures|Bruxism|Generalized hypotonia|Stereotypical body rocking|Stereotypical hand wringing|Stereotypy|Delayed speech and language development|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000158186	X	18606141	X	18588021	158186	170101	rs587783405	NC_000023.11:18588020:C:T	C	T	CLINICAL
NM_001323289.2(CDKL5):c.1648C>T (p.Arg550Ter)	CDKL5	R550*	Normal	Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143780	X	18622692	X	18604572	143780	153512	rs267608643	NC_000023.11:18604571:C:T	C	T	CLINICAL
NM_004586.3(RPS6KA3):c.1308C>A (p.Cys436Ter)	RPS6KA3	C436*	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547766	X	20190909	X	20172791	547766	538306	rs1160828151	NC_000023.11:20172790:G:T	G	T	CLINICAL
NM_004586.3(RPS6KA3):c.748G>A (p.Asp250Asn)	RPS6KA3	D250N	Normal	Coffin-Lowry syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803733	X	20205972	X	20187854	803733	792203	rs1603425338	NC_000023.11:20187853:C:T	C	T	CLINICAL
NM_004586.3(RPS6KA3):c.566T>A (p.Ile189Lys)	RPS6KA3	I189K	Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: Oct 1, 1999)	no assertion criteria provided	VCV000011660	X	20211632	X	20193514	11660	26699	rs122454130	NC_000023.11:20193513:A:T	A	T	CLINICAL
NM_004586.3(RPS6KA3):c.243+1G>A	RPS6KA3		Normal	Coffin-Lowry syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803734	X	20227405	X	20209287	803734	792204	rs1603428228	NC_000023.11:20209286:C:T	C	T	CLINICAL
NM_014927.5(CNKSR2):c.2134C>T (p.Arg712Ter)	CNKSR2	R712*, R633*, R682*, R663*	Normal	not provided|Intellectual disability, X-linked, syndromic, Houge type	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000446716	X	21624986	X	21606868	446716	440249	rs904072058	NC_000023.11:21606867:C:T	C	T	CLINICAL
NM_004595.5(SMS):c.388C>T (p.Arg130Cys)	SMS	R130C, R77C	Normal	Syndromic X-linked intellectual disability Snyder type	Pathogenic(Last reviewed: Jan 7, 2021)	criteria provided, single submitter	VCV000816629	X	21995237	X	21977119	816629	804834	rs1602210346	NC_000023.11:21977118:C:T	C	T	CLINICAL
NM_001415.4(EIF2S3):c.431C>T (p.Thr144Ile)	EIF2S3	T144I	Normal	MEHMO syndrome	Likely pathogenic(Last reviewed: Nov 16, 2017)	no assertion criteria provided	VCV000488501	X	24078252	X	24060135	488501	481369	rs751468976	NC_000023.11:24060134:C:T	C	T	CLINICAL
NM_001330360.2(POLA1):c.4160C>T (p.Pro1387Leu)	POLA1	P1381L, P1387L	Normal	Van Esch-O'Driscoll syndrome	Pathogenic(Last reviewed: Aug 5, 2019)	no assertion criteria provided	VCV000627633	X	24906235	X	24888118	627633	615989	rs1569350993	NC_000023.11:24888117:C:T	C	T	CLINICAL
NM_139058.3(ARX):c.1141G>A (p.Ala381Thr)	ARX	A381T	Normal	not provided	Pathogenic(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	VCV000156619	X	25025535	X	25007418	156619	166473	rs587783096	NC_000023.11:25007417:C:T	C	T	CLINICAL
NM_139058.3(ARX):c.998C>A (p.Thr333Asn)	ARX	T333N	Normal	not provided|Corpus callosum agenesis-abnormal genitalia syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000011200	X	25031114	X	25012997	11200	26239	rs104894745	NC_000023.11:25012996:G:T	G	T	CLINICAL
NM_000167.5(GK):c.1319A>T (p.Asp440Val)	GK	D440V, D446V	Normal	Deficiency of glycerol kinase	Pathogenic(Last reviewed: Jun 1, 1996)	no assertion criteria provided	VCV000010943	X	30738838	X	30720721	10943	25982	rs132630328	NC_000023.11:30720720:A:T	A	T	CLINICAL
NM_000109.4(DMD):c.9995G>A (p.Cys3332Tyr)	DMD	C3340Y, C1999Y, C3336Y, C611Y, C1996Y, C3217Y, C272Y, C3332Y, C880Y	Normal	Duchenne muscular dystrophy, mental retardation, and absence of erg b-wave	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000011236	X	31198554	X	31180437	11236	26275	rs104894788	NC_000023.11:31180436:C:T	C	T	CLINICAL
NM_004615.3(TSPAN7):c.652G>T (p.Gly218Ter)	TSPAN7	G218*	Normal	Mental retardation 58, X-linked	Pathogenic(Last reviewed: Feb 1, 2000)	no assertion criteria provided	VCV000011629	X	38540512	X	38681258	11629	26668	rs104894950	NC_000023.11:38681257:G:T	G	T	CLINICAL
NM_005765.3(ATP6AP2):c.321C>T (p.Asp107=)	ATP6AP2		Normal	Mental retardation, X-linked, syndromic, Hedera type	Pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000010801	X	40456521	X	40597269	10801	25840	rs121918521	NC_000023.11:40597268:C:T	C	T	CLINICAL
NM_001039591.3(USP9X):c.1111C>T (p.Arg371Ter)	USP9X	R371*	Normal	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000223098	X	41000634	X	41141381	223098	224825	rs869025592	NC_000023.11:41141380:C:T	C	T	CLINICAL
NM_001039591.3(USP9X):c.2554C>T (p.Arg852Ter)	USP9X	R852*	Normal	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000223094	X	41027389	X	41168136	223094	224821	rs869025588	NC_000023.11:41168135:C:T	C	T	CLINICAL
NM_001039591.3(USP9X):c.3763C>T (p.Gln1255Ter)	USP9X	Q1255*	Normal	Mental retardation, X-linked 99, syndromic, female-restricted	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000223097	X	41047323	X	41188070	223097	224824	rs869025591	NC_000023.11:41188069:C:T	C	T	CLINICAL
NM_001039591.3(USP9X):c.5047C>T (p.Gln1683Ter)	USP9X	Q1683*	Normal	Mental retardation, X-linked 99, syndromic, female-restricted	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000488397	X	41069793	X	41210540	488397	481245	rs1555932766	NC_000023.11:41210539:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.40C>T (p.Gln14Ter)	DDX3X	Q14*	Normal	Intellectual disability|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000504264	X	41193545	X	41334292	504264	495809	rs1555950676	NC_000023.11:41334291:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.121C>T (p.Pro41Ser)	DDX3X	P41S	Normal	not provided|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, multiple submitters, no conflicts	VCV000419328	X	41198306	X	41339053	419328	411341	rs1064793796	NC_000023.11:41339052:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.136C>T (p.Arg46Ter)	DDX3X	R46*	Normal	not provided|Mental retardation, X-linked 102	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000620156	X	41198321	X	41339068	620156	611947	rs1569234653	NC_000023.11:41339067:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.362G>T (p.Arg121Leu)	DDX3X	R121L, R105L	Normal	Mental retardation, X-linked 102	Pathogenic	no assertion criteria provided	VCV000375386	X	41201825	X	41342572	375386	362168	rs1057519446	NC_000023.11:41342571:G:T	G	T	CLINICAL
NM_001356.4(DDX3X):c.577G>T (p.Gly193Ter)	DDX3X	G177*, G193*, G7*	Normal	Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2015)	criteria provided, multiple submitters, no conflicts	VCV000225894	X	41202502	X	41343249	225894	227709	rs875989803	NC_000023.11:41343248:G:T	G	T	CLINICAL
NM_001356.4(DDX3X):c.619C>T (p.Gln207Ter)	DDX3X	Q207*, Q21*, Q191*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 1, 2015)	criteria provided, single submitter	VCV000224129	X	41202544	X	41343291	224129	225859	rs869312692	NC_000023.11:41343290:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.745G>T (p.Glu249Ter)	DDX3X	E249*, E233*, E63*	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Feb 12, 2015)	criteria provided, single submitter	VCV000224100	X	41203055	X	41343802	224100	225830	rs752738546	NC_000023.11:41343801:G:T	G	T	CLINICAL
NM_001356.4(DDX3X):c.820C>T (p.Pro274Ser)	DDX3X	P274S, P258S, P88S	Normal	Mental retardation, X-linked 102	Likely pathogenic(Last reviewed: Mar 28, 2018)	no assertion criteria provided	VCV000559641	X	41203337	X	41344084	559641	550376	rs1267519974	NC_000023.11:41344083:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.874C>T (p.Arg292Ter)	DDX3X	R292*, R276*, R106*	Normal	not provided|History of neurodevelopmental disorder|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000452201	X	41203501	X	41344248	452201	446655	rs1555953488	NC_000023.11:41344247:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.976C>T (p.Arg326Cys)	DDX3X	R326C, R140C, R310C	Normal	Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521573	X	41203603	X	41344350	521573	512673	rs1555953548	NC_000023.11:41344349:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.1084C>T (p.Arg362Cys)	DDX3X	R362C, R346C, R176C	Normal	Mental retardation, X-linked 102	Pathogenic(Last reviewed: Aug 6, 2015)	no assertion criteria provided	VCV000208549	X	41204491	X	41345238	208549	205066	rs797045026	NC_000023.11:41345237:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.1126C>T (p.Arg376Cys)	DDX3X	R376C, R360C, R190C	Normal	Mental retardation, X-linked 102|Congenital cerebellar hypoplasia|not provided	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV000207813	X	41204533	X	41345280	207813	204050	rs796052231	NC_000023.11:41345279:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.1595C>T (p.Thr532Met)	DDX3X	T532M, T346M, T516M	Normal	Mental retardation, X-linked 102|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000421830	X	41205855	X	41346602	421830	411356	rs1064795387	NC_000023.11:41346601:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.1600C>T (p.Arg534Cys)	DDX3X	R534C, R348C, R518C	Normal	Mental retardation, X-linked 102	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000522795	X	41205860	X	41346607	522795	513483	rs1555954284	NC_000023.11:41346606:C:T	C	T	CLINICAL
NM_001356.4(DDX3X):c.1703C>T (p.Pro568Leu)	DDX3X	P568L, P382L, P552L	Normal	Inborn genetic diseases|not provided|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000375367	X	41206199	X	41346946	375367	362169	rs1057519430	NC_000023.11:41346945:C:T	C	T	CLINICAL
NM_001193416.3(DDX3X):c.1804C>T (p.Arg602Ter)	DDX3X	R603*, R602*, R587*, R416*	Normal	not provided|Mental retardation, X-linked 102|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280514	X	41206602	X	41347349	280514	265017	rs886041705	NC_000023.11:41347348:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.2317+1G>A	CASK		Normal	Mental retardation, CASK-related, X-linked|not provided|Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446289	X	41393958	X	41534705	446289	439692	rs1555975458	NC_000023.11:41534704:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.2156-1G>A	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|Congenital cerebellar hypoplasia	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632600	X	41394227	X	41534974	632600	621040	rs1569291261	NC_000023.11:41534973:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.1976G>A (p.Gly659Asp)	CASK	G659D, G630D, G636D	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Jan 21, 2014)	no assertion criteria provided	VCV000180215	X	41413035	X	41553782	180215	178395	rs727505397	NC_000023.11:41553781:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.1970G>A (p.Trp657Ter)	CASK	W628*, W634*, W657*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000813943	X	41413041	X	41553788	813943	802235	rs1602253509	NC_000023.11:41553787:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.915G>A (p.Lys305=)	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000011531	X	41495831	X	41636578	11531	26570	rs387906499	NC_000023.11:41636577:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.824G>A (p.Trp275Ter)	CASK	W275*	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000638400	X	41519699	X	41660446	638400	626295	rs1602424764	NC_000023.11:41660445:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.787G>A (p.Glu263Lys)	CASK	E263K	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803985	X	41519736	X	41660483	803985	792455	rs1602424843	NC_000023.11:41660482:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.764G>A (p.Arg255His)	CASK	R255H	Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia|not provided	Likely pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000158084	X	41519759	X	41660506	158084	167935	rs587783369	NC_000023.11:41660505:C:T	C	T	CLINICAL
NM_001367721.1(CASK):c.708+1G>A	CASK		Normal	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000158082	X	41524529	X	41665276	158082	167932	rs587783368	NC_000023.11:41665275:C:T	C	T	CLINICAL
NM_000266.4(NDP):c.313G>A (p.Ala105Thr)	NDP|NDP-AS1	A105T	Normal	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Oct 17, 1997)	no assertion criteria provided	VCV000010693	X	43809134	X	43949888	10693	25732	rs104894875	NC_000023.11:43949887:C:T	C	T	CLINICAL
NM_000266.4(NDP):c.218C>A (p.Ser73Ter)	NDP|NDP-AS1	S73*	Normal	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000010698	X	43809229	X	43949983	10698	25737	rs104894882	NC_000023.11:43949982:G:T	G	T	CLINICAL
NM_000266.4(NDP):c.134T>A (p.Val45Glu)	NDP|NDP-AS1	V45E	Normal	Atrophia bulborum hereditaria	Pathogenic(Last reviewed: May 1, 2007)	no assertion criteria provided	VCV000010697	X	43817758	X	43958512	10697	25736	rs137852221	NC_000023.11:43958511:A:T	A	T	CLINICAL
NM_012280.4(FTSJ1):c.196C>T (p.Gln66Ter)	FTSJ1	Q66*	Normal	Mental retardation 9, X-linked	Pathogenic(Last reviewed: Aug 1, 2004)	no assertion criteria provided	VCV000010895	X	48337009	X	48478621	10895	25934	rs1602048836	NC_000023.11:48478620:C:T	C	T	CLINICAL
NM_001032382.2(PQBP1):c.463C>T (p.Arg155Ter)	PQBP1	R147*, R155*	Normal	Renpenning syndrome 1|Inborn genetic diseases	Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000816841	X	48759680	X	48902403	816841	805049	rs1602330420	NC_000023.11:48902402:C:T	C	T	CLINICAL
NM_005710.2(PQBP1):c.586C>T (p.Arg196Ter)	PQBP1	R196*, R188*, R101*, R195*, R96*	Normal	Renpenning syndrome 1|not provided	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000545093	X	48760017	X	48902740	545093	535359	rs1557041672	NC_000023.11:48902739:C:T	C	T	CLINICAL
NM_005710.2(PQBP1):c.731C>T (p.Pro244Leu)	PQBP1	P244L, P149L, P236L, P243L, P144L	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235848	X	48760294	X	48903017	235848	237507	rs878853145	NC_000023.11:48903016:C:T	C	T	CLINICAL
NM_004187.5(KDM5C):c.3442G>A (p.Val1148Met)	KDM5C	V1081M, V1148M, V1147M	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522629	X	53223917	X	53194735	522629	513397	rs782205045	NC_000023.11:53194734:C:T	C	T	CLINICAL
NM_004187.5(KDM5C):c.2172C>A (p.Cys724Ter)	KDM5C	C724*, C657*, C723*	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Jul 1, 2011)	no assertion criteria provided	VCV000029996	X	53228230	X	53199048	29996	38951	rs281860639	NC_000023.11:53199047:G:T	G	T	CLINICAL
NM_004187.5(KDM5C):c.1660C>A (p.Pro554Thr)	KDM5C	P554T, P487T, P553T	Normal	Inborn genetic diseases|Mental retardation, syndromic, Claes-Jensen type, X-linked	Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000029997	X	53239682	X	53210500	29997	38952	rs387906729	NC_000023.11:53210499:G:T	G	T	CLINICAL
NM_004187.5(KDM5C):c.229G>A (p.Ala77Thr)	KDM5C	A77T	Normal	Mental retardation, syndromic, Claes-Jensen type, X-linked	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	VCV000009778	X	53247580	X	53218398	9778	24817	rs199422239	NC_000023.11:53218397:C:T	C	T	CLINICAL
NM_001111125.3(IQSEC2):c.3387C>A (p.Tyr1129Ter)	IQSEC2	Y1129*, Y924*	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	VCV000566884	X	53265568	X	53236386	566884	573915	rs374220843	NC_000023.11:53236385:G:T	G	T	CLINICAL
NM_001111125.3(IQSEC2):c.3279G>A (p.Ser1093=)	IQSEC2		Normal	not provided|Mental retardation, X-linked 1	Likely pathogenic(Last reviewed: Jun 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000689766	X	53265676	X	53236494	689766	677473	rs1602260263	NC_000023.11:53236493:C:T	C	T	CLINICAL
NM_001111125.3(IQSEC2):c.2984G>A (p.Arg995Gln)	IQSEC2	R995Q, R790Q	Normal	Mental retardation, X-linked 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280590	X	53270997	X	53241815	280590	264909	rs886041767	NC_000023.11:53241814:C:T	C	T	CLINICAL
NM_001111125.3(IQSEC2):c.2889+1G>A	IQSEC2		Normal	not provided|Mental retardation, X-linked 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000452339	X	53272513	X	53243331	452339	446698	rs1556861311	NC_000023.11:53243330:C:T	C	T	CLINICAL
NM_001111125.3(IQSEC2):c.2273G>A (p.Arg758Gln)	IQSEC2	R758Q, R553Q	Normal	Mental retardation, X-linked 1	Pathogenic(Last reviewed: Jun 1, 2010)	no assertion criteria provided	VCV000010864	X	53279485	X	53250303	10864	25903	rs267607189	NC_000023.11:53250302:C:T	C	T	CLINICAL
NM_001281463.1(SMC1A):c.1421G>A (p.Arg474His)	SMC1A	R496H, R474H	Normal	not provided|Congenital muscular hypertrophy-cerebral syndrome	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011675	X	53436051	X	53409120	11675	26714	rs122454123	NC_000023.11:53409119:C:T	C	T	CLINICAL
NM_004493.3(HSD17B10):c.592C>A (p.Pro198Thr)	HSD17B10	P198T	Normal	HSD10 disease	Likely pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, single submitter	VCV000254239	X	53458749	X	53431801	254239	248741	rs886037927	NC_000023.11:53431800:G:T	G	T	CLINICAL
NM_001037811.2(HSD17B10):c.568+6C>A	HSD17B10		Normal	HSD10 disease	Pathogenic(Last reviewed: Feb 1, 2007)	no assertion criteria provided	VCV000011445	X	53458767	X	53431819	11445	26484	rs122462164	NC_000023.11:53431818:G:T	G	T	CLINICAL
NM_031407.7(HUWE1):c.12188G>A (p.Arg4063Gln)	HUWE1	R4063Q	Normal	Syndromic X-linked intellectual disability Turner type	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000627417	X	53563578	X	53536617	627417	615772	rs1569399945	NC_000023.11:53536616:C:T	C	T	CLINICAL
NM_031407.7(HUWE1):c.8942G>A (p.Arg2981His)	HUWE1	R2981H	Normal	Syndromic X-linked intellectual disability Turner type|not provided	Likely pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	VCV000010677	X	53578381	X	53551420	10677	25716	rs121918526	NC_000023.11:53551419:C:T	C	T	CLINICAL
NM_031407.7(HUWE1):c.3239G>A (p.Arg1080His)	HUWE1	R1080H	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Aug 24, 2015)	no assertion criteria provided	VCV000374333	X	53622288	X	53595328	374333	361247	rs1057518704	NC_000023.11:53595327:C:T	C	T	CLINICAL
NM_031407.7(HUWE1):c.1978G>A (p.Gly660Arg)	HUWE1	G660R	Normal	Syndromic X-linked intellectual disability Turner type	Likely pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, single submitter	VCV000375712	X	53642776	X	53615815	375712	362612	rs1557006903	NC_000023.11:53615814:C:T	C	T	CLINICAL
NM_031407.7(HUWE1):c.329G>A (p.Arg110Gln)	HUWE1	R110Q	Normal	Syndromic X-linked intellectual disability Turner type|not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000375709	X	53674333	X	53647390	375709	362615	rs1557036768	NC_000023.11:53647389:C:T	C	T	CLINICAL
NM_152424.4(AMER1):c.429T>A (p.Cys143Ter)	AMER1	C143*	Normal	Osteopathia striata with cranial sclerosis	Pathogenic(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000029979	X	63412738	X	64192858	29979	38934	rs387906722	NC_000023.11:64192857:A:T	A	T	CLINICAL
NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	ZC4H2	R198Q, R175Q, G144R	Normal	Wieacker-Wolff, X-linked recessive|not provided	Pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000050981	X	64137745	X	64917865	50981	65652	rs879255235	NC_000023.11:64917864:C:T	C	T	CLINICAL
NM_018684.4(ZC4H2):c.225+5G>A	ZC4H2		Normal	Wieacker-Wolff, X-linked recessive|not provided	Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000378044	X	64141692	X	64921812	378044	380136	rs1057520298	NC_000023.11:64921811:C:T	C	T	CLINICAL
NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)	ZC4H2	L66H, L43H	Normal	Wieacker-Wolff, X-linked recessive	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378042	X	64141725	X	64921845	378042	380135	rs1057520297	NC_000023.11:64921844:A:T	A	T	CLINICAL
NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)	ZC4H2	R18K	Normal	Wieacker-Wolff, X-linked recessive	Pathogenic(Last reviewed: Mar 2, 2017)	no assertion criteria provided	VCV000378045	X	64196205	X	64976325	378045	380137	rs1057520299	NC_000023.11:64976324:C:T	C	T	CLINICAL
NM_031206.4(LAS1L):c.1237G>A (p.Gly413Arg)	LAS1L	G396R, G413R, G354R	Normal	Wilson-Turner X-linked mental retardation syndrome	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666263	X	64743999	X	65524119	666263	653814	rs1602612611	NC_000023.11:65524118:C:T	C	T	CLINICAL
NM_002547.3(OPHN1):c.2035G>A (p.Asp679Asn)	OPHN1	D679N	Normal	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Likely pathogenic(Last reviewed: Nov 4, 2014)	criteria provided, single submitter	VCV000224098	X	67283819	X	68063977	224098	225828	rs869312676	NC_000023.11:68063976:C:T	C	T	CLINICAL
NM_002547.3(OPHN1):c.1361G>A (p.Arg454Lys)	OPHN1	R454K	Normal	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Likely pathogenic(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000636256	X	67339090	X	68119248	636256	624064	rs1602169116	NC_000023.11:68119247:C:T	C	T	CLINICAL
NM_002547.3(OPHN1):c.1138+1G>A	OPHN1		Normal	Mental retardation X-linked with cerebellar hypoplasia and distinctive facial appearance	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804020	X	67414306	X	68194464	804020	792490	rs1602226670	NC_000023.11:68194463:C:T	C	T	CLINICAL
NM_012310.5(KIF4A):c.794G>T (p.Arg265Leu)	KIF4A	R265L	Normal	Congenital cerebellar hypoplasia|Corpus callosum, agenesis of|Ventriculomegaly|Multicystic kidney dysplasia|Mental retardation, X-linked 100|Hydrocephalus	Likely pathogenic(Last reviewed: Feb 18, 2019)	no assertion criteria provided	VCV000632604	X	69549270	X	70329420	632604	621038	rs1569234334	NC_000023.11:70329419:G:T	G	T	CLINICAL
NM_005120.3(MED12):c.1546C>T (p.Arg516Cys)	MED12	R516C	Normal	FG syndrome 1	Likely pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000619013	X	70343005	X	71123155	619013	610411	rs1569481124	NC_000023.11:71123154:C:T	C	T	CLINICAL
NM_005120.3(MED12):c.2881C>T (p.Arg961Trp)	MED12	R961W	Normal	FG syndrome 1|not provided|X-linked mental retardation with marfanoid habitus syndrome|Ohdo syndrome, X-linked|FG syndrome 1|Ohdo syndrome, X-linked|Abnormal facial shape|Broad thumb|Imperforate anus|Corpus callosum, agenesis of|Intellectual disability|Global developmental delay|Intellectual disability|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011520	X	70347217	X	71127367	11520	26559	rs80338758	NC_000023.11:71127366:C:T	C	T	CLINICAL
NM_005120.3(MED12):c.3505G>T (p.Ala1169Ser)	MED12	A1169S	Normal	FG syndrome 1	Likely pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000666337	X	70348993	X	71129143	666337	653908	rs1602299778	NC_000023.11:71129142:G:T	G	T	CLINICAL
NM_181303.2(NLGN3):c.1411C>T (p.Arg471Cys)	NLGN3	R451C, R431C, R471C, R334C	Normal	Autism, susceptibility to, X-linked 1|Asperger syndrome X-linked 1	risk factor(Last reviewed: Jul 15, 2004)	no assertion criteria provided	VCV000011327	X	70387358	X	71167508	11327	26366	rs121917893	NC_000023.11:71167507:C:T	C	T	CLINICAL
NM_181303.2(NLGN3):c.1600C>T (p.Pro534Ser)	NLGN3	P514S, P397S, P494S, P534S	Normal	Intellectual disability|Autistic behavior	Pathogenic(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000631481	X	70387547	X	71167697	631481	619844	rs1569485503	NC_000023.11:71167696:C:T	C	T	CLINICAL
NM_181303.2(NLGN3):c.1849C>T (p.Arg617Trp)	NLGN3	R597W, R617W, R480W, R577W	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Jul 25, 2014)	criteria provided, single submitter	VCV000235850	X	70389249	X	71169399	235850	237512	rs878853147	NC_000023.11:71169398:C:T	C	T	CLINICAL
NM_007363.5(NONO):c.550C>T (p.Arg184Ter)	NONO	R184*, R95*	Normal	Inborn genetic diseases|Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000691621	X	70514278	X	71294428	691621	679342	rs1602387702	NC_000023.11:71294427:C:T	C	T	CLINICAL
NM_007363.5(NONO):c.1093C>T (p.Arg365Ter)	NONO	R365*, R276*	Normal	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000222083	X	70517750	X	71297900	222083	223782	rs869025345	NC_000023.11:71297899:C:T	C	T	CLINICAL
NM_007363.5(NONO):c.1171G>T (p.Gly391Cys)	NONO	G391C, G302C	Normal	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000427778	X	70518358	X	71298508	427778	417867	rs1114167441	NC_000023.11:71298507:G:T	G	T	CLINICAL
NM_007363.5(NONO):c.1171+1G>T	NONO		Normal	Mental retardation, X-linked, syndromic 34	Pathogenic(Last reviewed: Sep 16, 2019)	no assertion criteria provided	VCV000235099	X	70518359	X	71298509	235099	236862	rs876661316	NC_000023.11:71298508:G:T	G	T	CLINICAL
NM_004606.5(TAF1):c.1726C>T (p.Pro576Ser)	TAF1	P555S, P576S	Normal	not provided|Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	VCV000219117	X	70602671	X	71382821	219117	216919	rs864321630	NC_000023.11:71382820:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.2608C>T (p.Arg870Cys)	TAF1	R890C, R849C, R870C	Normal	Mental retardation, X-linked, syndromic 33|TAF1-related syndromic intellectual disability	Likely pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000694246	X	70608626	X	71388776	694246	682095	rs1602506017	NC_000023.11:71388775:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.2894C>T (p.Ser965Phe)	TAF1	S985F, S944F, S965F	Normal	Mental retardation, X-linked, syndromic 33|not provided	Likely pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000372844	X	70612531	X	71392681	372844	360676	rs1057518019	NC_000023.11:71392680:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.2975C>T (p.Thr992Ile)	TAF1	T1012I, T992I, T971I	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000694247	X	70612768	X	71392918	694247	682096	rs1602520317	NC_000023.11:71392917:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.3508C>T (p.Arg1170Cys)	TAF1	R1190C, R1149C, R1170C	Normal	Mental retardation, X-linked, syndromic 33	Pathogenic	criteria provided, single submitter	VCV000599303	X	70617204	X	71397354	599303	590565	rs1569301036	NC_000023.11:71397353:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.3676C>T (p.Arg1226Trp)	TAF1	R1205W, R1226W	Normal	not provided|Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV000219116	X	70618477	X	71398627	219116	216918	rs864321629	NC_000023.11:71398626:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.3700C>T (p.Arg1234Trp)	TAF1	R1254W, R1234W, R1213W	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000694248	X	70618501	X	71398651	694248	682097	rs1602538353	NC_000023.11:71398650:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.4226C>T (p.Pro1409Leu)	TAF1	P1388L, P1409L	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Jan 2, 2017)	criteria provided, single submitter	VCV000545434	X	70627843	X	71407993	545434	535715	rs1555980523	NC_000023.11:71407992:C:T	C	T	CLINICAL
NM_004606.5(TAF1):c.4382A>T (p.Asn1461Ile)	TAF1	N1481I, N1461I, N1440I	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000694251	X	70627999	X	71408149	694251	682101	rs1602572645	NC_000023.11:71408148:A:T	A	T	CLINICAL
NM_004606.5(TAF1):c.4520C>T (p.Ala1507Val)	TAF1	A1527V, A1507V, A1486V	Normal	Mental retardation, X-linked, syndromic 33	Likely pathogenic(Last reviewed: Sep 23, 2019)	no assertion criteria provided	VCV000694253	X	70643034	X	71423184	694253	682102	rs1602624950	NC_000023.11:71423183:C:T	C	T	CLINICAL
NM_181672.3(OGT):c.762G>T (p.Leu254Phe)	OGT	L254F, L244F	Normal	Intellectual disability, X-linked 106	Pathogenic(Last reviewed: Aug 19, 2021)	no assertion criteria provided	VCV000428570	X	70775073	X	71555223	428570	420004	rs1131692155	NC_000023.11:71555222:G:T	G	T	CLINICAL
NM_181672.3(OGT):c.1942A>T (p.Asn648Tyr)	OGT	N638Y, N648Y	Normal	Intellectual disability, X-linked 106	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000691611	X	70781715	X	71561865	691611	679332	rs1602152230	NC_000023.11:71561864:A:T	A	T	CLINICAL
NM_181672.3(OGT):c.2795C>T (p.Thr932Ile)	OGT	T932I, T922I	Normal	Intellectual disability, X-linked 106	Likely pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, single submitter	VCV000689775	X	70787555	X	71567705	689775	677474	rs1602155923	NC_000023.11:71567704:C:T	C	T	CLINICAL
NM_018486.3(HDAC8):c.653G>A (p.Gly218Asp)	HDAC8	G101D, G127D, G218D	Normal	Intellectual disability	Likely pathogenic(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000691276	X	71708867	X	72489017	691276	678952	rs1603060007	NC_000023.11:72489016:C:T	C	T	CLINICAL
NM_018486.3(HDAC8):c.562G>A (p.Ala188Thr)	HDAC8	A188T, A97T	Normal	not provided|Intellectual disability	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000691251	X	71710845	X	72490995	691251	678953	rs1603069440	NC_000023.11:72490994:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.277C>T (p.Gln93Ter)	SLC16A2	Q93*	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159906	X	73641749	X	74421914	159906	170180	rs587784386	NC_000023.11:74421913:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.359C>T (p.Ser120Phe)	SLC16A2	S120F	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Mar 9, 2010)	no assertion criteria provided	VCV000021463	X	73641831	X	74421996	21463	34315	rs113994162	NC_000023.11:74421995:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.449C>T (p.Ala150Val)	SLC16A2	A150V	Normal	Allan-Herndon-Dudley syndrome|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000011634	X	73740843	X	74521008	11634	26673	rs104894936	NC_000023.11:74521007:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.916C>T (p.Gln306Ter)	SLC16A2	Q306*	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159900	X	73744534	X	74524699	159900	170182	rs587784382	NC_000023.11:74524698:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.940C>T (p.Arg314Ter)	SLC16A2	R314*	Normal	not provided|Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212186	X	73744558	X	74524723	212186	209179	rs766773277	NC_000023.11:74524722:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.1026+1G>T	SLC16A2		Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: Nov 7, 2016)	criteria provided, single submitter	VCV000436736	X	73744645	X	74524810	436736	430916	rs1555989729	NC_000023.11:74524809:G:T	G	T	CLINICAL
NM_006517.5(SLC16A2):c.1111C>T (p.Arg371Cys)	SLC16A2	R371C	Normal	Spastic paraplegia|not provided|Inborn genetic diseases|Allan-Herndon-Dudley syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159902	X	73745669	X	74525834	159902	170184	rs587784384	NC_000023.11:74525833:C:T	C	T	CLINICAL
NM_006517.5(SLC16A2):c.1262G>T (p.Gly421Val)	SLC16A2	G421V	Normal	Allan-Herndon-Dudley syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804030	X	73749139	X	74529304	804030	792500	rs1602143383	NC_000023.11:74529303:G:T	G	T	CLINICAL
NM_006517.5(SLC16A2):c.1390C>T (p.Pro464Ser)	SLC16A2	P464S	Normal	Allan-Herndon-Dudley syndrome	Likely pathogenic(Last reviewed: Aug 7, 2014)	criteria provided, single submitter	VCV000559939	X	73749267	X	74529432	559939	550658	rs1363308293	NC_000023.11:74529431:C:T	C	T	CLINICAL
NM_016120.4(RLIM):c.1792G>A (p.Asp598Asn)	RLIM	D598N	Normal	Mental retardation, X-linked 61	Pathogenic(Last reviewed: Oct 31, 2019)	no assertion criteria provided	VCV000585243	X	73811358	X	74591523	585243	576292	rs1569309460	NC_000023.11:74591522:C:T	C	T	CLINICAL
NM_001008537.3(NEXMIF):c.3470C>A (p.Ser1157Ter)	NEXMIF	S1157*	Normal	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000397512	X	73960922	X	74741087	397512	384417	rs1060499652	NC_000023.11:74741086:G:T	G	T	CLINICAL
NM_001008537.3(NEXMIF):c.438C>A (p.Cys146Ter)	NEXMIF	C146*	Normal	Mental retardation, X-linked 98	Pathogenic(Last reviewed: Aug 20, 2021)	no assertion criteria provided	VCV000438477	X	73963954	X	74744119	438477	432099	rs1556016802	NC_000023.11:74744118:G:T	G	T	CLINICAL
NM_000489.5(ATRX):c.6392G>A (p.Arg2131Gln)	ATRX	R2093Q, R2131Q	Normal	Mental retardation-hypotonic facies syndrome, X-linked|Alpha thalassemia-X-linked intellectual disability syndrome|X-linked intellectual disability-hypotonic face syndrome	Pathogenic(Last reviewed: Jul 29, 2014)	criteria provided, single submitter	VCV000011731	X	76814252	X	77558781	11731	26770	rs122445101	NC_000023.11:77558780:C:T	C	T	CLINICAL
NM_000489.5(ATRX):c.6254G>A (p.Arg2085His)	ATRX	R2085H, R2047H	Normal	Alpha thalassemia-X-linked intellectual disability syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372728	X	76829787	X	77574322	372728	360681	rs1057517948	NC_000023.11:77574321:C:T	C	T	CLINICAL
NM_000489.5(ATRX):c.6122G>A (p.Ser2041Asn)	ATRX	S2041N, S2003N	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	VCV000397524	X	76845399	X	77589929	397524	384429	rs1060499658	NC_000023.11:77589928:C:T	C	T	CLINICAL
NM_000489.5(ATRX):c.5225G>A (p.Arg1742Lys)	ATRX	R1742K, R1704K	Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000011736	X	76875910	X	77620442	11736	26775	rs122445104	NC_000023.11:77620441:C:T	C	T	CLINICAL
NM_000489.5(ATRX):c.4317G>A (p.Lys1439=)	ATRX		Normal	Alpha thalassemia-X-linked intellectual disability syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000560933	X	76909588	X	77654098	560933	552266	rs1569535642	NC_000023.11:77654097:C:T	C	T	CLINICAL
NM_000489.5(ATRX):c.659G>A (p.Cys220Tyr)	ATRX	C220Y, C182Y	Normal	Inborn genetic diseases|Mental retardation-hypotonic facies syndrome, X-linked	Pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000011745	X	76940434	X	77684942	11745	26784	rs122445111	NC_000023.11:77684941:C:T	C	T	CLINICAL
NM_000489.5(ATRX):c.533T>A (p.Val178Asp)	ATRX	V178D, V140D	Normal	Global developmental delay|Microcephaly	Likely pathogenic	criteria provided, single submitter	VCV000402181	X	76944372	X	77688879	402181	389194	rs1060499759	NC_000023.11:77688878:A:T	A	T	CLINICAL
NM_153252.5(BRWD3):c.256G>A (p.Glu86Lys)	BRWD3	E86K	Normal	Mental retardation, X-linked 93	Likely pathogenic	no assertion criteria provided	VCV000626272	X	80049196	X	80793697	626272	614613	rs1569290395	NC_000023.11:80793696:C:T	C	T	CLINICAL
NM_001330574.2(ZNF711):c.1711A>T (p.Arg571Ter)	ZNF711	R525*, R571*	Normal	ZNF711-Related X-linked Mental Retardation	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000009763	X	84526121	X	85271115	9763	24802	rs199422240	NC_000023.11:85271114:A:T	A	T	CLINICAL
NM_002294.3(LAMP2):c.293G>A (p.Trp98Ter)	LAMP2	W98*	Normal	Danon disease|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044423	X	119589316	X	120455461	44423	53590	rs397516740	NC_000023.11:120455460:C:T	C	T	CLINICAL
NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg)	RAB39B	G192R	Normal	Early-onset parkinsonism-intellectual disability syndrome|Parkinson disease, X-linked dominant	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218362	X	154490156	X	155260871	218362	215090	rs864309527	NC_000023.11:155260870:C:T	C	T	CLINICAL
NM_001110792.2(MECP2):c.605G>A (p.Arg202His)	MECP2	R190H, R202H, R97H	Normal	Rett syndrome	Likely pathogenic	criteria provided, single submitter	VCV000548706	X	153296710	X	154031259	548706	539190	rs1557136818	NC_000023.11:154031258:C:T	C	T	CLINICAL
	SLC45A2/MATP		C:black hair	red hair				5	33958959	5	33958854			rs28777		C	A	PIGME
	SLC45A2/MATP		C:black hair	light pigmentation, melanoma risk				5	33951693	5	33951588			rs16891982		C	R	PIGME
	LOC105374875		C:black hair	blonde hair				6	457748	6	457748			rs4959270		C	D	PIGME
	IRF4		C:normal	freckles, sunburn sensitivity, brown hair				6	396321	6	396321			rs12203592		C	K	PIGME
	TYRP1		C:normal	light eye pigmentation				9	12709305	9	12709305			rs683		C	A	PIGME
	TYRP1		A:normal	light eye pigmentation				9	12710035	9	12710035			rs910		A	B	PIGME
	TYRP1		T:normal	blue eye, blonde hair, skin cancer risk				9	12672097	9	12672097			rs1408799		T	C	PIGME
	TYRP1		G:normal	blue eyes, light hair				9	12703484	9	12703484			rs2733831		G	A	PIGME
	BNC2		G:normal	freckles, teens scoliosis				9	16858084	9	16858086			rs10756819		G	H	PIGME
	TYR		C:normal	absence of freckles				11	88911696	11	89178528			rs1042602		C	A	PIGME
	TYR		G:normal	blue eyes, blonde hair, sunburn sensitivity				11	89011046	11	89277878			rs1393350		G	A	PIGME
	TYR		G:normal	skin cancer risk				11	89017961	11	89284793			rs1126809		G	A	PIGME
	GRM5		A:normal	light pigmentation				11	88557991	11	88824823			rs10831496		A	B	PIGME
	KITLG		T:normal	blonde hair				12	89328335	12	88934558			rs12821256		T	V	PIGME
	KITLG		C:light skin colour	dark skin colour				12	89299746	12	88905969			rs642742		C	W	PIGME
	SLC24A4		G:green eyes	blue eyes				14	92801203	14	92334859			rs2402130		G	H	PIGME
	SLC24A4		T:green eyes	blue eyes				14	92781001	14	92314657			rs4904868		T	C	PIGME
	SLC24A4		A:normal	light pigmentation				14	92882826	14	92416482			rs17128291		A	G	PIGME
	LOC105370627		G:normal	light pigmentation				14	92773663	14	92307319			rs12896399		G	W	PIGME
	SLC24A5		A:light skin colour	dark skin colour				15	48426484	15	48134287			rs1426654		A	K	PIGME
	SLC24A5		A:dark skin colour	light skin colour				15	48433494	15	48141297			rs2470102		A	S	PIGME
	OCA2		C:blue/gray eyes	green/brown eyes				15	28230318	15	27985172			rs1800407		C	T	PIGME
	OCA2		T:dark skin colour	light skin colour				15	28197037	15	27951891			rs1800414		T	M	PIGME
	OCA2		G:light eye colour	dark eye colour				15	28288121	15	28042975			rs1470608		G	H	PIGME
	OCA2		A:dark pigmentation	light pigmentation				15	28187772	15	27942626			rs1545397		A	T	PIGME
	OCA2		G:dark pigmentation	light pigmentation				15	28271775	15	28026629			rs12441727		G	M	PIGME
	HERC2		A:brown eyes	blue eyes				15	28365618	15	28120472			rs12913832		A	S	PIGME
	HERC2		G:normal	blue eyes				15	28453215	15	28208069			rs2238289		G	A	PIGME
	HERC2		A:normal	blue eyes				15	28496195	15	28251049			rs6497292		A	G	PIGME
	HERC2		C:normal	blue eyes				15	28356859	15	28111713			rs1129038		C	T	PIGME
	HERC2		C:dark pigmentation	blue eyes, blonde hair				15	28530182	15	28285036			rs1667394		C	W	PIGME
	OCA2-HERC2		G:normal	blue eyes				15	28359258	15	28114112			rs12593929		G	M	PIGME
	OCA2-HERC2		T:normal	blue eyes				15	28494202	15	28249056			rs2240203		T	V	PIGME
	OCA2-HERC2		T:normal	blue eyes				15	28374012	15	28128866			rs3935591		T	M	PIGME
	OCA2-HERC2		A:normal	blue eyes				15	28338713	15	28093567			rs4778241		A	C	PIGME
	OCA2-HERC2		T:normal	blue eyes				15	28427986	15	28182840			rs7170852		T	V	PIGME
	OCA2-HERC2		C:normal	blue eyes				15	28365733	15	28120587			rs7183877		C	A	PIGME
	OCA2-HERC2		T:normal	blue eyes				15	28488888	15	28243742			rs8028689		T	C	PIGME
	OCA2-HERC2		T:normal	blue eyes				15	28513364	15	28268218			rs916977		T	S	PIGME
	OCA2-HERC2		T:normal	blue eyes				15	28468723	15	28223577			rs3940272		T	G	PIGME
	OCA2-HERC2		A:normal	blue eyes				15	28502279	15	28257133			rs11631797		A	K	PIGME
	MC1R		AC:normal	light pigmentation, melanoma risk				16	89985751	16	89919342			rs796296176		C	A	PIGME
	MC1R		G:normal	red hair				16	89986091	16	89919683			rs11547464		G	A	PIGME
	MC1R		G:dark skin colour	light skin colour				16	89986154	16	89919746			rs885479		G	M	PIGME
	MC1R		C:normal	red hair, melanoma risk				16	89986144	16	89919736			rs1805008		C	T	PIGME
	MC1R		G:normal	light blonde hair				16	89985844	16	89919436			rs1805005		G	T	PIGME
	MC1R		C:normal	red hair, melanoma risk				16	89985918	16	89919510			rs1805006		C	R	PIGME
	MC1R		C:normal	red hair, melanoma risk				16	89986117	16	89919709			rs1805007		C	D	PIGME
	MC1R		T:normal	melanoma risk				16	89986130	16	89919722			rs1110400		T	C	PIGME
	MC1R		G:normal	red hair, melanoma risk				16	89986546	16	89920138			rs1805009		G	M	PIGME
	MC1R		G:dark pigmentation	red/blonde hair, poor tanning				16	89985940	16	89919532			rs2228479		G	M	PIGME
	MC1R		C:dark pigmentation	light pigmentation				16	89984378	16	89917970			rs3212355		C	T	PIGME
	MC1R		C:normal	melanoma risk				16	89986122	16	89919714			rs201326893		C	A	PIGME
	ANKRD11		T:low tan response	high tan response				16	89383725	16	89317317			rs3114908		T	V	PIGME
	PIGU		G:red/dark blonde hair	normal				20	33218090	20	34630286			rs2378249		G	M	PIGME
	ASIP		C:normal	light pigmentation				20	32785212	20	34197406			rs6119471		C	R	PIGME
	ASIP		G:normal	red hair, sunburn sensitivity, freckles, melanoma risk				20	33355046	20	34767243			rs4911442		G	M	PIGME
	RALY		G:normal	light pigmentation, freckles, low tan response				20	32665748	20	34077942			rs6059655		G	A	PIGME
	WNT10A		C:straight_hair	curly hair				2	219756383	2	218891661			rs7349332		C	T	PIGME
	TCHH		A:straighter_hair	curlier_hair				1	152083325	1	152110849			rs11803731		A	B	PIGME
	TCHH		A:straighter_hair	curlier_hair				1	152062767	1	152090291			rs17646946		A	G	PIGME
